data_1ntr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ntr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.425 ' C ' ' CD1' ' A' ' 5' ' ' ILE . . . -162.78 176.94 39.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 7' ' ' TRP . 3.6 mp -135.95 99.27 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.055 . . . . 0.0 109.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' CG1' ' CG2' ' A' ' 8' ' ' VAL . 2.7 t -101.19 111.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 109.821 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.593 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 9.5 m0 -100.18 92.78 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.574 ' CG2' ' HB2' ' A' ' 52' ' ' LEU . 48.3 t -95.98 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.484 -0.76 . . . . 0.0 110.735 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 36' ' ' GLY . 3.7 p -119.16 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.525 ' HB2' ' CG2' ' A' ' 15' ' ' ILE . 1.4 p30 -102.14 -120.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.913 -1.117 . . . . 0.0 110.181 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.409 ' CG ' ' HD3' ' A' ' 58' ' ' PRO . 31.8 t0 -135.43 -61.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.633 -1.292 . . . . 0.0 110.019 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 175.26 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -59.76 160.26 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.78 . . . . 0.0 109.634 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 13' ' ' SER . 2.1 m 79.93 -7.56 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.442 -0.786 . . . . 0.0 109.75 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.525 ' CG2' ' HB2' ' A' ' 10' ' ' ASP . 26.6 mm -96.89 -45.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.491 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -63.59 -30.96 72.0 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.468 ' O ' ' C ' ' A' ' 18' ' ' VAL . 5.7 t90 -67.28 -60.28 2.72 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 17' ' ' TRP . 24.8 t -36.6 -57.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.165 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' ARG . 8.8 mt -55.73 -72.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 1.8 tt0 -35.14 -30.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.868 -0.52 . . . . 0.0 110.674 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -66.37 -55.16 17.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 108.437 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 -12.96 61.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' CD2' ' HB2' ' A' ' 30' ' ' CYS . 0.9 OUTLIER -92.9 -11.11 34.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.765 . . . . 0.0 109.754 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.69 -46.09 40.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.83 -41.97 52.32 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.49 79.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -1.003 . . . . 0.0 108.572 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.05 50.22 3.32 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD23 ' CG1' ' A' ' 112' ' ' VAL . 0.5 OUTLIER -120.23 173.71 6.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 0.0 109.971 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.517 ' CG2' HG22 ' A' ' 5' ' ' ILE . 51.6 m -100.26 65.75 1.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 32.0 t -82.23 80.08 8.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.217 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.593 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 1.3 m -75.1 129.32 37.36 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.491 ' HB ' ' CB ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -126.96 136.76 52.71 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.059 -1.026 . . . . 0.0 109.686 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.542 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 2.1 m-85 -110.72 -176.15 2.9 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 19.4 mt-10 -95.43 -47.57 6.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.935 . . . . 0.0 110.429 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.468 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.2 t-20 -116.15 144.7 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.064 -1.022 . . . . 0.0 109.949 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 9' ' ' VAL . . . -54.14 -33.13 51.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 38' ' ' GLU . 11.4 t-20 -61.76 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.033 -1.275 . . . . 0.0 108.624 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 37' ' ' ASN . 2.5 mm-40 -34.64 -35.28 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.348 0.594 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 75.0 t -55.33 -59.09 2.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.396 -0.815 . . . . 0.0 109.453 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 72' ' ' ARG . 0.9 OUTLIER -67.66 -14.82 63.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.568 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 38' ' ' GLU . . . -68.25 -30.91 70.06 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.8 -31.9 19.35 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.556 ' CD1' HD12 ' A' ' 51' ' ' LEU . 89.9 mt -92.34 1.54 57.17 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.478 -0.764 . . . . 0.0 110.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.508 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -29.47 -38.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' LEU . 2.5 m -70.15 -55.73 8.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 108.746 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HA ' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER 169.86 135.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.415 -0.803 . . . . 0.0 109.969 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.559 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -50.19 157.2 1.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 109.666 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.56 ' CG ' ' CG2' ' A' ' 5' ' ' ILE . 36.7 Cg_endo -88.13 -70.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.918 1.483 . . . . 0.0 110.058 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -109.32 -65.22 1.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 0.0 109.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.57 ' CG2' ' HG2' ' A' ' 77' ' ' PRO . 2.6 t -149.57 144.16 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.055 -1.028 . . . . 0.0 110.123 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 43' ' ' LEU . 3.5 tp -100.54 155.16 18.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.894 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -145.43 169.45 18.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.677 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.4 p -154.56 139.7 17.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.69 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.419 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 25.4 m-20 -86.78 -172.25 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.294 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.527 ' HB ' ' CB ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -120.67 5.54 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.12 -0.988 . . . . 0.0 109.689 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.3 OUTLIER -86.62 174.13 9.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.638 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER 170.87 177.16 0.11 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.795 . . . . 0.0 109.176 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' SD ' ' A' ' 57' ' ' MET . 36.8 Cg_endo -98.32 120.33 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.953 1.502 . . . . 0.0 110.508 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.55 -144.89 23.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 12.2 mtt -88.56 -156.92 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 60' ' ' MET . 37.3 m-20 64.75 179.96 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.78 68.73 0.22 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HG ' ' HG3' ' A' ' 57' ' ' MET . 1.1 mp 61.64 92.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.41 14.24 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.208 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.478 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -100.9 14.26 32.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -0.846 . . . . 0.0 109.357 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.467 ' HA ' HD11 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -65.44 -65.0 0.73 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.4 ttpp -47.0 -26.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.573 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.03 -60.54 2.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.605 HG21 ' CE1' ' A' ' 73' ' ' HIS . 1.0 OUTLIER -33.54 -57.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.283 0.563 . . . . 0.0 110.415 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HE2' ' CG2' ' A' ' 69' ' ' ILE . 7.0 mmtt -59.84 -61.05 2.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.258 -0.901 . . . . 0.0 109.847 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 70' ' ' LYS . 21.9 mm-40 -32.98 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.894 -0.504 . . . . 0.0 111.385 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 40' ' ' LEU . 4.9 mpt_? -83.39 -91.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 110.801 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.606 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 3.0 p80 -68.49 151.95 96.92 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.388 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 33.8 Cg_endo -49.63 -178.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.638 1.336 . . . . 0.0 110.689 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.5 ptp -85.16 56.05 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.6 OUTLIER -70.42 158.68 87.12 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.4 Cg_endo -44.61 136.98 8.88 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.501 1.263 . . . . 0.0 112.642 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.641 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -145.24 177.99 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 78' ' ' VAL . 26.1 mt -158.67 119.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.216 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.5 mt -108.6 128.53 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 108.818 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.499 ' HB3' HG22 ' A' ' 55' ' ' ILE . 1.4 mtm -56.46 174.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -53.85 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 110.215 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 80.78 162.54 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -119.75 -21.55 7.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.421 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.7 m -123.57 18.22 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.74 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -96.73 -18.39 19.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.228 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 86' ' ' ASP . 1.2 tt -35.15 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.897 -0.502 . . . . 0.0 110.935 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASP . 11.0 t70 -70.27 -57.79 4.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.862 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.68 -16.07 63.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -83.12 -42.36 17.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 90' ' ' ALA . 46.4 t -35.85 -29.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.459 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ALA . 30.3 t -80.64 31.69 0.3 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.5 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.37 -53.6 2.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.912 -1.118 . . . . 0.0 108.624 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 10.7 m-30 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -0.894 . . . . 0.0 108.747 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 2.3 tp-100 -86.81 91.77 8.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.782 . . . . 0.0 109.424 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 45.69 64.99 1.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.29 -179.29 15.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.35 38.08 1.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.952 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.641 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 6.6 p90 -162.2 133.4 5.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.04 -1.038 . . . . 0.0 109.874 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 100' ' ' ASP . 58.7 p30 -97.98 -159.29 0.73 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.41 -0.806 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 101' ' ' TYR . 5.7 m-85 -100.66 139.02 36.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.23 120.02 52.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.026 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -95.29 -165.18 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.909 1.478 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -121.86 157.69 56.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.602 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -97.28 169.92 12.43 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.712 -2.62 . . . . 0.0 110.441 0.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 20.8 p90 -149.21 138.1 21.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 16.3 t70 -79.41 171.47 15.13 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.92 . . . . 0.0 109.018 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -70.82 -56.14 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.014 -1.054 . . . . 0.0 109.014 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.452 ' N ' HG23 ' A' ' 108' ' ' ILE . 23.5 t0 -68.7 -39.72 80.37 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.527 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 4.7 tp10 -48.42 -46.79 37.89 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -72.28 -74.06 0.17 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 23' ' ' LEU . 32.3 t -36.73 -73.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.367 0.603 . . . . 0.0 109.749 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -38.11 -64.41 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.79 -0.569 . . . . 0.0 110.292 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 113' ' ' ALA . 8.2 tp -34.83 -55.28 0.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.785 0.802 . . . . 0.0 109.741 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.552 HG12 ' CB ' ' A' ' 50' ' ' VAL . 1.5 t -57.01 -57.37 10.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -32.99 -40.3 0.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.324 0.583 . . . . 0.0 110.403 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' VAL . 18.1 mtm180 -75.42 -52.59 10.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.327 -0.858 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.2 -60.83 2.21 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.117 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.552 HG12 ' CG2' ' A' ' 50' ' ' VAL . 3.4 mt -36.06 -41.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.395 0.617 . . . . 0.0 109.978 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 61.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -135.42 -65.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 122' ' ' TYR . 2.9 p90 -99.07 95.4 7.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -117.1 0.79 12.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.284 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.961 0.886 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.541 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . 147.65 171.75 17.03 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 10.6 mt -147.89 97.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.954 . . . . 0.0 108.84 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 2.6 p -100.2 118.64 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.658 0.742 . . . . 0.0 110.651 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.623 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 37.4 m0 -103.27 104.25 14.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.938 . . . . 0.0 108.825 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 32' ' ' THR . 59.1 t -97.57 147.74 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.535 ' CG2' HG22 ' A' ' 39' ' ' VAL . 9.8 p -123.9 129.45 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.532 ' CB ' HG23 ' A' ' 15' ' ' ILE . 13.9 t0 -135.51 -77.15 0.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.817 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 34' ' ' GLU . 64.8 t0 -148.33 -70.73 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.697 -1.252 . . . . 0.0 111.624 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.71 178.05 4.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.01 -1.056 . . . . 0.0 111.141 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -66.36 -24.73 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.641 -0.662 . . . . 0.0 109.832 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -62.54 -25.24 67.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.393 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.58 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -66.59 -31.16 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 11.4 ttp180 -61.65 -49.13 77.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 13.2 t90 -48.73 -65.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 48.2 t -39.44 -70.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.048 0.928 . . . . 0.0 110.364 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -44.88 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.2 tt0 -32.73 -40.75 0.05 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.864 -0.522 . . . . 0.0 110.773 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 4.5 mtp180 -58.06 -57.19 13.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.977 . . . . 0.0 109.043 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -6.34 23.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 0.0 109.579 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.562 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -98.38 -12.53 21.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.79 51.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 -33.48 87.35 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.47 -24.78 60.25 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.482 -1.01 . . . . 0.0 108.761 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.41 62.84 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.546 HD21 ' CG1' ' A' ' 112' ' ' VAL . 1.2 mp -142.25 -176.5 4.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.113 -1.228 . . . . 0.0 109.974 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.548 ' CG2' HG21 ' A' ' 5' ' ' ILE . 24.2 m -92.44 100.61 13.13 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 8.9 t -95.28 88.72 5.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.393 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.623 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 2.3 m -99.45 141.63 32.0 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.54 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -134.55 167.13 21.36 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.655 -1.278 . . . . 0.0 110.14 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.536 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 26.8 m-85 -140.15 171.74 13.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -105.15 -13.23 15.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.175 -0.953 . . . . 0.0 108.946 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.442 ' OD1' ' OD1' ' A' ' 61' ' ' ASP . 55.6 m-20 -138.16 137.33 37.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.554 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 9' ' ' VAL . . . -55.43 -49.72 63.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.485 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 5.0 t30 -50.54 -69.41 0.11 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.187 -1.184 . . . . 0.0 108.727 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -36.06 -42.14 0.28 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.707 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.535 HG22 ' CG2' ' A' ' 9' ' ' VAL . 39.4 t -53.05 -53.43 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.205 -0.934 . . . . 0.0 108.934 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.556 HD22 ' CD2' ' A' ' 73' ' ' HIS . 10.8 mt -62.02 -28.57 69.67 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.66 75.42 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB1' ' CZ ' ' A' ' 33' ' ' PHE . . . -68.93 -40.52 78.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -43.0 -65.35 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . 28.14 -73.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.916 0.865 . . . . 0.0 110.761 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.76 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -84.69 27.33 0.74 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 82.69 134.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.345 0.593 . . . . 0.0 110.193 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.595 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -64.59 -149.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.367 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HG3' ' CE2' ' A' ' 7' ' ' TRP . 38.0 Cg_endo -125.54 -83.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 117.298 -1.335 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.575 ' OD2' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -114.31 -50.78 2.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.298 -1.501 . . . . 0.0 111.814 -178.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.561 ' CG2' HD13 ' A' ' 119' ' ' ILE . 2.1 t -149.51 149.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.396 -1.44 . . . . 0.0 109.896 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -100.96 156.72 17.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 109.293 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.515 HD11 ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -137.29 124.92 22.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.06 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -113.76 133.09 55.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.053 -1.029 . . . . 0.0 110.385 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.525 ' CB ' ' OD1' ' A' ' 10' ' ' ASP . 17.5 p-10 -80.0 -158.9 0.19 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.876 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.555 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -173.89 86.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.507 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -168.38 -163.86 0.48 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.372 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.539 ' CE ' ' O ' ' A' ' 61' ' ' ASP . 2.1 mtm 72.59 131.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.626 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.38 106.6 1.55 Allowed 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.098 1.578 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.84 -130.87 8.24 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 1.3 mtt -110.14 -164.51 0.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.682 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.539 ' O ' ' CE ' ' A' ' 57' ' ' MET . 2.0 t70 80.39 -9.72 1.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.99 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.426 ' C ' HD22 ' A' ' 63' ' ' LEU . . . -133.8 -48.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -105.88 -175.0 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.073 -1.251 . . . . 0.0 109.691 -179.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.62 21.96 9.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.035 -1.04 . . . . 0.0 108.304 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.56 ' HB3' ' NE2' ' A' ' 68' ' ' GLN . 6.1 mt -125.27 -12.47 6.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.767 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -61.1 -65.21 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.8 tptp -44.06 -37.53 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.613 ' HG2' ' N ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -57.16 -52.35 65.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.029 -1.045 . . . . 0.0 108.678 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.613 ' N ' ' HG2' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -35.2 -56.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.647 -0.658 . . . . 0.0 110.679 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.04 -53.89 13.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 110.443 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' LYS . 13.3 mm-40 -32.42 -44.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.755 -0.591 . . . . 0.0 110.815 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.521 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -91.85 -44.84 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.575 ' CD2' HD11 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -47.89 159.4 0.47 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.294 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.419 ' C ' ' HG3' ' A' ' 75' ' ' MET . 36.9 Cg_endo -80.8 -66.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.078 1.567 . . . . 0.0 110.15 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.419 ' HG3' ' C ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -175.45 52.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.26 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 1.1 pp -114.97 157.44 43.3 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 0.0 109.05 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.4 Cg_endo -63.81 151.7 83.97 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.931 1.49 . . . . 0.0 111.203 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.56 ' CG1' ' CB ' ' A' ' 51' ' ' LEU . 2.9 m -142.87 97.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG23 HD13 ' A' ' 102' ' ' LEU . 8.4 mt -59.99 167.03 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 109.479 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -161.93 133.79 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.098 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.513 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -63.78 158.0 22.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.407 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -98.0 151.65 20.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.411 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -173.46 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -178.49 65.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.683 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 p -173.67 -36.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.588 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.1 m-20 -57.17 -31.07 65.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 109.683 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -34.89 -28.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.752 -0.593 . . . . 0.0 111.437 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -93.46 -52.84 4.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.883 -1.136 . . . . 0.0 110.776 -178.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -1.69 10.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.938 -1.101 . . . . 0.0 110.484 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -107.09 -75.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 109.182 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.487 ' C ' ' O ' ' A' ' 90' ' ' ALA . 71.1 t -34.42 -32.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.279 0.561 . . . . 0.0 110.393 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -108.57 -149.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.66 -95.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -128.67 70.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 2.3 tm0? -60.46 -21.59 62.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -0.82 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -69.81 -165.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.56 99.33 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.506 ' C ' ' CD2' ' A' ' 99' ' ' PHE . . . -146.45 -43.51 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.276 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.526 ' CD2' ' CG2' ' A' ' 78' ' ' VAL . 16.1 p90 172.96 137.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.446 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -104.11 -161.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -0.808 . . . . 0.0 109.294 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -104.95 149.67 25.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 106' ' ' PHE . 13.3 mt -112.41 116.21 48.8 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.944 . . . . 0.0 109.356 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 36.5 Cg_endo -93.99 148.81 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.651 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 34.3 mtmt -101.88 149.84 36.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.07 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -78.4 140.52 60.72 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.749 -2.605 . . . . 0.0 110.439 -0.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CD2' ' N ' ' A' ' 107' ' ' ASP . 78.0 t80 -116.14 171.51 7.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.861 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.571 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 1.1 t70 -102.25 113.4 26.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.537 -0.727 . . . . 0.0 109.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.0 -30.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.96 -1.087 . . . . 0.0 109.335 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.98 -45.19 28.36 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 108.702 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.546 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 34.8 tt0 -50.89 -34.23 27.39 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -76.51 -72.99 0.3 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.651 -0.655 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 28' ' ' LEU . 7.0 t -35.27 -45.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.446 -0.784 . . . . 0.0 110.61 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -73.05 -72.94 0.22 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.73 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -34.69 -57.15 0.53 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.521 0.676 . . . . 0.0 109.536 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.546 ' CG1' HG22 ' A' ' 50' ' ' VAL . 1.2 t -49.78 -58.49 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 21.1 tp10 -35.71 -41.11 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.739 -0.601 . . . . 0.0 111.092 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 114' ' ' LEU . 4.3 ptm180 -82.47 -36.78 26.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.109 -0.994 . . . . 0.0 110.207 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.525 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.38 -62.67 1.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.87 -1.144 . . . . 0.0 108.308 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.601 ' O ' ' C ' ' A' ' 120' ' ' SER . 10.6 mt -33.71 -39.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.98 -0.45 . . . . 0.0 110.626 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.615 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 11.7 t -5.01 -69.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.254 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 120' ' ' SER . 6.6 m170 142.3 56.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 36.01 32.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.537 0.684 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-30 -69.43 -9.36 53.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.51 -0.744 . . . . 0.0 109.804 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 8.7 mt-10 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.626 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.494 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.187 0.517 . . . . 0.0 109.81 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 49' ' ' ASP . . . -165.62 119.52 0.87 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 59.0 mt -104.89 91.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.306 -1.114 . . . . 0.0 109.884 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 p -105.87 125.63 61.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' CG2' ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.73 90.01 4.09 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.808 -1.183 . . . . 0.0 109.433 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG2' HD13 ' A' ' 52' ' ' LEU . 86.1 t -79.88 113.56 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 7.5 p -88.82 98.29 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.213 -0.929 . . . . 0.0 109.571 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.588 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 23.0 t0 -156.61 133.21 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.627 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' C ' ' O ' ' A' ' 10' ' ' ASP . 2.0 t0 7.43 68.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.285 0.564 . . . . 0.0 111.804 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.4 p-10 -46.46 177.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.552 -0.718 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 3.1 t 82.86 -68.49 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -98.18 -40.0 8.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.101 -1.0 . . . . 0.0 108.951 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.588 ' CG2' ' HB3' ' A' ' 10' ' ' ASP . 20.0 mm -68.34 -36.3 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.475 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 22.9 ttp85 -60.93 -42.38 98.06 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.483 ' O ' ' C ' ' A' ' 18' ' ' VAL . 11.5 t90 -60.29 -62.03 2.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.483 ' C ' ' O ' ' A' ' 17' ' ' TRP . 31.1 t -37.9 -68.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 109.678 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.461 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -56.15 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.632 -0.667 . . . . 0.0 110.442 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 2.1 tt0 -36.05 -64.31 0.32 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.489 -0.757 . . . . 0.0 111.983 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -39.78 -43.53 1.44 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -178.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . -71.5 -39.69 70.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.695 -1.253 . . . . 0.0 108.548 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD1' ' CG2' ' A' ' 112' ' ' VAL . 1.3 tp -69.73 -6.13 29.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.36 -33.96 42.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.0 109.038 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.87 -27.85 73.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.83 1.52 56.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -1.108 . . . . 0.0 109.229 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.95 72.22 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD12 ' CG1' ' A' ' 112' ' ' VAL . 0.3 OUTLIER -133.92 -179.84 5.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.116 -1.226 . . . . 0.0 110.008 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.523 ' CG2' HG22 ' A' ' 5' ' ' ILE . 29.2 m -102.1 84.49 2.51 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.558 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 21.2 t -93.11 90.83 7.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.482 -0.761 . . . . 0.0 110.644 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.585 ' CG2' ' CE2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -97.39 138.66 34.5 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 16' ' ' ARG . 1.7 p -146.43 134.53 21.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.737 -1.227 . . . . 0.0 110.696 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.572 ' CD2' HG21 ' A' ' 39' ' ' VAL . 7.0 m-30 -108.53 -158.9 0.67 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -121.83 -32.88 3.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.607 -1.308 . . . . 0.0 109.592 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 28.1 m120 -116.44 123.32 47.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.863 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.536 ' HA3' ' CD2' ' A' ' 65' ' ' LEU . . . -41.37 -36.47 1.45 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -62.62 -61.2 2.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 0.0 108.488 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.2 tp10 -35.55 -50.95 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.496 0.665 . . . . 0.0 109.876 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 33' ' ' PHE . 2.1 t -63.58 -44.82 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.792 . . . . 0.0 108.907 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.575 ' CG ' ' HG3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -78.8 4.33 14.22 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 109.476 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.55 -23.25 13.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.78 -33.03 11.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.131 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.592 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 3.2 mm? -65.13 -12.34 49.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.152 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.46 -31.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.518 -0.738 . . . . 0.0 110.186 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -73.91 -55.98 5.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.616 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -174.33 152.89 1.85 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.135 -0.978 . . . . 0.0 109.671 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -95.65 171.04 6.86 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.251 -0.905 . . . . 0.0 108.92 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.586 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.9 Cg_endo -119.68 -67.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 117.211 -1.392 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.538 ' CA ' HD11 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -122.68 -78.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.403 -1.436 . . . . 0.0 111.741 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 119' ' ' ILE . 4.0 t -138.96 141.31 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.941 -1.1 . . . . 0.0 110.537 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -106.24 135.99 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 110.273 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.561 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 5.9 mt -115.99 152.77 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 0.0 109.634 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.503 ' CB ' ' CD2' ' A' ' 66' ' ' LEU . 1.5 t -114.77 125.95 54.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.656 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.58 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 28.1 p30 -64.52 -166.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.534 HG12 ' CB ' ' A' ' 83' ' ' ALA . 1.9 tt -178.89 33.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -130.41 6.9 4.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.678 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.468 ' HG3' ' CD1' ' A' ' 63' ' ' LEU . 56.8 mmm -42.97 117.39 2.19 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -55.04 145.91 61.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.89 1.469 . . . . 0.0 110.231 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.15 101.42 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 60.56 49.58 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -1.164 . . . . 0.0 109.248 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' MET . 11.1 p-10 -52.64 144.76 13.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.773 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 155.79 -81.81 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD21 HD12 ' A' ' 65' ' ' LEU . 0.1 OUTLIER 42.95 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -1.125 . . . . 0.0 109.889 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -58.76 -74.36 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 108.52 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.536 ' CD2' ' HA3' ' A' ' 36' ' ' GLY . 11.6 mt 76.48 -10.29 1.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.503 ' CD2' ' CB ' ' A' ' 53' ' ' SER . 4.0 mm? -74.92 -39.81 61.2 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.848 -1.157 . . . . 0.0 108.827 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -64.97 -27.86 69.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.575 ' HG3' ' CG ' ' A' ' 40' ' ' LEU . 22.2 tp60 -65.26 -62.35 1.59 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.542 ' CG1' HD12 ' A' ' 40' ' ' LEU . 17.4 mt -35.79 -76.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.557 -0.714 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -43.02 -61.23 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.972 -1.08 . . . . 0.0 109.384 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.0 mt-30 -36.56 -42.1 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.505 -0.747 . . . . 0.0 111.705 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -131.89 42.12 3.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.83 -1.169 . . . . 0.0 111.289 -177.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.592 ' NE2' ' HB2' ' A' ' 43' ' ' LEU . 54.6 m80 -147.9 154.16 43.19 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.817 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 75' ' ' MET . 35.8 Cg_endo -60.9 -5.71 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.806 1.424 . . . . 0.0 112.092 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 74' ' ' PRO . 8.2 mtp 80.02 104.86 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.026 -1.046 . . . . 0.0 110.204 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.618 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -146.24 156.13 50.26 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 31.3 Cg_endo -43.04 130.48 5.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 117.203 -1.398 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG22 ' CZ ' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -123.32 178.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.561 ' CG2' ' CD2' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -149.85 171.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 86' ' ' ASP . 2.7 tt -160.67 137.81 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.9 mtt -85.91 135.05 33.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.047 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -72.52 149.81 43.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.013 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.534 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . 166.32 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 109.722 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 69.46 158.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 109.975 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 58.2 m 58.64 84.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 109.759 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ASP . 2.3 p-10 165.89 -43.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -35.03 -29.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.869 -0.52 . . . . 0.0 111.139 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.6 t0 -67.35 -65.0 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.046 -1.034 . . . . 0.0 110.194 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.67 -10.91 9.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.078 -1.014 . . . . 0.0 110.291 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -97.28 -76.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.006 -1.059 . . . . 0.0 109.765 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 51.0 t -34.1 -30.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.834 -0.541 . . . . 0.0 110.961 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -106.34 171.49 7.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.872 -1.142 . . . . 0.0 109.992 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 77.18 56.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER 60.04 47.43 9.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 1.7 pt20 -43.31 -34.42 1.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.7 72.54 0.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.4 -69.0 0.03 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.38 59.81 1.59 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.25 . . . . 0.0 110.06 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 2.0 m-85 -129.52 167.23 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.087 -1.008 . . . . 0.0 109.255 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 4.0 t0 -134.66 -30.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 73.62 105.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.95 -1.094 . . . . 0.0 108.506 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.461 HD11 HG12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -116.95 118.77 35.92 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.043 -1.036 . . . . 0.0 110.25 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -105.97 149.0 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.046 1.551 . . . . 0.0 109.884 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -91.41 147.95 36.51 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 0.0 109.516 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -89.92 155.9 31.1 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 120.536 -2.693 . . . . 0.0 110.396 0.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 17.2 p90 -131.14 169.22 16.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 109.357 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 1.3 t70 -85.72 168.02 14.74 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.131 -0.981 . . . . 0.0 108.7 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.515 ' CG2' HD11 ' A' ' 23' ' ' LEU . 31.6 mm -95.15 -61.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.91 -1.119 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 110' ' ' GLU . 63.1 t0 -54.97 -50.06 69.86 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.057 -1.027 . . . . 0.0 108.934 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 21.7 tp10 -44.13 -47.57 9.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -62.46 -67.74 0.39 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.569 ' CG2' ' CD1' ' A' ' 23' ' ' LEU . 48.1 t -35.4 -73.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.15 0.5 . . . . 0.0 110.584 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -39.12 -66.53 0.28 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.539 -0.725 . . . . 0.0 110.492 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -34.8 -53.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.809 0.814 . . . . 0.0 109.663 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 119' ' ' ILE . 1.6 t -56.6 -60.81 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -37.82 -43.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.652 -0.655 . . . . 0.0 111.141 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.567 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 5.7 ptp180 -77.1 -36.66 55.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 110.594 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.567 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.71 -67.17 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.862 -1.149 . . . . 0.0 108.089 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.542 HD12 ' CG2' ' A' ' 50' ' ' VAL . 6.6 mt -37.07 -41.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.237 0.541 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.23 60.74 4.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -128.92 -54.47 1.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 122' ' ' TYR . 22.7 p90 -78.35 136.45 37.69 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.85 -30.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.397 179.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 28' ' ' LEU . 7.8 ttp180 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.629 0.728 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.479 ' O ' HG12 ' A' ' 5' ' ' ILE . . . 149.45 177.38 23.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -153.25 90.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -1.102 . . . . 0.0 108.821 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.567 ' CG1' ' CG2' ' A' ' 8' ' ' VAL . 4.1 t -94.85 110.5 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.587 -0.696 . . . . 0.0 110.044 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' THR . 12.0 m0 -99.94 81.05 2.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.567 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 43.8 t -83.91 172.34 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.347 0.594 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.507 HG21 ' N ' ' A' ' 10' ' ' ASP . 7.0 p -134.09 140.78 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 108.7 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.507 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.6 t0 -136.71 -153.39 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.965 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 13.6 t70 -80.6 -95.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' SER . 2.5 p-10 169.4 176.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 109.931 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 80.7 69.48 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.652 -0.655 . . . . 0.0 109.882 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 71.88 46.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.564 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -112.05 -44.34 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.483 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 14.7 ttp180 -65.72 -33.06 75.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.65 -66.29 0.57 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 17' ' ' TRP . 38.3 t -39.62 -65.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.012 0.91 . . . . 0.0 110.241 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.536 ' HB3' HD13 ' A' ' 23' ' ' LEU . 21.2 mt -55.08 -76.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.88 -0.512 . . . . 0.0 110.845 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 3.6 tm-20 -33.62 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.573 -0.704 . . . . 0.0 110.922 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 22.1 tpt180 -64.89 -56.3 14.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.982 -1.074 . . . . 0.0 108.486 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.46 -2.32 19.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 19' ' ' LEU . 9.7 mt -100.23 -17.37 17.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.12 -38.73 35.4 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.47 -40.3 91.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.94 -35.88 67.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.346 -1.09 . . . . 0.0 108.472 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 28' ' ' LEU . . . 101.63 42.79 2.25 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.664 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.53 ' CD1' HG13 ' A' ' 112' ' ' VAL . 1.1 mt -141.85 165.62 26.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.878 -1.366 . . . . 0.0 110.06 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.512 HG23 ' CG2' ' A' ' 5' ' ' ILE . 98.5 m -98.19 75.46 2.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.522 ' HB3' HD11 ' A' ' 23' ' ' LEU . 16.1 t -90.83 86.59 6.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.416 -0.803 . . . . 0.0 109.582 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -82.89 140.28 32.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.392 -0.818 . . . . 0.0 109.038 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -132.32 125.48 31.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.543 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 65.4 m-85 -88.32 -177.65 5.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.116 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -108.87 2.29 21.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.48 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -144.45 142.04 30.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 109.792 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' HG23 ' A' ' 9' ' ' VAL . . . -69.93 -60.72 4.73 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -45.84 -69.38 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.382 -1.069 . . . . 0.0 108.344 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' ALA . 2.8 tp10 -35.58 -49.22 0.55 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 0.0 110.912 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 65.2 t -45.22 -53.1 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.188 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.598 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 5.1 mp -60.59 -36.96 79.82 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 38' ' ' GLU . . . -49.71 -33.55 16.29 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.69 -22.75 19.24 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.559 ' CD2' ' HB ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -71.35 -1.23 12.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.891 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.1 65.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -100.06 26.48 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.6 ' HE3' ' CG ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 63.21 136.53 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.573 -0.704 . . . . 0.0 110.139 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.559 ' HB ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -76.8 -169.5 0.19 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.696 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HB2' ' CD1' ' A' ' 5' ' ' ILE . 37.0 Cg_endo -97.76 -75.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.808 1.425 . . . . 0.0 110.171 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 9.1 m-20 -101.62 -63.3 1.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.797 -1.189 . . . . 0.0 110.269 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG2' HG12 ' A' ' 119' ' ' ILE . 2.1 t -148.58 152.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.415 -1.428 . . . . 0.0 111.296 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.539 HD23 ' CG1' ' A' ' 39' ' ' VAL . 3.2 mt -102.03 131.16 48.64 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.557 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.81 164.07 21.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 109.818 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' A' ' 9' ' ' VAL . 28.8 p -161.71 133.51 5.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.261 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.95 -177.0 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.128 -0.982 . . . . 0.0 109.911 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.458 ' HA ' HD13 ' A' ' 63' ' ' LEU . 1.1 pp -117.9 137.33 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -155.82 -73.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.215 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' MET . 4.3 ptt? -55.72 134.92 72.07 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.089 -1.007 . . . . 0.0 109.884 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -114.83 71.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.748 1.394 . . . . 0.0 110.308 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.12 -94.86 1.38 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.06 -50.47 66.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.204 . . . . 0.0 109.074 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.02 179.62 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.199 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.492 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -87.65 45.24 3.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER 33.7 -111.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.015 -0.697 . . . . 0.0 109.993 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 63' ' ' LEU . . . 40.59 58.53 2.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.01 -1.056 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 HD21 ' N ' ' A' ' 37' ' ' ASN . 3.6 mp -80.04 73.48 6.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 110.28 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.456 HD23 HG23 ' A' ' 80' ' ' ILE . 10.0 tp -87.61 -53.47 4.77 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD2' ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -54.44 -23.57 16.5 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.526 ' N ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -79.23 -56.92 4.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.598 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.13 -42.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.498 0.666 . . . . 0.0 109.944 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -82.74 -56.98 3.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.54 -0.725 . . . . 0.0 109.286 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 70' ' ' LYS . 15.1 tt0 -33.99 -31.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.775 -0.578 . . . . 0.0 111.299 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.535 ' CB ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.09 -78.58 0.58 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.863 -1.148 . . . . 0.0 110.898 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.616 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 1.6 p80 -66.75 144.57 98.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.612 -1.305 . . . . 0.0 109.392 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 36.2 Cg_endo -35.52 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 124.066 1.561 . . . . 0.0 111.525 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.485 ' O ' ' CG ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -178.33 100.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.753 -1.217 . . . . 0.0 110.459 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.652 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 3.4 pp -120.67 156.48 55.98 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.5 Cg_endo -41.87 129.9 4.14 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 117.563 -1.158 . . . . 0.0 111.184 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.605 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -137.9 161.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.39 -0.819 . . . . 0.0 109.254 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.514 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 3.7 mm -142.84 147.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 80' ' ' ILE . 7.1 tt -136.4 141.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.831 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.563 ' SD ' ' CE1' ' A' ' 106' ' ' PHE . 5.1 ttm -88.5 98.26 11.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.318 -0.863 . . . . 0.0 109.045 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.29 149.87 27.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 109.675 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 84' ' ' HIS . . . 179.28 60.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.324 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 79.26 143.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 109.496 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 45.2 p 53.65 171.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.265 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 85' ' ' SER . 5.5 m-20 84.43 -54.61 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -34.82 -30.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 110.8 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.3 p30 -64.16 -97.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.026 -1.046 . . . . 0.0 110.141 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.543 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -43.39 -40.35 3.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.969 -1.082 . . . . 0.0 109.903 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -51.07 -50.58 58.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 t -32.6 -36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.222 0.534 . . . . 0.0 110.187 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.4 t -90.87 44.45 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.81 . . . . 0.0 109.465 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ALA . . . -132.31 -65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 109.19 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.486 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . 41.3 p90 -90.71 28.42 1.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.148 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.64 -42.69 99.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -86.87 -55.09 4.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.483 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . 165.91 -164.3 37.33 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . 81.73 22.27 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.599 -0.942 . . . . 0.0 109.688 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 89.4 m-85 -140.51 157.1 46.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -114.52 -29.91 6.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.438 ' OH ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER 70.93 99.6 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 0.0 109.329 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.447 HD11 HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -110.27 119.76 46.09 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.892 . . . . 0.0 109.654 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -108.45 12.74 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.45 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 64.71 159.25 0.12 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -76.14 172.6 62.33 Favored 'Cis proline' 0 C--N 1.314 -1.238 0 C-N-CA 120.664 -2.64 . . . . 0.0 110.336 -0.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.563 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 40.8 p90 -157.06 144.05 18.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 8.7 t70 -85.63 174.75 9.19 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -82.88 -48.69 17.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.778 -1.201 . . . . 0.0 109.864 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.543 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 22.9 t0 -73.38 -47.37 42.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.006 -1.059 . . . . 0.0 108.15 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 tp10 -49.24 -38.02 25.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.3 -72.94 0.18 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.228 -0.92 . . . . 0.0 108.672 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 28' ' ' LEU . 77.9 t -38.45 -74.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 121.513 0.673 . . . . 0.0 110.323 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.96 -62.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.714 . . . . 0.0 110.355 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 115' ' ' VAL . 1.3 tm? -33.19 -54.65 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.432 0.634 . . . . 0.0 110.003 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 119' ' ' ILE . 75.2 t -60.05 -55.69 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 3.5 pt-20 -34.24 -44.85 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.905 -0.497 . . . . 0.0 111.411 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -59.77 -47.46 85.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.127 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.546 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.41 -55.29 25.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.737 -1.227 . . . . 0.0 107.953 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 115' ' ' VAL . 3.3 mt -36.47 -34.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.943 -0.473 . . . . 0.0 109.796 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.674 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 6.8 p -22.85 -45.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.674 ' CB ' ' O ' ' A' ' 120' ' ' SER . 12.0 t-80 117.65 62.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER 32.04 39.28 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.473 0.654 . . . . 0.0 109.94 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -40.16 -30.93 0.11 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.231 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.411 ' OXT' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.546 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.413 ' C ' HD22 ' A' ' 28' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.544 ' N ' HD22 ' A' ' 28' ' ' LEU . . . 163.37 -168.49 38.07 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.387 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 0.7 OUTLIER -149.84 93.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.601 -0.941 . . . . 0.0 109.363 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 3.6 p -100.4 118.95 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.553 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.638 ' CD2' ' CG2' ' A' ' 31' ' ' THR . 11.7 m95 -103.06 102.58 12.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.96 -1.087 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG1' HD13 ' A' ' 52' ' ' LEU . 59.7 t -98.99 146.91 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.564 ' CG1' HG12 ' A' ' 39' ' ' VAL . 1.6 m -104.49 129.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 O-C-N 121.063 -1.023 . . . . 0.0 108.554 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.509 ' CG ' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -112.44 -99.21 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.343 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 34' ' ' GLU . 12.3 t0 -153.12 -49.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.679 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' HD11 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -144.0 -179.69 6.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.9 -1.125 . . . . 0.0 110.459 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -65.96 169.29 6.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 109.666 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.1 OUTLIER 78.08 -6.77 1.91 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.509 ' CG2' ' CG ' ' A' ' 10' ' ' ASP . 1.8 mp -96.91 -29.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.5 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -65.08 -36.75 85.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 54.4 t90 -61.9 -63.64 1.19 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 20.2 t -36.97 -65.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.527 0.68 . . . . 0.0 110.731 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' CD2' ' CD1' ' A' ' 108' ' ' ILE . 0.7 OUTLIER -50.77 -70.88 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.792 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -35.4 -35.4 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.0 110.77 -179.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.15 -54.19 47.59 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.15 65.71 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.251 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -87.21 -10.29 52.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.167 -0.958 . . . . 0.0 109.543 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.45 71.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.07 -34.46 66.25 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . . . -78.64 -24.16 45.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.466 -1.02 . . . . 0.0 109.143 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.37 49.58 14.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.599 ' CD2' ' CG1' ' A' ' 112' ' ' VAL . 0.9 OUTLIER -128.52 177.89 6.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.106 -1.232 . . . . 0.0 110.267 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 7.2 m -95.26 93.35 7.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 34.2 t -86.45 80.75 8.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.638 ' CG2' ' CD2' ' A' ' 7' ' ' TRP . 3.3 m -84.22 141.17 31.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -143.73 164.51 30.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.678 -1.264 . . . . 0.0 110.038 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.466 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 13.5 m-85 -131.13 -171.67 2.64 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 11' ' ' ASP . 4.6 pt-20 -107.02 -23.97 12.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.964 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 34' ' ' GLU . 13.4 m120 -140.25 147.04 39.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.927 -1.108 . . . . 0.0 109.884 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 64' ' ' ALA . . . -55.67 -31.15 57.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.57 -76.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -1.152 . . . . 0.0 108.005 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -33.83 -33.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.373 0.606 . . . . 0.0 109.753 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.564 HG12 ' CG1' ' A' ' 9' ' ' VAL . 63.1 t -60.84 -59.11 4.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 121.381 -0.824 . . . . 0.0 109.203 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 41' ' ' ALA . 1.6 pp -62.08 -17.46 57.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.572 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -68.01 -35.95 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.36 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.538 ' N ' HD21 ' A' ' 43' ' ' LEU . 3.9 mm? -66.31 -7.82 21.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.75 60.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.5 m -100.25 26.78 6.19 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.1 mptt 71.88 139.5 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.631 0.729 . . . . 0.0 110.263 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.54 HG22 ' CD2' ' A' ' 76' ' ' LEU . 2.6 t -71.25 -177.0 0.42 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.585 -0.697 . . . . 0.0 109.496 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HG3' ' NE1' ' A' ' 7' ' ' TRP . 36.5 Cg_endo -114.94 -67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.799 1.42 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -121.27 -53.5 2.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.846 -1.159 . . . . 0.0 110.527 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -156.12 129.08 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.552 -1.342 . . . . 0.0 110.206 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.633 ' CB ' ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.59 128.88 46.5 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.585 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.813 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 3.3 pp -141.39 165.84 26.4 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.753 -1.217 . . . . 0.0 110.008 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.485 ' HA ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -133.99 151.08 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' SD ' ' A' ' 81' ' ' MET . 4.4 t70 -115.91 129.4 56.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.531 ' CB ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -83.8 144.89 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.62 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.3 -65.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.5 151.89 0.72 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.613 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -99.84 163.6 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.055 1.555 . . . . 0.0 110.207 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.86 -167.47 22.75 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.1 mmt -64.17 -32.61 74.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -1.079 . . . . 0.0 109.585 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.04 92.44 3.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.95 -45.27 7.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.538 ' CD2' ' C ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -50.54 -83.12 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.136 -1.214 . . . . 0.0 109.402 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.488 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . 168.67 35.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.478 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER 57.56 62.33 2.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 69' ' ' ILE . 15.9 tp -75.35 -13.22 60.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.997 . . . . 0.0 108.891 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -78.08 -38.95 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.498 ' CG ' ' N ' ' A' ' 69' ' ' ILE . 2.1 pt20 -76.74 -52.67 9.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.065 -1.022 . . . . 0.0 108.51 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.498 ' N ' ' CG ' ' A' ' 68' ' ' GLN . 2.9 tt -37.58 -34.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.812 0.815 . . . . 0.0 109.313 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 7.5 tptp -78.03 -54.52 6.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.98 -46.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.525 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 1.4 tpt85 -87.59 -43.44 11.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.192 -0.942 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.646 ' CE1' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -40.45 162.65 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.437 -0.789 . . . . 0.0 110.341 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 75' ' ' MET . 37.0 Cg_endo -117.71 42.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 124.03 1.542 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.4 mtt 66.03 82.83 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 0.0 110.579 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.646 ' CD2' ' CE1' ' A' ' 73' ' ' HIS . 1.0 OUTLIER -147.82 151.23 38.15 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.561 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 36.8 Cg_endo -37.59 126.77 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.61 1.321 . . . . 0.0 111.691 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 99' ' ' PHE . 84.1 t -117.91 100.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.589 -0.694 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.813 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 1.7 mt -75.7 157.54 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 108.739 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 7.3 tt -154.15 123.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.028 -1.045 . . . . 0.0 110.569 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.516 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 15.9 mtt -97.89 99.76 11.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.491 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 58.13 161.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.49 ' HB3' HD13 ' A' ' 63' ' ' LEU . . . -172.95 -175.36 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.961 -1.087 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.537 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.5 t-80 -167.49 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.934 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.537 ' C ' ' O ' ' A' ' 84' ' ' HIS . 21.7 m 40.26 31.83 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 88' ' ' ASP . 3.1 m-20 63.43 126.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.56 ' C ' ' O ' ' A' ' 86' ' ' ASP . 3.8 tp -35.83 -31.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -38.02 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.485 0.659 . . . . 0.0 109.584 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 85' ' ' SER . . . -47.59 -32.14 5.18 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 87' ' ' LEU . . . -69.36 -87.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.329 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.485 HG22 ' HG ' ' A' ' 87' ' ' LEU . 91.2 t -33.18 -59.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.719 -0.613 . . . . 0.0 111.398 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -55.84 -99.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.356 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 48.4 -105.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.872 -1.143 . . . . 0.0 108.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.524 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -141.82 60.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 0.0 108.791 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 8.1 mm-40 -57.31 174.23 0.21 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.605 -0.685 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 27.7 mt-30 64.12 50.42 2.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.98 -120.22 0.54 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.68 89.0 2.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -1.187 . . . . 0.0 109.474 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 5.5 m-85 -133.39 136.46 45.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 0.0 109.696 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -120.06 -167.86 1.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.047 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -166.2 94.93 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.735 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.7 OUTLIER -120.64 151.67 54.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.149 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -119.36 -173.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.709 1.373 . . . . 0.0 110.594 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.2 mtmm -91.27 159.25 39.77 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.335 -0.853 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.465 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -87.33 169.76 39.54 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 120.274 -2.803 . . . . 0.0 110.308 0.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.516 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 52.6 p90 -161.97 150.05 14.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.529 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 6.1 t0 -80.19 117.99 21.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.197 -0.94 . . . . 0.0 108.584 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.511 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -41.77 -41.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.215 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 25.8 t70 -74.48 -38.85 62.79 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.51 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.529 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 8.1 tm-20 -51.33 -38.11 51.32 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -81.94 -69.7 0.6 Allowed 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.599 ' CG1' ' CD2' ' A' ' 28' ' ' LEU . 24.4 t -37.31 -35.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.499 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -78.61 -66.67 0.83 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.982 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.51 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 3.0 tm? -35.47 -51.72 0.63 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.506 0.67 . . . . 0.0 109.843 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.541 ' CG2' HD12 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -70.45 -51.47 37.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 108.948 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 115' ' ' VAL . 9.0 tm-20 -33.35 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.523 0.677 . . . . 0.0 109.933 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' VAL . 5.1 mtm180 -76.51 -57.27 3.96 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.62 -54.37 9.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -0.973 . . . . 0.0 109.065 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.546 ' CD1' HG22 ' A' ' 50' ' ' VAL . 6.2 mt -39.77 -44.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 110.793 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -86.34 -22.6 26.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 120' ' ' SER . 63.1 t60 -37.94 -55.5 1.22 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.427 -0.796 . . . . 0.0 110.649 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 122' ' ' TYR . 3.9 p90 -91.05 48.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -73.26 -28.65 62.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.796 -1.19 . . . . 0.0 109.296 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 7.5 tpp180 . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -167.21 50.11 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 3.6 mt -76.64 91.55 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.088 -1.242 . . . . 0.0 107.977 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -100.78 123.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.433 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.565 ' CE3' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.1 87.91 4.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 52' ' ' LEU . 29.9 t -84.95 146.06 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.877 . . . . 0.0 110.545 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' N ' ' A' ' 36' ' ' GLY . 8.9 t -91.64 153.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.491 ' CB ' HG23 ' A' ' 15' ' ' ILE . 9.5 t0 -179.31 -124.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.961 -1.087 . . . . 0.0 110.003 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.515 ' CA ' ' HA ' ' A' ' 34' ' ' GLU . 1.4 t70 -128.22 -8.45 5.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.602 -1.311 . . . . 0.0 110.547 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.555 ' HB2' ' N ' ' A' ' 34' ' ' GLU . 2.1 t70 48.87 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 70.01 13.44 7.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.3 p 161.62 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 10' ' ' ASP . 33.0 mm -82.27 -38.34 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 108.958 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 32' ' ' THR . 12.2 ttp85 -65.67 -35.13 79.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -66.4 -62.63 1.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 17' ' ' TRP . 53.4 t -40.32 -64.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' CD1' ' A' ' 108' ' ' ILE . 2.8 mt -60.24 -75.58 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.68 -0.637 . . . . 0.0 110.944 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 18.8 tt0 -34.88 -31.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.736 -0.602 . . . . 0.0 110.612 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -67.07 -56.4 10.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HB2' HG23 ' A' ' 108' ' ' ILE . . . -64.09 -13.04 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -82.39 -27.17 32.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.42 73.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.42 -0.8 . . . . 0.0 109.185 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.72 -27.06 39.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.73 -16.97 60.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -1.07 . . . . 0.0 109.233 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.433 ' O ' HD22 ' A' ' 28' ' ' LEU . . . 72.98 38.11 56.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.578 ' CD1' ' CG1' ' A' ' 112' ' ' VAL . 78.2 mt -137.71 163.3 31.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.942 -1.328 . . . . 0.0 109.887 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 29' ' ' THR . 21.1 m -104.8 79.8 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.489 -0.757 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.546 ' CB ' ' CD2' ' A' ' 23' ' ' LEU . 44.3 t -80.96 80.44 7.44 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.004 -1.06 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.1 m -77.45 129.74 36.12 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.7 p -124.29 133.95 53.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.635 -1.291 . . . . 0.0 110.499 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 3.2 m-30 -106.56 145.54 31.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' N ' ' HB2' ' A' ' 12' ' ' ASP . 1.2 pt-20 -63.03 -8.22 6.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 110.192 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -154.81 138.44 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.787 -1.195 . . . . 0.0 110.399 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.526 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -56.34 -26.16 50.33 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' GLU . 33.9 t-20 -56.28 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.261 -1.14 . . . . 0.0 108.052 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.3 mm-40 -36.14 -46.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 110.774 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.585 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -49.5 -54.19 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.013 -1.054 . . . . 0.0 108.537 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.661 ' HG ' ' CE1' ' A' ' 73' ' ' HIS . 8.2 tt -64.45 -26.74 68.57 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.757 . . . . 0.0 109.496 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -22.91 62.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.09 -24.05 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 ' CE3' ' A' ' 7' ' ' TRP . 1.3 mp -87.2 -6.87 58.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.88 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.05 -29.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.711 . . . . 0.0 109.319 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -80.88 -46.56 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER 169.91 151.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 110.117 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.566 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 5.9 m -87.23 164.36 36.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 108.79 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 36.9 Cg_endo -103.84 -71.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.611 1.322 . . . . 0.0 111.13 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' OD2' ' CA ' ' A' ' 4' ' ' GLY . 3.0 m-20 -110.75 -75.31 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 0.0 110.542 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG2' HG12 ' A' ' 119' ' ' ILE . 13.1 t -143.7 145.02 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.062 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.545 ' CD1' ' CD2' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -101.8 124.21 47.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 109.88 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -108.83 165.99 11.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.222 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -147.8 122.05 9.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 109.644 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -78.0 -171.13 2.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.459 ' CD1' ' O ' ' A' ' 85' ' ' SER . 2.6 tp -143.21 79.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB3' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -117.74 -166.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mtt 59.62 83.75 0.21 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.09 120.4 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.944 1.497 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.76 -87.23 0.07 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 ttm -109.94 -91.71 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -1.125 . . . . 0.0 109.429 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.7 m-20 -102.53 1.26 34.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.47 -90.35 0.13 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER 176.64 25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.384 -1.068 . . . . 0.0 110.377 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.553 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 56.94 -142.18 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.848 -1.157 . . . . 0.0 109.132 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 62.9 mt 80.04 -66.76 0.15 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.682 . . . . 0.0 110.535 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.536 ' O ' ' CG2' ' A' ' 69' ' ' ILE . 2.5 tm? -57.47 -36.03 70.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.584 -1.322 . . . . 0.0 109.251 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -66.11 -30.92 71.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.643 -1.286 . . . . 0.0 107.663 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG3' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -69.08 -65.26 0.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.606 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -37.4 -24.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 111.494 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 68' ' ' GLN . 3.1 tptt -89.24 -69.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.274 -1.517 . . . . 0.0 109.277 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -34.93 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.683 -0.636 . . . . 0.0 112.01 -178.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.554 ' CB ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.31 -68.7 0.86 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.545 -1.347 . . . . 0.0 111.777 -178.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.661 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 77.6 m80 -33.55 152.12 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.197 0 O-C-N 121.536 -0.728 . . . . 0.0 110.698 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -59.08 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.987 1.519 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.41 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.848 -1.158 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.545 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -146.31 -176.2 0.53 Allowed Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.0 Cg_endo -78.73 143.0 18.35 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 117.292 -1.338 . . . . 0.0 111.512 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.471 HG22 ' CE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -137.15 158.0 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 115' ' ' VAL . 4.4 mt -142.6 145.21 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 108.995 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.83 138.89 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.87 142.93 49.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -93.99 178.6 5.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 109.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 166.68 -57.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.543 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.98 -52.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -109.47 107.98 18.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.646 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.5 p-10 166.74 -42.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.471 HD13 HG22 ' A' ' 91' ' ' VAL . 31.5 tp -35.02 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.247 0.546 . . . . 0.0 110.313 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 86' ' ' ASP . 5.4 t0 -63.51 -72.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -43.71 -47.32 7.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -62.77 -76.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.471 HG22 HD13 ' A' ' 87' ' ' LEU . 72.5 t -33.69 -32.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.818 -0.551 . . . . 0.0 111.125 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' ALA . 5.1 p -92.25 -148.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.98 -1.075 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 94' ' ' TYR . . . 58.72 64.79 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.509 ' CB ' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER 76.39 -0.52 3.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.22 -179.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.6 mt-30 42.47 -97.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' TYR . 3.6 mt-30 -62.74 100.44 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.986 -1.071 . . . . 0.0 109.836 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.96 -121.63 1.01 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.12 72.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -1.21 . . . . 0.0 109.679 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CE1' HG22 ' A' ' 78' ' ' VAL . 52.4 m-85 -127.05 136.13 51.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 101' ' ' TYR . 3.7 m-20 -135.78 89.59 2.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -38.34 135.56 0.74 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.652 -0.655 . . . . 0.0 109.995 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.33 121.79 36.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -122.3 -177.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.762 1.401 . . . . 0.0 110.578 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -100.63 156.85 34.72 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -96.88 167.61 13.67 Favored 'Cis proline' 0 C--N 1.317 -1.082 0 C-N-CA 120.8 -2.584 . . . . 0.0 110.392 0.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -164.3 146.44 8.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.6 t70 -75.95 144.02 41.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.543 ' CD1' HD22 ' A' ' 19' ' ' LEU . 4.5 tp -60.13 -48.31 88.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.942 -1.099 . . . . 0.0 110.7 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.517 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 35.7 t0 -69.96 -54.78 11.76 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 108.744 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 9.7 tp10 -46.36 -28.73 1.42 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.96 -78.66 0.09 Allowed 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.504 -0.747 . . . . 0.0 109.328 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.578 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 47.5 t -41.42 -60.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 121.368 -0.832 . . . . 0.0 109.692 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -42.33 -62.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.773 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.502 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -35.0 -50.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.686 0.755 . . . . 0.0 109.317 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -59.8 -53.89 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.573 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.9 tt0 -34.48 -41.46 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.376 0.607 . . . . 0.0 110.386 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -61.99 -53.05 60.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.364 -0.835 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -52.32 -54.8 26.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.012 -1.055 . . . . 0.0 108.626 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.544 HG12 ' CG2' ' A' ' 50' ' ' VAL . 5.1 mt -36.2 -34.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.426 0.631 . . . . 0.0 110.467 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 118' ' ' ALA . 3.5 t -70.73 22.77 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.389 -0.819 . . . . 0.0 111.983 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' C ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER 53.5 35.84 21.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.353 -1.467 . . . . 0.0 109.572 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.5 OUTLIER 32.21 50.56 0.18 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.575 0.703 . . . . 0.0 110.162 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.99 -25.82 67.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.055 -1.028 . . . . 0.0 109.348 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 28' ' ' LEU . . . 178.75 141.95 4.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.535 HG13 ' CG2' ' A' ' 29' ' ' THR . 5.2 mp -104.94 103.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.43 -1.041 . . . . 0.0 109.729 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.39 128.04 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.536 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -101.57 81.56 2.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 110.608 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 32' ' ' THR . 42.6 t -72.61 146.6 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 109.539 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 36' ' ' GLY . 84.1 t -91.72 105.81 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.038 -1.039 . . . . 0.0 109.349 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.532 ' HA ' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -53.79 174.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 2.3 t70 -124.39 -50.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 110.277 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -172.42 94.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 111.271 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 12' ' ' ASP . 1.8 p 57.08 137.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.145 0.974 . . . . 0.0 111.557 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.655 ' N ' ' CE3' ' A' ' 17' ' ' TRP . 5.4 t 61.81 3.67 0.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.387 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 10' ' ' ASP . 21.4 mm -88.21 -54.81 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.184 -1.572 . . . . 0.0 109.286 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -62.69 -36.76 83.96 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.655 ' CE3' ' N ' ' A' ' 14' ' ' SER . 7.9 m-90 -71.27 -55.91 7.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.596 ' CG2' ' O ' ' A' ' 14' ' ' SER . 2.1 t -39.1 -61.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 122.057 0.932 . . . . 0.0 109.795 -177.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.3 mm? -55.95 -70.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.59 -0.694 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -35.56 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.5 tmt_? -68.12 -56.52 8.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 108' ' ' ILE . . . -69.94 -6.72 34.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.054 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD1' HG23 ' A' ' 112' ' ' VAL . 1.5 mm? -101.91 -9.11 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.67 -52.57 6.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.317 -0.865 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.48 71.43 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.42 74.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.437 -1.037 . . . . 0.0 108.809 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.37 57.73 1.34 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -140.97 179.7 6.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.073 -1.251 . . . . 0.0 110.347 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.535 ' CG2' HG13 ' A' ' 5' ' ' ILE . 16.4 m -103.4 83.44 2.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.489 ' HB2' ' CG ' ' A' ' 23' ' ' LEU . 19.1 t -92.64 92.54 8.05 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.17 -0.956 . . . . 0.0 110.807 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.536 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -94.18 144.87 25.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.545 ' CG2' ' HB ' ' A' ' 8' ' ' VAL . 82.3 p -149.96 129.25 12.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.702 -1.248 . . . . 0.0 110.258 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.519 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 5.6 m-85 -111.81 127.33 55.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.272 -0.892 . . . . 0.0 109.133 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HA ' ' CB ' ' A' ' 10' ' ' ASP . 1.9 pt-20 -47.63 -19.59 0.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.49 -0.756 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -131.85 132.98 44.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.503 -1.373 . . . . 0.0 111.098 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 9' ' ' VAL . . . -61.78 -18.4 56.6 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.46 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -68.25 -80.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.088 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -35.53 -45.86 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.848 -0.533 . . . . 0.0 110.321 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 0.5 OUTLIER -58.05 -52.22 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.215 -0.928 . . . . 0.0 108.995 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.545 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 2.9 tm? -63.52 -17.29 62.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . -84.47 -25.91 28.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.13 -35.51 64.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.6 ' CD1' ' NE2' ' A' ' 73' ' ' HIS . 4.7 mt -72.36 -102.97 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 81.61 -40.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.122 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 70.7 m -98.99 -40.19 8.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -0.932 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.4 OUTLIER 168.06 150.09 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.096 -1.002 . . . . 0.0 108.969 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.571 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -87.37 165.81 28.94 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.255 -0.903 . . . . 0.0 109.417 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -89.27 -66.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.234 1.649 . . . . 0.0 110.319 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -109.85 -75.32 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.548 ' CG2' HD12 ' A' ' 119' ' ' ILE . 2.8 t -149.99 151.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 0.0 109.964 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.577 HD13 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -99.88 134.57 42.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -125.85 148.16 49.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.941 -1.099 . . . . 0.0 109.147 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t -134.66 126.4 29.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.094 -1.003 . . . . 0.0 110.428 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 m-20 -73.27 -179.93 3.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 109.173 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 81' ' ' MET . 0.7 OUTLIER 176.89 38.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.21 11.09 10.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.96 . . . . 0.0 109.248 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ASP . 5.9 mmt -38.08 140.51 0.57 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -49.42 122.92 9.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.07 1.563 . . . . 0.0 110.631 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 44.39 -126.06 6.24 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 ptt? -70.44 -146.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.399 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 57' ' ' MET . 31.1 m-20 63.14 100.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 109.802 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -153.07 90.67 0.13 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 1.2 pt? -38.32 147.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.912 . . . . 0.0 110.429 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HB2' ' CE ' ' A' ' 67' ' ' LYS . . . -90.97 122.95 34.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.1 mt -134.21 -43.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.445 ' HB2' ' OD2' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -41.25 -51.01 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.464 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.463 ' CE ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -43.66 -50.02 7.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 6.3 pt20 -69.97 -43.09 72.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.616 -1.302 . . . . 0.0 109.429 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -37.48 -52.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 109.606 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -73.14 -57.96 3.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.851 -0.531 . . . . 0.0 110.417 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.41 -36.41 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.843 -0.536 . . . . 0.0 110.939 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -101.99 -30.84 10.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.694 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.6 ' NE2' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.21 -177.77 0.32 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' CD2' ' A' ' 76' ' ' LEU . 36.6 Cg_endo -113.73 39.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.162 1.612 . . . . 0.0 109.598 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 5.8 mmt 63.17 73.24 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 3.0 pp -130.61 176.9 2.51 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 108.886 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.2 Cg_endo -68.26 129.29 18.95 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.184 1.097 . . . . 0.0 112.778 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 51' ' ' LEU . 45.7 t -134.42 100.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.479 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 15.4 mm -80.43 160.52 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.03 -1.044 . . . . 0.0 111.055 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.423 HD13 ' N ' ' A' ' 80' ' ' ILE . 3.9 mp -139.71 136.19 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.519 -0.738 . . . . 0.0 109.31 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.474 ' O ' HG23 ' A' ' 55' ' ' ILE . 1.2 ttm -81.27 89.87 6.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.27 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 65.77 -177.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 109.201 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 55' ' ' ILE . . . 179.54 142.92 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.004 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -146.33 36.82 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.1 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.86 -32.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.573 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' ASP . 46.4 t0 -76.49 -17.62 59.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 109.571 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.535 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 5.3 mt -34.44 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.702 -0.624 . . . . 0.0 110.525 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 86' ' ' ASP . 16.5 t0 -62.85 -57.85 9.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.018 . . . . 0.0 109.746 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.55 -57.24 13.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -52.02 -66.78 0.32 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -0.951 . . . . 0.0 109.8 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' LEU . 47.8 t -33.7 -31.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.98 -0.45 . . . . 0.0 111.042 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 90' ' ' ALA . 32.6 t -95.48 170.69 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 109.897 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 78.0 74.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.82 -86.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.471 ' HG3' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 66.39 31.49 8.22 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.389 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -125.65 16.19 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . 161.9 151.11 6.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . 69.43 34.03 2.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 20.3 m-85 -152.16 29.93 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.38 124.84 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.566 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.03 137.04 38.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.803 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD11 ' CG2' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -110.64 111.05 57.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -104.91 144.21 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.38 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.39 151.54 87.26 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.315 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -81.32 175.53 41.93 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.52 -2.7 . . . . 0.0 110.517 -0.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -159.5 136.31 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 17.5 t0 -76.05 -176.75 3.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 108.551 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.49 -49.48 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.639 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 26.2 t70 -69.36 -45.84 68.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 108.53 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.3 tp10 -51.1 -37.08 43.76 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.06 -70.22 0.37 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.379 -0.826 . . . . 0.0 108.81 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.532 HG23 ' CD1' ' A' ' 23' ' ' LEU . 39.1 t -36.45 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.744 -0.597 . . . . 0.0 110.396 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -51.32 -61.22 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 110.45 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 113' ' ' ALA . 47.6 tp -34.47 -58.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.331 0.586 . . . . 0.0 110.174 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 117' ' ' ARG . 1.0 OUTLIER -59.66 -56.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 115' ' ' VAL . 4.0 tm-20 -35.59 -31.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.185 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtm180 -82.63 -56.37 3.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.632 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.18 -61.33 1.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 108.734 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.548 HD12 ' CG2' ' A' ' 50' ' ' VAL . 9.6 mt -35.43 -44.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.805 -0.559 . . . . 0.0 110.55 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.74 56.62 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.91 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 34.5 t-80 -117.73 0.28 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.393 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -99.56 9.98 42.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.262 -0.899 . . . . 0.0 109.606 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 22.8 mt-30 -90.53 40.78 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 29.0 tt0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.49 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.505 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -167.61 149.5 14.74 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.839 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.599 ' CG2' ' CG2' ' A' ' 29' ' ' THR . 0.0 OUTLIER -101.46 110.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.616 -0.932 . . . . 0.0 109.859 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -113.86 119.09 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.657 ' CE3' ' CG2' ' A' ' 31' ' ' THR . 10.5 m95 -101.04 88.45 3.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.656 -1.278 . . . . 0.0 109.235 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.535 ' CG2' ' CB ' ' A' ' 52' ' ' LEU . 48.4 t -82.77 153.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.528 -0.732 . . . . 0.0 110.45 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.545 HG21 ' CG2' ' A' ' 39' ' ' VAL . 93.5 t -96.58 106.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -63.22 156.31 25.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 109.147 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -102.92 -29.8 11.2 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.659 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 1.7 m-20 -124.51 169.66 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.905 -1.122 . . . . 0.0 110.229 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -67.07 -3.12 6.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.895 -1.128 . . . . 0.0 110.64 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 14' ' ' SER . 3.1 t -121.3 8.85 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.799 -1.188 . . . . 0.0 110.45 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 10' ' ' ASP . 16.1 mm -78.88 -35.24 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.909 -1.119 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -49.58 77.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.541 ' CZ2' ' NH2' ' A' ' 21' ' ' ARG . 19.0 t90 -53.86 -64.4 0.84 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.2 t -37.48 -65.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.636 0.731 . . . . 0.0 110.698 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -50.39 -79.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 111.002 -178.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.8 tt0 -33.68 -33.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.826 -0.546 . . . . 0.0 110.947 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' NH2' ' CZ2' ' A' ' 17' ' ' TRP . 2.5 tpp85 -66.84 -57.16 7.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 0.0 109.037 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' CB ' HG13 ' A' ' 108' ' ' ILE . . . -71.97 -4.31 27.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.347 -0.846 . . . . 0.0 109.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -100.11 -18.62 16.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.48 -43.5 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.94 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.22 62.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -1.071 . . . . 0.0 109.013 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.7 47.88 4.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.523 HD23 ' CG1' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -127.87 179.57 5.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.073 -1.251 . . . . 0.0 110.097 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.599 ' CG2' ' CG2' ' A' ' 5' ' ' ILE . 53.9 m -99.97 86.04 3.18 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.539 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 31.3 t -82.37 92.13 6.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.474 -0.767 . . . . 0.0 110.399 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.657 ' CG2' ' CE3' ' A' ' 7' ' ' TRP . 24.3 m -89.55 124.1 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.2 p -127.01 151.31 48.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.06 -1.025 . . . . 0.0 110.125 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 7.8 m-85 -143.14 119.07 10.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.48 -0.763 . . . . 0.0 109.207 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' HA ' ' OD2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -54.16 -27.82 36.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.167 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.453 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 18.1 m120 -109.45 125.33 52.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 110.39 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.569 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . -57.78 -46.72 91.98 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 38' ' ' GLU . 58.3 t-20 -53.62 -71.93 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.159 -1.201 . . . . 0.0 108.811 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -34.23 -38.05 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.878 -0.514 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.545 ' CG2' HG21 ' A' ' 9' ' ' VAL . 48.8 t -53.15 -59.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.49 ' HG ' ' HG2' ' A' ' 68' ' ' GLN . 3.9 mm? -62.57 -21.78 65.86 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.68 83.97 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.67 36.29 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.593 ' HG ' ' CD2' ' A' ' 73' ' ' HIS . 2.5 tm? -56.95 -19.84 20.29 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.48 -40.25 12.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 109.22 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -62.31 -39.81 94.27 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.085 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 99.33 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.351 0.596 . . . . 0.0 110.583 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 7' ' ' TRP . 34.5 p -65.15 169.53 5.59 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.554 ' HG2' ' CG1' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -129.89 -15.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 116.263 -2.025 . . . . 0.0 113.007 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -94.4 -71.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 119.867 -1.771 . . . . 0.0 110.912 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.54 HG22 ' CD1' ' A' ' 119' ' ' ILE . 11.3 t -163.78 144.36 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 110.168 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.607 ' CD2' ' NE2' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -101.92 125.27 48.56 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.779 178.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' CB ' ' CG2' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -113.18 160.12 18.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -153.42 131.22 11.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.397 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -92.43 144.06 25.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.555 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -88.31 82.74 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.096 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 6.5 tpt180 178.57 128.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 108.919 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.52 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -174.18 157.61 2.59 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 57' ' ' MET . 36.2 Cg_endo -63.4 155.9 59.49 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.784 1.412 . . . . 0.0 110.298 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.23 10.82 27.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 61.14 -177.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -1.098 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.72 -146.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' O ' ' CG ' ' A' ' 57' ' ' MET . . . -107.98 -111.27 3.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -130.74 -46.03 1.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -1.11 . . . . 0.0 109.413 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . 77.36 64.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.817 . . . . 0.0 109.762 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.569 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -149.42 14.94 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 1.2 mm? -65.21 -40.76 94.58 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -25.82 62.89 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.524 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.37 -58.68 7.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' HIS . 1.3 mp -37.71 -69.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.563 -0.71 . . . . 0.0 110.452 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -48.28 -69.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.987 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 12.3 mt-30 -34.77 -31.83 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.408 0.623 . . . . 0.0 110.428 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -108.64 -81.29 0.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.607 ' NE2' ' CD2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -35.78 140.33 0.36 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.313 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD2' ' ND1' ' A' ' 73' ' ' HIS . 36.8 Cg_endo -59.49 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.104 1.581 . . . . 0.0 110.278 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.418 ' HB3' ' HE1' ' A' ' 75' ' ' MET . 13.5 ptp 178.96 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.673 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 4.2 pp -115.95 146.61 37.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 32.8 Cg_endo -33.43 137.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.893 1.47 . . . . 0.0 112.626 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -131.13 106.8 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 16.0 mm -91.64 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.519 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.487 HG21 ' N ' ' A' ' 81' ' ' MET . 53.4 mt -150.22 145.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.487 ' N ' HG21 ' A' ' 80' ' ' ILE . 1.2 mpp? -78.79 136.94 37.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 91.3 m 67.18 -83.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.559 -0.713 . . . . 0.0 110.021 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 83.93 95.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.585 -0.697 . . . . 0.0 109.171 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 86' ' ' ASP . 29.8 t60 -136.0 -87.51 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.528 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 46.67 36.66 3.88 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -178.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 88' ' ' ASP . 14.5 t0 66.11 128.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -36.47 -31.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -36.89 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.519 0.676 . . . . 0.0 109.71 176.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 85' ' ' SER . . . -51.7 -34.36 38.32 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.463 -0.773 . . . . 0.0 109.16 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -59.06 -80.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.062 -1.024 . . . . 0.0 109.618 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 90' ' ' ALA . 33.3 t -14.26 -54.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 122.763 0.425 . . . . 0.0 111.987 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 90' ' ' ALA . 4.3 t -79.53 -149.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.926 -1.109 . . . . 0.0 109.766 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 72.96 36.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.902 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 61.69 57.21 2.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.09 -1.006 . . . . 0.0 109.529 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -75.54 150.96 38.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 19.2 tt0 56.42 22.17 6.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.135 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.43 -46.83 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 77' ' ' PRO . . . -157.52 54.9 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.243 . . . . 0.0 109.985 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.29 122.5 12.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 101' ' ' TYR . 38.7 t70 -113.1 6.77 17.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.053 -1.03 . . . . 0.0 110.354 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.485 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 2.4 m-85 46.88 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.066 -1.022 . . . . 0.0 109.106 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -91.89 137.62 25.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.0 110.018 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 37.4 Cg_endo -127.54 177.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.643 1.339 . . . . 0.0 110.048 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -93.29 159.53 35.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.265 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -79.59 172.79 57.37 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.655 -2.644 . . . . 0.0 110.492 0.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 10.7 p90 -156.05 133.8 11.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.363 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 18.3 t0 -81.16 -162.39 0.49 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 108.703 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.5 HG13 ' CB ' ' A' ' 22' ' ' ALA . 36.0 mm -106.67 -65.01 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 109.208 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -57.65 -51.91 67.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.9 tp10 -43.55 -38.2 2.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 108' ' ' ILE . . . -71.74 -73.71 0.18 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 28' ' ' LEU . 38.4 t -37.24 -69.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.513 -0.742 . . . . 0.0 110.233 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -45.29 -63.14 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 110.441 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.529 HD11 ' N ' ' A' ' 115' ' ' VAL . 2.3 tm? -35.29 -50.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.689 0.756 . . . . 0.0 109.524 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.529 ' N ' HD11 ' A' ' 114' ' ' LEU . 1.2 t -60.18 -57.01 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 115' ' ' VAL . 3.4 tt0 -34.02 -39.42 0.07 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.198 0.523 . . . . 0.0 110.288 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtp85 -71.72 -52.0 19.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 109.25 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -49.09 -56.46 9.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.188 -0.945 . . . . 0.0 108.6 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.54 ' CD1' HG22 ' A' ' 50' ' ' VAL . 5.4 mt -35.27 -41.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.336 0.589 . . . . 0.0 109.774 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -88.03 53.33 2.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.153 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 6.9 t-80 -94.93 -5.73 44.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.607 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -85.64 19.8 2.32 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.235 -0.916 . . . . 0.0 109.822 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.2 -16.05 25.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.579 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.561 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 116' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.452 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . 166.87 153.1 7.7 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.051 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.568 ' HB ' ' CB ' ' A' ' 48' ' ' PRO . 1.9 mt -124.17 131.52 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.159 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.55 ' CG1' HG21 ' A' ' 8' ' ' VAL . 1.9 t -126.74 113.07 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 108.796 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.61 ' CD1' ' HG3' ' A' ' 48' ' ' PRO . 9.2 m95 -99.9 86.9 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.425 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.55 HG21 ' CG1' ' A' ' 6' ' ' VAL . 48.7 t -84.09 159.82 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 111.076 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.536 HG12 ' CA ' ' A' ' 36' ' ' GLY . 14.3 t -95.1 121.76 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.511 ' OD2' ' CG2' ' A' ' 15' ' ' ILE . 8.3 m-20 -109.07 -169.98 1.58 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.19 -0.943 . . . . 0.0 110.0 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.4 ' CG ' ' HG3' ' A' ' 57' ' ' MET . 51.8 t0 -100.87 -57.13 2.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -130.73 173.74 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 109.845 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.538 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -58.71 -41.74 87.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.958 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -28.36 34.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 108.986 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG2' ' OD2' ' A' ' 10' ' ' ASP . 43.7 mm -71.38 -40.35 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.474 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.0 -49.46 71.43 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 27.0 t90 -55.22 -59.68 4.45 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.0 t -36.18 -70.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.5 tp -55.41 -72.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.423 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 10.3 tm-20 -34.89 -30.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.795 -0.566 . . . . 0.0 110.969 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -68.45 -55.94 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.243 -0.911 . . . . 0.0 108.57 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -72.1 -4.76 30.87 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.4 OUTLIER -100.22 -12.75 19.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.421 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.8 -43.48 68.57 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.81 97.48 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.27 67.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.03 49.37 4.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.527 ' CD1' HG12 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -130.14 178.12 6.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.878 -1.366 . . . . 0.0 110.165 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.557 ' CG2' HG22 ' A' ' 5' ' ' ILE . 96.6 m -97.9 77.84 2.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.541 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 40.5 t -76.09 88.31 3.0 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.931 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.58 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 13.0 m -100.51 127.09 46.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.201 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 16' ' ' ARG . 43.9 p -119.06 161.01 20.98 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 109.27 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CG ' HG21 ' A' ' 39' ' ' VAL . 2.0 m-85 -134.37 105.81 6.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HG2' ' N ' ' A' ' 13' ' ' SER . 1.1 mp0 -41.94 -31.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.537 -0.727 . . . . 0.0 109.777 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -106.91 126.21 52.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.551 ' O ' HG13 ' A' ' 39' ' ' VAL . . . -65.17 -57.35 11.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 26.5 t-20 -51.37 -66.52 0.37 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.772 -1.428 . . . . 0.0 108.956 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.5 tt0 -33.52 -53.16 0.41 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.855 -0.528 . . . . 0.0 111.465 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG21 ' CG ' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -58.3 -52.86 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.725 -1.235 . . . . 0.0 109.498 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.616 HD21 ' N ' ' A' ' 69' ' ' ILE . 8.5 mp -62.34 -14.7 42.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.2 -37.68 53.05 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.37 1.09 48.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.528 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.11 -6.16 54.07 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.323 -0.86 . . . . 0.0 109.439 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -10.38 52.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 109.59 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.7 m -97.39 1.04 48.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.486 ' CG ' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 65.33 90.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.847 . . . . 0.0 109.611 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.581 HG23 ' CZ2' ' A' ' 7' ' ' TRP . 1.6 m -99.25 -72.97 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.082 -1.011 . . . . 0.0 109.847 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 38.7 Cg_endo -75.65 -162.72 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.488 1.257 . . . . 0.0 110.411 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.8 p30 -110.81 -14.93 13.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.573 ' CG2' ' HG2' ' A' ' 77' ' ' PRO . 4.3 t -144.89 129.11 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.521 -0.737 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.583 ' CD2' ' HG2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -100.42 158.4 15.92 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -146.84 157.1 43.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.072 -1.018 . . . . 0.0 110.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.519 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -134.05 123.87 25.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 109.729 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.572 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 27.1 m-20 -62.5 -51.93 65.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 109.779 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.572 ' CG2' ' O ' ' A' ' 54' ' ' ASP . 2.2 tp 83.96 26.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.326 0.584 . . . . 0.0 109.454 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 57' ' ' MET . 17.3 ptm180 -113.67 -138.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.217 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.49 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.8 ttm 70.57 128.96 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.865 -1.147 . . . . 0.0 109.301 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -89.23 173.33 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.326 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.63 -66.87 0.96 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -91.17 29.62 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -1.194 . . . . 0.0 109.527 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t0 52.48 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -138.02 83.79 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 62' ' ' GLY . 1.2 mp -35.91 132.62 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.907 -0.76 . . . . 0.0 110.127 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -49.88 -80.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 53' ' ' SER . 1.0 OUTLIER 79.09 -35.93 0.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 110.529 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 13.5 tp -77.0 -62.11 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.405 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -50.71 -40.29 53.81 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.581 ' CG ' ' CD2' ' A' ' 40' ' ' LEU . 3.7 tp-100 -57.96 -56.76 17.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.616 ' N ' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -35.92 -53.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.37 0.605 . . . . 0.0 109.908 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 72' ' ' ARG . 11.3 mtmm -60.04 -63.0 1.45 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.928 -1.107 . . . . 0.0 109.609 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.96 -34.37 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.775 -0.578 . . . . 0.0 110.959 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -122.51 -68.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.066 -1.021 . . . . 0.0 109.656 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -40.07 160.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.37 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.486 ' HG3' ' CG ' ' A' ' 46' ' ' LYS . 36.8 Cg_endo -92.95 -96.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.899 1.473 . . . . 0.0 110.15 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.4 mtm -147.56 2.36 0.73 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.875 -1.14 . . . . 0.0 110.881 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 50' ' ' VAL . 2.5 pp -61.81 134.89 94.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 120.596 -1.315 . . . . 0.0 108.104 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HG2' ' CG2' ' A' ' 50' ' ' VAL . 32.1 Cg_endo -28.94 145.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 124.176 1.619 . . . . 0.0 112.487 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.619 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 21.5 t -147.45 95.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.723 -0.611 . . . . 0.0 109.388 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 19.1 mt -75.63 136.38 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.951 -1.093 . . . . 0.0 110.635 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.585 HD13 ' CE1' ' A' ' 101' ' ' TYR . 4.0 pt -126.79 115.19 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.011 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -66.97 129.52 40.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.169 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.503 ' CB ' HG23 ' A' ' 55' ' ' ILE . 1.3 m 71.98 -78.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.717 . . . . 0.0 109.922 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . . . 66.06 129.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 109.508 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.497 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.2 OUTLIER -178.82 -79.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.497 ' C ' ' O ' ' A' ' 84' ' ' HIS . 4.6 t 44.59 41.04 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 69.75 131.51 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -175.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' C ' ' O ' ' A' ' 86' ' ' ASP . 1.7 mm? -36.35 -28.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.042 0.925 . . . . 0.0 109.104 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -35.88 -63.55 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 66' ' ' LEU . . . -81.18 -32.49 33.56 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 108.929 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -63.68 -67.23 0.45 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 109.033 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.75 -53.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 C-N-CA 122.779 0.432 . . . . 0.0 111.611 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.595 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -61.8 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.998 -1.064 . . . . 0.0 109.088 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 79.18 -75.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.076 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' VAL . 22.5 p90 -78.79 5.76 10.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.055 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.69 -26.97 60.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 109.286 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER 163.24 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -0.827 . . . . 0.0 109.384 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.15 -146.2 8.88 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -138.88 67.6 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -1.126 . . . . 0.0 109.652 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 41.3 p90 170.66 -177.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -150.7 -176.01 5.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.272 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.585 ' CE1' HD13 ' A' ' 80' ' ' ILE . 5.0 m-30 -81.71 130.22 34.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.252 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -114.61 115.91 43.88 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 0.0 109.404 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -117.06 171.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.875 1.46 . . . . 0.0 110.415 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 16.5 mttm -63.03 157.96 58.03 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 109.402 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 37.3 Cg_endo -79.07 161.54 88.29 Favored 'Cis proline' 0 C--N 1.315 -1.225 0 C-N-CA 120.539 -2.692 . . . . 0.0 109.905 -0.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 1.8 p90 -143.26 129.5 19.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.5 t70 -91.28 -147.25 0.21 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.062 -1.024 . . . . 0.0 108.748 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -119.18 -69.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.479 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 13.7 t70 -62.16 -42.67 99.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.6 tm-20 -46.23 -45.7 17.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.79 -77.04 0.09 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 28' ' ' LEU . 65.2 t -38.39 -71.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 110.155 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.59 -65.4 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.961 -0.462 . . . . 0.0 110.27 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' ALA . 13.5 tp -34.76 -49.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.826 0.822 . . . . 0.0 109.507 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 50' ' ' VAL . 1.7 t -60.49 -55.81 21.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 115' ' ' VAL . 1.4 tt0 -34.88 -45.79 0.28 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 118' ' ' ALA . 12.5 mtm105 -70.72 -51.74 25.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 109.441 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.24 -67.56 0.27 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.889 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.541 ' CG1' HG22 ' A' ' 50' ' ' VAL . 5.5 mt -36.29 -43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.672 -0.642 . . . . 0.0 110.062 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 121' ' ' HIS . 3.7 t -48.73 -58.2 5.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 120' ' ' SER . 4.9 t60 -42.75 -41.33 3.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.338 -0.851 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.75 49.71 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.493 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.41 28.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.39 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.806 0.812 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.492 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . 161.23 168.59 23.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.61 ' HB ' ' CB ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -144.61 104.34 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -1.119 . . . . 0.0 108.315 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.461 HG12 HD11 ' A' ' 52' ' ' LEU . 2.7 t -120.87 115.95 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.08 . . . . 0.0 110.253 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.56 ' CD2' ' HB ' ' A' ' 31' ' ' THR . 0.2 OUTLIER -99.58 80.38 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 0.0 109.34 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 32' ' ' THR . 9.3 t -68.22 137.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.321 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' CG1' ' HA2' ' A' ' 36' ' ' GLY . 57.4 t -85.67 108.78 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.115 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.486 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 71.6 m-20 -87.15 -171.72 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.326 -0.859 . . . . 0.0 109.834 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.75 -87.06 0.14 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.38 -0.825 . . . . 0.0 109.637 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 15' ' ' ILE . 3.1 m-20 -112.05 170.7 7.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.635 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.8 p -49.55 164.72 0.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER 79.73 -8.67 1.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.486 ' CG2' ' HB3' ' A' ' 10' ' ' ASP . 46.4 mm -92.93 -36.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.973 -1.08 . . . . 0.0 108.398 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' A' ' 17' ' ' TRP . 15.8 ptt-85 -66.18 -32.59 74.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.613 ' CZ3' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -52.11 -66.34 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 49.6 t -42.49 -53.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.921 0.867 . . . . 0.0 110.072 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' ARG . 2.7 mm? -49.56 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.745 . . . . 0.0 110.343 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 2.0 mt-10 -35.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.369 0.604 . . . . 0.0 110.395 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.613 ' HD3' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -62.51 -56.35 18.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.809 -1.182 . . . . 0.0 108.839 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HB2' ' CD1' ' A' ' 108' ' ' ILE . . . -63.5 -20.84 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 19.6 tp -71.67 -25.59 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.84 -0.537 . . . . 0.0 110.165 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.66 73.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.27 -38.47 87.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.41 49.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 109.226 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.76 65.51 3.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.576 ' CD1' ' CG1' ' A' ' 112' ' ' VAL . 0.1 OUTLIER -136.43 -177.44 4.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.238 -1.154 . . . . 0.0 110.215 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.55 ' CG2' HG21 ' A' ' 5' ' ' ILE . 32.1 m -104.93 50.96 0.77 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.535 ' HB3' HD21 ' A' ' 23' ' ' LEU . 18.4 t -79.03 87.07 4.83 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.233 0.54 . . . . 0.0 109.579 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.56 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 1.4 m -85.83 170.29 12.54 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 108.66 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.545 ' CG2' ' HB ' ' A' ' 8' ' ' VAL . 1.1 p -155.18 143.16 20.04 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 7' ' ' TRP . 2.4 m-85 -118.44 -168.87 1.61 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.936 -1.103 . . . . 0.0 109.794 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.42 -1.71 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 110.2 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 4.8 m-20 -136.56 127.36 27.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.543 ' HA3' ' CG ' ' A' ' 65' ' ' LEU . . . -48.99 -50.68 26.78 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 39' ' ' VAL . 18.9 t-20 -58.94 -63.67 1.22 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.3 -1.118 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -34.37 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 0.0 110.592 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 37' ' ' ASN . 1.7 t -74.54 -64.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.592 ' CD2' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -59.68 -14.57 14.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.529 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -85.14 -39.58 17.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.175 -0.953 . . . . 0.0 108.469 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.53 74.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -65.23 -94.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.498 -0.752 . . . . 0.0 109.135 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 84.0 -63.33 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.427 0.632 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 62.3 p -102.3 -37.88 7.88 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.514 -0.741 . . . . 0.0 109.794 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 149.72 95.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m -100.32 -74.51 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.853 -1.154 . . . . 0.0 110.475 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 40.8 Cg_endo -81.2 -162.02 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 116.916 -1.59 . . . . 0.0 109.591 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 50' ' ' VAL . 53.2 p30 -113.43 -12.11 13.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.55 HG21 ' CD1' ' A' ' 119' ' ' ILE . 2.4 t -155.51 121.75 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.6 HD21 ' CE1' ' A' ' 73' ' ' HIS . 2.5 tp -99.51 136.05 40.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.041 -1.037 . . . . 0.0 108.631 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.517 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -117.12 174.18 6.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.917 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.471 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 91.0 p -149.01 133.97 18.07 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.502 ' OD2' ' CG1' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -95.93 3.92 53.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 110.051 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.516 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 1.3 tt 28.82 82.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.3 0.572 . . . . 0.0 110.738 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -162.63 73.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.995 -1.066 . . . . 0.0 109.688 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtm -128.26 136.55 29.23 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.98 113.08 2.45 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.062 1.559 . . . . 0.0 110.383 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.62 -160.99 24.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.8 mtt -76.66 -49.5 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.203 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.25 177.06 5.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.217 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.42 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.34 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER 178.88 29.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -1.122 . . . . 0.0 110.0 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 43.23 -92.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.96 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.543 ' CG ' ' HA3' ' A' ' 36' ' ' GLY . 0.5 OUTLIER 71.72 -82.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.854 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 65' ' ' LEU . 1.1 mm? -37.35 -29.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.123 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.91 -55.02 25.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.488 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.04 -41.72 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.153 . . . . 0.0 109.191 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -37.33 -59.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.187 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.31 -51.53 56.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.903 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -34.39 -36.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.715 -0.615 . . . . 0.0 111.119 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -109.33 -59.18 1.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 0.0 110.313 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.6 ' CE1' HD21 ' A' ' 51' ' ' LEU . 57.1 m170 -39.61 145.35 0.43 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.417 -0.802 . . . . 0.0 110.066 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 35.1 Cg_endo -87.06 47.32 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.111 1.585 . . . . 0.0 109.868 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.8 mtp 72.41 55.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.61 -0.681 . . . . 0.0 110.241 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 77' ' ' PRO . 1.2 pp -114.8 136.62 22.53 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.056 . . . . 0.0 109.235 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.546 ' HG2' ' CG2' ' A' ' 50' ' ' VAL . 35.6 Cg_endo -40.54 141.91 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.267 1.667 . . . . 0.0 112.994 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -147.5 142.76 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.533 ' CD1' HG23 ' A' ' 115' ' ' VAL . 8.7 mt -126.12 167.93 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.775 -1.203 . . . . 0.0 110.524 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.443 ' N ' ' CG2' ' A' ' 79' ' ' ILE . 4.2 tt -149.22 144.11 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 82' ' ' THR . 1.7 mpt? -88.14 65.49 8.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.543 ' CB ' ' O ' ' A' ' 81' ' ' MET . 1.1 m 158.1 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.89 46.11 0.94 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.477 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -123.4 -97.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 45.78 27.65 0.48 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 61.23 123.37 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.532 ' C ' ' O ' ' A' ' 86' ' ' ASP . 9.6 tp -39.32 -25.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 108.263 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -36.91 -75.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.064 -1.022 . . . . 0.0 110.234 176.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 92' ' ' SER . . . -68.43 -34.62 76.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -56.7 -62.2 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.37 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -27.25 -39.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 122.683 0.393 . . . . 0.0 111.099 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -38.37 -59.6 0.88 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 109.579 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -44.0 -69.24 0.14 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -51.99 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 93' ' ' ALA . 2.3 mm-40 -176.38 -42.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -136.78 -67.36 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . 156.65 173.9 25.72 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . 81.84 -0.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.914 . . . . 0.0 109.899 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 3.8 m-85 -112.81 119.73 39.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.082 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.31 164.39 21.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.819 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.443 ' OH ' ' C ' ' A' ' 90' ' ' ALA . 65.7 m-85 -110.75 94.57 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.143 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.529 ' HB2' ' CG2' ' A' ' 79' ' ' ILE . 1.6 tp -83.1 153.67 66.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -122.68 -174.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.707 1.372 . . . . 0.0 110.501 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -119.14 157.66 50.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -78.81 175.31 47.12 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.887 -2.547 . . . . 0.0 110.562 0.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 25.1 p90 -148.68 140.89 24.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.778 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 13.5 t0 -79.49 147.63 32.16 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -72.36 -31.09 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.722 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -82.96 -44.81 14.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 38.8 tt0 -55.46 -39.26 70.12 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.81 -65.9 0.77 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.37 -0.831 . . . . 0.0 109.173 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.576 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 41.0 t -36.5 -57.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.652 . . . . 0.0 110.576 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -58.72 -66.09 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.539 -0.726 . . . . 0.0 110.492 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.3 tp -35.19 -54.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.544 0.687 . . . . 0.0 110.09 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' A' ' 79' ' ' ILE . 27.3 t -56.63 -56.11 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 115' ' ' VAL . 54.9 tt0 -34.91 -42.17 0.15 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.421 0.629 . . . . 0.0 109.917 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' ALA . 22.4 mtp180 -73.57 -54.86 7.19 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.068 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.99 -66.84 0.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.163 -0.961 . . . . 0.0 109.157 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.55 ' CD1' HG21 ' A' ' 50' ' ' VAL . 4.1 mt -37.53 -41.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.672 . . . . 0.0 109.932 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 121' ' ' HIS . 6.1 m -46.15 -55.1 7.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.413 -0.805 . . . . 0.0 109.9 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 120' ' ' SER . 14.4 t-160 -38.64 -43.84 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.885 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.78 96.43 4.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.49 40.71 3.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.87 . . . . 0.0 109.334 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.471 ' OXT' ' CG ' ' A' ' 124' ' ' GLU . 35.5 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.226 0.536 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.542 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . -174.59 120.64 0.79 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.507 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 48' ' ' PRO . 1.1 mp -106.31 118.03 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.297 . . . . 0.0 108.601 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.8 OUTLIER -122.67 112.72 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.551 ' CZ2' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -98.45 92.31 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.69 -1.256 . . . . 0.0 108.746 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 52' ' ' LEU . 57.6 t -83.66 150.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.444 0.64 . . . . 0.0 110.899 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 76.2 t -89.7 122.34 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' HA ' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.94 143.05 55.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.824 0.821 . . . . 0.0 110.819 -178.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' OD1' ' HG3' ' A' ' 57' ' ' MET . 5.1 t0 -99.29 -65.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.523 ' O ' ' CG1' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -110.01 174.73 5.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.292 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 14' ' ' SER . 52.0 p -64.45 148.79 49.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 78.25 24.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.884 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 12' ' ' ASP . 3.2 mm -83.63 -47.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 7.4 mtm180 -53.17 -47.95 68.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.485 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 22.9 t90 -55.51 -61.5 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 14' ' ' SER . 15.9 t -36.98 -68.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.506 -0.746 . . . . 0.0 110.643 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 21' ' ' ARG . 6.9 mt -59.85 -74.56 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 110.878 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 19' ' ' LEU . 12.2 tt0 -34.56 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.771 -0.581 . . . . 0.0 111.057 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -69.87 -56.39 7.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.998 . . . . 0.0 108.593 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HB1' HG22 ' A' ' 108' ' ' ILE . . . -72.06 -3.75 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.38 -0.825 . . . . 0.0 108.82 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.557 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 3.1 mm? -103.43 -10.89 18.22 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.392 -0.818 . . . . 0.0 109.522 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.88 -35.11 24.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.31 -36.78 49.46 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.4 -34.04 73.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -1.052 . . . . 0.0 108.637 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.26 73.08 1.26 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.542 HD22 ' CA ' ' A' ' 4' ' ' GLY . 0.2 OUTLIER -146.67 174.61 11.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -1.207 . . . . 0.0 109.935 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.535 ' CG2' HG22 ' A' ' 5' ' ' ILE . 92.7 m -102.98 61.19 0.79 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.557 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . 35.9 t -83.85 96.79 8.89 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.551 HG23 ' CZ2' ' A' ' 7' ' ' TRP . 5.7 m -100.02 154.62 18.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 108.662 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.462 ' OG1' ' CG ' ' A' ' 16' ' ' ARG . 82.0 p -139.98 158.77 43.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.99 -1.069 . . . . 0.0 109.36 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.591 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 6.2 m-85 -135.95 120.56 18.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.602 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 3.0 mt-10 -42.84 -42.86 3.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.966 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -110.05 119.74 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 37' ' ' ASN . . . -51.68 -48.96 48.79 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.478 ' O ' ' C ' ' A' ' 38' ' ' GLU . 17.0 t30 -42.53 -71.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -1.045 . . . . 0.0 108.4 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.7 mt-10 -34.51 -42.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.79 -0.568 . . . . 0.0 109.755 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.591 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 1.2 t -58.01 -54.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.887 . . . . 0.0 108.688 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 39' ' ' VAL . 3.1 mm? -61.36 -19.28 61.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.1 -45.28 42.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.163 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.45 -19.34 59.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.645 ' CD1' ' CD2' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -80.76 -105.04 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 82.28 -57.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.74 . . . . 0.0 109.497 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.5 t -100.99 -3.73 28.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 83.42 110.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.78 0.8 . . . . 0.0 109.141 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.604 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 21.2 m -104.04 -74.77 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.584 -1.323 . . . . 0.0 111.84 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 45.4 Cg_endo -55.51 -161.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.441 1.232 . . . . 0.0 109.766 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 8.1 p30 -115.7 -8.4 12.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.182 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.535 HG22 ' CD1' ' A' ' 119' ' ' ILE . 2.3 t -156.91 123.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.959 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.661 ' CD2' ' HG2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -100.3 143.97 29.86 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 79' ' ' ILE . 5.2 mt -123.21 163.86 19.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.765 -1.209 . . . . 0.0 110.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 t -133.01 115.48 15.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' ILE . 8.8 m-20 -60.87 -25.85 66.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.173 -0.955 . . . . 0.0 110.44 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.533 ' CG2' ' HB1' ' A' ' 83' ' ' ALA . 0.3 OUTLIER 49.79 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 108.984 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 57.05 111.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.025 -1.047 . . . . 0.0 109.361 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.505 ' SD ' ' CD2' ' A' ' 63' ' ' LEU . 3.6 mtm -157.11 -176.15 0.59 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 109.649 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -103.43 70.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.008 1.53 . . . . 0.0 110.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.61 -155.43 7.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -81.81 127.33 32.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -1.147 . . . . 0.0 109.611 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.46 -92.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 109.537 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -119.51 -111.28 2.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.505 ' CD2' ' SD ' ' A' ' 57' ' ' MET . 11.4 tp -124.02 -7.06 7.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.66 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . 73.78 50.62 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.77 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.57 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -162.17 16.98 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.106 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.4 mm? -70.61 -67.29 0.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.043 -1.036 . . . . 0.0 108.825 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -28.05 3.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 65' ' ' LEU . 1.7 tt0 -57.07 -53.44 58.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.511 ' N ' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -33.57 -32.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.935 -0.478 . . . . 0.0 110.432 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.9 mmmt -99.15 -65.1 0.98 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.035 -1.041 . . . . 0.0 109.935 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -33.17 -33.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.799 -0.563 . . . . 0.0 110.896 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -92.5 -68.34 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.645 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -126.14 112.03 24.01 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 38.1 Cg_endo -134.05 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.67 1.353 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.528 ' CB ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -131.04 -14.89 3.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.912 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.619 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 3.7 pp -131.23 167.16 22.96 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.092 -1.005 . . . . 0.0 108.531 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.2 Cg_endo -65.69 159.63 47.42 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.222 1.117 . . . . 0.0 111.247 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -126.48 101.26 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 109.337 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.541 ' CG2' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -65.24 157.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.195 -0.941 . . . . 0.0 109.108 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.481 ' CG2' ' O ' ' A' ' 79' ' ' ILE . 6.5 pt -157.11 118.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.468 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.08 138.24 57.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.402 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 103' ' ' PRO . 16.8 m -75.39 121.65 22.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -171.4 40.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.754 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.3 m-70 67.92 110.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 84' ' ' HIS . 12.3 t 156.68 -73.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' ASP . 2.2 p30 -48.22 -28.98 3.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 110.054 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -36.06 -29.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -0.881 . . . . 0.0 111.198 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' ASP . 47.4 m-20 -107.61 -79.87 0.57 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.045 -1.034 . . . . 0.0 110.517 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 92' ' ' SER . . . -36.68 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.405 -0.809 . . . . 0.0 110.355 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 88' ' ' ASP . . . -74.39 -79.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 85.2 t -33.49 -41.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -113.61 -172.21 2.03 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 109.406 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 70.67 68.41 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.778 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.63 65.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HG3' ' N ' ' A' ' 96' ' ' GLN . 3.2 pt20 -73.87 -125.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.323 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.5 ' N ' ' HG3' ' A' ' 95' ' ' GLN . 2.4 tp60 76.85 69.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.871 -1.143 . . . . 0.0 109.546 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 48.53 -158.38 0.88 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 67.8 20.32 9.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -1.152 . . . . 0.0 109.481 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' O ' ' CE1' ' A' ' 101' ' ' TYR . 1.1 m-85 -151.54 53.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.75 154.24 41.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.209 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.565 ' CE1' ' O ' ' A' ' 99' ' ' PHE . 1.3 m-85 -108.98 166.87 10.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.22 89.05 24.32 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.847 . . . . 0.0 109.163 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 82' ' ' THR . 36.7 Cg_endo -58.94 168.21 4.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.076 1.566 . . . . 0.0 110.971 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -116.02 158.35 42.69 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.771 . . . . 0.0 109.058 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -83.23 169.74 56.67 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.63 -2.654 . . . . 0.0 110.312 0.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 13.7 p90 -149.39 163.1 38.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 109.09 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 5.6 t70 -87.78 -156.21 0.34 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.457 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 19.4 mm -120.61 -70.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.857 -1.152 . . . . 0.0 109.606 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' GLU . 9.2 t70 -54.46 -51.18 65.81 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 19.1 tp10 -42.85 -42.27 3.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -67.3 -72.98 0.15 Allowed 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.335 -0.853 . . . . 0.0 108.988 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 23' ' ' LEU . 35.8 t -36.86 -68.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.789 -0.57 . . . . 0.0 110.2 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.35 -65.17 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' O ' ' A' ' 113' ' ' ALA . 33.7 tp -35.47 -53.93 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.676 0.751 . . . . 0.0 109.763 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.534 ' CG1' HG23 ' A' ' 50' ' ' VAL . 1.8 t -56.09 -57.53 8.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.497 ' C ' ' O ' ' A' ' 115' ' ' VAL . 19.3 mt-10 -33.54 -41.94 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.422 0.63 . . . . 0.0 110.187 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.6 mtt-85 -76.04 -54.85 6.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.697 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.2 -63.22 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 108.931 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.572 ' CG2' ' HB2' ' A' ' 49' ' ' ASP . 7.6 mt -33.84 -44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.152 0.501 . . . . 0.0 110.55 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.22 61.81 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.64 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -106.8 -40.25 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.611 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.0 p90 -120.55 31.01 6.64 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -135.66 36.08 2.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.947 -1.096 . . . . 0.0 109.728 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.578 179.713 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 8.6 tpt180 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.372 0.606 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.474 ' HA3' HD22 ' A' ' 28' ' ' LEU . . . 165.34 93.95 0.1 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 5.8 mt -83.4 93.12 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.401 -1.058 . . . . 0.0 109.671 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.588 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 8.5 p -96.1 122.48 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.722 -0.611 . . . . 0.0 109.412 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.523 ' NE1' ' CG2' ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.71 102.97 14.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.686 -1.259 . . . . 0.0 109.047 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.549 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 13.4 t -100.93 125.03 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.958 . . . . 0.0 110.625 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG2' ' N ' ' A' ' 36' ' ' GLY . 2.6 p -59.15 112.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.572 -1.33 . . . . 0.0 108.366 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' OD1' ' CG2' ' A' ' 15' ' ' ILE . 20.9 t0 -68.1 164.98 19.07 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.272 0.558 . . . . 0.0 109.88 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 1.5 m-20 -96.21 -89.07 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.397 -0.815 . . . . 0.0 109.643 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 15' ' ' ILE . 1.1 m-20 -106.59 174.75 5.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.4 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 14.0 m -57.75 148.16 25.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.4 t 81.79 -11.96 1.01 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.961 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.547 ' CG2' ' OD1' ' A' ' 10' ' ' ASP . 12.6 mm -79.19 -35.81 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.0 -1.063 . . . . 0.0 108.745 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.577 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.3 ttp-105 -59.94 -46.03 90.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.482 ' O ' ' C ' ' A' ' 18' ' ' VAL . 55.1 t90 -58.29 -59.68 4.95 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.297 -0.877 . . . . 0.0 108.919 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.6 t -34.92 -60.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.579 0.704 . . . . 0.0 110.506 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 21' ' ' ARG . 3.1 mt -53.1 -71.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.978 -1.076 . . . . 0.0 109.152 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -35.13 -33.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.263 0.554 . . . . 0.0 110.818 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.02 -56.13 19.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 108.241 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . -64.96 -9.83 24.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.119 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -85.77 -24.5 26.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.631 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.7 -43.96 85.53 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.26 -47.79 28.01 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.405 ' O ' HD11 ' A' ' 28' ' ' LEU . . . -58.45 -17.59 21.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.157 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' O ' HD13 ' A' ' 28' ' ' LEU . . . 63.08 54.01 36.08 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.539 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 2.7 mp -144.48 175.4 10.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.289 . . . . 0.0 109.999 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.465 ' CG2' HG22 ' A' ' 5' ' ' ILE . 30.4 m -107.78 85.34 2.1 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.858 -0.526 . . . . 0.0 110.994 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.567 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . 50.8 t -88.69 83.34 6.73 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.872 -1.143 . . . . 0.0 109.853 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.523 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 15.7 m -80.04 125.15 29.41 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 75.2 p -118.52 140.61 49.61 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.83 -1.169 . . . . 0.0 110.642 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.573 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 3.3 m-30 -116.24 113.38 22.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.618 -0.676 . . . . 0.0 109.215 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 47.1 mt-10 -37.24 -28.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.557 -0.714 . . . . 0.0 110.014 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -118.36 116.63 27.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.585 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . -49.19 -51.89 24.4 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.607 ' O ' HD21 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -43.56 -72.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.568 -0.96 . . . . 0.0 108.934 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 37' ' ' ASN . 32.1 tp10 -31.49 -39.32 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.811 . . . . 0.0 110.133 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.573 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -63.99 -56.41 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.607 HD21 ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -78.87 3.01 18.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.585 -1.322 . . . . 0.0 109.689 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.517 ' N ' HD21 ' A' ' 40' ' ' LEU . . . -99.47 -24.08 14.9 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.35 -19.85 15.44 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.588 ' CB ' ' NE2' ' A' ' 73' ' ' HIS . 13.8 mt -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.505 -0.747 . . . . 0.0 109.47 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . . . -35.21 -31.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.786 -0.571 . . . . 0.0 110.732 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -65.51 -55.26 18.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 108.527 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER 164.86 115.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.532 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -44.59 167.54 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.186 -0.946 . . . . 0.0 109.103 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 36.8 Cg_endo -90.92 -65.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.679 1.358 . . . . 0.0 111.456 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.521 ' CA ' HG22 ' A' ' 119' ' ' ILE . 17.7 m-20 -121.49 -55.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.704 -1.248 . . . . 0.0 111.363 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.588 ' CG1' ' CG2' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -148.97 139.24 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.723 -1.236 . . . . 0.0 110.353 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.487 HD12 ' CG1' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.26 108.4 20.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.731 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.48 178.94 4.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.984 . . . . 0.0 108.971 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.55 ' CB ' HG13 ' A' ' 9' ' ' VAL . 38.2 m -162.42 126.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.087 . . . . 0.0 110.601 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 14.0 t0 -73.0 -144.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.094 -1.004 . . . . 0.0 108.401 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER 174.57 78.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' CD ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -174.98 83.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.642 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.4 ' HB2' HD21 ' A' ' 63' ' ' LEU . 1.4 mmm -131.31 125.03 20.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -48.72 107.9 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.08 1.569 . . . . 0.0 110.518 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 125.1 140.73 5.49 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 87.3 mmm 61.64 11.83 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -1.086 . . . . 0.0 109.837 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 44.68 80.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.282 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . 66.54 90.09 0.05 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -56.76 -162.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -1.127 . . . . 0.0 109.416 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' N ' ' HG ' ' A' ' 63' ' ' LEU . . . -171.33 89.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.008 . . . . 0.0 109.994 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.501 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -88.24 -6.51 57.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 109.122 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -49.74 -22.02 1.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.33 -45.48 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.022 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.542 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.55 -45.96 23.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.15 . . . . 0.0 109.931 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.487 ' CG1' HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -38.82 -32.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.902 -1.123 . . . . 0.0 110.161 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -95.6 -67.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.836 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -36.25 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.745 0.784 . . . . 0.0 110.339 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' LYS . 1.6 mmt85 -88.53 -93.32 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.262 0.553 . . . . 0.0 111.094 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.642 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 2.1 m-70 -53.03 144.38 27.83 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.3 Cg_endo -34.74 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 124.17 1.616 . . . . 0.0 111.196 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.42 94.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.661 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 1.8 pp -125.61 151.73 70.94 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.9 Cg_endo -28.84 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.991 1.521 . . . . 0.0 112.219 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.89 146.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.506 HD13 ' CG2' ' A' ' 115' ' ' VAL . 42.8 mt -143.92 148.48 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.488 ' N ' HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -133.6 150.3 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.539 ' CE ' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.58 164.46 25.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.406 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 1.2 m -93.02 162.78 13.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 161.3 -62.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 109.063 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.467 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 t60 -176.44 -176.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 t 61.04 -124.0 0.9 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.609 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 36.56 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.254 -0.904 . . . . 0.0 109.818 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 10.79 -77.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.309 0.576 . . . . 0.0 111.78 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' ASP . 9.3 t70 -53.27 -64.74 0.72 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.193 . . . . 0.0 109.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -52.28 -46.16 65.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.272 -0.893 . . . . 0.0 110.56 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.5 -73.97 0.13 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 110.536 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 62.4 t -32.02 -32.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.996 -0.44 . . . . 0.0 111.205 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 90' ' ' ALA . 19.4 t -102.95 161.45 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.758 -1.214 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 79.07 82.05 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.484 -0.76 . . . . 0.0 109.76 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ALA . 58.4 m-85 42.47 63.2 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -0.827 . . . . 0.0 109.899 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.27 134.66 49.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.065 -1.022 . . . . 0.0 109.345 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER 76.54 151.06 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . 80.37 94.52 0.4 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . 76.08 5.23 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -1.127 . . . . 0.0 109.111 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -126.87 112.36 15.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.276 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -124.72 167.52 14.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.168 -0.957 . . . . 0.0 109.661 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.17 105.19 9.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.042 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.553 HD22 ' CG ' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -73.36 124.73 90.79 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 110.032 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -91.3 171.59 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.143 1.601 . . . . 0.0 109.716 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -117.21 145.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.725 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -82.05 166.99 70.15 Favored 'Cis proline' 0 C--N 1.317 -1.084 0 C-N-CA 120.401 -2.749 . . . . 0.0 110.114 -0.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.553 ' CG ' HD22 ' A' ' 102' ' ' LEU . 39.4 p90 -136.61 140.85 43.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.342 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.3 t0 -72.47 122.94 22.11 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.096 -1.003 . . . . 0.0 108.801 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 22' ' ' ALA . 1.5 tp -61.44 -29.58 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 110.137 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -80.45 -49.43 11.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 108.518 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 17.2 tp10 -52.3 -31.65 33.92 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -78.72 -69.65 0.55 Allowed 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.293 -0.879 . . . . 0.0 109.194 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 23' ' ' LEU . 1.2 t -35.37 -55.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.506 0.67 . . . . 0.0 110.148 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -64.55 -65.4 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 110.196 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 115' ' ' VAL . 1.3 tm? -33.46 -61.44 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.408 0.623 . . . . 0.0 110.293 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.55 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 84.4 t -56.64 -52.15 57.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 115' ' ' VAL . 18.6 tp10 -35.42 -45.12 0.32 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.32 0.581 . . . . 0.0 110.233 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -52.55 -55.91 18.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.092 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.17 -58.39 5.69 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.258 -0.901 . . . . 0.0 108.765 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 120' ' ' SER . 2.4 mm -37.37 -38.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.73 -0.606 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.546 ' C ' ' O ' ' A' ' 119' ' ' ILE . 6.0 t -20.0 -66.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.173 0.511 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.508 ' CB ' ' O ' ' A' ' 120' ' ' SER . 21.0 t-80 160.2 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 121' ' ' HIS . 2.4 m-85 37.91 30.58 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.716 0.77 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -49.8 -24.68 2.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.759 -0.588 . . . . 0.0 109.728 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.35 179.86 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 4.1 ptm180 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.09 0.472 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -134.54 87.46 0.25 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.087 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.36 87.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.159 -1.201 . . . . 0.0 108.468 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.75 111.46 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.743 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.532 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 10.6 m0 -101.71 106.86 17.94 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.995 . . . . 0.0 108.524 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -85.6 169.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.794 0.807 . . . . 0.0 111.688 -177.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -121.42 94.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.496 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 64.1 m-20 -93.37 -173.08 3.12 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.501 0.667 . . . . 0.0 110.432 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.44 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 24.5 t0 -122.24 -9.71 8.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.426 ' HB2' HG12 ' A' ' 15' ' ' ILE . 8.2 m-20 -147.12 164.48 32.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -42.6 73.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.408 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -54.52 -24.93 22.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.308 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.491 ' CG2' ' CG ' ' A' ' 10' ' ' ASP . 15.3 mm -71.59 -43.07 71.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.352 -0.843 . . . . 0.0 109.112 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.493 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.3 -44.14 75.49 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.456 ' O ' ' C ' ' A' ' 18' ' ' VAL . 19.8 t90 -60.41 -58.03 10.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.437 -0.789 . . . . 0.0 109.169 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.456 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.3 t -36.2 -62.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.645 -0.659 . . . . 0.0 110.743 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -57.36 -68.91 0.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.056 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -34.5 -32.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.683 -0.635 . . . . 0.0 110.455 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.7 tpp180 -66.97 -55.86 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.438 ' CB ' HD12 ' A' ' 108' ' ' ILE . . . -68.25 -5.99 21.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.462 -0.773 . . . . 0.0 109.059 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.565 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 3.3 mm? -102.15 -12.57 17.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.69 -40.85 28.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.66 97.52 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.0 -32.88 65.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.417 -1.049 . . . . 0.0 109.248 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.73 66.41 1.46 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.572 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 0.6 OUTLIER -134.71 -176.14 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.195 -1.179 . . . . 0.0 110.587 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.536 ' CG2' HG21 ' A' ' 5' ' ' ILE . 18.1 m -99.21 78.23 2.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 43.8 t -80.23 84.77 5.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.587 -0.696 . . . . 0.0 111.331 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 2.6 m -88.52 141.24 28.69 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 66.5 p -146.33 119.66 8.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.702 -1.249 . . . . 0.0 109.846 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.558 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 12.1 m-85 -103.55 129.74 50.83 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.365 -0.834 . . . . 0.0 109.019 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -63.45 -8.49 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.864 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 10.6 t30 -136.61 133.57 36.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.622 -1.299 . . . . 0.0 110.48 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 39' ' ' VAL . . . -51.09 -59.95 7.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -46.78 -73.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.272 -1.134 . . . . 0.0 108.92 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 37' ' ' ASN . 13.9 tp10 -32.7 -34.43 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.364 -0.835 . . . . 0.0 110.616 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 15.3 t -61.61 -57.97 9.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.099 -1.001 . . . . 0.0 109.015 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.586 ' CD2' ' HB2' ' A' ' 68' ' ' GLN . 1.3 pp -62.42 -12.38 21.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.236 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.55 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -81.02 -30.2 34.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.468 -0.77 . . . . 0.0 109.183 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.47 -28.45 20.83 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.536 ' O ' ' CE1' ' A' ' 73' ' ' HIS . 13.0 mt -88.08 6.14 37.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 109.853 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -36.27 -28.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.876 -0.515 . . . . 0.0 110.327 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' LEU . 11.6 t -61.98 -56.68 16.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.882 -1.136 . . . . 0.0 108.222 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 173.59 -165.81 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.441 -0.787 . . . . 0.0 110.524 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.584 ' CG2' ' CB ' ' A' ' 76' ' ' LEU . 4.4 m -70.15 154.0 94.89 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.67 . . . . 0.0 110.929 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.6 Cg_endo -115.6 -116.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 N-CA-C 107.395 -1.81 . . . . 0.0 107.395 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.538 ' CA ' HD11 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -100.08 -75.32 0.58 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.207 -1.558 . . . . 0.0 108.605 178.083 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 115' ' ' VAL . 13.1 t -145.63 137.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.164 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.543 HD22 ' CD1' ' A' ' 69' ' ' ILE . 2.8 mp -102.51 110.61 22.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.931 -1.106 . . . . 0.0 110.606 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.557 ' HG ' ' CG1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -83.72 161.11 21.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.31 -0.869 . . . . 0.0 109.685 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 m -152.23 136.31 16.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.369 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 55' ' ' ILE . 2.4 p30 -100.72 -158.61 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.072 -1.017 . . . . 0.0 110.047 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.537 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 1.2 pp -143.09 120.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 3.2 ttm-85 178.72 -78.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.476 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 12.7 mmt 54.22 170.06 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.076 -1.015 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.2 Cg_endo -84.32 161.68 13.09 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.856 1.45 . . . . 0.0 110.24 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.71 101.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -176.84 -40.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.0 109.491 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 60' ' ' MET . 0.4 OUTLIER -162.8 -77.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' MET . . . 152.74 -45.53 0.59 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -154.69 -76.48 0.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.312 -1.111 . . . . 0.0 109.3 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 63' ' ' LEU . . . 41.34 44.26 2.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 6.4 mt -130.86 -25.01 2.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.578 ' HA ' ' CG2' ' A' ' 69' ' ' ILE . 1.2 tp -66.24 -10.39 41.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.718 -1.239 . . . . 0.0 108.719 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' CG ' ' HB3' ' A' ' 89' ' ' ALA . 17.3 mtmt -71.86 -55.06 8.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.586 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -67.02 -53.78 27.97 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.701 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 0.8 OUTLIER -43.13 -14.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.228 -0.92 . . . . 0.0 111.017 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' GLN . 19.1 tptp -100.93 -74.08 0.62 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.31 -1.494 . . . . 0.0 108.003 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 70' ' ' LYS . 32.9 mm-40 -36.96 -59.25 0.72 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.501 0.667 . . . . 0.0 111.216 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.701 ' NE ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -35.74 -48.09 0.52 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.504 -0.748 . . . . 0.0 111.716 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.755 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 14.6 m-70 -107.58 142.16 24.57 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.68 -1.262 . . . . 0.0 109.428 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.755 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 32.1 Cg_endo -26.36 -78.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 124.203 1.633 . . . . 0.0 112.777 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.46 ' O ' ' CG ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -175.58 100.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.42 -1.425 . . . . 0.0 110.544 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER -123.14 168.09 13.06 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 108.857 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.598 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 33.7 Cg_endo -71.37 137.43 30.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.676 1.356 . . . . 0.0 111.63 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.586 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -126.32 156.29 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.557 ' CG1' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.1 147.44 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -153.91 125.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 2.7 mtt -66.43 125.73 26.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.6 p -86.93 87.35 7.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 84' ' ' HIS . . . -109.76 -19.27 13.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER 171.42 -65.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.287 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.549 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 3.5 m -77.94 -172.22 2.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 83.76 -44.52 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.666 -0.647 . . . . 0.0 109.551 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 86' ' ' ASP . 1.2 mm? -34.19 -32.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.786 -0.571 . . . . 0.0 110.482 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.8 t0 -70.28 -68.91 0.39 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.501 ' HB3' ' CG ' ' A' ' 67' ' ' LYS . . . -41.89 -26.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -82.51 -74.59 0.34 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.091 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 99.0 t -34.25 -30.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.863 -0.523 . . . . 0.0 111.162 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.0 m -97.94 -153.32 0.42 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.974 -1.079 . . . . 0.0 109.708 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.12 69.81 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.049 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 95' ' ' GLN . 1.4 t80 67.64 10.42 7.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.3 -0.875 . . . . 0.0 109.004 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 10.7 tm0? 44.78 82.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.8 mt-30 163.37 -25.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.03 -144.35 44.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -143.06 59.5 1.42 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -1.125 . . . . 0.0 109.346 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER 82.61 -24.57 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.633 -0.667 . . . . 0.0 109.887 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 44.3 p-10 -42.07 127.89 3.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 162.78 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.495 -0.753 . . . . 0.0 109.412 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' MET . 12.6 tp -109.12 141.83 24.26 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 108.977 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -104.93 -167.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.758 1.399 . . . . 0.0 111.04 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -154.69 160.63 30.74 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -72.76 143.87 79.03 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.387 -2.339 . . . . 0.0 110.764 0.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.558 ' CG ' ' N ' ' A' ' 107' ' ' ASP . 88.4 t80 -129.64 169.68 14.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' CG ' ' A' ' 106' ' ' PHE . 3.7 t70 -85.91 -157.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.625 -0.672 . . . . 0.0 109.948 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.438 HD12 ' CB ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -130.12 -48.88 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 108.443 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.2 -41.45 81.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 11.3 tp10 -50.77 -47.84 59.5 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -62.0 -65.24 0.72 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 28' ' ' LEU . 2.2 t -34.7 -78.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.528 ' N ' ' CG1' ' A' ' 112' ' ' VAL . . . -39.03 -70.28 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.647 -0.658 . . . . 0.0 111.578 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 113' ' ' ALA . 27.8 tp -36.35 -43.21 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.972 0.891 . . . . 0.0 110.073 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.547 ' CG2' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -68.43 -58.73 5.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.527 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 4.1 mt-10 -36.92 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.488 0.661 . . . . 0.0 109.536 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 115' ' ' VAL . 1.7 mtp180 -85.05 -48.04 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.481 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -53.79 -62.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 108.96 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.542 HD12 ' CG2' ' A' ' 50' ' ' VAL . 7.1 mt -36.22 -40.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 t -71.86 -46.02 59.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.991 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -47.86 -71.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 109.903 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 3.2 m-85 -44.85 112.13 0.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.912 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER 168.85 -27.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.405 -0.809 . . . . 0.0 109.362 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.53 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.287 0.565 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.428 ' O ' HD22 ' A' ' 28' ' ' LEU . . . -103.74 145.41 16.14 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.586 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -99.39 95.81 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.471 -1.017 . . . . 0.0 110.419 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -91.22 113.04 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.009 -1.057 . . . . 0.0 108.604 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.646 ' CD2' ' CG2' ' A' ' 31' ' ' THR . 12.8 m95 -102.84 98.85 8.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 109.934 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 9' ' ' VAL . 15.2 t -85.48 167.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.483 -0.76 . . . . 0.0 109.378 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.554 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 99.0 t -132.4 113.59 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 109.792 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.535 ' O ' ' C ' ' A' ' 11' ' ' ASP . 6.1 t70 177.87 -65.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.807 . . . . 0.0 109.484 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.546 ' HB3' ' CA ' ' A' ' 34' ' ' GLU . 20.9 t0 17.21 55.07 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.198 0.523 . . . . 0.0 111.478 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.628 ' O ' ' CB ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -112.95 52.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 11.9 t 144.22 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.21 42.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.663 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.529 ' HB ' ' N ' ' A' ' 11' ' ' ASP . 2.4 mp -89.49 -40.53 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.987 . . . . 0.0 108.979 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.517 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 23.7 ttp180 -61.21 -41.39 96.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.455 ' O ' ' C ' ' A' ' 18' ' ' VAL . 76.5 t90 -62.66 -63.71 1.14 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.6 t -37.99 -65.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.759 0.79 . . . . 0.0 110.528 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' ARG . 16.4 mt -56.52 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 110.785 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 15.2 tm-20 -34.61 -30.13 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.907 -0.495 . . . . 0.0 111.215 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.3 tpt180 -68.12 -56.64 8.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.943 -1.098 . . . . 0.0 108.644 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.583 ' CB ' ' CD1' ' A' ' 108' ' ' ILE . . . -71.34 -8.69 55.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 0.0 109.015 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 3.0 mp -96.31 -16.69 21.18 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.82 -37.4 64.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.6 -36.3 58.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.21 -13.95 62.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -1.177 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.63 56.84 7.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.514 HD21 ' CG1' ' A' ' 112' ' ' VAL . 0.3 OUTLIER -131.1 -178.04 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -1.234 . . . . 0.0 110.009 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 5' ' ' ILE . 30.0 m -101.47 90.45 4.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 25.2 t -84.46 86.05 7.33 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.646 ' CG2' ' CD2' ' A' ' 7' ' ' TRP . 17.4 m -91.0 137.48 32.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 16.1 p -156.34 135.79 12.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.677 -1.264 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 29.8 m-85 -108.87 -170.44 1.66 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.546 ' CA ' ' HB3' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -108.92 -6.08 15.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.055 . . . . 0.0 109.536 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.417 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -148.86 143.84 26.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.255 -179.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.55 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -60.02 -42.86 98.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 38' ' ' GLU . 4.4 t-20 -49.42 -79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.052 -1.263 . . . . 0.0 108.866 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 37' ' ' ASN . 50.2 mt-10 -34.46 -42.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.765 -0.584 . . . . 0.0 110.434 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 18.1 t -54.84 -55.48 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 36' ' ' GLY . 2.6 mm? -65.98 -18.13 65.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 108.829 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.8 -25.53 60.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 108.951 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.6 -17.27 17.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HG ' ' CD2' ' A' ' 73' ' ' HIS . 1.4 mm? -77.69 -9.2 58.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.99 -19.81 0.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -57.38 4.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -164.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 76' ' ' LEU . 10.2 t -100.03 135.72 20.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.491 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 36.2 Cg_endo -95.17 -95.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.04 1.547 . . . . 0.0 109.389 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -115.39 -75.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.864 -1.148 . . . . 0.0 109.086 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 119' ' ' ILE . 2.8 t -149.57 142.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.33 -0.856 . . . . 0.0 109.467 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 6.5 tp -94.75 158.74 15.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.033 . . . . 0.0 108.797 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -141.57 127.76 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.998 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.3 p -94.04 103.79 15.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.333 -0.855 . . . . 0.0 108.889 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.464 ' HB3' ' OD2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -88.01 122.64 31.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.955 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.54 HG22 ' CB ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -98.06 81.86 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -114.27 -19.35 11.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.883 . . . . 0.0 109.754 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -45.14 140.89 3.53 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -100.11 147.36 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.956 1.503 . . . . 0.0 110.199 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.65 -174.77 17.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -24.24 64.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -1.153 . . . . 0.0 109.661 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -111.73 159.44 18.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 55' ' ' ILE . . . -118.94 -53.82 0.28 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER 179.13 111.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.99 29.47 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.364 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -99.74 6.61 45.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 10.4 tp -65.8 -60.74 2.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.649 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -48.02 -39.12 18.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.171 -0.956 . . . . 0.0 108.523 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 69' ' ' ILE . 3.8 tp60 -52.09 -56.59 13.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 68' ' ' GLN . 8.2 mt -33.49 -76.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.266 0.555 . . . . 0.0 110.025 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -40.49 -59.37 1.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 110.085 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.85 -68.38 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.785 -0.572 . . . . 0.0 110.9 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 73' ' ' HIS . 1.7 mpp_? -73.06 -62.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -31.81 115.85 0.38 Allowed Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.778 -0.576 . . . . 0.0 110.327 -179.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.46 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 36.9 Cg_endo -41.26 -74.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.017 1.535 . . . . 0.0 110.441 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.2 ptp -178.39 64.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.54 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.6 OUTLIER -126.31 148.63 64.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.0 Cg_endo -48.53 141.16 20.36 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.828 1.436 . . . . 0.0 111.815 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 99' ' ' PHE . 2.5 m -139.63 97.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 80' ' ' ILE . 11.2 mt -65.72 160.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 101' ' ' TYR . 1.3 pp -142.69 133.98 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.573 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -71.74 170.47 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.148 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.09 157.36 15.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.091 -1.006 . . . . 0.0 110.283 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.54 ' CB ' HG22 ' A' ' 55' ' ' ILE . . . 169.6 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.463 ' O ' ' OG ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 178.18 -77.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 110.497 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 86' ' ' ASP . 78.9 p 47.62 26.99 0.93 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 60.22 120.28 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.545 ' O ' ' C ' ' A' ' 88' ' ' ASP . 18.5 tp -38.12 -26.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.21 1.005 . . . . 0.0 108.523 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.7 t0 -32.7 -65.39 0.16 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.065 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.55 ' O ' ' CD2' ' A' ' 66' ' ' LEU . . . -82.43 -30.89 29.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -64.34 -65.65 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.171 -0.955 . . . . 0.0 109.144 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.49 -53.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 122.978 0.511 . . . . 0.0 111.504 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.59 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 1.6 t -56.66 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.043 -1.036 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 99' ' ' PHE . . . -128.27 -73.89 0.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.485 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 11.61 35.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 96' ' ' GLN . 5.5 mt-30 -98.24 108.54 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 108.55 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 11.3 tt0 61.39 164.13 0.08 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.988 . . . . 0.0 108.508 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.01 172.92 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -125.63 103.83 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.05 -1.265 . . . . 0.0 109.791 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.576 ' CE1' HG22 ' A' ' 78' ' ' VAL . 33.2 p90 170.63 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.0 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.07 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -167.04 138.16 3.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.007 . . . . 0.0 110.024 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -128.47 113.46 19.52 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -103.94 164.95 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.668 1.351 . . . . 0.0 111.187 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 13.0 pttp -92.87 160.34 34.16 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.515 -0.741 . . . . 0.0 109.286 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -79.29 159.02 90.23 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 120.773 -2.594 . . . . 0.0 110.483 -0.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CE1' ' HE3' ' A' ' 81' ' ' MET . 13.1 p90 -139.12 146.46 40.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 2.4 t70 -86.36 146.61 26.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 108.868 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' A' ' 22' ' ' ALA . 1.5 mp -76.8 -26.56 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.267 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.11 -36.58 19.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.535 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 40.8 tt0 -61.73 -42.19 98.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.96 -67.46 0.53 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.514 ' CG1' HD21 ' A' ' 28' ' ' LEU . 24.8 t -38.01 -52.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.497 -0.752 . . . . 0.0 110.937 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -62.58 -69.45 0.26 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.495 -0.753 . . . . 0.0 110.873 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.489 ' C ' ' O ' ' A' ' 113' ' ' ALA . 16.9 tp -34.79 -55.68 0.56 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.509 0.671 . . . . 0.0 109.943 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.534 HG23 ' CG2' ' A' ' 50' ' ' VAL . 1.2 t -54.79 -56.77 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER -38.02 -37.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 110.751 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.616 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -83.53 -35.69 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 110.268 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.616 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.4 -59.88 4.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.787 -1.195 . . . . 0.0 108.326 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.541 HG12 ' CG2' ' A' ' 50' ' ' VAL . 8.6 mt -34.5 -40.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.12 0.486 . . . . 0.0 110.384 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -85.61 53.32 2.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.585 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.564 ' NE2' ' CE1' ' A' ' 122' ' ' TYR . 23.7 p-80 -96.31 -9.19 30.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.564 ' CE1' ' NE2' ' A' ' 121' ' ' HIS . 8.2 m-85 -69.3 -5.86 25.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.79 53.01 1.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.395 179.9 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.462 ' C ' HD22 ' A' ' 28' ' ' LEU . 14.7 mtm-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.489 0.662 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.63 112.42 0.61 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.354 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' CG2' ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -90.73 111.62 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 108.892 179.27 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' CG1' HG22 ' A' ' 8' ' ' VAL . 61.5 t -104.51 107.28 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.031 . . . . 0.0 109.555 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.45 93.77 6.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 108.551 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.525 HG21 ' CB ' ' A' ' 52' ' ' LEU . 54.4 t -102.89 127.43 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.535 ' CG1' ' HA2' ' A' ' 36' ' ' GLY . 1.9 m -66.6 121.37 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 53.7 p-10 -110.45 178.67 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.206 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 34.1 t0 -74.4 -86.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.32 -0.862 . . . . 0.0 109.788 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.72 173.65 11.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 11.7 p -75.93 -30.37 58.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.805 . . . . 0.0 109.358 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -73.82 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.317 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.473 ' CG2' ' HB2' ' A' ' 10' ' ' ASP . 24.6 mm -66.01 -32.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 108.831 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.599 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 11.6 ptt180 -68.08 -35.31 77.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.493 ' CH2' ' HG3' ' A' ' 21' ' ' ARG . 1.8 t-105 -55.12 -66.16 0.46 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 54.0 t -40.77 -65.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.816 0.817 . . . . 0.0 110.478 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 21' ' ' ARG . 4.1 mm? -54.78 -75.07 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.569 -0.707 . . . . 0.0 110.986 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -34.5 -31.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.331 0.586 . . . . 0.0 110.219 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.08 -58.61 6.69 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.92 -10.07 50.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -0.823 . . . . 0.0 109.238 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.561 ' CD2' ' CB ' ' A' ' 30' ' ' CYS . 1.5 mt -93.15 -13.03 28.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 109.758 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.34 61.95 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.93 -38.0 37.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -64.36 -35.02 79.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -1.142 . . . . 0.0 108.726 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' O ' ' HG ' ' A' ' 28' ' ' LEU . . . 95.69 50.11 2.03 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.534 HD21 ' CG1' ' A' ' 112' ' ' VAL . 1.1 mt -141.03 166.66 24.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.937 -1.331 . . . . 0.0 109.941 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.496 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 87.5 m -101.4 60.04 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.561 ' CB ' ' CD2' ' A' ' 23' ' ' LEU . 33.7 t -81.4 88.49 6.12 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 109.658 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 11.8 m -101.18 137.46 39.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 109.472 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 1.2 p -109.66 165.49 11.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 108.671 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.6 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 2.0 m-85 -137.91 115.97 11.68 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.082 -1.012 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 14.3 tt0 -36.67 -39.1 0.19 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.96 -0.462 . . . . 0.0 110.461 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -111.92 126.1 54.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 110.521 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.535 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -51.68 -45.84 54.36 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.588 ' O ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -60.28 -63.53 1.27 Allowed 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.181 -1.187 . . . . 0.0 107.866 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 20.0 tp10 -34.57 -28.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.551 -0.718 . . . . 0.0 110.809 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.6 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -81.88 -51.08 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.919 -1.113 . . . . 0.0 110.504 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.588 HD11 ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -73.47 -11.36 60.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.791 -1.193 . . . . 0.0 109.753 -179.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.562 ' N ' HD11 ' A' ' 40' ' ' LEU . . . -94.44 -49.11 5.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.24 -25.11 46.43 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 7.9 mt -73.17 -77.64 0.1 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 82.39 -47.94 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -99.24 -26.12 14.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.642 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 64.42 62.82 0.79 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 123.49 1.614 . . . . 0.0 109.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.609 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -104.33 40.97 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 119.752 -1.842 . . . . 0.0 112.771 -179.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 47' ' ' THR . 38.0 Cg_endo -101.08 -167.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 116.842 -1.638 . . . . 0.0 109.633 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -92.97 -52.48 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.539 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 6.6 t -146.59 128.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 108.89 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -98.47 114.82 27.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 0.0 108.376 179.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.525 ' CB ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -108.4 -174.28 2.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.371 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.48 ' HA ' HG21 ' A' ' 9' ' ' VAL . 26.6 t -155.24 123.89 6.05 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 9' ' ' VAL . 13.9 p-10 -102.63 149.75 24.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.98 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -102.88 109.78 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -161.63 28.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.469 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.7 mtt -93.74 125.94 51.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.6 Cg_endo -103.55 131.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.929 1.489 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.15 -74.23 0.31 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -161.1 128.28 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.422 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 68.72 149.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.98 -84.15 0.66 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' ' CD1' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -146.52 -54.3 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -1.107 . . . . 0.0 109.484 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 47.47 60.83 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.427 -0.795 . . . . 0.0 109.477 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD1' ' HB2' ' A' ' 63' ' ' LEU . 1.4 mt -124.35 8.41 8.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.449 HD12 ' CD1' ' A' ' 80' ' ' ILE . 4.9 mp -75.73 -19.18 59.25 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.278 -0.889 . . . . 0.0 108.699 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 2.9 pttt -66.01 -39.2 90.07 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.529 ' OE1' ' CA ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -80.38 -57.06 3.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 109.235 179.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.52 ' CG2' HG12 ' A' ' 78' ' ' VAL . 2.6 mt -39.71 -32.71 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.896 -1.127 . . . . 0.0 110.239 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -92.09 -73.09 0.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.087 -1.008 . . . . 0.0 110.379 -178.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -35.22 -30.78 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.554 -0.716 . . . . 0.0 110.565 -179.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -97.91 -58.55 1.96 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 110.368 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' CB ' ' A' ' 46' ' ' LYS . 1.2 m-70 -98.38 133.03 23.2 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.403 -0.811 . . . . 0.0 109.496 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.57 ' N ' ' HE2' ' A' ' 46' ' ' LYS . 39.6 Cg_endo -138.59 1.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 117.341 -1.306 . . . . 0.0 112.162 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.542 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 3.6 mtt -68.59 7.12 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.695 -1.253 . . . . 0.0 112.778 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -163.06 177.76 1.78 Allowed Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.186 -1.571 . . . . 0.0 109.918 179.007 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.0 Cg_endo -86.99 164.66 8.72 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.885 1.466 . . . . 0.0 111.064 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.17 144.91 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 80' ' ' ILE . 3.5 mp -137.78 164.0 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 109.739 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.506 ' N ' ' CG2' ' A' ' 79' ' ' ILE . 11.9 tt -141.99 157.39 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -81.93 166.49 19.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.28 102.7 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.564 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -96.74 -151.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -144.23 32.36 1.22 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.62 -34.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 88' ' ' ASP . 1.3 p30 -49.93 -24.17 2.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.017 -1.052 . . . . 0.0 109.692 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 86' ' ' ASP . 4.0 tp -34.97 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.83 -0.544 . . . . 0.0 110.913 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 86' ' ' ASP . 42.8 t0 -58.83 -59.19 5.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.995 -1.065 . . . . 0.0 109.883 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.26 -44.49 29.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 109.961 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -50.21 -41.7 50.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.689 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -33.07 -41.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.457 0.646 . . . . 0.0 109.99 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 5.9 t -64.11 86.18 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.359 0.6 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.75 -47.96 0.19 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -72.67 -18.95 61.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -69.02 -12.04 61.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.54 -0.725 . . . . 0.0 109.204 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.42 -157.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 109.33 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.81 67.88 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . -168.08 52.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -1.122 . . . . 0.0 109.324 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 36.7 m-85 -151.92 164.41 37.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.607 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB3' HG12 ' A' ' 79' ' ' ILE . 2.4 t0 -158.44 -157.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.37 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.14 142.83 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 109.791 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.23 139.86 35.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 108.893 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -114.72 176.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.748 1.394 . . . . 0.0 110.806 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 2.6 mtmp? -121.92 158.41 54.87 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 0.0 109.153 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -89.72 174.04 24.02 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 120.505 -2.706 . . . . 0.0 110.195 -0.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 33.2 p90 -153.59 161.17 42.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 14.6 t0 -73.92 -146.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.2 mm -120.48 -68.05 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 108.798 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 110' ' ' GLU . 11.7 t0 -59.79 -46.55 88.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 109' ' ' ASP . 28.1 tt0 -43.09 -41.69 3.69 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.76 -75.88 0.11 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.534 ' CG1' HD21 ' A' ' 28' ' ' LEU . 52.1 t -38.39 -69.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 110.243 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.497 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -39.36 -62.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' A' ' 113' ' ' ALA . 7.4 tp -34.3 -56.11 0.51 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.375 0.607 . . . . 0.0 109.944 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.526 ' CG1' ' N ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -58.24 -52.66 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.526 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 37.7 tp10 -39.19 -36.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.419 -0.801 . . . . 0.0 110.807 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.602 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -77.92 -36.77 49.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 110.74 -178.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.75 -53.61 51.77 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.733 -1.229 . . . . 0.0 108.044 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.539 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 5.3 mt -41.14 -50.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.517 0.675 . . . . 0.0 111.008 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.487 ' O ' ' C ' ' A' ' 121' ' ' HIS . 1.5 t -35.02 -34.9 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.447 -0.783 . . . . 0.0 111.998 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 t-80 -32.65 -66.37 0.14 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.546 -0.721 . . . . 0.0 111.273 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.63 -19.31 13.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.03 -1.044 . . . . 0.0 109.931 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 55.99 3.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.498 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.182 0.515 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.582 ' N ' ' CD2' ' A' ' 28' ' ' LEU . . . -162.62 119.84 0.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.558 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.1 mm -102.54 116.12 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -1.205 . . . . 0.0 109.528 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' CG1' HG21 ' A' ' 8' ' ' VAL . 1.5 t -123.65 109.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -0.796 . . . . 0.0 108.951 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.631 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 27.7 m0 -99.13 89.16 4.15 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.351 -1.339 . . . . 0.0 107.489 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.535 HG23 ' CD1' ' A' ' 52' ' ' LEU . 27.6 t -73.28 142.68 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.547 -0.721 . . . . 0.0 110.136 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 36' ' ' GLY . 40.6 t -92.7 102.4 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.95 -1.094 . . . . 0.0 109.251 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 88.8 m-20 -53.96 -173.23 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 110.002 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -137.47 -5.97 1.77 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.337 -0.852 . . . . 0.0 110.786 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 171.29 55.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.458 -1.402 . . . . 0.0 110.871 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 54.69 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.559 0.695 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 75.4 -7.82 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.161 -0.962 . . . . 0.0 109.828 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' A' ' 10' ' ' ASP . 18.0 mm -85.48 -32.16 7.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.074 -1.017 . . . . 0.0 108.718 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.7 OUTLIER -62.38 -45.5 92.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.436 ' O ' ' C ' ' A' ' 18' ' ' VAL . 26.9 t90 -58.7 -60.49 3.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.5 t -39.21 -70.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 110.914 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 21' ' ' ARG . 7.8 mt -57.35 -72.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.391 -0.818 . . . . 0.0 110.838 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 19' ' ' LEU . 3.3 tt0 -35.8 -30.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 110.526 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 8.7 tpt85 -66.41 -56.0 13.08 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.435 ' CB ' HG13 ' A' ' 108' ' ' ILE . . . -71.11 -4.43 25.16 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.484 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -103.73 -11.35 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -43.88 42.68 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.62 -19.56 69.2 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.71 -19.37 32.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.581 -0.952 . . . . 0.0 108.726 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.6 50.03 33.62 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.631 ' CD1' ' CG1' ' A' ' 112' ' ' VAL . 13.8 mt -123.77 179.01 4.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 110.425 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.537 ' CG2' HG22 ' A' ' 5' ' ' ILE . 18.0 m -95.49 67.3 2.87 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.536 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 38.6 t -79.64 83.64 5.59 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.953 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.631 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 5.2 m -94.84 143.29 26.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.7 p -138.67 119.43 14.15 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.519 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 7.5 m-85 -85.01 -157.65 0.31 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.629 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -118.36 -37.36 3.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.913 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' O ' HG22 ' A' ' 39' ' ' VAL . 49.1 m-80 -131.1 146.8 52.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.005 . . . . 0.0 109.81 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.526 ' N ' HG12 ' A' ' 9' ' ' VAL . . . -53.12 -39.71 58.18 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 2.2 m-20 -47.63 -84.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.904 -1.35 . . . . 0.0 108.343 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' ASN . 2.8 mt-10 -35.14 -48.09 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.757 -0.589 . . . . 0.0 110.969 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 48.6 t -50.37 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 72' ' ' ARG . 3.4 tm? -54.21 -20.72 7.36 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.527 -0.733 . . . . 0.0 109.527 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 -41.49 79.08 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.6 -15.63 48.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.537 HD12 ' NE2' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -84.1 -0.81 53.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.0 109.862 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.91 -19.59 7.01 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.14 -0.975 . . . . 0.0 108.753 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 2.4 m -88.74 -27.81 20.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER 90.21 69.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -102.32 -90.57 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 111.185 -179.119 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 37.4 Cg_endo -40.55 130.84 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.835 1.439 . . . . 0.0 111.129 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.474 ' OD2' HG12 ' A' ' 5' ' ' ILE . 4.8 m-20 -75.88 -23.76 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -136.95 123.52 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.567 ' CD2' ' HG2' ' A' ' 48' ' ' PRO . 3.9 mm? -102.06 132.25 48.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.301 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.575 ' CD2' ' HB ' ' A' ' 79' ' ' ILE . 2.5 mt -104.71 165.37 11.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.065 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.474 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 49.1 m -142.5 109.95 5.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.43 169.98 16.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.54 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 2.1 tp -130.33 97.04 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -175.53 73.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.414 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.7 mtm -134.1 171.69 8.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.378 -0.826 . . . . 0.0 109.452 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -97.64 143.45 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.001 1.527 . . . . 0.0 110.181 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.37 -173.92 16.87 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -59.99 109.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' CA ' ' A' ' 85' ' ' SER . 0.1 OUTLIER 72.21 -165.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.969 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' ILE . . . 169.85 39.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 51.7 tp -105.09 64.54 0.72 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -1.184 . . . . 0.0 109.549 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' A' ' 9' ' ' VAL . . . 41.8 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.348 -0.845 . . . . 0.0 109.787 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.505 ' HB3' ' CG ' ' A' ' 68' ' ' GLN . 1.1 tp -127.7 70.85 1.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 109.296 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -71.45 -59.68 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 109.713 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -46.58 -31.72 2.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.818 -1.176 . . . . 0.0 108.261 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.58 ' HG3' ' N ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -66.74 -57.41 7.17 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.604 HG21 ' CG ' ' A' ' 73' ' ' HIS . 1.5 mt -38.67 -64.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.529 ' N ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -42.75 -64.61 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.233 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.1 tp60 -34.05 -43.35 0.14 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.847 -0.533 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.52 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.7 60.55 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.057 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.637 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 18.7 t-80 -156.71 131.17 5.05 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.637 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -52.39 -170.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.604 1.318 . . . . 0.0 110.49 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mmt -95.53 48.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 110.763 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.608 ' CD2' ' CE1' ' A' ' 73' ' ' HIS . 3.3 pp -91.17 122.41 66.44 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.869 -1.144 . . . . 0.0 108.463 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.538 ' HG2' ' CG2' ' A' ' 50' ' ' VAL . 34.8 Cg_endo -34.31 147.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.11 1.584 . . . . 0.0 112.52 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.453 HG11 ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.8 124.3 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.575 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -89.16 133.31 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.0 109.313 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 53' ' ' SER . 0.5 OUTLIER -119.35 140.66 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.385 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.522 ' HE3' ' CZ ' ' A' ' 106' ' ' PHE . 2.9 ttm -109.56 113.64 26.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.461 ' O ' HG22 ' A' ' 55' ' ' ILE . 87.5 m 49.89 72.83 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' ' OH ' ' A' ' 101' ' ' TYR . . . -91.0 165.11 13.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.888 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -167.78 -88.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.533 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER 40.19 44.64 1.59 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 10.2 t70 67.74 132.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.547 ' C ' ' O ' ' A' ' 86' ' ' ASP . 15.1 mt -35.17 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 109.271 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -35.68 -67.03 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 85' ' ' SER . . . -72.46 -24.28 61.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 108.626 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -71.41 -76.17 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 109.564 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' A' ' 90' ' ' ALA . 2.9 t -11.27 -58.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 122.804 0.442 . . . . 0.0 111.744 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 90' ' ' ALA . 4.9 t -40.42 108.81 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 109.75 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 99' ' ' PHE . . . 176.4 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.802 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.54 -11.21 59.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.279 -0.888 . . . . 0.0 109.96 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.35 107.49 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.834 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER 55.77 45.46 24.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.88 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 96' ' ' GLN . . . 43.14 -122.63 3.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.58 -93.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.454 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.497 ' CD1' ' OG ' ' A' ' 92' ' ' SER . 5.6 m-85 -62.92 171.52 2.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.87 134.52 7.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.0 109.998 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.417 ' OH ' ' O ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -92.01 95.22 9.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 79' ' ' ILE . 2.3 tp -101.27 132.55 21.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.97 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -121.57 -161.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.834 1.439 . . . . 0.0 109.94 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 8.4 mttt -117.99 159.75 41.65 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.213 -0.929 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -83.22 173.23 44.99 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.703 -2.624 . . . . 0.0 110.476 0.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.522 ' CZ ' ' HE3' ' A' ' 81' ' ' MET . 38.6 p90 -167.9 130.32 1.54 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.531 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 7.4 t70 -70.28 149.07 47.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.154 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.524 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 36.9 mm -66.11 -40.72 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -74.96 -40.85 60.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.531 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 9.9 tp10 -51.05 -33.64 26.42 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -83.06 -73.67 0.39 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.47 -0.769 . . . . 0.0 109.666 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.631 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -36.6 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.495 -0.753 . . . . 0.0 110.069 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.576 ' O ' ' CG ' ' A' ' 116' ' ' GLU . . . -79.9 -66.83 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.747 0.784 . . . . 0.0 109.861 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 2.8 tm? -38.47 -36.71 0.26 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.278 1.037 . . . . 0.0 109.259 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.522 HG11 HG22 ' A' ' 50' ' ' VAL . 1.1 t -74.13 -59.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.576 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 4.1 pt-20 -38.72 -30.88 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.939 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -77.14 -54.36 6.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.118 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 121' ' ' HIS . . . -46.07 -60.93 1.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 108.972 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.581 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 6.2 mt -35.78 -42.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.227 0.537 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -92.21 50.29 1.62 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 3.4 t60 -97.79 -41.36 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.219 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -84.35 10.99 9.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.325 -0.86 . . . . 0.0 109.584 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -95.74 18.75 12.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.609 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 122.142 0.973 . . . . 0.0 108.858 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.497 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . 136.07 161.38 9.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HB ' ' CB ' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -131.61 112.37 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.245 . . . . 0.0 109.628 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.1 t -126.84 114.22 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.687 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.618 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 15.3 m0 -99.88 89.59 4.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.793 -1.192 . . . . 0.0 108.668 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 32' ' ' THR . 70.8 t -77.18 143.64 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.661 -0.649 . . . . 0.0 110.846 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 75.5 t -82.44 110.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 0.0 109.109 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 16' ' ' ARG . 14.0 m-20 -56.32 168.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 109.923 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.85 23.44 4.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 109.321 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 170.49 176.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.156 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' SER . 81.0 p -79.05 146.57 33.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.0 OUTLIER 75.74 4.65 3.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 12' ' ' ASP . 45.5 mm -78.11 -32.47 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.796 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -58.93 -47.61 84.44 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 15.3 t90 -58.19 -64.22 0.99 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.2 t -37.0 -69.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.534 -0.729 . . . . 0.0 110.83 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.4 mt -49.54 -76.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 110.52 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 19' ' ' LEU . 10.6 tp10 -36.05 -29.38 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.701 -0.624 . . . . 0.0 110.737 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -65.4 -55.77 16.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.0 -7.27 33.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.485 -0.759 . . . . 0.0 109.135 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.56 ' CD2' ' CG2' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -104.9 -5.36 21.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.79 26.92 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.35 38.59 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.94 80.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -1.12 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.23 61.42 0.89 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.52 HD21 ' CG1' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -136.82 179.1 6.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -1.162 . . . . 0.0 109.765 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 29' ' ' THR . 24.2 m -100.4 75.56 1.8 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.0 t -81.09 88.66 5.97 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.384 -0.823 . . . . 0.0 110.02 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.618 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 20.2 m -97.79 145.28 26.54 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -139.93 152.16 46.15 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.732 -1.23 . . . . 0.0 110.09 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.594 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.9 m-85 -134.1 122.91 23.58 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.778 0.799 . . . . 0.0 109.023 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -43.81 -49.75 8.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.538 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 1.5 m120 -117.25 138.28 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.437 -1.415 . . . . 0.0 112.188 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 39' ' ' VAL . . . -57.56 -15.03 15.92 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' VAL . 9.4 t30 -67.28 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.0 tt0 -35.66 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.869 -0.519 . . . . 0.0 109.821 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 33' ' ' PHE . 35.2 t -61.93 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.606 ' CD1' ' CB ' ' A' ' 72' ' ' ARG . 3.4 tm? -64.88 -16.58 63.38 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.319 0.581 . . . . 0.0 109.65 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.35 -21.06 21.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.935 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.08 -21.26 18.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 7.5 mt -88.85 -96.84 0.09 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 82.38 -54.72 0.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 12.6 m -101.06 -5.51 25.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.546 ' HG2' ' CD2' ' A' ' 73' ' ' HIS . 11.7 mttt 62.73 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 109.202 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -100.66 -61.88 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 111.638 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 36.8 Cg_endo -49.88 -177.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.6 1.316 . . . . 0.0 110.56 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.544 ' HB2' ' CD1' ' A' ' 119' ' ' ILE . 2.5 m-20 -90.85 -25.3 19.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 110.487 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.576 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 2.5 t -148.79 132.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.846 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' CD2' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -101.23 126.65 47.98 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.483 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -108.71 174.42 5.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.455 ' HB2' HG23 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -155.72 124.07 5.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.03 169.78 10.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.464 ' HB ' HD12 ' A' ' 63' ' ' LEU . 1.1 tp -144.31 115.3 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 109.403 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -141.91 -28.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.358 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.45 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -97.36 105.22 23.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.973 -1.08 . . . . 0.0 109.513 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 36.6 Cg_endo -75.99 137.91 20.11 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.042 1.549 . . . . 0.0 110.399 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 60' ' ' MET . . . 144.26 -114.18 0.79 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 3.2 mpp? -145.78 32.9 1.03 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -1.129 . . . . 0.0 109.403 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.17 4.4 2.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.897 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.45 ' HA3' ' HG3' ' A' ' 57' ' ' MET . . . -105.73 -86.88 1.94 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -79.13 -0.5 31.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 109.488 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.33 64.49 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 108.944 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.0 mp -81.65 0.21 39.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.522 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 2.6 mm? -78.23 -14.55 59.4 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.181 -0.949 . . . . 0.0 108.525 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.08 57.09 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -69.46 -50.94 40.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 108.847 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.63 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 2.2 tt -33.59 -60.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.643 -0.66 . . . . 0.0 110.302 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 1.1 tptm -69.72 -55.75 9.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.797 -1.189 . . . . 0.0 110.152 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.8 tt0 -35.49 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.84 -0.538 . . . . 0.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.606 ' CB ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.16 -48.4 3.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.682 -1.261 . . . . 0.0 112.232 -178.18 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.63 ' ND1' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -105.08 134.54 19.59 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.286 -1.509 . . . . 0.0 111.482 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 75' ' ' MET . 38.6 Cg_endo -133.97 95.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 117.376 -1.283 . . . . 0.0 111.173 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 23.1 mtt -152.41 -102.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.125 -0.984 . . . . 0.0 109.601 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -55.82 176.89 0.16 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.872 -1.143 . . . . 0.0 109.215 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.5 Cg_endo -83.85 173.16 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.716 1.377 . . . . 0.0 110.412 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 118.53 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 2.8 mt -113.56 133.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 109.767 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.48 ' CD1' HD11 ' A' ' 87' ' ' LEU . 4.1 pt -131.13 172.22 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.404 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -85.96 153.06 22.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -89.84 137.28 32.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.396 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 169.61 41.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -162.51 164.79 26.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.463 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 29.0 t -62.04 87.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 108.705 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.614 ' HB3' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 61.84 30.13 18.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER 35.55 35.71 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -177.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 10.49 -61.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.082 -1.872 . . . . 0.0 111.199 -177.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . -69.68 14.49 0.1 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.825 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB1' ' CG ' ' A' ' 87' ' ' LEU . . . -128.38 -77.37 0.56 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 119.812 -1.805 . . . . 0.0 107.464 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 86' ' ' ASP . 53.0 t -38.01 -29.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -103.32 -165.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 109.786 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 76.29 -165.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.306 -0.871 . . . . 0.0 109.473 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -45.56 -58.22 3.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.156 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.09 55.19 9.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -33.66 0.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . -50.95 -73.81 0.34 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . 167.65 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -137.28 -176.24 4.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.551 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.6 OUTLIER -150.76 -42.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.923 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' A' ' 100' ' ' ASP . 9.8 m-85 75.91 136.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.2 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.81 118.87 16.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.67 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -94.79 179.38 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.013 1.533 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -113.9 153.87 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.19 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -88.7 167.3 38.07 Favored 'Cis proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.535 -2.694 . . . . 0.0 110.427 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -152.09 152.19 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.3 t0 -82.3 174.13 11.42 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.046 -1.034 . . . . 0.0 108.927 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 mm -90.47 -64.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.727 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 110' ' ' GLU . 48.3 t0 -57.28 -46.95 82.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 108.567 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 1.5 tm-20 -44.5 -42.67 7.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.05 -72.27 0.2 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.52 ' CG1' HD21 ' A' ' 28' ' ' LEU . 40.8 t -36.21 -70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.333 0.587 . . . . 0.0 110.204 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.3 -65.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.967 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.512 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.0 tt -34.07 -52.69 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.692 0.758 . . . . 0.0 109.576 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.544 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.3 t -55.9 -56.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 115' ' ' VAL . 59.3 mm-40 -36.9 -37.45 0.15 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 110.61 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.558 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -84.86 -36.06 21.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.109 -179.11 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.558 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.23 -61.36 2.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.779 -1.201 . . . . 0.0 108.007 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.576 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 6.1 mt -34.84 -42.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.298 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.12 56.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -138.76 -64.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.519 ' O ' ' CD2' ' A' ' 122' ' ' TYR . 36.6 p90 -91.28 29.78 1.38 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.327 -0.858 . . . . 0.0 109.773 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -80.44 -15.27 57.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.0 109.532 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.58 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.524 0.678 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.529 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -146.55 177.98 24.53 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 69.9 mt -142.11 104.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.058 . . . . 0.0 109.006 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.527 ' CG2' HG22 ' A' ' 50' ' ' VAL . 2.4 t -99.47 106.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.728 -0.607 . . . . 0.0 110.464 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.604 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 40.6 m0 -98.73 92.32 5.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 52' ' ' LEU . 59.7 t -90.86 167.76 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.904 0.859 . . . . 0.0 112.076 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.493 ' N ' HG13 ' A' ' 8' ' ' VAL . 58.0 t -98.36 129.95 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.533 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 6.5 m-20 -49.3 -171.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.262 1.03 . . . . 0.0 112.187 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 56' ' ' ARG . 29.6 t0 -159.58 -67.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -108.1 174.91 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.5 t -70.44 137.13 50.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.2 p 79.61 33.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.445 -0.785 . . . . 0.0 109.738 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 12' ' ' ASP . 2.1 mm -80.95 -36.51 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 108.86 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 32' ' ' THR . 12.9 mtt180 -59.74 -44.54 93.74 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.446 ' O ' ' C ' ' A' ' 18' ' ' VAL . 10.7 t90 -64.57 -67.55 0.43 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.3 t -38.39 -68.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 110.734 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -52.1 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.486 -0.759 . . . . 0.0 110.693 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 19' ' ' LEU . 5.4 tt0 -34.62 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.795 -0.566 . . . . 0.0 110.821 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' LEU . 2.2 mmm180 -67.82 -56.65 8.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.972 -1.08 . . . . 0.0 108.655 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -6.08 34.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.184 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD2' ' CG2' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -102.92 -8.7 20.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.893 . . . . 0.0 109.646 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.43 -42.24 23.04 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.24 97.97 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.82 71.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.35 -1.088 . . . . 0.0 108.552 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.01 49.7 1.44 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.596 ' CD2' ' CG1' ' A' ' 112' ' ' VAL . 2.3 mp -141.03 173.48 11.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.867 -1.373 . . . . 0.0 110.081 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.468 ' HB ' HG12 ' A' ' 5' ' ' ILE . 3.6 m -98.96 89.93 4.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.539 -0.726 . . . . 0.0 109.165 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 21.1 t -90.75 90.91 8.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 110.283 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.572 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 m -92.74 146.97 23.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.533 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.77 135.57 28.01 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.913 -1.117 . . . . 0.0 109.464 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.577 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 47.3 m-85 -108.82 126.37 52.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.065 -1.022 . . . . 0.0 109.159 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.533 ' HA ' ' CB ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -42.13 -25.26 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.043 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' PHE . 16.7 t-20 -125.96 127.95 46.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.054 . . . . 0.0 110.487 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' CA ' HG23 ' A' ' 9' ' ' VAL . . . -55.81 -50.0 63.32 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -45.26 -65.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 2.9 tt0 -34.63 -48.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.977 -0.452 . . . . 0.0 110.484 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 99.7 t -47.48 -55.56 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HG ' ' HG3' ' A' ' 68' ' ' GLN . 2.9 mm? -65.41 -27.59 68.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' A' ' 38' ' ' GLU . . . -62.4 -29.06 70.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.0 -35.25 29.1 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.517 ' CD1' ' C ' ' A' ' 43' ' ' LEU . 1.2 tm? -48.57 -25.76 1.88 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -35.52 -49.01 0.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.596 0.712 . . . . 0.0 109.156 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -78.41 -51.86 9.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 160.91 135.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.435 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -78.93 -155.92 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.69 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.2 Cg_endo -129.64 -86.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 117.205 -1.397 . . . . 0.0 111.474 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 66.7 m-20 -115.52 -73.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.453 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.607 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -119.29 124.02 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.08 . . . . 0.0 111.41 -177.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 78' ' ' VAL . 7.7 tp -99.16 109.91 22.54 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.575 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 4.0 mp -103.33 160.85 14.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.07 112.81 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.47 -0.769 . . . . 0.0 109.324 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 53' ' ' SER . 5.8 t0 -61.09 -143.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.279 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.548 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 1.1 tp -172.34 84.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.944 -1.098 . . . . 0.0 110.185 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 163.72 129.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.565 ' CB ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 166.95 -61.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.442 -0.786 . . . . 0.0 109.443 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 57' ' ' MET . 36.7 Cg_endo -70.09 142.5 46.64 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 124.305 1.687 . . . . 0.0 110.233 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.39 -21.52 66.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 25.3 ttp -94.0 114.79 27.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER 44.32 -159.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.549 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.494 ' C ' ' CD2' ' A' ' 63' ' ' LEU . . . -101.42 -109.73 3.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.539 HD21 ' CD ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -175.7 105.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.658 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -57.48 -79.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.27 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 23.4 mt 81.49 -22.57 0.26 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD22 ' CG1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -60.17 -42.9 95.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.669 -1.27 . . . . 0.0 108.68 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -31.57 72.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 27.1 tp60 -60.36 -62.4 1.89 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.579 HG21 ' CG ' ' A' ' 73' ' ' HIS . 1.8 mp -35.92 -77.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.755 -0.591 . . . . 0.0 109.933 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -34.07 -64.8 0.22 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.949 -0.47 . . . . 0.0 109.902 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.1 mm-40 -35.05 -51.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.738 -0.601 . . . . 0.0 110.21 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.39 53.92 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 110.911 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.579 ' CG ' HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -130.55 163.79 45.92 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.948 -1.095 . . . . 0.0 109.406 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 36.7 Cg_endo -84.05 -69.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.041 1.548 . . . . 0.0 110.161 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.07 45.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.539 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 3.1 pp -109.28 161.55 23.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.086 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 31.9 Cg_endo -68.63 155.06 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.88 1.463 . . . . 0.0 112.001 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -136.93 165.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.57 HG13 ' CE2' ' A' ' 99' ' ' PHE . 4.4 tt -132.59 145.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.753 -1.217 . . . . 0.0 110.796 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.519 ' CG1' HD22 ' A' ' 66' ' ' LEU . 8.8 mt -108.46 93.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.617 ' O ' ' CB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -65.2 96.88 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.97 . . . . 0.0 109.537 -179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.617 ' CB ' ' O ' ' A' ' 81' ' ' MET . 14.9 t 123.72 177.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.67 19.81 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 109.154 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -91.49 -95.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.63 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m -71.73 86.51 0.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.059 -1.026 . . . . 0.0 109.405 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ASP . 9.8 t70 -179.3 -36.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.016 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -35.35 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.292 0.568 . . . . 0.0 110.536 -179.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -91.77 -53.51 4.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.348 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -17.55 1.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 110.361 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -96.57 -74.51 0.56 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.968 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 90' ' ' ALA . 45.8 t -33.71 -33.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.762 -0.586 . . . . 0.0 110.872 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -97.58 -160.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.814 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 95' ' ' GLN . . . 45.48 -168.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -58.2 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.126 -0.983 . . . . 0.0 109.096 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp0? -94.47 15.2 18.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.762 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -38.74 24.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . 167.02 -94.38 0.11 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . 69.64 7.25 6.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -1.091 . . . . 0.0 110.047 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.607 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER 49.14 112.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.636 0.732 . . . . 0.0 110.401 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -147.09 -169.2 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.662 -1.274 . . . . 0.0 109.843 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 100' ' ' ASP . 4.8 m-85 65.32 96.1 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.433 0.635 . . . . 0.0 110.672 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.517 HD23 ' CD1' ' A' ' 79' ' ' ILE . 12.8 tp -139.36 95.59 9.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.01 -172.44 0.71 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.084 1.571 . . . . 0.0 111.525 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -141.38 166.21 23.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -75.63 119.8 6.35 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.249 -2.396 . . . . 0.0 110.767 0.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.618 ' CD2' ' N ' ' A' ' 107' ' ' ASP . 58.5 t80 -93.18 167.17 11.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.202 -0.936 . . . . 0.0 109.398 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.618 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 16.6 t0 -74.5 -145.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.475 -0.765 . . . . 0.0 109.48 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.527 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 6.7 mm -139.93 -73.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.101 -0.999 . . . . 0.0 109.119 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -60.76 -31.82 71.15 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 69.0 tt0 -55.83 -38.21 69.72 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.552 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . . . -75.47 -70.84 0.4 Allowed 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.352 -0.842 . . . . 0.0 109.504 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.596 ' CG1' ' CD2' ' A' ' 28' ' ' LEU . 47.6 t -36.99 -45.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.66 0.743 . . . . 0.0 110.962 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -76.81 -72.0 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.802 . . . . 0.0 110.944 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.512 ' C ' ' O ' ' A' ' 113' ' ' ALA . 54.5 tp -33.07 -56.34 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.365 0.602 . . . . 0.0 109.946 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.541 ' CG1' HG12 ' A' ' 50' ' ' VAL . 93.5 t -61.86 -55.44 24.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 115' ' ' VAL . 17.3 tt0 -33.09 -34.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.406 0.622 . . . . 0.0 109.962 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 115' ' ' VAL . 35.5 mtm180 -60.17 -60.71 3.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -55.13 -52.89 61.83 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.607 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 4.5 mt -35.63 -35.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.245 0.545 . . . . 0.0 110.365 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -77.35 31.48 0.15 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.267 -0.896 . . . . 0.0 110.791 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -64.86 -18.04 64.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.68 -1.263 . . . . 0.0 109.228 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -86.78 40.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 109.621 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.34 50.88 2.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.398 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 59.8 ttm-85 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.549 ' N ' ' CD2' ' A' ' 28' ' ' LEU . . . -151.46 92.39 0.14 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.102 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -92.93 88.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 108.581 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.535 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 5.4 p -98.46 118.2 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.445 0.641 . . . . 0.0 110.566 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CD2' ' CG2' ' A' ' 31' ' ' THR . 11.4 m0 -101.77 87.74 3.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.006 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.02 156.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.821 0.82 . . . . 0.0 111.079 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.48 HG21 HG12 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -118.61 114.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 3.6 t0 -175.83 172.93 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.586 -0.696 . . . . 0.0 109.418 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.514 ' N ' HG13 ' A' ' 15' ' ' ILE . 64.0 t0 -144.72 -76.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.15 -0.968 . . . . 0.0 109.151 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 13' ' ' SER . 5.1 t70 35.91 53.09 0.87 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.672 -0.642 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.0 p 36.97 100.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.129 0.49 . . . . 0.0 111.106 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 83.39 45.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.463 -0.773 . . . . 0.0 110.712 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -81.5 -38.15 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.66 -1.275 . . . . 0.0 107.86 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.53 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 1.6 mtm-85 -66.81 -31.89 72.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.595 ' CE3' ' HG3' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -61.54 -69.35 0.25 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.214 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.582 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 41.1 t -40.43 -64.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.708 0.765 . . . . 0.0 110.75 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 21' ' ' ARG . 51.4 mt -62.02 -72.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 111.349 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 1.6 tt0 -33.81 -34.64 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.683 -0.636 . . . . 0.0 110.832 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.595 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 63.9 mmt-85 -67.22 -55.38 14.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 108.529 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . -71.3 -3.21 19.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.203 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.554 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 1.7 mm? -102.7 -17.15 15.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 109.393 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.0 11.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.7 -21.05 49.62 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.24 -31.16 19.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.405 -1.056 . . . . 0.0 108.941 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.63 63.72 1.4 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.607 ' CD1' ' CG1' ' A' ' 112' ' ' VAL . 17.7 mt -144.73 177.53 8.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 11.5 m -98.93 93.27 5.93 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.554 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 22.4 t -89.36 78.97 7.1 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.283 -0.885 . . . . 0.0 110.07 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.588 ' CG2' ' CD2' ' A' ' 7' ' ' TRP . 11.5 m -76.03 126.33 30.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 108.619 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.53 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 65.3 p -132.01 138.45 48.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.953 -1.092 . . . . 0.0 109.698 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CB ' HG21 ' A' ' 39' ' ' VAL . 11.8 m-85 -127.61 137.51 52.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 1.4 mt-10 -72.11 -27.55 62.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.46 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 5.7 m-80 -111.01 133.71 53.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 110.137 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.557 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . -56.37 -64.74 4.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -39.15 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.611 -0.935 . . . . 0.0 109.627 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.0 mm-40 -31.21 -43.82 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.43 0.634 . . . . 0.0 110.103 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' CB ' ' A' ' 33' ' ' PHE . 21.5 t -54.55 -61.83 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.429 -0.794 . . . . 0.0 109.2 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -63.07 -12.53 27.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 38' ' ' GLU . . . -77.2 -35.03 56.06 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.17 62.64 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 46' ' ' LYS . 27.8 mt -68.97 -8.61 46.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.533 -0.729 . . . . 0.0 109.078 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -3.84 -64.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.337 0.589 . . . . 0.0 112.054 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -70.68 -61.01 1.93 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.84 -173.77 3.1 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.553 0.692 . . . . 0.0 109.407 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.592 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 31.5 m -99.98 150.42 36.85 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.592 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 32.8 Cg_endo -75.39 -81.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 117.485 -1.21 . . . . 0.0 112.448 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.455 ' C ' HD12 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -100.85 -76.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.356 -1.465 . . . . 0.0 110.462 -178.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.542 HG22 ' CG1' ' A' ' 115' ' ' VAL . 9.8 t -132.92 143.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.83 . . . . 0.0 109.062 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CD1' HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -100.08 133.0 45.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.591 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.493 ' CD2' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -118.85 137.86 53.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -139.22 118.98 13.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.048 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 10' ' ' ASP . 1.5 p30 -104.67 160.25 15.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.087 -1.008 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.549 ' CG2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -87.67 135.42 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.499 -0.751 . . . . 0.0 109.189 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' CZ ' ' HE3' ' A' ' 57' ' ' MET . 7.1 ptt85 -151.15 34.36 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.297 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.488 ' HE3' ' CZ ' ' A' ' 56' ' ' ARG . 11.6 mtm -148.41 112.2 3.74 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.564 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -107.94 136.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.11 1.584 . . . . 0.0 110.149 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.23 -84.42 0.23 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.09 -32.67 4.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.172 . . . . 0.0 109.951 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' MET . 0.8 OUTLIER -122.02 150.76 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.856 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 -67.89 0.11 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.48 94.09 3.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -1.177 . . . . 0.0 109.729 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 44.04 2.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.208 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.557 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 11.4 mt -118.37 -28.86 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -69.85 -50.92 37.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.1 . . . . 0.0 108.108 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 66' ' ' LEU . 15.6 tttm -44.54 -35.26 2.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.535 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.26 -56.67 18.74 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.591 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 2.2 tp -36.39 -54.13 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.656 -0.653 . . . . 0.0 110.561 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 13.1 mmtp -53.25 -66.18 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.2 tt0 -36.74 -29.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.868 -0.52 . . . . 0.0 110.321 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -105.23 -81.22 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.154 -0.966 . . . . 0.0 111.567 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.532 ' NE2' ' C ' ' A' ' 43' ' ' LEU . 2.4 p-80 -153.44 133.76 7.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.627 -1.295 . . . . 0.0 112.048 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 75' ' ' MET . 37.7 Cg_endo -134.46 -93.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.988 1.52 . . . . 0.0 109.224 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.55 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 19.0 mtt 69.19 4.6 4.66 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.403 -0.81 . . . . 0.0 110.676 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.589 ' CD2' ' HB ' ' A' ' 47' ' ' THR . 0.3 OUTLIER -142.37 167.12 17.37 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.984 -1.073 . . . . 0.0 109.548 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.588 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 32.1 Cg_endo -62.96 155.03 63.0 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.556 1.293 . . . . 0.0 111.255 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -142.86 101.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.824 . . . . 0.0 110.083 -178.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.529 ' N ' HD11 ' A' ' 79' ' ' ILE . 1.7 mp -76.44 138.83 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.128 -0.982 . . . . 0.0 109.645 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 80' ' ' ILE . 3.0 tt -126.55 113.8 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.472 ' O ' HG21 ' A' ' 82' ' ' THR . 0.1 OUTLIER -62.5 148.53 45.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 109.529 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.549 HG23 ' CG2' ' A' ' 55' ' ' ILE . 0.4 OUTLIER 60.84 175.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.423 -0.798 . . . . 0.0 109.487 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' N ' HG22 ' A' ' 82' ' ' THR . . . -145.96 76.21 1.45 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.469 ' O ' ' OG ' ' A' ' 85' ' ' SER . 7.1 m-70 -138.9 -101.19 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.958 . . . . 0.0 110.524 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 86' ' ' ASP . 21.7 p 46.87 30.09 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -177.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 88' ' ' ASP . 73.2 m-20 63.57 125.38 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.575 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -36.15 -32.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -37.45 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.343 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -44.17 -35.99 2.46 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 87' ' ' LEU . . . -62.3 -90.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.337 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.512 ' CG2' HD13 ' A' ' 87' ' ' LEU . 35.6 t -35.61 -63.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.602 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 14.5 m -79.94 -149.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.833 . . . . 0.0 110.351 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' ALA . . . 68.19 -87.12 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 109.901 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 96' ' ' GLN . 2.0 p90 -106.66 -16.36 14.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.081 -1.012 . . . . 0.0 109.514 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 14.5 mt-30 44.45 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -83.72 136.33 34.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.848 -1.158 . . . . 0.0 109.358 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.03 -174.79 30.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -121.86 95.21 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.356 -1.085 . . . . 0.0 109.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 50.7 p90 163.54 -174.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -144.28 134.0 23.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.554 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.459 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 88.3 m-85 -43.77 122.24 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.456 HD11 HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -100.38 112.12 63.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.151 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 36.8 Cg_endo -91.8 168.27 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.907 1.477 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -95.03 158.6 34.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -101.44 166.52 7.53 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.043 -2.482 . . . . 0.0 110.16 0.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 25.3 p90 -147.7 174.17 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 10.6 t0 -87.23 -154.91 0.26 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.302 -0.874 . . . . 0.0 108.907 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.538 ' CG2' HD23 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -121.69 -42.92 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 108.677 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -82.34 -35.07 28.23 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.49 -38.09 76.91 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -79.95 -72.14 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.639 -0.663 . . . . 0.0 109.343 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.607 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -37.4 -53.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.661 -0.649 . . . . 0.0 110.066 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' N ' HG13 ' A' ' 112' ' ' VAL . . . -60.58 -60.86 3.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.602 -0.686 . . . . 0.0 109.988 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.5 tm? -34.45 -46.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.749 0.785 . . . . 0.0 109.66 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.542 ' CG1' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -66.49 -54.67 23.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 115' ' ' VAL . 6.1 tt0 -34.08 -39.46 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.433 0.635 . . . . 0.0 109.847 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' VAL . 11.4 mtp180 -77.43 -47.71 19.06 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.242 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' VAL . . . -52.22 -64.53 0.79 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 0.0 108.835 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.536 ' CD1' HG22 ' A' ' 50' ' ' VAL . 6.3 mt -35.45 -41.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.597 . . . . 0.0 110.22 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.46 58.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -117.73 -19.89 9.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -78.06 -7.85 57.46 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.32 -0.863 . . . . 0.0 109.396 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.27 -34.92 24.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.442 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.455 ' O ' HD21 ' A' ' 28' ' ' LEU . . . -153.43 146.41 14.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 2.7 mp -105.59 112.74 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -1.159 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.552 ' CG2' ' CD1' ' A' ' 52' ' ' LEU . 2.3 p -105.59 120.52 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.578 -0.701 . . . . 0.0 110.016 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CB ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.19 105.81 16.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.136 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HA ' ' HB2' ' A' ' 52' ' ' LEU . 42.6 t -87.99 146.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.141 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' HG11 ' A' ' 8' ' ' VAL . 22.6 t -99.24 95.73 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 110.084 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.618 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 31.52 -160.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.78 0.8 . . . . 0.0 112.696 178.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 6.8 t0 152.48 -25.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.62 146.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 14' ' ' SER . 11.3 t -45.4 135.8 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.717 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 77.45 34.7 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -72.73 -47.55 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 108.975 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -53.0 -47.74 68.05 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.484 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 83.9 t90 -56.56 -63.77 1.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 109.667 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 17' ' ' TRP . 42.1 t -38.88 -74.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.07 0.938 . . . . 0.0 110.648 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -60.53 -68.18 0.32 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.531 -0.731 . . . . 0.0 110.858 -178.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -35.52 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.547 -0.721 . . . . 0.0 110.88 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -71.82 -53.63 12.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.991 -1.068 . . . . 0.0 108.252 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . -71.87 -2.98 19.8 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.984 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 2.5 mm? -103.88 -14.9 15.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.353 -0.842 . . . . 0.0 109.411 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.58 -30.65 32.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 -38.96 58.22 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.52 72.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -1.113 . . . . 0.0 108.913 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.26 66.01 0.91 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.516 HD23 ' CG1' ' A' ' 112' ' ' VAL . 0.3 OUTLIER -141.52 176.9 8.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.091 -1.241 . . . . 0.0 110.019 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 6.8 m -100.13 77.09 1.96 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.1 t -83.08 90.37 7.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.313 -0.867 . . . . 0.0 110.427 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 3.3 m -100.7 140.67 34.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.484 ' OG1' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -142.31 138.47 31.33 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.571 -1.331 . . . . 0.0 110.164 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.572 ' CD2' HG21 ' A' ' 39' ' ' VAL . 18.3 m-85 -107.46 159.82 16.12 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -92.02 11.5 25.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.898 -1.126 . . . . 0.0 109.711 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -149.94 128.56 12.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.549 ' O ' ' CD2' ' A' ' 40' ' ' LEU . . . -56.24 -62.45 6.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.473 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -41.47 -65.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.354 -1.086 . . . . 0.0 109.383 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.5 tp10 -35.05 -47.01 0.35 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.611 -0.68 . . . . 0.0 110.276 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 33' ' ' PHE . 1.4 t -60.83 -50.7 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 108.636 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.618 HD13 ' CE1' ' A' ' 73' ' ' HIS . 0.9 OUTLIER -69.81 -5.85 28.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 0.0 109.572 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.36 -22.07 18.57 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.3 -0.875 . . . . 0.0 108.802 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.77 -33.5 18.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.4 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 4.1 mt -98.59 -114.35 0.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.214 -0.929 . . . . 0.0 108.742 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 82.4 -51.28 0.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 58.7 m -75.23 -34.65 61.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.326 -0.859 . . . . 0.0 108.924 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 176.77 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.581 ' CG2' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -71.27 -152.85 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.581 ' CD ' ' CG2' ' A' ' 47' ' ' THR . 37.0 Cg_endo -125.32 -75.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 117.093 -1.471 . . . . 0.0 111.2 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -112.85 -73.92 0.65 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.733 -1.229 . . . . 0.0 111.14 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.59 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 2.6 t -140.27 137.0 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.013 -1.054 . . . . 0.0 110.672 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.549 HD13 ' CB ' ' A' ' 7' ' ' TRP . 12.5 tp -100.42 159.89 14.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.552 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -138.93 141.7 38.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 -179.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.516 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 6.3 t -119.27 111.21 17.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 10' ' ' ASP . 34.0 p-10 -59.77 175.13 0.39 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.909 -1.119 . . . . 0.0 109.097 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.491 ' CG1' HD13 ' A' ' 63' ' ' LEU . 1.2 tt -161.72 38.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -80.22 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.46 ' CE ' ' CA ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -48.59 139.0 11.53 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.653 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -113.61 165.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.818 1.43 . . . . 0.0 110.167 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 61' ' ' ASP . . . 124.03 89.31 0.85 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.1 mmt 49.05 -95.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -1.109 . . . . 0.0 109.738 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' GLY . 2.0 m-20 -50.89 164.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.09 -1.006 . . . . 0.0 109.353 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.46 ' CA ' ' CE ' ' A' ' 57' ' ' MET . . . 108.73 -62.38 0.29 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.557 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 2.4 mm? -116.92 1.76 12.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -1.167 . . . . 0.0 109.715 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.69 67.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.176 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.582 ' CB ' ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -167.77 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.503 ' CD1' ' CB ' ' A' ' 53' ' ' SER . 2.9 tp -40.18 -30.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.109 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 65' ' ' LEU . 10.8 tptt -57.66 -54.73 43.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.609 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 65' ' ' LEU . 9.4 pm0 -58.09 -39.23 78.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.204 . . . . 0.0 108.241 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.541 ' CG1' HD21 ' A' ' 51' ' ' LEU . 1.4 tt -38.21 -36.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.577 -0.702 . . . . 0.0 110.064 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' ARG . 5.0 tptm -109.05 -69.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 110.334 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.3 tt0 -36.12 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.402 -0.811 . . . . 0.0 110.834 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -96.89 -34.93 11.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.277 -0.889 . . . . 0.0 110.06 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.618 ' CE1' HD13 ' A' ' 40' ' ' LEU . 4.7 m80 -96.83 137.14 21.37 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.547 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.6 Cg_endo -39.23 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.999 1.526 . . . . 0.0 110.999 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.85 95.72 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.6 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -133.23 171.71 8.66 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.2 Cg_endo -59.28 107.87 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.441 1.232 . . . . 0.0 110.982 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.521 ' CG1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -102.12 82.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.54 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mp -62.73 155.56 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.988 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 79' ' ' ILE . 1.3 pp -160.39 150.88 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.467 ' HB2' HG23 ' A' ' 55' ' ' ILE . 40.3 mtt -90.85 126.99 36.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 109.511 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 77.8 p -74.27 153.53 39.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 0.0 109.708 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 163.65 39.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.349 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER 69.06 157.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 51.0 m 63.04 152.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' SER . 32.1 t0 84.2 -49.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.726 -0.609 . . . . 0.0 109.868 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -33.75 -51.02 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.0 110.528 -179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.23 -55.48 10.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.649 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.5 -40.1 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 109.679 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -73.19 -81.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 42.8 t -33.38 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.776 -0.578 . . . . 0.0 110.613 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -99.79 -155.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.919 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.402 ' HB3' ' HD2' ' A' ' 67' ' ' LYS . . . 56.63 75.68 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.442 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' GLN . 0.7 OUTLIER 59.95 -89.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.378 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 71.42 138.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -146.01 -63.18 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.303 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.37 52.72 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.82 38.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -1.151 . . . . 0.0 109.398 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 100' ' ' ASP . 8.2 m-85 -120.42 105.52 10.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.794 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.584 ' O ' ' CD1' ' A' ' 101' ' ' TYR . 14.1 t0 -61.96 -139.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.886 . . . . 0.0 109.181 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 169.78 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 108.959 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.74 132.17 62.0 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 109.777 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 104' ' ' LYS . 36.8 Cg_endo -105.87 -92.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.89 1.469 . . . . 0.0 110.135 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER 161.28 147.77 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.253 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -82.26 170.9 56.84 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.721 -2.616 . . . . 0.0 110.392 -0.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 81' ' ' MET . 49.6 p90 -149.7 138.96 21.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 25.3 t0 -76.77 170.67 16.03 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.036 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 108' ' ' ILE . 19.1 mm -84.23 -58.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.049 -1.032 . . . . 0.0 109.896 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -63.33 -46.16 87.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 108.533 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 20.7 tp10 -47.22 -37.9 11.22 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -75.04 -73.76 0.23 Allowed 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.349 -0.844 . . . . 0.0 109.796 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.516 ' CG1' HD23 ' A' ' 28' ' ' LEU . 41.4 t -39.02 -56.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -59.97 -70.15 0.18 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.729 . . . . 0.0 110.987 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.501 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 2.0 tm? -34.37 -57.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.435 0.636 . . . . 0.0 110.016 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.541 ' CG1' ' N ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -53.92 -52.66 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.541 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 4.0 tt0 -34.56 -49.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.274 0.559 . . . . 0.0 110.324 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -56.02 -54.95 38.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.61 -60.56 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.09 -1.007 . . . . 0.0 108.366 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.59 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 5.7 mt -37.0 -35.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.739 -0.601 . . . . 0.0 110.865 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.593 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 7.6 t -33.87 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.936 -0.478 . . . . 0.0 111.52 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.593 ' CB ' ' O ' ' A' ' 120' ' ' SER . 2.2 t-160 86.52 39.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' HIS . 1.1 m-85 37.36 77.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.583 0.706 . . . . 0.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.07 39.28 1.04 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.74 . . . . 0.0 109.595 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.602 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.318 0.58 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 3' ' ' ARG . 3.5 mm-40 63.92 -163.83 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 109.277 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 65.41 156.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 109.198 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.425 ' C ' ' CD1' ' A' ' 5' ' ' ILE . . . -162.78 176.94 39.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 7' ' ' TRP . 3.6 mp -135.95 99.27 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.055 . . . . 0.0 109.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' CG1' ' CG2' ' A' ' 8' ' ' VAL . 2.7 t -101.19 111.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 109.821 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.593 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 9.5 m0 -100.18 92.78 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.574 ' CG2' ' HB2' ' A' ' 52' ' ' LEU . 48.3 t -95.98 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.484 -0.76 . . . . 0.0 110.735 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 36' ' ' GLY . 3.7 p -119.16 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.525 ' HB2' ' CG2' ' A' ' 15' ' ' ILE . 1.4 p30 -102.14 -120.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.913 -1.117 . . . . 0.0 110.181 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.409 ' CG ' ' HD3' ' A' ' 58' ' ' PRO . 31.8 t0 -135.43 -61.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.633 -1.292 . . . . 0.0 110.019 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 175.26 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -59.76 160.26 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.78 . . . . 0.0 109.634 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 13' ' ' SER . 2.1 m 79.93 -7.56 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.442 -0.786 . . . . 0.0 109.75 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.525 ' CG2' ' HB2' ' A' ' 10' ' ' ASP . 26.6 mm -96.89 -45.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.491 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -63.59 -30.96 72.0 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.468 ' O ' ' C ' ' A' ' 18' ' ' VAL . 5.7 t90 -67.28 -60.28 2.72 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 17' ' ' TRP . 24.8 t -36.6 -57.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.165 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' ARG . 8.8 mt -55.73 -72.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 1.8 tt0 -35.14 -30.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.868 -0.52 . . . . 0.0 110.674 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -66.37 -55.16 17.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 108.437 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 -12.96 61.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.53 ' CD2' ' HB2' ' A' ' 30' ' ' CYS . 0.9 OUTLIER -92.9 -11.11 34.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.765 . . . . 0.0 109.754 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.69 -46.09 40.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.83 -41.97 52.32 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.49 79.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -1.003 . . . . 0.0 108.572 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.05 50.22 3.32 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD23 ' CG1' ' A' ' 112' ' ' VAL . 0.5 OUTLIER -120.23 173.71 6.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 0.0 109.971 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.517 ' CG2' HG22 ' A' ' 5' ' ' ILE . 51.6 m -100.26 65.75 1.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 32.0 t -82.23 80.08 8.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.217 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.593 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 1.3 m -75.1 129.32 37.36 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.491 ' HB ' ' CB ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -126.96 136.76 52.71 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.059 -1.026 . . . . 0.0 109.686 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.542 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 2.1 m-85 -110.72 -176.15 2.9 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 19.4 mt-10 -95.43 -47.57 6.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.935 . . . . 0.0 110.429 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.468 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.2 t-20 -116.15 144.7 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.064 -1.022 . . . . 0.0 109.949 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 9' ' ' VAL . . . -54.14 -33.13 51.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 38' ' ' GLU . 11.4 t-20 -61.76 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.033 -1.275 . . . . 0.0 108.624 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 37' ' ' ASN . 2.5 mm-40 -34.64 -35.28 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.348 0.594 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 75.0 t -55.33 -59.09 2.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.396 -0.815 . . . . 0.0 109.453 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 72' ' ' ARG . 0.9 OUTLIER -67.66 -14.82 63.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.568 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 38' ' ' GLU . . . -68.25 -30.91 70.06 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.8 -31.9 19.35 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.556 ' CD1' HD12 ' A' ' 51' ' ' LEU . 89.9 mt -92.34 1.54 57.17 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.478 -0.764 . . . . 0.0 110.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.508 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -29.47 -38.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' LEU . 2.5 m -70.15 -55.73 8.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 108.746 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HA ' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER 169.86 135.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.415 -0.803 . . . . 0.0 109.969 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.559 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -50.19 157.2 1.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 109.666 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.56 ' CG ' ' CG2' ' A' ' 5' ' ' ILE . 36.7 Cg_endo -88.13 -70.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.918 1.483 . . . . 0.0 110.058 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -109.32 -65.22 1.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 0.0 109.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.57 ' CG2' ' HG2' ' A' ' 77' ' ' PRO . 2.6 t -149.57 144.16 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.055 -1.028 . . . . 0.0 110.123 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 43' ' ' LEU . 3.5 tp -100.54 155.16 18.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.894 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -145.43 169.45 18.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.677 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.4 p -154.56 139.7 17.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.69 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.419 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 25.4 m-20 -86.78 -172.25 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.294 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.527 ' HB ' ' CB ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -120.67 5.54 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.12 -0.988 . . . . 0.0 109.689 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.3 OUTLIER -86.62 174.13 9.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.638 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER 170.87 177.16 0.11 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.795 . . . . 0.0 109.176 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' SD ' ' A' ' 57' ' ' MET . 36.8 Cg_endo -98.32 120.33 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.953 1.502 . . . . 0.0 110.508 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.55 -144.89 23.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 12.2 mtt -88.56 -156.92 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 60' ' ' MET . 37.3 m-20 64.75 179.96 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.78 68.73 0.22 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HG ' ' HG3' ' A' ' 57' ' ' MET . 1.1 mp 61.64 92.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.41 14.24 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.208 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.478 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -100.9 14.26 32.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -0.846 . . . . 0.0 109.357 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' HA ' HD11 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -65.44 -65.0 0.73 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.4 ttpp -47.0 -26.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.573 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.03 -60.54 2.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.605 HG21 ' CE1' ' A' ' 73' ' ' HIS . 1.0 OUTLIER -33.54 -57.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.283 0.563 . . . . 0.0 110.415 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HE2' ' CG2' ' A' ' 69' ' ' ILE . 7.0 mmtt -59.84 -61.05 2.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.258 -0.901 . . . . 0.0 109.847 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 70' ' ' LYS . 21.9 mm-40 -32.98 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.894 -0.504 . . . . 0.0 111.385 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 40' ' ' LEU . 4.9 mpt_? -83.39 -91.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 110.801 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.606 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 3.0 p80 -68.49 151.95 96.92 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.388 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 33.8 Cg_endo -49.63 -178.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.638 1.336 . . . . 0.0 110.689 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.5 ptp -85.16 56.05 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.6 OUTLIER -70.42 158.68 87.12 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.4 Cg_endo -44.61 136.98 8.88 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.501 1.263 . . . . 0.0 112.642 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.641 ' CG2' ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -145.24 177.99 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 78' ' ' VAL . 26.1 mt -158.67 119.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.216 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.5 mt -108.6 128.53 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 108.818 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.499 ' HB3' HG22 ' A' ' 55' ' ' ILE . 1.4 mtm -56.46 174.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -53.85 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 110.215 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 80.78 162.54 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -119.75 -21.55 7.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.421 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.7 m -123.57 18.22 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.74 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -96.73 -18.39 19.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.228 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 86' ' ' ASP . 1.2 tt -35.15 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.897 -0.502 . . . . 0.0 110.935 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASP . 11.0 t70 -70.27 -57.79 4.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.862 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.68 -16.07 63.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -83.12 -42.36 17.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 90' ' ' ALA . 46.4 t -35.85 -29.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.459 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ALA . 30.3 t -80.64 31.69 0.3 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.5 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.37 -53.6 2.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.912 -1.118 . . . . 0.0 108.624 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 10.7 m-30 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -0.894 . . . . 0.0 108.747 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 2.3 tp-100 -86.81 91.77 8.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.782 . . . . 0.0 109.424 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 45.69 64.99 1.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.29 -179.29 15.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.35 38.08 1.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.952 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.641 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 6.6 p90 -162.2 133.4 5.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.04 -1.038 . . . . 0.0 109.874 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 100' ' ' ASP . 58.7 p30 -97.98 -159.29 0.73 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.41 -0.806 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 101' ' ' TYR . 5.7 m-85 -100.66 139.02 36.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.23 120.02 52.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.026 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -95.29 -165.18 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.909 1.478 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -121.86 157.69 56.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.602 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -97.28 169.92 12.43 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.712 -2.62 . . . . 0.0 110.441 0.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 20.8 p90 -149.21 138.1 21.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 16.3 t70 -79.41 171.47 15.13 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.92 . . . . 0.0 109.018 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -70.82 -56.14 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.014 -1.054 . . . . 0.0 109.014 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.452 ' N ' HG23 ' A' ' 108' ' ' ILE . 23.5 t0 -68.7 -39.72 80.37 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.527 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 4.7 tp10 -48.42 -46.79 37.89 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -72.28 -74.06 0.17 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 23' ' ' LEU . 32.3 t -36.73 -73.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.367 0.603 . . . . 0.0 109.749 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -38.11 -64.41 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.79 -0.569 . . . . 0.0 110.292 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 113' ' ' ALA . 8.2 tp -34.83 -55.28 0.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.785 0.802 . . . . 0.0 109.741 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.552 HG12 ' CB ' ' A' ' 50' ' ' VAL . 1.5 t -57.01 -57.37 10.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -32.99 -40.3 0.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.324 0.583 . . . . 0.0 110.403 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' VAL . 18.1 mtm180 -75.42 -52.59 10.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.327 -0.858 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.2 -60.83 2.21 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.117 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.552 HG12 ' CG2' ' A' ' 50' ' ' VAL . 3.4 mt -36.06 -41.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.395 0.617 . . . . 0.0 109.978 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 61.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -135.42 -65.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 122' ' ' TYR . 2.9 p90 -99.07 95.4 7.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -117.1 0.79 12.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.284 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 2' ' ' GLN . 7.2 pt20 -159.91 101.53 1.45 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.031 -1.043 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.53 44.15 1.04 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.136 -0.977 . . . . 0.0 109.34 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.541 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . 147.65 171.75 17.03 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 10.6 mt -147.89 97.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.954 . . . . 0.0 108.84 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 2.6 p -100.2 118.64 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.658 0.742 . . . . 0.0 110.651 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.623 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 37.4 m0 -103.27 104.25 14.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.938 . . . . 0.0 108.825 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 32' ' ' THR . 59.1 t -97.57 147.74 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.535 ' CG2' HG22 ' A' ' 39' ' ' VAL . 9.8 p -123.9 129.45 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.532 ' CB ' HG23 ' A' ' 15' ' ' ILE . 13.9 t0 -135.51 -77.15 0.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.817 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 34' ' ' GLU . 64.8 t0 -148.33 -70.73 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.697 -1.252 . . . . 0.0 111.624 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.71 178.05 4.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.01 -1.056 . . . . 0.0 111.141 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -66.36 -24.73 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.641 -0.662 . . . . 0.0 109.832 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -62.54 -25.24 67.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.393 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.58 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -66.59 -31.16 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 11.4 ttp180 -61.65 -49.13 77.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 13.2 t90 -48.73 -65.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 48.2 t -39.44 -70.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.048 0.928 . . . . 0.0 110.364 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -44.88 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.2 tt0 -32.73 -40.75 0.05 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.864 -0.522 . . . . 0.0 110.773 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 4.5 mtp180 -58.06 -57.19 13.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.977 . . . . 0.0 109.043 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -6.34 23.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 0.0 109.579 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.562 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -98.38 -12.53 21.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.79 51.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 -33.48 87.35 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.47 -24.78 60.25 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.482 -1.01 . . . . 0.0 108.761 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.41 62.84 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.546 HD21 ' CG1' ' A' ' 112' ' ' VAL . 1.2 mp -142.25 -176.5 4.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.113 -1.228 . . . . 0.0 109.974 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.548 ' CG2' HG21 ' A' ' 5' ' ' ILE . 24.2 m -92.44 100.61 13.13 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 8.9 t -95.28 88.72 5.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.393 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.623 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 2.3 m -99.45 141.63 32.0 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.54 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -134.55 167.13 21.36 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.655 -1.278 . . . . 0.0 110.14 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.536 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 26.8 m-85 -140.15 171.74 13.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -105.15 -13.23 15.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.175 -0.953 . . . . 0.0 108.946 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.442 ' OD1' ' OD1' ' A' ' 61' ' ' ASP . 55.6 m-20 -138.16 137.33 37.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.554 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 9' ' ' VAL . . . -55.43 -49.72 63.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.485 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 5.0 t30 -50.54 -69.41 0.11 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.187 -1.184 . . . . 0.0 108.727 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -36.06 -42.14 0.28 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.707 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.535 HG22 ' CG2' ' A' ' 9' ' ' VAL . 39.4 t -53.05 -53.43 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.205 -0.934 . . . . 0.0 108.934 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.556 HD22 ' CD2' ' A' ' 73' ' ' HIS . 10.8 mt -62.02 -28.57 69.67 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.66 75.42 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB1' ' CZ ' ' A' ' 33' ' ' PHE . . . -68.93 -40.52 78.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -43.0 -65.35 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . 28.14 -73.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.916 0.865 . . . . 0.0 110.761 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.76 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -84.69 27.33 0.74 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 82.69 134.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.345 0.593 . . . . 0.0 110.193 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.595 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -64.59 -149.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.367 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HG3' ' CE2' ' A' ' 7' ' ' TRP . 38.0 Cg_endo -125.54 -83.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 117.298 -1.335 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.575 ' OD2' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -114.31 -50.78 2.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.298 -1.501 . . . . 0.0 111.814 -178.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.561 ' CG2' HD13 ' A' ' 119' ' ' ILE . 2.1 t -149.51 149.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.396 -1.44 . . . . 0.0 109.896 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -100.96 156.72 17.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 109.293 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.515 HD11 ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -137.29 124.92 22.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.06 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -113.76 133.09 55.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.053 -1.029 . . . . 0.0 110.385 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.525 ' CB ' ' OD1' ' A' ' 10' ' ' ASP . 17.5 p-10 -80.0 -158.9 0.19 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.876 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.555 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -173.89 86.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.507 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -168.38 -163.86 0.48 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.372 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.539 ' CE ' ' O ' ' A' ' 61' ' ' ASP . 2.1 mtm 72.59 131.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.626 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.38 106.6 1.55 Allowed 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.098 1.578 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.84 -130.87 8.24 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 1.3 mtt -110.14 -164.51 0.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.682 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.539 ' O ' ' CE ' ' A' ' 57' ' ' MET . 2.0 t70 80.39 -9.72 1.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.99 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' C ' HD22 ' A' ' 63' ' ' LEU . . . -133.8 -48.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -105.88 -175.0 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.073 -1.251 . . . . 0.0 109.691 -179.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.62 21.96 9.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.035 -1.04 . . . . 0.0 108.304 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.56 ' HB3' ' NE2' ' A' ' 68' ' ' GLN . 6.1 mt -125.27 -12.47 6.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.767 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -61.1 -65.21 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.8 tptp -44.06 -37.53 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.613 ' HG2' ' N ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -57.16 -52.35 65.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.029 -1.045 . . . . 0.0 108.678 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.613 ' N ' ' HG2' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -35.2 -56.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.647 -0.658 . . . . 0.0 110.679 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.04 -53.89 13.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 110.443 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' LYS . 13.3 mm-40 -32.42 -44.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.755 -0.591 . . . . 0.0 110.815 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.521 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -91.85 -44.84 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.575 ' CD2' HD11 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -47.89 159.4 0.47 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.294 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.419 ' C ' ' HG3' ' A' ' 75' ' ' MET . 36.9 Cg_endo -80.8 -66.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.078 1.567 . . . . 0.0 110.15 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.419 ' HG3' ' C ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -175.45 52.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.26 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 1.1 pp -114.97 157.44 43.3 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 0.0 109.05 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.4 Cg_endo -63.81 151.7 83.97 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.931 1.49 . . . . 0.0 111.203 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.56 ' CG1' ' CB ' ' A' ' 51' ' ' LEU . 2.9 m -142.87 97.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG23 HD13 ' A' ' 102' ' ' LEU . 8.4 mt -59.99 167.03 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 109.479 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -161.93 133.79 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.098 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.513 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -63.78 158.0 22.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.407 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -98.0 151.65 20.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.411 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' CB ' HD11 ' A' ' 55' ' ' ILE . . . -173.46 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -178.49 65.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.683 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 p -173.67 -36.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.588 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.1 m-20 -57.17 -31.07 65.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 109.683 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -34.89 -28.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.752 -0.593 . . . . 0.0 111.437 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -93.46 -52.84 4.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.883 -1.136 . . . . 0.0 110.776 -178.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -1.69 10.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.938 -1.101 . . . . 0.0 110.484 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -107.09 -75.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 109.182 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.487 ' C ' ' O ' ' A' ' 90' ' ' ALA . 71.1 t -34.42 -32.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.279 0.561 . . . . 0.0 110.393 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -108.57 -149.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.66 -95.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -128.67 70.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 2.3 tm0? -60.46 -21.59 62.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -0.82 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -69.81 -165.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.56 99.33 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.506 ' C ' ' CD2' ' A' ' 99' ' ' PHE . . . -146.45 -43.51 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.276 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.526 ' CD2' ' CG2' ' A' ' 78' ' ' VAL . 16.1 p90 172.96 137.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.446 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -104.11 -161.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -0.808 . . . . 0.0 109.294 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -104.95 149.67 25.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 106' ' ' PHE . 13.3 mt -112.41 116.21 48.8 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.944 . . . . 0.0 109.356 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 36.5 Cg_endo -93.99 148.81 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.651 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 34.3 mtmt -101.88 149.84 36.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.07 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -78.4 140.52 60.72 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.749 -2.605 . . . . 0.0 110.439 -0.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CD2' ' N ' ' A' ' 107' ' ' ASP . 78.0 t80 -116.14 171.51 7.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.861 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.571 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 1.1 t70 -102.25 113.4 26.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.537 -0.727 . . . . 0.0 109.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.0 -30.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.96 -1.087 . . . . 0.0 109.335 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.98 -45.19 28.36 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 108.702 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.546 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 34.8 tt0 -50.89 -34.23 27.39 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -76.51 -72.99 0.3 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.651 -0.655 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 28' ' ' LEU . 7.0 t -35.27 -45.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.446 -0.784 . . . . 0.0 110.61 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -73.05 -72.94 0.22 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.73 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -34.69 -57.15 0.53 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.521 0.676 . . . . 0.0 109.536 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.546 ' CG1' HG22 ' A' ' 50' ' ' VAL . 1.2 t -49.78 -58.49 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 21.1 tp10 -35.71 -41.11 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.739 -0.601 . . . . 0.0 111.092 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 114' ' ' LEU . 4.3 ptm180 -82.47 -36.78 26.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.109 -0.994 . . . . 0.0 110.207 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.525 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.38 -62.67 1.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.87 -1.144 . . . . 0.0 108.308 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.601 ' O ' ' C ' ' A' ' 120' ' ' SER . 10.6 mt -33.71 -39.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.98 -0.45 . . . . 0.0 110.626 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.615 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 11.7 t -5.01 -69.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.254 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 120' ' ' SER . 6.6 m170 142.3 56.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 36.01 32.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.537 0.684 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-30 -69.43 -9.36 53.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.51 -0.744 . . . . 0.0 109.804 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 8.7 mt-10 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.626 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.389 0.614 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 1.3 mt-30 -73.41 -178.43 3.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.494 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.8 OUTLIER 70.66 89.81 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.917 . . . . 0.0 109.81 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 49' ' ' ASP . . . -165.62 119.52 0.87 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 59.0 mt -104.89 91.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.306 -1.114 . . . . 0.0 109.884 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 p -105.87 125.63 61.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' CG2' ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.73 90.01 4.09 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.808 -1.183 . . . . 0.0 109.433 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG2' HD13 ' A' ' 52' ' ' LEU . 86.1 t -79.88 113.56 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 7.5 p -88.82 98.29 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.213 -0.929 . . . . 0.0 109.571 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.588 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 23.0 t0 -156.61 133.21 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.627 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' C ' ' O ' ' A' ' 10' ' ' ASP . 2.0 t0 7.43 68.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.285 0.564 . . . . 0.0 111.804 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.4 p-10 -46.46 177.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.552 -0.718 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 3.1 t 82.86 -68.49 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -98.18 -40.0 8.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.101 -1.0 . . . . 0.0 108.951 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.588 ' CG2' ' HB3' ' A' ' 10' ' ' ASP . 20.0 mm -68.34 -36.3 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.475 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 22.9 ttp85 -60.93 -42.38 98.06 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.483 ' O ' ' C ' ' A' ' 18' ' ' VAL . 11.5 t90 -60.29 -62.03 2.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.483 ' C ' ' O ' ' A' ' 17' ' ' TRP . 31.1 t -37.9 -68.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 109.678 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.461 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -56.15 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.632 -0.667 . . . . 0.0 110.442 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 2.1 tt0 -36.05 -64.31 0.32 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.489 -0.757 . . . . 0.0 111.983 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -39.78 -43.53 1.44 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -178.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . -71.5 -39.69 70.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.695 -1.253 . . . . 0.0 108.548 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD1' ' CG2' ' A' ' 112' ' ' VAL . 1.3 tp -69.73 -6.13 29.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.36 -33.96 42.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.0 109.038 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.87 -27.85 73.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' A' ' 2' ' ' GLN . . . -93.83 1.52 56.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -1.108 . . . . 0.0 109.229 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.95 72.22 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD12 ' CG1' ' A' ' 112' ' ' VAL . 0.3 OUTLIER -133.92 -179.84 5.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.116 -1.226 . . . . 0.0 110.008 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.523 ' CG2' HG22 ' A' ' 5' ' ' ILE . 29.2 m -102.1 84.49 2.51 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.558 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 21.2 t -93.11 90.83 7.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.482 -0.761 . . . . 0.0 110.644 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.585 ' CG2' ' CE2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -97.39 138.66 34.5 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 16' ' ' ARG . 1.7 p -146.43 134.53 21.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.737 -1.227 . . . . 0.0 110.696 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.572 ' CD2' HG21 ' A' ' 39' ' ' VAL . 7.0 m-30 -108.53 -158.9 0.67 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -121.83 -32.88 3.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.607 -1.308 . . . . 0.0 109.592 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 28.1 m120 -116.44 123.32 47.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.863 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.536 ' HA3' ' CD2' ' A' ' 65' ' ' LEU . . . -41.37 -36.47 1.45 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -62.62 -61.2 2.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 0.0 108.488 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.2 tp10 -35.55 -50.95 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.496 0.665 . . . . 0.0 109.876 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 33' ' ' PHE . 2.1 t -63.58 -44.82 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.792 . . . . 0.0 108.907 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.575 ' CG ' ' HG3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -78.8 4.33 14.22 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 109.476 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.55 -23.25 13.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.78 -33.03 11.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.131 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.592 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 3.2 mm? -65.13 -12.34 49.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.152 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.46 -31.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.518 -0.738 . . . . 0.0 110.186 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -73.91 -55.98 5.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.616 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -174.33 152.89 1.85 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.135 -0.978 . . . . 0.0 109.671 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -95.65 171.04 6.86 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.251 -0.905 . . . . 0.0 108.92 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.586 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.9 Cg_endo -119.68 -67.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 117.211 -1.392 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' CA ' HD11 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -122.68 -78.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.403 -1.436 . . . . 0.0 111.741 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 119' ' ' ILE . 4.0 t -138.96 141.31 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.941 -1.1 . . . . 0.0 110.537 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -106.24 135.99 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 110.273 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.561 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 5.9 mt -115.99 152.77 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 0.0 109.634 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.503 ' CB ' ' CD2' ' A' ' 66' ' ' LEU . 1.5 t -114.77 125.95 54.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.656 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.58 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 28.1 p30 -64.52 -166.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.534 HG12 ' CB ' ' A' ' 83' ' ' ALA . 1.9 tt -178.89 33.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -130.41 6.9 4.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.678 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.468 ' HG3' ' CD1' ' A' ' 63' ' ' LEU . 56.8 mmm -42.97 117.39 2.19 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -55.04 145.91 61.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.89 1.469 . . . . 0.0 110.231 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.15 101.42 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 60.56 49.58 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -1.164 . . . . 0.0 109.248 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' MET . 11.1 p-10 -52.64 144.76 13.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.773 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 155.79 -81.81 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD21 HD12 ' A' ' 65' ' ' LEU . 0.1 OUTLIER 42.95 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -1.125 . . . . 0.0 109.889 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -58.76 -74.36 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 108.52 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.536 ' CD2' ' HA3' ' A' ' 36' ' ' GLY . 11.6 mt 76.48 -10.29 1.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.503 ' CD2' ' CB ' ' A' ' 53' ' ' SER . 4.0 mm? -74.92 -39.81 61.2 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.848 -1.157 . . . . 0.0 108.827 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -64.97 -27.86 69.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.575 ' HG3' ' CG ' ' A' ' 40' ' ' LEU . 22.2 tp60 -65.26 -62.35 1.59 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.542 ' CG1' HD12 ' A' ' 40' ' ' LEU . 17.4 mt -35.79 -76.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.557 -0.714 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -43.02 -61.23 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.972 -1.08 . . . . 0.0 109.384 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.0 mt-30 -36.56 -42.1 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.505 -0.747 . . . . 0.0 111.705 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -131.89 42.12 3.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.83 -1.169 . . . . 0.0 111.289 -177.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.592 ' NE2' ' HB2' ' A' ' 43' ' ' LEU . 54.6 m80 -147.9 154.16 43.19 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.817 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 75' ' ' MET . 35.8 Cg_endo -60.9 -5.71 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.806 1.424 . . . . 0.0 112.092 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 74' ' ' PRO . 8.2 mtp 80.02 104.86 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.026 -1.046 . . . . 0.0 110.204 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.618 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -146.24 156.13 50.26 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 31.3 Cg_endo -43.04 130.48 5.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 117.203 -1.398 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG22 ' CZ ' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -123.32 178.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.561 ' CG2' ' CD2' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -149.85 171.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 86' ' ' ASP . 2.7 tt -160.67 137.81 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.9 mtt -85.91 135.05 33.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.047 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -72.52 149.81 43.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.013 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.534 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . 166.32 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 109.722 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 69.46 158.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 109.975 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 58.2 m 58.64 84.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 109.759 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ASP . 2.3 p-10 165.89 -43.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -35.03 -29.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.869 -0.52 . . . . 0.0 111.139 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.6 t0 -67.35 -65.0 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.046 -1.034 . . . . 0.0 110.194 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.67 -10.91 9.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.078 -1.014 . . . . 0.0 110.291 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -97.28 -76.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.006 -1.059 . . . . 0.0 109.765 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 51.0 t -34.1 -30.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.834 -0.541 . . . . 0.0 110.961 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -106.34 171.49 7.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.872 -1.142 . . . . 0.0 109.992 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 77.18 56.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER 60.04 47.43 9.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 1.7 pt20 -43.31 -34.42 1.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.7 72.54 0.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.4 -69.0 0.03 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.38 59.81 1.59 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.25 . . . . 0.0 110.06 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 2.0 m-85 -129.52 167.23 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.087 -1.008 . . . . 0.0 109.255 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 4.0 t0 -134.66 -30.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 73.62 105.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.95 -1.094 . . . . 0.0 108.506 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.461 HD11 HG12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -116.95 118.77 35.92 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.043 -1.036 . . . . 0.0 110.25 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -105.97 149.0 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.046 1.551 . . . . 0.0 109.884 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -91.41 147.95 36.51 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 0.0 109.516 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -89.92 155.9 31.1 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 120.536 -2.693 . . . . 0.0 110.396 0.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 17.2 p90 -131.14 169.22 16.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 109.357 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 1.3 t70 -85.72 168.02 14.74 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.131 -0.981 . . . . 0.0 108.7 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.515 ' CG2' HD11 ' A' ' 23' ' ' LEU . 31.6 mm -95.15 -61.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.91 -1.119 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 110' ' ' GLU . 63.1 t0 -54.97 -50.06 69.86 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.057 -1.027 . . . . 0.0 108.934 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 21.7 tp10 -44.13 -47.57 9.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -62.46 -67.74 0.39 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.569 ' CG2' ' CD1' ' A' ' 23' ' ' LEU . 48.1 t -35.4 -73.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.15 0.5 . . . . 0.0 110.584 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -39.12 -66.53 0.28 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.539 -0.725 . . . . 0.0 110.492 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -34.8 -53.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.809 0.814 . . . . 0.0 109.663 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 119' ' ' ILE . 1.6 t -56.6 -60.81 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -37.82 -43.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.652 -0.655 . . . . 0.0 111.141 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.567 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 5.7 ptp180 -77.1 -36.66 55.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 110.594 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.567 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.71 -67.17 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.862 -1.149 . . . . 0.0 108.089 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.542 HD12 ' CG2' ' A' ' 50' ' ' VAL . 6.6 mt -37.07 -41.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.237 0.541 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.23 60.74 4.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -128.92 -54.47 1.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 122' ' ' TYR . 22.7 p90 -78.35 136.45 37.69 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.85 -30.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.397 179.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 17.1 ttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 1' ' ' MET . 2.2 pt20 173.99 164.39 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.35 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 28' ' ' LEU . 7.8 ttp180 -156.13 51.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.479 ' O ' HG12 ' A' ' 5' ' ' ILE . . . 149.45 177.38 23.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -153.25 90.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -1.102 . . . . 0.0 108.821 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.567 ' CG1' ' CG2' ' A' ' 8' ' ' VAL . 4.1 t -94.85 110.5 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.587 -0.696 . . . . 0.0 110.044 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' THR . 12.0 m0 -99.94 81.05 2.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.567 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 43.8 t -83.91 172.34 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.347 0.594 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.507 HG21 ' N ' ' A' ' 10' ' ' ASP . 7.0 p -134.09 140.78 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 108.7 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.507 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.6 t0 -136.71 -153.39 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.965 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 13.6 t70 -80.6 -95.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' SER . 2.5 p-10 169.4 176.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 109.931 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 80.7 69.48 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.652 -0.655 . . . . 0.0 109.882 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 71.88 46.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.564 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -112.05 -44.34 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.483 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 14.7 ttp180 -65.72 -33.06 75.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.65 -66.29 0.57 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 17' ' ' TRP . 38.3 t -39.62 -65.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.012 0.91 . . . . 0.0 110.241 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.536 ' HB3' HD13 ' A' ' 23' ' ' LEU . 21.2 mt -55.08 -76.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.88 -0.512 . . . . 0.0 110.845 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 3.6 tm-20 -33.62 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.573 -0.704 . . . . 0.0 110.922 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 22.1 tpt180 -64.89 -56.3 14.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.982 -1.074 . . . . 0.0 108.486 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.46 -2.32 19.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 19' ' ' LEU . 9.7 mt -100.23 -17.37 17.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.12 -38.73 35.4 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.47 -40.3 91.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.94 -35.88 67.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.346 -1.09 . . . . 0.0 108.472 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 28' ' ' LEU . . . 101.63 42.79 2.25 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.664 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.53 ' CD1' HG13 ' A' ' 112' ' ' VAL . 1.1 mt -141.85 165.62 26.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.878 -1.366 . . . . 0.0 110.06 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.512 HG23 ' CG2' ' A' ' 5' ' ' ILE . 98.5 m -98.19 75.46 2.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.522 ' HB3' HD11 ' A' ' 23' ' ' LEU . 16.1 t -90.83 86.59 6.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.416 -0.803 . . . . 0.0 109.582 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -82.89 140.28 32.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.392 -0.818 . . . . 0.0 109.038 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -132.32 125.48 31.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.543 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 65.4 m-85 -88.32 -177.65 5.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.116 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -108.87 2.29 21.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.48 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -144.45 142.04 30.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 109.792 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' HG23 ' A' ' 9' ' ' VAL . . . -69.93 -60.72 4.73 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -45.84 -69.38 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.382 -1.069 . . . . 0.0 108.344 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' ALA . 2.8 tp10 -35.58 -49.22 0.55 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 0.0 110.912 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 65.2 t -45.22 -53.1 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.188 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.598 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 5.1 mp -60.59 -36.96 79.82 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 38' ' ' GLU . . . -49.71 -33.55 16.29 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.69 -22.75 19.24 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.559 ' CD2' ' HB ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -71.35 -1.23 12.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.891 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.1 65.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -100.06 26.48 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.6 ' HE3' ' CG ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 63.21 136.53 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.573 -0.704 . . . . 0.0 110.139 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.559 ' HB ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -76.8 -169.5 0.19 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.696 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HB2' ' CD1' ' A' ' 5' ' ' ILE . 37.0 Cg_endo -97.76 -75.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.808 1.425 . . . . 0.0 110.171 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 9.1 m-20 -101.62 -63.3 1.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.797 -1.189 . . . . 0.0 110.269 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG2' HG12 ' A' ' 119' ' ' ILE . 2.1 t -148.58 152.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.415 -1.428 . . . . 0.0 111.296 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD23 ' CG1' ' A' ' 39' ' ' VAL . 3.2 mt -102.03 131.16 48.64 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.557 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.81 164.07 21.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 109.818 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' A' ' 9' ' ' VAL . 28.8 p -161.71 133.51 5.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.261 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.95 -177.0 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.128 -0.982 . . . . 0.0 109.911 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.458 ' HA ' HD13 ' A' ' 63' ' ' LEU . 1.1 pp -117.9 137.33 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -155.82 -73.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.215 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' MET . 4.3 ptt? -55.72 134.92 72.07 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.089 -1.007 . . . . 0.0 109.884 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -114.83 71.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.748 1.394 . . . . 0.0 110.308 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.12 -94.86 1.38 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.06 -50.47 66.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.204 . . . . 0.0 109.074 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.02 179.62 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.199 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.492 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -87.65 45.24 3.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER 33.7 -111.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.015 -0.697 . . . . 0.0 109.993 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 63' ' ' LEU . . . 40.59 58.53 2.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.01 -1.056 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 HD21 ' N ' ' A' ' 37' ' ' ASN . 3.6 mp -80.04 73.48 6.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 110.28 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD23 HG23 ' A' ' 80' ' ' ILE . 10.0 tp -87.61 -53.47 4.77 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD2' ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -54.44 -23.57 16.5 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.526 ' N ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -79.23 -56.92 4.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.598 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.13 -42.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.498 0.666 . . . . 0.0 109.944 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -82.74 -56.98 3.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.54 -0.725 . . . . 0.0 109.286 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 70' ' ' LYS . 15.1 tt0 -33.99 -31.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.775 -0.578 . . . . 0.0 111.299 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.535 ' CB ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.09 -78.58 0.58 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.863 -1.148 . . . . 0.0 110.898 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.616 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 1.6 p80 -66.75 144.57 98.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.612 -1.305 . . . . 0.0 109.392 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 36.2 Cg_endo -35.52 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 124.066 1.561 . . . . 0.0 111.525 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.485 ' O ' ' CG ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -178.33 100.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.753 -1.217 . . . . 0.0 110.459 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.652 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 3.4 pp -120.67 156.48 55.98 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.5 Cg_endo -41.87 129.9 4.14 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 117.563 -1.158 . . . . 0.0 111.184 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.605 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -137.9 161.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.39 -0.819 . . . . 0.0 109.254 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.514 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 3.7 mm -142.84 147.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 80' ' ' ILE . 7.1 tt -136.4 141.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.831 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.563 ' SD ' ' CE1' ' A' ' 106' ' ' PHE . 5.1 ttm -88.5 98.26 11.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.318 -0.863 . . . . 0.0 109.045 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.29 149.87 27.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 109.675 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 84' ' ' HIS . . . 179.28 60.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.324 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 79.26 143.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 109.496 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 45.2 p 53.65 171.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.265 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 85' ' ' SER . 5.5 m-20 84.43 -54.61 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -34.82 -30.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 110.8 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.3 p30 -64.16 -97.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.026 -1.046 . . . . 0.0 110.141 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.543 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -43.39 -40.35 3.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.969 -1.082 . . . . 0.0 109.903 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -51.07 -50.58 58.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 t -32.6 -36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.222 0.534 . . . . 0.0 110.187 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.4 t -90.87 44.45 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.81 . . . . 0.0 109.465 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ALA . . . -132.31 -65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 109.19 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.486 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . 41.3 p90 -90.71 28.42 1.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.148 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.64 -42.69 99.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -86.87 -55.09 4.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.483 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . 165.91 -164.3 37.33 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . 81.73 22.27 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.599 -0.942 . . . . 0.0 109.688 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 89.4 m-85 -140.51 157.1 46.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -114.52 -29.91 6.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.438 ' OH ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER 70.93 99.6 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 0.0 109.329 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.447 HD11 HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -110.27 119.76 46.09 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.892 . . . . 0.0 109.654 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -108.45 12.74 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.45 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 64.71 159.25 0.12 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -76.14 172.6 62.33 Favored 'Cis proline' 0 C--N 1.314 -1.238 0 C-N-CA 120.664 -2.64 . . . . 0.0 110.336 -0.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.563 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 40.8 p90 -157.06 144.05 18.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 8.7 t70 -85.63 174.75 9.19 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -82.88 -48.69 17.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.778 -1.201 . . . . 0.0 109.864 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.543 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 22.9 t0 -73.38 -47.37 42.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.006 -1.059 . . . . 0.0 108.15 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 tp10 -49.24 -38.02 25.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.3 -72.94 0.18 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.228 -0.92 . . . . 0.0 108.672 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 28' ' ' LEU . 77.9 t -38.45 -74.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 121.513 0.673 . . . . 0.0 110.323 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.96 -62.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.714 . . . . 0.0 110.355 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 115' ' ' VAL . 1.3 tm? -33.19 -54.65 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.432 0.634 . . . . 0.0 110.003 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 119' ' ' ILE . 75.2 t -60.05 -55.69 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 3.5 pt-20 -34.24 -44.85 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.905 -0.497 . . . . 0.0 111.411 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -59.77 -47.46 85.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.127 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.546 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.41 -55.29 25.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.737 -1.227 . . . . 0.0 107.953 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 115' ' ' VAL . 3.3 mt -36.47 -34.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.943 -0.473 . . . . 0.0 109.796 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.674 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 6.8 p -22.85 -45.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.674 ' CB ' ' O ' ' A' ' 120' ' ' SER . 12.0 t-80 117.65 62.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER 32.04 39.28 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.473 0.654 . . . . 0.0 109.94 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -40.16 -30.93 0.11 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.231 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.411 ' OXT' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.546 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.376 0.608 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 2.2 tt0 -113.95 121.4 43.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.439 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -156.76 172.83 17.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.342 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.544 ' N ' HD22 ' A' ' 28' ' ' LEU . . . 163.37 -168.49 38.07 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.387 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 0.7 OUTLIER -149.84 93.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.601 -0.941 . . . . 0.0 109.363 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 3.6 p -100.4 118.95 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.553 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.638 ' CD2' ' CG2' ' A' ' 31' ' ' THR . 11.7 m95 -103.06 102.58 12.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.96 -1.087 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG1' HD13 ' A' ' 52' ' ' LEU . 59.7 t -98.99 146.91 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.564 ' CG1' HG12 ' A' ' 39' ' ' VAL . 1.6 m -104.49 129.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 O-C-N 121.063 -1.023 . . . . 0.0 108.554 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.509 ' CG ' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -112.44 -99.21 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.343 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 34' ' ' GLU . 12.3 t0 -153.12 -49.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.679 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' HD11 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -144.0 -179.69 6.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.9 -1.125 . . . . 0.0 110.459 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -65.96 169.29 6.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 109.666 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.1 OUTLIER 78.08 -6.77 1.91 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.509 ' CG2' ' CG ' ' A' ' 10' ' ' ASP . 1.8 mp -96.91 -29.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.5 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -65.08 -36.75 85.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 54.4 t90 -61.9 -63.64 1.19 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 20.2 t -36.97 -65.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.527 0.68 . . . . 0.0 110.731 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' CD2' ' CD1' ' A' ' 108' ' ' ILE . 0.7 OUTLIER -50.77 -70.88 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.792 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -35.4 -35.4 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.0 110.77 -179.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.15 -54.19 47.59 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.15 65.71 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.251 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -87.21 -10.29 52.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.167 -0.958 . . . . 0.0 109.543 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.45 71.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.07 -34.46 66.25 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . . . -78.64 -24.16 45.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.466 -1.02 . . . . 0.0 109.143 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.37 49.58 14.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.599 ' CD2' ' CG1' ' A' ' 112' ' ' VAL . 0.9 OUTLIER -128.52 177.89 6.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.106 -1.232 . . . . 0.0 110.267 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 7.2 m -95.26 93.35 7.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 34.2 t -86.45 80.75 8.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.638 ' CG2' ' CD2' ' A' ' 7' ' ' TRP . 3.3 m -84.22 141.17 31.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -143.73 164.51 30.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.678 -1.264 . . . . 0.0 110.038 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.466 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 13.5 m-85 -131.13 -171.67 2.64 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 11' ' ' ASP . 4.6 pt-20 -107.02 -23.97 12.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.964 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 34' ' ' GLU . 13.4 m120 -140.25 147.04 39.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.927 -1.108 . . . . 0.0 109.884 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 64' ' ' ALA . . . -55.67 -31.15 57.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.57 -76.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -1.152 . . . . 0.0 108.005 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -33.83 -33.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.373 0.606 . . . . 0.0 109.753 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.564 HG12 ' CG1' ' A' ' 9' ' ' VAL . 63.1 t -60.84 -59.11 4.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 121.381 -0.824 . . . . 0.0 109.203 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 41' ' ' ALA . 1.6 pp -62.08 -17.46 57.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.572 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -68.01 -35.95 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.36 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.538 ' N ' HD21 ' A' ' 43' ' ' LEU . 3.9 mm? -66.31 -7.82 21.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.75 60.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.5 m -100.25 26.78 6.19 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.1 mptt 71.88 139.5 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.631 0.729 . . . . 0.0 110.263 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.54 HG22 ' CD2' ' A' ' 76' ' ' LEU . 2.6 t -71.25 -177.0 0.42 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.585 -0.697 . . . . 0.0 109.496 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HG3' ' NE1' ' A' ' 7' ' ' TRP . 36.5 Cg_endo -114.94 -67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.799 1.42 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -121.27 -53.5 2.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.846 -1.159 . . . . 0.0 110.527 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -156.12 129.08 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.552 -1.342 . . . . 0.0 110.206 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.633 ' CB ' ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.59 128.88 46.5 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.585 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.813 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 3.3 pp -141.39 165.84 26.4 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.753 -1.217 . . . . 0.0 110.008 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.485 ' HA ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -133.99 151.08 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' SD ' ' A' ' 81' ' ' MET . 4.4 t70 -115.91 129.4 56.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.531 ' CB ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -83.8 144.89 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.62 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.3 -65.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.5 151.89 0.72 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.613 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -99.84 163.6 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.055 1.555 . . . . 0.0 110.207 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.86 -167.47 22.75 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.1 mmt -64.17 -32.61 74.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -1.079 . . . . 0.0 109.585 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.04 92.44 3.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.95 -45.27 7.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.538 ' CD2' ' C ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -50.54 -83.12 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.136 -1.214 . . . . 0.0 109.402 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.488 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . 168.67 35.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.478 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER 57.56 62.33 2.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 69' ' ' ILE . 15.9 tp -75.35 -13.22 60.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.997 . . . . 0.0 108.891 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -78.08 -38.95 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.498 ' CG ' ' N ' ' A' ' 69' ' ' ILE . 2.1 pt20 -76.74 -52.67 9.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.065 -1.022 . . . . 0.0 108.51 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.498 ' N ' ' CG ' ' A' ' 68' ' ' GLN . 2.9 tt -37.58 -34.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.812 0.815 . . . . 0.0 109.313 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 7.5 tptp -78.03 -54.52 6.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.98 -46.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.525 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 1.4 tpt85 -87.59 -43.44 11.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.192 -0.942 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.646 ' CE1' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -40.45 162.65 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.437 -0.789 . . . . 0.0 110.341 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 75' ' ' MET . 37.0 Cg_endo -117.71 42.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 124.03 1.542 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.4 mtt 66.03 82.83 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 0.0 110.579 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.646 ' CD2' ' CE1' ' A' ' 73' ' ' HIS . 1.0 OUTLIER -147.82 151.23 38.15 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.561 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 36.8 Cg_endo -37.59 126.77 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.61 1.321 . . . . 0.0 111.691 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 99' ' ' PHE . 84.1 t -117.91 100.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.589 -0.694 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.813 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 1.7 mt -75.7 157.54 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 108.739 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 7.3 tt -154.15 123.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.028 -1.045 . . . . 0.0 110.569 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.516 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 15.9 mtt -97.89 99.76 11.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.491 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 58.13 161.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.49 ' HB3' HD13 ' A' ' 63' ' ' LEU . . . -172.95 -175.36 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.961 -1.087 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.537 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.5 t-80 -167.49 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.934 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.537 ' C ' ' O ' ' A' ' 84' ' ' HIS . 21.7 m 40.26 31.83 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 88' ' ' ASP . 3.1 m-20 63.43 126.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.56 ' C ' ' O ' ' A' ' 86' ' ' ASP . 3.8 tp -35.83 -31.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -38.02 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.485 0.659 . . . . 0.0 109.584 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 85' ' ' SER . . . -47.59 -32.14 5.18 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 87' ' ' LEU . . . -69.36 -87.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.329 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.485 HG22 ' HG ' ' A' ' 87' ' ' LEU . 91.2 t -33.18 -59.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.719 -0.613 . . . . 0.0 111.398 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -55.84 -99.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.356 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 48.4 -105.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.872 -1.143 . . . . 0.0 108.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.524 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -141.82 60.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 0.0 108.791 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 8.1 mm-40 -57.31 174.23 0.21 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.605 -0.685 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 27.7 mt-30 64.12 50.42 2.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.98 -120.22 0.54 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.68 89.0 2.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -1.187 . . . . 0.0 109.474 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 5.5 m-85 -133.39 136.46 45.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 0.0 109.696 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -120.06 -167.86 1.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.047 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -166.2 94.93 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.735 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.7 OUTLIER -120.64 151.67 54.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.149 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -119.36 -173.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.709 1.373 . . . . 0.0 110.594 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 1.2 mtmm -91.27 159.25 39.77 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.335 -0.853 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.465 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -87.33 169.76 39.54 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 120.274 -2.803 . . . . 0.0 110.308 0.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.516 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 52.6 p90 -161.97 150.05 14.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.529 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 6.1 t0 -80.19 117.99 21.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.197 -0.94 . . . . 0.0 108.584 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.511 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -41.77 -41.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.215 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 25.8 t70 -74.48 -38.85 62.79 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.51 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.529 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 8.1 tm-20 -51.33 -38.11 51.32 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -81.94 -69.7 0.6 Allowed 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.599 ' CG1' ' CD2' ' A' ' 28' ' ' LEU . 24.4 t -37.31 -35.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.499 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -78.61 -66.67 0.83 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.982 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.51 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 3.0 tm? -35.47 -51.72 0.63 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.506 0.67 . . . . 0.0 109.843 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.541 ' CG2' HD12 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -70.45 -51.47 37.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 108.948 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 115' ' ' VAL . 9.0 tm-20 -33.35 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.523 0.677 . . . . 0.0 109.933 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' VAL . 5.1 mtm180 -76.51 -57.27 3.96 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.62 -54.37 9.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -0.973 . . . . 0.0 109.065 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.546 ' CD1' HG22 ' A' ' 50' ' ' VAL . 6.2 mt -39.77 -44.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 110.793 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -86.34 -22.6 26.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 120' ' ' SER . 63.1 t60 -37.94 -55.5 1.22 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.427 -0.796 . . . . 0.0 110.649 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 122' ' ' TYR . 3.9 p90 -91.05 48.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -73.26 -28.65 62.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.796 -1.19 . . . . 0.0 109.296 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.501 ' O ' ' CB ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 1' ' ' MET . 1.3 mm100 76.31 105.47 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 7.5 tpp180 -101.3 66.1 1.09 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.288 -0.882 . . . . 0.0 109.342 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -167.21 50.11 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 3.6 mt -76.64 91.55 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.088 -1.242 . . . . 0.0 107.977 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -100.78 123.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.433 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.565 ' CE3' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.1 87.91 4.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 52' ' ' LEU . 29.9 t -84.95 146.06 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.877 . . . . 0.0 110.545 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' N ' ' A' ' 36' ' ' GLY . 8.9 t -91.64 153.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.491 ' CB ' HG23 ' A' ' 15' ' ' ILE . 9.5 t0 -179.31 -124.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.961 -1.087 . . . . 0.0 110.003 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' CA ' ' HA ' ' A' ' 34' ' ' GLU . 1.4 t70 -128.22 -8.45 5.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.602 -1.311 . . . . 0.0 110.547 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.555 ' HB2' ' N ' ' A' ' 34' ' ' GLU . 2.1 t70 48.87 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 70.01 13.44 7.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.3 p 161.62 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 10' ' ' ASP . 33.0 mm -82.27 -38.34 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 108.958 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 32' ' ' THR . 12.2 ttp85 -65.67 -35.13 79.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -66.4 -62.63 1.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 17' ' ' TRP . 53.4 t -40.32 -64.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' CD1' ' A' ' 108' ' ' ILE . 2.8 mt -60.24 -75.58 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.68 -0.637 . . . . 0.0 110.944 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 18.8 tt0 -34.88 -31.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.736 -0.602 . . . . 0.0 110.612 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -67.07 -56.4 10.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HB2' HG23 ' A' ' 108' ' ' ILE . . . -64.09 -13.04 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -82.39 -27.17 32.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.42 73.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.42 -0.8 . . . . 0.0 109.185 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.72 -27.06 39.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.73 -16.97 60.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -1.07 . . . . 0.0 109.233 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.433 ' O ' HD22 ' A' ' 28' ' ' LEU . . . 72.98 38.11 56.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' CD1' ' CG1' ' A' ' 112' ' ' VAL . 78.2 mt -137.71 163.3 31.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.942 -1.328 . . . . 0.0 109.887 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 29' ' ' THR . 21.1 m -104.8 79.8 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.489 -0.757 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.546 ' CB ' ' CD2' ' A' ' 23' ' ' LEU . 44.3 t -80.96 80.44 7.44 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.004 -1.06 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.1 m -77.45 129.74 36.12 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.7 p -124.29 133.95 53.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.635 -1.291 . . . . 0.0 110.499 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 3.2 m-30 -106.56 145.54 31.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' N ' ' HB2' ' A' ' 12' ' ' ASP . 1.2 pt-20 -63.03 -8.22 6.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 110.192 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -154.81 138.44 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.787 -1.195 . . . . 0.0 110.399 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.526 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -56.34 -26.16 50.33 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' GLU . 33.9 t-20 -56.28 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.261 -1.14 . . . . 0.0 108.052 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.3 mm-40 -36.14 -46.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 110.774 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.585 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -49.5 -54.19 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.013 -1.054 . . . . 0.0 108.537 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.661 ' HG ' ' CE1' ' A' ' 73' ' ' HIS . 8.2 tt -64.45 -26.74 68.57 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.757 . . . . 0.0 109.496 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -22.91 62.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.09 -24.05 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 ' CE3' ' A' ' 7' ' ' TRP . 1.3 mp -87.2 -6.87 58.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.88 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.05 -29.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.711 . . . . 0.0 109.319 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -80.88 -46.56 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER 169.91 151.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 110.117 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.566 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 5.9 m -87.23 164.36 36.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 108.79 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 36.9 Cg_endo -103.84 -71.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.611 1.322 . . . . 0.0 111.13 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.488 ' OD2' ' CA ' ' A' ' 4' ' ' GLY . 3.0 m-20 -110.75 -75.31 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 0.0 110.542 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG2' HG12 ' A' ' 119' ' ' ILE . 13.1 t -143.7 145.02 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.062 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.545 ' CD1' ' CD2' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -101.8 124.21 47.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 109.88 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -108.83 165.99 11.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.222 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -147.8 122.05 9.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 109.644 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -78.0 -171.13 2.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.459 ' CD1' ' O ' ' A' ' 85' ' ' SER . 2.6 tp -143.21 79.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB3' ' NH1' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -117.74 -166.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mtt 59.62 83.75 0.21 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.09 120.4 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.944 1.497 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.76 -87.23 0.07 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 ttm -109.94 -91.71 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -1.125 . . . . 0.0 109.429 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.7 m-20 -102.53 1.26 34.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.47 -90.35 0.13 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER 176.64 25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.384 -1.068 . . . . 0.0 110.377 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.553 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 56.94 -142.18 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.848 -1.157 . . . . 0.0 109.132 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 62.9 mt 80.04 -66.76 0.15 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.682 . . . . 0.0 110.535 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.536 ' O ' ' CG2' ' A' ' 69' ' ' ILE . 2.5 tm? -57.47 -36.03 70.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.584 -1.322 . . . . 0.0 109.251 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -66.11 -30.92 71.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.643 -1.286 . . . . 0.0 107.663 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG3' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -69.08 -65.26 0.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.606 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -37.4 -24.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 111.494 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 68' ' ' GLN . 3.1 tptt -89.24 -69.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.274 -1.517 . . . . 0.0 109.277 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -34.93 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.683 -0.636 . . . . 0.0 112.01 -178.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.554 ' CB ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.31 -68.7 0.86 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.545 -1.347 . . . . 0.0 111.777 -178.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.661 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 77.6 m80 -33.55 152.12 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.197 0 O-C-N 121.536 -0.728 . . . . 0.0 110.698 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -59.08 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.987 1.519 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.41 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.848 -1.158 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.545 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -146.31 -176.2 0.53 Allowed Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.0 Cg_endo -78.73 143.0 18.35 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 117.292 -1.338 . . . . 0.0 111.512 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.471 HG22 ' CE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -137.15 158.0 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 115' ' ' VAL . 4.4 mt -142.6 145.21 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 108.995 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.83 138.89 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.87 142.93 49.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -93.99 178.6 5.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 109.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 166.68 -57.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.543 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.98 -52.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -109.47 107.98 18.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.646 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.5 p-10 166.74 -42.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.471 HD13 HG22 ' A' ' 91' ' ' VAL . 31.5 tp -35.02 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.247 0.546 . . . . 0.0 110.313 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 86' ' ' ASP . 5.4 t0 -63.51 -72.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -43.71 -47.32 7.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -62.77 -76.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.471 HG22 HD13 ' A' ' 87' ' ' LEU . 72.5 t -33.69 -32.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.818 -0.551 . . . . 0.0 111.125 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' ALA . 5.1 p -92.25 -148.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.98 -1.075 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 94' ' ' TYR . . . 58.72 64.79 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.509 ' CB ' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER 76.39 -0.52 3.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.22 -179.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.6 mt-30 42.47 -97.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' TYR . 3.6 mt-30 -62.74 100.44 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.986 -1.071 . . . . 0.0 109.836 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.96 -121.63 1.01 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.12 72.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -1.21 . . . . 0.0 109.679 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CE1' HG22 ' A' ' 78' ' ' VAL . 52.4 m-85 -127.05 136.13 51.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 101' ' ' TYR . 3.7 m-20 -135.78 89.59 2.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -38.34 135.56 0.74 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.652 -0.655 . . . . 0.0 109.995 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.33 121.79 36.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -122.3 -177.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.762 1.401 . . . . 0.0 110.578 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -100.63 156.85 34.72 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -96.88 167.61 13.67 Favored 'Cis proline' 0 C--N 1.317 -1.082 0 C-N-CA 120.8 -2.584 . . . . 0.0 110.392 0.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -164.3 146.44 8.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.6 t70 -75.95 144.02 41.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.543 ' CD1' HD22 ' A' ' 19' ' ' LEU . 4.5 tp -60.13 -48.31 88.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.942 -1.099 . . . . 0.0 110.7 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.517 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 35.7 t0 -69.96 -54.78 11.76 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 108.744 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 9.7 tp10 -46.36 -28.73 1.42 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.96 -78.66 0.09 Allowed 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.504 -0.747 . . . . 0.0 109.328 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.578 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 47.5 t -41.42 -60.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 121.368 -0.832 . . . . 0.0 109.692 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -42.33 -62.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.773 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.502 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -35.0 -50.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.686 0.755 . . . . 0.0 109.317 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -59.8 -53.89 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.573 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.9 tt0 -34.48 -41.46 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.376 0.607 . . . . 0.0 110.386 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -61.99 -53.05 60.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.364 -0.835 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -52.32 -54.8 26.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.012 -1.055 . . . . 0.0 108.626 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.544 HG12 ' CG2' ' A' ' 50' ' ' VAL . 5.1 mt -36.2 -34.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.426 0.631 . . . . 0.0 110.467 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 118' ' ' ALA . 3.5 t -70.73 22.77 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.389 -0.819 . . . . 0.0 111.983 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' C ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER 53.5 35.84 21.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.353 -1.467 . . . . 0.0 109.572 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.5 OUTLIER 32.21 50.56 0.18 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.575 0.703 . . . . 0.0 110.162 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.99 -25.82 67.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.055 -1.028 . . . . 0.0 109.348 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.302 0.572 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 68.13 85.79 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.614 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.02 145.71 2.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 28' ' ' LEU . . . 178.75 141.95 4.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.535 HG13 ' CG2' ' A' ' 29' ' ' THR . 5.2 mp -104.94 103.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.43 -1.041 . . . . 0.0 109.729 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.39 128.04 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.536 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -101.57 81.56 2.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 110.608 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 32' ' ' THR . 42.6 t -72.61 146.6 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 109.539 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 36' ' ' GLY . 84.1 t -91.72 105.81 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.038 -1.039 . . . . 0.0 109.349 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.532 ' HA ' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -53.79 174.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 2.3 t70 -124.39 -50.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 110.277 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -172.42 94.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 111.271 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 12' ' ' ASP . 1.8 p 57.08 137.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.145 0.974 . . . . 0.0 111.557 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.655 ' N ' ' CE3' ' A' ' 17' ' ' TRP . 5.4 t 61.81 3.67 0.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.387 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 10' ' ' ASP . 21.4 mm -88.21 -54.81 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.184 -1.572 . . . . 0.0 109.286 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -62.69 -36.76 83.96 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.655 ' CE3' ' N ' ' A' ' 14' ' ' SER . 7.9 m-90 -71.27 -55.91 7.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.596 ' CG2' ' O ' ' A' ' 14' ' ' SER . 2.1 t -39.1 -61.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 122.057 0.932 . . . . 0.0 109.795 -177.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.3 mm? -55.95 -70.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.59 -0.694 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -35.56 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.5 tmt_? -68.12 -56.52 8.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 108' ' ' ILE . . . -69.94 -6.72 34.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.054 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD1' HG23 ' A' ' 112' ' ' VAL . 1.5 mm? -101.91 -9.11 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.67 -52.57 6.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.317 -0.865 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.48 71.43 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.42 74.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.437 -1.037 . . . . 0.0 108.809 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.37 57.73 1.34 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -140.97 179.7 6.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.073 -1.251 . . . . 0.0 110.347 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.535 ' CG2' HG13 ' A' ' 5' ' ' ILE . 16.4 m -103.4 83.44 2.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.489 ' HB2' ' CG ' ' A' ' 23' ' ' LEU . 19.1 t -92.64 92.54 8.05 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.17 -0.956 . . . . 0.0 110.807 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.536 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -94.18 144.87 25.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.545 ' CG2' ' HB ' ' A' ' 8' ' ' VAL . 82.3 p -149.96 129.25 12.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.702 -1.248 . . . . 0.0 110.258 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.519 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 5.6 m-85 -111.81 127.33 55.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.272 -0.892 . . . . 0.0 109.133 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HA ' ' CB ' ' A' ' 10' ' ' ASP . 1.9 pt-20 -47.63 -19.59 0.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.49 -0.756 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -131.85 132.98 44.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.503 -1.373 . . . . 0.0 111.098 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 9' ' ' VAL . . . -61.78 -18.4 56.6 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.46 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -68.25 -80.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.088 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -35.53 -45.86 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.848 -0.533 . . . . 0.0 110.321 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 0.5 OUTLIER -58.05 -52.22 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.215 -0.928 . . . . 0.0 108.995 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.545 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 2.9 tm? -63.52 -17.29 62.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . -84.47 -25.91 28.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.13 -35.51 64.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.6 ' CD1' ' NE2' ' A' ' 73' ' ' HIS . 4.7 mt -72.36 -102.97 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 81.61 -40.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.122 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 70.7 m -98.99 -40.19 8.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -0.932 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.4 OUTLIER 168.06 150.09 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.096 -1.002 . . . . 0.0 108.969 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.571 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -87.37 165.81 28.94 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.255 -0.903 . . . . 0.0 109.417 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -89.27 -66.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.234 1.649 . . . . 0.0 110.319 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -109.85 -75.32 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.548 ' CG2' HD12 ' A' ' 119' ' ' ILE . 2.8 t -149.99 151.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 0.0 109.964 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.577 HD13 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -99.88 134.57 42.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -125.85 148.16 49.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.941 -1.099 . . . . 0.0 109.147 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t -134.66 126.4 29.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.094 -1.003 . . . . 0.0 110.428 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 m-20 -73.27 -179.93 3.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 109.173 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 81' ' ' MET . 0.7 OUTLIER 176.89 38.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.21 11.09 10.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.96 . . . . 0.0 109.248 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ASP . 5.9 mmt -38.08 140.51 0.57 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -49.42 122.92 9.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.07 1.563 . . . . 0.0 110.631 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 44.39 -126.06 6.24 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 ptt? -70.44 -146.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.399 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 57' ' ' MET . 31.1 m-20 63.14 100.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 109.802 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -153.07 90.67 0.13 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 1.2 pt? -38.32 147.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.912 . . . . 0.0 110.429 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HB2' ' CE ' ' A' ' 67' ' ' LYS . . . -90.97 122.95 34.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.1 mt -134.21 -43.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.445 ' HB2' ' OD2' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -41.25 -51.01 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.464 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.463 ' CE ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -43.66 -50.02 7.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 6.3 pt20 -69.97 -43.09 72.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.616 -1.302 . . . . 0.0 109.429 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -37.48 -52.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 109.606 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -73.14 -57.96 3.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.851 -0.531 . . . . 0.0 110.417 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.41 -36.41 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.843 -0.536 . . . . 0.0 110.939 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -101.99 -30.84 10.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.694 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.6 ' NE2' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.21 -177.77 0.32 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' CD2' ' A' ' 76' ' ' LEU . 36.6 Cg_endo -113.73 39.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.162 1.612 . . . . 0.0 109.598 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 5.8 mmt 63.17 73.24 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 3.0 pp -130.61 176.9 2.51 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 108.886 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.2 Cg_endo -68.26 129.29 18.95 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.184 1.097 . . . . 0.0 112.778 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 51' ' ' LEU . 45.7 t -134.42 100.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.479 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 15.4 mm -80.43 160.52 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.03 -1.044 . . . . 0.0 111.055 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.423 HD13 ' N ' ' A' ' 80' ' ' ILE . 3.9 mp -139.71 136.19 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.519 -0.738 . . . . 0.0 109.31 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.474 ' O ' HG23 ' A' ' 55' ' ' ILE . 1.2 ttm -81.27 89.87 6.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.27 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 65.77 -177.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 109.201 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 55' ' ' ILE . . . 179.54 142.92 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.004 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -146.33 36.82 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.1 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.86 -32.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.573 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' ASP . 46.4 t0 -76.49 -17.62 59.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 109.571 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.535 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 5.3 mt -34.44 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.702 -0.624 . . . . 0.0 110.525 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 86' ' ' ASP . 16.5 t0 -62.85 -57.85 9.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.018 . . . . 0.0 109.746 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.55 -57.24 13.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -52.02 -66.78 0.32 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -0.951 . . . . 0.0 109.8 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' LEU . 47.8 t -33.7 -31.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.98 -0.45 . . . . 0.0 111.042 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 90' ' ' ALA . 32.6 t -95.48 170.69 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 109.897 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 78.0 74.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.82 -86.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.471 ' HG3' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 66.39 31.49 8.22 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.389 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -125.65 16.19 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . 161.9 151.11 6.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . 69.43 34.03 2.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 20.3 m-85 -152.16 29.93 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.38 124.84 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.566 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.03 137.04 38.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.803 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD11 ' CG2' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -110.64 111.05 57.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -104.91 144.21 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.38 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.39 151.54 87.26 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.315 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -81.32 175.53 41.93 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.52 -2.7 . . . . 0.0 110.517 -0.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -159.5 136.31 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 17.5 t0 -76.05 -176.75 3.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 108.551 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.49 -49.48 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.639 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 26.2 t70 -69.36 -45.84 68.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 108.53 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.3 tp10 -51.1 -37.08 43.76 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.06 -70.22 0.37 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.379 -0.826 . . . . 0.0 108.81 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.532 HG23 ' CD1' ' A' ' 23' ' ' LEU . 39.1 t -36.45 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.744 -0.597 . . . . 0.0 110.396 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -51.32 -61.22 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 110.45 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 113' ' ' ALA . 47.6 tp -34.47 -58.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.331 0.586 . . . . 0.0 110.174 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 117' ' ' ARG . 1.0 OUTLIER -59.66 -56.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 115' ' ' VAL . 4.0 tm-20 -35.59 -31.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.185 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtm180 -82.63 -56.37 3.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.632 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.18 -61.33 1.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 108.734 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.548 HD12 ' CG2' ' A' ' 50' ' ' VAL . 9.6 mt -35.43 -44.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.805 -0.559 . . . . 0.0 110.55 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.74 56.62 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.91 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 34.5 t-80 -117.73 0.28 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.393 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -99.56 9.98 42.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.262 -0.899 . . . . 0.0 109.606 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 22.8 mt-30 -90.53 40.78 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 29.0 tt0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.49 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.6 mt-30 68.52 20.24 8.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -112.9 145.99 39.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 108.715 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.505 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -167.61 149.5 14.74 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.839 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.599 ' CG2' ' CG2' ' A' ' 29' ' ' THR . 0.0 OUTLIER -101.46 110.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.616 -0.932 . . . . 0.0 109.859 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -113.86 119.09 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.657 ' CE3' ' CG2' ' A' ' 31' ' ' THR . 10.5 m95 -101.04 88.45 3.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.656 -1.278 . . . . 0.0 109.235 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' CG2' ' CB ' ' A' ' 52' ' ' LEU . 48.4 t -82.77 153.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.528 -0.732 . . . . 0.0 110.45 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.545 HG21 ' CG2' ' A' ' 39' ' ' VAL . 93.5 t -96.58 106.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -63.22 156.31 25.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 109.147 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -102.92 -29.8 11.2 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.659 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 1.7 m-20 -124.51 169.66 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.905 -1.122 . . . . 0.0 110.229 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -67.07 -3.12 6.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.895 -1.128 . . . . 0.0 110.64 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 14' ' ' SER . 3.1 t -121.3 8.85 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.799 -1.188 . . . . 0.0 110.45 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 10' ' ' ASP . 16.1 mm -78.88 -35.24 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.909 -1.119 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -49.58 77.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.541 ' CZ2' ' NH2' ' A' ' 21' ' ' ARG . 19.0 t90 -53.86 -64.4 0.84 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.2 t -37.48 -65.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.636 0.731 . . . . 0.0 110.698 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -50.39 -79.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 111.002 -178.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.8 tt0 -33.68 -33.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.826 -0.546 . . . . 0.0 110.947 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' NH2' ' CZ2' ' A' ' 17' ' ' TRP . 2.5 tpp85 -66.84 -57.16 7.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 0.0 109.037 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' CB ' HG13 ' A' ' 108' ' ' ILE . . . -71.97 -4.31 27.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.347 -0.846 . . . . 0.0 109.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -100.11 -18.62 16.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.48 -43.5 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.94 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.22 62.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -1.071 . . . . 0.0 109.013 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.7 47.88 4.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.523 HD23 ' CG1' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -127.87 179.57 5.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.073 -1.251 . . . . 0.0 110.097 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.599 ' CG2' ' CG2' ' A' ' 5' ' ' ILE . 53.9 m -99.97 86.04 3.18 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.539 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 31.3 t -82.37 92.13 6.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.474 -0.767 . . . . 0.0 110.399 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.657 ' CG2' ' CE3' ' A' ' 7' ' ' TRP . 24.3 m -89.55 124.1 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.2 p -127.01 151.31 48.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.06 -1.025 . . . . 0.0 110.125 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 7.8 m-85 -143.14 119.07 10.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.48 -0.763 . . . . 0.0 109.207 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' HA ' ' OD2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -54.16 -27.82 36.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.167 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.453 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 18.1 m120 -109.45 125.33 52.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 110.39 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.569 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . -57.78 -46.72 91.98 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 38' ' ' GLU . 58.3 t-20 -53.62 -71.93 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.159 -1.201 . . . . 0.0 108.811 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -34.23 -38.05 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.878 -0.514 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.545 ' CG2' HG21 ' A' ' 9' ' ' VAL . 48.8 t -53.15 -59.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.49 ' HG ' ' HG2' ' A' ' 68' ' ' GLN . 3.9 mm? -62.57 -21.78 65.86 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.68 83.97 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.67 36.29 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.593 ' HG ' ' CD2' ' A' ' 73' ' ' HIS . 2.5 tm? -56.95 -19.84 20.29 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.48 -40.25 12.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 109.22 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -62.31 -39.81 94.27 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.085 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 99.33 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.351 0.596 . . . . 0.0 110.583 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 7' ' ' TRP . 34.5 p -65.15 169.53 5.59 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.554 ' HG2' ' CG1' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -129.89 -15.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 116.263 -2.025 . . . . 0.0 113.007 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -94.4 -71.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 119.867 -1.771 . . . . 0.0 110.912 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.54 HG22 ' CD1' ' A' ' 119' ' ' ILE . 11.3 t -163.78 144.36 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 110.168 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.607 ' CD2' ' NE2' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -101.92 125.27 48.56 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.779 178.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' CB ' ' CG2' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -113.18 160.12 18.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -153.42 131.22 11.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.397 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -92.43 144.06 25.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.555 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -88.31 82.74 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.096 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 6.5 tpt180 178.57 128.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 108.919 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.52 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -174.18 157.61 2.59 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 57' ' ' MET . 36.2 Cg_endo -63.4 155.9 59.49 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.784 1.412 . . . . 0.0 110.298 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.23 10.82 27.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 61.14 -177.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -1.098 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.72 -146.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' O ' ' CG ' ' A' ' 57' ' ' MET . . . -107.98 -111.27 3.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -130.74 -46.03 1.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -1.11 . . . . 0.0 109.413 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . 77.36 64.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.817 . . . . 0.0 109.762 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.569 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -149.42 14.94 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 1.2 mm? -65.21 -40.76 94.58 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -25.82 62.89 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.524 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.37 -58.68 7.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' HIS . 1.3 mp -37.71 -69.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.563 -0.71 . . . . 0.0 110.452 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -48.28 -69.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.987 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 12.3 mt-30 -34.77 -31.83 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.408 0.623 . . . . 0.0 110.428 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -108.64 -81.29 0.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.607 ' NE2' ' CD2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -35.78 140.33 0.36 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.313 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HD2' ' ND1' ' A' ' 73' ' ' HIS . 36.8 Cg_endo -59.49 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.104 1.581 . . . . 0.0 110.278 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.418 ' HB3' ' HE1' ' A' ' 75' ' ' MET . 13.5 ptp 178.96 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.673 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 4.2 pp -115.95 146.61 37.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 32.8 Cg_endo -33.43 137.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.893 1.47 . . . . 0.0 112.626 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -131.13 106.8 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 16.0 mm -91.64 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.519 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.487 HG21 ' N ' ' A' ' 81' ' ' MET . 53.4 mt -150.22 145.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.487 ' N ' HG21 ' A' ' 80' ' ' ILE . 1.2 mpp? -78.79 136.94 37.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.568 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 91.3 m 67.18 -83.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.559 -0.713 . . . . 0.0 110.021 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 83.93 95.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.585 -0.697 . . . . 0.0 109.171 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 86' ' ' ASP . 29.8 t60 -136.0 -87.51 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.528 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 46.67 36.66 3.88 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -178.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 88' ' ' ASP . 14.5 t0 66.11 128.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -36.47 -31.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -36.89 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.519 0.676 . . . . 0.0 109.71 176.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 85' ' ' SER . . . -51.7 -34.36 38.32 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.463 -0.773 . . . . 0.0 109.16 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -59.06 -80.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.062 -1.024 . . . . 0.0 109.618 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 90' ' ' ALA . 33.3 t -14.26 -54.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 122.763 0.425 . . . . 0.0 111.987 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 90' ' ' ALA . 4.3 t -79.53 -149.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.926 -1.109 . . . . 0.0 109.766 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 72.96 36.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.902 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 61.69 57.21 2.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.09 -1.006 . . . . 0.0 109.529 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -75.54 150.96 38.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 19.2 tt0 56.42 22.17 6.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.135 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.43 -46.83 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 77' ' ' PRO . . . -157.52 54.9 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.243 . . . . 0.0 109.985 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.29 122.5 12.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 101' ' ' TYR . 38.7 t70 -113.1 6.77 17.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.053 -1.03 . . . . 0.0 110.354 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.485 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 2.4 m-85 46.88 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.066 -1.022 . . . . 0.0 109.106 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -91.89 137.62 25.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.0 110.018 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 37.4 Cg_endo -127.54 177.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.643 1.339 . . . . 0.0 110.048 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -93.29 159.53 35.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.265 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -79.59 172.79 57.37 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.655 -2.644 . . . . 0.0 110.492 0.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 10.7 p90 -156.05 133.8 11.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.363 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 18.3 t0 -81.16 -162.39 0.49 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 108.703 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.5 HG13 ' CB ' ' A' ' 22' ' ' ALA . 36.0 mm -106.67 -65.01 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 109.208 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -57.65 -51.91 67.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.9 tp10 -43.55 -38.2 2.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 108' ' ' ILE . . . -71.74 -73.71 0.18 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 28' ' ' LEU . 38.4 t -37.24 -69.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.513 -0.742 . . . . 0.0 110.233 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -45.29 -63.14 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 110.441 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.529 HD11 ' N ' ' A' ' 115' ' ' VAL . 2.3 tm? -35.29 -50.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.689 0.756 . . . . 0.0 109.524 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.529 ' N ' HD11 ' A' ' 114' ' ' LEU . 1.2 t -60.18 -57.01 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 115' ' ' VAL . 3.4 tt0 -34.02 -39.42 0.07 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.198 0.523 . . . . 0.0 110.288 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtp85 -71.72 -52.0 19.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 109.25 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -49.09 -56.46 9.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.188 -0.945 . . . . 0.0 108.6 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.54 ' CD1' HG22 ' A' ' 50' ' ' VAL . 5.4 mt -35.27 -41.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.336 0.589 . . . . 0.0 109.774 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -88.03 53.33 2.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.153 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 6.9 t-80 -94.93 -5.73 44.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.607 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -85.64 19.8 2.32 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.235 -0.916 . . . . 0.0 109.822 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.2 -16.05 25.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.579 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.561 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -146.37 177.18 9.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 109.615 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 116' ' ' GLU . 0.3 OUTLIER -151.63 120.79 6.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 109.395 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.452 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . 166.87 153.1 7.7 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.051 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.568 ' HB ' ' CB ' ' A' ' 48' ' ' PRO . 1.9 mt -124.17 131.52 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.159 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.55 ' CG1' HG21 ' A' ' 8' ' ' VAL . 1.9 t -126.74 113.07 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 108.796 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.61 ' CD1' ' HG3' ' A' ' 48' ' ' PRO . 9.2 m95 -99.9 86.9 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.425 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.55 HG21 ' CG1' ' A' ' 6' ' ' VAL . 48.7 t -84.09 159.82 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 111.076 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.536 HG12 ' CA ' ' A' ' 36' ' ' GLY . 14.3 t -95.1 121.76 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.511 ' OD2' ' CG2' ' A' ' 15' ' ' ILE . 8.3 m-20 -109.07 -169.98 1.58 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.19 -0.943 . . . . 0.0 110.0 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.4 ' CG ' ' HG3' ' A' ' 57' ' ' MET . 51.8 t0 -100.87 -57.13 2.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -130.73 173.74 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 109.845 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.538 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -58.71 -41.74 87.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.958 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -28.36 34.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 108.986 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG2' ' OD2' ' A' ' 10' ' ' ASP . 43.7 mm -71.38 -40.35 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.474 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.0 -49.46 71.43 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 27.0 t90 -55.22 -59.68 4.45 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.0 t -36.18 -70.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.5 tp -55.41 -72.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.423 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 10.3 tm-20 -34.89 -30.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.795 -0.566 . . . . 0.0 110.969 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -68.45 -55.94 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.243 -0.911 . . . . 0.0 108.57 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -72.1 -4.76 30.87 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.4 OUTLIER -100.22 -12.75 19.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.421 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.8 -43.48 68.57 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.81 97.48 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.27 67.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.03 49.37 4.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.527 ' CD1' HG12 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -130.14 178.12 6.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.878 -1.366 . . . . 0.0 110.165 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.557 ' CG2' HG22 ' A' ' 5' ' ' ILE . 96.6 m -97.9 77.84 2.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.541 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 40.5 t -76.09 88.31 3.0 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.931 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.58 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 13.0 m -100.51 127.09 46.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.201 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 16' ' ' ARG . 43.9 p -119.06 161.01 20.98 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 109.27 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CG ' HG21 ' A' ' 39' ' ' VAL . 2.0 m-85 -134.37 105.81 6.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HG2' ' N ' ' A' ' 13' ' ' SER . 1.1 mp0 -41.94 -31.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.537 -0.727 . . . . 0.0 109.777 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -106.91 126.21 52.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.551 ' O ' HG13 ' A' ' 39' ' ' VAL . . . -65.17 -57.35 11.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 26.5 t-20 -51.37 -66.52 0.37 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.772 -1.428 . . . . 0.0 108.956 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.5 tt0 -33.52 -53.16 0.41 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.855 -0.528 . . . . 0.0 111.465 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG21 ' CG ' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -58.3 -52.86 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.725 -1.235 . . . . 0.0 109.498 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.616 HD21 ' N ' ' A' ' 69' ' ' ILE . 8.5 mp -62.34 -14.7 42.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.2 -37.68 53.05 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.37 1.09 48.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.528 HD13 ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.11 -6.16 54.07 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.323 -0.86 . . . . 0.0 109.439 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -10.38 52.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 109.59 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.7 m -97.39 1.04 48.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.486 ' CG ' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 65.33 90.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.847 . . . . 0.0 109.611 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.581 HG23 ' CZ2' ' A' ' 7' ' ' TRP . 1.6 m -99.25 -72.97 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.082 -1.011 . . . . 0.0 109.847 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 38.7 Cg_endo -75.65 -162.72 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.488 1.257 . . . . 0.0 110.411 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.8 p30 -110.81 -14.93 13.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.573 ' CG2' ' HG2' ' A' ' 77' ' ' PRO . 4.3 t -144.89 129.11 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.521 -0.737 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.583 ' CD2' ' HG2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -100.42 158.4 15.92 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -146.84 157.1 43.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.072 -1.018 . . . . 0.0 110.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.519 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -134.05 123.87 25.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 109.729 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.572 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 27.1 m-20 -62.5 -51.93 65.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 109.779 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.572 ' CG2' ' O ' ' A' ' 54' ' ' ASP . 2.2 tp 83.96 26.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.326 0.584 . . . . 0.0 109.454 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 57' ' ' MET . 17.3 ptm180 -113.67 -138.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.217 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.49 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.8 ttm 70.57 128.96 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.865 -1.147 . . . . 0.0 109.301 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -89.23 173.33 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.326 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.63 -66.87 0.96 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -91.17 29.62 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -1.194 . . . . 0.0 109.527 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t0 52.48 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -138.02 83.79 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 62' ' ' GLY . 1.2 mp -35.91 132.62 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.907 -0.76 . . . . 0.0 110.127 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -49.88 -80.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 53' ' ' SER . 1.0 OUTLIER 79.09 -35.93 0.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 110.529 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 13.5 tp -77.0 -62.11 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.405 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -50.71 -40.29 53.81 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.581 ' CG ' ' CD2' ' A' ' 40' ' ' LEU . 3.7 tp-100 -57.96 -56.76 17.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.616 ' N ' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -35.92 -53.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.37 0.605 . . . . 0.0 109.908 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 72' ' ' ARG . 11.3 mtmm -60.04 -63.0 1.45 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.928 -1.107 . . . . 0.0 109.609 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.96 -34.37 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.775 -0.578 . . . . 0.0 110.959 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -122.51 -68.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.066 -1.021 . . . . 0.0 109.656 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -40.07 160.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.37 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.486 ' HG3' ' CG ' ' A' ' 46' ' ' LYS . 36.8 Cg_endo -92.95 -96.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.899 1.473 . . . . 0.0 110.15 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.4 mtm -147.56 2.36 0.73 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.875 -1.14 . . . . 0.0 110.881 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 50' ' ' VAL . 2.5 pp -61.81 134.89 94.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 120.596 -1.315 . . . . 0.0 108.104 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HG2' ' CG2' ' A' ' 50' ' ' VAL . 32.1 Cg_endo -28.94 145.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 124.176 1.619 . . . . 0.0 112.487 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.619 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 21.5 t -147.45 95.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.723 -0.611 . . . . 0.0 109.388 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 19.1 mt -75.63 136.38 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.951 -1.093 . . . . 0.0 110.635 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.585 HD13 ' CE1' ' A' ' 101' ' ' TYR . 4.0 pt -126.79 115.19 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.011 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -66.97 129.52 40.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.169 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.503 ' CB ' HG23 ' A' ' 55' ' ' ILE . 1.3 m 71.98 -78.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.717 . . . . 0.0 109.922 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . . . 66.06 129.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 109.508 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.497 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.2 OUTLIER -178.82 -79.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.497 ' C ' ' O ' ' A' ' 84' ' ' HIS . 4.6 t 44.59 41.04 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 69.75 131.51 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -175.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' C ' ' O ' ' A' ' 86' ' ' ASP . 1.7 mm? -36.35 -28.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.042 0.925 . . . . 0.0 109.104 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -35.88 -63.55 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 66' ' ' LEU . . . -81.18 -32.49 33.56 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 108.929 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -63.68 -67.23 0.45 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 109.033 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.75 -53.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 C-N-CA 122.779 0.432 . . . . 0.0 111.611 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.595 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -61.8 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.998 -1.064 . . . . 0.0 109.088 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 79.18 -75.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.076 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' VAL . 22.5 p90 -78.79 5.76 10.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.055 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.69 -26.97 60.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 109.286 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER 163.24 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -0.827 . . . . 0.0 109.384 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.15 -146.2 8.88 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -138.88 67.6 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -1.126 . . . . 0.0 109.652 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 41.3 p90 170.66 -177.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -150.7 -176.01 5.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.272 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.585 ' CE1' HD13 ' A' ' 80' ' ' ILE . 5.0 m-30 -81.71 130.22 34.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.252 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -114.61 115.91 43.88 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 0.0 109.404 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -117.06 171.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.875 1.46 . . . . 0.0 110.415 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 16.5 mttm -63.03 157.96 58.03 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 109.402 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 37.3 Cg_endo -79.07 161.54 88.29 Favored 'Cis proline' 0 C--N 1.315 -1.225 0 C-N-CA 120.539 -2.692 . . . . 0.0 109.905 -0.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 1.8 p90 -143.26 129.5 19.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.5 t70 -91.28 -147.25 0.21 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.062 -1.024 . . . . 0.0 108.748 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -119.18 -69.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.479 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 13.7 t70 -62.16 -42.67 99.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.6 tm-20 -46.23 -45.7 17.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.79 -77.04 0.09 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 28' ' ' LEU . 65.2 t -38.39 -71.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 110.155 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.59 -65.4 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.961 -0.462 . . . . 0.0 110.27 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' ALA . 13.5 tp -34.76 -49.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.826 0.822 . . . . 0.0 109.507 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 50' ' ' VAL . 1.7 t -60.49 -55.81 21.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 115' ' ' VAL . 1.4 tt0 -34.88 -45.79 0.28 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 118' ' ' ALA . 12.5 mtm105 -70.72 -51.74 25.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 109.441 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.24 -67.56 0.27 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.889 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.541 ' CG1' HG22 ' A' ' 50' ' ' VAL . 5.5 mt -36.29 -43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.672 -0.642 . . . . 0.0 110.062 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 121' ' ' HIS . 3.7 t -48.73 -58.2 5.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 120' ' ' SER . 4.9 t60 -42.75 -41.33 3.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.338 -0.851 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.75 49.71 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.493 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.41 28.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.39 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 67.11 129.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 109.653 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 2' ' ' GLN . 7.7 mtt180 -165.88 46.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.779 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.492 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . 161.23 168.59 23.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.61 ' HB ' ' CB ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -144.61 104.34 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -1.119 . . . . 0.0 108.315 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.461 HG12 HD11 ' A' ' 52' ' ' LEU . 2.7 t -120.87 115.95 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.08 . . . . 0.0 110.253 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.56 ' CD2' ' HB ' ' A' ' 31' ' ' THR . 0.2 OUTLIER -99.58 80.38 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 0.0 109.34 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 32' ' ' THR . 9.3 t -68.22 137.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.321 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' CG1' ' HA2' ' A' ' 36' ' ' GLY . 57.4 t -85.67 108.78 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.115 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.486 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 71.6 m-20 -87.15 -171.72 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.326 -0.859 . . . . 0.0 109.834 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.75 -87.06 0.14 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.38 -0.825 . . . . 0.0 109.637 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 15' ' ' ILE . 3.1 m-20 -112.05 170.7 7.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.635 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.8 p -49.55 164.72 0.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER 79.73 -8.67 1.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.486 ' CG2' ' HB3' ' A' ' 10' ' ' ASP . 46.4 mm -92.93 -36.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.973 -1.08 . . . . 0.0 108.398 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' A' ' 17' ' ' TRP . 15.8 ptt-85 -66.18 -32.59 74.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.613 ' CZ3' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -52.11 -66.34 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 49.6 t -42.49 -53.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.921 0.867 . . . . 0.0 110.072 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' ARG . 2.7 mm? -49.56 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.745 . . . . 0.0 110.343 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 2.0 mt-10 -35.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.369 0.604 . . . . 0.0 110.395 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.613 ' HD3' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -62.51 -56.35 18.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.809 -1.182 . . . . 0.0 108.839 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HB2' ' CD1' ' A' ' 108' ' ' ILE . . . -63.5 -20.84 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 19.6 tp -71.67 -25.59 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.84 -0.537 . . . . 0.0 110.165 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.66 73.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.27 -38.47 87.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.41 49.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 109.226 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 57.76 65.51 3.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.576 ' CD1' ' CG1' ' A' ' 112' ' ' VAL . 0.1 OUTLIER -136.43 -177.44 4.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.238 -1.154 . . . . 0.0 110.215 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.55 ' CG2' HG21 ' A' ' 5' ' ' ILE . 32.1 m -104.93 50.96 0.77 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.535 ' HB3' HD21 ' A' ' 23' ' ' LEU . 18.4 t -79.03 87.07 4.83 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.233 0.54 . . . . 0.0 109.579 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.56 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 1.4 m -85.83 170.29 12.54 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 108.66 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.545 ' CG2' ' HB ' ' A' ' 8' ' ' VAL . 1.1 p -155.18 143.16 20.04 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 7' ' ' TRP . 2.4 m-85 -118.44 -168.87 1.61 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.936 -1.103 . . . . 0.0 109.794 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.42 -1.71 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 110.2 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 4.8 m-20 -136.56 127.36 27.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.543 ' HA3' ' CG ' ' A' ' 65' ' ' LEU . . . -48.99 -50.68 26.78 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 39' ' ' VAL . 18.9 t-20 -58.94 -63.67 1.22 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.3 -1.118 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -34.37 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 0.0 110.592 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 37' ' ' ASN . 1.7 t -74.54 -64.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.592 ' CD2' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -59.68 -14.57 14.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.529 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -85.14 -39.58 17.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.175 -0.953 . . . . 0.0 108.469 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.53 74.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -65.23 -94.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.498 -0.752 . . . . 0.0 109.135 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 84.0 -63.33 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.427 0.632 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 62.3 p -102.3 -37.88 7.88 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.514 -0.741 . . . . 0.0 109.794 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 149.72 95.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m -100.32 -74.51 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.853 -1.154 . . . . 0.0 110.475 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 40.8 Cg_endo -81.2 -162.02 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 116.916 -1.59 . . . . 0.0 109.591 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 50' ' ' VAL . 53.2 p30 -113.43 -12.11 13.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.55 HG21 ' CD1' ' A' ' 119' ' ' ILE . 2.4 t -155.51 121.75 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.6 HD21 ' CE1' ' A' ' 73' ' ' HIS . 2.5 tp -99.51 136.05 40.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.041 -1.037 . . . . 0.0 108.631 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.517 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -117.12 174.18 6.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.917 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.471 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 91.0 p -149.01 133.97 18.07 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.502 ' OD2' ' CG1' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -95.93 3.92 53.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 110.051 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.516 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 1.3 tt 28.82 82.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.3 0.572 . . . . 0.0 110.738 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -162.63 73.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.995 -1.066 . . . . 0.0 109.688 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtm -128.26 136.55 29.23 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.98 113.08 2.45 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.062 1.559 . . . . 0.0 110.383 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.62 -160.99 24.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.8 mtt -76.66 -49.5 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.203 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.25 177.06 5.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.217 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.42 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.34 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER 178.88 29.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -1.122 . . . . 0.0 110.0 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 43.23 -92.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.96 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.543 ' CG ' ' HA3' ' A' ' 36' ' ' GLY . 0.5 OUTLIER 71.72 -82.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.854 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 65' ' ' LEU . 1.1 mm? -37.35 -29.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.123 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.91 -55.02 25.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.488 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.04 -41.72 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.153 . . . . 0.0 109.191 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -37.33 -59.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.187 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.31 -51.53 56.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.903 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -34.39 -36.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.715 -0.615 . . . . 0.0 111.119 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -109.33 -59.18 1.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 0.0 110.313 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.6 ' CE1' HD21 ' A' ' 51' ' ' LEU . 57.1 m170 -39.61 145.35 0.43 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.417 -0.802 . . . . 0.0 110.066 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 35.1 Cg_endo -87.06 47.32 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.111 1.585 . . . . 0.0 109.868 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.8 mtp 72.41 55.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.61 -0.681 . . . . 0.0 110.241 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 77' ' ' PRO . 1.2 pp -114.8 136.62 22.53 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.056 . . . . 0.0 109.235 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.546 ' HG2' ' CG2' ' A' ' 50' ' ' VAL . 35.6 Cg_endo -40.54 141.91 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.267 1.667 . . . . 0.0 112.994 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -147.5 142.76 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.533 ' CD1' HG23 ' A' ' 115' ' ' VAL . 8.7 mt -126.12 167.93 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.775 -1.203 . . . . 0.0 110.524 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.443 ' N ' ' CG2' ' A' ' 79' ' ' ILE . 4.2 tt -149.22 144.11 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 82' ' ' THR . 1.7 mpt? -88.14 65.49 8.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.543 ' CB ' ' O ' ' A' ' 81' ' ' MET . 1.1 m 158.1 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.89 46.11 0.94 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.477 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -123.4 -97.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 45.78 27.65 0.48 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 61.23 123.37 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.532 ' C ' ' O ' ' A' ' 86' ' ' ASP . 9.6 tp -39.32 -25.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 108.263 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -36.91 -75.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.064 -1.022 . . . . 0.0 110.234 176.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 92' ' ' SER . . . -68.43 -34.62 76.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -56.7 -62.2 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.37 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -27.25 -39.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 122.683 0.393 . . . . 0.0 111.099 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -38.37 -59.6 0.88 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 109.579 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -44.0 -69.24 0.14 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -51.99 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 93' ' ' ALA . 2.3 mm-40 -176.38 -42.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -136.78 -67.36 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . 156.65 173.9 25.72 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . 81.84 -0.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.914 . . . . 0.0 109.899 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 3.8 m-85 -112.81 119.73 39.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.082 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.31 164.39 21.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.819 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.443 ' OH ' ' C ' ' A' ' 90' ' ' ALA . 65.7 m-85 -110.75 94.57 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.143 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.529 ' HB2' ' CG2' ' A' ' 79' ' ' ILE . 1.6 tp -83.1 153.67 66.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -122.68 -174.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.707 1.372 . . . . 0.0 110.501 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -119.14 157.66 50.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -78.81 175.31 47.12 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.887 -2.547 . . . . 0.0 110.562 0.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 25.1 p90 -148.68 140.89 24.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.778 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 13.5 t0 -79.49 147.63 32.16 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -72.36 -31.09 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.722 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -82.96 -44.81 14.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 38.8 tt0 -55.46 -39.26 70.12 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.81 -65.9 0.77 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.37 -0.831 . . . . 0.0 109.173 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.576 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 41.0 t -36.5 -57.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.652 . . . . 0.0 110.576 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -58.72 -66.09 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.539 -0.726 . . . . 0.0 110.492 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.3 tp -35.19 -54.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.544 0.687 . . . . 0.0 110.09 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' A' ' 79' ' ' ILE . 27.3 t -56.63 -56.11 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 115' ' ' VAL . 54.9 tt0 -34.91 -42.17 0.15 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.421 0.629 . . . . 0.0 109.917 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' ALA . 22.4 mtp180 -73.57 -54.86 7.19 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.068 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.99 -66.84 0.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.163 -0.961 . . . . 0.0 109.157 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.55 ' CD1' HG21 ' A' ' 50' ' ' VAL . 4.1 mt -37.53 -41.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.672 . . . . 0.0 109.932 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 121' ' ' HIS . 6.1 m -46.15 -55.1 7.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.413 -0.805 . . . . 0.0 109.9 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 120' ' ' SER . 14.4 t-160 -38.64 -43.84 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.885 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.78 96.43 4.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.49 40.71 3.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.87 . . . . 0.0 109.334 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.471 ' OXT' ' CG ' ' A' ' 124' ' ' GLU . 35.5 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 12.4 mt-30 -135.7 122.31 20.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.165 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -132.28 52.74 2.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 110.22 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.542 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . -174.59 120.64 0.79 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.507 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 48' ' ' PRO . 1.1 mp -106.31 118.03 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.297 . . . . 0.0 108.601 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.8 OUTLIER -122.67 112.72 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.551 ' CZ2' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -98.45 92.31 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.69 -1.256 . . . . 0.0 108.746 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 52' ' ' LEU . 57.6 t -83.66 150.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.444 0.64 . . . . 0.0 110.899 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 76.2 t -89.7 122.34 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' HA ' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.94 143.05 55.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.824 0.821 . . . . 0.0 110.819 -178.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' OD1' ' HG3' ' A' ' 57' ' ' MET . 5.1 t0 -99.29 -65.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.523 ' O ' ' CG1' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -110.01 174.73 5.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.292 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 14' ' ' SER . 52.0 p -64.45 148.79 49.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 78.25 24.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.884 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 12' ' ' ASP . 3.2 mm -83.63 -47.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 7.4 mtm180 -53.17 -47.95 68.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.485 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 22.9 t90 -55.51 -61.5 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 14' ' ' SER . 15.9 t -36.98 -68.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.506 -0.746 . . . . 0.0 110.643 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 21' ' ' ARG . 6.9 mt -59.85 -74.56 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 110.878 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 19' ' ' LEU . 12.2 tt0 -34.56 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.771 -0.581 . . . . 0.0 111.057 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -69.87 -56.39 7.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.998 . . . . 0.0 108.593 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HB1' HG22 ' A' ' 108' ' ' ILE . . . -72.06 -3.75 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.38 -0.825 . . . . 0.0 108.82 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.557 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 3.1 mm? -103.43 -10.89 18.22 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.392 -0.818 . . . . 0.0 109.522 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.88 -35.11 24.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.31 -36.78 49.46 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.4 -34.04 73.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -1.052 . . . . 0.0 108.637 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 90.26 73.08 1.26 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.542 HD22 ' CA ' ' A' ' 4' ' ' GLY . 0.2 OUTLIER -146.67 174.61 11.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -1.207 . . . . 0.0 109.935 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.535 ' CG2' HG22 ' A' ' 5' ' ' ILE . 92.7 m -102.98 61.19 0.79 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.557 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . 35.9 t -83.85 96.79 8.89 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.551 HG23 ' CZ2' ' A' ' 7' ' ' TRP . 5.7 m -100.02 154.62 18.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 108.662 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.462 ' OG1' ' CG ' ' A' ' 16' ' ' ARG . 82.0 p -139.98 158.77 43.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.99 -1.069 . . . . 0.0 109.36 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.591 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 6.2 m-85 -135.95 120.56 18.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.602 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 3.0 mt-10 -42.84 -42.86 3.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.966 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -110.05 119.74 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 37' ' ' ASN . . . -51.68 -48.96 48.79 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.478 ' O ' ' C ' ' A' ' 38' ' ' GLU . 17.0 t30 -42.53 -71.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -1.045 . . . . 0.0 108.4 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.7 mt-10 -34.51 -42.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.79 -0.568 . . . . 0.0 109.755 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 1.2 t -58.01 -54.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.887 . . . . 0.0 108.688 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 39' ' ' VAL . 3.1 mm? -61.36 -19.28 61.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.1 -45.28 42.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.163 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.45 -19.34 59.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.645 ' CD1' ' CD2' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -80.76 -105.04 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 82.28 -57.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.74 . . . . 0.0 109.497 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.5 t -100.99 -3.73 28.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 83.42 110.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.78 0.8 . . . . 0.0 109.141 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.604 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 21.2 m -104.04 -74.77 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.584 -1.323 . . . . 0.0 111.84 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 45.4 Cg_endo -55.51 -161.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.441 1.232 . . . . 0.0 109.766 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 8.1 p30 -115.7 -8.4 12.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.182 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.535 HG22 ' CD1' ' A' ' 119' ' ' ILE . 2.3 t -156.91 123.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.959 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.661 ' CD2' ' HG2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -100.3 143.97 29.86 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 79' ' ' ILE . 5.2 mt -123.21 163.86 19.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.765 -1.209 . . . . 0.0 110.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 t -133.01 115.48 15.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' ILE . 8.8 m-20 -60.87 -25.85 66.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.173 -0.955 . . . . 0.0 110.44 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.533 ' CG2' ' HB1' ' A' ' 83' ' ' ALA . 0.3 OUTLIER 49.79 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 108.984 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 57.05 111.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.025 -1.047 . . . . 0.0 109.361 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.505 ' SD ' ' CD2' ' A' ' 63' ' ' LEU . 3.6 mtm -157.11 -176.15 0.59 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 109.649 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -103.43 70.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.008 1.53 . . . . 0.0 110.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.61 -155.43 7.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -81.81 127.33 32.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -1.147 . . . . 0.0 109.611 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.46 -92.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 109.537 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -119.51 -111.28 2.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.505 ' CD2' ' SD ' ' A' ' 57' ' ' MET . 11.4 tp -124.02 -7.06 7.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.66 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . 73.78 50.62 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.77 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.57 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -162.17 16.98 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.106 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.4 mm? -70.61 -67.29 0.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.043 -1.036 . . . . 0.0 108.825 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -28.05 3.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 65' ' ' LEU . 1.7 tt0 -57.07 -53.44 58.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.511 ' N ' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -33.57 -32.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.935 -0.478 . . . . 0.0 110.432 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.9 mmmt -99.15 -65.1 0.98 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.035 -1.041 . . . . 0.0 109.935 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -33.17 -33.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.799 -0.563 . . . . 0.0 110.896 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -92.5 -68.34 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.645 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -126.14 112.03 24.01 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 38.1 Cg_endo -134.05 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.67 1.353 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.528 ' CB ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -131.04 -14.89 3.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.912 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.619 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 3.7 pp -131.23 167.16 22.96 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.092 -1.005 . . . . 0.0 108.531 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.2 Cg_endo -65.69 159.63 47.42 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.222 1.117 . . . . 0.0 111.247 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -126.48 101.26 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 109.337 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.541 ' CG2' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -65.24 157.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.195 -0.941 . . . . 0.0 109.108 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.481 ' CG2' ' O ' ' A' ' 79' ' ' ILE . 6.5 pt -157.11 118.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.468 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.08 138.24 57.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.402 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 103' ' ' PRO . 16.8 m -75.39 121.65 22.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -171.4 40.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.754 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.3 m-70 67.92 110.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 84' ' ' HIS . 12.3 t 156.68 -73.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' ASP . 2.2 p30 -48.22 -28.98 3.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 110.054 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -36.06 -29.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -0.881 . . . . 0.0 111.198 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' ASP . 47.4 m-20 -107.61 -79.87 0.57 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.045 -1.034 . . . . 0.0 110.517 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 92' ' ' SER . . . -36.68 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.405 -0.809 . . . . 0.0 110.355 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 88' ' ' ASP . . . -74.39 -79.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 85.2 t -33.49 -41.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -113.61 -172.21 2.03 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 109.406 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 70.67 68.41 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.778 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.63 65.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HG3' ' N ' ' A' ' 96' ' ' GLN . 3.2 pt20 -73.87 -125.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.323 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.5 ' N ' ' HG3' ' A' ' 95' ' ' GLN . 2.4 tp60 76.85 69.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.871 -1.143 . . . . 0.0 109.546 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 48.53 -158.38 0.88 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 67.8 20.32 9.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -1.152 . . . . 0.0 109.481 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' O ' ' CE1' ' A' ' 101' ' ' TYR . 1.1 m-85 -151.54 53.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.75 154.24 41.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.209 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.565 ' CE1' ' O ' ' A' ' 99' ' ' PHE . 1.3 m-85 -108.98 166.87 10.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.22 89.05 24.32 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.847 . . . . 0.0 109.163 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 82' ' ' THR . 36.7 Cg_endo -58.94 168.21 4.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.076 1.566 . . . . 0.0 110.971 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -116.02 158.35 42.69 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.771 . . . . 0.0 109.058 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -83.23 169.74 56.67 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.63 -2.654 . . . . 0.0 110.312 0.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 13.7 p90 -149.39 163.1 38.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 109.09 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 5.6 t70 -87.78 -156.21 0.34 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.457 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 19.4 mm -120.61 -70.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.857 -1.152 . . . . 0.0 109.606 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' GLU . 9.2 t70 -54.46 -51.18 65.81 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 19.1 tp10 -42.85 -42.27 3.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -67.3 -72.98 0.15 Allowed 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.335 -0.853 . . . . 0.0 108.988 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 23' ' ' LEU . 35.8 t -36.86 -68.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.789 -0.57 . . . . 0.0 110.2 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.35 -65.17 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' O ' ' A' ' 113' ' ' ALA . 33.7 tp -35.47 -53.93 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.676 0.751 . . . . 0.0 109.763 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.534 ' CG1' HG23 ' A' ' 50' ' ' VAL . 1.8 t -56.09 -57.53 8.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.497 ' C ' ' O ' ' A' ' 115' ' ' VAL . 19.3 mt-10 -33.54 -41.94 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.422 0.63 . . . . 0.0 110.187 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.6 mtt-85 -76.04 -54.85 6.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.697 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.2 -63.22 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 108.931 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.572 ' CG2' ' HB2' ' A' ' 49' ' ' ASP . 7.6 mt -33.84 -44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.152 0.501 . . . . 0.0 110.55 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.22 61.81 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.64 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -106.8 -40.25 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.611 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.0 p90 -120.55 31.01 6.64 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -135.66 36.08 2.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.947 -1.096 . . . . 0.0 109.728 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.578 179.713 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 2.4 pt20 -154.32 82.68 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 108.991 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 8.6 tpt180 -121.9 60.73 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.031 -1.043 . . . . 0.0 110.506 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.474 ' HA3' HD22 ' A' ' 28' ' ' LEU . . . 165.34 93.95 0.1 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 5.8 mt -83.4 93.12 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.401 -1.058 . . . . 0.0 109.671 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.588 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 8.5 p -96.1 122.48 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.722 -0.611 . . . . 0.0 109.412 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.523 ' NE1' ' CG2' ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.71 102.97 14.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.686 -1.259 . . . . 0.0 109.047 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 13.4 t -100.93 125.03 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.958 . . . . 0.0 110.625 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG2' ' N ' ' A' ' 36' ' ' GLY . 2.6 p -59.15 112.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.572 -1.33 . . . . 0.0 108.366 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' OD1' ' CG2' ' A' ' 15' ' ' ILE . 20.9 t0 -68.1 164.98 19.07 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.272 0.558 . . . . 0.0 109.88 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 1.5 m-20 -96.21 -89.07 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.397 -0.815 . . . . 0.0 109.643 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 15' ' ' ILE . 1.1 m-20 -106.59 174.75 5.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.4 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 14.0 m -57.75 148.16 25.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.4 t 81.79 -11.96 1.01 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.961 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.547 ' CG2' ' OD1' ' A' ' 10' ' ' ASP . 12.6 mm -79.19 -35.81 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.0 -1.063 . . . . 0.0 108.745 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.577 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.3 ttp-105 -59.94 -46.03 90.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.482 ' O ' ' C ' ' A' ' 18' ' ' VAL . 55.1 t90 -58.29 -59.68 4.95 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.297 -0.877 . . . . 0.0 108.919 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.6 t -34.92 -60.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.579 0.704 . . . . 0.0 110.506 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 21' ' ' ARG . 3.1 mt -53.1 -71.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.978 -1.076 . . . . 0.0 109.152 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -35.13 -33.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.263 0.554 . . . . 0.0 110.818 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.02 -56.13 19.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 108.241 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . -64.96 -9.83 24.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.119 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -85.77 -24.5 26.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.631 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.7 -43.96 85.53 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.26 -47.79 28.01 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' O ' HD11 ' A' ' 28' ' ' LEU . . . -58.45 -17.59 21.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.157 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 63.08 54.01 36.08 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.539 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 2.7 mp -144.48 175.4 10.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.289 . . . . 0.0 109.999 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.465 ' CG2' HG22 ' A' ' 5' ' ' ILE . 30.4 m -107.78 85.34 2.1 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.858 -0.526 . . . . 0.0 110.994 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.567 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . 50.8 t -88.69 83.34 6.73 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.872 -1.143 . . . . 0.0 109.853 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.523 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 15.7 m -80.04 125.15 29.41 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 75.2 p -118.52 140.61 49.61 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.83 -1.169 . . . . 0.0 110.642 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.573 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 3.3 m-30 -116.24 113.38 22.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.618 -0.676 . . . . 0.0 109.215 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 47.1 mt-10 -37.24 -28.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.557 -0.714 . . . . 0.0 110.014 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -118.36 116.63 27.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.585 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . -49.19 -51.89 24.4 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.607 ' O ' HD21 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -43.56 -72.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.568 -0.96 . . . . 0.0 108.934 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 37' ' ' ASN . 32.1 tp10 -31.49 -39.32 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.811 . . . . 0.0 110.133 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.573 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -63.99 -56.41 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.607 HD21 ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -78.87 3.01 18.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.585 -1.322 . . . . 0.0 109.689 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.517 ' N ' HD21 ' A' ' 40' ' ' LEU . . . -99.47 -24.08 14.9 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.35 -19.85 15.44 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.588 ' CB ' ' NE2' ' A' ' 73' ' ' HIS . 13.8 mt -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.505 -0.747 . . . . 0.0 109.47 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . . . -35.21 -31.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.786 -0.571 . . . . 0.0 110.732 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -65.51 -55.26 18.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 108.527 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER 164.86 115.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.532 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -44.59 167.54 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.186 -0.946 . . . . 0.0 109.103 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 36.8 Cg_endo -90.92 -65.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.679 1.358 . . . . 0.0 111.456 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.521 ' CA ' HG22 ' A' ' 119' ' ' ILE . 17.7 m-20 -121.49 -55.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.704 -1.248 . . . . 0.0 111.363 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.588 ' CG1' ' CG2' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -148.97 139.24 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.723 -1.236 . . . . 0.0 110.353 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.487 HD12 ' CG1' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.26 108.4 20.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.731 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.48 178.94 4.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.984 . . . . 0.0 108.971 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.55 ' CB ' HG13 ' A' ' 9' ' ' VAL . 38.2 m -162.42 126.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.087 . . . . 0.0 110.601 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 14.0 t0 -73.0 -144.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.094 -1.004 . . . . 0.0 108.401 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER 174.57 78.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' CD ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -174.98 83.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.642 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.4 ' HB2' HD21 ' A' ' 63' ' ' LEU . 1.4 mmm -131.31 125.03 20.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -48.72 107.9 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.08 1.569 . . . . 0.0 110.518 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 125.1 140.73 5.49 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 87.3 mmm 61.64 11.83 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -1.086 . . . . 0.0 109.837 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 44.68 80.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.282 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . 66.54 90.09 0.05 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -56.76 -162.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -1.127 . . . . 0.0 109.416 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' N ' ' HG ' ' A' ' 63' ' ' LEU . . . -171.33 89.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.008 . . . . 0.0 109.994 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.501 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -88.24 -6.51 57.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 109.122 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -49.74 -22.02 1.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.33 -45.48 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.022 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.542 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.55 -45.96 23.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.15 . . . . 0.0 109.931 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.487 ' CG1' HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -38.82 -32.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.902 -1.123 . . . . 0.0 110.161 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -95.6 -67.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.836 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -36.25 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.745 0.784 . . . . 0.0 110.339 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' LYS . 1.6 mmt85 -88.53 -93.32 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.262 0.553 . . . . 0.0 111.094 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.642 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 2.1 m-70 -53.03 144.38 27.83 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.3 Cg_endo -34.74 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 124.17 1.616 . . . . 0.0 111.196 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.42 94.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.661 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 1.8 pp -125.61 151.73 70.94 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.9 Cg_endo -28.84 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.991 1.521 . . . . 0.0 112.219 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.89 146.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.506 HD13 ' CG2' ' A' ' 115' ' ' VAL . 42.8 mt -143.92 148.48 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.488 ' N ' HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -133.6 150.3 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.539 ' CE ' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.58 164.46 25.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.406 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 1.2 m -93.02 162.78 13.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 161.3 -62.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 109.063 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.467 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 t60 -176.44 -176.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 t 61.04 -124.0 0.9 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.609 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 36.56 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.254 -0.904 . . . . 0.0 109.818 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 10.79 -77.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.309 0.576 . . . . 0.0 111.78 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' ASP . 9.3 t70 -53.27 -64.74 0.72 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.193 . . . . 0.0 109.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -52.28 -46.16 65.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.272 -0.893 . . . . 0.0 110.56 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.5 -73.97 0.13 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 110.536 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 62.4 t -32.02 -32.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.996 -0.44 . . . . 0.0 111.205 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 90' ' ' ALA . 19.4 t -102.95 161.45 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.758 -1.214 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 79.07 82.05 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.484 -0.76 . . . . 0.0 109.76 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ALA . 58.4 m-85 42.47 63.2 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -0.827 . . . . 0.0 109.899 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.27 134.66 49.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.065 -1.022 . . . . 0.0 109.345 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER 76.54 151.06 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . 80.37 94.52 0.4 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . 76.08 5.23 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -1.127 . . . . 0.0 109.111 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -126.87 112.36 15.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.276 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -124.72 167.52 14.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.168 -0.957 . . . . 0.0 109.661 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.17 105.19 9.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.042 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.553 HD22 ' CG ' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -73.36 124.73 90.79 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 110.032 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -91.3 171.59 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.143 1.601 . . . . 0.0 109.716 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -117.21 145.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.725 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -82.05 166.99 70.15 Favored 'Cis proline' 0 C--N 1.317 -1.084 0 C-N-CA 120.401 -2.749 . . . . 0.0 110.114 -0.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.553 ' CG ' HD22 ' A' ' 102' ' ' LEU . 39.4 p90 -136.61 140.85 43.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.342 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.3 t0 -72.47 122.94 22.11 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.096 -1.003 . . . . 0.0 108.801 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 22' ' ' ALA . 1.5 tp -61.44 -29.58 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 110.137 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -80.45 -49.43 11.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 108.518 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 17.2 tp10 -52.3 -31.65 33.92 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -78.72 -69.65 0.55 Allowed 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.293 -0.879 . . . . 0.0 109.194 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 23' ' ' LEU . 1.2 t -35.37 -55.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.506 0.67 . . . . 0.0 110.148 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -64.55 -65.4 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 110.196 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 115' ' ' VAL . 1.3 tm? -33.46 -61.44 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.408 0.623 . . . . 0.0 110.293 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.55 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 84.4 t -56.64 -52.15 57.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 115' ' ' VAL . 18.6 tp10 -35.42 -45.12 0.32 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.32 0.581 . . . . 0.0 110.233 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -52.55 -55.91 18.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.092 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.17 -58.39 5.69 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.258 -0.901 . . . . 0.0 108.765 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 120' ' ' SER . 2.4 mm -37.37 -38.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.73 -0.606 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.546 ' C ' ' O ' ' A' ' 119' ' ' ILE . 6.0 t -20.0 -66.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.173 0.511 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.508 ' CB ' ' O ' ' A' ' 120' ' ' SER . 21.0 t-80 160.2 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 121' ' ' HIS . 2.4 m-85 37.91 30.58 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.716 0.77 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -49.8 -24.68 2.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.759 -0.588 . . . . 0.0 109.728 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.35 179.86 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.242 0.544 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -75.74 167.64 21.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 4.1 ptm180 -154.0 83.56 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.996 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -134.54 87.46 0.25 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.087 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.36 87.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.159 -1.201 . . . . 0.0 108.468 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.75 111.46 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.743 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.532 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 10.6 m0 -101.71 106.86 17.94 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.995 . . . . 0.0 108.524 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -85.6 169.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.794 0.807 . . . . 0.0 111.688 -177.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -121.42 94.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.496 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 64.1 m-20 -93.37 -173.08 3.12 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.501 0.667 . . . . 0.0 110.432 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.44 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 24.5 t0 -122.24 -9.71 8.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.426 ' HB2' HG12 ' A' ' 15' ' ' ILE . 8.2 m-20 -147.12 164.48 32.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -42.6 73.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.408 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -54.52 -24.93 22.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.308 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.491 ' CG2' ' CG ' ' A' ' 10' ' ' ASP . 15.3 mm -71.59 -43.07 71.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.352 -0.843 . . . . 0.0 109.112 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.493 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.3 -44.14 75.49 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.456 ' O ' ' C ' ' A' ' 18' ' ' VAL . 19.8 t90 -60.41 -58.03 10.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.437 -0.789 . . . . 0.0 109.169 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.456 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.3 t -36.2 -62.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.645 -0.659 . . . . 0.0 110.743 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -57.36 -68.91 0.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.056 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -34.5 -32.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.683 -0.635 . . . . 0.0 110.455 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.7 tpp180 -66.97 -55.86 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.438 ' CB ' HD12 ' A' ' 108' ' ' ILE . . . -68.25 -5.99 21.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.462 -0.773 . . . . 0.0 109.059 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.565 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 3.3 mm? -102.15 -12.57 17.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.69 -40.85 28.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.66 97.52 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.0 -32.88 65.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.417 -1.049 . . . . 0.0 109.248 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 2' ' ' GLN . . . 84.73 66.41 1.46 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.572 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 0.6 OUTLIER -134.71 -176.14 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.195 -1.179 . . . . 0.0 110.587 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.536 ' CG2' HG21 ' A' ' 5' ' ' ILE . 18.1 m -99.21 78.23 2.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 43.8 t -80.23 84.77 5.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.587 -0.696 . . . . 0.0 111.331 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 2.6 m -88.52 141.24 28.69 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 66.5 p -146.33 119.66 8.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.702 -1.249 . . . . 0.0 109.846 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.558 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 12.1 m-85 -103.55 129.74 50.83 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.365 -0.834 . . . . 0.0 109.019 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -63.45 -8.49 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.864 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 10.6 t30 -136.61 133.57 36.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.622 -1.299 . . . . 0.0 110.48 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 39' ' ' VAL . . . -51.09 -59.95 7.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -46.78 -73.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.272 -1.134 . . . . 0.0 108.92 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 37' ' ' ASN . 13.9 tp10 -32.7 -34.43 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.364 -0.835 . . . . 0.0 110.616 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 15.3 t -61.61 -57.97 9.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.099 -1.001 . . . . 0.0 109.015 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.586 ' CD2' ' HB2' ' A' ' 68' ' ' GLN . 1.3 pp -62.42 -12.38 21.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.236 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.55 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -81.02 -30.2 34.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.468 -0.77 . . . . 0.0 109.183 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.47 -28.45 20.83 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.536 ' O ' ' CE1' ' A' ' 73' ' ' HIS . 13.0 mt -88.08 6.14 37.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 109.853 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -36.27 -28.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.876 -0.515 . . . . 0.0 110.327 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' LEU . 11.6 t -61.98 -56.68 16.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.882 -1.136 . . . . 0.0 108.222 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 173.59 -165.81 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.441 -0.787 . . . . 0.0 110.524 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.584 ' CG2' ' CB ' ' A' ' 76' ' ' LEU . 4.4 m -70.15 154.0 94.89 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.67 . . . . 0.0 110.929 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.6 Cg_endo -115.6 -116.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 N-CA-C 107.395 -1.81 . . . . 0.0 107.395 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' CA ' HD11 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -100.08 -75.32 0.58 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.207 -1.558 . . . . 0.0 108.605 178.083 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 115' ' ' VAL . 13.1 t -145.63 137.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.164 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.543 HD22 ' CD1' ' A' ' 69' ' ' ILE . 2.8 mp -102.51 110.61 22.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.931 -1.106 . . . . 0.0 110.606 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.557 ' HG ' ' CG1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -83.72 161.11 21.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.31 -0.869 . . . . 0.0 109.685 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 m -152.23 136.31 16.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.369 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 55' ' ' ILE . 2.4 p30 -100.72 -158.61 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.072 -1.017 . . . . 0.0 110.047 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.537 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 1.2 pp -143.09 120.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 3.2 ttm-85 178.72 -78.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.476 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 12.7 mmt 54.22 170.06 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.076 -1.015 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.2 Cg_endo -84.32 161.68 13.09 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.856 1.45 . . . . 0.0 110.24 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.71 101.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -176.84 -40.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.0 109.491 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 60' ' ' MET . 0.4 OUTLIER -162.8 -77.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' MET . . . 152.74 -45.53 0.59 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -154.69 -76.48 0.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.312 -1.111 . . . . 0.0 109.3 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 63' ' ' LEU . . . 41.34 44.26 2.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 6.4 mt -130.86 -25.01 2.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.578 ' HA ' ' CG2' ' A' ' 69' ' ' ILE . 1.2 tp -66.24 -10.39 41.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.718 -1.239 . . . . 0.0 108.719 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' CG ' ' HB3' ' A' ' 89' ' ' ALA . 17.3 mtmt -71.86 -55.06 8.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.586 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -67.02 -53.78 27.97 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.701 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 0.8 OUTLIER -43.13 -14.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.228 -0.92 . . . . 0.0 111.017 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' GLN . 19.1 tptp -100.93 -74.08 0.62 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.31 -1.494 . . . . 0.0 108.003 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 70' ' ' LYS . 32.9 mm-40 -36.96 -59.25 0.72 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.501 0.667 . . . . 0.0 111.216 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.701 ' NE ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -35.74 -48.09 0.52 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.504 -0.748 . . . . 0.0 111.716 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.755 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 14.6 m-70 -107.58 142.16 24.57 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.68 -1.262 . . . . 0.0 109.428 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.755 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 32.1 Cg_endo -26.36 -78.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 124.203 1.633 . . . . 0.0 112.777 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.46 ' O ' ' CG ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -175.58 100.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.42 -1.425 . . . . 0.0 110.544 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER -123.14 168.09 13.06 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 108.857 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.598 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 33.7 Cg_endo -71.37 137.43 30.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.676 1.356 . . . . 0.0 111.63 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.586 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -126.32 156.29 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.557 ' CG1' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.1 147.44 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -153.91 125.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 2.7 mtt -66.43 125.73 26.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.6 p -86.93 87.35 7.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 84' ' ' HIS . . . -109.76 -19.27 13.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER 171.42 -65.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.287 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.549 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 3.5 m -77.94 -172.22 2.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 83.76 -44.52 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.666 -0.647 . . . . 0.0 109.551 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 86' ' ' ASP . 1.2 mm? -34.19 -32.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.786 -0.571 . . . . 0.0 110.482 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.8 t0 -70.28 -68.91 0.39 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.501 ' HB3' ' CG ' ' A' ' 67' ' ' LYS . . . -41.89 -26.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -82.51 -74.59 0.34 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.091 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 99.0 t -34.25 -30.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.863 -0.523 . . . . 0.0 111.162 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.0 m -97.94 -153.32 0.42 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.974 -1.079 . . . . 0.0 109.708 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.12 69.81 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.049 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 95' ' ' GLN . 1.4 t80 67.64 10.42 7.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.3 -0.875 . . . . 0.0 109.004 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 10.7 tm0? 44.78 82.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.8 mt-30 163.37 -25.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.03 -144.35 44.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -143.06 59.5 1.42 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -1.125 . . . . 0.0 109.346 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER 82.61 -24.57 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.633 -0.667 . . . . 0.0 109.887 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 44.3 p-10 -42.07 127.89 3.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 162.78 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.495 -0.753 . . . . 0.0 109.412 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' MET . 12.6 tp -109.12 141.83 24.26 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 108.977 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -104.93 -167.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.758 1.399 . . . . 0.0 111.04 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -154.69 160.63 30.74 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -72.76 143.87 79.03 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.387 -2.339 . . . . 0.0 110.764 0.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.558 ' CG ' ' N ' ' A' ' 107' ' ' ASP . 88.4 t80 -129.64 169.68 14.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' CG ' ' A' ' 106' ' ' PHE . 3.7 t70 -85.91 -157.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.625 -0.672 . . . . 0.0 109.948 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.438 HD12 ' CB ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -130.12 -48.88 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 108.443 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.2 -41.45 81.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 11.3 tp10 -50.77 -47.84 59.5 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -62.0 -65.24 0.72 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 28' ' ' LEU . 2.2 t -34.7 -78.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.528 ' N ' ' CG1' ' A' ' 112' ' ' VAL . . . -39.03 -70.28 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.647 -0.658 . . . . 0.0 111.578 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 113' ' ' ALA . 27.8 tp -36.35 -43.21 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.972 0.891 . . . . 0.0 110.073 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.547 ' CG2' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -68.43 -58.73 5.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.527 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 4.1 mt-10 -36.92 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.488 0.661 . . . . 0.0 109.536 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 115' ' ' VAL . 1.7 mtp180 -85.05 -48.04 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.481 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -53.79 -62.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 108.96 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.542 HD12 ' CG2' ' A' ' 50' ' ' VAL . 7.1 mt -36.22 -40.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 t -71.86 -46.02 59.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.991 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -47.86 -71.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 109.903 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 3.2 m-85 -44.85 112.13 0.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.912 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER 168.85 -27.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.405 -0.809 . . . . 0.0 109.362 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.53 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.318 0.58 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 178.2 -81.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.563 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 63.01 144.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.428 ' O ' HD22 ' A' ' 28' ' ' LEU . . . -103.74 145.41 16.14 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.586 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -99.39 95.81 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.471 -1.017 . . . . 0.0 110.419 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -91.22 113.04 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.009 -1.057 . . . . 0.0 108.604 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.646 ' CD2' ' CG2' ' A' ' 31' ' ' THR . 12.8 m95 -102.84 98.85 8.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 109.934 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 9' ' ' VAL . 15.2 t -85.48 167.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.483 -0.76 . . . . 0.0 109.378 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.554 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 99.0 t -132.4 113.59 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 109.792 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.535 ' O ' ' C ' ' A' ' 11' ' ' ASP . 6.1 t70 177.87 -65.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.807 . . . . 0.0 109.484 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.546 ' HB3' ' CA ' ' A' ' 34' ' ' GLU . 20.9 t0 17.21 55.07 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.198 0.523 . . . . 0.0 111.478 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.628 ' O ' ' CB ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -112.95 52.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 11.9 t 144.22 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.21 42.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.663 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.529 ' HB ' ' N ' ' A' ' 11' ' ' ASP . 2.4 mp -89.49 -40.53 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.987 . . . . 0.0 108.979 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.517 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 23.7 ttp180 -61.21 -41.39 96.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.455 ' O ' ' C ' ' A' ' 18' ' ' VAL . 76.5 t90 -62.66 -63.71 1.14 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.6 t -37.99 -65.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.759 0.79 . . . . 0.0 110.528 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' ARG . 16.4 mt -56.52 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 110.785 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 15.2 tm-20 -34.61 -30.13 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.907 -0.495 . . . . 0.0 111.215 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.3 tpt180 -68.12 -56.64 8.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.943 -1.098 . . . . 0.0 108.644 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.583 ' CB ' ' CD1' ' A' ' 108' ' ' ILE . . . -71.34 -8.69 55.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 0.0 109.015 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 3.0 mp -96.31 -16.69 21.18 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.82 -37.4 64.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.6 -36.3 58.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.21 -13.95 62.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -1.177 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.63 56.84 7.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.514 HD21 ' CG1' ' A' ' 112' ' ' VAL . 0.3 OUTLIER -131.1 -178.04 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -1.234 . . . . 0.0 110.009 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 5' ' ' ILE . 30.0 m -101.47 90.45 4.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 25.2 t -84.46 86.05 7.33 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.646 ' CG2' ' CD2' ' A' ' 7' ' ' TRP . 17.4 m -91.0 137.48 32.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 16.1 p -156.34 135.79 12.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.677 -1.264 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 29.8 m-85 -108.87 -170.44 1.66 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.546 ' CA ' ' HB3' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -108.92 -6.08 15.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.055 . . . . 0.0 109.536 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.417 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -148.86 143.84 26.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.255 -179.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.55 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -60.02 -42.86 98.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 38' ' ' GLU . 4.4 t-20 -49.42 -79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.052 -1.263 . . . . 0.0 108.866 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 37' ' ' ASN . 50.2 mt-10 -34.46 -42.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.765 -0.584 . . . . 0.0 110.434 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 18.1 t -54.84 -55.48 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 36' ' ' GLY . 2.6 mm? -65.98 -18.13 65.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 108.829 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.8 -25.53 60.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 108.951 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.6 -17.27 17.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HG ' ' CD2' ' A' ' 73' ' ' HIS . 1.4 mm? -77.69 -9.2 58.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.99 -19.81 0.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -57.38 4.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -164.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 76' ' ' LEU . 10.2 t -100.03 135.72 20.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.491 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 36.2 Cg_endo -95.17 -95.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.04 1.547 . . . . 0.0 109.389 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -115.39 -75.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.864 -1.148 . . . . 0.0 109.086 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 119' ' ' ILE . 2.8 t -149.57 142.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.33 -0.856 . . . . 0.0 109.467 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 6.5 tp -94.75 158.74 15.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.033 . . . . 0.0 108.797 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -141.57 127.76 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.998 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.3 p -94.04 103.79 15.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.333 -0.855 . . . . 0.0 108.889 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.464 ' HB3' ' OD2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -88.01 122.64 31.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.955 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.54 HG22 ' CB ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -98.06 81.86 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -114.27 -19.35 11.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.883 . . . . 0.0 109.754 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -45.14 140.89 3.53 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -100.11 147.36 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.956 1.503 . . . . 0.0 110.199 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.65 -174.77 17.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -24.24 64.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -1.153 . . . . 0.0 109.661 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -111.73 159.44 18.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 55' ' ' ILE . . . -118.94 -53.82 0.28 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER 179.13 111.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.99 29.47 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.364 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -99.74 6.61 45.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.55 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 10.4 tp -65.8 -60.74 2.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.649 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -48.02 -39.12 18.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.171 -0.956 . . . . 0.0 108.523 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 69' ' ' ILE . 3.8 tp60 -52.09 -56.59 13.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 68' ' ' GLN . 8.2 mt -33.49 -76.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.266 0.555 . . . . 0.0 110.025 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -40.49 -59.37 1.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 110.085 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.85 -68.38 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.785 -0.572 . . . . 0.0 110.9 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 73' ' ' HIS . 1.7 mpp_? -73.06 -62.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -31.81 115.85 0.38 Allowed Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.778 -0.576 . . . . 0.0 110.327 -179.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.46 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 36.9 Cg_endo -41.26 -74.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.017 1.535 . . . . 0.0 110.441 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.2 ptp -178.39 64.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.54 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.6 OUTLIER -126.31 148.63 64.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.0 Cg_endo -48.53 141.16 20.36 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.828 1.436 . . . . 0.0 111.815 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 99' ' ' PHE . 2.5 m -139.63 97.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 80' ' ' ILE . 11.2 mt -65.72 160.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 101' ' ' TYR . 1.3 pp -142.69 133.98 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.573 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -71.74 170.47 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.148 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.09 157.36 15.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.091 -1.006 . . . . 0.0 110.283 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.54 ' CB ' HG22 ' A' ' 55' ' ' ILE . . . 169.6 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.463 ' O ' ' OG ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 178.18 -77.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 110.497 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 86' ' ' ASP . 78.9 p 47.62 26.99 0.93 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 60.22 120.28 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.545 ' O ' ' C ' ' A' ' 88' ' ' ASP . 18.5 tp -38.12 -26.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.21 1.005 . . . . 0.0 108.523 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.7 t0 -32.7 -65.39 0.16 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.065 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.55 ' O ' ' CD2' ' A' ' 66' ' ' LEU . . . -82.43 -30.89 29.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -64.34 -65.65 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.171 -0.955 . . . . 0.0 109.144 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.49 -53.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 122.978 0.511 . . . . 0.0 111.504 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.59 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 1.6 t -56.66 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.043 -1.036 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 99' ' ' PHE . . . -128.27 -73.89 0.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.485 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 11.61 35.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 96' ' ' GLN . 5.5 mt-30 -98.24 108.54 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 108.55 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 11.3 tt0 61.39 164.13 0.08 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.988 . . . . 0.0 108.508 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.01 172.92 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -125.63 103.83 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.05 -1.265 . . . . 0.0 109.791 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.576 ' CE1' HG22 ' A' ' 78' ' ' VAL . 33.2 p90 170.63 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.0 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.07 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -167.04 138.16 3.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.007 . . . . 0.0 110.024 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -128.47 113.46 19.52 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -103.94 164.95 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.668 1.351 . . . . 0.0 111.187 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 13.0 pttp -92.87 160.34 34.16 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.515 -0.741 . . . . 0.0 109.286 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -79.29 159.02 90.23 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 120.773 -2.594 . . . . 0.0 110.483 -0.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CE1' ' HE3' ' A' ' 81' ' ' MET . 13.1 p90 -139.12 146.46 40.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 2.4 t70 -86.36 146.61 26.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 108.868 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' A' ' 22' ' ' ALA . 1.5 mp -76.8 -26.56 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.267 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.11 -36.58 19.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.535 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 40.8 tt0 -61.73 -42.19 98.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.96 -67.46 0.53 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.514 ' CG1' HD21 ' A' ' 28' ' ' LEU . 24.8 t -38.01 -52.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.497 -0.752 . . . . 0.0 110.937 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -62.58 -69.45 0.26 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.495 -0.753 . . . . 0.0 110.873 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.489 ' C ' ' O ' ' A' ' 113' ' ' ALA . 16.9 tp -34.79 -55.68 0.56 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.509 0.671 . . . . 0.0 109.943 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.534 HG23 ' CG2' ' A' ' 50' ' ' VAL . 1.2 t -54.79 -56.77 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER -38.02 -37.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 110.751 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.616 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -83.53 -35.69 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 110.268 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.616 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.4 -59.88 4.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.787 -1.195 . . . . 0.0 108.326 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.541 HG12 ' CG2' ' A' ' 50' ' ' VAL . 8.6 mt -34.5 -40.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.12 0.486 . . . . 0.0 110.384 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -85.61 53.32 2.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.585 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.564 ' NE2' ' CE1' ' A' ' 122' ' ' TYR . 23.7 p-80 -96.31 -9.19 30.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.564 ' CE1' ' NE2' ' A' ' 121' ' ' HIS . 8.2 m-85 -69.3 -5.86 25.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.79 53.01 1.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.395 179.9 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 3.8 pt20 -121.67 160.99 23.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.851 . . . . 0.0 109.341 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.462 ' C ' HD22 ' A' ' 28' ' ' LEU . 14.7 mtm-85 -152.25 49.5 0.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.056 -1.028 . . . . 0.0 109.907 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.63 112.42 0.61 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.354 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' CG2' ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -90.73 111.62 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 108.892 179.27 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' CG1' HG22 ' A' ' 8' ' ' VAL . 61.5 t -104.51 107.28 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.031 . . . . 0.0 109.555 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.45 93.77 6.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 108.551 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.525 HG21 ' CB ' ' A' ' 52' ' ' LEU . 54.4 t -102.89 127.43 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.535 ' CG1' ' HA2' ' A' ' 36' ' ' GLY . 1.9 m -66.6 121.37 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 53.7 p-10 -110.45 178.67 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.206 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 34.1 t0 -74.4 -86.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.32 -0.862 . . . . 0.0 109.788 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.72 173.65 11.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 11.7 p -75.93 -30.37 58.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.805 . . . . 0.0 109.358 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -73.82 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.317 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.473 ' CG2' ' HB2' ' A' ' 10' ' ' ASP . 24.6 mm -66.01 -32.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 108.831 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.599 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 11.6 ptt180 -68.08 -35.31 77.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.493 ' CH2' ' HG3' ' A' ' 21' ' ' ARG . 1.8 t-105 -55.12 -66.16 0.46 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 54.0 t -40.77 -65.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.816 0.817 . . . . 0.0 110.478 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 21' ' ' ARG . 4.1 mm? -54.78 -75.07 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.569 -0.707 . . . . 0.0 110.986 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -34.5 -31.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.331 0.586 . . . . 0.0 110.219 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.08 -58.61 6.69 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.92 -10.07 50.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -0.823 . . . . 0.0 109.238 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.561 ' CD2' ' CB ' ' A' ' 30' ' ' CYS . 1.5 mt -93.15 -13.03 28.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 109.758 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.34 61.95 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.93 -38.0 37.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -64.36 -35.02 79.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -1.142 . . . . 0.0 108.726 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 95.69 50.11 2.03 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD21 ' CG1' ' A' ' 112' ' ' VAL . 1.1 mt -141.03 166.66 24.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.937 -1.331 . . . . 0.0 109.941 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.496 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 87.5 m -101.4 60.04 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.561 ' CB ' ' CD2' ' A' ' 23' ' ' LEU . 33.7 t -81.4 88.49 6.12 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 109.658 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 11.8 m -101.18 137.46 39.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 109.472 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 1.2 p -109.66 165.49 11.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 108.671 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.6 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 2.0 m-85 -137.91 115.97 11.68 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.082 -1.012 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 14.3 tt0 -36.67 -39.1 0.19 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.96 -0.462 . . . . 0.0 110.461 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -111.92 126.1 54.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 110.521 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.535 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -51.68 -45.84 54.36 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.588 ' O ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -60.28 -63.53 1.27 Allowed 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.181 -1.187 . . . . 0.0 107.866 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 20.0 tp10 -34.57 -28.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.551 -0.718 . . . . 0.0 110.809 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.6 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -81.88 -51.08 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.919 -1.113 . . . . 0.0 110.504 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.588 HD11 ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -73.47 -11.36 60.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.791 -1.193 . . . . 0.0 109.753 -179.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.562 ' N ' HD11 ' A' ' 40' ' ' LEU . . . -94.44 -49.11 5.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.24 -25.11 46.43 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 7.9 mt -73.17 -77.64 0.1 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 82.39 -47.94 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -99.24 -26.12 14.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.642 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 64.42 62.82 0.79 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 123.49 1.614 . . . . 0.0 109.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.609 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -104.33 40.97 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 119.752 -1.842 . . . . 0.0 112.771 -179.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 47' ' ' THR . 38.0 Cg_endo -101.08 -167.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 116.842 -1.638 . . . . 0.0 109.633 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -92.97 -52.48 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.539 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 6.6 t -146.59 128.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 108.89 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -98.47 114.82 27.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 0.0 108.376 179.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.525 ' CB ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -108.4 -174.28 2.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.371 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.48 ' HA ' HG21 ' A' ' 9' ' ' VAL . 26.6 t -155.24 123.89 6.05 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 9' ' ' VAL . 13.9 p-10 -102.63 149.75 24.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.98 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -102.88 109.78 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -161.63 28.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.469 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.7 mtt -93.74 125.94 51.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.6 Cg_endo -103.55 131.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.929 1.489 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.15 -74.23 0.31 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -161.1 128.28 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.422 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 68.72 149.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.98 -84.15 0.66 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' ' CD1' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -146.52 -54.3 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -1.107 . . . . 0.0 109.484 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 47.47 60.83 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.427 -0.795 . . . . 0.0 109.477 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD1' ' HB2' ' A' ' 63' ' ' LEU . 1.4 mt -124.35 8.41 8.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.449 HD12 ' CD1' ' A' ' 80' ' ' ILE . 4.9 mp -75.73 -19.18 59.25 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.278 -0.889 . . . . 0.0 108.699 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 2.9 pttt -66.01 -39.2 90.07 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.529 ' OE1' ' CA ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -80.38 -57.06 3.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 109.235 179.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.52 ' CG2' HG12 ' A' ' 78' ' ' VAL . 2.6 mt -39.71 -32.71 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.896 -1.127 . . . . 0.0 110.239 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -92.09 -73.09 0.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.087 -1.008 . . . . 0.0 110.379 -178.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -35.22 -30.78 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.554 -0.716 . . . . 0.0 110.565 -179.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -97.91 -58.55 1.96 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 110.368 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' CB ' ' A' ' 46' ' ' LYS . 1.2 m-70 -98.38 133.03 23.2 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.403 -0.811 . . . . 0.0 109.496 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.57 ' N ' ' HE2' ' A' ' 46' ' ' LYS . 39.6 Cg_endo -138.59 1.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 117.341 -1.306 . . . . 0.0 112.162 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.542 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 3.6 mtt -68.59 7.12 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.695 -1.253 . . . . 0.0 112.778 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -163.06 177.76 1.78 Allowed Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.186 -1.571 . . . . 0.0 109.918 179.007 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.0 Cg_endo -86.99 164.66 8.72 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.885 1.466 . . . . 0.0 111.064 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.17 144.91 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 80' ' ' ILE . 3.5 mp -137.78 164.0 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 109.739 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.506 ' N ' ' CG2' ' A' ' 79' ' ' ILE . 11.9 tt -141.99 157.39 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -81.93 166.49 19.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.28 102.7 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.564 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -96.74 -151.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -144.23 32.36 1.22 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.62 -34.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 88' ' ' ASP . 1.3 p30 -49.93 -24.17 2.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.017 -1.052 . . . . 0.0 109.692 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 86' ' ' ASP . 4.0 tp -34.97 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.83 -0.544 . . . . 0.0 110.913 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 86' ' ' ASP . 42.8 t0 -58.83 -59.19 5.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.995 -1.065 . . . . 0.0 109.883 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.26 -44.49 29.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 109.961 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -50.21 -41.7 50.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.689 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -33.07 -41.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.457 0.646 . . . . 0.0 109.99 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 5.9 t -64.11 86.18 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.359 0.6 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.75 -47.96 0.19 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -72.67 -18.95 61.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -69.02 -12.04 61.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.54 -0.725 . . . . 0.0 109.204 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.42 -157.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 109.33 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.81 67.88 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . -168.08 52.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -1.122 . . . . 0.0 109.324 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 36.7 m-85 -151.92 164.41 37.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.607 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB3' HG12 ' A' ' 79' ' ' ILE . 2.4 t0 -158.44 -157.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.37 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.14 142.83 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 109.791 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.23 139.86 35.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 108.893 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -114.72 176.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.748 1.394 . . . . 0.0 110.806 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 2.6 mtmp? -121.92 158.41 54.87 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 0.0 109.153 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -89.72 174.04 24.02 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 120.505 -2.706 . . . . 0.0 110.195 -0.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 33.2 p90 -153.59 161.17 42.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 14.6 t0 -73.92 -146.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.2 mm -120.48 -68.05 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 108.798 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 110' ' ' GLU . 11.7 t0 -59.79 -46.55 88.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 109' ' ' ASP . 28.1 tt0 -43.09 -41.69 3.69 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.76 -75.88 0.11 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.534 ' CG1' HD21 ' A' ' 28' ' ' LEU . 52.1 t -38.39 -69.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 110.243 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -39.36 -62.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' A' ' 113' ' ' ALA . 7.4 tp -34.3 -56.11 0.51 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.375 0.607 . . . . 0.0 109.944 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.526 ' CG1' ' N ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -58.24 -52.66 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.526 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 37.7 tp10 -39.19 -36.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.419 -0.801 . . . . 0.0 110.807 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.602 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -77.92 -36.77 49.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 110.74 -178.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.75 -53.61 51.77 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.733 -1.229 . . . . 0.0 108.044 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.539 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 5.3 mt -41.14 -50.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.517 0.675 . . . . 0.0 111.008 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.487 ' O ' ' C ' ' A' ' 121' ' ' HIS . 1.5 t -35.02 -34.9 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.447 -0.783 . . . . 0.0 111.998 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 t-80 -32.65 -66.37 0.14 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.546 -0.721 . . . . 0.0 111.273 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.63 -19.31 13.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.03 -1.044 . . . . 0.0 109.931 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 55.99 3.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.207 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.498 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' ' C ' ' A' ' 2' ' ' GLN . 6.7 ttt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' ARG . 3.0 pt20 -43.54 131.07 5.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.271 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 2' ' ' GLN . 6.3 ttp85 179.47 95.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.184 -0.947 . . . . 0.0 109.676 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.582 ' N ' ' CD2' ' A' ' 28' ' ' LEU . . . -162.62 119.84 0.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.558 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.1 mm -102.54 116.12 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -1.205 . . . . 0.0 109.528 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' CG1' HG21 ' A' ' 8' ' ' VAL . 1.5 t -123.65 109.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -0.796 . . . . 0.0 108.951 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.631 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 27.7 m0 -99.13 89.16 4.15 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.351 -1.339 . . . . 0.0 107.489 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.535 HG23 ' CD1' ' A' ' 52' ' ' LEU . 27.6 t -73.28 142.68 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.547 -0.721 . . . . 0.0 110.136 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 36' ' ' GLY . 40.6 t -92.7 102.4 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.95 -1.094 . . . . 0.0 109.251 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 88.8 m-20 -53.96 -173.23 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 110.002 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -137.47 -5.97 1.77 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.337 -0.852 . . . . 0.0 110.786 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 171.29 55.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.458 -1.402 . . . . 0.0 110.871 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 54.69 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.559 0.695 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 75.4 -7.82 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.161 -0.962 . . . . 0.0 109.828 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' A' ' 10' ' ' ASP . 18.0 mm -85.48 -32.16 7.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.074 -1.017 . . . . 0.0 108.718 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.7 OUTLIER -62.38 -45.5 92.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.436 ' O ' ' C ' ' A' ' 18' ' ' VAL . 26.9 t90 -58.7 -60.49 3.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.5 t -39.21 -70.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 110.914 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 21' ' ' ARG . 7.8 mt -57.35 -72.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.391 -0.818 . . . . 0.0 110.838 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 19' ' ' LEU . 3.3 tt0 -35.8 -30.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 110.526 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 8.7 tpt85 -66.41 -56.0 13.08 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.435 ' CB ' HG13 ' A' ' 108' ' ' ILE . . . -71.11 -4.43 25.16 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.484 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -103.73 -11.35 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -43.88 42.68 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.62 -19.56 69.2 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.71 -19.37 32.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.581 -0.952 . . . . 0.0 108.726 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.6 50.03 33.62 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.631 ' CD1' ' CG1' ' A' ' 112' ' ' VAL . 13.8 mt -123.77 179.01 4.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 110.425 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.537 ' CG2' HG22 ' A' ' 5' ' ' ILE . 18.0 m -95.49 67.3 2.87 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.536 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 38.6 t -79.64 83.64 5.59 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.953 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.631 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 5.2 m -94.84 143.29 26.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.7 p -138.67 119.43 14.15 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.519 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 7.5 m-85 -85.01 -157.65 0.31 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.629 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -118.36 -37.36 3.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.913 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' O ' HG22 ' A' ' 39' ' ' VAL . 49.1 m-80 -131.1 146.8 52.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.005 . . . . 0.0 109.81 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.526 ' N ' HG12 ' A' ' 9' ' ' VAL . . . -53.12 -39.71 58.18 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 2.2 m-20 -47.63 -84.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.904 -1.35 . . . . 0.0 108.343 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' ASN . 2.8 mt-10 -35.14 -48.09 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.757 -0.589 . . . . 0.0 110.969 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 48.6 t -50.37 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 72' ' ' ARG . 3.4 tm? -54.21 -20.72 7.36 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.527 -0.733 . . . . 0.0 109.527 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 -41.49 79.08 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.6 -15.63 48.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.537 HD12 ' NE2' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -84.1 -0.81 53.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.0 109.862 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.91 -19.59 7.01 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.14 -0.975 . . . . 0.0 108.753 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 2.4 m -88.74 -27.81 20.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER 90.21 69.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -102.32 -90.57 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 111.185 -179.119 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 37.4 Cg_endo -40.55 130.84 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.835 1.439 . . . . 0.0 111.129 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.474 ' OD2' HG12 ' A' ' 5' ' ' ILE . 4.8 m-20 -75.88 -23.76 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -136.95 123.52 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.567 ' CD2' ' HG2' ' A' ' 48' ' ' PRO . 3.9 mm? -102.06 132.25 48.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.301 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.575 ' CD2' ' HB ' ' A' ' 79' ' ' ILE . 2.5 mt -104.71 165.37 11.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.065 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.474 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 49.1 m -142.5 109.95 5.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.43 169.98 16.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.54 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 2.1 tp -130.33 97.04 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -175.53 73.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.414 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.7 mtm -134.1 171.69 8.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.378 -0.826 . . . . 0.0 109.452 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -97.64 143.45 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.001 1.527 . . . . 0.0 110.181 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.37 -173.92 16.87 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -59.99 109.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' CA ' ' A' ' 85' ' ' SER . 0.1 OUTLIER 72.21 -165.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.969 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' ILE . . . 169.85 39.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 51.7 tp -105.09 64.54 0.72 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -1.184 . . . . 0.0 109.549 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' A' ' 9' ' ' VAL . . . 41.8 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.348 -0.845 . . . . 0.0 109.787 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.505 ' HB3' ' CG ' ' A' ' 68' ' ' GLN . 1.1 tp -127.7 70.85 1.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 109.296 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -71.45 -59.68 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 109.713 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -46.58 -31.72 2.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.818 -1.176 . . . . 0.0 108.261 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.58 ' HG3' ' N ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -66.74 -57.41 7.17 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.604 HG21 ' CG ' ' A' ' 73' ' ' HIS . 1.5 mt -38.67 -64.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.529 ' N ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -42.75 -64.61 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.233 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.1 tp60 -34.05 -43.35 0.14 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.847 -0.533 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.7 60.55 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.057 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.637 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 18.7 t-80 -156.71 131.17 5.05 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.637 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -52.39 -170.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.604 1.318 . . . . 0.0 110.49 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mmt -95.53 48.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 110.763 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.608 ' CD2' ' CE1' ' A' ' 73' ' ' HIS . 3.3 pp -91.17 122.41 66.44 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.869 -1.144 . . . . 0.0 108.463 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.538 ' HG2' ' CG2' ' A' ' 50' ' ' VAL . 34.8 Cg_endo -34.31 147.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.11 1.584 . . . . 0.0 112.52 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.453 HG11 ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.8 124.3 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.575 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -89.16 133.31 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.0 109.313 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 53' ' ' SER . 0.5 OUTLIER -119.35 140.66 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.385 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.522 ' HE3' ' CZ ' ' A' ' 106' ' ' PHE . 2.9 ttm -109.56 113.64 26.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.461 ' O ' HG22 ' A' ' 55' ' ' ILE . 87.5 m 49.89 72.83 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' ' OH ' ' A' ' 101' ' ' TYR . . . -91.0 165.11 13.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.888 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -167.78 -88.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.533 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER 40.19 44.64 1.59 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 10.2 t70 67.74 132.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.547 ' C ' ' O ' ' A' ' 86' ' ' ASP . 15.1 mt -35.17 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 109.271 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -35.68 -67.03 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 85' ' ' SER . . . -72.46 -24.28 61.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 108.626 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -71.41 -76.17 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 109.564 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' A' ' 90' ' ' ALA . 2.9 t -11.27 -58.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 122.804 0.442 . . . . 0.0 111.744 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 90' ' ' ALA . 4.9 t -40.42 108.81 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 109.75 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 99' ' ' PHE . . . 176.4 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.802 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.54 -11.21 59.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.279 -0.888 . . . . 0.0 109.96 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.35 107.49 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.834 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER 55.77 45.46 24.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.88 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 96' ' ' GLN . . . 43.14 -122.63 3.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.58 -93.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.454 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.497 ' CD1' ' OG ' ' A' ' 92' ' ' SER . 5.6 m-85 -62.92 171.52 2.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.87 134.52 7.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.0 109.998 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.417 ' OH ' ' O ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -92.01 95.22 9.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 79' ' ' ILE . 2.3 tp -101.27 132.55 21.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.97 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -121.57 -161.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.834 1.439 . . . . 0.0 109.94 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 8.4 mttt -117.99 159.75 41.65 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.213 -0.929 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -83.22 173.23 44.99 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.703 -2.624 . . . . 0.0 110.476 0.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.522 ' CZ ' ' HE3' ' A' ' 81' ' ' MET . 38.6 p90 -167.9 130.32 1.54 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.531 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 7.4 t70 -70.28 149.07 47.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.154 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.524 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 36.9 mm -66.11 -40.72 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -74.96 -40.85 60.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.531 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 9.9 tp10 -51.05 -33.64 26.42 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -83.06 -73.67 0.39 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.47 -0.769 . . . . 0.0 109.666 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.631 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -36.6 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.495 -0.753 . . . . 0.0 110.069 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.576 ' O ' ' CG ' ' A' ' 116' ' ' GLU . . . -79.9 -66.83 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.747 0.784 . . . . 0.0 109.861 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 2.8 tm? -38.47 -36.71 0.26 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.278 1.037 . . . . 0.0 109.259 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.522 HG11 HG22 ' A' ' 50' ' ' VAL . 1.1 t -74.13 -59.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.576 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 4.1 pt-20 -38.72 -30.88 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.939 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -77.14 -54.36 6.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.118 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 121' ' ' HIS . . . -46.07 -60.93 1.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 108.972 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.581 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 6.2 mt -35.78 -42.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.227 0.537 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -92.21 50.29 1.62 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 3.4 t60 -97.79 -41.36 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.219 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -84.35 10.99 9.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.325 -0.86 . . . . 0.0 109.584 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -95.74 18.75 12.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.609 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 1.4 mp0 -103.11 -80.33 0.52 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.43 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.71 40.1 0.65 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.142 0.973 . . . . 0.0 108.858 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.497 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . 136.07 161.38 9.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HB ' ' CB ' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -131.61 112.37 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.245 . . . . 0.0 109.628 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.1 t -126.84 114.22 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.687 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.618 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 15.3 m0 -99.88 89.59 4.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.793 -1.192 . . . . 0.0 108.668 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 32' ' ' THR . 70.8 t -77.18 143.64 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.661 -0.649 . . . . 0.0 110.846 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 75.5 t -82.44 110.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 0.0 109.109 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 16' ' ' ARG . 14.0 m-20 -56.32 168.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 109.923 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.85 23.44 4.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 109.321 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 170.49 176.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.156 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' SER . 81.0 p -79.05 146.57 33.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.0 OUTLIER 75.74 4.65 3.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 12' ' ' ASP . 45.5 mm -78.11 -32.47 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.796 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -58.93 -47.61 84.44 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 15.3 t90 -58.19 -64.22 0.99 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.2 t -37.0 -69.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.534 -0.729 . . . . 0.0 110.83 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.4 mt -49.54 -76.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 110.52 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 19' ' ' LEU . 10.6 tp10 -36.05 -29.38 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.701 -0.624 . . . . 0.0 110.737 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -65.4 -55.77 16.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.0 -7.27 33.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.485 -0.759 . . . . 0.0 109.135 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.56 ' CD2' ' CG2' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -104.9 -5.36 21.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.79 26.92 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.35 38.59 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.94 80.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -1.12 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 2' ' ' GLN . . . 98.23 61.42 0.89 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.52 HD21 ' CG1' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -136.82 179.1 6.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -1.162 . . . . 0.0 109.765 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 29' ' ' THR . 24.2 m -100.4 75.56 1.8 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.0 t -81.09 88.66 5.97 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.384 -0.823 . . . . 0.0 110.02 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.618 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 20.2 m -97.79 145.28 26.54 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -139.93 152.16 46.15 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.732 -1.23 . . . . 0.0 110.09 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.594 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.9 m-85 -134.1 122.91 23.58 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.778 0.799 . . . . 0.0 109.023 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -43.81 -49.75 8.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.538 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 1.5 m120 -117.25 138.28 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.437 -1.415 . . . . 0.0 112.188 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 39' ' ' VAL . . . -57.56 -15.03 15.92 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' VAL . 9.4 t30 -67.28 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.0 tt0 -35.66 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.869 -0.519 . . . . 0.0 109.821 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 33' ' ' PHE . 35.2 t -61.93 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.606 ' CD1' ' CB ' ' A' ' 72' ' ' ARG . 3.4 tm? -64.88 -16.58 63.38 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.319 0.581 . . . . 0.0 109.65 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.35 -21.06 21.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.935 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.08 -21.26 18.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 7.5 mt -88.85 -96.84 0.09 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 82.38 -54.72 0.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 12.6 m -101.06 -5.51 25.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.546 ' HG2' ' CD2' ' A' ' 73' ' ' HIS . 11.7 mttt 62.73 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 109.202 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -100.66 -61.88 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 111.638 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 36.8 Cg_endo -49.88 -177.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.6 1.316 . . . . 0.0 110.56 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.544 ' HB2' ' CD1' ' A' ' 119' ' ' ILE . 2.5 m-20 -90.85 -25.3 19.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 110.487 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.576 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 2.5 t -148.79 132.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.846 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' CD2' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -101.23 126.65 47.98 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.483 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -108.71 174.42 5.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.455 ' HB2' HG23 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -155.72 124.07 5.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.03 169.78 10.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.464 ' HB ' HD12 ' A' ' 63' ' ' LEU . 1.1 tp -144.31 115.3 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 109.403 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -141.91 -28.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.358 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.45 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -97.36 105.22 23.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.973 -1.08 . . . . 0.0 109.513 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 36.6 Cg_endo -75.99 137.91 20.11 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.042 1.549 . . . . 0.0 110.399 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 60' ' ' MET . . . 144.26 -114.18 0.79 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 3.2 mpp? -145.78 32.9 1.03 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -1.129 . . . . 0.0 109.403 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.17 4.4 2.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.897 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.45 ' HA3' ' HG3' ' A' ' 57' ' ' MET . . . -105.73 -86.88 1.94 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -79.13 -0.5 31.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 109.488 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.33 64.49 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 108.944 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.0 mp -81.65 0.21 39.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.522 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 2.6 mm? -78.23 -14.55 59.4 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.181 -0.949 . . . . 0.0 108.525 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.08 57.09 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -69.46 -50.94 40.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 108.847 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.63 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 2.2 tt -33.59 -60.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.643 -0.66 . . . . 0.0 110.302 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 1.1 tptm -69.72 -55.75 9.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.797 -1.189 . . . . 0.0 110.152 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.8 tt0 -35.49 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.84 -0.538 . . . . 0.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.606 ' CB ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.16 -48.4 3.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.682 -1.261 . . . . 0.0 112.232 -178.18 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.63 ' ND1' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -105.08 134.54 19.59 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.286 -1.509 . . . . 0.0 111.482 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 75' ' ' MET . 38.6 Cg_endo -133.97 95.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 117.376 -1.283 . . . . 0.0 111.173 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 23.1 mtt -152.41 -102.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.125 -0.984 . . . . 0.0 109.601 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -55.82 176.89 0.16 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.872 -1.143 . . . . 0.0 109.215 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.5 Cg_endo -83.85 173.16 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.716 1.377 . . . . 0.0 110.412 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 118.53 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 2.8 mt -113.56 133.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 109.767 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.48 ' CD1' HD11 ' A' ' 87' ' ' LEU . 4.1 pt -131.13 172.22 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.404 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -85.96 153.06 22.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -89.84 137.28 32.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.396 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 169.61 41.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -162.51 164.79 26.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.463 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 29.0 t -62.04 87.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 108.705 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.614 ' HB3' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 61.84 30.13 18.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER 35.55 35.71 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -177.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 10.49 -61.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.082 -1.872 . . . . 0.0 111.199 -177.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . -69.68 14.49 0.1 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.825 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB1' ' CG ' ' A' ' 87' ' ' LEU . . . -128.38 -77.37 0.56 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 119.812 -1.805 . . . . 0.0 107.464 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 86' ' ' ASP . 53.0 t -38.01 -29.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -103.32 -165.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 109.786 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 92' ' ' SER . . . 76.29 -165.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.306 -0.871 . . . . 0.0 109.473 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -45.56 -58.22 3.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.156 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.09 55.19 9.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -33.66 0.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 98' ' ' ALA . . . -50.95 -73.81 0.34 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . 167.65 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -137.28 -176.24 4.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.551 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.6 OUTLIER -150.76 -42.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.923 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' A' ' 100' ' ' ASP . 9.8 m-85 75.91 136.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.2 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.81 118.87 16.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.67 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -94.79 179.38 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.013 1.533 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -113.9 153.87 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.19 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -88.7 167.3 38.07 Favored 'Cis proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.535 -2.694 . . . . 0.0 110.427 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -152.09 152.19 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.3 t0 -82.3 174.13 11.42 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.046 -1.034 . . . . 0.0 108.927 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 mm -90.47 -64.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.727 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 110' ' ' GLU . 48.3 t0 -57.28 -46.95 82.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 108.567 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 1.5 tm-20 -44.5 -42.67 7.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.05 -72.27 0.2 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.52 ' CG1' HD21 ' A' ' 28' ' ' LEU . 40.8 t -36.21 -70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.333 0.587 . . . . 0.0 110.204 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.3 -65.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.967 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.512 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.0 tt -34.07 -52.69 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.692 0.758 . . . . 0.0 109.576 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.544 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.3 t -55.9 -56.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 115' ' ' VAL . 59.3 mm-40 -36.9 -37.45 0.15 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 110.61 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.558 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -84.86 -36.06 21.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.109 -179.11 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.558 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.23 -61.36 2.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.779 -1.201 . . . . 0.0 108.007 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.576 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 6.1 mt -34.84 -42.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.298 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.12 56.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -138.76 -64.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.519 ' O ' ' CD2' ' A' ' 122' ' ' TYR . 36.6 p90 -91.28 29.78 1.38 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.327 -0.858 . . . . 0.0 109.773 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -80.44 -15.27 57.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.0 109.532 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.58 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -124.66 -29.73 3.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.58 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -78.62 -179.76 6.64 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.19 -0.943 . . . . 0.0 109.464 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.529 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -146.55 177.98 24.53 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 69.9 mt -142.11 104.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.058 . . . . 0.0 109.006 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.527 ' CG2' HG22 ' A' ' 50' ' ' VAL . 2.4 t -99.47 106.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.728 -0.607 . . . . 0.0 110.464 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.604 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 40.6 m0 -98.73 92.32 5.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 52' ' ' LEU . 59.7 t -90.86 167.76 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.904 0.859 . . . . 0.0 112.076 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.493 ' N ' HG13 ' A' ' 8' ' ' VAL . 58.0 t -98.36 129.95 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.533 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 6.5 m-20 -49.3 -171.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.262 1.03 . . . . 0.0 112.187 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 56' ' ' ARG . 29.6 t0 -159.58 -67.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -108.1 174.91 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.5 t -70.44 137.13 50.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.2 p 79.61 33.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.445 -0.785 . . . . 0.0 109.738 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 12' ' ' ASP . 2.1 mm -80.95 -36.51 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 108.86 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 32' ' ' THR . 12.9 mtt180 -59.74 -44.54 93.74 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.446 ' O ' ' C ' ' A' ' 18' ' ' VAL . 10.7 t90 -64.57 -67.55 0.43 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.3 t -38.39 -68.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 110.734 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -52.1 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.486 -0.759 . . . . 0.0 110.693 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 19' ' ' LEU . 5.4 tt0 -34.62 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.795 -0.566 . . . . 0.0 110.821 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' LEU . 2.2 mmm180 -67.82 -56.65 8.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.972 -1.08 . . . . 0.0 108.655 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -6.08 34.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.184 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD2' ' CG2' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -102.92 -8.7 20.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.893 . . . . 0.0 109.646 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.43 -42.24 23.04 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.24 97.97 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.82 71.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.35 -1.088 . . . . 0.0 108.552 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.01 49.7 1.44 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.596 ' CD2' ' CG1' ' A' ' 112' ' ' VAL . 2.3 mp -141.03 173.48 11.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.867 -1.373 . . . . 0.0 110.081 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.468 ' HB ' HG12 ' A' ' 5' ' ' ILE . 3.6 m -98.96 89.93 4.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.539 -0.726 . . . . 0.0 109.165 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 21.1 t -90.75 90.91 8.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 110.283 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.572 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 m -92.74 146.97 23.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.533 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.77 135.57 28.01 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.913 -1.117 . . . . 0.0 109.464 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.577 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 47.3 m-85 -108.82 126.37 52.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.065 -1.022 . . . . 0.0 109.159 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' HA ' ' CB ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -42.13 -25.26 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.043 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' PHE . 16.7 t-20 -125.96 127.95 46.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.054 . . . . 0.0 110.487 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' CA ' HG23 ' A' ' 9' ' ' VAL . . . -55.81 -50.0 63.32 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -45.26 -65.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 2.9 tt0 -34.63 -48.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.977 -0.452 . . . . 0.0 110.484 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 33' ' ' PHE . 99.7 t -47.48 -55.56 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HG ' ' HG3' ' A' ' 68' ' ' GLN . 2.9 mm? -65.41 -27.59 68.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' A' ' 38' ' ' GLU . . . -62.4 -29.06 70.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.0 -35.25 29.1 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.517 ' CD1' ' C ' ' A' ' 43' ' ' LEU . 1.2 tm? -48.57 -25.76 1.88 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -35.52 -49.01 0.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.596 0.712 . . . . 0.0 109.156 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -78.41 -51.86 9.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 160.91 135.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.435 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -78.93 -155.92 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.69 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.2 Cg_endo -129.64 -86.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 117.205 -1.397 . . . . 0.0 111.474 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 66.7 m-20 -115.52 -73.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.453 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.607 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -119.29 124.02 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.08 . . . . 0.0 111.41 -177.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 78' ' ' VAL . 7.7 tp -99.16 109.91 22.54 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.575 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 4.0 mp -103.33 160.85 14.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.07 112.81 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.47 -0.769 . . . . 0.0 109.324 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 53' ' ' SER . 5.8 t0 -61.09 -143.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.279 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.548 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 1.1 tp -172.34 84.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.944 -1.098 . . . . 0.0 110.185 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 163.72 129.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.565 ' CB ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 166.95 -61.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.442 -0.786 . . . . 0.0 109.443 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 57' ' ' MET . 36.7 Cg_endo -70.09 142.5 46.64 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 124.305 1.687 . . . . 0.0 110.233 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.39 -21.52 66.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 25.3 ttp -94.0 114.79 27.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER 44.32 -159.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.549 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.494 ' C ' ' CD2' ' A' ' 63' ' ' LEU . . . -101.42 -109.73 3.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.539 HD21 ' CD ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -175.7 105.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.658 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -57.48 -79.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.27 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 23.4 mt 81.49 -22.57 0.26 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD22 ' CG1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -60.17 -42.9 95.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.669 -1.27 . . . . 0.0 108.68 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -31.57 72.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 27.1 tp60 -60.36 -62.4 1.89 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.579 HG21 ' CG ' ' A' ' 73' ' ' HIS . 1.8 mp -35.92 -77.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.755 -0.591 . . . . 0.0 109.933 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -34.07 -64.8 0.22 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.949 -0.47 . . . . 0.0 109.902 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.1 mm-40 -35.05 -51.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.738 -0.601 . . . . 0.0 110.21 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.39 53.92 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 110.911 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.579 ' CG ' HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -130.55 163.79 45.92 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.948 -1.095 . . . . 0.0 109.406 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 36.7 Cg_endo -84.05 -69.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.041 1.548 . . . . 0.0 110.161 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.07 45.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.539 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 3.1 pp -109.28 161.55 23.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.086 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 31.9 Cg_endo -68.63 155.06 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.88 1.463 . . . . 0.0 112.001 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -136.93 165.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.57 HG13 ' CE2' ' A' ' 99' ' ' PHE . 4.4 tt -132.59 145.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.753 -1.217 . . . . 0.0 110.796 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.519 ' CG1' HD22 ' A' ' 66' ' ' LEU . 8.8 mt -108.46 93.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.617 ' O ' ' CB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -65.2 96.88 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.97 . . . . 0.0 109.537 -179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.617 ' CB ' ' O ' ' A' ' 81' ' ' MET . 14.9 t 123.72 177.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.67 19.81 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 109.154 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -91.49 -95.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.63 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m -71.73 86.51 0.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.059 -1.026 . . . . 0.0 109.405 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ASP . 9.8 t70 -179.3 -36.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.016 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -35.35 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.292 0.568 . . . . 0.0 110.536 -179.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -91.77 -53.51 4.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.348 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -17.55 1.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 110.361 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -96.57 -74.51 0.56 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.968 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 90' ' ' ALA . 45.8 t -33.71 -33.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.762 -0.586 . . . . 0.0 110.872 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -97.58 -160.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.814 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 95' ' ' GLN . . . 45.48 -168.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -58.2 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.126 -0.983 . . . . 0.0 109.096 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp0? -94.47 15.2 18.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.762 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -38.74 24.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . 167.02 -94.38 0.11 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . 69.64 7.25 6.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -1.091 . . . . 0.0 110.047 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.607 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER 49.14 112.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.636 0.732 . . . . 0.0 110.401 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -147.09 -169.2 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.662 -1.274 . . . . 0.0 109.843 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 100' ' ' ASP . 4.8 m-85 65.32 96.1 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.433 0.635 . . . . 0.0 110.672 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.517 HD23 ' CD1' ' A' ' 79' ' ' ILE . 12.8 tp -139.36 95.59 9.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.01 -172.44 0.71 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.084 1.571 . . . . 0.0 111.525 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -141.38 166.21 23.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -75.63 119.8 6.35 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.249 -2.396 . . . . 0.0 110.767 0.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.618 ' CD2' ' N ' ' A' ' 107' ' ' ASP . 58.5 t80 -93.18 167.17 11.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.202 -0.936 . . . . 0.0 109.398 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.618 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 16.6 t0 -74.5 -145.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.475 -0.765 . . . . 0.0 109.48 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.527 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 6.7 mm -139.93 -73.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.101 -0.999 . . . . 0.0 109.119 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -60.76 -31.82 71.15 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 69.0 tt0 -55.83 -38.21 69.72 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.552 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . . . -75.47 -70.84 0.4 Allowed 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.352 -0.842 . . . . 0.0 109.504 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.596 ' CG1' ' CD2' ' A' ' 28' ' ' LEU . 47.6 t -36.99 -45.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.66 0.743 . . . . 0.0 110.962 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -76.81 -72.0 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.802 . . . . 0.0 110.944 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.512 ' C ' ' O ' ' A' ' 113' ' ' ALA . 54.5 tp -33.07 -56.34 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.365 0.602 . . . . 0.0 109.946 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.541 ' CG1' HG12 ' A' ' 50' ' ' VAL . 93.5 t -61.86 -55.44 24.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 115' ' ' VAL . 17.3 tt0 -33.09 -34.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.406 0.622 . . . . 0.0 109.962 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 115' ' ' VAL . 35.5 mtm180 -60.17 -60.71 3.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -55.13 -52.89 61.83 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.607 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 4.5 mt -35.63 -35.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.245 0.545 . . . . 0.0 110.365 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -77.35 31.48 0.15 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.267 -0.896 . . . . 0.0 110.791 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -64.86 -18.04 64.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.68 -1.263 . . . . 0.0 109.228 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -86.78 40.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 109.621 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.34 50.88 2.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.398 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.1 mtm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -64.97 135.67 55.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.324 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 59.8 ttm-85 -179.66 68.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.32 -0.862 . . . . 0.0 109.321 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.549 ' N ' ' CD2' ' A' ' 28' ' ' LEU . . . -151.46 92.39 0.14 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.102 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -92.93 88.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 108.581 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 5.4 p -98.46 118.2 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.445 0.641 . . . . 0.0 110.566 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CD2' ' CG2' ' A' ' 31' ' ' THR . 11.4 m0 -101.77 87.74 3.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.006 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.02 156.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.821 0.82 . . . . 0.0 111.079 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.48 HG21 HG12 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -118.61 114.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 3.6 t0 -175.83 172.93 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.586 -0.696 . . . . 0.0 109.418 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' N ' HG13 ' A' ' 15' ' ' ILE . 64.0 t0 -144.72 -76.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.15 -0.968 . . . . 0.0 109.151 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 13' ' ' SER . 5.1 t70 35.91 53.09 0.87 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.672 -0.642 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.0 p 36.97 100.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.129 0.49 . . . . 0.0 111.106 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 83.39 45.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.463 -0.773 . . . . 0.0 110.712 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -81.5 -38.15 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.66 -1.275 . . . . 0.0 107.86 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.53 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 1.6 mtm-85 -66.81 -31.89 72.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.595 ' CE3' ' HG3' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -61.54 -69.35 0.25 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.214 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.582 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 41.1 t -40.43 -64.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.708 0.765 . . . . 0.0 110.75 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 21' ' ' ARG . 51.4 mt -62.02 -72.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 111.349 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 1.6 tt0 -33.81 -34.64 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.683 -0.636 . . . . 0.0 110.832 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.595 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 63.9 mmt-85 -67.22 -55.38 14.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 108.529 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . -71.3 -3.21 19.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.203 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.554 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 1.7 mm? -102.7 -17.15 15.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 109.393 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.0 11.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.7 -21.05 49.62 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.24 -31.16 19.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.405 -1.056 . . . . 0.0 108.941 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.63 63.72 1.4 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.607 ' CD1' ' CG1' ' A' ' 112' ' ' VAL . 17.7 mt -144.73 177.53 8.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 11.5 m -98.93 93.27 5.93 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.554 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 22.4 t -89.36 78.97 7.1 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.283 -0.885 . . . . 0.0 110.07 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.588 ' CG2' ' CD2' ' A' ' 7' ' ' TRP . 11.5 m -76.03 126.33 30.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 108.619 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.53 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 65.3 p -132.01 138.45 48.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.953 -1.092 . . . . 0.0 109.698 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CB ' HG21 ' A' ' 39' ' ' VAL . 11.8 m-85 -127.61 137.51 52.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 1.4 mt-10 -72.11 -27.55 62.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.46 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 5.7 m-80 -111.01 133.71 53.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 110.137 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.557 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . -56.37 -64.74 4.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -39.15 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.611 -0.935 . . . . 0.0 109.627 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.0 mm-40 -31.21 -43.82 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.43 0.634 . . . . 0.0 110.103 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' CB ' ' A' ' 33' ' ' PHE . 21.5 t -54.55 -61.83 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.429 -0.794 . . . . 0.0 109.2 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -63.07 -12.53 27.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 38' ' ' GLU . . . -77.2 -35.03 56.06 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.17 62.64 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 46' ' ' LYS . 27.8 mt -68.97 -8.61 46.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.533 -0.729 . . . . 0.0 109.078 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -3.84 -64.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.337 0.589 . . . . 0.0 112.054 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -70.68 -61.01 1.93 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.84 -173.77 3.1 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.553 0.692 . . . . 0.0 109.407 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.592 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 31.5 m -99.98 150.42 36.85 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.592 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 32.8 Cg_endo -75.39 -81.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 117.485 -1.21 . . . . 0.0 112.448 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.455 ' C ' HD12 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -100.85 -76.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.356 -1.465 . . . . 0.0 110.462 -178.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.542 HG22 ' CG1' ' A' ' 115' ' ' VAL . 9.8 t -132.92 143.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.83 . . . . 0.0 109.062 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CD1' HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -100.08 133.0 45.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.591 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.493 ' CD2' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -118.85 137.86 53.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -139.22 118.98 13.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.048 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 10' ' ' ASP . 1.5 p30 -104.67 160.25 15.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.087 -1.008 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.549 ' CG2' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -87.67 135.42 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.499 -0.751 . . . . 0.0 109.189 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' CZ ' ' HE3' ' A' ' 57' ' ' MET . 7.1 ptt85 -151.15 34.36 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.297 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.488 ' HE3' ' CZ ' ' A' ' 56' ' ' ARG . 11.6 mtm -148.41 112.2 3.74 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.564 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -107.94 136.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.11 1.584 . . . . 0.0 110.149 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.23 -84.42 0.23 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.09 -32.67 4.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.172 . . . . 0.0 109.951 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' MET . 0.8 OUTLIER -122.02 150.76 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.856 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 -67.89 0.11 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.48 94.09 3.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -1.177 . . . . 0.0 109.729 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 44.04 2.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.208 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.557 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 11.4 mt -118.37 -28.86 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -69.85 -50.92 37.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.1 . . . . 0.0 108.108 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 66' ' ' LEU . 15.6 tttm -44.54 -35.26 2.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.535 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.26 -56.67 18.74 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.591 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 2.2 tp -36.39 -54.13 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.656 -0.653 . . . . 0.0 110.561 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 13.1 mmtp -53.25 -66.18 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.2 tt0 -36.74 -29.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.868 -0.52 . . . . 0.0 110.321 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -105.23 -81.22 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.154 -0.966 . . . . 0.0 111.567 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.532 ' NE2' ' C ' ' A' ' 43' ' ' LEU . 2.4 p-80 -153.44 133.76 7.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.627 -1.295 . . . . 0.0 112.048 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 75' ' ' MET . 37.7 Cg_endo -134.46 -93.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.988 1.52 . . . . 0.0 109.224 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.55 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 19.0 mtt 69.19 4.6 4.66 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.403 -0.81 . . . . 0.0 110.676 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.589 ' CD2' ' HB ' ' A' ' 47' ' ' THR . 0.3 OUTLIER -142.37 167.12 17.37 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.984 -1.073 . . . . 0.0 109.548 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.588 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 32.1 Cg_endo -62.96 155.03 63.0 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.556 1.293 . . . . 0.0 111.255 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -142.86 101.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.824 . . . . 0.0 110.083 -178.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.529 ' N ' HD11 ' A' ' 79' ' ' ILE . 1.7 mp -76.44 138.83 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.128 -0.982 . . . . 0.0 109.645 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 80' ' ' ILE . 3.0 tt -126.55 113.8 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.472 ' O ' HG21 ' A' ' 82' ' ' THR . 0.1 OUTLIER -62.5 148.53 45.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 109.529 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.549 HG23 ' CG2' ' A' ' 55' ' ' ILE . 0.4 OUTLIER 60.84 175.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.423 -0.798 . . . . 0.0 109.487 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' N ' HG22 ' A' ' 82' ' ' THR . . . -145.96 76.21 1.45 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.469 ' O ' ' OG ' ' A' ' 85' ' ' SER . 7.1 m-70 -138.9 -101.19 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.958 . . . . 0.0 110.524 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 86' ' ' ASP . 21.7 p 46.87 30.09 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -177.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 88' ' ' ASP . 73.2 m-20 63.57 125.38 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.575 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -36.15 -32.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -37.45 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.343 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -44.17 -35.99 2.46 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 87' ' ' LEU . . . -62.3 -90.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.337 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.512 ' CG2' HD13 ' A' ' 87' ' ' LEU . 35.6 t -35.61 -63.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.602 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 14.5 m -79.94 -149.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.833 . . . . 0.0 110.351 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' ALA . . . 68.19 -87.12 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 109.901 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 96' ' ' GLN . 2.0 p90 -106.66 -16.36 14.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.081 -1.012 . . . . 0.0 109.514 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 14.5 mt-30 44.45 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -83.72 136.33 34.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.848 -1.158 . . . . 0.0 109.358 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.03 -174.79 30.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -121.86 95.21 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.356 -1.085 . . . . 0.0 109.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 50.7 p90 163.54 -174.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -144.28 134.0 23.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.554 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.459 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 88.3 m-85 -43.77 122.24 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.456 HD11 HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -100.38 112.12 63.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.151 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 36.8 Cg_endo -91.8 168.27 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.907 1.477 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -95.03 158.6 34.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -101.44 166.52 7.53 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.043 -2.482 . . . . 0.0 110.16 0.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 25.3 p90 -147.7 174.17 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 10.6 t0 -87.23 -154.91 0.26 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.302 -0.874 . . . . 0.0 108.907 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.538 ' CG2' HD23 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -121.69 -42.92 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 108.677 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -82.34 -35.07 28.23 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.49 -38.09 76.91 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -79.95 -72.14 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.639 -0.663 . . . . 0.0 109.343 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.607 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -37.4 -53.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.661 -0.649 . . . . 0.0 110.066 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' N ' HG13 ' A' ' 112' ' ' VAL . . . -60.58 -60.86 3.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.602 -0.686 . . . . 0.0 109.988 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.5 tm? -34.45 -46.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.749 0.785 . . . . 0.0 109.66 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.542 ' CG1' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -66.49 -54.67 23.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 115' ' ' VAL . 6.1 tt0 -34.08 -39.46 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.433 0.635 . . . . 0.0 109.847 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' VAL . 11.4 mtp180 -77.43 -47.71 19.06 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.242 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' VAL . . . -52.22 -64.53 0.79 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 0.0 108.835 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.536 ' CD1' HG22 ' A' ' 50' ' ' VAL . 6.3 mt -35.45 -41.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.597 . . . . 0.0 110.22 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.46 58.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -117.73 -19.89 9.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -78.06 -7.85 57.46 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.32 -0.863 . . . . 0.0 109.396 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.27 -34.92 24.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.442 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' O ' ' CG ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -154.77 74.92 0.95 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.8 162.62 38.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.455 ' O ' HD21 ' A' ' 28' ' ' LEU . . . -153.43 146.41 14.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 2.7 mp -105.59 112.74 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -1.159 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.552 ' CG2' ' CD1' ' A' ' 52' ' ' LEU . 2.3 p -105.59 120.52 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.578 -0.701 . . . . 0.0 110.016 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CB ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.19 105.81 16.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.136 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HA ' ' HB2' ' A' ' 52' ' ' LEU . 42.6 t -87.99 146.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.141 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' HG11 ' A' ' 8' ' ' VAL . 22.6 t -99.24 95.73 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 110.084 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.618 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 31.52 -160.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.78 0.8 . . . . 0.0 112.696 178.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 6.8 t0 152.48 -25.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.62 146.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 14' ' ' SER . 11.3 t -45.4 135.8 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.717 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 77.45 34.7 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -72.73 -47.55 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 108.975 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -53.0 -47.74 68.05 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.484 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 83.9 t90 -56.56 -63.77 1.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 109.667 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 17' ' ' TRP . 42.1 t -38.88 -74.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.07 0.938 . . . . 0.0 110.648 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -60.53 -68.18 0.32 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.531 -0.731 . . . . 0.0 110.858 -178.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -35.52 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.547 -0.721 . . . . 0.0 110.88 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -71.82 -53.63 12.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.991 -1.068 . . . . 0.0 108.252 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . -71.87 -2.98 19.8 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.984 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 2.5 mm? -103.88 -14.9 15.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.353 -0.842 . . . . 0.0 109.411 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.58 -30.65 32.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 -38.96 58.22 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.52 72.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -1.113 . . . . 0.0 108.913 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.26 66.01 0.91 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.516 HD23 ' CG1' ' A' ' 112' ' ' VAL . 0.3 OUTLIER -141.52 176.9 8.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.091 -1.241 . . . . 0.0 110.019 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 6.8 m -100.13 77.09 1.96 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.1 t -83.08 90.37 7.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.313 -0.867 . . . . 0.0 110.427 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 3.3 m -100.7 140.67 34.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.484 ' OG1' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -142.31 138.47 31.33 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.571 -1.331 . . . . 0.0 110.164 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.572 ' CD2' HG21 ' A' ' 39' ' ' VAL . 18.3 m-85 -107.46 159.82 16.12 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -92.02 11.5 25.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.898 -1.126 . . . . 0.0 109.711 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -149.94 128.56 12.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.549 ' O ' ' CD2' ' A' ' 40' ' ' LEU . . . -56.24 -62.45 6.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.473 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -41.47 -65.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.354 -1.086 . . . . 0.0 109.383 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.5 tp10 -35.05 -47.01 0.35 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.611 -0.68 . . . . 0.0 110.276 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 33' ' ' PHE . 1.4 t -60.83 -50.7 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 108.636 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.618 HD13 ' CE1' ' A' ' 73' ' ' HIS . 0.9 OUTLIER -69.81 -5.85 28.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 0.0 109.572 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.36 -22.07 18.57 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.3 -0.875 . . . . 0.0 108.802 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.77 -33.5 18.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.4 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 4.1 mt -98.59 -114.35 0.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.214 -0.929 . . . . 0.0 108.742 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 43' ' ' LEU . . . 82.4 -51.28 0.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 58.7 m -75.23 -34.65 61.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.326 -0.859 . . . . 0.0 108.924 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 176.77 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.581 ' CG2' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -71.27 -152.85 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.581 ' CD ' ' CG2' ' A' ' 47' ' ' THR . 37.0 Cg_endo -125.32 -75.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 117.093 -1.471 . . . . 0.0 111.2 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -112.85 -73.92 0.65 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.733 -1.229 . . . . 0.0 111.14 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.59 ' CG2' ' CD1' ' A' ' 119' ' ' ILE . 2.6 t -140.27 137.0 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.013 -1.054 . . . . 0.0 110.672 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.549 HD13 ' CB ' ' A' ' 7' ' ' TRP . 12.5 tp -100.42 159.89 14.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.552 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -138.93 141.7 38.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 -179.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.516 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 6.3 t -119.27 111.21 17.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 10' ' ' ASP . 34.0 p-10 -59.77 175.13 0.39 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.909 -1.119 . . . . 0.0 109.097 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.491 ' CG1' HD13 ' A' ' 63' ' ' LEU . 1.2 tt -161.72 38.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -80.22 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.46 ' CE ' ' CA ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -48.59 139.0 11.53 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.653 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -113.61 165.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.818 1.43 . . . . 0.0 110.167 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 61' ' ' ASP . . . 124.03 89.31 0.85 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.1 mmt 49.05 -95.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -1.109 . . . . 0.0 109.738 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' GLY . 2.0 m-20 -50.89 164.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.09 -1.006 . . . . 0.0 109.353 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' CA ' ' CE ' ' A' ' 57' ' ' MET . . . 108.73 -62.38 0.29 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.557 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 2.4 mm? -116.92 1.76 12.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -1.167 . . . . 0.0 109.715 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.69 67.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.176 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.582 ' CB ' ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -167.77 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.503 ' CD1' ' CB ' ' A' ' 53' ' ' SER . 2.9 tp -40.18 -30.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.109 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 65' ' ' LEU . 10.8 tptt -57.66 -54.73 43.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.609 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 65' ' ' LEU . 9.4 pm0 -58.09 -39.23 78.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.204 . . . . 0.0 108.241 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.541 ' CG1' HD21 ' A' ' 51' ' ' LEU . 1.4 tt -38.21 -36.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.577 -0.702 . . . . 0.0 110.064 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' ARG . 5.0 tptm -109.05 -69.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 110.334 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.3 tt0 -36.12 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.402 -0.811 . . . . 0.0 110.834 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -96.89 -34.93 11.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.277 -0.889 . . . . 0.0 110.06 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.618 ' CE1' HD13 ' A' ' 40' ' ' LEU . 4.7 m80 -96.83 137.14 21.37 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.547 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.6 Cg_endo -39.23 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.999 1.526 . . . . 0.0 110.999 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.85 95.72 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.6 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -133.23 171.71 8.66 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.2 Cg_endo -59.28 107.87 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.441 1.232 . . . . 0.0 110.982 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.521 ' CG1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -102.12 82.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.54 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mp -62.73 155.56 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.988 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 79' ' ' ILE . 1.3 pp -160.39 150.88 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.467 ' HB2' HG23 ' A' ' 55' ' ' ILE . 40.3 mtt -90.85 126.99 36.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 109.511 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 77.8 p -74.27 153.53 39.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 0.0 109.708 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . 163.65 39.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.349 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER 69.06 157.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 51.0 m 63.04 152.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' SER . 32.1 t0 84.2 -49.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.726 -0.609 . . . . 0.0 109.868 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -33.75 -51.02 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.0 110.528 -179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.23 -55.48 10.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.649 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.5 -40.1 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 109.679 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -73.19 -81.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 42.8 t -33.38 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.776 -0.578 . . . . 0.0 110.613 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -99.79 -155.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.919 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.402 ' HB3' ' HD2' ' A' ' 67' ' ' LYS . . . 56.63 75.68 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.442 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' GLN . 0.7 OUTLIER 59.95 -89.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.378 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 71.42 138.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -146.01 -63.18 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.303 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.37 52.72 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.82 38.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -1.151 . . . . 0.0 109.398 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 100' ' ' ASP . 8.2 m-85 -120.42 105.52 10.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.794 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.584 ' O ' ' CD1' ' A' ' 101' ' ' TYR . 14.1 t0 -61.96 -139.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.886 . . . . 0.0 109.181 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 169.78 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 108.959 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.74 132.17 62.0 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 109.777 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 104' ' ' LYS . 36.8 Cg_endo -105.87 -92.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.89 1.469 . . . . 0.0 110.135 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER 161.28 147.77 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.253 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -82.26 170.9 56.84 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.721 -2.616 . . . . 0.0 110.392 -0.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 81' ' ' MET . 49.6 p90 -149.7 138.96 21.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 25.3 t0 -76.77 170.67 16.03 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.036 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 108' ' ' ILE . 19.1 mm -84.23 -58.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.049 -1.032 . . . . 0.0 109.896 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -63.33 -46.16 87.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 108.533 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 20.7 tp10 -47.22 -37.9 11.22 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -75.04 -73.76 0.23 Allowed 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.349 -0.844 . . . . 0.0 109.796 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.516 ' CG1' HD23 ' A' ' 28' ' ' LEU . 41.4 t -39.02 -56.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -59.97 -70.15 0.18 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.729 . . . . 0.0 110.987 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.501 ' CD1' ' C ' ' A' ' 114' ' ' LEU . 2.0 tm? -34.37 -57.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.435 0.636 . . . . 0.0 110.016 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.541 ' CG1' ' N ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -53.92 -52.66 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.541 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 4.0 tt0 -34.56 -49.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.274 0.559 . . . . 0.0 110.324 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -56.02 -54.95 38.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.61 -60.56 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.09 -1.007 . . . . 0.0 108.366 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.59 ' CD1' ' CG2' ' A' ' 50' ' ' VAL . 5.7 mt -37.0 -35.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.739 -0.601 . . . . 0.0 110.865 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.593 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 7.6 t -33.87 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.936 -0.478 . . . . 0.0 111.52 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.593 ' CB ' ' O ' ' A' ' 120' ' ' SER . 2.2 t-160 86.52 39.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' HIS . 1.1 m-85 37.36 77.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.583 0.706 . . . . 0.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.07 39.28 1.04 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.74 . . . . 0.0 109.595 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.602 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.841 ' C ' HD12 ' A' ' 5' ' ' ILE . . . -162.78 176.94 39.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.841 HD12 ' C ' ' A' ' 4' ' ' GLY . 3.6 mp -135.95 99.27 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.055 . . . . 0.0 109.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 8' ' ' VAL . 2.7 t -101.19 111.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 109.821 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.606 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 9.5 m0 -100.18 92.78 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.106 HG22 ' HB2' ' A' ' 52' ' ' LEU . 48.3 t -95.98 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.484 -0.76 . . . . 0.0 110.735 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.686 ' HB ' HG21 ' A' ' 39' ' ' VAL . 3.7 p -119.16 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 15' ' ' ILE . 1.4 p30 -102.14 -120.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.913 -1.117 . . . . 0.0 110.181 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' HD3' ' A' ' 58' ' ' PRO . 31.8 t0 -135.43 -61.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.633 -1.292 . . . . 0.0 110.019 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 175.26 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -59.76 160.26 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.78 . . . . 0.0 109.634 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 13' ' ' SER . 2.1 m 79.93 -7.56 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.442 -0.786 . . . . 0.0 109.75 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.629 HG21 ' HB2' ' A' ' 10' ' ' ASP . 26.6 mm -96.89 -45.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -63.59 -30.96 72.0 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.468 ' O ' ' C ' ' A' ' 18' ' ' VAL . 5.7 t90 -67.28 -60.28 2.72 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 24.8 t -36.6 -57.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.165 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.585 ' C ' HD12 ' A' ' 23' ' ' LEU . 8.8 mt -55.73 -72.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 1.8 tt0 -35.14 -30.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.868 -0.52 . . . . 0.0 110.674 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -66.37 -55.16 17.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 108.437 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 -12.96 61.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD22 ' HB2' ' A' ' 30' ' ' CYS . 0.9 OUTLIER -92.9 -11.11 34.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.765 . . . . 0.0 109.754 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.69 -46.09 40.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.83 -41.97 52.32 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.49 79.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -1.003 . . . . 0.0 108.572 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.05 50.22 3.32 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.895 HD13 HG11 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -120.23 173.71 6.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 0.0 109.971 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 29' ' ' THR . 51.6 m -100.26 65.75 1.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 1.035 ' HB2' HD22 ' A' ' 23' ' ' LEU . 32.0 t -82.23 80.08 8.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.217 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.606 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 1.3 m -75.1 129.32 37.36 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -126.96 136.76 52.71 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.059 -1.026 . . . . 0.0 109.686 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.085 ' HB2' HG22 ' A' ' 39' ' ' VAL . 2.1 m-85 -110.72 -176.15 2.9 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 19.4 mt-10 -95.43 -47.57 6.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.935 . . . . 0.0 110.429 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.977 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.2 t-20 -116.15 144.7 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.064 -1.022 . . . . 0.0 109.949 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.514 ' CA ' HG21 ' A' ' 9' ' ' VAL . . . -54.14 -33.13 51.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 38' ' ' GLU . 11.4 t-20 -61.76 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.033 -1.275 . . . . 0.0 108.624 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.5 mm-40 -34.64 -35.28 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.348 0.594 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.085 HG22 ' HB2' ' A' ' 33' ' ' PHE . 75.0 t -55.33 -59.09 2.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.396 -0.815 . . . . 0.0 109.453 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.849 HD12 ' CB ' ' A' ' 72' ' ' ARG . 0.9 OUTLIER -67.66 -14.82 63.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.568 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -68.25 -30.91 70.06 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.8 -31.9 19.35 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.657 HD13 HG23 ' A' ' 47' ' ' THR . 89.9 mt -92.34 1.54 57.17 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.478 -0.764 . . . . 0.0 110.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.508 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -29.47 -38.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' LEU . 2.5 m -70.15 -55.73 8.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 108.746 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER 169.86 135.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.415 -0.803 . . . . 0.0 109.969 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.01 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -50.19 157.2 1.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 109.666 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.94 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.7 Cg_endo -88.13 -70.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.918 1.483 . . . . 0.0 110.058 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -109.32 -65.22 1.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 0.0 109.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.799 HG21 HG13 ' A' ' 115' ' ' VAL . 2.6 t -149.57 144.16 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.055 -1.028 . . . . 0.0 110.123 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 47' ' ' THR . 3.5 tp -100.54 155.16 18.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.894 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.106 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -145.43 169.45 18.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.677 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.748 ' OG ' HG23 ' A' ' 80' ' ' ILE . 27.4 p -154.56 139.7 17.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.69 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 25.4 m-20 -86.78 -172.25 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.294 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -120.67 5.54 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.12 -0.988 . . . . 0.0 109.689 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.3 OUTLIER -86.62 174.13 9.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.638 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.48 ' SD ' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 170.87 177.16 0.11 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.795 . . . . 0.0 109.176 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' SD ' ' A' ' 57' ' ' MET . 36.8 Cg_endo -98.32 120.33 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.953 1.502 . . . . 0.0 110.508 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.55 -144.89 23.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 12.2 mtt -88.56 -156.92 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' MET . 37.3 m-20 64.75 179.96 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.78 68.73 0.22 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HG ' ' HG3' ' A' ' 57' ' ' MET . 1.1 mp 61.64 92.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.611 ' C ' HD13 ' A' ' 65' ' ' LEU . . . -91.41 14.24 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.208 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.774 HD22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -100.9 14.26 32.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -0.846 . . . . 0.0 109.357 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.741 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -65.44 -65.0 0.73 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.4 ttpp -47.0 -26.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.573 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.03 -60.54 2.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -33.54 -57.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.283 0.563 . . . . 0.0 110.415 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HE2' ' CG2' ' A' ' 69' ' ' ILE . 7.0 mmtt -59.84 -61.05 2.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.258 -0.901 . . . . 0.0 109.847 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 70' ' ' LYS . 21.9 mm-40 -32.98 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.894 -0.504 . . . . 0.0 111.385 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.849 ' CB ' HD12 ' A' ' 40' ' ' LEU . 4.9 mpt_? -83.39 -91.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 110.801 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.769 ' NE2' HD22 ' A' ' 51' ' ' LEU . 3.0 p80 -68.49 151.95 96.92 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.388 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 33.8 Cg_endo -49.63 -178.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.638 1.336 . . . . 0.0 110.689 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.5 ptp -85.16 56.05 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.907 HD21 ' OG1' ' A' ' 47' ' ' THR . 0.6 OUTLIER -70.42 158.68 87.12 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.4 Cg_endo -44.61 136.98 8.88 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.501 1.263 . . . . 0.0 112.642 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.884 HG23 ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -145.24 177.99 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.547 ' O ' HD23 ' A' ' 52' ' ' LEU . 26.1 mt -158.67 119.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.216 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.748 HG23 ' OG ' ' A' ' 53' ' ' SER . 30.5 mt -108.6 128.53 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 108.818 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 54' ' ' ASP . 1.4 mtm -56.46 174.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -53.85 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 110.215 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 82' ' ' THR . . . 80.78 162.54 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -119.75 -21.55 7.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.421 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.7 m -123.57 18.22 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.74 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -96.73 -18.39 19.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.228 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.765 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.2 tt -35.15 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.897 -0.502 . . . . 0.0 110.935 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASP . 11.0 t70 -70.27 -57.79 4.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.862 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 66' ' ' LEU . . . -65.68 -16.07 63.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB1' ' OH ' ' A' ' 101' ' ' TYR . . . -83.12 -42.36 17.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 87' ' ' LEU . 46.4 t -35.85 -29.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.459 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ALA . 30.3 t -80.64 31.69 0.3 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.5 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.37 -53.6 2.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.912 -1.118 . . . . 0.0 108.624 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 10.7 m-30 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -0.894 . . . . 0.0 108.747 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 32.2 tp60 -86.81 91.77 8.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.782 . . . . 0.0 109.424 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 45.69 64.99 1.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.29 -179.29 15.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.35 38.08 1.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.952 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.884 ' CD1' HG23 ' A' ' 78' ' ' VAL . 6.6 p90 -162.2 133.4 5.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.04 -1.038 . . . . 0.0 109.874 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 100' ' ' ASP . 58.7 p30 -97.98 -159.29 0.73 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.41 -0.806 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.594 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 5.7 m-85 -100.66 139.02 36.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.23 120.02 52.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.026 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -95.29 -165.18 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.909 1.478 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -121.86 157.69 56.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.602 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -97.28 169.92 12.43 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.712 -2.62 . . . . 0.0 110.441 0.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 106' ' ' PHE . 20.8 p90 -149.21 138.1 21.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.549 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 16.3 t70 -79.41 171.47 15.13 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.92 . . . . 0.0 109.018 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -70.82 -56.14 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.014 -1.054 . . . . 0.0 109.014 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' HG22 ' A' ' 108' ' ' ILE . 23.5 t0 -68.7 -39.72 80.37 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.549 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 4.7 tp10 -48.42 -46.79 37.89 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -72.28 -74.06 0.17 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.895 HG11 HD13 ' A' ' 28' ' ' LEU . 32.3 t -36.73 -73.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.367 0.603 . . . . 0.0 109.749 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -38.11 -64.41 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.79 -0.569 . . . . 0.0 110.292 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 113' ' ' ALA . 8.2 tp -34.83 -55.28 0.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.785 0.802 . . . . 0.0 109.741 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.799 HG13 HG21 ' A' ' 50' ' ' VAL . 1.5 t -57.01 -57.37 10.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -32.99 -40.3 0.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.324 0.583 . . . . 0.0 110.403 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' VAL . 18.1 mtm180 -75.42 -52.59 10.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.327 -0.858 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.2 -60.83 2.21 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.117 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.772 ' CD1' HG23 ' A' ' 50' ' ' VAL . 3.4 mt -36.06 -41.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.395 0.617 . . . . 0.0 109.978 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 61.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -135.42 -65.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 2.9 p90 -99.07 95.4 7.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -117.1 0.79 12.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.284 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.961 0.886 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.692 ' HA3' HD21 ' A' ' 28' ' ' LEU . . . 147.65 171.75 17.03 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 10.6 mt -147.89 97.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.954 . . . . 0.0 108.84 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.878 ' CG2' HD12 ' A' ' 52' ' ' LEU . 2.6 p -100.2 118.64 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.658 0.742 . . . . 0.0 110.651 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.635 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 37.4 m0 -103.27 104.25 14.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.938 . . . . 0.0 108.825 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.791 HG22 ' CB ' ' A' ' 52' ' ' LEU . 59.1 t -97.57 147.74 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.913 ' HB ' HG21 ' A' ' 39' ' ' VAL . 9.8 p -123.9 129.45 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.698 ' CB ' HG21 ' A' ' 15' ' ' ILE . 13.9 t0 -135.51 -77.15 0.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.817 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 34' ' ' GLU . 64.8 t0 -148.33 -70.73 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.697 -1.252 . . . . 0.0 111.624 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.71 178.05 4.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.01 -1.056 . . . . 0.0 111.141 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -66.36 -24.73 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.641 -0.662 . . . . 0.0 109.832 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -62.54 -25.24 67.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.393 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.698 HG21 ' CB ' ' A' ' 10' ' ' ASP . 1.2 mp -66.59 -31.16 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 11.4 ttp180 -61.65 -49.13 77.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 13.2 t90 -48.73 -65.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 48.2 t -39.44 -70.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.048 0.928 . . . . 0.0 110.364 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -44.88 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.2 tt0 -32.73 -40.75 0.05 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.864 -0.522 . . . . 0.0 110.773 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 4.5 mtp180 -58.06 -57.19 13.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.977 . . . . 0.0 109.043 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 108' ' ' ILE . . . -68.29 -6.34 23.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 0.0 109.579 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -98.38 -12.53 21.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.79 51.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 -33.48 87.35 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 23' ' ' LEU . . . -73.47 -24.78 60.25 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.482 -1.01 . . . . 0.0 108.761 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.768 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 69.41 62.84 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.109 HD22 HG13 ' A' ' 112' ' ' VAL . 1.2 mp -142.25 -176.5 4.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.113 -1.228 . . . . 0.0 109.974 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.562 ' CG2' HG23 ' A' ' 5' ' ' ILE . 24.2 m -92.44 100.61 13.13 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 8.9 t -95.28 88.72 5.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.393 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.631 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 2.3 m -99.45 141.63 32.0 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.54 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -134.55 167.13 21.36 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.655 -1.278 . . . . 0.0 110.14 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.827 ' HB2' HG22 ' A' ' 39' ' ' VAL . 26.8 m-85 -140.15 171.74 13.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -105.15 -13.23 15.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.175 -0.953 . . . . 0.0 108.946 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.709 ' O ' HG23 ' A' ' 39' ' ' VAL . 55.6 m-20 -138.16 137.33 37.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.554 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.543 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -55.43 -49.72 63.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.644 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 13.9 t-20 -50.54 -69.41 0.11 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.187 -1.184 . . . . 0.0 108.727 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.681 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -36.06 -42.14 0.28 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.707 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.913 HG21 ' HB ' ' A' ' 9' ' ' VAL . 39.4 t -53.05 -53.43 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.205 -0.934 . . . . 0.0 108.934 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.04 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.8 mt -62.02 -28.57 69.67 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -61.19 -34.66 75.42 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . . . -68.93 -40.52 78.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -43.0 -65.35 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' N ' HD23 ' A' ' 43' ' ' LEU . . . 28.14 -73.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.916 0.865 . . . . 0.0 110.761 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.76 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -84.69 27.33 0.74 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 82.69 134.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.345 0.593 . . . . 0.0 110.193 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.595 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -64.59 -149.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.367 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HG3' ' CE2' ' A' ' 7' ' ' TRP . 38.0 Cg_endo -125.54 -83.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 117.298 -1.335 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.575 ' OD2' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -114.31 -50.78 2.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.298 -1.501 . . . . 0.0 111.814 -178.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.851 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.1 t -149.51 149.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.396 -1.44 . . . . 0.0 109.896 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.073 HD12 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.96 156.72 17.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 109.293 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.878 HD12 ' CG2' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -137.29 124.92 22.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.06 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.716 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -113.76 133.09 55.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.053 -1.029 . . . . 0.0 110.385 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.525 ' CB ' ' OD1' ' A' ' 10' ' ' ASP . 17.5 p-10 -80.0 -158.9 0.19 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.876 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.779 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -173.89 86.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.762 ' N ' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -168.38 -163.86 0.48 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.372 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.539 ' CE ' ' O ' ' A' ' 61' ' ' ASP . 2.1 mtm 72.59 131.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.626 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.38 106.6 1.55 Allowed 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.098 1.578 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.84 -130.87 8.24 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 1.3 mtt -110.14 -164.51 0.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.682 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.539 ' O ' ' CE ' ' A' ' 57' ' ' MET . 2.0 t70 80.39 -9.72 1.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.99 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.925 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -133.8 -48.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.925 HD23 ' C ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -105.88 -175.0 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.073 -1.251 . . . . 0.0 109.691 -179.251 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.62 21.96 9.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.035 -1.04 . . . . 0.0 108.304 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 69' ' ' ILE . 6.1 mt -125.27 -12.47 6.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.767 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.578 HD11 HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -61.1 -65.21 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.8 tptp -44.06 -37.53 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.861 ' HG3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -57.16 -52.35 65.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.029 -1.045 . . . . 0.0 108.678 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.944 HG23 HD13 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -35.2 -56.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.647 -0.658 . . . . 0.0 110.679 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.04 -53.89 13.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 110.443 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' LYS . 13.3 mm-40 -32.42 -44.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.755 -0.591 . . . . 0.0 110.815 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 1.04 ' HB2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -91.85 -44.84 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.073 ' CE1' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -47.89 159.4 0.47 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.294 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD2' HD23 ' A' ' 76' ' ' LEU . 36.9 Cg_endo -80.8 -66.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.078 1.567 . . . . 0.0 110.15 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.419 ' O ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -175.45 52.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.26 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 77' ' ' PRO . 1.1 pp -114.97 157.44 43.3 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 0.0 109.05 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 50' ' ' VAL . 37.4 Cg_endo -63.81 151.7 83.97 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.931 1.49 . . . . 0.0 111.203 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.037 HG12 ' CB ' ' A' ' 51' ' ' LEU . 2.9 m -142.87 97.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.808 HD11 ' CG2' ' A' ' 115' ' ' VAL . 8.4 mt -59.99 167.03 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 109.479 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.716 HD12 ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -161.93 133.79 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.098 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.502 ' N ' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -63.78 158.0 22.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.407 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -98.0 151.65 20.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.411 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -173.46 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -178.49 65.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.683 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 p -173.67 -36.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.588 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.1 m-20 -57.17 -31.07 65.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 109.683 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -34.89 -28.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.752 -0.593 . . . . 0.0 111.437 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -93.46 -52.84 4.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.883 -1.136 . . . . 0.0 110.776 -178.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -1.69 10.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.938 -1.101 . . . . 0.0 110.484 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -107.09 -75.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 109.182 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 71.1 t -34.42 -32.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.279 0.561 . . . . 0.0 110.393 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -108.57 -149.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.66 -95.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -128.67 70.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 2.3 tm0? -60.46 -21.59 62.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -0.82 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -69.81 -165.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.56 99.33 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.506 ' C ' ' CD2' ' A' ' 99' ' ' PHE . . . -146.45 -43.51 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.276 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CD2' HG23 ' A' ' 78' ' ' VAL . 16.1 p90 172.96 137.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.446 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -104.11 -161.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -0.808 . . . . 0.0 109.294 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -104.95 149.67 25.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 106' ' ' PHE . 13.3 mt -112.41 116.21 48.8 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.944 . . . . 0.0 109.356 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 36.5 Cg_endo -93.99 148.81 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.651 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 34.3 mtmt -101.88 149.84 36.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.07 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -78.4 140.52 60.72 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.749 -2.605 . . . . 0.0 110.439 -0.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 78.0 t80 -116.14 171.51 7.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.861 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 1.1 t70 -102.25 113.4 26.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.537 -0.727 . . . . 0.0 109.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.714 HG21 ' HB1' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -55.0 -30.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.96 -1.087 . . . . 0.0 109.335 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.98 -45.19 28.36 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 108.702 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 34.8 tt0 -50.89 -34.23 27.39 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -76.51 -72.99 0.3 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.651 -0.655 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.109 HG13 HD22 ' A' ' 28' ' ' LEU . 7.0 t -35.27 -45.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.446 -0.784 . . . . 0.0 110.61 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -73.05 -72.94 0.22 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.73 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -34.69 -57.15 0.53 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.521 0.676 . . . . 0.0 109.536 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.808 ' CG2' HD11 ' A' ' 79' ' ' ILE . 1.2 t -49.78 -58.49 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.659 ' N ' HG12 ' A' ' 115' ' ' VAL . 21.1 tp10 -35.71 -41.11 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.739 -0.601 . . . . 0.0 111.092 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 114' ' ' LEU . 4.3 ptm180 -82.47 -36.78 26.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.109 -0.994 . . . . 0.0 110.207 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.38 -62.67 1.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.87 -1.144 . . . . 0.0 108.308 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 50' ' ' VAL . 10.6 mt -33.71 -39.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.98 -0.45 . . . . 0.0 110.626 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.615 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 11.7 t -5.01 -69.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.254 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 120' ' ' SER . 6.6 m170 142.3 56.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 36.01 32.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.537 0.684 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-30 -69.43 -9.36 53.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.51 -0.744 . . . . 0.0 109.804 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 8.7 mt-10 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.626 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.187 0.517 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.489 ' HA2' ' OD2' ' A' ' 49' ' ' ASP . . . -165.62 119.52 0.87 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.598 HG23 HG21 ' A' ' 29' ' ' THR . 59.0 mt -104.89 91.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.306 -1.114 . . . . 0.0 109.884 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 p -105.87 125.63 61.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.89 ' CZ2' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.73 90.01 4.09 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.808 -1.183 . . . . 0.0 109.433 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.782 HG22 HD12 ' A' ' 52' ' ' LEU . 86.1 t -79.88 113.56 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.791 HG21 ' HA2' ' A' ' 36' ' ' GLY . 7.5 p -88.82 98.29 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.213 -0.929 . . . . 0.0 109.571 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 1.046 ' HB3' HG21 ' A' ' 15' ' ' ILE . 23.0 t0 -156.61 133.21 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.627 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.56 ' HB3' ' CG1' ' A' ' 15' ' ' ILE . 2.0 t0 7.43 68.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.285 0.564 . . . . 0.0 111.804 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.4 p-10 -46.46 177.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.552 -0.718 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 3.1 t 82.86 -68.49 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -98.18 -40.0 8.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.101 -1.0 . . . . 0.0 108.951 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 1.046 HG21 ' HB3' ' A' ' 10' ' ' ASP . 20.0 mm -68.34 -36.3 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 22.9 ttp85 -60.93 -42.38 98.06 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.483 ' O ' ' C ' ' A' ' 18' ' ' VAL . 11.5 t90 -60.29 -62.03 2.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 31.1 t -37.9 -68.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 109.678 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -56.15 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.632 -0.667 . . . . 0.0 110.442 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.543 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 2.1 tt0 -36.05 -64.31 0.32 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.489 -0.757 . . . . 0.0 111.983 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -39.78 -43.53 1.44 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -178.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . -71.5 -39.69 70.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.695 -1.253 . . . . 0.0 108.548 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD11 ' CG2' ' A' ' 112' ' ' VAL . 1.3 tp -69.73 -6.13 29.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.36 -33.96 42.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.0 109.038 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.87 -27.85 73.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.83 1.52 56.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -1.108 . . . . 0.0 109.229 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.95 72.22 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.751 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -133.92 -179.84 5.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.116 -1.226 . . . . 0.0 110.008 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.598 HG21 HG23 ' A' ' 5' ' ' ILE . 29.2 m -102.1 84.49 2.51 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.2 t -93.11 90.83 7.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.482 -0.761 . . . . 0.0 110.644 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.89 HG21 ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -97.39 138.66 34.5 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 1.7 p -146.43 134.53 21.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.737 -1.227 . . . . 0.0 110.696 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.962 ' HB2' HG23 ' A' ' 39' ' ' VAL . 7.0 m-30 -108.53 -158.9 0.67 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.526 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 6.7 pt-20 -121.83 -32.88 3.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.607 -1.308 . . . . 0.0 109.592 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.568 ' C ' HG21 ' A' ' 9' ' ' VAL . 70.3 m-80 -116.44 123.32 47.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.863 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.8 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -41.37 -36.47 1.45 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -62.62 -61.2 2.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 0.0 108.488 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.2 tp10 -35.55 -50.95 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.496 0.665 . . . . 0.0 109.876 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.076 HG12 HD13 ' A' ' 40' ' ' LEU . 2.1 t -63.58 -44.82 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.792 . . . . 0.0 108.907 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.076 HD13 HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -78.8 4.33 14.22 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 109.476 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.55 -23.25 13.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.78 -33.03 11.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.131 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.83 HD12 ' CG2' ' A' ' 47' ' ' THR . 3.2 mm? -65.13 -12.34 49.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.152 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.46 -31.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.518 -0.738 . . . . 0.0 110.186 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -73.91 -55.98 5.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.616 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -174.33 152.89 1.85 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.135 -0.978 . . . . 0.0 109.671 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.83 ' CG2' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -95.65 171.04 6.86 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.251 -0.905 . . . . 0.0 108.92 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.9 Cg_endo -119.68 -67.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 117.211 -1.392 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.708 ' C ' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -122.68 -78.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.403 -1.436 . . . . 0.0 111.741 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.807 HG23 ' CD1' ' A' ' 119' ' ' ILE . 4.0 t -138.96 141.31 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.941 -1.1 . . . . 0.0 110.537 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.936 HD11 HG11 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -106.24 135.99 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 110.273 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.049 HD22 ' CG2' ' A' ' 79' ' ' ILE . 5.9 mt -115.99 152.77 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 0.0 109.634 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.732 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.5 t -114.77 125.95 54.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.656 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.61 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 28.1 p30 -64.52 -166.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.01 HG12 ' HB3' ' A' ' 83' ' ' ALA . 1.9 tt -178.89 33.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -130.41 6.9 4.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.678 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.926 ' HG3' HD13 ' A' ' 63' ' ' LEU . 56.8 mmm -42.97 117.39 2.19 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -55.04 145.91 61.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.89 1.469 . . . . 0.0 110.231 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.15 101.42 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 60.56 49.58 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -1.164 . . . . 0.0 109.248 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 57' ' ' MET . 11.1 p-10 -52.64 144.76 13.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.773 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 155.79 -81.81 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.926 HD13 ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER 42.95 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -1.125 . . . . 0.0 109.889 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -58.76 -74.36 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 108.52 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.822 HD21 HD23 ' A' ' 63' ' ' LEU . 11.6 mt 76.48 -10.29 1.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 53' ' ' SER . 4.0 mm? -74.92 -39.81 61.2 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.848 -1.157 . . . . 0.0 108.827 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -64.97 -27.86 69.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.86 ' CG ' HD23 ' A' ' 40' ' ' LEU . 22.2 tp60 -65.26 -62.35 1.59 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.607 ' CG1' HD11 ' A' ' 40' ' ' LEU . 17.4 mt -35.79 -76.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.557 -0.714 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -43.02 -61.23 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.972 -1.08 . . . . 0.0 109.384 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.0 mt-30 -36.56 -42.1 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.505 -0.747 . . . . 0.0 111.705 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -131.89 42.12 3.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.83 -1.169 . . . . 0.0 111.289 -177.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.63 ' NE2' ' HB2' ' A' ' 43' ' ' LEU . 54.6 m80 -147.9 154.16 43.19 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.817 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 75' ' ' MET . 35.8 Cg_endo -60.9 -5.71 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.806 1.424 . . . . 0.0 112.092 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 74' ' ' PRO . 8.2 mtp 80.02 104.86 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.026 -1.046 . . . . 0.0 110.204 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.65 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -146.24 156.13 50.26 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 31.3 Cg_endo -43.04 130.48 5.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 117.203 -1.398 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.411 HG11 HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -123.32 178.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.049 ' CG2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -149.85 171.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 79' ' ' ILE . 2.7 tt -160.67 137.81 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.59 ' O ' HD13 ' A' ' 55' ' ' ILE . 7.9 mtt -85.91 135.05 33.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.047 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -72.52 149.81 43.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.013 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . 166.32 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 109.722 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 69.46 158.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 109.975 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 58.2 m 58.64 84.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 109.759 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' HD11 ' A' ' 55' ' ' ILE . 2.3 p-10 165.89 -43.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.59 HD23 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -35.03 -29.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.869 -0.52 . . . . 0.0 111.139 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.6 t0 -67.35 -65.0 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.046 -1.034 . . . . 0.0 110.194 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.67 -10.91 9.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.078 -1.014 . . . . 0.0 110.291 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -97.28 -76.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.006 -1.059 . . . . 0.0 109.765 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG2' HD23 ' A' ' 87' ' ' LEU . 51.0 t -34.1 -30.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.834 -0.541 . . . . 0.0 110.961 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.69 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -106.34 171.49 7.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.872 -1.142 . . . . 0.0 109.992 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 77.18 56.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER 60.04 47.43 9.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 1.7 pt20 -43.31 -34.42 1.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.7 72.54 0.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.4 -69.0 0.03 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . -139.38 59.81 1.59 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.25 . . . . 0.0 110.06 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.52 167.23 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.087 -1.008 . . . . 0.0 109.255 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 4.0 t0 -134.66 -30.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 73.62 105.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.95 -1.094 . . . . 0.0 108.506 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -116.95 118.77 35.92 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.043 -1.036 . . . . 0.0 110.25 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -105.97 149.0 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.046 1.551 . . . . 0.0 109.884 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -91.41 147.95 36.51 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 0.0 109.516 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -89.92 155.9 31.1 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 120.536 -2.693 . . . . 0.0 110.396 0.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 17.2 p90 -131.14 169.22 16.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 109.357 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 1.3 t70 -85.72 168.02 14.74 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.131 -0.981 . . . . 0.0 108.7 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 23' ' ' LEU . 31.6 mm -95.15 -61.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.91 -1.119 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 110' ' ' GLU . 63.1 t0 -54.97 -50.06 69.86 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.057 -1.027 . . . . 0.0 108.934 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 21.7 tp10 -44.13 -47.57 9.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -62.46 -67.74 0.39 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.066 ' CG2' HD11 ' A' ' 23' ' ' LEU . 48.1 t -35.4 -73.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.15 0.5 . . . . 0.0 110.584 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -39.12 -66.53 0.28 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.539 -0.725 . . . . 0.0 110.492 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.78 HD13 ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -34.8 -53.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.809 0.814 . . . . 0.0 109.663 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 114' ' ' LEU . 1.6 t -56.6 -60.81 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG12 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -37.82 -43.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.652 -0.655 . . . . 0.0 111.141 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 5.7 ptp180 -77.1 -36.66 55.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 110.594 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.588 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.71 -67.17 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.862 -1.149 . . . . 0.0 108.089 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.807 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.6 mt -37.07 -41.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.237 0.541 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.23 60.74 4.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -128.92 -54.47 1.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 22.7 p90 -78.35 136.45 37.69 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.85 -30.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.397 179.889 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.629 0.728 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 5' ' ' ILE . . . 149.45 177.38 23.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -153.25 90.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -1.102 . . . . 0.0 108.821 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.882 HG12 HG23 ' A' ' 8' ' ' VAL . 4.1 t -94.85 110.5 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.587 -0.696 . . . . 0.0 110.044 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.753 ' O ' HD23 ' A' ' 51' ' ' LEU . 12.0 m0 -99.94 81.05 2.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.009 HG22 ' CB ' ' A' ' 52' ' ' LEU . 43.8 t -83.91 172.34 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.347 0.594 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.971 ' HB ' HG21 ' A' ' 39' ' ' VAL . 7.0 p -134.09 140.78 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 108.7 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.887 ' HB3' HG21 ' A' ' 15' ' ' ILE . 4.6 t0 -136.71 -153.39 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.965 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD1' ' HB3' ' A' ' 57' ' ' MET . 13.6 t70 -80.6 -95.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' SER . 2.5 p-10 169.4 176.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 109.931 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 80.7 69.48 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.652 -0.655 . . . . 0.0 109.882 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.72 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.88 46.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.887 HG21 ' HB3' ' A' ' 10' ' ' ASP . 1.2 mp -112.05 -44.34 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 14.7 ttp180 -65.72 -33.06 75.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.65 -66.29 0.57 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 17' ' ' TRP . 38.3 t -39.62 -65.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.012 0.91 . . . . 0.0 110.241 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 23' ' ' LEU . 21.2 mt -55.08 -76.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.88 -0.512 . . . . 0.0 110.845 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 3.6 tm-20 -33.62 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.573 -0.704 . . . . 0.0 110.922 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 22.1 tpt180 -64.89 -56.3 14.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.982 -1.074 . . . . 0.0 108.486 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 108' ' ' ILE . . . -72.46 -2.32 19.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD22 ' CB ' ' A' ' 30' ' ' CYS . 9.7 mt -100.23 -17.37 17.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.12 -38.73 35.4 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.47 -40.3 91.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.94 -35.88 67.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.346 -1.09 . . . . 0.0 108.472 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 28' ' ' LEU . . . 101.63 42.79 2.25 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.664 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.852 HD22 ' CG1' ' A' ' 112' ' ' VAL . 1.1 mt -141.85 165.62 26.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.878 -1.366 . . . . 0.0 110.06 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 5' ' ' ILE . 98.5 m -98.19 75.46 2.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.786 ' CB ' HD22 ' A' ' 23' ' ' LEU . 16.1 t -90.83 86.59 6.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.416 -0.803 . . . . 0.0 109.582 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -82.89 140.28 32.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.392 -0.818 . . . . 0.0 109.038 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -132.32 125.48 31.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.705 ' CD2' HG22 ' A' ' 39' ' ' VAL . 65.4 m-85 -88.32 -177.65 5.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.116 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -108.87 2.29 21.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.88 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -144.45 142.04 30.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 109.792 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.728 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -69.93 -60.72 4.73 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.447 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -45.84 -69.38 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.382 -1.069 . . . . 0.0 108.344 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.635 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.8 tp10 -35.58 -49.22 0.55 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 0.0 110.912 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.971 HG21 ' HB ' ' A' ' 9' ' ' VAL . 65.2 t -45.22 -53.1 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.188 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.926 HD21 ' CA ' ' A' ' 69' ' ' ILE . 5.1 mp -60.59 -36.96 79.82 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -49.71 -33.55 16.29 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.69 -22.75 19.24 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.01 HD21 ' HB ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -71.35 -1.23 12.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.891 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.1 65.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -100.06 26.48 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HE3' ' CG ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 63.21 136.53 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.573 -0.704 . . . . 0.0 110.139 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.01 ' HB ' HD21 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -76.8 -169.5 0.19 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.696 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HB2' HD12 ' A' ' 5' ' ' ILE . 37.0 Cg_endo -97.76 -75.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.808 1.425 . . . . 0.0 110.171 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 9.1 m-20 -101.62 -63.3 1.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.797 -1.189 . . . . 0.0 110.269 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.611 HG23 HD13 ' A' ' 119' ' ' ILE . 2.1 t -148.58 152.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.415 -1.428 . . . . 0.0 111.296 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 7' ' ' TRP . 3.2 mt -102.03 131.16 48.64 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.009 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.81 164.07 21.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 109.818 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' A' ' 9' ' ' VAL . 28.8 p -161.71 133.51 5.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.261 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.627 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.95 -177.0 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.128 -0.982 . . . . 0.0 109.911 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.939 HG22 ' HB2' ' A' ' 64' ' ' ALA . 1.1 pp -117.9 137.33 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.741 ' H ' HD21 ' A' ' 63' ' ' LEU . 4.5 mtt180 -155.82 -73.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.215 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.868 ' HG2' HD22 ' A' ' 63' ' ' LEU . 4.3 ptt? -55.72 134.92 72.07 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.089 -1.007 . . . . 0.0 109.884 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -114.83 71.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.748 1.394 . . . . 0.0 110.308 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.12 -94.86 1.38 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.06 -50.47 66.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.204 . . . . 0.0 109.074 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.02 179.62 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.199 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.753 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -87.65 45.24 3.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.868 HD22 ' HG2' ' A' ' 57' ' ' MET . 0.3 OUTLIER 33.7 -111.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.015 -0.697 . . . . 0.0 109.993 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.939 ' HB2' HG22 ' A' ' 55' ' ' ILE . . . 40.59 58.53 2.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.01 -1.056 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 37' ' ' ASN . 3.6 mp -80.04 73.48 6.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 110.28 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.764 HD22 ' CG2' ' A' ' 80' ' ' ILE . 10.0 tp -87.61 -53.47 4.77 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HD2' ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -54.44 -23.57 16.5 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.922 ' OE1' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -79.23 -56.92 4.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.926 ' CA ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.13 -42.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.498 0.666 . . . . 0.0 109.944 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -82.74 -56.98 3.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.54 -0.725 . . . . 0.0 109.286 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 70' ' ' LYS . 15.1 tt0 -33.99 -31.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.775 -0.578 . . . . 0.0 111.299 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.67 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.09 -78.58 0.58 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.863 -1.148 . . . . 0.0 110.898 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.663 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 1.6 p80 -66.75 144.57 98.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.612 -1.305 . . . . 0.0 109.392 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.663 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 36.2 Cg_endo -35.52 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 124.066 1.561 . . . . 0.0 111.525 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.485 ' CG ' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -178.33 100.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.753 -1.217 . . . . 0.0 110.459 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.874 HD22 HG22 ' A' ' 47' ' ' THR . 3.4 pp -120.67 156.48 55.98 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.705 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.5 Cg_endo -41.87 129.9 4.14 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 117.563 -1.158 . . . . 0.0 111.184 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.921 HG23 ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -137.9 161.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.39 -0.819 . . . . 0.0 109.254 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.781 HD13 ' O ' ' A' ' 78' ' ' VAL . 3.7 mm -142.84 147.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.764 ' CG2' HD22 ' A' ' 66' ' ' LEU . 7.1 tt -136.4 141.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.831 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.563 ' SD ' ' CE1' ' A' ' 106' ' ' PHE . 5.1 ttm -88.5 98.26 11.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.318 -0.863 . . . . 0.0 109.045 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -59.29 149.87 27.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 109.675 -179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.87 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . 179.28 60.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.324 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 79.26 143.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 109.496 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 45.2 p 53.65 171.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.265 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 85' ' ' SER . 5.5 m-20 84.43 -54.61 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.971 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -34.82 -30.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 110.8 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.3 p30 -64.16 -97.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.026 -1.046 . . . . 0.0 110.141 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -43.39 -40.35 3.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.969 -1.082 . . . . 0.0 109.903 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -51.07 -50.58 58.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 87' ' ' LEU . 3.3 t -32.6 -36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.222 0.534 . . . . 0.0 110.187 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.4 t -90.87 44.45 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.81 . . . . 0.0 109.465 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ALA . . . -132.31 -65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 109.19 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . 41.3 p90 -90.71 28.42 1.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.148 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.64 -42.69 99.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -86.87 -55.09 4.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.483 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.727 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 165.91 -164.3 37.33 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 81.73 22.27 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.599 -0.942 . . . . 0.0 109.688 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.921 ' CE2' HG23 ' A' ' 78' ' ' VAL . 89.4 m-85 -140.51 157.1 46.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.557 ' OD2' HD11 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -114.52 -29.91 6.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 70.93 99.6 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 0.0 109.329 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.58 HD12 ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -110.27 119.76 46.09 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.892 . . . . 0.0 109.654 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -108.45 12.74 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.45 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 64.71 159.25 0.12 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -76.14 172.6 62.33 Favored 'Cis proline' 0 C--N 1.314 -1.238 0 C-N-CA 120.664 -2.64 . . . . 0.0 110.336 -0.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.563 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 40.8 p90 -157.06 144.05 18.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 8.7 t70 -85.63 174.75 9.19 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -82.88 -48.69 17.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.778 -1.201 . . . . 0.0 109.864 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 108' ' ' ILE . 22.9 t0 -73.38 -47.37 42.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.006 -1.059 . . . . 0.0 108.15 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 tp10 -49.24 -38.02 25.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.3 -72.94 0.18 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.228 -0.92 . . . . 0.0 108.672 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.852 ' CG1' HD22 ' A' ' 28' ' ' LEU . 77.9 t -38.45 -74.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 121.513 0.673 . . . . 0.0 110.323 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.96 -62.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.714 . . . . 0.0 110.355 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -33.19 -54.65 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.432 0.634 . . . . 0.0 110.003 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.742 ' N ' HD13 ' A' ' 114' ' ' LEU . 75.2 t -60.05 -55.69 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 3.5 pt-20 -34.24 -44.85 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.905 -0.497 . . . . 0.0 111.411 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -59.77 -47.46 85.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.127 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.41 -55.29 25.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.737 -1.227 . . . . 0.0 107.953 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.611 HD13 HG23 ' A' ' 50' ' ' VAL . 3.3 mt -36.47 -34.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.943 -0.473 . . . . 0.0 109.796 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.674 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 6.8 p -22.85 -45.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.674 ' CB ' ' O ' ' A' ' 120' ' ' SER . 28.8 t60 117.65 62.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER 32.04 39.28 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.473 0.654 . . . . 0.0 109.94 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -40.16 -30.93 0.11 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.231 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.411 ' OXT' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.546 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 -168.49 38.07 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.387 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.731 HG22 ' HE1' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -149.84 93.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.601 -0.941 . . . . 0.0 109.363 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.958 HG23 HG12 ' A' ' 50' ' ' VAL . 3.6 p -100.4 118.95 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.553 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.946 ' CE3' HG21 ' A' ' 31' ' ' THR . 11.7 m95 -103.06 102.58 12.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.96 -1.087 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.801 HG22 ' CG ' ' A' ' 52' ' ' LEU . 59.7 t -98.99 146.91 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.028 ' CG1' HG21 ' A' ' 39' ' ' VAL . 1.6 m -104.49 129.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 O-C-N 121.063 -1.023 . . . . 0.0 108.554 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.91 ' CB ' HG21 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -112.44 -99.21 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.343 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' GLU . 12.3 t0 -153.12 -49.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.679 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -144.0 -179.69 6.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.9 -1.125 . . . . 0.0 110.459 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -65.96 169.29 6.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 109.666 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.1 OUTLIER 78.08 -6.77 1.91 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.91 HG21 ' CB ' ' A' ' 10' ' ' ASP . 1.8 mp -96.91 -29.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -65.08 -36.75 85.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 54.4 t90 -61.9 -63.64 1.19 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 20.2 t -36.97 -65.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.527 0.68 . . . . 0.0 110.731 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' CD2' ' CD1' ' A' ' 108' ' ' ILE . 0.7 OUTLIER -50.77 -70.88 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.792 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -35.4 -35.4 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.0 110.77 -179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.15 -54.19 47.59 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -66.53 -19.15 65.71 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.251 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -87.21 -10.29 52.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.167 -0.958 . . . . 0.0 109.543 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.45 71.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.07 -34.46 66.25 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.16 45.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.466 -1.02 . . . . 0.0 109.143 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.37 49.58 14.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.064 HD22 ' CG1' ' A' ' 112' ' ' VAL . 0.9 OUTLIER -128.52 177.89 6.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.106 -1.232 . . . . 0.0 110.267 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.608 ' HB ' HG23 ' A' ' 5' ' ' ILE . 7.2 m -95.26 93.35 7.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.746 ' HB2' HD22 ' A' ' 23' ' ' LEU . 34.2 t -86.45 80.75 8.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.946 HG21 ' CE3' ' A' ' 7' ' ' TRP . 3.3 m -84.22 141.17 31.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -143.73 164.51 30.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.678 -1.264 . . . . 0.0 110.038 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.874 ' HB2' HG22 ' A' ' 39' ' ' VAL . 13.5 m-85 -131.13 -171.67 2.64 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.6 pt-20 -107.02 -23.97 12.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.964 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.854 ' O ' HG23 ' A' ' 39' ' ' VAL . 51.0 m-20 -140.25 147.04 39.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.927 -1.108 . . . . 0.0 109.884 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 64' ' ' ALA . . . -55.67 -31.15 57.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.57 -76.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -1.152 . . . . 0.0 108.005 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.591 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -33.83 -33.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.373 0.606 . . . . 0.0 109.753 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.028 HG21 ' CG1' ' A' ' 9' ' ' VAL . 63.1 t -60.84 -59.11 4.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 121.381 -0.824 . . . . 0.0 109.203 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.984 HD12 ' N ' ' A' ' 41' ' ' ALA . 1.6 pp -62.08 -17.46 57.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.572 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.984 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -68.01 -35.95 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.36 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.764 HD21 HD11 ' A' ' 51' ' ' LEU . 3.9 mm? -66.31 -7.82 21.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.75 60.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.5 m -100.25 26.78 6.19 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.1 mptt 71.88 139.5 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.631 0.729 . . . . 0.0 110.263 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.95 ' CG2' HD22 ' A' ' 76' ' ' LEU . 2.6 t -71.25 -177.0 0.42 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.585 -0.697 . . . . 0.0 109.496 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HB2' HD12 ' A' ' 5' ' ' ILE . 36.5 Cg_endo -114.94 -67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.799 1.42 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.665 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -121.27 -53.5 2.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.846 -1.159 . . . . 0.0 110.527 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.958 HG12 HG23 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.12 129.08 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.552 -1.342 . . . . 0.0 110.206 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.963 HD22 ' NE2' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.59 128.88 46.5 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.585 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.89 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 3.3 pp -141.39 165.84 26.4 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.753 -1.217 . . . . 0.0 110.008 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.604 ' N ' HD12 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -133.99 151.08 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' SD ' ' A' ' 81' ' ' MET . 4.4 t70 -115.91 129.4 56.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.8 144.89 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.62 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -179.3 -65.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.419 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -45.5 151.89 0.72 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.613 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -99.84 163.6 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.055 1.555 . . . . 0.0 110.207 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.86 -167.47 22.75 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.1 mmt -64.17 -32.61 74.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -1.079 . . . . 0.0 109.585 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.04 92.44 3.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.95 -45.27 7.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.97 HD11 HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -50.54 -83.12 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.136 -1.214 . . . . 0.0 109.402 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' A' ' 9' ' ' VAL . . . 168.67 35.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER 57.56 62.33 2.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 80' ' ' ILE . 15.9 tp -75.35 -13.22 60.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.997 . . . . 0.0 108.891 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -78.08 -38.95 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.592 ' HG3' HD23 ' A' ' 40' ' ' LEU . 2.1 pt20 -76.74 -52.67 9.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.065 -1.022 . . . . 0.0 108.51 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.69 HG21 HD12 ' A' ' 66' ' ' LEU . 2.9 tt -37.58 -34.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.812 0.815 . . . . 0.0 109.313 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 7.5 tptp -78.03 -54.52 6.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.98 -46.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.543 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 1.4 tpt85 -87.59 -43.44 11.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.192 -0.942 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.963 ' NE2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -40.45 162.65 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.437 -0.789 . . . . 0.0 110.341 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD2' HD23 ' A' ' 76' ' ' LEU . 37.0 Cg_endo -117.71 42.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 124.03 1.542 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.4 mtt 66.03 82.83 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 0.0 110.579 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.95 HD22 ' CG2' ' A' ' 47' ' ' THR . 1.0 OUTLIER -147.82 151.23 38.15 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.082 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 50' ' ' VAL . 36.8 Cg_endo -37.59 126.77 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.61 1.321 . . . . 0.0 111.691 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 99' ' ' PHE . 84.1 t -117.91 100.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.589 -0.694 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.89 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 1.7 mt -75.7 157.54 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 108.739 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.97 HD11 HD11 ' A' ' 63' ' ' LEU . 7.3 tt -154.15 123.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.028 -1.045 . . . . 0.0 110.569 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.516 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 15.9 mtt -97.89 99.76 11.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 58.13 161.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . . . -172.95 -175.36 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.961 -1.087 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.537 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.5 t-80 -167.49 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.934 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.537 ' C ' ' O ' ' A' ' 84' ' ' HIS . 21.7 m 40.26 31.83 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 88' ' ' ASP . 3.1 m-20 63.43 126.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 91' ' ' VAL . 3.8 tp -35.83 -31.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -38.02 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.485 0.659 . . . . 0.0 109.584 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.497 ' HB3' ' CB ' ' A' ' 85' ' ' SER . . . -47.59 -32.14 5.18 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -69.36 -87.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.329 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.869 HG23 ' HG ' ' A' ' 87' ' ' LEU . 91.2 t -33.18 -59.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.719 -0.613 . . . . 0.0 111.398 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -55.84 -99.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.356 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 48.4 -105.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.872 -1.143 . . . . 0.0 108.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -141.82 60.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 0.0 108.791 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 8.1 mm-40 -57.31 174.23 0.21 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.605 -0.685 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 27.7 mt-30 64.12 50.42 2.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.98 -120.22 0.54 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.68 89.0 2.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -1.187 . . . . 0.0 109.474 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.58 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 5.5 m-85 -133.39 136.46 45.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 0.0 109.696 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -120.06 -167.86 1.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.047 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.509 ' OH ' ' HB3' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -166.2 94.93 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.735 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.7 OUTLIER -120.64 151.67 54.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.149 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 36.8 Cg_endo -119.36 -173.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.709 1.373 . . . . 0.0 110.594 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HG2' ' CD1' ' A' ' 106' ' ' PHE . 1.2 mtmm -91.27 159.25 39.77 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.335 -0.853 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -87.33 169.76 39.54 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 120.274 -2.803 . . . . 0.0 110.308 0.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.516 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 52.6 p90 -161.97 150.05 14.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . 6.1 t0 -80.19 117.99 21.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.197 -0.94 . . . . 0.0 108.584 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.547 HG21 ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -41.77 -41.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.215 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 108' ' ' ILE . 25.8 t70 -74.48 -38.85 62.79 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.51 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 8.1 tm-20 -51.33 -38.11 51.32 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -81.94 -69.7 0.6 Allowed 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.064 ' CG1' HD22 ' A' ' 28' ' ' LEU . 24.4 t -37.31 -35.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.499 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -78.61 -66.67 0.83 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.982 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.776 HD13 ' C ' ' A' ' 114' ' ' LEU . 3.0 tm? -35.47 -51.72 0.63 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.506 0.67 . . . . 0.0 109.843 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.858 HG21 ' CG1' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -70.45 -51.47 37.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 108.948 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 9.0 tm-20 -33.35 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.523 0.677 . . . . 0.0 109.933 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' VAL . 5.1 mtm180 -76.51 -57.27 3.96 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.62 -54.37 9.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -0.973 . . . . 0.0 109.065 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.691 HG23 ' HG3' ' A' ' 77' ' ' PRO . 6.2 mt -39.77 -44.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 110.793 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -86.34 -22.6 26.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 120' ' ' SER . 63.1 t60 -37.94 -55.5 1.22 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.427 -0.796 . . . . 0.0 110.649 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.631 ' O ' ' CG ' ' A' ' 122' ' ' TYR . 3.9 p90 -91.05 48.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -73.26 -28.65 62.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.796 -1.19 . . . . 0.0 109.296 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 7.5 tpp180 . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 1.047 ' HA3' HD22 ' A' ' 28' ' ' LEU . . . -167.21 50.11 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 48' ' ' PRO . 3.6 mt -76.64 91.55 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.088 -1.242 . . . . 0.0 107.977 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.718 ' CG2' HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -100.78 123.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.433 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.708 ' CE3' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.1 87.91 4.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.018 HG22 ' HB2' ' A' ' 52' ' ' LEU . 29.9 t -84.95 146.06 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.877 . . . . 0.0 110.545 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' LEU . 8.9 t -91.64 153.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.875 ' CG ' HG21 ' A' ' 15' ' ' ILE . 9.5 t0 -179.31 -124.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.961 -1.087 . . . . 0.0 110.003 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.514 ' CA ' ' HA ' ' A' ' 34' ' ' GLU . 1.4 t70 -128.22 -8.45 5.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.602 -1.311 . . . . 0.0 110.547 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.575 ' HB2' ' N ' ' A' ' 34' ' ' GLU . 2.1 t70 48.87 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 70.01 13.44 7.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.3 p 161.62 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.875 HG21 ' CG ' ' A' ' 10' ' ' ASP . 33.0 mm -82.27 -38.34 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 108.958 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 32' ' ' THR . 12.2 ttp85 -65.67 -35.13 79.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -66.4 -62.63 1.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 14' ' ' SER . 53.4 t -40.32 -64.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.906 ' CD2' HD11 ' A' ' 108' ' ' ILE . 2.8 mt -60.24 -75.58 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.68 -0.637 . . . . 0.0 110.944 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 18.8 tt0 -34.88 -31.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.736 -0.602 . . . . 0.0 110.612 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -67.07 -56.4 10.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -13.04 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.821 HD12 ' HB2' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -82.39 -27.17 32.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.42 73.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.42 -0.8 . . . . 0.0 109.185 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.72 -27.06 39.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.73 -16.97 60.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -1.07 . . . . 0.0 109.233 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.697 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 72.98 38.11 56.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.047 HD22 ' HA3' ' A' ' 4' ' ' GLY . 78.2 mt -137.71 163.3 31.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.942 -1.328 . . . . 0.0 109.887 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 29' ' ' THR . 21.1 m -104.8 79.8 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.489 -0.757 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.672 ' HA ' HG12 ' A' ' 6' ' ' VAL . 44.3 t -80.96 80.44 7.44 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.004 -1.06 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.1 m -77.45 129.74 36.12 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.7 p -124.29 133.95 53.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.635 -1.291 . . . . 0.0 110.499 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.008 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.2 m-30 -106.56 145.54 31.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.575 ' N ' ' HB2' ' A' ' 12' ' ' ASP . 1.2 pt-20 -63.03 -8.22 6.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 110.192 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -154.81 138.44 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.787 -1.195 . . . . 0.0 110.399 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.696 ' H ' HD13 ' A' ' 65' ' ' LEU . . . -56.34 -26.16 50.33 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' GLU . 33.9 t-20 -56.28 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.261 -1.14 . . . . 0.0 108.052 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.3 mm-40 -36.14 -46.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 110.774 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.008 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -49.5 -54.19 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.013 -1.054 . . . . 0.0 108.537 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.84 HD11 ' CB ' ' A' ' 72' ' ' ARG . 8.2 tt -64.45 -26.74 68.57 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.757 . . . . 0.0 109.496 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -22.91 62.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.09 -24.05 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.765 ' CD2' HD11 ' A' ' 51' ' ' LEU . 1.3 mp -87.2 -6.87 58.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.88 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.05 -29.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.711 . . . . 0.0 109.319 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -80.88 -46.56 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER 169.91 151.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 110.117 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.708 ' HB ' HD22 ' A' ' 76' ' ' LEU . 5.9 m -87.23 164.36 36.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 108.79 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.9 Cg_endo -103.84 -71.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.611 1.322 . . . . 0.0 111.13 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' OD2' ' CA ' ' A' ' 4' ' ' GLY . 3.0 m-20 -110.75 -75.31 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 0.0 110.542 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.866 HG22 ' HG2' ' A' ' 77' ' ' PRO . 13.1 t -143.7 145.02 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.062 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.765 HD11 ' CD2' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -101.8 124.21 47.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 109.88 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.018 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -108.83 165.99 11.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.222 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -147.8 122.05 9.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 109.644 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -78.0 -171.13 2.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 55' ' ' ILE . 2.6 tp -143.21 79.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.581 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -117.74 -166.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mtt 59.62 83.75 0.21 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.09 120.4 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.944 1.497 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.76 -87.23 0.07 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 ttm -109.94 -91.71 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -1.125 . . . . 0.0 109.429 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.7 m-20 -102.53 1.26 34.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . 152.47 -90.35 0.13 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.884 HD13 HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER 176.64 25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.384 -1.068 . . . . 0.0 110.377 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 56.94 -142.18 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.848 -1.157 . . . . 0.0 109.132 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.884 HD12 HD13 ' A' ' 63' ' ' LEU . 62.9 mt 80.04 -66.76 0.15 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.682 . . . . 0.0 110.535 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 66' ' ' LEU . 2.5 tm? -57.47 -36.03 70.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.584 -1.322 . . . . 0.0 109.251 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -66.11 -30.92 71.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.643 -1.286 . . . . 0.0 107.663 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.677 ' HG3' HD13 ' A' ' 40' ' ' LEU . 2.5 tp-100 -69.08 -65.26 0.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.805 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -37.4 -24.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 111.494 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 68' ' ' GLN . 3.1 tptt -89.24 -69.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.274 -1.517 . . . . 0.0 109.277 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -34.93 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.683 -0.636 . . . . 0.0 112.01 -178.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.84 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.31 -68.7 0.86 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.545 -1.347 . . . . 0.0 111.777 -178.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.658 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 77.6 m80 -33.55 152.12 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.197 0 O-C-N 121.536 -0.728 . . . . 0.0 110.698 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -59.08 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.987 1.519 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.41 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.848 -1.158 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.708 HD22 ' HB ' ' A' ' 47' ' ' THR . 0.5 OUTLIER -146.31 -176.2 0.53 Allowed Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.866 ' HG2' HG22 ' A' ' 50' ' ' VAL . 36.0 Cg_endo -78.73 143.0 18.35 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 117.292 -1.338 . . . . 0.0 111.512 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -137.15 158.0 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.579 HG21 HD12 ' A' ' 102' ' ' LEU . 4.4 mt -142.6 145.21 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 108.995 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -127.83 138.89 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.87 142.93 49.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -93.99 178.6 5.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 109.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 166.68 -57.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.543 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.98 -52.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -109.47 107.98 18.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.646 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.5 p-10 166.74 -42.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 31.5 tp -35.02 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.247 0.546 . . . . 0.0 110.313 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 86' ' ' ASP . 5.4 t0 -63.51 -72.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -43.71 -47.32 7.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 80' ' ' ILE . . . -62.77 -76.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 72.5 t -33.69 -32.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.818 -0.551 . . . . 0.0 111.125 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' ALA . 5.1 p -92.25 -148.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.98 -1.075 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 94' ' ' TYR . . . 58.72 64.79 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.509 ' CB ' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER 76.39 -0.52 3.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.22 -179.268 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 27.0 mt-30 42.47 -97.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' TYR . 3.6 mt-30 -62.74 100.44 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.986 -1.071 . . . . 0.0 109.836 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.96 -121.63 1.01 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.12 72.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -1.21 . . . . 0.0 109.679 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 52.4 m-85 -127.05 136.13 51.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 101' ' ' TYR . 3.7 m-20 -135.78 89.59 2.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -38.34 135.56 0.74 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.652 -0.655 . . . . 0.0 109.995 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.579 HD12 HG21 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -113.33 121.79 36.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -122.3 -177.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.762 1.401 . . . . 0.0 110.578 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -100.63 156.85 34.72 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -96.88 167.61 13.67 Favored 'Cis proline' 0 C--N 1.317 -1.082 0 C-N-CA 120.8 -2.584 . . . . 0.0 110.392 0.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -164.3 146.44 8.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.6 t70 -75.95 144.02 41.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.906 HD11 ' CD2' ' A' ' 19' ' ' LEU . 4.5 tp -60.13 -48.31 88.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.942 -1.099 . . . . 0.0 110.7 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.611 ' N ' HG23 ' A' ' 108' ' ' ILE . 35.7 t0 -69.96 -54.78 11.76 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 108.744 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 9.7 tp10 -46.36 -28.73 1.42 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.96 -78.66 0.09 Allowed 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.504 -0.747 . . . . 0.0 109.328 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.819 ' CG1' HD13 ' A' ' 28' ' ' LEU . 47.5 t -41.42 -60.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 121.368 -0.832 . . . . 0.0 109.692 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -42.33 -62.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.773 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.779 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -35.0 -50.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.686 0.755 . . . . 0.0 109.317 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.767 HG21 HG11 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -59.8 -53.89 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.573 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.9 tt0 -34.48 -41.46 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.376 0.607 . . . . 0.0 110.386 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -61.99 -53.05 60.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.364 -0.835 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -52.32 -54.8 26.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.012 -1.055 . . . . 0.0 108.626 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.862 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.1 mt -36.2 -34.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.426 0.631 . . . . 0.0 110.467 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 118' ' ' ALA . 3.5 t -70.73 22.77 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.389 -0.819 . . . . 0.0 111.983 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' C ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER 53.5 35.84 21.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.353 -1.467 . . . . 0.0 109.572 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.5 OUTLIER 32.21 50.56 0.18 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.575 0.703 . . . . 0.0 110.162 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.99 -25.82 67.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.055 -1.028 . . . . 0.0 109.348 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 28' ' ' LEU . . . 178.75 141.95 4.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.563 HG13 HG21 ' A' ' 29' ' ' THR . 5.2 mp -104.94 103.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.43 -1.041 . . . . 0.0 109.729 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -104.39 128.04 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.545 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -101.57 81.56 2.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 110.608 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.808 ' HB ' HG22 ' A' ' 32' ' ' THR . 42.6 t -72.61 146.6 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 109.539 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 84.1 t -91.72 105.81 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.038 -1.039 . . . . 0.0 109.349 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.566 ' HA ' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -53.79 174.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 2.3 t70 -124.39 -50.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 110.277 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -172.42 94.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 111.271 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 12' ' ' ASP . 1.8 p 57.08 137.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.145 0.974 . . . . 0.0 111.557 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.655 ' N ' ' CE3' ' A' ' 17' ' ' TRP . 5.4 t 61.81 3.67 0.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.387 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 10' ' ' ASP . 21.4 mm -88.21 -54.81 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.184 -1.572 . . . . 0.0 109.286 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -62.69 -36.76 83.96 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.655 ' CE3' ' N ' ' A' ' 14' ' ' SER . 7.9 m-90 -71.27 -55.91 7.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 14' ' ' SER . 2.1 t -39.1 -61.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 122.057 0.932 . . . . 0.0 109.795 -177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.3 mm? -55.95 -70.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.59 -0.694 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -35.56 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.5 tmt_? -68.12 -56.52 8.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.94 -6.72 34.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.054 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.866 HD11 HG21 ' A' ' 112' ' ' VAL . 1.5 mm? -101.91 -9.11 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.67 -52.57 6.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.317 -0.865 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.48 71.43 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.42 74.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.437 -1.037 . . . . 0.0 108.809 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.37 57.73 1.34 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.857 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -140.97 179.7 6.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.073 -1.251 . . . . 0.0 110.347 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.563 HG21 HG13 ' A' ' 5' ' ' ILE . 16.4 m -103.4 83.44 2.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.503 ' HB2' ' CG ' ' A' ' 23' ' ' LEU . 19.1 t -92.64 92.54 8.05 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.17 -0.956 . . . . 0.0 110.807 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.545 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -94.18 144.87 25.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.808 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.3 p -149.96 129.25 12.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.702 -1.248 . . . . 0.0 110.258 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.66 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.6 m-85 -111.81 127.33 55.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.272 -0.892 . . . . 0.0 109.133 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HA ' ' CB ' ' A' ' 10' ' ' ASP . 1.9 pt-20 -47.63 -19.59 0.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.49 -0.756 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -131.85 132.98 44.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.503 -1.373 . . . . 0.0 111.098 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -61.78 -18.4 56.6 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.461 ' HA ' ' CD ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -68.25 -80.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.088 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -35.53 -45.86 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.848 -0.533 . . . . 0.0 110.321 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.5 OUTLIER -58.05 -52.22 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.215 -0.928 . . . . 0.0 108.995 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.9 tm? -63.52 -17.29 62.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -84.47 -25.91 28.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.13 -35.51 64.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.087 HD13 ' NE2' ' A' ' 73' ' ' HIS . 4.7 mt -72.36 -102.97 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 81.61 -40.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.122 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 70.7 m -98.99 -40.19 8.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -0.932 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.4 OUTLIER 168.06 150.09 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.096 -1.002 . . . . 0.0 108.969 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.584 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -87.37 165.81 28.94 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.255 -0.903 . . . . 0.0 109.417 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.54 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -89.27 -66.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.234 1.649 . . . . 0.0 110.319 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.755 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -109.85 -75.32 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.785 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -149.99 151.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 0.0 109.964 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.983 HD12 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -99.88 134.57 42.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.85 148.16 49.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.941 -1.099 . . . . 0.0 109.147 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.47 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t -134.66 126.4 29.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.094 -1.003 . . . . 0.0 110.428 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 m-20 -73.27 -179.93 3.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 109.173 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.578 HG21 ' O ' ' A' ' 82' ' ' THR . 0.7 OUTLIER 176.89 38.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.21 11.09 10.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.96 . . . . 0.0 109.248 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ASP . 5.9 mmt -38.08 140.51 0.57 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.3 Cg_endo -49.42 122.92 9.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.07 1.563 . . . . 0.0 110.631 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 44.39 -126.06 6.24 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 ptt? -70.44 -146.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.399 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 57' ' ' MET . 31.1 m-20 63.14 100.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 109.802 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -153.07 90.67 0.13 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.933 HD11 HD11 ' A' ' 65' ' ' LEU . 1.2 pt? -38.32 147.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.912 . . . . 0.0 110.429 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.954 ' HB1' ' HD3' ' A' ' 67' ' ' LYS . . . -90.97 122.95 34.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.933 HD11 HD11 ' A' ' 63' ' ' LEU . 5.1 mt -134.21 -43.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.535 ' HA ' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -41.25 -51.01 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.464 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.954 ' HD3' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -43.66 -50.02 7.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 6.3 pt20 -69.97 -43.09 72.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.616 -1.302 . . . . 0.0 109.429 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.587 HG21 HG11 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -37.48 -52.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 109.606 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -73.14 -57.96 3.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.851 -0.531 . . . . 0.0 110.417 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.41 -36.41 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.843 -0.536 . . . . 0.0 110.939 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.913 ' HB2' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -101.99 -30.84 10.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.694 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.087 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.21 -177.77 0.32 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.855 ' HD2' HD23 ' A' ' 76' ' ' LEU . 36.6 Cg_endo -113.73 39.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.162 1.612 . . . . 0.0 109.598 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 5.8 mmt 63.17 73.24 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.855 HD23 ' HD2' ' A' ' 74' ' ' PRO . 3.0 pp -130.61 176.9 2.51 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 108.886 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.638 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 36.2 Cg_endo -68.26 129.29 18.95 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.184 1.097 . . . . 0.0 112.778 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.983 HG13 ' HB3' ' A' ' 51' ' ' LEU . 45.7 t -134.42 100.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 100' ' ' ASP . 15.4 mm -80.43 160.52 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.03 -1.044 . . . . 0.0 111.055 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 80' ' ' ILE . 3.9 mp -139.71 136.19 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.519 -0.738 . . . . 0.0 109.31 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.508 ' O ' HG22 ' A' ' 55' ' ' ILE . 1.2 ttm -81.27 89.87 6.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.27 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.578 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 65.77 -177.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 109.201 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.477 ' H ' HG22 ' A' ' 82' ' ' THR . . . 179.54 142.92 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.004 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -146.33 36.82 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.1 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.86 -32.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.573 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.74 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 46.4 t0 -76.49 -17.62 59.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 109.571 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.3 mt -34.44 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.702 -0.624 . . . . 0.0 110.525 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 86' ' ' ASP . 16.5 t0 -62.85 -57.85 9.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.018 . . . . 0.0 109.746 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . . . -60.55 -57.24 13.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -52.02 -66.78 0.32 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -0.951 . . . . 0.0 109.8 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 87' ' ' LEU . 47.8 t -33.7 -31.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.98 -0.45 . . . . 0.0 111.042 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.703 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 32.6 t -95.48 170.69 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 109.897 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 78.0 74.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.82 -86.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.512 ' HG3' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 66.39 31.49 8.22 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.389 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -125.65 16.19 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 161.9 151.11 6.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . 69.43 34.03 2.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 20.3 m-85 -152.16 29.93 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.542 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -55.38 124.84 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.03 137.04 38.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.803 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -110.64 111.05 57.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -104.91 144.21 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.38 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.39 151.54 87.26 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.315 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -81.32 175.53 41.93 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.52 -2.7 . . . . 0.0 110.517 -0.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -159.5 136.31 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 17.5 t0 -76.05 -176.75 3.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 108.551 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.49 -49.48 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.639 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 26.2 t70 -69.36 -45.84 68.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 108.53 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.3 tp10 -51.1 -37.08 43.76 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.06 -70.22 0.37 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.379 -0.826 . . . . 0.0 108.81 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.866 HG21 HD11 ' A' ' 23' ' ' LEU . 39.1 t -36.45 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.744 -0.597 . . . . 0.0 110.396 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -51.32 -61.22 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 110.45 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 113' ' ' ALA . 47.6 tp -34.47 -58.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.331 0.586 . . . . 0.0 110.174 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.701 HG22 HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -59.66 -56.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.623 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.0 tm-20 -35.59 -31.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.185 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtm180 -82.63 -56.37 3.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.632 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.18 -61.33 1.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 108.734 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.785 ' CD1' HG23 ' A' ' 50' ' ' VAL . 9.6 mt -35.43 -44.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.805 -0.559 . . . . 0.0 110.55 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.74 56.62 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.91 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 34.5 t-80 -117.73 0.28 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.393 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -99.56 9.98 42.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.262 -0.899 . . . . 0.0 109.606 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 60.6 mt-30 -90.53 40.78 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 29.0 tt0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.49 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.956 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -167.61 149.5 14.74 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.839 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.827 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -101.46 110.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.616 -0.932 . . . . 0.0 109.859 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -113.86 119.09 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 1.178 ' CE3' HG21 ' A' ' 31' ' ' THR . 10.5 m95 -101.04 88.45 3.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.656 -1.278 . . . . 0.0 109.235 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.048 HG22 ' CB ' ' A' ' 52' ' ' LEU . 48.4 t -82.77 153.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.528 -0.732 . . . . 0.0 110.45 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.06 HG22 HG21 ' A' ' 39' ' ' VAL . 93.5 t -96.58 106.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -63.22 156.31 25.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 109.147 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -102.92 -29.8 11.2 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.659 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 1.7 m-20 -124.51 169.66 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.905 -1.122 . . . . 0.0 110.229 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -67.07 -3.12 6.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.895 -1.128 . . . . 0.0 110.64 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 t -121.3 8.85 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.799 -1.188 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.509 HG22 ' HB2' ' A' ' 10' ' ' ASP . 16.1 mm -78.88 -35.24 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.909 -1.119 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -49.58 77.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.541 ' CZ2' ' NH2' ' A' ' 21' ' ' ARG . 19.0 t90 -53.86 -64.4 0.84 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.2 t -37.48 -65.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.636 0.731 . . . . 0.0 110.698 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -50.39 -79.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 111.002 -178.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.8 tt0 -33.68 -33.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.826 -0.546 . . . . 0.0 110.947 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' NH2' ' CZ2' ' A' ' 17' ' ' TRP . 2.5 tpp85 -66.84 -57.16 7.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 0.0 109.037 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.617 ' CB ' HG21 ' A' ' 108' ' ' ILE . . . -71.97 -4.31 27.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.347 -0.846 . . . . 0.0 109.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.907 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -100.11 -18.62 16.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.48 -43.5 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.94 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.22 62.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -1.071 . . . . 0.0 109.013 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.7 47.88 4.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.956 HD23 ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -127.87 179.57 5.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.073 -1.251 . . . . 0.0 110.097 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.763 HG21 ' CG2' ' A' ' 5' ' ' ILE . 53.9 m -99.97 86.04 3.18 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 31.3 t -82.37 92.13 6.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.474 -0.767 . . . . 0.0 110.399 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.178 HG21 ' CE3' ' A' ' 7' ' ' TRP . 24.3 m -89.55 124.1 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 34.2 p -127.01 151.31 48.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.06 -1.025 . . . . 0.0 110.125 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.061 ' HB2' HG22 ' A' ' 39' ' ' VAL . 7.8 m-85 -143.14 119.07 10.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.48 -0.763 . . . . 0.0 109.207 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.458 ' HA ' ' OD2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -54.16 -27.82 36.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.167 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.828 ' O ' HG23 ' A' ' 39' ' ' VAL . 46.2 m-20 -109.45 125.33 52.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 110.39 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . -57.78 -46.72 91.98 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 38' ' ' GLU . 58.3 t-20 -53.62 -71.93 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.159 -1.201 . . . . 0.0 108.811 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -34.23 -38.05 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.878 -0.514 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.061 HG22 ' HB2' ' A' ' 33' ' ' PHE . 48.8 t -53.15 -59.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.764 HD23 ' NE2' ' A' ' 68' ' ' GLN . 3.9 mm? -62.57 -21.78 65.86 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -65.99 -36.68 83.97 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.67 36.29 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 43' ' ' LEU . 2.5 tm? -56.95 -19.84 20.29 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.48 -40.25 12.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 109.22 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -62.31 -39.81 94.27 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.085 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 99.33 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.351 0.596 . . . . 0.0 110.583 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.494 HG21 HD21 ' A' ' 51' ' ' LEU . 34.5 p -65.15 169.53 5.59 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HG2' ' CG1' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -129.89 -15.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 116.263 -2.025 . . . . 0.0 113.007 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -94.4 -71.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 119.867 -1.771 . . . . 0.0 110.912 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.753 HG21 HG13 ' A' ' 115' ' ' VAL . 11.3 t -163.78 144.36 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 110.168 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -101.92 125.27 48.56 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.779 178.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.048 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -113.18 160.12 18.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -153.42 131.22 11.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.397 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.581 ' O ' HD21 ' A' ' 63' ' ' LEU . 7.7 t0 -92.43 144.06 25.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.807 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -88.31 82.74 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.096 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 6.5 tpt180 178.57 128.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 108.919 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.539 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -174.18 157.61 2.59 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 57' ' ' MET . 36.2 Cg_endo -63.4 155.9 59.49 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.784 1.412 . . . . 0.0 110.298 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.23 10.82 27.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 61.14 -177.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -1.098 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.72 -146.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' O ' ' CG ' ' A' ' 57' ' ' MET . . . -107.98 -111.27 3.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.762 ' HB2' HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -130.74 -46.03 1.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -1.11 . . . . 0.0 109.413 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 63' ' ' LEU . . . 77.36 64.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.817 . . . . 0.0 109.762 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.861 HD12 HE22 ' A' ' 68' ' ' GLN . 1.0 OUTLIER -149.42 14.94 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.922 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 1.2 mm? -65.21 -40.76 94.58 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -25.82 62.89 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.861 HE22 HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.37 -58.68 7.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.3 mp -37.71 -69.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.563 -0.71 . . . . 0.0 110.452 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -48.28 -69.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.987 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 12.3 mt-30 -34.77 -31.83 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.408 0.623 . . . . 0.0 110.428 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.762 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -108.64 -81.29 0.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.73 ' NE2' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -35.78 140.33 0.36 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.313 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.522 ' HD2' ' ND1' ' A' ' 73' ' ' HIS . 36.8 Cg_endo -59.49 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.104 1.581 . . . . 0.0 110.278 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.5 ptp 178.96 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 4.2 pp -115.95 146.61 37.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 32.8 Cg_endo -33.43 137.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.893 1.47 . . . . 0.0 112.626 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -131.13 106.8 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 16.0 mm -91.64 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.519 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 53' ' ' SER . 53.4 mt -150.22 145.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.496 ' O ' ' HB ' ' A' ' 82' ' ' THR . 1.2 mpp? -78.79 136.94 37.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 91.3 m 67.18 -83.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.559 -0.713 . . . . 0.0 110.021 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 82' ' ' THR . . . 83.93 95.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.585 -0.697 . . . . 0.0 109.171 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 85' ' ' SER . 11.6 t-80 -136.0 -87.51 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.952 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 46.67 36.66 3.88 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -178.139 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 88' ' ' ASP . 14.5 t0 66.11 128.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.872 HD12 HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -36.47 -31.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -36.89 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.519 0.676 . . . . 0.0 109.71 176.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.952 ' HB3' ' HB2' ' A' ' 85' ' ' SER . . . -51.7 -34.36 38.32 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.463 -0.773 . . . . 0.0 109.16 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.658 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -59.06 -80.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.062 -1.024 . . . . 0.0 109.618 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.872 HG23 HD12 ' A' ' 87' ' ' LEU . 33.3 t -14.26 -54.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 122.763 0.425 . . . . 0.0 111.987 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.658 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 4.3 t -79.53 -149.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.926 -1.109 . . . . 0.0 109.766 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 72.96 36.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.902 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 61.69 57.21 2.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.09 -1.006 . . . . 0.0 109.529 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -75.54 150.96 38.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 19.2 tt0 56.42 22.17 6.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.135 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.43 -46.83 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . -157.52 54.9 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.243 . . . . 0.0 109.985 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.29 122.5 12.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 101' ' ' TYR . 38.7 t70 -113.1 6.77 17.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.053 -1.03 . . . . 0.0 110.354 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 2.4 m-85 46.88 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.066 -1.022 . . . . 0.0 109.106 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -91.89 137.62 25.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.0 110.018 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 37.4 Cg_endo -127.54 177.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.643 1.339 . . . . 0.0 110.048 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.42 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -93.29 159.53 35.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.265 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -79.59 172.79 57.37 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.655 -2.644 . . . . 0.0 110.492 0.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 10.7 p90 -156.05 133.8 11.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.363 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 18.3 t0 -81.16 -162.39 0.49 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 108.703 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.617 HG21 ' CB ' ' A' ' 22' ' ' ALA . 36.0 mm -106.67 -65.01 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 109.208 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -57.65 -51.91 67.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.9 tp10 -43.55 -38.2 2.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.74 -73.71 0.18 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.907 HG21 HD11 ' A' ' 23' ' ' LEU . 38.4 t -37.24 -69.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.513 -0.742 . . . . 0.0 110.233 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -45.29 -63.14 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 110.441 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.3 tm? -35.29 -50.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.689 0.756 . . . . 0.0 109.524 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.753 HG13 HG21 ' A' ' 50' ' ' VAL . 1.2 t -60.18 -57.01 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.624 ' N ' HG12 ' A' ' 115' ' ' VAL . 3.4 tt0 -34.02 -39.42 0.07 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.198 0.523 . . . . 0.0 110.288 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtp85 -71.72 -52.0 19.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 109.25 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -49.09 -56.46 9.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.188 -0.945 . . . . 0.0 108.6 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.534 HG12 ' CG2' ' A' ' 50' ' ' VAL . 5.4 mt -35.27 -41.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.336 0.589 . . . . 0.0 109.774 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -88.03 53.33 2.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.153 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 6.9 t-80 -94.93 -5.73 44.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.607 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -85.64 19.8 2.32 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.235 -0.916 . . . . 0.0 109.822 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -93.2 -16.05 25.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.579 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.561 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 116' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.639 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 166.87 153.1 7.7 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.051 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.901 HG23 ' HB ' ' A' ' 29' ' ' THR . 1.9 mt -124.17 131.52 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.159 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.777 ' CG1' HG23 ' A' ' 8' ' ' VAL . 1.9 t -126.74 113.07 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 108.796 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.84 ' O ' HD13 ' A' ' 51' ' ' LEU . 9.2 m95 -99.9 86.9 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.425 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.041 HG22 ' HB2' ' A' ' 52' ' ' LEU . 48.7 t -84.09 159.82 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 111.076 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 65' ' ' LEU . 14.3 t -95.1 121.76 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.917 ' OD2' HG22 ' A' ' 15' ' ' ILE . 8.3 m-20 -109.07 -169.98 1.58 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.19 -0.943 . . . . 0.0 110.0 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' CG ' ' HG3' ' A' ' 57' ' ' MET . 51.8 t0 -100.87 -57.13 2.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.446 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -130.73 173.74 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 109.845 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.562 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -58.71 -41.74 87.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.958 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -28.36 34.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 108.986 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.917 HG22 ' OD2' ' A' ' 10' ' ' ASP . 43.7 mm -71.38 -40.35 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.0 -49.46 71.43 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 27.0 t90 -55.22 -59.68 4.45 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.0 t -36.18 -70.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.5 tp -55.41 -72.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.423 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 10.3 tm-20 -34.89 -30.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.795 -0.566 . . . . 0.0 110.969 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -68.45 -55.94 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.243 -0.911 . . . . 0.0 108.57 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 108' ' ' ILE . . . -72.1 -4.76 30.87 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 112' ' ' VAL . 0.4 OUTLIER -100.22 -12.75 19.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.421 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.8 -43.48 68.57 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.81 97.48 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.27 67.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.03 49.37 4.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.078 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -130.14 178.12 6.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.878 -1.366 . . . . 0.0 110.165 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.901 ' HB ' HG23 ' A' ' 5' ' ' ILE . 96.6 m -97.9 77.84 2.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 40.5 t -76.09 88.31 3.0 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.931 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.716 HG21 ' CD2' ' A' ' 7' ' ' TRP . 13.0 m -100.51 127.09 46.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.201 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 16' ' ' ARG . 43.9 p -119.06 161.01 20.98 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 109.27 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.827 ' CG ' HG23 ' A' ' 39' ' ' VAL . 2.0 m-85 -134.37 105.81 6.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' N ' ' A' ' 13' ' ' SER . 1.1 mp0 -41.94 -31.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.537 -0.727 . . . . 0.0 109.777 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -106.91 126.21 52.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.865 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -65.17 -57.35 11.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 26.5 t-20 -51.37 -66.52 0.37 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.772 -1.428 . . . . 0.0 108.956 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.55 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.5 tt0 -33.52 -53.16 0.41 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.855 -0.528 . . . . 0.0 111.465 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.92 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -58.3 -52.86 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.725 -1.235 . . . . 0.0 109.498 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.92 HD12 ' CG1' ' A' ' 39' ' ' VAL . 8.5 mp -62.34 -14.7 42.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -77.2 -37.68 53.05 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.37 1.09 48.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.774 HD11 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.11 -6.16 54.07 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.323 -0.86 . . . . 0.0 109.439 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -10.38 52.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 109.59 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.7 m -97.39 1.04 48.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HG3' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 65.33 90.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.847 . . . . 0.0 109.611 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.597 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.6 m -99.25 -72.97 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.082 -1.011 . . . . 0.0 109.847 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 38.7 Cg_endo -75.65 -162.72 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.488 1.257 . . . . 0.0 110.411 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.929 ' O ' HD13 ' A' ' 76' ' ' LEU . 2.8 p30 -110.81 -14.93 13.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.874 HG21 HG13 ' A' ' 115' ' ' VAL . 4.3 t -144.89 129.11 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.521 -0.737 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -100.42 158.4 15.92 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.041 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -146.84 157.1 43.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.072 -1.018 . . . . 0.0 110.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.883 ' CB ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -134.05 123.87 25.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 109.729 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.771 ' O ' HG22 ' A' ' 55' ' ' ILE . 27.1 m-20 -62.5 -51.93 65.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 109.779 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.906 HG21 ' HB ' ' A' ' 82' ' ' THR . 2.2 tp 83.96 26.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.326 0.584 . . . . 0.0 109.454 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 57' ' ' MET . 17.3 ptm180 -113.67 -138.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.217 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.485 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.8 ttm 70.57 128.96 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.865 -1.147 . . . . 0.0 109.301 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -89.23 173.33 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.326 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.63 -66.87 0.96 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -91.17 29.62 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -1.194 . . . . 0.0 109.527 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t0 52.48 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -138.02 83.79 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.2 mp -35.91 132.62 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.907 -0.76 . . . . 0.0 110.127 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -49.88 -80.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.014 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.0 OUTLIER 79.09 -35.93 0.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 110.529 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 89' ' ' ALA . 13.5 tp -77.0 -62.11 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.405 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -50.71 -40.29 53.81 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.679 ' CG ' HD22 ' A' ' 40' ' ' LEU . 3.7 tp-100 -57.96 -56.76 17.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.014 HD12 ' O ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -35.92 -53.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.37 0.605 . . . . 0.0 109.908 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 72' ' ' ARG . 11.3 mtmm -60.04 -63.0 1.45 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.928 -1.107 . . . . 0.0 109.609 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.4 mt-30 -33.96 -34.37 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.775 -0.578 . . . . 0.0 110.959 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -122.51 -68.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.066 -1.021 . . . . 0.0 109.656 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -40.07 160.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.37 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 36.8 Cg_endo -92.95 -96.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.899 1.473 . . . . 0.0 110.15 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.4 mtm -147.56 2.36 0.73 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.875 -1.14 . . . . 0.0 110.881 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.929 HD13 ' O ' ' A' ' 49' ' ' ASP . 2.5 pp -61.81 134.89 94.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 120.596 -1.315 . . . . 0.0 108.104 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.848 ' HG2' HG22 ' A' ' 50' ' ' VAL . 32.1 Cg_endo -28.94 145.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 124.176 1.619 . . . . 0.0 112.487 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.619 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 21.5 t -147.45 95.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.723 -0.611 . . . . 0.0 109.388 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 19.1 mt -75.63 136.38 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.951 -1.093 . . . . 0.0 110.635 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.89 HD12 ' CB ' ' A' ' 83' ' ' ALA . 4.0 pt -126.79 115.19 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.011 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -66.97 129.52 40.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.169 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.906 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.3 m 71.98 -78.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.717 . . . . 0.0 109.922 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.89 ' CB ' HD12 ' A' ' 80' ' ' ILE . . . 66.06 129.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 109.508 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.766 ' HA ' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -178.82 -79.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.6 t 44.59 41.04 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 69.75 131.51 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -175.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.836 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 1.7 mm? -36.35 -28.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.042 0.925 . . . . 0.0 109.104 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -35.88 -63.55 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.891 ' O ' HD23 ' A' ' 66' ' ' LEU . . . -81.18 -32.49 33.56 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 108.929 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -63.68 -67.23 0.45 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 109.033 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.75 -53.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 C-N-CA 122.779 0.432 . . . . 0.0 111.611 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.733 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -61.8 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.998 -1.064 . . . . 0.0 109.088 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 79.18 -75.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.076 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' VAL . 22.5 p90 -78.79 5.76 10.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.055 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.69 -26.97 60.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 109.286 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER 163.24 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -0.827 . . . . 0.0 109.384 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.15 -146.2 8.88 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . . . -138.88 67.6 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -1.126 . . . . 0.0 109.652 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 41.3 p90 170.66 -177.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -150.7 -176.01 5.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.272 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 83' ' ' ALA . 5.0 m-30 -81.71 130.22 34.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.252 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -114.61 115.91 43.88 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 0.0 109.404 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -117.06 171.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.875 1.46 . . . . 0.0 110.415 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 16.5 mttm -63.03 157.96 58.03 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 109.402 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 37.3 Cg_endo -79.07 161.54 88.29 Favored 'Cis proline' 0 C--N 1.315 -1.225 0 C-N-CA 120.539 -2.692 . . . . 0.0 109.905 -0.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 1.8 p90 -143.26 129.5 19.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.5 t70 -91.28 -147.25 0.21 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.062 -1.024 . . . . 0.0 108.748 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.721 HG22 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -119.18 -69.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.721 ' N ' HG22 ' A' ' 108' ' ' ILE . 13.7 t70 -62.16 -42.67 99.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.6 tm-20 -46.23 -45.7 17.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.79 -77.04 0.09 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.078 HG11 HD13 ' A' ' 28' ' ' LEU . 65.2 t -38.39 -71.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 110.155 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.59 -65.4 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.961 -0.462 . . . . 0.0 110.27 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' ALA . 13.5 tp -34.76 -49.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.826 0.822 . . . . 0.0 109.507 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.874 HG13 HG21 ' A' ' 50' ' ' VAL . 1.7 t -60.49 -55.81 21.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 115' ' ' VAL . 1.4 tt0 -34.88 -45.79 0.28 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 118' ' ' ALA . 12.5 mtm105 -70.72 -51.74 25.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 109.441 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.24 -67.56 0.27 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.889 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.756 HG21 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mt -36.29 -43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.672 -0.642 . . . . 0.0 110.062 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 121' ' ' HIS . 3.7 t -48.73 -58.2 5.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 120' ' ' SER . 4.9 t60 -42.75 -41.33 3.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.338 -0.851 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.75 49.71 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.493 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.41 28.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.39 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.806 0.812 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.719 ' HA3' HD21 ' A' ' 28' ' ' LEU . . . 161.23 168.59 23.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.667 HG23 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -144.61 104.34 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -1.119 . . . . 0.0 108.315 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' CG1' HG23 ' A' ' 8' ' ' VAL . 2.7 t -120.87 115.95 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.08 . . . . 0.0 110.253 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.82 ' CZ2' HG21 ' A' ' 31' ' ' THR . 0.2 OUTLIER -99.58 80.38 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 0.0 109.34 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 52' ' ' LEU . 9.3 t -68.22 137.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.321 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.714 HG22 HG21 ' A' ' 39' ' ' VAL . 57.4 t -85.67 108.78 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.115 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.587 ' CG ' HG22 ' A' ' 15' ' ' ILE . 71.6 m-20 -87.15 -171.72 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.326 -0.859 . . . . 0.0 109.834 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.75 -87.06 0.14 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.38 -0.825 . . . . 0.0 109.637 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 15' ' ' ILE . 3.1 m-20 -112.05 170.7 7.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.635 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.8 p -49.55 164.72 0.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER 79.73 -8.67 1.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.587 HG22 ' CG ' ' A' ' 10' ' ' ASP . 46.4 mm -92.93 -36.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.973 -1.08 . . . . 0.0 108.398 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 17' ' ' TRP . 15.8 ptt-85 -66.18 -32.59 74.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.609 ' CZ3' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -52.11 -66.34 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.14 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 49.6 t -42.49 -53.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.921 0.867 . . . . 0.0 110.072 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.704 ' HG ' HG21 ' A' ' 32' ' ' THR . 2.7 mm? -49.56 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.745 . . . . 0.0 110.343 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 23' ' ' LEU . 2.0 mt-10 -35.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.369 0.604 . . . . 0.0 110.395 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.609 ' HD3' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -62.51 -56.35 18.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.809 -1.182 . . . . 0.0 108.839 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.785 ' HB3' HD13 ' A' ' 108' ' ' ILE . . . -63.5 -20.84 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.795 HD13 ' HB2' ' A' ' 30' ' ' CYS . 19.6 tp -71.67 -25.59 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.84 -0.537 . . . . 0.0 110.165 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.66 73.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.27 -38.47 87.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.41 49.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 109.226 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.76 65.51 3.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.05 HD13 HG11 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -136.43 -177.44 4.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.238 -1.154 . . . . 0.0 110.215 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.667 ' HB ' HG23 ' A' ' 5' ' ' ILE . 32.1 m -104.93 50.96 0.77 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.795 ' HB2' HD13 ' A' ' 23' ' ' LEU . 18.4 t -79.03 87.07 4.83 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.233 0.54 . . . . 0.0 109.579 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.82 HG21 ' CZ2' ' A' ' 7' ' ' TRP . 1.4 m -85.83 170.29 12.54 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 108.66 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.71 HG22 ' HB ' ' A' ' 8' ' ' VAL . 1.1 p -155.18 143.16 20.04 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.4 m-85 -118.44 -168.87 1.61 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.936 -1.103 . . . . 0.0 109.794 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.42 -1.71 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 110.2 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 4.8 m-20 -136.56 127.36 27.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.955 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -48.99 -50.68 26.78 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 39' ' ' VAL . 18.9 t-20 -58.94 -63.67 1.22 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.3 -1.118 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -34.37 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 0.0 110.592 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 33' ' ' PHE . 1.7 t -74.54 -64.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.081 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -59.68 -14.57 14.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.949 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -85.14 -39.58 17.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.175 -0.953 . . . . 0.0 108.469 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.53 74.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.979 HD13 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -65.23 -94.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.498 -0.752 . . . . 0.0 109.135 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 84.0 -63.33 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.427 0.632 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 62.3 p -102.3 -37.88 7.88 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.514 -0.741 . . . . 0.0 109.794 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 149.72 95.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.673 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m -100.32 -74.51 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.853 -1.154 . . . . 0.0 110.475 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.673 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 40.8 Cg_endo -81.2 -162.02 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 116.916 -1.59 . . . . 0.0 109.591 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 119' ' ' ILE . 53.2 p30 -113.43 -12.11 13.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.645 HG21 HG13 ' A' ' 115' ' ' VAL . 2.4 t -155.51 121.75 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.979 HD22 HD13 ' A' ' 43' ' ' LEU . 2.5 tp -99.51 136.05 40.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.041 -1.037 . . . . 0.0 108.631 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.813 ' HB3' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -117.12 174.18 6.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.917 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 91.0 p -149.01 133.97 18.07 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.502 ' OD2' ' CG1' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -95.93 3.92 53.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 110.051 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.737 HG21 ' HB ' ' A' ' 82' ' ' THR . 1.3 tt 28.82 82.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.3 0.572 . . . . 0.0 110.738 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -162.63 73.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.995 -1.066 . . . . 0.0 109.688 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtm -128.26 136.55 29.23 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.98 113.08 2.45 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.062 1.559 . . . . 0.0 110.383 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.62 -160.99 24.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.8 mtt -76.66 -49.5 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.203 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.25 177.06 5.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.217 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.34 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.991 HD13 HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER 178.88 29.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -1.122 . . . . 0.0 110.0 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 43.23 -92.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.96 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.991 HD12 HD13 ' A' ' 63' ' ' LEU . 0.5 OUTLIER 71.72 -82.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.854 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 66' ' ' LEU . 1.1 mm? -37.35 -29.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.123 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.91 -55.02 25.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.04 -41.72 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.153 . . . . 0.0 109.191 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.674 HG22 ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -37.33 -59.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.187 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.674 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.31 -51.53 56.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.903 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -34.39 -36.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.715 -0.615 . . . . 0.0 111.119 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -109.33 -59.18 1.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 0.0 110.313 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.718 ' CD2' HD22 ' A' ' 43' ' ' LEU . 57.1 m170 -39.61 145.35 0.43 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.417 -0.802 . . . . 0.0 110.066 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.555 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 35.1 Cg_endo -87.06 47.32 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.111 1.585 . . . . 0.0 109.868 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.8 mtp 72.41 55.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.61 -0.681 . . . . 0.0 110.241 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 77' ' ' PRO . 1.2 pp -114.8 136.62 22.53 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.056 . . . . 0.0 109.235 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.786 ' O ' HD12 ' A' ' 76' ' ' LEU . 35.6 Cg_endo -40.54 141.91 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.267 1.667 . . . . 0.0 112.994 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -147.5 142.76 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.797 HD11 HG22 ' A' ' 115' ' ' VAL . 8.7 mt -126.12 167.93 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.775 -1.203 . . . . 0.0 110.524 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.616 ' N ' HG22 ' A' ' 79' ' ' ILE . 4.2 tt -149.22 144.11 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 82' ' ' THR . 1.7 mpt? -88.14 65.49 8.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.737 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.1 m 158.1 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' ' 101' ' ' TYR . . . -101.89 46.11 0.94 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.514 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.549 ' H ' HG22 ' A' ' 82' ' ' THR . 0.3 OUTLIER -123.4 -97.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 45.78 27.65 0.48 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 61.23 123.37 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.815 HD12 ' HB3' ' A' ' 90' ' ' ALA . 9.6 tp -39.32 -25.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 108.263 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -36.91 -75.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.064 -1.022 . . . . 0.0 110.234 176.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' SER . . . -68.43 -34.62 76.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.815 ' HB3' HD12 ' A' ' 87' ' ' LEU . . . -56.7 -62.2 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.37 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -27.25 -39.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 122.683 0.393 . . . . 0.0 111.099 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -38.37 -59.6 0.88 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 109.579 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.566 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -44.0 -69.24 0.14 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -51.99 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 93' ' ' ALA . 2.3 mm-40 -176.38 -42.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -136.78 -67.36 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.71 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 156.65 173.9 25.72 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 81.84 -0.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.914 . . . . 0.0 109.899 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 3.8 m-85 -112.81 119.73 39.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.082 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.31 164.39 21.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.819 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.475 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 65.7 m-85 -110.75 94.57 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.143 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.551 ' HB2' ' CG2' ' A' ' 79' ' ' ILE . 1.6 tp -83.1 153.67 66.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -122.68 -174.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.707 1.372 . . . . 0.0 110.501 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -119.14 157.66 50.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -78.81 175.31 47.12 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.887 -2.547 . . . . 0.0 110.562 0.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 106' ' ' PHE . 25.1 p90 -148.68 140.89 24.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.778 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 13.5 t0 -79.49 147.63 32.16 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -72.36 -31.09 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.722 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -82.96 -44.81 14.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 38.8 tt0 -55.46 -39.26 70.12 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.81 -65.9 0.77 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.37 -0.831 . . . . 0.0 109.173 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.05 HG11 HD13 ' A' ' 28' ' ' LEU . 41.0 t -36.5 -57.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.652 . . . . 0.0 110.576 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -58.72 -66.09 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.539 -0.726 . . . . 0.0 110.492 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.3 tp -35.19 -54.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.544 0.687 . . . . 0.0 110.09 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.797 HG22 HD11 ' A' ' 79' ' ' ILE . 27.3 t -56.63 -56.11 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 115' ' ' VAL . 54.9 tt0 -34.91 -42.17 0.15 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.421 0.629 . . . . 0.0 109.917 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' ALA . 22.4 mtp180 -73.57 -54.86 7.19 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.068 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.99 -66.84 0.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.163 -0.961 . . . . 0.0 109.157 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 50' ' ' VAL . 4.1 mt -37.53 -41.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.672 . . . . 0.0 109.932 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 121' ' ' HIS . 6.1 m -46.15 -55.1 7.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.413 -0.805 . . . . 0.0 109.9 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -38.64 -43.84 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.885 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.78 96.43 4.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.49 40.71 3.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.87 . . . . 0.0 109.334 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.471 ' CG ' ' OXT' ' A' ' 124' ' ' GLU . 35.5 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.226 0.536 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.683 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -174.59 120.64 0.79 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.507 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.83 HD12 ' H ' ' A' ' 5' ' ' ILE . 1.1 mp -106.31 118.03 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.297 . . . . 0.0 108.601 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.67 112.72 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.594 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.45 92.31 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.69 -1.256 . . . . 0.0 108.746 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.88 HG22 ' HB2' ' A' ' 52' ' ' LEU . 57.6 t -83.66 150.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.444 0.64 . . . . 0.0 110.899 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 76.2 t -89.7 122.34 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.978 ' HA ' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.94 143.05 55.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.824 0.821 . . . . 0.0 110.819 -178.389 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 57' ' ' MET . 5.1 t0 -99.29 -65.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.523 ' O ' ' CG1' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -110.01 174.73 5.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.292 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 14' ' ' SER . 52.0 p -64.45 148.79 49.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 78.25 24.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.884 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.978 HG21 ' HA ' ' A' ' 10' ' ' ASP . 3.2 mm -83.63 -47.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 7.4 mtm180 -53.17 -47.95 68.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.494 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 22.9 t90 -55.51 -61.5 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 17' ' ' TRP . 15.9 t -36.98 -68.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.506 -0.746 . . . . 0.0 110.643 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 21' ' ' ARG . 6.9 mt -59.85 -74.56 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 110.878 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 19' ' ' LEU . 12.2 tt0 -34.56 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.771 -0.581 . . . . 0.0 111.057 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -69.87 -56.39 7.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.998 . . . . 0.0 108.593 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.679 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -72.06 -3.75 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.38 -0.825 . . . . 0.0 108.82 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.04 HD11 HG21 ' A' ' 112' ' ' VAL . 3.1 mm? -103.43 -10.89 18.22 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.392 -0.818 . . . . 0.0 109.522 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.88 -35.11 24.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.31 -36.78 49.46 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -69.4 -34.04 73.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -1.052 . . . . 0.0 108.637 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.26 73.08 1.26 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.04 HD13 HG11 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -146.67 174.61 11.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -1.207 . . . . 0.0 109.935 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.712 ' CG2' HG23 ' A' ' 5' ' ' ILE . 92.7 m -102.98 61.19 0.79 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.569 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . 35.9 t -83.85 96.79 8.89 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.532 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 5.7 m -100.02 154.62 18.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 108.662 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.486 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 p -139.98 158.77 43.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.99 -1.069 . . . . 0.0 109.36 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.895 ' HB2' HG23 ' A' ' 39' ' ' VAL . 6.2 m-85 -135.95 120.56 18.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.602 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 3.0 mt-10 -42.84 -42.86 3.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.966 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -110.05 119.74 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -51.68 -48.96 48.79 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.621 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 17.0 t30 -42.53 -71.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -1.045 . . . . 0.0 108.4 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.7 mt-10 -34.51 -42.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.79 -0.568 . . . . 0.0 109.755 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.969 HG12 HD22 ' A' ' 40' ' ' LEU . 1.2 t -58.01 -54.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.887 . . . . 0.0 108.688 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.969 HD22 HG12 ' A' ' 39' ' ' VAL . 3.1 mm? -61.36 -19.28 61.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -75.1 -45.28 42.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.163 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.45 -19.34 59.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.094 HD12 ' CD2' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -80.76 -105.04 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.28 -57.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.74 . . . . 0.0 109.497 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.5 t -100.99 -3.73 28.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.742 ' HE2' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER 83.42 110.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.78 0.8 . . . . 0.0 109.141 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.652 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 21.2 m -104.04 -74.77 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.584 -1.323 . . . . 0.0 111.84 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.715 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 45.4 Cg_endo -55.51 -161.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.441 1.232 . . . . 0.0 109.766 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.909 ' HB2' HD13 ' A' ' 119' ' ' ILE . 8.1 p30 -115.7 -8.4 12.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.182 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.924 HG21 HG13 ' A' ' 115' ' ' VAL . 2.3 t -156.91 123.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.959 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.915 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -100.3 143.97 29.86 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.954 HD22 ' CG2' ' A' ' 79' ' ' ILE . 5.2 mt -123.21 163.86 19.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.765 -1.209 . . . . 0.0 110.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 80' ' ' ILE . 20.4 t -133.01 115.48 15.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.642 ' O ' HG22 ' A' ' 55' ' ' ILE . 8.8 m-20 -60.87 -25.85 66.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.173 -0.955 . . . . 0.0 110.44 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER 49.79 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 108.984 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER 57.05 111.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.025 -1.047 . . . . 0.0 109.361 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.916 ' SD ' HD22 ' A' ' 63' ' ' LEU . 3.6 mtm -157.11 -176.15 0.59 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 109.649 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -103.43 70.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.008 1.53 . . . . 0.0 110.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.61 -155.43 7.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -81.81 127.33 32.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -1.147 . . . . 0.0 109.611 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.46 -92.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 109.537 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -119.51 -111.28 2.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.916 HD22 ' SD ' ' A' ' 57' ' ' MET . 11.4 tp -124.02 -7.06 7.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.66 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 63' ' ' LEU . . . 73.78 50.62 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.77 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.655 HD21 HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -162.17 16.98 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.106 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.4 mm? -70.61 -67.29 0.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.043 -1.036 . . . . 0.0 108.825 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -28.05 3.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.621 ' NE2' ' HA ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -57.07 -53.44 58.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.75 ' HA ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.57 -32.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.935 -0.478 . . . . 0.0 110.432 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.9 mmmt -99.15 -65.1 0.98 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.035 -1.041 . . . . 0.0 109.935 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -33.17 -33.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.799 -0.563 . . . . 0.0 110.896 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.565 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -92.5 -68.34 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.094 ' CD2' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -126.14 112.03 24.01 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 38.1 Cg_endo -134.05 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.67 1.353 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.545 ' CB ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -131.04 -14.89 3.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.912 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 50' ' ' VAL . 3.7 pp -131.23 167.16 22.96 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.092 -1.005 . . . . 0.0 108.531 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.2 Cg_endo -65.69 159.63 47.42 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.222 1.117 . . . . 0.0 111.247 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -126.48 101.26 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 109.337 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.954 ' CG2' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -65.24 157.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.195 -0.941 . . . . 0.0 109.108 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.581 HD11 ' CD1' ' A' ' 101' ' ' TYR . 6.5 pt -157.11 118.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.64 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.08 138.24 57.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.402 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 103' ' ' PRO . 16.8 m -75.39 121.65 22.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' HG23 ' A' ' 55' ' ' ILE . . . -171.4 40.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.754 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.3 m-70 67.92 110.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 84' ' ' HIS . 12.3 t 156.68 -73.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' ASP . 2.2 p30 -48.22 -28.98 3.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 110.054 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -36.06 -29.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -0.881 . . . . 0.0 111.198 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' ASP . 47.4 m-20 -107.61 -79.87 0.57 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.045 -1.034 . . . . 0.0 110.517 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 92' ' ' SER . . . -36.68 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.405 -0.809 . . . . 0.0 110.355 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 88' ' ' ASP . . . -74.39 -79.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 85.2 t -33.49 -41.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -113.61 -172.21 2.03 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 109.406 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 70.67 68.41 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.778 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.63 65.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 15.1 pt20 -73.87 -125.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.323 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.4 tp60 76.85 69.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.871 -1.143 . . . . 0.0 109.546 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 48.53 -158.38 0.88 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 67.8 20.32 9.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -1.152 . . . . 0.0 109.481 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' O ' ' CE1' ' A' ' 101' ' ' TYR . 1.1 m-85 -151.54 53.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.75 154.24 41.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.209 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 80' ' ' ILE . 1.3 m-85 -108.98 166.87 10.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.22 89.05 24.32 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.847 . . . . 0.0 109.163 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' A' ' 82' ' ' THR . 36.7 Cg_endo -58.94 168.21 4.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.076 1.566 . . . . 0.0 110.971 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -116.02 158.35 42.69 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.771 . . . . 0.0 109.058 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -83.23 169.74 56.67 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.63 -2.654 . . . . 0.0 110.312 0.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 13.7 p90 -149.39 163.1 38.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 109.09 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 5.6 t70 -87.78 -156.21 0.34 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.679 HG21 ' HB3' ' A' ' 22' ' ' ALA . 19.4 mm -120.61 -70.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.857 -1.152 . . . . 0.0 109.606 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' GLU . 9.2 t70 -54.46 -51.18 65.81 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 19.1 tp10 -42.85 -42.27 3.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -67.3 -72.98 0.15 Allowed 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.335 -0.853 . . . . 0.0 108.988 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.04 HG21 HD11 ' A' ' 23' ' ' LEU . 35.8 t -36.86 -68.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.789 -0.57 . . . . 0.0 110.2 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.35 -65.17 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' O ' ' A' ' 113' ' ' ALA . 33.7 tp -35.47 -53.93 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.676 0.751 . . . . 0.0 109.763 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.924 HG13 HG21 ' A' ' 50' ' ' VAL . 1.8 t -56.09 -57.53 8.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.497 ' C ' ' O ' ' A' ' 115' ' ' VAL . 19.3 mt-10 -33.54 -41.94 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.422 0.63 . . . . 0.0 110.187 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.6 mtt-85 -76.04 -54.85 6.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.697 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.2 -63.22 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 108.931 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.909 HD13 ' HB2' ' A' ' 49' ' ' ASP . 7.6 mt -33.84 -44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.152 0.501 . . . . 0.0 110.55 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.22 61.81 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.64 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -106.8 -40.25 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.611 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.0 p90 -120.55 31.01 6.64 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -135.66 36.08 2.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.947 -1.096 . . . . 0.0 109.728 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.578 179.713 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 8.6 tpt180 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.372 0.606 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 165.34 93.95 0.1 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 48' ' ' PRO . 5.8 mt -83.4 93.12 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.401 -1.058 . . . . 0.0 109.671 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.105 HG23 ' CG1' ' A' ' 50' ' ' VAL . 8.5 p -96.1 122.48 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.722 -0.611 . . . . 0.0 109.412 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.81 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.71 102.97 14.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.686 -1.259 . . . . 0.0 109.047 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.01 HG22 ' CB ' ' A' ' 52' ' ' LEU . 13.4 t -100.93 125.03 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.958 . . . . 0.0 110.625 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.15 112.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.572 -1.33 . . . . 0.0 108.366 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.698 ' OD1' HG22 ' A' ' 15' ' ' ILE . 20.9 t0 -68.1 164.98 19.07 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.272 0.558 . . . . 0.0 109.88 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 1.5 m-20 -96.21 -89.07 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.397 -0.815 . . . . 0.0 109.643 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 15' ' ' ILE . 1.1 m-20 -106.59 174.75 5.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.4 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 14.0 m -57.75 148.16 25.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.4 t 81.79 -11.96 1.01 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.961 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.698 HG22 ' OD1' ' A' ' 10' ' ' ASP . 12.6 mm -79.19 -35.81 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.0 -1.063 . . . . 0.0 108.745 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.601 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.3 ttp-105 -59.94 -46.03 90.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.482 ' O ' ' C ' ' A' ' 18' ' ' VAL . 55.1 t90 -58.29 -59.68 4.95 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.297 -0.877 . . . . 0.0 108.919 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.6 t -34.92 -60.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.579 0.704 . . . . 0.0 110.506 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 21' ' ' ARG . 3.1 mt -53.1 -71.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.978 -1.076 . . . . 0.0 109.152 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -35.13 -33.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.263 0.554 . . . . 0.0 110.818 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.02 -56.13 19.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 108.241 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.982 ' HB1' HG21 ' A' ' 108' ' ' ILE . . . -64.96 -9.83 24.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.119 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.785 HD11 HG21 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -85.77 -24.5 26.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.631 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.7 -43.96 85.53 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.26 -47.79 28.01 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -58.45 -17.59 21.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.157 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.815 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 63.08 54.01 36.08 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.933 HD22 HG13 ' A' ' 112' ' ' VAL . 2.7 mp -144.48 175.4 10.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.289 . . . . 0.0 109.999 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.526 ' CG2' HG23 ' A' ' 5' ' ' ILE . 30.4 m -107.78 85.34 2.1 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.858 -0.526 . . . . 0.0 110.994 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.58 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 50.8 t -88.69 83.34 6.73 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.872 -1.143 . . . . 0.0 109.853 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.523 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 15.7 m -80.04 125.15 29.41 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 8' ' ' VAL . 75.2 p -118.52 140.61 49.61 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.83 -1.169 . . . . 0.0 110.642 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.934 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 m-30 -116.24 113.38 22.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.618 -0.676 . . . . 0.0 109.215 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 47.1 mt-10 -37.24 -28.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.557 -0.714 . . . . 0.0 110.014 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -118.36 116.63 27.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.628 ' O ' HD13 ' A' ' 40' ' ' LEU . . . -49.19 -51.89 24.4 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.652 ' O ' HD22 ' A' ' 40' ' ' LEU . 17.3 t-20 -43.56 -72.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.568 -0.96 . . . . 0.0 108.934 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 37' ' ' ASN . 32.1 tp10 -31.49 -39.32 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.811 . . . . 0.0 110.133 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.934 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -63.99 -56.41 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.989 ' H ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -78.87 3.01 18.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.585 -1.322 . . . . 0.0 109.689 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.491 ' N ' HD22 ' A' ' 40' ' ' LEU . . . -99.47 -24.08 14.9 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.35 -19.85 15.44 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.041 HD13 HG23 ' A' ' 47' ' ' THR . 13.8 mt -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.505 -0.747 . . . . 0.0 109.47 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . . . -35.21 -31.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.786 -0.571 . . . . 0.0 110.732 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -65.51 -55.26 18.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 108.527 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER 164.86 115.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.056 HG22 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -44.59 167.54 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.186 -0.946 . . . . 0.0 109.103 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.056 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.8 Cg_endo -90.92 -65.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.679 1.358 . . . . 0.0 111.456 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.792 ' HB3' HG21 ' A' ' 119' ' ' ILE . 17.7 m-20 -121.49 -55.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.704 -1.248 . . . . 0.0 111.363 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.105 ' CG1' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -148.97 139.24 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.723 -1.236 . . . . 0.0 110.353 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.829 HD13 HG23 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.26 108.4 20.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.731 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.01 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.48 178.94 4.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.984 . . . . 0.0 108.971 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.754 ' HA ' HG12 ' A' ' 9' ' ' VAL . 38.2 m -162.42 126.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.087 . . . . 0.0 110.601 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 14.0 t0 -73.0 -144.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.094 -1.004 . . . . 0.0 108.401 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 54' ' ' ASP . 0.8 OUTLIER 174.57 78.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' CD ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -174.98 83.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.642 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.43 ' HB2' HD22 ' A' ' 63' ' ' LEU . 1.4 mmm -131.31 125.03 20.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -48.72 107.9 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.08 1.569 . . . . 0.0 110.518 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 125.1 140.73 5.49 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 87.3 mmm 61.64 11.83 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -1.086 . . . . 0.0 109.837 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 44.68 80.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.282 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . 66.54 90.09 0.05 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.718 ' CD1' HD21 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -56.76 -162.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -1.127 . . . . 0.0 109.416 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' N ' ' HG ' ' A' ' 63' ' ' LEU . . . -171.33 89.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.008 . . . . 0.0 109.994 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.718 HD21 ' CD1' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -88.24 -6.51 57.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 109.122 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -49.74 -22.02 1.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.33 -45.48 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.022 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.701 ' HG3' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.55 -45.96 23.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.15 . . . . 0.0 109.931 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.829 HG23 HD13 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -38.82 -32.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.902 -1.123 . . . . 0.0 110.161 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -95.6 -67.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.836 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -36.25 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.745 0.784 . . . . 0.0 110.339 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' LYS . 1.6 mmt85 -88.53 -93.32 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.262 0.553 . . . . 0.0 111.094 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.703 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 2.1 m-70 -53.03 144.38 27.83 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.3 Cg_endo -34.74 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 124.17 1.616 . . . . 0.0 111.196 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.42 94.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.802 HD21 ' OG1' ' A' ' 47' ' ' THR . 1.8 pp -125.61 151.73 70.94 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 1.075 ' HG2' HG23 ' A' ' 50' ' ' VAL . 36.9 Cg_endo -28.84 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.991 1.521 . . . . 0.0 112.219 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.89 146.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 42.8 mt -143.92 148.48 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -133.6 150.3 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.539 ' CE ' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.58 164.46 25.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.406 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 1.2 m -93.02 162.78 13.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 161.3 -62.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 109.063 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.467 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 t60 -176.44 -176.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 t 61.04 -124.0 0.9 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.609 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 36.56 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.254 -0.904 . . . . 0.0 109.818 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 10.79 -77.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.309 0.576 . . . . 0.0 111.78 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' ASP . 9.3 t70 -53.27 -64.74 0.72 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.193 . . . . 0.0 109.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -52.28 -46.16 65.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.272 -0.893 . . . . 0.0 110.56 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.5 -73.97 0.13 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 110.536 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 62.4 t -32.02 -32.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.996 -0.44 . . . . 0.0 111.205 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 19.4 t -102.95 161.45 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.758 -1.214 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 79.07 82.05 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.484 -0.76 . . . . 0.0 109.76 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ALA . 58.4 m-85 42.47 63.2 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -0.827 . . . . 0.0 109.899 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.27 134.66 49.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.065 -1.022 . . . . 0.0 109.345 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER 76.54 151.06 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 80.37 94.52 0.4 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 76.08 5.23 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -1.127 . . . . 0.0 109.111 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -126.87 112.36 15.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.276 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -124.72 167.52 14.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.168 -0.957 . . . . 0.0 109.661 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.17 105.19 9.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.042 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.8 OUTLIER -73.36 124.73 90.79 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 110.032 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -91.3 171.59 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.143 1.601 . . . . 0.0 109.716 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -117.21 145.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.725 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -82.05 166.99 70.15 Favored 'Cis proline' 0 C--N 1.317 -1.084 0 C-N-CA 120.401 -2.749 . . . . 0.0 110.114 -0.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.539 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 39.4 p90 -136.61 140.85 43.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.342 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.3 t0 -72.47 122.94 22.11 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.096 -1.003 . . . . 0.0 108.801 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.982 HG21 ' HB1' ' A' ' 22' ' ' ALA . 1.5 tp -61.44 -29.58 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 110.137 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -80.45 -49.43 11.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 108.518 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 17.2 tp10 -52.3 -31.65 33.92 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -78.72 -69.65 0.55 Allowed 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.293 -0.879 . . . . 0.0 109.194 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.933 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 t -35.37 -55.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.506 0.67 . . . . 0.0 110.148 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.595 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -64.55 -65.4 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 110.196 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.887 HD13 ' N ' ' A' ' 115' ' ' VAL . 1.3 tm? -33.46 -61.44 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.408 0.623 . . . . 0.0 110.293 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.989 ' CG1' HG21 ' A' ' 50' ' ' VAL . 84.4 t -56.64 -52.15 57.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 18.6 tp10 -35.42 -45.12 0.32 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.32 0.581 . . . . 0.0 110.233 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -52.55 -55.91 18.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.092 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.17 -58.39 5.69 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.258 -0.901 . . . . 0.0 108.765 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.828 HD11 HG12 ' A' ' 115' ' ' VAL . 2.4 mm -37.37 -38.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.73 -0.606 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.546 ' C ' ' O ' ' A' ' 119' ' ' ILE . 6.0 t -20.0 -66.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.173 0.511 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 120' ' ' SER . 21.0 t-80 160.2 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 121' ' ' HIS . 2.4 m-85 37.91 30.58 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.716 0.77 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -49.8 -24.68 2.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.759 -0.588 . . . . 0.0 109.728 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.35 179.86 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 4.1 ptm180 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.09 0.472 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -134.54 87.46 0.25 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.087 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.847 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.36 87.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.159 -1.201 . . . . 0.0 108.468 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.75 111.46 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.743 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.855 ' CE3' HG21 ' A' ' 31' ' ' THR . 10.6 m0 -101.71 106.86 17.94 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.995 . . . . 0.0 108.524 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.001 HG23 ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -85.6 169.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.794 0.807 . . . . 0.0 111.688 -177.507 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 39' ' ' VAL . 68.8 t -121.42 94.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 64.1 m-20 -93.37 -173.08 3.12 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.501 0.667 . . . . 0.0 110.432 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 24.5 t0 -122.24 -9.71 8.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB2' HG12 ' A' ' 15' ' ' ILE . 8.2 m-20 -147.12 164.48 32.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -42.6 73.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.408 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -54.52 -24.93 22.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.308 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.491 ' CG2' ' CG ' ' A' ' 10' ' ' ASP . 15.3 mm -71.59 -43.07 71.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.352 -0.843 . . . . 0.0 109.112 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.493 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.3 -44.14 75.49 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.456 ' O ' ' C ' ' A' ' 18' ' ' VAL . 19.8 t90 -60.41 -58.03 10.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.437 -0.789 . . . . 0.0 109.169 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.456 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.3 t -36.2 -62.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.645 -0.659 . . . . 0.0 110.743 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -57.36 -68.91 0.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.056 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -34.5 -32.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.683 -0.635 . . . . 0.0 110.455 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.7 tpp180 -66.97 -55.86 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.907 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -68.25 -5.99 21.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.462 -0.773 . . . . 0.0 109.059 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 3.3 mm? -102.15 -12.57 17.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.69 -40.85 28.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.66 97.52 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.0 -32.88 65.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.417 -1.049 . . . . 0.0 109.248 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 84.73 66.41 1.46 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.683 HD21 HG13 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -134.71 -176.14 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.195 -1.179 . . . . 0.0 110.587 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 18.1 m -99.21 78.23 2.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.59 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 43.8 t -80.23 84.77 5.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.587 -0.696 . . . . 0.0 111.331 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.855 HG21 ' CE3' ' A' ' 7' ' ' TRP . 2.6 m -88.52 141.24 28.69 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.617 ' CB ' HG12 ' A' ' 8' ' ' VAL . 66.5 p -146.33 119.66 8.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.702 -1.249 . . . . 0.0 109.846 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.128 ' HB2' HG22 ' A' ' 39' ' ' VAL . 12.1 m-85 -103.55 129.74 50.83 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.365 -0.834 . . . . 0.0 109.019 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG2' ' C ' ' A' ' 11' ' ' ASP . 0.8 OUTLIER -63.45 -8.49 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.864 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 1.019 ' O ' HG23 ' A' ' 39' ' ' VAL . 10.6 t30 -136.61 133.57 36.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.622 -1.299 . . . . 0.0 110.48 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.864 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . -51.09 -59.95 7.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.567 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -46.78 -73.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.272 -1.134 . . . . 0.0 108.92 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 37' ' ' ASN . 13.9 tp10 -32.7 -34.43 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.364 -0.835 . . . . 0.0 110.616 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.128 HG22 ' HB2' ' A' ' 33' ' ' PHE . 15.3 t -61.61 -57.97 9.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.099 -1.001 . . . . 0.0 109.015 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.956 HD12 ' N ' ' A' ' 41' ' ' ALA . 1.3 pp -62.42 -12.38 21.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.236 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.956 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -81.02 -30.2 34.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.468 -0.77 . . . . 0.0 109.183 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . . . -88.47 -28.45 20.83 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.604 HD11 ' HG3' ' A' ' 48' ' ' PRO . 13.0 mt -88.08 6.14 37.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 109.853 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -36.27 -28.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.876 -0.515 . . . . 0.0 110.327 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' LEU . 11.6 t -61.98 -56.68 16.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.882 -1.136 . . . . 0.0 108.222 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 173.59 -165.81 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.441 -0.787 . . . . 0.0 110.524 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.584 ' CG2' ' CB ' ' A' ' 76' ' ' LEU . 4.4 m -70.15 154.0 94.89 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.67 . . . . 0.0 110.929 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.604 ' HG3' HD11 ' A' ' 43' ' ' LEU . 38.6 Cg_endo -115.6 -116.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 N-CA-C 107.395 -1.81 . . . . 0.0 107.395 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.706 ' C ' HD13 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -100.08 -75.32 0.58 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.207 -1.558 . . . . 0.0 108.605 178.083 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.026 HG21 HG22 ' A' ' 115' ' ' VAL . 13.1 t -145.63 137.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.164 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.7 HD23 ' CG1' ' A' ' 69' ' ' ILE . 2.8 mp -102.51 110.61 22.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.931 -1.106 . . . . 0.0 110.606 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.001 ' HB3' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -83.72 161.11 21.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.31 -0.869 . . . . 0.0 109.685 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 80' ' ' ILE . 68.4 m -152.23 136.31 16.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 2.4 p30 -100.72 -158.61 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.072 -1.017 . . . . 0.0 110.047 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.69 HG12 ' HB3' ' A' ' 83' ' ' ALA . 1.2 pp -143.09 120.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 57' ' ' MET . 3.2 ttm-85 178.72 -78.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 12.7 mmt 54.22 170.06 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.076 -1.015 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.2 Cg_endo -84.32 161.68 13.09 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.856 1.45 . . . . 0.0 110.24 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.71 101.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -176.84 -40.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.0 109.491 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 60' ' ' MET . 0.4 OUTLIER -162.8 -77.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 57' ' ' MET . . . 152.74 -45.53 0.59 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -154.69 -76.48 0.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.312 -1.111 . . . . 0.0 109.3 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 63' ' ' LEU . . . 41.34 44.26 2.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.864 HD22 ' HA3' ' A' ' 36' ' ' GLY . 6.4 mt -130.86 -25.01 2.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HA ' ' CG2' ' A' ' 69' ' ' ILE . 1.2 tp -66.24 -10.39 41.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.718 -1.239 . . . . 0.0 108.719 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -71.86 -55.06 8.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.595 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -67.02 -53.78 27.97 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.701 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 0.8 OUTLIER -43.13 -14.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.228 -0.92 . . . . 0.0 111.017 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' GLN . 19.1 tptp -100.93 -74.08 0.62 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.31 -1.494 . . . . 0.0 108.003 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 70' ' ' LYS . 32.9 mm-40 -36.96 -59.25 0.72 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.501 0.667 . . . . 0.0 111.216 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.701 ' NE ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -35.74 -48.09 0.52 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.504 -0.748 . . . . 0.0 111.716 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.804 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 14.6 m-70 -107.58 142.16 24.57 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.68 -1.262 . . . . 0.0 109.428 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 32.1 Cg_endo -26.36 -78.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 124.203 1.633 . . . . 0.0 112.777 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -175.58 100.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.42 -1.425 . . . . 0.0 110.544 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER -123.14 168.09 13.06 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 108.857 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.801 ' HG2' HG22 ' A' ' 50' ' ' VAL . 33.7 Cg_endo -71.37 137.43 30.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.676 1.356 . . . . 0.0 111.63 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.673 ' CG2' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -126.32 156.29 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.932 HD11 HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -131.1 147.44 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.81 HG22 ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -153.91 125.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 2.7 mtt -66.43 125.73 26.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.474 HG21 ' HD1' ' A' ' 101' ' ' TYR . 27.6 p -86.93 87.35 7.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.609 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.69 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -109.76 -19.27 13.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.42 -65.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.549 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 3.5 m -77.94 -172.22 2.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 83.76 -44.52 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.666 -0.647 . . . . 0.0 109.551 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.2 mm? -34.19 -32.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.786 -0.571 . . . . 0.0 110.482 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.8 t0 -70.28 -68.91 0.39 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 88' ' ' ASP . . . -41.89 -26.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -82.51 -74.59 0.34 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.091 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 87' ' ' LEU . 99.0 t -34.25 -30.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.863 -0.523 . . . . 0.0 111.162 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.0 m -97.94 -153.32 0.42 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.974 -1.079 . . . . 0.0 109.708 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.12 69.81 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.049 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 95' ' ' GLN . 1.4 t80 67.64 10.42 7.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.3 -0.875 . . . . 0.0 109.004 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 10.7 tm0? 44.78 82.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.8 mt-30 163.37 -25.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.03 -144.35 44.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -143.06 59.5 1.42 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -1.125 . . . . 0.0 109.346 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.727 ' CE1' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 82.61 -24.57 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.633 -0.667 . . . . 0.0 109.887 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.81 ' HB2' HG22 ' A' ' 80' ' ' ILE . 44.3 p-10 -42.07 127.89 3.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 162.78 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.495 -0.753 . . . . 0.0 109.412 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' MET . 12.6 tp -109.12 141.83 24.26 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 108.977 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -104.93 -167.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.758 1.399 . . . . 0.0 111.04 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -154.69 160.63 30.74 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -72.76 143.87 79.03 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.387 -2.339 . . . . 0.0 110.764 0.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.773 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 88.4 t80 -129.64 169.68 14.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' CG ' ' A' ' 106' ' ' PHE . 3.7 t70 -85.91 -157.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.625 -0.672 . . . . 0.0 109.948 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.907 HD13 ' CB ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -130.12 -48.88 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 108.443 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.2 -41.45 81.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 11.3 tp10 -50.77 -47.84 59.5 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.773 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -62.0 -65.24 0.72 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.78 HG12 ' N ' ' A' ' 113' ' ' ALA . 2.2 t -34.7 -78.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.78 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -39.03 -70.28 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.647 -0.658 . . . . 0.0 111.578 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 113' ' ' ALA . 27.8 tp -36.35 -43.21 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.972 0.891 . . . . 0.0 110.073 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.026 HG22 HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -68.43 -58.73 5.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.657 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.1 mt-10 -36.92 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.488 0.661 . . . . 0.0 109.536 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 115' ' ' VAL . 1.7 mtp180 -85.05 -48.04 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.481 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -53.79 -62.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 108.96 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.839 ' CD1' HG23 ' A' ' 50' ' ' VAL . 7.1 mt -36.22 -40.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 t -71.86 -46.02 59.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.991 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -47.86 -71.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 109.903 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 3.2 m-85 -44.85 112.13 0.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.912 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER 168.85 -27.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.405 -0.809 . . . . 0.0 109.362 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.53 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.287 0.565 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.74 145.41 16.14 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.887 HG22 HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.39 95.81 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.471 -1.017 . . . . 0.0 110.419 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -91.22 113.04 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.009 -1.057 . . . . 0.0 108.604 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CE3' HG21 ' A' ' 31' ' ' THR . 12.8 m95 -102.84 98.85 8.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 109.934 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.689 HG22 ' CB ' ' A' ' 52' ' ' LEU . 15.2 t -85.48 167.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.483 -0.76 . . . . 0.0 109.378 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 39' ' ' VAL . 99.0 t -132.4 113.59 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 109.792 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.869 ' HB3' HG21 ' A' ' 15' ' ' ILE . 6.1 t70 177.87 -65.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.807 . . . . 0.0 109.484 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.562 ' HB3' ' CA ' ' A' ' 34' ' ' GLU . 20.9 t0 17.21 55.07 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.198 0.523 . . . . 0.0 111.478 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.893 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -112.95 52.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 11.9 t 144.22 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER 178.21 42.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.663 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.893 HD13 ' H ' ' A' ' 12' ' ' ASP . 2.4 mp -89.49 -40.53 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.987 . . . . 0.0 108.979 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.517 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 23.7 ttp180 -61.21 -41.39 96.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.455 ' O ' ' C ' ' A' ' 18' ' ' VAL . 76.5 t90 -62.66 -63.71 1.14 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 14' ' ' SER . 41.6 t -37.99 -65.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.759 0.79 . . . . 0.0 110.528 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' ARG . 16.4 mt -56.52 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 110.785 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.518 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 15.2 tm-20 -34.61 -30.13 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.907 -0.495 . . . . 0.0 111.215 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.3 tpt180 -68.12 -56.64 8.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.943 -1.098 . . . . 0.0 108.644 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.092 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -71.34 -8.69 55.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 0.0 109.015 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.804 HD22 ' SG ' ' A' ' 30' ' ' CYS . 3.0 mp -96.31 -16.69 21.18 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.82 -37.4 64.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.6 -36.3 58.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.21 -13.95 62.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -1.177 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.63 56.84 7.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.853 HD22 HG13 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -131.1 -178.04 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -1.234 . . . . 0.0 110.009 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.887 HG21 HG22 ' A' ' 5' ' ' ILE . 30.0 m -101.47 90.45 4.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.804 ' SG ' HD22 ' A' ' 23' ' ' LEU . 25.2 t -84.46 86.05 7.33 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.942 HG21 ' CE3' ' A' ' 7' ' ' TRP . 17.4 m -91.0 137.48 32.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 16.1 p -156.34 135.79 12.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.677 -1.264 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.569 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 29.8 m-85 -108.87 -170.44 1.66 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' CA ' ' HB3' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -108.92 -6.08 15.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.055 . . . . 0.0 109.536 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.86 143.84 26.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.86 ' CA ' HG11 ' A' ' 9' ' ' VAL . . . -60.02 -42.86 98.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.671 ' H ' HD22 ' A' ' 65' ' ' LEU . 4.4 t-20 -49.42 -79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.052 -1.263 . . . . 0.0 108.866 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 37' ' ' ASN . 50.2 mt-10 -34.46 -42.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.765 -0.584 . . . . 0.0 110.434 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.886 HG21 HG22 ' A' ' 9' ' ' VAL . 18.1 t -54.84 -55.48 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 40' ' ' LEU . 2.6 mm? -65.98 -18.13 65.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 108.829 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -73.8 -25.53 60.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 108.951 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.6 -17.27 17.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 73' ' ' HIS . 1.4 mm? -77.69 -9.2 58.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.99 -19.81 0.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -57.38 4.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 179.3 -164.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.935 ' CB ' HD22 ' A' ' 76' ' ' LEU . 10.2 t -100.03 135.72 20.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 36.2 Cg_endo -95.17 -95.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.04 1.547 . . . . 0.0 109.389 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.712 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -115.39 -75.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.864 -1.148 . . . . 0.0 109.086 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.834 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -149.57 142.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.33 -0.856 . . . . 0.0 109.467 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.948 ' CB ' HG12 ' A' ' 78' ' ' VAL . 6.5 tp -94.75 158.74 15.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.033 . . . . 0.0 108.797 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.689 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -141.57 127.76 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.998 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.3 p -94.04 103.79 15.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.333 -0.855 . . . . 0.0 108.889 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -88.01 122.64 31.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.955 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -98.06 81.86 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.65 ' HD3' HD11 ' A' ' 15' ' ' ILE . 1.8 ttt180 -114.27 -19.35 11.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.883 . . . . 0.0 109.754 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -45.14 140.89 3.53 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -100.11 147.36 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.956 1.503 . . . . 0.0 110.199 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.65 -174.77 17.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -24.24 64.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -1.153 . . . . 0.0 109.661 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -111.73 159.44 18.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.534 ' HA3' ' CD1' ' A' ' 55' ' ' ILE . . . -118.94 -53.82 0.28 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.889 ' HB2' HD12 ' A' ' 65' ' ' LEU . 0.7 OUTLIER 179.13 111.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.99 29.47 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.364 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.889 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -99.74 6.61 45.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 89' ' ' ALA . 10.4 tp -65.8 -60.74 2.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.649 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -48.02 -39.12 18.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.171 -0.956 . . . . 0.0 108.523 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 69' ' ' ILE . 3.8 tp60 -52.09 -56.59 13.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.692 HG12 HD23 ' A' ' 51' ' ' LEU . 8.2 mt -33.49 -76.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.266 0.555 . . . . 0.0 110.025 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.62 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -40.49 -59.37 1.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 110.085 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.85 -68.38 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.785 -0.572 . . . . 0.0 110.9 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 73' ' ' HIS . 1.7 mpp_? -73.06 -62.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -31.81 115.85 0.38 Allowed Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.778 -0.576 . . . . 0.0 110.327 -179.567 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 36.9 Cg_endo -41.26 -74.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.017 1.535 . . . . 0.0 110.441 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.2 ptp -178.39 64.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.54 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.935 HD22 ' CB ' ' A' ' 47' ' ' THR . 0.6 OUTLIER -126.31 148.63 64.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.726 ' HG2' HG22 ' A' ' 50' ' ' VAL . 37.0 Cg_endo -48.53 141.16 20.36 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.828 1.436 . . . . 0.0 111.815 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.948 HG12 ' CB ' ' A' ' 51' ' ' LEU . 2.5 m -139.63 97.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.643 HD11 HG23 ' A' ' 115' ' ' VAL . 11.2 mt -65.72 160.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 101' ' ' TYR . 1.3 pp -142.69 133.98 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -71.74 170.47 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.148 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.603 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.09 157.36 15.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.091 -1.006 . . . . 0.0 110.283 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.789 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . 169.6 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.46 ' C ' ' N ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 178.18 -77.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 110.497 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 86' ' ' ASP . 78.9 p 47.62 26.99 0.93 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 60.22 120.28 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.916 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 18.5 tp -38.12 -26.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.21 1.005 . . . . 0.0 108.523 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.7 t0 -32.7 -65.39 0.16 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.065 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.791 ' O ' HD23 ' A' ' 66' ' ' LEU . . . -82.43 -30.89 29.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.956 ' HB1' ' OH ' ' A' ' 101' ' ' TYR . . . -64.34 -65.65 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.171 -0.955 . . . . 0.0 109.144 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.49 -53.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 122.978 0.511 . . . . 0.0 111.504 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.59 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 1.6 t -56.66 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.043 -1.036 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 99' ' ' PHE . . . -128.27 -73.89 0.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.485 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 11.61 35.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 96' ' ' GLN . 5.5 mt-30 -98.24 108.54 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 108.55 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 11.3 tt0 61.39 164.13 0.08 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.988 . . . . 0.0 108.508 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.01 172.92 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.674 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . . . -125.63 103.83 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.05 -1.265 . . . . 0.0 109.791 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.836 ' CD1' HG23 ' A' ' 78' ' ' VAL . 33.2 p90 170.63 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.0 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.07 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.956 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -167.04 138.16 3.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.007 . . . . 0.0 110.024 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -128.47 113.46 19.52 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -103.94 164.95 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.668 1.351 . . . . 0.0 111.187 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 13.0 pttp -92.87 160.34 34.16 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.515 -0.741 . . . . 0.0 109.286 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -79.29 159.02 90.23 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 120.773 -2.594 . . . . 0.0 110.483 -0.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' A' ' 81' ' ' MET . 13.1 p90 -139.12 146.46 40.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.563 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 2.4 t70 -86.36 146.61 26.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 108.868 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.092 HD13 ' CB ' ' A' ' 22' ' ' ALA . 1.5 mp -76.8 -26.56 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.267 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.11 -36.58 19.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 40.8 tt0 -61.73 -42.19 98.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.96 -67.46 0.53 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.853 HG13 HD22 ' A' ' 28' ' ' LEU . 24.8 t -38.01 -52.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.497 -0.752 . . . . 0.0 110.937 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -62.58 -69.45 0.26 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.495 -0.753 . . . . 0.0 110.873 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.489 ' C ' ' O ' ' A' ' 113' ' ' ALA . 16.9 tp -34.79 -55.68 0.56 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.509 0.671 . . . . 0.0 109.943 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.712 HG22 HG21 ' A' ' 50' ' ' VAL . 1.2 t -54.79 -56.77 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.614 ' N ' HG12 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -38.02 -37.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 110.751 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.619 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -83.53 -35.69 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 110.268 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.619 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.4 -59.88 4.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.787 -1.195 . . . . 0.0 108.326 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.834 ' CD1' HG23 ' A' ' 50' ' ' VAL . 8.6 mt -34.5 -40.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.12 0.486 . . . . 0.0 110.384 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -85.61 53.32 2.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.585 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.564 ' NE2' ' CE1' ' A' ' 122' ' ' TYR . 23.7 p-80 -96.31 -9.19 30.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.564 ' CE1' ' NE2' ' A' ' 121' ' ' HIS . 8.2 m-85 -69.3 -5.86 25.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.79 53.01 1.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.395 179.9 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.489 0.662 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.63 112.42 0.61 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.354 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.84 HG23 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -90.73 111.62 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 108.892 179.27 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.696 HG12 HG23 ' A' ' 8' ' ' VAL . 61.5 t -104.51 107.28 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.031 . . . . 0.0 109.555 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.762 ' CZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.45 93.77 6.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 108.551 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.974 HG22 ' CB ' ' A' ' 52' ' ' LEU . 54.4 t -102.89 127.43 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.557 ' CG1' ' HA2' ' A' ' 36' ' ' GLY . 1.9 m -66.6 121.37 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB2' HG21 ' A' ' 15' ' ' ILE . 53.7 p-10 -110.45 178.67 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.206 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 34.1 t0 -74.4 -86.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.32 -0.862 . . . . 0.0 109.788 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.72 173.65 11.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 11.7 p -75.93 -30.37 58.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.805 . . . . 0.0 109.358 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -73.82 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.317 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 10' ' ' ASP . 24.6 mm -66.01 -32.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 108.831 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.63 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 11.6 ptt180 -68.08 -35.31 77.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.517 ' CH2' ' HG3' ' A' ' 21' ' ' ARG . 1.8 t-105 -55.12 -66.16 0.46 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 54.0 t -40.77 -65.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.816 0.817 . . . . 0.0 110.478 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.659 ' C ' HD12 ' A' ' 23' ' ' LEU . 4.1 mm? -54.78 -75.07 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.569 -0.707 . . . . 0.0 110.986 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -34.5 -31.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.331 0.586 . . . . 0.0 110.219 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.08 -58.61 6.69 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.92 -10.07 50.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -0.823 . . . . 0.0 109.238 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.993 HD22 ' CB ' ' A' ' 30' ' ' CYS . 1.5 mt -93.15 -13.03 28.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 109.758 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.34 61.95 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.93 -38.0 37.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.02 79.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -1.142 . . . . 0.0 108.726 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' HG ' ' A' ' 28' ' ' LEU . . . 95.69 50.11 2.03 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.977 HD13 HG11 ' A' ' 112' ' ' VAL . 1.1 mt -141.03 166.66 24.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.937 -1.331 . . . . 0.0 109.941 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 5' ' ' ILE . 87.5 m -101.4 60.04 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.993 ' CB ' HD22 ' A' ' 23' ' ' LEU . 33.7 t -81.4 88.49 6.12 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 109.658 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 11.8 m -101.18 137.46 39.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 109.472 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 8' ' ' VAL . 1.2 p -109.66 165.49 11.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 108.671 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.65 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.0 m-85 -137.91 115.97 11.68 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.082 -1.012 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 14.3 tt0 -36.67 -39.1 0.19 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.96 -0.462 . . . . 0.0 110.461 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -111.92 126.1 54.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 110.521 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.557 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -51.68 -45.84 54.36 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.699 ' HA ' HD12 ' A' ' 40' ' ' LEU . 8.7 t-20 -60.28 -63.53 1.27 Allowed 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.181 -1.187 . . . . 0.0 107.866 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 20.0 tp10 -34.57 -28.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.551 -0.718 . . . . 0.0 110.809 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -81.88 -51.08 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.919 -1.113 . . . . 0.0 110.504 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.059 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.47 -11.36 60.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.791 -1.193 . . . . 0.0 109.753 -179.124 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.973 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -94.44 -49.11 5.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.24 -25.11 46.43 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.762 HD21 ' CZ3' ' A' ' 7' ' ' TRP . 7.9 mt -73.17 -77.64 0.1 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.39 -47.94 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -99.24 -26.12 14.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.732 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 64.42 62.82 0.79 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 123.49 1.614 . . . . 0.0 109.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.62 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -104.33 40.97 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 119.752 -1.842 . . . . 0.0 112.771 -179.135 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.766 ' HA ' HD12 ' A' ' 5' ' ' ILE . 38.0 Cg_endo -101.08 -167.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 116.842 -1.638 . . . . 0.0 109.633 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -92.97 -52.48 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.969 HG23 ' CD1' ' A' ' 119' ' ' ILE . 6.6 t -146.59 128.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 108.89 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.943 ' O ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -98.47 114.82 27.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 0.0 108.376 179.096 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.974 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -108.4 -174.28 2.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.371 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.569 ' OG ' HD13 ' A' ' 63' ' ' LEU . 26.6 t -155.24 123.89 6.05 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 9' ' ' VAL . 13.9 p-10 -102.63 149.75 24.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.98 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -102.88 109.78 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -161.63 28.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.469 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.404 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 3.7 mtt -93.74 125.94 51.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.491 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.6 Cg_endo -103.55 131.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.929 1.489 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.15 -74.23 0.31 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -161.1 128.28 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.422 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 68.72 149.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.98 -84.15 0.66 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.992 ' HB2' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -146.52 -54.3 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -1.107 . . . . 0.0 109.484 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . . . 47.47 60.83 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.427 -0.795 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.992 HD12 ' HB2' ' A' ' 63' ' ' LEU . 1.4 mt -124.35 8.41 8.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.742 HD11 HD12 ' A' ' 80' ' ' ILE . 4.9 mp -75.73 -19.18 59.25 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.278 -0.889 . . . . 0.0 108.699 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 2.9 pttt -66.01 -39.2 90.07 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.529 ' OE1' ' CA ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -80.38 -57.06 3.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 109.235 179.28 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.892 HG12 HD23 ' A' ' 51' ' ' LEU . 2.6 mt -39.71 -32.71 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.896 -1.127 . . . . 0.0 110.239 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -92.09 -73.09 0.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.087 -1.008 . . . . 0.0 110.379 -178.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -35.22 -30.78 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.554 -0.716 . . . . 0.0 110.565 -179.021 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.548 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -97.91 -58.55 1.96 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 110.368 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' CB ' ' A' ' 46' ' ' LYS . 1.2 m-70 -98.38 133.03 23.2 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.403 -0.811 . . . . 0.0 109.496 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.598 ' N ' ' HE2' ' A' ' 46' ' ' LYS . 39.6 Cg_endo -138.59 1.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 117.341 -1.306 . . . . 0.0 112.162 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.56 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 3.6 mtt -68.59 7.12 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.695 -1.253 . . . . 0.0 112.778 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -163.06 177.76 1.78 Allowed Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.186 -1.571 . . . . 0.0 109.918 179.007 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.0 Cg_endo -86.99 164.66 8.72 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.885 1.466 . . . . 0.0 111.064 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.943 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.17 144.91 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.734 HD12 ' C ' ' A' ' 78' ' ' VAL . 3.5 mp -137.78 164.0 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 109.739 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.742 HD12 HD11 ' A' ' 66' ' ' LEU . 11.9 tt -141.99 157.39 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -81.93 166.49 19.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.28 102.7 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.564 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.76 ' HB3' ' OD2' ' A' ' 86' ' ' ASP . . . -96.74 -151.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -144.23 32.36 1.22 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.62 -34.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.76 ' OD2' ' HB3' ' A' ' 83' ' ' ALA . 1.3 p30 -49.93 -24.17 2.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.017 -1.052 . . . . 0.0 109.692 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 87' ' ' LEU . 4.0 tp -34.97 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.83 -0.544 . . . . 0.0 110.913 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 86' ' ' ASP . 42.8 t0 -58.83 -59.19 5.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.995 -1.065 . . . . 0.0 109.883 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.26 -44.49 29.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 109.961 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -50.21 -41.7 50.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.689 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -33.07 -41.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.457 0.646 . . . . 0.0 109.99 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 5.9 t -64.11 86.18 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.359 0.6 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.75 -47.96 0.19 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -72.67 -18.95 61.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -69.02 -12.04 61.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.54 -0.725 . . . . 0.0 109.204 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.42 -157.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 109.33 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.81 67.88 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . -168.08 52.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -1.122 . . . . 0.0 109.324 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 36.7 m-85 -151.92 164.41 37.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.607 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.469 ' HB3' HG12 ' A' ' 79' ' ' ILE . 2.4 t0 -158.44 -157.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.37 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.14 142.83 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 109.791 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.23 139.86 35.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 108.893 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -114.72 176.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.748 1.394 . . . . 0.0 110.806 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 2.6 mtmp? -121.92 158.41 54.87 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 0.0 109.153 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -89.72 174.04 24.02 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 120.505 -2.706 . . . . 0.0 110.195 -0.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 33.2 p90 -153.59 161.17 42.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 14.6 t0 -73.92 -146.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 108' ' ' ILE . 16.2 mm -120.48 -68.05 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 108.798 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.514 ' OD1' ' HB2' ' A' ' 113' ' ' ALA . 11.7 t0 -59.79 -46.55 88.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 28.1 tt0 -43.09 -41.69 3.69 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.76 -75.88 0.11 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.977 HG11 HD13 ' A' ' 28' ' ' LEU . 52.1 t -38.39 -69.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 110.243 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . . . -39.36 -62.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' A' ' 113' ' ' ALA . 7.4 tp -34.3 -56.11 0.51 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.375 0.607 . . . . 0.0 109.944 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -58.24 -52.66 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.526 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 37.7 tp10 -39.19 -36.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.419 -0.801 . . . . 0.0 110.807 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.615 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -77.92 -36.77 49.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 110.74 -178.388 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.615 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.75 -53.61 51.77 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.733 -1.229 . . . . 0.0 108.044 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.969 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.3 mt -41.14 -50.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.517 0.675 . . . . 0.0 111.008 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.487 ' O ' ' C ' ' A' ' 121' ' ' HIS . 1.5 t -35.02 -34.9 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.447 -0.783 . . . . 0.0 111.998 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 t-80 -32.65 -66.37 0.14 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.546 -0.721 . . . . 0.0 111.273 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.63 -19.31 13.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.03 -1.044 . . . . 0.0 109.931 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.403 ' HB2' HG22 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -88.54 55.99 3.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.207 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.498 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.182 0.515 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.772 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -162.62 119.84 0.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.799 HD13 ' N ' ' A' ' 5' ' ' ILE . 1.1 mm -102.54 116.12 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -1.205 . . . . 0.0 109.528 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.586 ' CG1' HG23 ' A' ' 8' ' ' VAL . 1.5 t -123.65 109.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -0.796 . . . . 0.0 108.951 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.646 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 27.7 m0 -99.13 89.16 4.15 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.351 -1.339 . . . . 0.0 107.489 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.821 HG22 ' CG ' ' A' ' 52' ' ' LEU . 27.6 t -73.28 142.68 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.547 -0.721 . . . . 0.0 110.136 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.899 HG22 HG21 ' A' ' 39' ' ' VAL . 40.6 t -92.7 102.4 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.95 -1.094 . . . . 0.0 109.251 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.656 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 88.8 m-20 -53.96 -173.23 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 110.002 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -137.47 -5.97 1.77 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.337 -0.852 . . . . 0.0 110.786 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 171.29 55.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.458 -1.402 . . . . 0.0 110.871 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 54.69 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.559 0.695 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 75.4 -7.82 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.161 -0.962 . . . . 0.0 109.828 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' A' ' 10' ' ' ASP . 18.0 mm -85.48 -32.16 7.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.074 -1.017 . . . . 0.0 108.718 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.486 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.7 OUTLIER -62.38 -45.5 92.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.436 ' O ' ' C ' ' A' ' 18' ' ' VAL . 26.9 t90 -58.7 -60.49 3.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.5 t -39.21 -70.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 110.914 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 8' ' ' VAL . 7.8 mt -57.35 -72.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.391 -0.818 . . . . 0.0 110.838 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 19' ' ' LEU . 3.3 tt0 -35.8 -30.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 110.526 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 8.7 tpt85 -66.41 -56.0 13.08 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -71.11 -4.43 25.16 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.484 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.775 HD12 ' HB2' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -103.73 -11.35 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -43.88 42.68 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.62 -19.56 69.2 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.71 -19.37 32.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.581 -0.952 . . . . 0.0 108.726 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.6 50.03 33.62 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.808 HD12 HG11 ' A' ' 112' ' ' VAL . 13.8 mt -123.77 179.01 4.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 110.425 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 29' ' ' THR . 18.0 m -95.49 67.3 2.87 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 23' ' ' LEU . 38.6 t -79.64 83.64 5.59 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.953 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.646 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 5.2 m -94.84 143.29 26.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.7 p -138.67 119.43 14.15 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.519 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.99 ' HB2' HG22 ' A' ' 39' ' ' VAL . 7.5 m-85 -85.01 -157.65 0.31 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -118.36 -37.36 3.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.913 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.786 ' O ' HG23 ' A' ' 39' ' ' VAL . 49.1 m-80 -131.1 146.8 52.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.005 . . . . 0.0 109.81 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 37' ' ' ASN . . . -53.12 -39.71 58.18 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 2.2 m-20 -47.63 -84.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.904 -1.35 . . . . 0.0 108.343 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.8 mt-10 -35.14 -48.09 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.757 -0.589 . . . . 0.0 110.969 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 33' ' ' PHE . 48.6 t -50.37 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.984 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.4 tm? -54.21 -20.72 7.36 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.527 -0.733 . . . . 0.0 109.527 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -68.7 -41.49 79.08 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.6 -15.63 48.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.919 HD11 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -84.1 -0.81 53.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.0 109.862 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.91 -19.59 7.01 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.14 -0.975 . . . . 0.0 108.753 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 2.4 m -88.74 -27.81 20.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER 90.21 69.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -102.32 -90.57 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 111.185 -179.119 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 1.038 ' HG2' HD21 ' A' ' 51' ' ' LEU . 37.4 Cg_endo -40.55 130.84 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.835 1.439 . . . . 0.0 111.129 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.814 ' HB3' HG21 ' A' ' 119' ' ' ILE . 4.8 m-20 -75.88 -23.76 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.89 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -136.95 123.52 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.038 HD21 ' HG2' ' A' ' 48' ' ' PRO . 3.9 mm? -102.06 132.25 48.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.301 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 79' ' ' ILE . 2.5 mt -104.71 165.37 11.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.065 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.479 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 49.1 m -142.5 109.95 5.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.43 169.98 16.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.726 ' HB ' HD13 ' A' ' 63' ' ' LEU . 2.1 tp -130.33 97.04 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -175.53 73.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.414 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.4 ' HB2' ' CA ' ' A' ' 62' ' ' GLY . 26.7 mtm -134.1 171.69 8.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.378 -0.826 . . . . 0.0 109.452 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -97.64 143.45 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.001 1.527 . . . . 0.0 110.181 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.37 -173.92 16.87 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -59.99 109.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' CA ' ' A' ' 85' ' ' SER . 0.1 OUTLIER 72.21 -165.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.969 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 169.85 39.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.846 HD23 HD21 ' A' ' 66' ' ' LEU . 51.7 tp -105.09 64.54 0.72 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -1.184 . . . . 0.0 109.549 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . 41.8 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.348 -0.845 . . . . 0.0 109.787 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 68' ' ' GLN . 1.1 tp -127.7 70.85 1.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 109.296 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.947 HD11 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -71.45 -59.68 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 109.713 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -46.58 -31.72 2.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.818 -1.176 . . . . 0.0 108.261 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.579 ' HG3' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.74 -57.41 7.17 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.63 HG23 ' CG ' ' A' ' 73' ' ' HIS . 1.5 mt -38.67 -64.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.569 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -42.75 -64.61 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.233 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.1 tp60 -34.05 -43.35 0.14 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.847 -0.533 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.721 ' O ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.7 60.55 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.057 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.818 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.7 t-80 -156.71 131.17 5.05 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -52.39 -170.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.604 1.318 . . . . 0.0 110.49 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mmt -95.53 48.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 110.763 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 73' ' ' HIS . 3.3 pp -91.17 122.41 66.44 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.869 -1.144 . . . . 0.0 108.463 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.687 ' O ' HD12 ' A' ' 76' ' ' LEU . 34.8 Cg_endo -34.31 147.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.11 1.584 . . . . 0.0 112.52 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.8 124.3 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.939 HG21 HD13 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -89.16 133.31 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.0 109.313 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.605 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -119.35 140.66 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.385 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.9 ttm -109.56 113.64 26.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.507 ' O ' HG21 ' A' ' 55' ' ' ILE . 87.5 m 49.89 72.83 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.605 ' HB2' ' CG2' ' A' ' 80' ' ' ILE . . . -91.0 165.11 13.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.888 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -167.78 -88.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.699 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER 40.19 44.64 1.59 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 10.2 t70 67.74 132.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.901 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 15.1 mt -35.17 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 109.271 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -35.68 -67.03 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.947 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -72.46 -24.28 61.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 108.626 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -71.41 -76.17 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 109.564 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' A' ' 90' ' ' ALA . 2.9 t -11.27 -58.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 122.804 0.442 . . . . 0.0 111.744 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 90' ' ' ALA . 4.9 t -40.42 108.81 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 109.75 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 92' ' ' SER . . . 176.4 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.802 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.54 -11.21 59.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.279 -0.888 . . . . 0.0 109.96 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.35 107.49 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.834 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER 55.77 45.46 24.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.88 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 96' ' ' GLN . . . 43.14 -122.63 3.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.58 -93.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.454 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 92' ' ' SER . 5.6 m-85 -62.92 171.52 2.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.87 134.52 7.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.0 109.998 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.01 95.22 9.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 79' ' ' ILE . 2.3 tp -101.27 132.55 21.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.97 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -121.57 -161.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.834 1.439 . . . . 0.0 109.94 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 8.4 mttt -117.99 159.75 41.65 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.213 -0.929 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -83.22 173.23 44.99 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.703 -2.624 . . . . 0.0 110.476 0.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 38.6 p90 -167.9 130.32 1.54 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 7.4 t70 -70.28 149.07 47.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.154 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 19' ' ' LEU . 36.9 mm -66.11 -40.72 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -74.96 -40.85 60.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 9.9 tp10 -51.05 -33.64 26.42 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -83.06 -73.67 0.39 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.47 -0.769 . . . . 0.0 109.666 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -36.6 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.495 -0.753 . . . . 0.0 110.069 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.596 ' HA ' ' HG2' ' A' ' 116' ' ' GLU . . . -79.9 -66.83 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.747 0.784 . . . . 0.0 109.861 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.8 tm? -38.47 -36.71 0.26 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.278 1.037 . . . . 0.0 109.259 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 50' ' ' VAL . 1.1 t -74.13 -59.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.62 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.1 pt-20 -38.72 -30.88 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.939 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -77.14 -54.36 6.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.118 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 121' ' ' HIS . . . -46.07 -60.93 1.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 108.972 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.89 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.2 mt -35.78 -42.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.227 0.537 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -92.21 50.29 1.62 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 3.4 t60 -97.79 -41.36 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.219 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -84.35 10.99 9.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.325 -0.86 . . . . 0.0 109.584 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -95.74 18.75 12.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.609 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 122.142 0.973 . . . . 0.0 108.858 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.833 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 136.07 161.38 9.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.833 HD13 ' O ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER -131.61 112.37 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.245 . . . . 0.0 109.628 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 6' ' ' VAL . 1.1 t -126.84 114.22 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.687 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.63 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 15.3 m0 -99.88 89.59 4.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.793 -1.192 . . . . 0.0 108.668 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.977 HG22 ' CB ' ' A' ' 52' ' ' LEU . 70.8 t -77.18 143.64 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.661 -0.649 . . . . 0.0 110.846 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 75.5 t -82.44 110.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 0.0 109.109 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 16' ' ' ARG . 14.0 m-20 -56.32 168.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 109.923 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.85 23.44 4.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 109.321 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 170.49 176.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.156 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' SER . 81.0 p -79.05 146.57 33.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.0 OUTLIER 75.74 4.65 3.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 12' ' ' ASP . 45.5 mm -78.11 -32.47 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.796 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -58.93 -47.61 84.44 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 15.3 t90 -58.19 -64.22 0.99 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.2 t -37.0 -69.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.534 -0.729 . . . . 0.0 110.83 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.4 mt -49.54 -76.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 110.52 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 19' ' ' LEU . 10.6 tp10 -36.05 -29.38 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.701 -0.624 . . . . 0.0 110.737 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -65.4 -55.77 16.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.0 -7.27 33.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.485 -0.759 . . . . 0.0 109.135 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.012 HD11 HG21 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -104.9 -5.36 21.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.79 26.92 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.35 38.59 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.94 80.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -1.12 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 3' ' ' ARG . . . 98.23 61.42 0.89 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.83 HD13 HG11 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -136.82 179.1 6.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -1.162 . . . . 0.0 109.765 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 29' ' ' THR . 24.2 m -100.4 75.56 1.8 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.0 t -81.09 88.66 5.97 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.384 -0.823 . . . . 0.0 110.02 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.63 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 20.2 m -97.79 145.28 26.54 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -139.93 152.16 46.15 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.732 -1.23 . . . . 0.0 110.09 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.895 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.9 m-85 -134.1 122.91 23.58 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.778 0.799 . . . . 0.0 109.023 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -43.81 -49.75 8.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.997 ' O ' HG23 ' A' ' 39' ' ' VAL . 6.5 m-20 -117.25 138.28 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.437 -1.415 . . . . 0.0 112.188 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.56 -15.03 15.92 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' VAL . 9.4 t30 -67.28 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.0 tt0 -35.66 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.869 -0.519 . . . . 0.0 109.821 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 35' ' ' ASN . 35.2 t -61.93 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.064 HD11 ' CB ' ' A' ' 72' ' ' ARG . 3.4 tm? -64.88 -16.58 63.38 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.319 0.581 . . . . 0.0 109.65 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.35 -21.06 21.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.935 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.08 -21.26 18.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 46' ' ' LYS . 7.5 mt -88.85 -96.84 0.09 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.38 -54.72 0.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 12.6 m -101.06 -5.51 25.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.941 ' HA ' HD22 ' A' ' 43' ' ' LEU . 11.7 mttt 62.73 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 109.202 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -100.66 -61.88 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 111.638 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.738 ' O ' HD22 ' A' ' 76' ' ' LEU . 36.8 Cg_endo -49.88 -177.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.6 1.316 . . . . 0.0 110.56 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.705 ' HB3' HG21 ' A' ' 119' ' ' ILE . 2.5 m-20 -90.85 -25.3 19.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 110.487 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.5 t -148.79 132.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.846 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -101.23 126.65 47.98 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.977 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -108.71 174.42 5.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.803 ' OG ' HD21 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -155.72 124.07 5.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.03 169.78 10.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 ' CE1' ' A' ' 84' ' ' HIS . 1.1 tp -144.31 115.3 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 109.403 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -141.91 -28.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.358 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.487 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -97.36 105.22 23.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.973 -1.08 . . . . 0.0 109.513 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 36.6 Cg_endo -75.99 137.91 20.11 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.042 1.549 . . . . 0.0 110.399 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 60' ' ' MET . . . 144.26 -114.18 0.79 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 3.2 mpp? -145.78 32.9 1.03 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -1.129 . . . . 0.0 109.403 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.17 4.4 2.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.897 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.487 ' HA3' ' HG3' ' A' ' 57' ' ' MET . . . -105.73 -86.88 1.94 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -79.13 -0.5 31.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 109.488 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.33 64.49 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 108.944 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.0 mp -81.65 0.21 39.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.522 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.803 HD21 ' OG ' ' A' ' 53' ' ' SER . 2.6 mm? -78.23 -14.55 59.4 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.181 -0.949 . . . . 0.0 108.525 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.08 57.09 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -69.46 -50.94 40.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 108.847 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.63 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 2.2 tt -33.59 -60.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.643 -0.66 . . . . 0.0 110.302 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 1.1 tptm -69.72 -55.75 9.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.797 -1.189 . . . . 0.0 110.152 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.8 tt0 -35.49 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.84 -0.538 . . . . 0.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 1.064 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.16 -48.4 3.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.682 -1.261 . . . . 0.0 112.232 -178.18 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.63 ' HD2' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -105.08 134.54 19.59 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.286 -1.509 . . . . 0.0 111.482 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.508 ' O ' ' HG2' ' A' ' 75' ' ' MET . 38.6 Cg_endo -133.97 95.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 117.376 -1.283 . . . . 0.0 111.173 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 23.1 mtt -152.41 -102.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.125 -0.984 . . . . 0.0 109.601 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -55.82 176.89 0.16 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.872 -1.143 . . . . 0.0 109.215 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.5 Cg_endo -83.85 173.16 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.716 1.377 . . . . 0.0 110.412 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 118.53 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 2.8 mt -113.56 133.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 109.767 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 ' HB2' ' A' ' 53' ' ' SER . 4.1 pt -131.13 172.22 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -85.96 153.06 22.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -89.84 137.28 32.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.396 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 169.61 41.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -162.51 164.79 26.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.463 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 29.0 t -62.04 87.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 108.705 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.919 ' HA ' HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER 61.84 30.13 18.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.945 HD12 ' CB ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 35.55 35.71 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -177.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 10.49 -61.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.082 -1.872 . . . . 0.0 111.199 -177.295 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . -69.68 14.49 0.1 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.825 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.945 ' CB ' HD12 ' A' ' 87' ' ' LEU . . . -128.38 -77.37 0.56 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 119.812 -1.805 . . . . 0.0 107.464 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.919 HG21 ' HA ' ' A' ' 86' ' ' ASP . 53.0 t -38.01 -29.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.711 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -103.32 -165.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 109.786 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 76.29 -165.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.306 -0.871 . . . . 0.0 109.473 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -45.56 -58.22 3.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.156 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.09 55.19 9.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -33.66 0.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 98' ' ' ALA . . . -50.95 -73.81 0.34 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . 167.65 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -137.28 -176.24 4.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.551 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.6 OUTLIER -150.76 -42.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.923 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' A' ' 100' ' ' ASP . 9.8 m-85 75.91 136.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.2 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.81 118.87 16.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.67 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -94.79 179.38 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.013 1.533 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -113.9 153.87 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.19 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -88.7 167.3 38.07 Favored 'Cis proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.535 -2.694 . . . . 0.0 110.427 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -152.09 152.19 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.3 t0 -82.3 174.13 11.42 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.046 -1.034 . . . . 0.0 108.927 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 mm -90.47 -64.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.727 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 110' ' ' GLU . 48.3 t0 -57.28 -46.95 82.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 108.567 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 1.5 tm-20 -44.5 -42.67 7.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.05 -72.27 0.2 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.012 HG21 HD11 ' A' ' 23' ' ' LEU . 40.8 t -36.21 -70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.333 0.587 . . . . 0.0 110.204 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.3 -65.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.967 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 117' ' ' ARG . 2.0 tt -34.07 -52.69 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.692 0.758 . . . . 0.0 109.576 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 50' ' ' VAL . 2.3 t -55.9 -56.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 115' ' ' VAL . 59.3 mm-40 -36.9 -37.45 0.15 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 110.61 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.552 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -84.86 -36.06 21.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.109 -179.11 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.552 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.23 -61.36 2.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.779 -1.201 . . . . 0.0 108.007 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.1 mt -34.84 -42.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.298 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.12 56.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -138.76 -64.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 122' ' ' TYR . 36.6 p90 -91.28 29.78 1.38 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.327 -0.858 . . . . 0.0 109.773 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -80.44 -15.27 57.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.0 109.532 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.58 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.524 0.678 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.509 ' CA ' HD23 ' A' ' 28' ' ' LEU . . . -146.55 177.98 24.53 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.723 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 69.9 mt -142.11 104.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.058 . . . . 0.0 109.006 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.979 HG13 HD13 ' A' ' 52' ' ' LEU . 2.4 t -99.47 106.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.728 -0.607 . . . . 0.0 110.464 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.661 ' HB2' HD12 ' A' ' 51' ' ' LEU . 40.6 m0 -98.73 92.32 5.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.997 HG22 ' HB2' ' A' ' 52' ' ' LEU . 59.7 t -90.86 167.76 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.904 0.859 . . . . 0.0 112.076 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.654 HG22 ' HA2' ' A' ' 36' ' ' GLY . 58.0 t -98.36 129.95 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.823 ' HA ' HG21 ' A' ' 15' ' ' ILE . 6.5 m-20 -49.3 -171.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.262 1.03 . . . . 0.0 112.187 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 29.6 t0 -159.58 -67.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -108.1 174.91 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.5 t -70.44 137.13 50.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.2 p 79.61 33.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.445 -0.785 . . . . 0.0 109.738 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.823 HG21 ' HA ' ' A' ' 10' ' ' ASP . 2.1 mm -80.95 -36.51 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 108.86 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 12.9 mtt180 -59.74 -44.54 93.74 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.446 ' O ' ' C ' ' A' ' 18' ' ' VAL . 10.7 t90 -64.57 -67.55 0.43 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.3 t -38.39 -68.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 110.734 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' HD23 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -52.1 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.486 -0.759 . . . . 0.0 110.693 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 19' ' ' LEU . 5.4 tt0 -34.62 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.795 -0.566 . . . . 0.0 110.821 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' LEU . 2.2 mmm180 -67.82 -56.65 8.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.972 -1.08 . . . . 0.0 108.655 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -6.08 34.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.184 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.997 HD11 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -102.92 -8.7 20.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.893 . . . . 0.0 109.646 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.43 -42.24 23.04 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.24 97.97 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.82 71.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.35 -1.088 . . . . 0.0 108.552 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.01 49.7 1.44 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.09 HD22 ' CG1' ' A' ' 112' ' ' VAL . 2.3 mp -141.03 173.48 11.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.867 -1.373 . . . . 0.0 110.081 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 29' ' ' THR . 3.6 m -98.96 89.93 4.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.539 -0.726 . . . . 0.0 109.165 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.516 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 21.1 t -90.75 90.91 8.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 110.283 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.575 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 m -92.74 146.97 23.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.77 135.57 28.01 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.913 -1.117 . . . . 0.0 109.464 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.584 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 47.3 m-85 -108.82 126.37 52.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.065 -1.022 . . . . 0.0 109.159 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -42.13 -25.26 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.043 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' PHE . 16.7 t-20 -125.96 127.95 46.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.054 . . . . 0.0 110.487 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.717 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -55.81 -50.0 63.32 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -45.26 -65.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 2.9 tt0 -34.63 -48.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.977 -0.452 . . . . 0.0 110.484 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.796 ' CG1' HD11 ' A' ' 51' ' ' LEU . 99.7 t -47.48 -55.56 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 40' ' ' LEU . 2.9 mm? -65.41 -27.59 68.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -62.4 -29.06 70.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.0 -35.25 29.1 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 43' ' ' LEU . 1.2 tm? -48.57 -25.76 1.88 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -35.52 -49.01 0.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.596 0.712 . . . . 0.0 109.156 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -78.41 -51.86 9.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.319 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 160.91 135.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.639 HG21 HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.93 -155.92 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.723 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.2 Cg_endo -129.64 -86.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 117.205 -1.397 . . . . 0.0 111.474 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.487 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 66.7 m-20 -115.52 -73.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.453 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.881 HG22 ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -119.29 124.02 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.08 . . . . 0.0 111.41 -177.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.796 HD11 ' CG1' ' A' ' 39' ' ' VAL . 7.7 tp -99.16 109.91 22.54 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.997 ' HB2' HG22 ' A' ' 8' ' ' VAL . 4.0 mp -103.33 160.85 14.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.6 ' OG ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.07 112.81 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.47 -0.769 . . . . 0.0 109.324 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 11' ' ' ASP . 5.8 t0 -61.09 -143.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.279 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.805 ' O ' HG23 ' A' ' 55' ' ' ILE . 1.1 tp -172.34 84.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.944 -1.098 . . . . 0.0 110.185 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.781 ' H ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER 163.72 129.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.566 ' CB ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 166.95 -61.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.442 -0.786 . . . . 0.0 109.443 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.598 ' HD3' HD22 ' A' ' 63' ' ' LEU . 36.7 Cg_endo -70.09 142.5 46.64 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 124.305 1.687 . . . . 0.0 110.233 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.39 -21.52 66.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 25.3 ttp -94.0 114.79 27.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 0.7 OUTLIER 44.32 -159.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.549 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.908 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -101.42 -109.73 3.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.908 HD23 ' C ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -175.7 105.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.658 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -57.48 -79.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.27 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.785 HD11 HD12 ' A' ' 63' ' ' LEU . 23.4 mt 81.49 -22.57 0.26 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -60.17 -42.9 95.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.669 -1.27 . . . . 0.0 108.68 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -31.57 72.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 4.4 tp-100 -60.36 -62.4 1.89 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.854 HG23 ' CD2' ' A' ' 73' ' ' HIS . 1.8 mp -35.92 -77.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.755 -0.591 . . . . 0.0 109.933 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -34.07 -64.8 0.22 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.949 -0.47 . . . . 0.0 109.902 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.1 mm-40 -35.05 -51.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.738 -0.601 . . . . 0.0 110.21 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.39 53.92 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 110.911 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.854 ' CD2' HG23 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -130.55 163.79 45.92 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.948 -1.095 . . . . 0.0 109.406 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 36.7 Cg_endo -84.05 -69.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.041 1.548 . . . . 0.0 110.161 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.07 45.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 77' ' ' PRO . 3.1 pp -109.28 161.55 23.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.086 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.878 ' O ' HD12 ' A' ' 76' ' ' LEU . 31.9 Cg_endo -68.63 155.06 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.88 1.463 . . . . 0.0 112.001 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -136.93 165.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.785 ' CD1' HD22 ' A' ' 102' ' ' LEU . 4.4 tt -132.59 145.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.753 -1.217 . . . . 0.0 110.796 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 100' ' ' ASP . 8.8 mt -108.46 93.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.653 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER -65.2 96.88 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.97 . . . . 0.0 109.537 -179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 81' ' ' MET . 14.9 t 123.72 177.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.67 19.81 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 109.154 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -91.49 -95.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.63 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m -71.73 86.51 0.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.059 -1.026 . . . . 0.0 109.405 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.897 ' OD2' HD13 ' A' ' 80' ' ' ILE . 9.8 t70 -179.3 -36.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.016 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.598 HD13 ' OH ' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -35.35 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.292 0.568 . . . . 0.0 110.536 -179.685 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -91.77 -53.51 4.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.348 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -17.55 1.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 110.361 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -96.57 -74.51 0.56 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.968 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 90' ' ' ALA . 45.8 t -33.71 -33.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.762 -0.586 . . . . 0.0 110.872 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -97.58 -160.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.814 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 95' ' ' GLN . . . 45.48 -168.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -58.2 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.126 -0.983 . . . . 0.0 109.096 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp0? -94.47 15.2 18.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.762 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -38.74 24.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 167.02 -94.38 0.11 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 69.64 7.25 6.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -1.091 . . . . 0.0 110.047 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER 49.14 112.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.636 0.732 . . . . 0.0 110.401 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.026 ' HB2' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -147.09 -169.2 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.662 -1.274 . . . . 0.0 109.843 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.598 ' OH ' HD13 ' A' ' 87' ' ' LEU . 4.8 m-85 65.32 96.1 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.433 0.635 . . . . 0.0 110.672 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.785 HD22 ' CD1' ' A' ' 79' ' ' ILE . 12.8 tp -139.36 95.59 9.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.01 -172.44 0.71 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.084 1.571 . . . . 0.0 111.525 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -141.38 166.21 23.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.592 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -75.63 119.8 6.35 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.249 -2.396 . . . . 0.0 110.767 0.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.994 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 58.5 t80 -93.18 167.17 11.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.202 -0.936 . . . . 0.0 109.398 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.618 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 16.6 t0 -74.5 -145.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.475 -0.765 . . . . 0.0 109.48 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.614 HG23 ' CD2' ' A' ' 23' ' ' LEU . 6.7 mm -139.93 -73.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.101 -0.999 . . . . 0.0 109.119 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.497 ' N ' HG22 ' A' ' 108' ' ' ILE . 42.0 t0 -60.76 -31.82 71.15 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 69.0 tt0 -55.83 -38.21 69.72 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.994 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -75.47 -70.84 0.4 Allowed 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.352 -0.842 . . . . 0.0 109.504 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.09 ' CG1' HD22 ' A' ' 28' ' ' LEU . 47.6 t -36.99 -45.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.66 0.743 . . . . 0.0 110.962 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -76.81 -72.0 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.802 . . . . 0.0 110.944 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.512 ' C ' ' O ' ' A' ' 113' ' ' ALA . 54.5 tp -33.07 -56.34 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.365 0.602 . . . . 0.0 109.946 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.799 HG11 HG11 ' A' ' 50' ' ' VAL . 93.5 t -61.86 -55.44 24.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.687 ' HA ' HD12 ' A' ' 119' ' ' ILE . 17.3 tt0 -33.09 -34.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.406 0.622 . . . . 0.0 109.962 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 115' ' ' VAL . 35.5 mtm180 -60.17 -60.71 3.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -55.13 -52.89 61.83 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 50' ' ' VAL . 4.5 mt -35.63 -35.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.245 0.545 . . . . 0.0 110.365 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -77.35 31.48 0.15 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.267 -0.896 . . . . 0.0 110.791 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -64.86 -18.04 64.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.68 -1.263 . . . . 0.0 109.228 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -86.78 40.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 109.621 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.34 50.88 2.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.398 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 59.8 ttm-85 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.709 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . -151.46 92.39 0.14 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.102 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.806 HG22 ' HE1' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -92.93 88.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 108.581 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 6' ' ' VAL . 5.4 p -98.46 118.2 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.445 0.641 . . . . 0.0 110.566 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 1.054 ' CE3' HG21 ' A' ' 31' ' ' THR . 11.4 m0 -101.77 87.74 3.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.006 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 19' ' ' LEU . 24.1 t -76.02 156.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.821 0.82 . . . . 0.0 111.079 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.992 ' CG2' HG21 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -118.61 114.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.589 ' HB3' HG21 ' A' ' 15' ' ' ILE . 3.6 t0 -175.83 172.93 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.586 -0.696 . . . . 0.0 109.418 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' N ' HG13 ' A' ' 15' ' ' ILE . 64.0 t0 -144.72 -76.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.15 -0.968 . . . . 0.0 109.151 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 13' ' ' SER . 5.1 t70 35.91 53.09 0.87 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.672 -0.642 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.0 p 36.97 100.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.129 0.49 . . . . 0.0 111.106 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 83.39 45.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.463 -0.773 . . . . 0.0 110.712 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -81.5 -38.15 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.66 -1.275 . . . . 0.0 107.86 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.53 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 1.6 mtm-85 -66.81 -31.89 72.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CE3' ' HG3' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -61.54 -69.35 0.25 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.214 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.582 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 41.1 t -40.43 -64.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.708 0.765 . . . . 0.0 110.75 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 21' ' ' ARG . 51.4 mt -62.02 -72.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 111.349 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 1.6 tt0 -33.81 -34.64 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.683 -0.636 . . . . 0.0 110.832 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.62 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 63.9 mmt-85 -67.22 -55.38 14.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 108.529 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.666 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -71.3 -3.21 19.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.203 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.042 HD11 HG21 ' A' ' 112' ' ' VAL . 1.7 mm? -102.7 -17.15 15.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 109.393 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.0 11.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.7 -21.05 49.62 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.24 -31.16 19.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.405 -1.056 . . . . 0.0 108.941 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.63 63.72 1.4 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.814 HD12 HG11 ' A' ' 112' ' ' VAL . 17.7 mt -144.73 177.53 8.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 11.5 m -98.93 93.27 5.93 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 22.4 t -89.36 78.97 7.1 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.283 -0.885 . . . . 0.0 110.07 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.054 HG21 ' CE3' ' A' ' 7' ' ' TRP . 11.5 m -76.03 126.33 30.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 108.619 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.53 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 65.3 p -132.01 138.45 48.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.953 -1.092 . . . . 0.0 109.698 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.021 ' HB2' HG22 ' A' ' 39' ' ' VAL . 11.8 m-85 -127.61 137.51 52.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 1.4 mt-10 -72.11 -27.55 62.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.46 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.978 ' O ' HG23 ' A' ' 39' ' ' VAL . 5.7 m-80 -111.01 133.71 53.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 110.137 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.862 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -56.37 -64.74 4.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -39.15 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.611 -0.935 . . . . 0.0 109.627 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.0 mm-40 -31.21 -43.82 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.43 0.634 . . . . 0.0 110.103 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.021 HG22 ' HB2' ' A' ' 33' ' ' PHE . 21.5 t -54.55 -61.83 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.429 -0.794 . . . . 0.0 109.2 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.037 HD12 HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -63.07 -12.53 27.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -77.2 -35.03 56.06 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.17 62.64 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.094 HD12 HD11 ' A' ' 69' ' ' ILE . 27.8 mt -68.97 -8.61 46.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.533 -0.729 . . . . 0.0 109.078 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -3.84 -64.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.337 0.589 . . . . 0.0 112.054 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.573 ' C ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -70.68 -61.01 1.93 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.84 -173.77 3.1 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.553 0.692 . . . . 0.0 109.407 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.024 ' HA ' HD22 ' A' ' 43' ' ' LEU . 31.5 m -99.98 150.42 36.85 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 32.8 Cg_endo -75.39 -81.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 117.485 -1.21 . . . . 0.0 112.448 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.85 -76.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.356 -1.465 . . . . 0.0 110.462 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.999 HG23 ' CD1' ' A' ' 119' ' ' ILE . 9.8 t -132.92 143.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.83 . . . . 0.0 109.062 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.899 ' HB3' HG12 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -100.08 133.0 45.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.591 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -118.85 137.86 53.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -139.22 118.98 13.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.048 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 10' ' ' ASP . 1.5 p30 -104.67 160.25 15.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.087 -1.008 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.579 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -87.67 135.42 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.499 -0.751 . . . . 0.0 109.189 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.752 ' HG3' ' HE2' ' A' ' 57' ' ' MET . 7.1 ptt85 -151.15 34.36 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.297 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.752 ' HE2' ' HG3' ' A' ' 56' ' ' ARG . 11.6 mtm -148.41 112.2 3.74 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.564 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -107.94 136.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.11 1.584 . . . . 0.0 110.149 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.23 -84.42 0.23 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.09 -32.67 4.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.172 . . . . 0.0 109.951 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' MET . 0.8 OUTLIER -122.02 150.76 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.856 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 -67.89 0.11 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.48 94.09 3.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -1.177 . . . . 0.0 109.729 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 44.04 2.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.208 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' HA3' ' A' ' 36' ' ' GLY . 11.4 mt -118.37 -28.86 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -69.85 -50.92 37.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.1 . . . . 0.0 108.108 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 66' ' ' LEU . 15.6 tttm -44.54 -35.26 2.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.886 ' HG2' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.26 -56.67 18.74 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.094 HD11 HD12 ' A' ' 43' ' ' LEU . 2.2 tp -36.39 -54.13 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.656 -0.653 . . . . 0.0 110.561 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 13.1 mmtp -53.25 -66.18 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.2 tt0 -36.74 -29.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.868 -0.52 . . . . 0.0 110.321 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -105.23 -81.22 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.154 -0.966 . . . . 0.0 111.567 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.543 ' CD2' ' HB3' ' A' ' 43' ' ' LEU . 2.4 p-80 -153.44 133.76 7.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.627 -1.295 . . . . 0.0 112.048 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.558 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 37.7 Cg_endo -134.46 -93.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.988 1.52 . . . . 0.0 109.224 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.555 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 19.0 mtt 69.19 4.6 4.66 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.403 -0.81 . . . . 0.0 110.676 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.768 HD21 ' HB ' ' A' ' 47' ' ' THR . 0.3 OUTLIER -142.37 167.12 17.37 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.984 -1.073 . . . . 0.0 109.548 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.867 ' HG2' HG22 ' A' ' 50' ' ' VAL . 32.1 Cg_endo -62.96 155.03 63.0 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.556 1.293 . . . . 0.0 111.255 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.86 101.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.824 . . . . 0.0 110.083 -178.643 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 50' ' ' VAL . 1.7 mp -76.44 138.83 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.128 -0.982 . . . . 0.0 109.645 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 80' ' ' ILE . 3.0 tt -126.55 113.8 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.484 ' O ' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER -62.5 148.53 45.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 109.529 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER 60.84 175.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.423 -0.798 . . . . 0.0 109.487 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' N ' HG23 ' A' ' 82' ' ' THR . . . -145.96 76.21 1.45 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' C ' ' N ' ' A' ' 86' ' ' ASP . 13.5 m80 -138.9 -101.19 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.958 . . . . 0.0 110.524 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.54 ' OG ' ' HB3' ' A' ' 89' ' ' ALA . 21.7 p 46.87 30.09 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -177.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 88' ' ' ASP . 73.2 m-20 63.57 125.38 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.024 HD12 HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -36.15 -32.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -37.45 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.343 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -44.17 -35.99 2.46 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.974 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -62.3 -90.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.337 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.024 HG23 HD12 ' A' ' 87' ' ' LEU . 35.6 t -35.61 -63.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.602 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 14.5 m -79.94 -149.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.833 . . . . 0.0 110.351 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' ALA . . . 68.19 -87.12 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 109.901 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.504 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 2.0 p90 -106.66 -16.36 14.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.081 -1.012 . . . . 0.0 109.514 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 14.5 mt-30 44.45 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -83.72 136.33 34.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.848 -1.158 . . . . 0.0 109.358 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.03 -174.79 30.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -121.86 95.21 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.356 -1.085 . . . . 0.0 109.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 50.7 p90 163.54 -174.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -144.28 134.0 23.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.554 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.476 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 88.3 m-85 -43.77 122.24 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -100.38 112.12 63.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.151 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 36.8 Cg_endo -91.8 168.27 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.907 1.477 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -95.03 158.6 34.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -101.44 166.52 7.53 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.043 -2.482 . . . . 0.0 110.16 0.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 25.3 p90 -147.7 174.17 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 10.6 t0 -87.23 -154.91 0.26 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.302 -0.874 . . . . 0.0 108.907 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.666 HD13 ' CB ' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -121.69 -42.92 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 108.677 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -82.34 -35.07 28.23 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.49 -38.09 76.91 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -79.95 -72.14 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.639 -0.663 . . . . 0.0 109.343 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.042 HG21 HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -37.4 -53.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.661 -0.649 . . . . 0.0 110.066 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.57 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -60.58 -60.86 3.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.602 -0.686 . . . . 0.0 109.988 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -34.45 -46.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.749 0.785 . . . . 0.0 109.66 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 116' ' ' GLU . 0.8 OUTLIER -66.49 -54.67 23.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.151 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.604 ' N ' HG12 ' A' ' 115' ' ' VAL . 6.1 tt0 -34.08 -39.46 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.433 0.635 . . . . 0.0 109.847 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' VAL . 11.4 mtp180 -77.43 -47.71 19.06 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.242 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' VAL . . . -52.22 -64.53 0.79 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 0.0 108.835 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.999 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.3 mt -35.45 -41.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.597 . . . . 0.0 110.22 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.46 58.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -117.73 -19.89 9.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -78.06 -7.85 57.46 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.32 -0.863 . . . . 0.0 109.396 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.27 -34.92 24.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.442 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -153.43 146.41 14.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.625 HG23 ' CG2' ' A' ' 29' ' ' THR . 2.7 mp -105.59 112.74 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -1.159 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 52' ' ' LEU . 2.3 p -105.59 120.52 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.578 -0.701 . . . . 0.0 110.016 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.742 ' CZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -101.19 105.81 16.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.136 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' A' ' 52' ' ' LEU . 42.6 t -87.99 146.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.141 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 22.6 t -99.24 95.73 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 110.084 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 31.52 -160.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.78 0.8 . . . . 0.0 112.696 178.288 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.698 ' HB3' HD11 ' A' ' 15' ' ' ILE . 6.8 t0 152.48 -25.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.62 146.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 14' ' ' SER . 11.3 t -45.4 135.8 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.717 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 77.45 34.7 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -72.73 -47.55 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 108.975 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -53.0 -47.74 68.05 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.492 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 83.9 t90 -56.56 -63.77 1.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 109.667 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 17' ' ' TRP . 42.1 t -38.88 -74.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.07 0.938 . . . . 0.0 110.648 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -60.53 -68.18 0.32 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.531 -0.731 . . . . 0.0 110.858 -178.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -35.52 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.547 -0.721 . . . . 0.0 110.88 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -71.82 -53.63 12.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.991 -1.068 . . . . 0.0 108.252 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -71.87 -2.98 19.8 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.984 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.956 HD11 HG21 ' A' ' 112' ' ' VAL . 2.5 mm? -103.88 -14.9 15.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.353 -0.842 . . . . 0.0 109.411 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.58 -30.65 32.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 -38.96 58.22 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.52 72.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -1.113 . . . . 0.0 108.913 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.26 66.01 0.91 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.027 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -141.52 176.9 8.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.091 -1.241 . . . . 0.0 110.019 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 29' ' ' THR . 6.8 m -100.13 77.09 1.96 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.1 t -83.08 90.37 7.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.313 -0.867 . . . . 0.0 110.427 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 3.3 m -100.7 140.67 34.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.499 ' OG1' HG22 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -142.31 138.47 31.33 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.571 -1.331 . . . . 0.0 110.164 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.888 ' HB2' HG23 ' A' ' 39' ' ' VAL . 18.3 m-85 -107.46 159.82 16.12 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -92.02 11.5 25.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.898 -1.126 . . . . 0.0 109.711 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -149.94 128.56 12.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.813 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -56.24 -62.45 6.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.473 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -41.47 -65.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.354 -1.086 . . . . 0.0 109.383 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.5 tp10 -35.05 -47.01 0.35 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.611 -0.68 . . . . 0.0 110.276 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.895 HG12 HD13 ' A' ' 40' ' ' LEU . 1.4 t -60.83 -50.7 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 108.636 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.895 HD13 HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -69.81 -5.85 28.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 0.0 109.572 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.36 -22.07 18.57 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.3 -0.875 . . . . 0.0 108.802 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.77 -33.5 18.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.4 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 47' ' ' THR . 4.1 mt -98.59 -114.35 0.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.214 -0.929 . . . . 0.0 108.742 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.4 -51.28 0.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 58.7 m -75.23 -34.65 61.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.326 -0.859 . . . . 0.0 108.924 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 176.77 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.01 HG23 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -71.27 -152.85 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.884 ' CD ' HG22 ' A' ' 47' ' ' THR . 37.0 Cg_endo -125.32 -75.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 117.093 -1.471 . . . . 0.0 111.2 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -112.85 -73.92 0.65 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.733 -1.229 . . . . 0.0 111.14 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.907 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.6 t -140.27 137.0 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.013 -1.054 . . . . 0.0 110.672 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.653 HD23 ' CG1' ' A' ' 69' ' ' ILE . 12.5 tp -100.42 159.89 14.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.583 ' CD1' HG22 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -138.93 141.7 38.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 -179.797 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.541 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 6.3 t -119.27 111.21 17.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 10' ' ' ASP . 34.0 p-10 -59.77 175.13 0.39 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.909 -1.119 . . . . 0.0 109.097 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.606 HG21 ' O ' ' A' ' 81' ' ' MET . 1.2 tt -161.72 38.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -80.22 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.46 ' CE ' ' CA ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -48.59 139.0 11.53 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.653 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -113.61 165.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.818 1.43 . . . . 0.0 110.167 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 61' ' ' ASP . . . 124.03 89.31 0.85 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.1 mmt 49.05 -95.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -1.109 . . . . 0.0 109.738 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' GLY . 2.0 m-20 -50.89 164.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.09 -1.006 . . . . 0.0 109.353 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.646 ' C ' HD22 ' A' ' 63' ' ' LEU . . . 108.73 -62.38 0.29 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 86' ' ' ASP . 2.4 mm? -116.92 1.76 12.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -1.167 . . . . 0.0 109.715 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.69 67.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.176 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.713 HD22 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -167.77 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.661 ' O ' HG22 ' A' ' 69' ' ' ILE . 2.9 tp -40.18 -30.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.109 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 65' ' ' LEU . 10.8 tptt -57.66 -54.73 43.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.609 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 65' ' ' LEU . 9.4 pm0 -58.09 -39.23 78.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.204 . . . . 0.0 108.241 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 66' ' ' LEU . 1.4 tt -38.21 -36.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.577 -0.702 . . . . 0.0 110.064 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' ARG . 5.0 tptm -109.05 -69.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 110.334 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 5.7 tt0 -36.12 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.402 -0.811 . . . . 0.0 110.834 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -96.89 -34.93 11.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.277 -0.889 . . . . 0.0 110.06 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.759 ' CE1' HD12 ' A' ' 40' ' ' LEU . 4.7 m80 -96.83 137.14 21.37 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.547 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.6 Cg_endo -39.23 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.999 1.526 . . . . 0.0 110.999 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.85 95.72 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.726 HD12 ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -133.23 171.71 8.66 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.769 ' HG2' HG22 ' A' ' 50' ' ' VAL . 34.2 Cg_endo -59.28 107.87 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.441 1.232 . . . . 0.0 110.982 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.517 ' CG1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -102.12 82.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.54 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mp -62.73 155.56 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.988 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 79' ' ' ILE . 1.3 pp -160.39 150.88 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.606 ' O ' HG21 ' A' ' 55' ' ' ILE . 40.3 mtt -90.85 126.99 36.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 109.511 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 77.8 p -74.27 153.53 39.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 0.0 109.708 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 163.65 39.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.349 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER 69.06 157.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 51.0 m 63.04 152.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.838 ' HB2' HD12 ' A' ' 63' ' ' LEU . 32.1 t0 84.2 -49.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.726 -0.609 . . . . 0.0 109.868 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -33.75 -51.02 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.0 110.528 -179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.23 -55.48 10.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.649 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.5 -40.1 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 109.679 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -73.19 -81.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 42.8 t -33.38 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.776 -0.578 . . . . 0.0 110.613 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -99.79 -155.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.919 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 56.63 75.68 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.442 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' GLN . 0.7 OUTLIER 59.95 -89.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.378 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 71.42 138.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -146.01 -63.18 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.303 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.37 52.72 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.82 38.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -1.151 . . . . 0.0 109.398 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 100' ' ' ASP . 8.2 m-85 -120.42 105.52 10.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.794 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.584 ' O ' ' CD1' ' A' ' 101' ' ' TYR . 14.1 t0 -61.96 -139.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.886 . . . . 0.0 109.181 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 169.78 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 108.959 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.74 132.17 62.0 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 109.777 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 104' ' ' LYS . 36.8 Cg_endo -105.87 -92.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.89 1.469 . . . . 0.0 110.135 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER 161.28 147.77 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.253 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.436 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -82.26 170.9 56.84 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.721 -2.616 . . . . 0.0 110.392 -0.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -149.7 138.96 21.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 25.3 t0 -76.77 170.67 16.03 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.036 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 22' ' ' ALA . 19.1 mm -84.23 -58.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.049 -1.032 . . . . 0.0 109.896 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -63.33 -46.16 87.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 108.533 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 20.7 tp10 -47.22 -37.9 11.22 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -75.04 -73.76 0.23 Allowed 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.349 -0.844 . . . . 0.0 109.796 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 28' ' ' LEU . 41.4 t -39.02 -56.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -59.97 -70.15 0.18 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.729 . . . . 0.0 110.987 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.769 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.0 tm? -34.37 -57.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.435 0.636 . . . . 0.0 110.016 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.69 ' N ' HD13 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -53.92 -52.66 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.555 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.0 tt0 -34.56 -49.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.274 0.559 . . . . 0.0 110.324 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -56.02 -54.95 38.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.61 -60.56 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.09 -1.007 . . . . 0.0 108.366 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.907 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.7 mt -37.0 -35.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.739 -0.601 . . . . 0.0 110.865 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.593 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 7.6 t -33.87 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.936 -0.478 . . . . 0.0 111.52 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.593 ' CB ' ' O ' ' A' ' 120' ' ' SER . 2.2 t-160 86.52 39.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' HIS . 1.1 m-85 37.36 77.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.583 0.706 . . . . 0.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.07 39.28 1.04 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.74 . . . . 0.0 109.595 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.602 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.318 0.58 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 3' ' ' ARG . 3.5 mm-40 63.92 -163.83 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 109.277 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 65.41 156.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 109.198 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.841 ' C ' HD12 ' A' ' 5' ' ' ILE . . . -162.78 176.94 39.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.841 HD12 ' C ' ' A' ' 4' ' ' GLY . 3.6 mp -135.95 99.27 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.055 . . . . 0.0 109.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 8' ' ' VAL . 2.7 t -101.19 111.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 109.821 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.606 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 9.5 m0 -100.18 92.78 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.106 HG22 ' HB2' ' A' ' 52' ' ' LEU . 48.3 t -95.98 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.484 -0.76 . . . . 0.0 110.735 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.686 ' HB ' HG21 ' A' ' 39' ' ' VAL . 3.7 p -119.16 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 15' ' ' ILE . 1.4 p30 -102.14 -120.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.913 -1.117 . . . . 0.0 110.181 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' HD3' ' A' ' 58' ' ' PRO . 31.8 t0 -135.43 -61.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.633 -1.292 . . . . 0.0 110.019 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 175.26 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -59.76 160.26 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.78 . . . . 0.0 109.634 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 13' ' ' SER . 2.1 m 79.93 -7.56 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.442 -0.786 . . . . 0.0 109.75 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.629 HG21 ' HB2' ' A' ' 10' ' ' ASP . 26.6 mm -96.89 -45.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -63.59 -30.96 72.0 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.468 ' O ' ' C ' ' A' ' 18' ' ' VAL . 5.7 t90 -67.28 -60.28 2.72 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 24.8 t -36.6 -57.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.165 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.585 ' C ' HD12 ' A' ' 23' ' ' LEU . 8.8 mt -55.73 -72.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 1.8 tt0 -35.14 -30.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.868 -0.52 . . . . 0.0 110.674 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -66.37 -55.16 17.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 108.437 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 -12.96 61.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD22 ' HB2' ' A' ' 30' ' ' CYS . 0.9 OUTLIER -92.9 -11.11 34.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.765 . . . . 0.0 109.754 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.69 -46.09 40.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.83 -41.97 52.32 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.49 79.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -1.003 . . . . 0.0 108.572 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.05 50.22 3.32 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.895 HD13 HG11 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -120.23 173.71 6.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 0.0 109.971 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 29' ' ' THR . 51.6 m -100.26 65.75 1.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 1.035 ' HB2' HD22 ' A' ' 23' ' ' LEU . 32.0 t -82.23 80.08 8.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.217 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.606 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 1.3 m -75.1 129.32 37.36 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -126.96 136.76 52.71 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.059 -1.026 . . . . 0.0 109.686 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.085 ' HB2' HG22 ' A' ' 39' ' ' VAL . 2.1 m-85 -110.72 -176.15 2.9 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 19.4 mt-10 -95.43 -47.57 6.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.935 . . . . 0.0 110.429 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.977 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.2 t-20 -116.15 144.7 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.064 -1.022 . . . . 0.0 109.949 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.514 ' CA ' HG21 ' A' ' 9' ' ' VAL . . . -54.14 -33.13 51.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 38' ' ' GLU . 11.4 t-20 -61.76 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.033 -1.275 . . . . 0.0 108.624 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.5 mm-40 -34.64 -35.28 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.348 0.594 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.085 HG22 ' HB2' ' A' ' 33' ' ' PHE . 75.0 t -55.33 -59.09 2.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.396 -0.815 . . . . 0.0 109.453 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.849 HD12 ' CB ' ' A' ' 72' ' ' ARG . 0.9 OUTLIER -67.66 -14.82 63.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.568 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -68.25 -30.91 70.06 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.8 -31.9 19.35 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.657 HD13 HG23 ' A' ' 47' ' ' THR . 89.9 mt -92.34 1.54 57.17 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.478 -0.764 . . . . 0.0 110.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.508 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -29.47 -38.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' LEU . 2.5 m -70.15 -55.73 8.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 108.746 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER 169.86 135.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.415 -0.803 . . . . 0.0 109.969 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.01 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -50.19 157.2 1.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 109.666 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.94 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.7 Cg_endo -88.13 -70.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.918 1.483 . . . . 0.0 110.058 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -109.32 -65.22 1.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 0.0 109.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.799 HG21 HG13 ' A' ' 115' ' ' VAL . 2.6 t -149.57 144.16 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.055 -1.028 . . . . 0.0 110.123 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 47' ' ' THR . 3.5 tp -100.54 155.16 18.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.894 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.106 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -145.43 169.45 18.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.677 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.748 ' OG ' HG23 ' A' ' 80' ' ' ILE . 27.4 p -154.56 139.7 17.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.69 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 25.4 m-20 -86.78 -172.25 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.294 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -120.67 5.54 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.12 -0.988 . . . . 0.0 109.689 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.3 OUTLIER -86.62 174.13 9.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.638 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.48 ' SD ' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 170.87 177.16 0.11 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.795 . . . . 0.0 109.176 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' SD ' ' A' ' 57' ' ' MET . 36.8 Cg_endo -98.32 120.33 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.953 1.502 . . . . 0.0 110.508 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.55 -144.89 23.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 12.2 mtt -88.56 -156.92 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' MET . 37.3 m-20 64.75 179.96 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.78 68.73 0.22 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HG ' ' HG3' ' A' ' 57' ' ' MET . 1.1 mp 61.64 92.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.611 ' C ' HD13 ' A' ' 65' ' ' LEU . . . -91.41 14.24 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.208 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.774 HD22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -100.9 14.26 32.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -0.846 . . . . 0.0 109.357 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.741 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -65.44 -65.0 0.73 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.4 ttpp -47.0 -26.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.573 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.03 -60.54 2.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -33.54 -57.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.283 0.563 . . . . 0.0 110.415 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HE2' ' CG2' ' A' ' 69' ' ' ILE . 7.0 mmtt -59.84 -61.05 2.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.258 -0.901 . . . . 0.0 109.847 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 70' ' ' LYS . 21.9 mm-40 -32.98 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.894 -0.504 . . . . 0.0 111.385 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.849 ' CB ' HD12 ' A' ' 40' ' ' LEU . 4.9 mpt_? -83.39 -91.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 110.801 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.769 ' NE2' HD22 ' A' ' 51' ' ' LEU . 3.0 p80 -68.49 151.95 96.92 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.388 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 33.8 Cg_endo -49.63 -178.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.638 1.336 . . . . 0.0 110.689 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.5 ptp -85.16 56.05 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.907 HD21 ' OG1' ' A' ' 47' ' ' THR . 0.6 OUTLIER -70.42 158.68 87.12 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.4 Cg_endo -44.61 136.98 8.88 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.501 1.263 . . . . 0.0 112.642 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.884 HG23 ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -145.24 177.99 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.547 ' O ' HD23 ' A' ' 52' ' ' LEU . 26.1 mt -158.67 119.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.216 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.748 HG23 ' OG ' ' A' ' 53' ' ' SER . 30.5 mt -108.6 128.53 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 108.818 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 54' ' ' ASP . 1.4 mtm -56.46 174.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -53.85 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 110.215 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 82' ' ' THR . . . 80.78 162.54 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -119.75 -21.55 7.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.421 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.7 m -123.57 18.22 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.74 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -96.73 -18.39 19.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.228 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.765 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.2 tt -35.15 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.897 -0.502 . . . . 0.0 110.935 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASP . 11.0 t70 -70.27 -57.79 4.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.862 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 66' ' ' LEU . . . -65.68 -16.07 63.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB1' ' OH ' ' A' ' 101' ' ' TYR . . . -83.12 -42.36 17.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 87' ' ' LEU . 46.4 t -35.85 -29.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.459 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ALA . 30.3 t -80.64 31.69 0.3 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.5 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.37 -53.6 2.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.912 -1.118 . . . . 0.0 108.624 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 10.7 m-30 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -0.894 . . . . 0.0 108.747 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 32.2 tp60 -86.81 91.77 8.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.782 . . . . 0.0 109.424 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 45.69 64.99 1.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.29 -179.29 15.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.35 38.08 1.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.952 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.884 ' CD1' HG23 ' A' ' 78' ' ' VAL . 6.6 p90 -162.2 133.4 5.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.04 -1.038 . . . . 0.0 109.874 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 100' ' ' ASP . 58.7 p30 -97.98 -159.29 0.73 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.41 -0.806 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.594 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 5.7 m-85 -100.66 139.02 36.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.23 120.02 52.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.026 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -95.29 -165.18 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.909 1.478 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -121.86 157.69 56.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.602 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -97.28 169.92 12.43 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.712 -2.62 . . . . 0.0 110.441 0.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 106' ' ' PHE . 20.8 p90 -149.21 138.1 21.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.549 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 16.3 t70 -79.41 171.47 15.13 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.92 . . . . 0.0 109.018 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -70.82 -56.14 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.014 -1.054 . . . . 0.0 109.014 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' HG22 ' A' ' 108' ' ' ILE . 23.5 t0 -68.7 -39.72 80.37 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.549 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 4.7 tp10 -48.42 -46.79 37.89 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -72.28 -74.06 0.17 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.895 HG11 HD13 ' A' ' 28' ' ' LEU . 32.3 t -36.73 -73.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.367 0.603 . . . . 0.0 109.749 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -38.11 -64.41 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.79 -0.569 . . . . 0.0 110.292 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 113' ' ' ALA . 8.2 tp -34.83 -55.28 0.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.785 0.802 . . . . 0.0 109.741 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.799 HG13 HG21 ' A' ' 50' ' ' VAL . 1.5 t -57.01 -57.37 10.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -32.99 -40.3 0.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.324 0.583 . . . . 0.0 110.403 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' VAL . 18.1 mtm180 -75.42 -52.59 10.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.327 -0.858 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.2 -60.83 2.21 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.117 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.772 ' CD1' HG23 ' A' ' 50' ' ' VAL . 3.4 mt -36.06 -41.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.395 0.617 . . . . 0.0 109.978 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 61.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -135.42 -65.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 2.9 p90 -99.07 95.4 7.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -117.1 0.79 12.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.284 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 2' ' ' GLN . 7.2 pt20 -159.91 101.53 1.45 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.031 -1.043 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.53 44.15 1.04 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.136 -0.977 . . . . 0.0 109.34 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.692 ' HA3' HD21 ' A' ' 28' ' ' LEU . . . 147.65 171.75 17.03 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 10.6 mt -147.89 97.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.954 . . . . 0.0 108.84 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.878 ' CG2' HD12 ' A' ' 52' ' ' LEU . 2.6 p -100.2 118.64 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.658 0.742 . . . . 0.0 110.651 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.635 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 37.4 m0 -103.27 104.25 14.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.938 . . . . 0.0 108.825 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.791 HG22 ' CB ' ' A' ' 52' ' ' LEU . 59.1 t -97.57 147.74 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.913 ' HB ' HG21 ' A' ' 39' ' ' VAL . 9.8 p -123.9 129.45 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.698 ' CB ' HG21 ' A' ' 15' ' ' ILE . 13.9 t0 -135.51 -77.15 0.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.817 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 34' ' ' GLU . 64.8 t0 -148.33 -70.73 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.697 -1.252 . . . . 0.0 111.624 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.71 178.05 4.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.01 -1.056 . . . . 0.0 111.141 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -66.36 -24.73 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.641 -0.662 . . . . 0.0 109.832 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -62.54 -25.24 67.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.393 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.698 HG21 ' CB ' ' A' ' 10' ' ' ASP . 1.2 mp -66.59 -31.16 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 11.4 ttp180 -61.65 -49.13 77.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 13.2 t90 -48.73 -65.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 48.2 t -39.44 -70.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.048 0.928 . . . . 0.0 110.364 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -44.88 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.2 tt0 -32.73 -40.75 0.05 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.864 -0.522 . . . . 0.0 110.773 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 4.5 mtp180 -58.06 -57.19 13.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.977 . . . . 0.0 109.043 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 108' ' ' ILE . . . -68.29 -6.34 23.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 0.0 109.579 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -98.38 -12.53 21.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.79 51.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 -33.48 87.35 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 23' ' ' LEU . . . -73.47 -24.78 60.25 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.482 -1.01 . . . . 0.0 108.761 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.768 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 69.41 62.84 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.109 HD22 HG13 ' A' ' 112' ' ' VAL . 1.2 mp -142.25 -176.5 4.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.113 -1.228 . . . . 0.0 109.974 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.562 ' CG2' HG23 ' A' ' 5' ' ' ILE . 24.2 m -92.44 100.61 13.13 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 8.9 t -95.28 88.72 5.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.393 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.631 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 2.3 m -99.45 141.63 32.0 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.54 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -134.55 167.13 21.36 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.655 -1.278 . . . . 0.0 110.14 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.827 ' HB2' HG22 ' A' ' 39' ' ' VAL . 26.8 m-85 -140.15 171.74 13.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -105.15 -13.23 15.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.175 -0.953 . . . . 0.0 108.946 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.709 ' O ' HG23 ' A' ' 39' ' ' VAL . 55.6 m-20 -138.16 137.33 37.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.554 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.543 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -55.43 -49.72 63.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.644 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 13.9 t-20 -50.54 -69.41 0.11 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.187 -1.184 . . . . 0.0 108.727 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.681 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -36.06 -42.14 0.28 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.707 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.913 HG21 ' HB ' ' A' ' 9' ' ' VAL . 39.4 t -53.05 -53.43 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.205 -0.934 . . . . 0.0 108.934 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.04 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.8 mt -62.02 -28.57 69.67 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -61.19 -34.66 75.42 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . . . -68.93 -40.52 78.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -43.0 -65.35 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' N ' HD23 ' A' ' 43' ' ' LEU . . . 28.14 -73.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.916 0.865 . . . . 0.0 110.761 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.76 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -84.69 27.33 0.74 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 82.69 134.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.345 0.593 . . . . 0.0 110.193 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.595 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -64.59 -149.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.367 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HG3' ' CE2' ' A' ' 7' ' ' TRP . 38.0 Cg_endo -125.54 -83.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 117.298 -1.335 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.575 ' OD2' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -114.31 -50.78 2.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.298 -1.501 . . . . 0.0 111.814 -178.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.851 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.1 t -149.51 149.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.396 -1.44 . . . . 0.0 109.896 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.073 HD12 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.96 156.72 17.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 109.293 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.878 HD12 ' CG2' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -137.29 124.92 22.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.06 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.716 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -113.76 133.09 55.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.053 -1.029 . . . . 0.0 110.385 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.525 ' CB ' ' OD1' ' A' ' 10' ' ' ASP . 17.5 p-10 -80.0 -158.9 0.19 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.876 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.779 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -173.89 86.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.762 ' N ' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -168.38 -163.86 0.48 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.372 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.539 ' CE ' ' O ' ' A' ' 61' ' ' ASP . 2.1 mtm 72.59 131.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.626 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.38 106.6 1.55 Allowed 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.098 1.578 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.84 -130.87 8.24 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 1.3 mtt -110.14 -164.51 0.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.682 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.539 ' O ' ' CE ' ' A' ' 57' ' ' MET . 2.0 t70 80.39 -9.72 1.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.99 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.925 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -133.8 -48.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.925 HD23 ' C ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -105.88 -175.0 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.073 -1.251 . . . . 0.0 109.691 -179.251 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.62 21.96 9.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.035 -1.04 . . . . 0.0 108.304 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 69' ' ' ILE . 6.1 mt -125.27 -12.47 6.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.767 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.578 HD11 HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -61.1 -65.21 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.8 tptp -44.06 -37.53 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.861 ' HG3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -57.16 -52.35 65.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.029 -1.045 . . . . 0.0 108.678 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.944 HG23 HD13 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -35.2 -56.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.647 -0.658 . . . . 0.0 110.679 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.04 -53.89 13.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 110.443 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' LYS . 13.3 mm-40 -32.42 -44.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.755 -0.591 . . . . 0.0 110.815 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 1.04 ' HB2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -91.85 -44.84 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.073 ' CE1' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -47.89 159.4 0.47 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.294 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD2' HD23 ' A' ' 76' ' ' LEU . 36.9 Cg_endo -80.8 -66.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.078 1.567 . . . . 0.0 110.15 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.419 ' O ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -175.45 52.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.26 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 77' ' ' PRO . 1.1 pp -114.97 157.44 43.3 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 0.0 109.05 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 50' ' ' VAL . 37.4 Cg_endo -63.81 151.7 83.97 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.931 1.49 . . . . 0.0 111.203 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.037 HG12 ' CB ' ' A' ' 51' ' ' LEU . 2.9 m -142.87 97.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.808 HD11 ' CG2' ' A' ' 115' ' ' VAL . 8.4 mt -59.99 167.03 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 109.479 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.716 HD12 ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -161.93 133.79 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.098 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.502 ' N ' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -63.78 158.0 22.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.407 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -98.0 151.65 20.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.411 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -173.46 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -178.49 65.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.683 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 p -173.67 -36.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.588 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.1 m-20 -57.17 -31.07 65.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 109.683 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -34.89 -28.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.752 -0.593 . . . . 0.0 111.437 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -93.46 -52.84 4.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.883 -1.136 . . . . 0.0 110.776 -178.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -1.69 10.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.938 -1.101 . . . . 0.0 110.484 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -107.09 -75.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 109.182 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 71.1 t -34.42 -32.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.279 0.561 . . . . 0.0 110.393 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -108.57 -149.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.66 -95.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -128.67 70.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 2.3 tm0? -60.46 -21.59 62.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -0.82 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -69.81 -165.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.56 99.33 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.506 ' C ' ' CD2' ' A' ' 99' ' ' PHE . . . -146.45 -43.51 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.276 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CD2' HG23 ' A' ' 78' ' ' VAL . 16.1 p90 172.96 137.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.446 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -104.11 -161.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -0.808 . . . . 0.0 109.294 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -104.95 149.67 25.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 106' ' ' PHE . 13.3 mt -112.41 116.21 48.8 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.944 . . . . 0.0 109.356 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 36.5 Cg_endo -93.99 148.81 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.651 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 34.3 mtmt -101.88 149.84 36.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.07 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -78.4 140.52 60.72 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.749 -2.605 . . . . 0.0 110.439 -0.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 78.0 t80 -116.14 171.51 7.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.861 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 1.1 t70 -102.25 113.4 26.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.537 -0.727 . . . . 0.0 109.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.714 HG21 ' HB1' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -55.0 -30.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.96 -1.087 . . . . 0.0 109.335 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.98 -45.19 28.36 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 108.702 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 34.8 tt0 -50.89 -34.23 27.39 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -76.51 -72.99 0.3 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.651 -0.655 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.109 HG13 HD22 ' A' ' 28' ' ' LEU . 7.0 t -35.27 -45.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.446 -0.784 . . . . 0.0 110.61 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -73.05 -72.94 0.22 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.73 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -34.69 -57.15 0.53 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.521 0.676 . . . . 0.0 109.536 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.808 ' CG2' HD11 ' A' ' 79' ' ' ILE . 1.2 t -49.78 -58.49 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.659 ' N ' HG12 ' A' ' 115' ' ' VAL . 21.1 tp10 -35.71 -41.11 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.739 -0.601 . . . . 0.0 111.092 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 114' ' ' LEU . 4.3 ptm180 -82.47 -36.78 26.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.109 -0.994 . . . . 0.0 110.207 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.38 -62.67 1.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.87 -1.144 . . . . 0.0 108.308 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 50' ' ' VAL . 10.6 mt -33.71 -39.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.98 -0.45 . . . . 0.0 110.626 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.615 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 11.7 t -5.01 -69.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.254 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 120' ' ' SER . 6.6 m170 142.3 56.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 36.01 32.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.537 0.684 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-30 -69.43 -9.36 53.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.51 -0.744 . . . . 0.0 109.804 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 8.7 mt-10 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.626 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.389 0.614 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 2.4 mt-30 -73.41 -178.43 3.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.438 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.8 OUTLIER 70.66 89.81 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.917 . . . . 0.0 109.81 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.489 ' HA2' ' OD2' ' A' ' 49' ' ' ASP . . . -165.62 119.52 0.87 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.598 HG23 HG21 ' A' ' 29' ' ' THR . 59.0 mt -104.89 91.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.306 -1.114 . . . . 0.0 109.884 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 p -105.87 125.63 61.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.89 ' CZ2' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.73 90.01 4.09 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.808 -1.183 . . . . 0.0 109.433 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.782 HG22 HD12 ' A' ' 52' ' ' LEU . 86.1 t -79.88 113.56 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.791 HG21 ' HA2' ' A' ' 36' ' ' GLY . 7.5 p -88.82 98.29 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.213 -0.929 . . . . 0.0 109.571 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 1.046 ' HB3' HG21 ' A' ' 15' ' ' ILE . 23.0 t0 -156.61 133.21 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.627 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.56 ' HB3' ' CG1' ' A' ' 15' ' ' ILE . 2.0 t0 7.43 68.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.285 0.564 . . . . 0.0 111.804 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.4 p-10 -46.46 177.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.552 -0.718 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 3.1 t 82.86 -68.49 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -98.18 -40.0 8.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.101 -1.0 . . . . 0.0 108.951 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 1.046 HG21 ' HB3' ' A' ' 10' ' ' ASP . 20.0 mm -68.34 -36.3 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 22.9 ttp85 -60.93 -42.38 98.06 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.483 ' O ' ' C ' ' A' ' 18' ' ' VAL . 11.5 t90 -60.29 -62.03 2.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 31.1 t -37.9 -68.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 109.678 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -56.15 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.632 -0.667 . . . . 0.0 110.442 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 2.1 tt0 -36.05 -64.31 0.32 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.489 -0.757 . . . . 0.0 111.983 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -39.78 -43.53 1.44 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -178.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . -71.5 -39.69 70.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.695 -1.253 . . . . 0.0 108.548 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD11 ' CG2' ' A' ' 112' ' ' VAL . 1.3 tp -69.73 -6.13 29.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.36 -33.96 42.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.0 109.038 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.87 -27.85 73.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' A' ' 2' ' ' GLN . . . -93.83 1.52 56.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -1.108 . . . . 0.0 109.229 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.95 72.22 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.751 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -133.92 -179.84 5.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.116 -1.226 . . . . 0.0 110.008 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.598 HG21 HG23 ' A' ' 5' ' ' ILE . 29.2 m -102.1 84.49 2.51 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.2 t -93.11 90.83 7.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.482 -0.761 . . . . 0.0 110.644 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.89 HG21 ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -97.39 138.66 34.5 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 1.7 p -146.43 134.53 21.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.737 -1.227 . . . . 0.0 110.696 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.962 ' HB2' HG23 ' A' ' 39' ' ' VAL . 7.0 m-30 -108.53 -158.9 0.67 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.526 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 6.7 pt-20 -121.83 -32.88 3.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.607 -1.308 . . . . 0.0 109.592 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.568 ' C ' HG21 ' A' ' 9' ' ' VAL . 70.3 m-80 -116.44 123.32 47.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.863 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.8 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -41.37 -36.47 1.45 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -62.62 -61.2 2.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 0.0 108.488 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.2 tp10 -35.55 -50.95 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.496 0.665 . . . . 0.0 109.876 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.076 HG12 HD13 ' A' ' 40' ' ' LEU . 2.1 t -63.58 -44.82 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.792 . . . . 0.0 108.907 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.076 HD13 HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -78.8 4.33 14.22 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 109.476 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.55 -23.25 13.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.78 -33.03 11.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.131 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.83 HD12 ' CG2' ' A' ' 47' ' ' THR . 3.2 mm? -65.13 -12.34 49.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.152 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.46 -31.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.518 -0.738 . . . . 0.0 110.186 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -73.91 -55.98 5.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.616 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -174.33 152.89 1.85 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.135 -0.978 . . . . 0.0 109.671 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.83 ' CG2' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -95.65 171.04 6.86 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.251 -0.905 . . . . 0.0 108.92 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.9 Cg_endo -119.68 -67.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 117.211 -1.392 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.708 ' C ' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -122.68 -78.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.403 -1.436 . . . . 0.0 111.741 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.807 HG23 ' CD1' ' A' ' 119' ' ' ILE . 4.0 t -138.96 141.31 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.941 -1.1 . . . . 0.0 110.537 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.936 HD11 HG11 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -106.24 135.99 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 110.273 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.049 HD22 ' CG2' ' A' ' 79' ' ' ILE . 5.9 mt -115.99 152.77 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 0.0 109.634 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.732 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.5 t -114.77 125.95 54.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.656 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.61 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 28.1 p30 -64.52 -166.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.01 HG12 ' HB3' ' A' ' 83' ' ' ALA . 1.9 tt -178.89 33.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -130.41 6.9 4.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.678 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.926 ' HG3' HD13 ' A' ' 63' ' ' LEU . 56.8 mmm -42.97 117.39 2.19 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -55.04 145.91 61.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.89 1.469 . . . . 0.0 110.231 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.15 101.42 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 60.56 49.58 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -1.164 . . . . 0.0 109.248 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 57' ' ' MET . 11.1 p-10 -52.64 144.76 13.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.773 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 155.79 -81.81 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.926 HD13 ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER 42.95 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -1.125 . . . . 0.0 109.889 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -58.76 -74.36 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 108.52 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.822 HD21 HD23 ' A' ' 63' ' ' LEU . 11.6 mt 76.48 -10.29 1.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 53' ' ' SER . 4.0 mm? -74.92 -39.81 61.2 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.848 -1.157 . . . . 0.0 108.827 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -64.97 -27.86 69.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.86 ' CG ' HD23 ' A' ' 40' ' ' LEU . 22.2 tp60 -65.26 -62.35 1.59 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.607 ' CG1' HD11 ' A' ' 40' ' ' LEU . 17.4 mt -35.79 -76.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.557 -0.714 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -43.02 -61.23 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.972 -1.08 . . . . 0.0 109.384 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.0 mt-30 -36.56 -42.1 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.505 -0.747 . . . . 0.0 111.705 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -131.89 42.12 3.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.83 -1.169 . . . . 0.0 111.289 -177.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.63 ' NE2' ' HB2' ' A' ' 43' ' ' LEU . 54.6 m80 -147.9 154.16 43.19 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.817 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 75' ' ' MET . 35.8 Cg_endo -60.9 -5.71 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.806 1.424 . . . . 0.0 112.092 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 74' ' ' PRO . 8.2 mtp 80.02 104.86 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.026 -1.046 . . . . 0.0 110.204 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.65 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -146.24 156.13 50.26 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 31.3 Cg_endo -43.04 130.48 5.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 117.203 -1.398 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.411 HG11 HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -123.32 178.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.049 ' CG2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -149.85 171.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 79' ' ' ILE . 2.7 tt -160.67 137.81 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.59 ' O ' HD13 ' A' ' 55' ' ' ILE . 7.9 mtt -85.91 135.05 33.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.047 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -72.52 149.81 43.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.013 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . 166.32 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 109.722 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 69.46 158.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 109.975 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 58.2 m 58.64 84.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 109.759 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' HD11 ' A' ' 55' ' ' ILE . 2.3 p-10 165.89 -43.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.59 HD23 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -35.03 -29.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.869 -0.52 . . . . 0.0 111.139 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.6 t0 -67.35 -65.0 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.046 -1.034 . . . . 0.0 110.194 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.67 -10.91 9.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.078 -1.014 . . . . 0.0 110.291 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -97.28 -76.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.006 -1.059 . . . . 0.0 109.765 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG2' HD23 ' A' ' 87' ' ' LEU . 51.0 t -34.1 -30.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.834 -0.541 . . . . 0.0 110.961 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.69 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -106.34 171.49 7.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.872 -1.142 . . . . 0.0 109.992 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 77.18 56.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER 60.04 47.43 9.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 1.7 pt20 -43.31 -34.42 1.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.7 72.54 0.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.4 -69.0 0.03 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . -139.38 59.81 1.59 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.25 . . . . 0.0 110.06 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.52 167.23 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.087 -1.008 . . . . 0.0 109.255 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 4.0 t0 -134.66 -30.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 73.62 105.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.95 -1.094 . . . . 0.0 108.506 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -116.95 118.77 35.92 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.043 -1.036 . . . . 0.0 110.25 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -105.97 149.0 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.046 1.551 . . . . 0.0 109.884 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -91.41 147.95 36.51 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 0.0 109.516 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -89.92 155.9 31.1 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 120.536 -2.693 . . . . 0.0 110.396 0.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 17.2 p90 -131.14 169.22 16.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 109.357 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 1.3 t70 -85.72 168.02 14.74 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.131 -0.981 . . . . 0.0 108.7 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 23' ' ' LEU . 31.6 mm -95.15 -61.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.91 -1.119 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 110' ' ' GLU . 63.1 t0 -54.97 -50.06 69.86 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.057 -1.027 . . . . 0.0 108.934 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 21.7 tp10 -44.13 -47.57 9.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -62.46 -67.74 0.39 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.066 ' CG2' HD11 ' A' ' 23' ' ' LEU . 48.1 t -35.4 -73.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.15 0.5 . . . . 0.0 110.584 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -39.12 -66.53 0.28 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.539 -0.725 . . . . 0.0 110.492 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.78 HD13 ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -34.8 -53.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.809 0.814 . . . . 0.0 109.663 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 114' ' ' LEU . 1.6 t -56.6 -60.81 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG12 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -37.82 -43.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.652 -0.655 . . . . 0.0 111.141 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 5.7 ptp180 -77.1 -36.66 55.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 110.594 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.588 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.71 -67.17 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.862 -1.149 . . . . 0.0 108.089 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.807 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.6 mt -37.07 -41.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.237 0.541 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.23 60.74 4.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -128.92 -54.47 1.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 22.7 p90 -78.35 136.45 37.69 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.85 -30.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.397 179.889 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 17.1 ttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 1' ' ' MET . 2.2 pt20 173.99 164.39 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.35 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -156.13 51.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 5' ' ' ILE . . . 149.45 177.38 23.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -153.25 90.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -1.102 . . . . 0.0 108.821 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.882 HG12 HG23 ' A' ' 8' ' ' VAL . 4.1 t -94.85 110.5 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.587 -0.696 . . . . 0.0 110.044 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.753 ' O ' HD23 ' A' ' 51' ' ' LEU . 12.0 m0 -99.94 81.05 2.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.009 HG22 ' CB ' ' A' ' 52' ' ' LEU . 43.8 t -83.91 172.34 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.347 0.594 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.971 ' HB ' HG21 ' A' ' 39' ' ' VAL . 7.0 p -134.09 140.78 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 108.7 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.887 ' HB3' HG21 ' A' ' 15' ' ' ILE . 4.6 t0 -136.71 -153.39 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.965 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD1' ' HB3' ' A' ' 57' ' ' MET . 13.6 t70 -80.6 -95.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' SER . 2.5 p-10 169.4 176.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 109.931 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 80.7 69.48 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.652 -0.655 . . . . 0.0 109.882 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.72 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.88 46.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.887 HG21 ' HB3' ' A' ' 10' ' ' ASP . 1.2 mp -112.05 -44.34 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 14.7 ttp180 -65.72 -33.06 75.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.65 -66.29 0.57 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 17' ' ' TRP . 38.3 t -39.62 -65.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.012 0.91 . . . . 0.0 110.241 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 23' ' ' LEU . 21.2 mt -55.08 -76.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.88 -0.512 . . . . 0.0 110.845 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 3.6 tm-20 -33.62 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.573 -0.704 . . . . 0.0 110.922 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 22.1 tpt180 -64.89 -56.3 14.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.982 -1.074 . . . . 0.0 108.486 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 108' ' ' ILE . . . -72.46 -2.32 19.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD22 ' CB ' ' A' ' 30' ' ' CYS . 9.7 mt -100.23 -17.37 17.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.12 -38.73 35.4 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.47 -40.3 91.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.94 -35.88 67.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.346 -1.09 . . . . 0.0 108.472 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 28' ' ' LEU . . . 101.63 42.79 2.25 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.664 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.852 HD22 ' CG1' ' A' ' 112' ' ' VAL . 1.1 mt -141.85 165.62 26.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.878 -1.366 . . . . 0.0 110.06 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 5' ' ' ILE . 98.5 m -98.19 75.46 2.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.786 ' CB ' HD22 ' A' ' 23' ' ' LEU . 16.1 t -90.83 86.59 6.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.416 -0.803 . . . . 0.0 109.582 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -82.89 140.28 32.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.392 -0.818 . . . . 0.0 109.038 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -132.32 125.48 31.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.705 ' CD2' HG22 ' A' ' 39' ' ' VAL . 65.4 m-85 -88.32 -177.65 5.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.116 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -108.87 2.29 21.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.88 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -144.45 142.04 30.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 109.792 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.728 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -69.93 -60.72 4.73 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.447 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -45.84 -69.38 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.382 -1.069 . . . . 0.0 108.344 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.635 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.8 tp10 -35.58 -49.22 0.55 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 0.0 110.912 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.971 HG21 ' HB ' ' A' ' 9' ' ' VAL . 65.2 t -45.22 -53.1 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.188 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.926 HD21 ' CA ' ' A' ' 69' ' ' ILE . 5.1 mp -60.59 -36.96 79.82 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -49.71 -33.55 16.29 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.69 -22.75 19.24 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.01 HD21 ' HB ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -71.35 -1.23 12.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.891 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.1 65.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -100.06 26.48 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HE3' ' CG ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 63.21 136.53 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.573 -0.704 . . . . 0.0 110.139 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.01 ' HB ' HD21 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -76.8 -169.5 0.19 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.696 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HB2' HD12 ' A' ' 5' ' ' ILE . 37.0 Cg_endo -97.76 -75.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.808 1.425 . . . . 0.0 110.171 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 9.1 m-20 -101.62 -63.3 1.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.797 -1.189 . . . . 0.0 110.269 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.611 HG23 HD13 ' A' ' 119' ' ' ILE . 2.1 t -148.58 152.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.415 -1.428 . . . . 0.0 111.296 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 7' ' ' TRP . 3.2 mt -102.03 131.16 48.64 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.009 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.81 164.07 21.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 109.818 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' A' ' 9' ' ' VAL . 28.8 p -161.71 133.51 5.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.261 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.627 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.95 -177.0 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.128 -0.982 . . . . 0.0 109.911 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.939 HG22 ' HB2' ' A' ' 64' ' ' ALA . 1.1 pp -117.9 137.33 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.741 ' H ' HD21 ' A' ' 63' ' ' LEU . 4.5 mtt180 -155.82 -73.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.215 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.868 ' HG2' HD22 ' A' ' 63' ' ' LEU . 4.3 ptt? -55.72 134.92 72.07 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.089 -1.007 . . . . 0.0 109.884 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -114.83 71.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.748 1.394 . . . . 0.0 110.308 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.12 -94.86 1.38 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.06 -50.47 66.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.204 . . . . 0.0 109.074 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.02 179.62 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.199 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.753 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -87.65 45.24 3.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.868 HD22 ' HG2' ' A' ' 57' ' ' MET . 0.3 OUTLIER 33.7 -111.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.015 -0.697 . . . . 0.0 109.993 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.939 ' HB2' HG22 ' A' ' 55' ' ' ILE . . . 40.59 58.53 2.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.01 -1.056 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 37' ' ' ASN . 3.6 mp -80.04 73.48 6.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 110.28 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.764 HD22 ' CG2' ' A' ' 80' ' ' ILE . 10.0 tp -87.61 -53.47 4.77 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HD2' ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -54.44 -23.57 16.5 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.922 ' OE1' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -79.23 -56.92 4.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.926 ' CA ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.13 -42.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.498 0.666 . . . . 0.0 109.944 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -82.74 -56.98 3.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.54 -0.725 . . . . 0.0 109.286 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 70' ' ' LYS . 15.1 tt0 -33.99 -31.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.775 -0.578 . . . . 0.0 111.299 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.67 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.09 -78.58 0.58 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.863 -1.148 . . . . 0.0 110.898 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.663 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 1.6 p80 -66.75 144.57 98.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.612 -1.305 . . . . 0.0 109.392 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.663 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 36.2 Cg_endo -35.52 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 124.066 1.561 . . . . 0.0 111.525 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.485 ' CG ' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -178.33 100.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.753 -1.217 . . . . 0.0 110.459 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.874 HD22 HG22 ' A' ' 47' ' ' THR . 3.4 pp -120.67 156.48 55.98 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.705 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.5 Cg_endo -41.87 129.9 4.14 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 117.563 -1.158 . . . . 0.0 111.184 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.921 HG23 ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -137.9 161.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.39 -0.819 . . . . 0.0 109.254 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.781 HD13 ' O ' ' A' ' 78' ' ' VAL . 3.7 mm -142.84 147.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.764 ' CG2' HD22 ' A' ' 66' ' ' LEU . 7.1 tt -136.4 141.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.831 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.563 ' SD ' ' CE1' ' A' ' 106' ' ' PHE . 5.1 ttm -88.5 98.26 11.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.318 -0.863 . . . . 0.0 109.045 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -59.29 149.87 27.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 109.675 -179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.87 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . 179.28 60.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.324 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 79.26 143.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 109.496 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 45.2 p 53.65 171.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.265 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 85' ' ' SER . 5.5 m-20 84.43 -54.61 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.971 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -34.82 -30.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 110.8 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.3 p30 -64.16 -97.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.026 -1.046 . . . . 0.0 110.141 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -43.39 -40.35 3.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.969 -1.082 . . . . 0.0 109.903 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -51.07 -50.58 58.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 87' ' ' LEU . 3.3 t -32.6 -36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.222 0.534 . . . . 0.0 110.187 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.4 t -90.87 44.45 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.81 . . . . 0.0 109.465 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ALA . . . -132.31 -65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 109.19 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . 41.3 p90 -90.71 28.42 1.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.148 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.64 -42.69 99.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -86.87 -55.09 4.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.483 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.727 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 165.91 -164.3 37.33 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 81.73 22.27 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.599 -0.942 . . . . 0.0 109.688 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.921 ' CE2' HG23 ' A' ' 78' ' ' VAL . 89.4 m-85 -140.51 157.1 46.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.557 ' OD2' HD11 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -114.52 -29.91 6.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 70.93 99.6 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 0.0 109.329 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.58 HD12 ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -110.27 119.76 46.09 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.892 . . . . 0.0 109.654 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -108.45 12.74 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.45 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 64.71 159.25 0.12 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -76.14 172.6 62.33 Favored 'Cis proline' 0 C--N 1.314 -1.238 0 C-N-CA 120.664 -2.64 . . . . 0.0 110.336 -0.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.563 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 40.8 p90 -157.06 144.05 18.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 8.7 t70 -85.63 174.75 9.19 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -82.88 -48.69 17.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.778 -1.201 . . . . 0.0 109.864 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 108' ' ' ILE . 22.9 t0 -73.38 -47.37 42.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.006 -1.059 . . . . 0.0 108.15 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 tp10 -49.24 -38.02 25.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.3 -72.94 0.18 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.228 -0.92 . . . . 0.0 108.672 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.852 ' CG1' HD22 ' A' ' 28' ' ' LEU . 77.9 t -38.45 -74.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 121.513 0.673 . . . . 0.0 110.323 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.96 -62.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.714 . . . . 0.0 110.355 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -33.19 -54.65 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.432 0.634 . . . . 0.0 110.003 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.742 ' N ' HD13 ' A' ' 114' ' ' LEU . 75.2 t -60.05 -55.69 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 3.5 pt-20 -34.24 -44.85 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.905 -0.497 . . . . 0.0 111.411 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -59.77 -47.46 85.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.127 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.41 -55.29 25.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.737 -1.227 . . . . 0.0 107.953 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.611 HD13 HG23 ' A' ' 50' ' ' VAL . 3.3 mt -36.47 -34.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.943 -0.473 . . . . 0.0 109.796 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.674 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 6.8 p -22.85 -45.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.674 ' CB ' ' O ' ' A' ' 120' ' ' SER . 28.8 t60 117.65 62.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER 32.04 39.28 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.473 0.654 . . . . 0.0 109.94 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -40.16 -30.93 0.11 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.231 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.411 ' OXT' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.546 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.376 0.608 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 2.0 tt0 -113.95 121.4 43.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.439 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -156.76 172.83 17.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.342 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 -168.49 38.07 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.387 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.731 HG22 ' HE1' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -149.84 93.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.601 -0.941 . . . . 0.0 109.363 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.958 HG23 HG12 ' A' ' 50' ' ' VAL . 3.6 p -100.4 118.95 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.553 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.946 ' CE3' HG21 ' A' ' 31' ' ' THR . 11.7 m95 -103.06 102.58 12.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.96 -1.087 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.801 HG22 ' CG ' ' A' ' 52' ' ' LEU . 59.7 t -98.99 146.91 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.028 ' CG1' HG21 ' A' ' 39' ' ' VAL . 1.6 m -104.49 129.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 O-C-N 121.063 -1.023 . . . . 0.0 108.554 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.91 ' CB ' HG21 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -112.44 -99.21 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.343 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' GLU . 12.3 t0 -153.12 -49.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.679 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -144.0 -179.69 6.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.9 -1.125 . . . . 0.0 110.459 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -65.96 169.29 6.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 109.666 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.1 OUTLIER 78.08 -6.77 1.91 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.91 HG21 ' CB ' ' A' ' 10' ' ' ASP . 1.8 mp -96.91 -29.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -65.08 -36.75 85.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 54.4 t90 -61.9 -63.64 1.19 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 20.2 t -36.97 -65.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.527 0.68 . . . . 0.0 110.731 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' CD2' ' CD1' ' A' ' 108' ' ' ILE . 0.7 OUTLIER -50.77 -70.88 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.792 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -35.4 -35.4 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.0 110.77 -179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.15 -54.19 47.59 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -66.53 -19.15 65.71 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.251 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -87.21 -10.29 52.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.167 -0.958 . . . . 0.0 109.543 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.45 71.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.07 -34.46 66.25 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.16 45.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.466 -1.02 . . . . 0.0 109.143 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.37 49.58 14.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.064 HD22 ' CG1' ' A' ' 112' ' ' VAL . 0.9 OUTLIER -128.52 177.89 6.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.106 -1.232 . . . . 0.0 110.267 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.608 ' HB ' HG23 ' A' ' 5' ' ' ILE . 7.2 m -95.26 93.35 7.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.746 ' HB2' HD22 ' A' ' 23' ' ' LEU . 34.2 t -86.45 80.75 8.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.946 HG21 ' CE3' ' A' ' 7' ' ' TRP . 3.3 m -84.22 141.17 31.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -143.73 164.51 30.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.678 -1.264 . . . . 0.0 110.038 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.874 ' HB2' HG22 ' A' ' 39' ' ' VAL . 13.5 m-85 -131.13 -171.67 2.64 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.6 pt-20 -107.02 -23.97 12.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.964 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.854 ' O ' HG23 ' A' ' 39' ' ' VAL . 51.0 m-20 -140.25 147.04 39.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.927 -1.108 . . . . 0.0 109.884 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 64' ' ' ALA . . . -55.67 -31.15 57.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.57 -76.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -1.152 . . . . 0.0 108.005 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.591 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -33.83 -33.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.373 0.606 . . . . 0.0 109.753 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.028 HG21 ' CG1' ' A' ' 9' ' ' VAL . 63.1 t -60.84 -59.11 4.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 121.381 -0.824 . . . . 0.0 109.203 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.984 HD12 ' N ' ' A' ' 41' ' ' ALA . 1.6 pp -62.08 -17.46 57.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.572 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.984 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -68.01 -35.95 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.36 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.764 HD21 HD11 ' A' ' 51' ' ' LEU . 3.9 mm? -66.31 -7.82 21.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.75 60.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.5 m -100.25 26.78 6.19 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.1 mptt 71.88 139.5 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.631 0.729 . . . . 0.0 110.263 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.95 ' CG2' HD22 ' A' ' 76' ' ' LEU . 2.6 t -71.25 -177.0 0.42 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.585 -0.697 . . . . 0.0 109.496 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HB2' HD12 ' A' ' 5' ' ' ILE . 36.5 Cg_endo -114.94 -67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.799 1.42 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.665 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -121.27 -53.5 2.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.846 -1.159 . . . . 0.0 110.527 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.958 HG12 HG23 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.12 129.08 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.552 -1.342 . . . . 0.0 110.206 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.963 HD22 ' NE2' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.59 128.88 46.5 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.585 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.89 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 3.3 pp -141.39 165.84 26.4 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.753 -1.217 . . . . 0.0 110.008 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.604 ' N ' HD12 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -133.99 151.08 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' SD ' ' A' ' 81' ' ' MET . 4.4 t70 -115.91 129.4 56.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.8 144.89 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.62 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -179.3 -65.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.419 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -45.5 151.89 0.72 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.613 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -99.84 163.6 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.055 1.555 . . . . 0.0 110.207 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.86 -167.47 22.75 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.1 mmt -64.17 -32.61 74.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -1.079 . . . . 0.0 109.585 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.04 92.44 3.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.95 -45.27 7.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.97 HD11 HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -50.54 -83.12 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.136 -1.214 . . . . 0.0 109.402 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' A' ' 9' ' ' VAL . . . 168.67 35.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER 57.56 62.33 2.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 80' ' ' ILE . 15.9 tp -75.35 -13.22 60.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.997 . . . . 0.0 108.891 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -78.08 -38.95 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.592 ' HG3' HD23 ' A' ' 40' ' ' LEU . 2.1 pt20 -76.74 -52.67 9.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.065 -1.022 . . . . 0.0 108.51 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.69 HG21 HD12 ' A' ' 66' ' ' LEU . 2.9 tt -37.58 -34.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.812 0.815 . . . . 0.0 109.313 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 7.5 tptp -78.03 -54.52 6.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.98 -46.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.543 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 1.4 tpt85 -87.59 -43.44 11.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.192 -0.942 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.963 ' NE2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -40.45 162.65 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.437 -0.789 . . . . 0.0 110.341 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD2' HD23 ' A' ' 76' ' ' LEU . 37.0 Cg_endo -117.71 42.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 124.03 1.542 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.4 mtt 66.03 82.83 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 0.0 110.579 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.95 HD22 ' CG2' ' A' ' 47' ' ' THR . 1.0 OUTLIER -147.82 151.23 38.15 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.082 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 50' ' ' VAL . 36.8 Cg_endo -37.59 126.77 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.61 1.321 . . . . 0.0 111.691 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 99' ' ' PHE . 84.1 t -117.91 100.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.589 -0.694 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.89 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 1.7 mt -75.7 157.54 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 108.739 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.97 HD11 HD11 ' A' ' 63' ' ' LEU . 7.3 tt -154.15 123.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.028 -1.045 . . . . 0.0 110.569 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.516 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 15.9 mtt -97.89 99.76 11.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 58.13 161.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . . . -172.95 -175.36 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.961 -1.087 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.537 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.5 t-80 -167.49 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.934 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.537 ' C ' ' O ' ' A' ' 84' ' ' HIS . 21.7 m 40.26 31.83 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 88' ' ' ASP . 3.1 m-20 63.43 126.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 91' ' ' VAL . 3.8 tp -35.83 -31.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -38.02 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.485 0.659 . . . . 0.0 109.584 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.497 ' HB3' ' CB ' ' A' ' 85' ' ' SER . . . -47.59 -32.14 5.18 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -69.36 -87.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.329 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.869 HG23 ' HG ' ' A' ' 87' ' ' LEU . 91.2 t -33.18 -59.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.719 -0.613 . . . . 0.0 111.398 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -55.84 -99.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.356 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 48.4 -105.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.872 -1.143 . . . . 0.0 108.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -141.82 60.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 0.0 108.791 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 8.1 mm-40 -57.31 174.23 0.21 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.605 -0.685 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 27.7 mt-30 64.12 50.42 2.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.98 -120.22 0.54 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.68 89.0 2.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -1.187 . . . . 0.0 109.474 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.58 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 5.5 m-85 -133.39 136.46 45.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 0.0 109.696 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -120.06 -167.86 1.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.047 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.509 ' OH ' ' HB3' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -166.2 94.93 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.735 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.7 OUTLIER -120.64 151.67 54.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.149 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 36.8 Cg_endo -119.36 -173.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.709 1.373 . . . . 0.0 110.594 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HG2' ' CD1' ' A' ' 106' ' ' PHE . 1.2 mtmm -91.27 159.25 39.77 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.335 -0.853 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -87.33 169.76 39.54 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 120.274 -2.803 . . . . 0.0 110.308 0.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.516 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 52.6 p90 -161.97 150.05 14.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . 6.1 t0 -80.19 117.99 21.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.197 -0.94 . . . . 0.0 108.584 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.547 HG21 ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -41.77 -41.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.215 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 108' ' ' ILE . 25.8 t70 -74.48 -38.85 62.79 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.51 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 8.1 tm-20 -51.33 -38.11 51.32 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -81.94 -69.7 0.6 Allowed 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.064 ' CG1' HD22 ' A' ' 28' ' ' LEU . 24.4 t -37.31 -35.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.499 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -78.61 -66.67 0.83 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.982 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.776 HD13 ' C ' ' A' ' 114' ' ' LEU . 3.0 tm? -35.47 -51.72 0.63 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.506 0.67 . . . . 0.0 109.843 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.858 HG21 ' CG1' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -70.45 -51.47 37.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 108.948 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 9.0 tm-20 -33.35 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.523 0.677 . . . . 0.0 109.933 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' VAL . 5.1 mtm180 -76.51 -57.27 3.96 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.62 -54.37 9.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -0.973 . . . . 0.0 109.065 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.691 HG23 ' HG3' ' A' ' 77' ' ' PRO . 6.2 mt -39.77 -44.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 110.793 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -86.34 -22.6 26.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 120' ' ' SER . 63.1 t60 -37.94 -55.5 1.22 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.427 -0.796 . . . . 0.0 110.649 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.631 ' O ' ' CG ' ' A' ' 122' ' ' TYR . 3.9 p90 -91.05 48.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -73.26 -28.65 62.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.796 -1.19 . . . . 0.0 109.296 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.501 ' O ' ' CB ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 1' ' ' MET . 1.3 mm100 76.31 105.47 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 7.5 tpp180 -101.3 66.1 1.09 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.288 -0.882 . . . . 0.0 109.342 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 1.047 ' HA3' HD22 ' A' ' 28' ' ' LEU . . . -167.21 50.11 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 48' ' ' PRO . 3.6 mt -76.64 91.55 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.088 -1.242 . . . . 0.0 107.977 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.718 ' CG2' HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -100.78 123.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.433 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.708 ' CE3' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.1 87.91 4.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.018 HG22 ' HB2' ' A' ' 52' ' ' LEU . 29.9 t -84.95 146.06 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.877 . . . . 0.0 110.545 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' LEU . 8.9 t -91.64 153.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.875 ' CG ' HG21 ' A' ' 15' ' ' ILE . 9.5 t0 -179.31 -124.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.961 -1.087 . . . . 0.0 110.003 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' CA ' ' HA ' ' A' ' 34' ' ' GLU . 1.4 t70 -128.22 -8.45 5.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.602 -1.311 . . . . 0.0 110.547 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.575 ' HB2' ' N ' ' A' ' 34' ' ' GLU . 2.1 t70 48.87 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 70.01 13.44 7.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.3 p 161.62 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.875 HG21 ' CG ' ' A' ' 10' ' ' ASP . 33.0 mm -82.27 -38.34 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 108.958 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 32' ' ' THR . 12.2 ttp85 -65.67 -35.13 79.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -66.4 -62.63 1.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 14' ' ' SER . 53.4 t -40.32 -64.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.906 ' CD2' HD11 ' A' ' 108' ' ' ILE . 2.8 mt -60.24 -75.58 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.68 -0.637 . . . . 0.0 110.944 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 18.8 tt0 -34.88 -31.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.736 -0.602 . . . . 0.0 110.612 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -67.07 -56.4 10.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -13.04 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.821 HD12 ' HB2' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -82.39 -27.17 32.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.42 73.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.42 -0.8 . . . . 0.0 109.185 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.72 -27.06 39.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.73 -16.97 60.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -1.07 . . . . 0.0 109.233 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.697 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 72.98 38.11 56.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.047 HD22 ' HA3' ' A' ' 4' ' ' GLY . 78.2 mt -137.71 163.3 31.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.942 -1.328 . . . . 0.0 109.887 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 29' ' ' THR . 21.1 m -104.8 79.8 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.489 -0.757 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.672 ' HA ' HG12 ' A' ' 6' ' ' VAL . 44.3 t -80.96 80.44 7.44 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.004 -1.06 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.1 m -77.45 129.74 36.12 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.7 p -124.29 133.95 53.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.635 -1.291 . . . . 0.0 110.499 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.008 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.2 m-30 -106.56 145.54 31.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.575 ' N ' ' HB2' ' A' ' 12' ' ' ASP . 1.2 pt-20 -63.03 -8.22 6.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 110.192 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -154.81 138.44 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.787 -1.195 . . . . 0.0 110.399 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.696 ' H ' HD13 ' A' ' 65' ' ' LEU . . . -56.34 -26.16 50.33 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' GLU . 33.9 t-20 -56.28 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.261 -1.14 . . . . 0.0 108.052 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.3 mm-40 -36.14 -46.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 110.774 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.008 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -49.5 -54.19 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.013 -1.054 . . . . 0.0 108.537 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.84 HD11 ' CB ' ' A' ' 72' ' ' ARG . 8.2 tt -64.45 -26.74 68.57 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.757 . . . . 0.0 109.496 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -22.91 62.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.09 -24.05 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.765 ' CD2' HD11 ' A' ' 51' ' ' LEU . 1.3 mp -87.2 -6.87 58.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.88 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.05 -29.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.711 . . . . 0.0 109.319 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -80.88 -46.56 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER 169.91 151.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 110.117 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.708 ' HB ' HD22 ' A' ' 76' ' ' LEU . 5.9 m -87.23 164.36 36.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 108.79 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.9 Cg_endo -103.84 -71.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.611 1.322 . . . . 0.0 111.13 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.488 ' OD2' ' CA ' ' A' ' 4' ' ' GLY . 3.0 m-20 -110.75 -75.31 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 0.0 110.542 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.866 HG22 ' HG2' ' A' ' 77' ' ' PRO . 13.1 t -143.7 145.02 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.062 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.765 HD11 ' CD2' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -101.8 124.21 47.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 109.88 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.018 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -108.83 165.99 11.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.222 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -147.8 122.05 9.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 109.644 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -78.0 -171.13 2.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 55' ' ' ILE . 2.6 tp -143.21 79.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.581 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -117.74 -166.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mtt 59.62 83.75 0.21 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.09 120.4 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.944 1.497 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.76 -87.23 0.07 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 ttm -109.94 -91.71 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -1.125 . . . . 0.0 109.429 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.7 m-20 -102.53 1.26 34.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . 152.47 -90.35 0.13 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.884 HD13 HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER 176.64 25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.384 -1.068 . . . . 0.0 110.377 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 56.94 -142.18 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.848 -1.157 . . . . 0.0 109.132 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.884 HD12 HD13 ' A' ' 63' ' ' LEU . 62.9 mt 80.04 -66.76 0.15 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.682 . . . . 0.0 110.535 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 66' ' ' LEU . 2.5 tm? -57.47 -36.03 70.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.584 -1.322 . . . . 0.0 109.251 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -66.11 -30.92 71.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.643 -1.286 . . . . 0.0 107.663 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.677 ' HG3' HD13 ' A' ' 40' ' ' LEU . 2.5 tp-100 -69.08 -65.26 0.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.805 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -37.4 -24.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 111.494 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 68' ' ' GLN . 3.1 tptt -89.24 -69.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.274 -1.517 . . . . 0.0 109.277 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -34.93 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.683 -0.636 . . . . 0.0 112.01 -178.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.84 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.31 -68.7 0.86 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.545 -1.347 . . . . 0.0 111.777 -178.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.658 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 77.6 m80 -33.55 152.12 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.197 0 O-C-N 121.536 -0.728 . . . . 0.0 110.698 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -59.08 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.987 1.519 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.41 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.848 -1.158 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.708 HD22 ' HB ' ' A' ' 47' ' ' THR . 0.5 OUTLIER -146.31 -176.2 0.53 Allowed Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.866 ' HG2' HG22 ' A' ' 50' ' ' VAL . 36.0 Cg_endo -78.73 143.0 18.35 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 117.292 -1.338 . . . . 0.0 111.512 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -137.15 158.0 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.579 HG21 HD12 ' A' ' 102' ' ' LEU . 4.4 mt -142.6 145.21 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 108.995 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -127.83 138.89 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.87 142.93 49.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -93.99 178.6 5.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 109.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 166.68 -57.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.543 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.98 -52.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -109.47 107.98 18.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.646 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.5 p-10 166.74 -42.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 31.5 tp -35.02 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.247 0.546 . . . . 0.0 110.313 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 86' ' ' ASP . 5.4 t0 -63.51 -72.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -43.71 -47.32 7.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 80' ' ' ILE . . . -62.77 -76.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 72.5 t -33.69 -32.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.818 -0.551 . . . . 0.0 111.125 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' ALA . 5.1 p -92.25 -148.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.98 -1.075 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 94' ' ' TYR . . . 58.72 64.79 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.509 ' CB ' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER 76.39 -0.52 3.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.22 -179.268 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 27.0 mt-30 42.47 -97.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' TYR . 3.6 mt-30 -62.74 100.44 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.986 -1.071 . . . . 0.0 109.836 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.96 -121.63 1.01 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.12 72.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -1.21 . . . . 0.0 109.679 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 52.4 m-85 -127.05 136.13 51.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 101' ' ' TYR . 3.7 m-20 -135.78 89.59 2.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -38.34 135.56 0.74 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.652 -0.655 . . . . 0.0 109.995 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.579 HD12 HG21 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -113.33 121.79 36.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -122.3 -177.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.762 1.401 . . . . 0.0 110.578 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -100.63 156.85 34.72 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -96.88 167.61 13.67 Favored 'Cis proline' 0 C--N 1.317 -1.082 0 C-N-CA 120.8 -2.584 . . . . 0.0 110.392 0.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -164.3 146.44 8.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.6 t70 -75.95 144.02 41.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.906 HD11 ' CD2' ' A' ' 19' ' ' LEU . 4.5 tp -60.13 -48.31 88.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.942 -1.099 . . . . 0.0 110.7 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.611 ' N ' HG23 ' A' ' 108' ' ' ILE . 35.7 t0 -69.96 -54.78 11.76 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 108.744 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 9.7 tp10 -46.36 -28.73 1.42 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.96 -78.66 0.09 Allowed 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.504 -0.747 . . . . 0.0 109.328 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.819 ' CG1' HD13 ' A' ' 28' ' ' LEU . 47.5 t -41.42 -60.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 121.368 -0.832 . . . . 0.0 109.692 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -42.33 -62.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.773 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.779 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -35.0 -50.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.686 0.755 . . . . 0.0 109.317 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.767 HG21 HG11 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -59.8 -53.89 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.573 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.9 tt0 -34.48 -41.46 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.376 0.607 . . . . 0.0 110.386 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -61.99 -53.05 60.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.364 -0.835 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -52.32 -54.8 26.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.012 -1.055 . . . . 0.0 108.626 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.862 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.1 mt -36.2 -34.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.426 0.631 . . . . 0.0 110.467 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 118' ' ' ALA . 3.5 t -70.73 22.77 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.389 -0.819 . . . . 0.0 111.983 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' C ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER 53.5 35.84 21.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.353 -1.467 . . . . 0.0 109.572 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.5 OUTLIER 32.21 50.56 0.18 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.575 0.703 . . . . 0.0 110.162 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.99 -25.82 67.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.055 -1.028 . . . . 0.0 109.348 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.302 0.572 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 68.13 85.79 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.614 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.02 145.71 2.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 28' ' ' LEU . . . 178.75 141.95 4.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.563 HG13 HG21 ' A' ' 29' ' ' THR . 5.2 mp -104.94 103.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.43 -1.041 . . . . 0.0 109.729 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -104.39 128.04 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.545 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -101.57 81.56 2.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 110.608 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.808 ' HB ' HG22 ' A' ' 32' ' ' THR . 42.6 t -72.61 146.6 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 109.539 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 84.1 t -91.72 105.81 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.038 -1.039 . . . . 0.0 109.349 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.566 ' HA ' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -53.79 174.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 2.3 t70 -124.39 -50.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 110.277 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -172.42 94.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 111.271 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 12' ' ' ASP . 1.8 p 57.08 137.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.145 0.974 . . . . 0.0 111.557 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.655 ' N ' ' CE3' ' A' ' 17' ' ' TRP . 5.4 t 61.81 3.67 0.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.387 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 10' ' ' ASP . 21.4 mm -88.21 -54.81 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.184 -1.572 . . . . 0.0 109.286 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -62.69 -36.76 83.96 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.655 ' CE3' ' N ' ' A' ' 14' ' ' SER . 7.9 m-90 -71.27 -55.91 7.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 14' ' ' SER . 2.1 t -39.1 -61.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 122.057 0.932 . . . . 0.0 109.795 -177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.3 mm? -55.95 -70.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.59 -0.694 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -35.56 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.5 tmt_? -68.12 -56.52 8.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.94 -6.72 34.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.054 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.866 HD11 HG21 ' A' ' 112' ' ' VAL . 1.5 mm? -101.91 -9.11 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.67 -52.57 6.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.317 -0.865 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.48 71.43 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.42 74.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.437 -1.037 . . . . 0.0 108.809 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.37 57.73 1.34 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.857 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -140.97 179.7 6.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.073 -1.251 . . . . 0.0 110.347 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.563 HG21 HG13 ' A' ' 5' ' ' ILE . 16.4 m -103.4 83.44 2.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.503 ' HB2' ' CG ' ' A' ' 23' ' ' LEU . 19.1 t -92.64 92.54 8.05 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.17 -0.956 . . . . 0.0 110.807 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.545 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -94.18 144.87 25.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.808 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.3 p -149.96 129.25 12.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.702 -1.248 . . . . 0.0 110.258 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.66 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.6 m-85 -111.81 127.33 55.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.272 -0.892 . . . . 0.0 109.133 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HA ' ' CB ' ' A' ' 10' ' ' ASP . 1.9 pt-20 -47.63 -19.59 0.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.49 -0.756 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -131.85 132.98 44.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.503 -1.373 . . . . 0.0 111.098 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -61.78 -18.4 56.6 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.461 ' HA ' ' CD ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -68.25 -80.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.088 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -35.53 -45.86 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.848 -0.533 . . . . 0.0 110.321 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.5 OUTLIER -58.05 -52.22 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.215 -0.928 . . . . 0.0 108.995 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.9 tm? -63.52 -17.29 62.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -84.47 -25.91 28.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.13 -35.51 64.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.087 HD13 ' NE2' ' A' ' 73' ' ' HIS . 4.7 mt -72.36 -102.97 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 81.61 -40.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.122 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 70.7 m -98.99 -40.19 8.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -0.932 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.4 OUTLIER 168.06 150.09 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.096 -1.002 . . . . 0.0 108.969 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.584 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -87.37 165.81 28.94 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.255 -0.903 . . . . 0.0 109.417 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.54 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -89.27 -66.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.234 1.649 . . . . 0.0 110.319 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.755 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -109.85 -75.32 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.785 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -149.99 151.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 0.0 109.964 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.983 HD12 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -99.88 134.57 42.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.85 148.16 49.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.941 -1.099 . . . . 0.0 109.147 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.47 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t -134.66 126.4 29.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.094 -1.003 . . . . 0.0 110.428 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 m-20 -73.27 -179.93 3.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 109.173 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.578 HG21 ' O ' ' A' ' 82' ' ' THR . 0.7 OUTLIER 176.89 38.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.21 11.09 10.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.96 . . . . 0.0 109.248 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ASP . 5.9 mmt -38.08 140.51 0.57 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.3 Cg_endo -49.42 122.92 9.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.07 1.563 . . . . 0.0 110.631 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 44.39 -126.06 6.24 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 ptt? -70.44 -146.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.399 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 57' ' ' MET . 31.1 m-20 63.14 100.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 109.802 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -153.07 90.67 0.13 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.933 HD11 HD11 ' A' ' 65' ' ' LEU . 1.2 pt? -38.32 147.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.912 . . . . 0.0 110.429 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.954 ' HB1' ' HD3' ' A' ' 67' ' ' LYS . . . -90.97 122.95 34.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.933 HD11 HD11 ' A' ' 63' ' ' LEU . 5.1 mt -134.21 -43.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.535 ' HA ' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -41.25 -51.01 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.464 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.954 ' HD3' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -43.66 -50.02 7.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 6.3 pt20 -69.97 -43.09 72.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.616 -1.302 . . . . 0.0 109.429 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.587 HG21 HG11 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -37.48 -52.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 109.606 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -73.14 -57.96 3.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.851 -0.531 . . . . 0.0 110.417 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.41 -36.41 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.843 -0.536 . . . . 0.0 110.939 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.913 ' HB2' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -101.99 -30.84 10.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.694 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.087 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.21 -177.77 0.32 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.855 ' HD2' HD23 ' A' ' 76' ' ' LEU . 36.6 Cg_endo -113.73 39.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.162 1.612 . . . . 0.0 109.598 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 5.8 mmt 63.17 73.24 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.855 HD23 ' HD2' ' A' ' 74' ' ' PRO . 3.0 pp -130.61 176.9 2.51 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 108.886 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.638 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 36.2 Cg_endo -68.26 129.29 18.95 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.184 1.097 . . . . 0.0 112.778 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.983 HG13 ' HB3' ' A' ' 51' ' ' LEU . 45.7 t -134.42 100.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 100' ' ' ASP . 15.4 mm -80.43 160.52 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.03 -1.044 . . . . 0.0 111.055 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 80' ' ' ILE . 3.9 mp -139.71 136.19 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.519 -0.738 . . . . 0.0 109.31 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.508 ' O ' HG22 ' A' ' 55' ' ' ILE . 1.2 ttm -81.27 89.87 6.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.27 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.578 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 65.77 -177.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 109.201 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' H ' HG22 ' A' ' 82' ' ' THR . . . 179.54 142.92 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.004 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -146.33 36.82 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.1 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.86 -32.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.573 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.74 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 46.4 t0 -76.49 -17.62 59.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 109.571 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.3 mt -34.44 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.702 -0.624 . . . . 0.0 110.525 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 86' ' ' ASP . 16.5 t0 -62.85 -57.85 9.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.018 . . . . 0.0 109.746 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . . . -60.55 -57.24 13.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -52.02 -66.78 0.32 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -0.951 . . . . 0.0 109.8 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 87' ' ' LEU . 47.8 t -33.7 -31.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.98 -0.45 . . . . 0.0 111.042 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.703 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 32.6 t -95.48 170.69 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 109.897 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 78.0 74.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.82 -86.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.512 ' HG3' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 66.39 31.49 8.22 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.389 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -125.65 16.19 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 161.9 151.11 6.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . 69.43 34.03 2.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 20.3 m-85 -152.16 29.93 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.542 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -55.38 124.84 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.03 137.04 38.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.803 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -110.64 111.05 57.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -104.91 144.21 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.38 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.39 151.54 87.26 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.315 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -81.32 175.53 41.93 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.52 -2.7 . . . . 0.0 110.517 -0.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -159.5 136.31 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 17.5 t0 -76.05 -176.75 3.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 108.551 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.49 -49.48 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.639 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 26.2 t70 -69.36 -45.84 68.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 108.53 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.3 tp10 -51.1 -37.08 43.76 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.06 -70.22 0.37 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.379 -0.826 . . . . 0.0 108.81 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.866 HG21 HD11 ' A' ' 23' ' ' LEU . 39.1 t -36.45 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.744 -0.597 . . . . 0.0 110.396 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -51.32 -61.22 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 110.45 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 113' ' ' ALA . 47.6 tp -34.47 -58.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.331 0.586 . . . . 0.0 110.174 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.701 HG22 HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -59.66 -56.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.623 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.0 tm-20 -35.59 -31.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.185 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtm180 -82.63 -56.37 3.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.632 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.18 -61.33 1.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 108.734 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.785 ' CD1' HG23 ' A' ' 50' ' ' VAL . 9.6 mt -35.43 -44.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.805 -0.559 . . . . 0.0 110.55 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.74 56.62 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.91 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 34.5 t-80 -117.73 0.28 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.393 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -99.56 9.98 42.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.262 -0.899 . . . . 0.0 109.606 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 60.6 mt-30 -90.53 40.78 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 29.0 tt0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.49 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.6 mt-30 68.52 20.24 8.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -112.9 145.99 39.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 108.715 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.956 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -167.61 149.5 14.74 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.839 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.827 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -101.46 110.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.616 -0.932 . . . . 0.0 109.859 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -113.86 119.09 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 1.178 ' CE3' HG21 ' A' ' 31' ' ' THR . 10.5 m95 -101.04 88.45 3.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.656 -1.278 . . . . 0.0 109.235 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.048 HG22 ' CB ' ' A' ' 52' ' ' LEU . 48.4 t -82.77 153.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.528 -0.732 . . . . 0.0 110.45 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.06 HG22 HG21 ' A' ' 39' ' ' VAL . 93.5 t -96.58 106.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -63.22 156.31 25.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 109.147 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -102.92 -29.8 11.2 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.659 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 1.7 m-20 -124.51 169.66 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.905 -1.122 . . . . 0.0 110.229 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -67.07 -3.12 6.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.895 -1.128 . . . . 0.0 110.64 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 t -121.3 8.85 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.799 -1.188 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.509 HG22 ' HB2' ' A' ' 10' ' ' ASP . 16.1 mm -78.88 -35.24 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.909 -1.119 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -49.58 77.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.541 ' CZ2' ' NH2' ' A' ' 21' ' ' ARG . 19.0 t90 -53.86 -64.4 0.84 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.2 t -37.48 -65.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.636 0.731 . . . . 0.0 110.698 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -50.39 -79.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 111.002 -178.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.8 tt0 -33.68 -33.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.826 -0.546 . . . . 0.0 110.947 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' NH2' ' CZ2' ' A' ' 17' ' ' TRP . 2.5 tpp85 -66.84 -57.16 7.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 0.0 109.037 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.617 ' CB ' HG21 ' A' ' 108' ' ' ILE . . . -71.97 -4.31 27.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.347 -0.846 . . . . 0.0 109.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.907 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -100.11 -18.62 16.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.48 -43.5 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.94 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.22 62.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -1.071 . . . . 0.0 109.013 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.7 47.88 4.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.956 HD23 ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -127.87 179.57 5.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.073 -1.251 . . . . 0.0 110.097 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.763 HG21 ' CG2' ' A' ' 5' ' ' ILE . 53.9 m -99.97 86.04 3.18 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 31.3 t -82.37 92.13 6.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.474 -0.767 . . . . 0.0 110.399 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.178 HG21 ' CE3' ' A' ' 7' ' ' TRP . 24.3 m -89.55 124.1 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 34.2 p -127.01 151.31 48.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.06 -1.025 . . . . 0.0 110.125 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.061 ' HB2' HG22 ' A' ' 39' ' ' VAL . 7.8 m-85 -143.14 119.07 10.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.48 -0.763 . . . . 0.0 109.207 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.458 ' HA ' ' OD2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -54.16 -27.82 36.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.167 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.828 ' O ' HG23 ' A' ' 39' ' ' VAL . 46.2 m-20 -109.45 125.33 52.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 110.39 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . -57.78 -46.72 91.98 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 38' ' ' GLU . 58.3 t-20 -53.62 -71.93 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.159 -1.201 . . . . 0.0 108.811 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -34.23 -38.05 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.878 -0.514 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.061 HG22 ' HB2' ' A' ' 33' ' ' PHE . 48.8 t -53.15 -59.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.764 HD23 ' NE2' ' A' ' 68' ' ' GLN . 3.9 mm? -62.57 -21.78 65.86 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -65.99 -36.68 83.97 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.67 36.29 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 43' ' ' LEU . 2.5 tm? -56.95 -19.84 20.29 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.48 -40.25 12.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 109.22 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -62.31 -39.81 94.27 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.085 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 99.33 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.351 0.596 . . . . 0.0 110.583 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.494 HG21 HD21 ' A' ' 51' ' ' LEU . 34.5 p -65.15 169.53 5.59 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HG2' ' CG1' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -129.89 -15.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 116.263 -2.025 . . . . 0.0 113.007 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -94.4 -71.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 119.867 -1.771 . . . . 0.0 110.912 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.753 HG21 HG13 ' A' ' 115' ' ' VAL . 11.3 t -163.78 144.36 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 110.168 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -101.92 125.27 48.56 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.779 178.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.048 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -113.18 160.12 18.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -153.42 131.22 11.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.397 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.581 ' O ' HD21 ' A' ' 63' ' ' LEU . 7.7 t0 -92.43 144.06 25.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.807 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -88.31 82.74 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.096 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 6.5 tpt180 178.57 128.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 108.919 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.539 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -174.18 157.61 2.59 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 57' ' ' MET . 36.2 Cg_endo -63.4 155.9 59.49 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.784 1.412 . . . . 0.0 110.298 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.23 10.82 27.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 61.14 -177.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -1.098 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.72 -146.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' O ' ' CG ' ' A' ' 57' ' ' MET . . . -107.98 -111.27 3.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.762 ' HB2' HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -130.74 -46.03 1.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -1.11 . . . . 0.0 109.413 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 63' ' ' LEU . . . 77.36 64.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.817 . . . . 0.0 109.762 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.861 HD12 HE22 ' A' ' 68' ' ' GLN . 1.0 OUTLIER -149.42 14.94 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.922 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 1.2 mm? -65.21 -40.76 94.58 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -25.82 62.89 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.861 HE22 HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.37 -58.68 7.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.3 mp -37.71 -69.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.563 -0.71 . . . . 0.0 110.452 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -48.28 -69.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.987 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 12.3 mt-30 -34.77 -31.83 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.408 0.623 . . . . 0.0 110.428 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.762 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -108.64 -81.29 0.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.73 ' NE2' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -35.78 140.33 0.36 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.313 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.522 ' HD2' ' ND1' ' A' ' 73' ' ' HIS . 36.8 Cg_endo -59.49 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.104 1.581 . . . . 0.0 110.278 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.5 ptp 178.96 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 4.2 pp -115.95 146.61 37.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 32.8 Cg_endo -33.43 137.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.893 1.47 . . . . 0.0 112.626 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -131.13 106.8 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 16.0 mm -91.64 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.519 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 53' ' ' SER . 53.4 mt -150.22 145.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.496 ' O ' ' HB ' ' A' ' 82' ' ' THR . 1.2 mpp? -78.79 136.94 37.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 91.3 m 67.18 -83.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.559 -0.713 . . . . 0.0 110.021 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 82' ' ' THR . . . 83.93 95.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.585 -0.697 . . . . 0.0 109.171 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.47 ' O ' ' C ' ' A' ' 85' ' ' SER . 11.6 t-80 -136.0 -87.51 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.952 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 46.67 36.66 3.88 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -178.139 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 88' ' ' ASP . 14.5 t0 66.11 128.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.872 HD12 HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -36.47 -31.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -36.89 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.519 0.676 . . . . 0.0 109.71 176.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.952 ' HB3' ' HB2' ' A' ' 85' ' ' SER . . . -51.7 -34.36 38.32 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.463 -0.773 . . . . 0.0 109.16 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.658 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -59.06 -80.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.062 -1.024 . . . . 0.0 109.618 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.872 HG23 HD12 ' A' ' 87' ' ' LEU . 33.3 t -14.26 -54.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 122.763 0.425 . . . . 0.0 111.987 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.658 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 4.3 t -79.53 -149.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.926 -1.109 . . . . 0.0 109.766 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 72.96 36.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.902 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 61.69 57.21 2.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.09 -1.006 . . . . 0.0 109.529 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -75.54 150.96 38.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 19.2 tt0 56.42 22.17 6.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.135 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.43 -46.83 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . -157.52 54.9 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.243 . . . . 0.0 109.985 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.29 122.5 12.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 101' ' ' TYR . 38.7 t70 -113.1 6.77 17.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.053 -1.03 . . . . 0.0 110.354 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 2.4 m-85 46.88 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.066 -1.022 . . . . 0.0 109.106 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -91.89 137.62 25.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.0 110.018 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 37.4 Cg_endo -127.54 177.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.643 1.339 . . . . 0.0 110.048 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -93.29 159.53 35.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.265 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -79.59 172.79 57.37 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.655 -2.644 . . . . 0.0 110.492 0.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 10.7 p90 -156.05 133.8 11.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.363 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 18.3 t0 -81.16 -162.39 0.49 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 108.703 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.617 HG21 ' CB ' ' A' ' 22' ' ' ALA . 36.0 mm -106.67 -65.01 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 109.208 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -57.65 -51.91 67.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.9 tp10 -43.55 -38.2 2.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.74 -73.71 0.18 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.907 HG21 HD11 ' A' ' 23' ' ' LEU . 38.4 t -37.24 -69.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.513 -0.742 . . . . 0.0 110.233 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -45.29 -63.14 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 110.441 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.3 tm? -35.29 -50.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.689 0.756 . . . . 0.0 109.524 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.753 HG13 HG21 ' A' ' 50' ' ' VAL . 1.2 t -60.18 -57.01 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.624 ' N ' HG12 ' A' ' 115' ' ' VAL . 3.4 tt0 -34.02 -39.42 0.07 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.198 0.523 . . . . 0.0 110.288 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtp85 -71.72 -52.0 19.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 109.25 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -49.09 -56.46 9.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.188 -0.945 . . . . 0.0 108.6 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.534 HG12 ' CG2' ' A' ' 50' ' ' VAL . 5.4 mt -35.27 -41.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.336 0.589 . . . . 0.0 109.774 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -88.03 53.33 2.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.153 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 6.9 t-80 -94.93 -5.73 44.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.607 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -85.64 19.8 2.32 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.235 -0.916 . . . . 0.0 109.822 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -93.2 -16.05 25.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.579 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.561 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.436 ' OE1' HD11 ' A' ' 28' ' ' LEU . 16.0 mt-30 -146.37 177.18 9.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 109.615 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 116' ' ' GLU . 0.3 OUTLIER -151.63 120.79 6.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 109.395 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.639 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 166.87 153.1 7.7 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.051 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.901 HG23 ' HB ' ' A' ' 29' ' ' THR . 1.9 mt -124.17 131.52 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.159 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.777 ' CG1' HG23 ' A' ' 8' ' ' VAL . 1.9 t -126.74 113.07 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 108.796 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.84 ' O ' HD13 ' A' ' 51' ' ' LEU . 9.2 m95 -99.9 86.9 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.425 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.041 HG22 ' HB2' ' A' ' 52' ' ' LEU . 48.7 t -84.09 159.82 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 111.076 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 65' ' ' LEU . 14.3 t -95.1 121.76 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.917 ' OD2' HG22 ' A' ' 15' ' ' ILE . 8.3 m-20 -109.07 -169.98 1.58 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.19 -0.943 . . . . 0.0 110.0 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' CG ' ' HG3' ' A' ' 57' ' ' MET . 51.8 t0 -100.87 -57.13 2.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.446 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -130.73 173.74 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 109.845 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.562 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -58.71 -41.74 87.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.958 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -28.36 34.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 108.986 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.917 HG22 ' OD2' ' A' ' 10' ' ' ASP . 43.7 mm -71.38 -40.35 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.0 -49.46 71.43 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 27.0 t90 -55.22 -59.68 4.45 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.0 t -36.18 -70.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.5 tp -55.41 -72.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.423 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 10.3 tm-20 -34.89 -30.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.795 -0.566 . . . . 0.0 110.969 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -68.45 -55.94 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.243 -0.911 . . . . 0.0 108.57 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 108' ' ' ILE . . . -72.1 -4.76 30.87 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 112' ' ' VAL . 0.4 OUTLIER -100.22 -12.75 19.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.421 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.8 -43.48 68.57 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.81 97.48 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.27 67.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.03 49.37 4.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.078 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -130.14 178.12 6.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.878 -1.366 . . . . 0.0 110.165 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.901 ' HB ' HG23 ' A' ' 5' ' ' ILE . 96.6 m -97.9 77.84 2.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 40.5 t -76.09 88.31 3.0 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.931 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.716 HG21 ' CD2' ' A' ' 7' ' ' TRP . 13.0 m -100.51 127.09 46.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.201 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 16' ' ' ARG . 43.9 p -119.06 161.01 20.98 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 109.27 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.827 ' CG ' HG23 ' A' ' 39' ' ' VAL . 2.0 m-85 -134.37 105.81 6.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' N ' ' A' ' 13' ' ' SER . 1.1 mp0 -41.94 -31.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.537 -0.727 . . . . 0.0 109.777 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -106.91 126.21 52.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.865 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -65.17 -57.35 11.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 26.5 t-20 -51.37 -66.52 0.37 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.772 -1.428 . . . . 0.0 108.956 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.55 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.5 tt0 -33.52 -53.16 0.41 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.855 -0.528 . . . . 0.0 111.465 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.92 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -58.3 -52.86 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.725 -1.235 . . . . 0.0 109.498 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.92 HD12 ' CG1' ' A' ' 39' ' ' VAL . 8.5 mp -62.34 -14.7 42.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -77.2 -37.68 53.05 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.37 1.09 48.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.774 HD11 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.11 -6.16 54.07 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.323 -0.86 . . . . 0.0 109.439 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -10.38 52.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 109.59 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.7 m -97.39 1.04 48.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HG3' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 65.33 90.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.847 . . . . 0.0 109.611 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.597 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.6 m -99.25 -72.97 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.082 -1.011 . . . . 0.0 109.847 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 38.7 Cg_endo -75.65 -162.72 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.488 1.257 . . . . 0.0 110.411 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.929 ' O ' HD13 ' A' ' 76' ' ' LEU . 2.8 p30 -110.81 -14.93 13.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.874 HG21 HG13 ' A' ' 115' ' ' VAL . 4.3 t -144.89 129.11 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.521 -0.737 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -100.42 158.4 15.92 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.041 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -146.84 157.1 43.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.072 -1.018 . . . . 0.0 110.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.883 ' CB ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -134.05 123.87 25.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 109.729 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.771 ' O ' HG22 ' A' ' 55' ' ' ILE . 27.1 m-20 -62.5 -51.93 65.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 109.779 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.906 HG21 ' HB ' ' A' ' 82' ' ' THR . 2.2 tp 83.96 26.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.326 0.584 . . . . 0.0 109.454 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 57' ' ' MET . 17.3 ptm180 -113.67 -138.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.217 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.485 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.8 ttm 70.57 128.96 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.865 -1.147 . . . . 0.0 109.301 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -89.23 173.33 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.326 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.63 -66.87 0.96 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -91.17 29.62 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -1.194 . . . . 0.0 109.527 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t0 52.48 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -138.02 83.79 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.2 mp -35.91 132.62 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.907 -0.76 . . . . 0.0 110.127 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -49.88 -80.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.014 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.0 OUTLIER 79.09 -35.93 0.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 110.529 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 89' ' ' ALA . 13.5 tp -77.0 -62.11 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.405 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -50.71 -40.29 53.81 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.679 ' CG ' HD22 ' A' ' 40' ' ' LEU . 3.7 tp-100 -57.96 -56.76 17.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.014 HD12 ' O ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -35.92 -53.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.37 0.605 . . . . 0.0 109.908 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 72' ' ' ARG . 11.3 mtmm -60.04 -63.0 1.45 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.928 -1.107 . . . . 0.0 109.609 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.4 mt-30 -33.96 -34.37 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.775 -0.578 . . . . 0.0 110.959 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -122.51 -68.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.066 -1.021 . . . . 0.0 109.656 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -40.07 160.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.37 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 36.8 Cg_endo -92.95 -96.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.899 1.473 . . . . 0.0 110.15 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.4 mtm -147.56 2.36 0.73 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.875 -1.14 . . . . 0.0 110.881 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.929 HD13 ' O ' ' A' ' 49' ' ' ASP . 2.5 pp -61.81 134.89 94.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 120.596 -1.315 . . . . 0.0 108.104 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.848 ' HG2' HG22 ' A' ' 50' ' ' VAL . 32.1 Cg_endo -28.94 145.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 124.176 1.619 . . . . 0.0 112.487 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.619 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 21.5 t -147.45 95.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.723 -0.611 . . . . 0.0 109.388 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 19.1 mt -75.63 136.38 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.951 -1.093 . . . . 0.0 110.635 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.89 HD12 ' CB ' ' A' ' 83' ' ' ALA . 4.0 pt -126.79 115.19 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.011 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -66.97 129.52 40.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.169 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.906 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.3 m 71.98 -78.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.717 . . . . 0.0 109.922 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.89 ' CB ' HD12 ' A' ' 80' ' ' ILE . . . 66.06 129.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 109.508 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.766 ' HA ' ' HB2' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -178.82 -79.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.6 t 44.59 41.04 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 69.75 131.51 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -175.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.836 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 1.7 mm? -36.35 -28.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.042 0.925 . . . . 0.0 109.104 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -35.88 -63.55 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.891 ' O ' HD23 ' A' ' 66' ' ' LEU . . . -81.18 -32.49 33.56 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 108.929 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -63.68 -67.23 0.45 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 109.033 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.75 -53.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 C-N-CA 122.779 0.432 . . . . 0.0 111.611 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.733 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -61.8 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.998 -1.064 . . . . 0.0 109.088 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 79.18 -75.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.076 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' VAL . 22.5 p90 -78.79 5.76 10.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.055 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.69 -26.97 60.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 109.286 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER 163.24 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -0.827 . . . . 0.0 109.384 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.15 -146.2 8.88 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . . . -138.88 67.6 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -1.126 . . . . 0.0 109.652 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 41.3 p90 170.66 -177.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -150.7 -176.01 5.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.272 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 83' ' ' ALA . 5.0 m-30 -81.71 130.22 34.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.252 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -114.61 115.91 43.88 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 0.0 109.404 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -117.06 171.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.875 1.46 . . . . 0.0 110.415 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 16.5 mttm -63.03 157.96 58.03 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 109.402 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 37.3 Cg_endo -79.07 161.54 88.29 Favored 'Cis proline' 0 C--N 1.315 -1.225 0 C-N-CA 120.539 -2.692 . . . . 0.0 109.905 -0.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 1.8 p90 -143.26 129.5 19.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.5 t70 -91.28 -147.25 0.21 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.062 -1.024 . . . . 0.0 108.748 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.721 HG22 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -119.18 -69.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.721 ' N ' HG22 ' A' ' 108' ' ' ILE . 13.7 t70 -62.16 -42.67 99.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.6 tm-20 -46.23 -45.7 17.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.79 -77.04 0.09 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.078 HG11 HD13 ' A' ' 28' ' ' LEU . 65.2 t -38.39 -71.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 110.155 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.59 -65.4 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.961 -0.462 . . . . 0.0 110.27 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' ALA . 13.5 tp -34.76 -49.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.826 0.822 . . . . 0.0 109.507 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.874 HG13 HG21 ' A' ' 50' ' ' VAL . 1.7 t -60.49 -55.81 21.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 115' ' ' VAL . 1.4 tt0 -34.88 -45.79 0.28 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 118' ' ' ALA . 12.5 mtm105 -70.72 -51.74 25.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 109.441 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.24 -67.56 0.27 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.889 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.756 HG21 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mt -36.29 -43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.672 -0.642 . . . . 0.0 110.062 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 121' ' ' HIS . 3.7 t -48.73 -58.2 5.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 120' ' ' SER . 4.9 t60 -42.75 -41.33 3.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.338 -0.851 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.75 49.71 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.493 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.41 28.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.39 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 67.11 129.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 109.653 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 2' ' ' GLN . 7.7 mtt180 -165.88 46.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.779 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.719 ' HA3' HD21 ' A' ' 28' ' ' LEU . . . 161.23 168.59 23.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.667 HG23 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -144.61 104.34 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -1.119 . . . . 0.0 108.315 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' CG1' HG23 ' A' ' 8' ' ' VAL . 2.7 t -120.87 115.95 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.08 . . . . 0.0 110.253 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.82 ' CZ2' HG21 ' A' ' 31' ' ' THR . 0.2 OUTLIER -99.58 80.38 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 0.0 109.34 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 52' ' ' LEU . 9.3 t -68.22 137.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.321 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.714 HG22 HG21 ' A' ' 39' ' ' VAL . 57.4 t -85.67 108.78 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.115 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.587 ' CG ' HG22 ' A' ' 15' ' ' ILE . 71.6 m-20 -87.15 -171.72 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.326 -0.859 . . . . 0.0 109.834 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.75 -87.06 0.14 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.38 -0.825 . . . . 0.0 109.637 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 15' ' ' ILE . 3.1 m-20 -112.05 170.7 7.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.635 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.8 p -49.55 164.72 0.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER 79.73 -8.67 1.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.587 HG22 ' CG ' ' A' ' 10' ' ' ASP . 46.4 mm -92.93 -36.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.973 -1.08 . . . . 0.0 108.398 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 17' ' ' TRP . 15.8 ptt-85 -66.18 -32.59 74.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.609 ' CZ3' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -52.11 -66.34 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 49.6 t -42.49 -53.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.921 0.867 . . . . 0.0 110.072 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.704 ' HG ' HG21 ' A' ' 32' ' ' THR . 2.7 mm? -49.56 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.745 . . . . 0.0 110.343 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 23' ' ' LEU . 2.0 mt-10 -35.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.369 0.604 . . . . 0.0 110.395 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.609 ' HD3' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -62.51 -56.35 18.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.809 -1.182 . . . . 0.0 108.839 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.785 ' HB3' HD13 ' A' ' 108' ' ' ILE . . . -63.5 -20.84 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.795 HD13 ' HB2' ' A' ' 30' ' ' CYS . 19.6 tp -71.67 -25.59 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.84 -0.537 . . . . 0.0 110.165 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.66 73.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.27 -38.47 87.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.41 49.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 109.226 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 57.76 65.51 3.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.05 HD13 HG11 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -136.43 -177.44 4.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.238 -1.154 . . . . 0.0 110.215 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.667 ' HB ' HG23 ' A' ' 5' ' ' ILE . 32.1 m -104.93 50.96 0.77 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.795 ' HB2' HD13 ' A' ' 23' ' ' LEU . 18.4 t -79.03 87.07 4.83 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.233 0.54 . . . . 0.0 109.579 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.82 HG21 ' CZ2' ' A' ' 7' ' ' TRP . 1.4 m -85.83 170.29 12.54 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 108.66 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.71 HG22 ' HB ' ' A' ' 8' ' ' VAL . 1.1 p -155.18 143.16 20.04 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.4 m-85 -118.44 -168.87 1.61 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.936 -1.103 . . . . 0.0 109.794 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.42 -1.71 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 110.2 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 4.8 m-20 -136.56 127.36 27.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.955 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -48.99 -50.68 26.78 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 39' ' ' VAL . 18.9 t-20 -58.94 -63.67 1.22 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.3 -1.118 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -34.37 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 0.0 110.592 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 33' ' ' PHE . 1.7 t -74.54 -64.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.081 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -59.68 -14.57 14.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.949 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -85.14 -39.58 17.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.175 -0.953 . . . . 0.0 108.469 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.53 74.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.979 HD13 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -65.23 -94.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.498 -0.752 . . . . 0.0 109.135 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 84.0 -63.33 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.427 0.632 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 62.3 p -102.3 -37.88 7.88 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.514 -0.741 . . . . 0.0 109.794 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 149.72 95.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.673 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m -100.32 -74.51 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.853 -1.154 . . . . 0.0 110.475 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.673 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 40.8 Cg_endo -81.2 -162.02 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 116.916 -1.59 . . . . 0.0 109.591 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 119' ' ' ILE . 53.2 p30 -113.43 -12.11 13.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.645 HG21 HG13 ' A' ' 115' ' ' VAL . 2.4 t -155.51 121.75 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.979 HD22 HD13 ' A' ' 43' ' ' LEU . 2.5 tp -99.51 136.05 40.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.041 -1.037 . . . . 0.0 108.631 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.813 ' HB3' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -117.12 174.18 6.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.917 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 91.0 p -149.01 133.97 18.07 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.502 ' OD2' ' CG1' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -95.93 3.92 53.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 110.051 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.737 HG21 ' HB ' ' A' ' 82' ' ' THR . 1.3 tt 28.82 82.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.3 0.572 . . . . 0.0 110.738 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -162.63 73.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.995 -1.066 . . . . 0.0 109.688 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtm -128.26 136.55 29.23 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.98 113.08 2.45 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.062 1.559 . . . . 0.0 110.383 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.62 -160.99 24.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.8 mtt -76.66 -49.5 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.203 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.25 177.06 5.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.217 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.34 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.991 HD13 HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER 178.88 29.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -1.122 . . . . 0.0 110.0 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 43.23 -92.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.96 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.991 HD12 HD13 ' A' ' 63' ' ' LEU . 0.5 OUTLIER 71.72 -82.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.854 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 66' ' ' LEU . 1.1 mm? -37.35 -29.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.123 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.91 -55.02 25.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.04 -41.72 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.153 . . . . 0.0 109.191 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.674 HG22 ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -37.33 -59.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.187 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.674 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.31 -51.53 56.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.903 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -34.39 -36.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.715 -0.615 . . . . 0.0 111.119 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -109.33 -59.18 1.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 0.0 110.313 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.718 ' CD2' HD22 ' A' ' 43' ' ' LEU . 57.1 m170 -39.61 145.35 0.43 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.417 -0.802 . . . . 0.0 110.066 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.555 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 35.1 Cg_endo -87.06 47.32 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.111 1.585 . . . . 0.0 109.868 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.8 mtp 72.41 55.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.61 -0.681 . . . . 0.0 110.241 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 77' ' ' PRO . 1.2 pp -114.8 136.62 22.53 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.056 . . . . 0.0 109.235 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.786 ' O ' HD12 ' A' ' 76' ' ' LEU . 35.6 Cg_endo -40.54 141.91 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.267 1.667 . . . . 0.0 112.994 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -147.5 142.76 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.797 HD11 HG22 ' A' ' 115' ' ' VAL . 8.7 mt -126.12 167.93 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.775 -1.203 . . . . 0.0 110.524 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.616 ' N ' HG22 ' A' ' 79' ' ' ILE . 4.2 tt -149.22 144.11 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 82' ' ' THR . 1.7 mpt? -88.14 65.49 8.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.737 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.1 m 158.1 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' ' 101' ' ' TYR . . . -101.89 46.11 0.94 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.514 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.549 ' H ' HG22 ' A' ' 82' ' ' THR . 0.3 OUTLIER -123.4 -97.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 45.78 27.65 0.48 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 61.23 123.37 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.815 HD12 ' HB3' ' A' ' 90' ' ' ALA . 9.6 tp -39.32 -25.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 108.263 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -36.91 -75.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.064 -1.022 . . . . 0.0 110.234 176.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' SER . . . -68.43 -34.62 76.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.815 ' HB3' HD12 ' A' ' 87' ' ' LEU . . . -56.7 -62.2 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.37 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -27.25 -39.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 122.683 0.393 . . . . 0.0 111.099 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -38.37 -59.6 0.88 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 109.579 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.566 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -44.0 -69.24 0.14 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -51.99 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 93' ' ' ALA . 2.3 mm-40 -176.38 -42.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -136.78 -67.36 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.71 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 156.65 173.9 25.72 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 81.84 -0.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.914 . . . . 0.0 109.899 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 3.8 m-85 -112.81 119.73 39.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.082 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.31 164.39 21.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.819 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.475 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 65.7 m-85 -110.75 94.57 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.143 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.551 ' HB2' ' CG2' ' A' ' 79' ' ' ILE . 1.6 tp -83.1 153.67 66.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -122.68 -174.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.707 1.372 . . . . 0.0 110.501 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -119.14 157.66 50.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -78.81 175.31 47.12 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.887 -2.547 . . . . 0.0 110.562 0.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 106' ' ' PHE . 25.1 p90 -148.68 140.89 24.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.778 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 13.5 t0 -79.49 147.63 32.16 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -72.36 -31.09 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.722 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -82.96 -44.81 14.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 38.8 tt0 -55.46 -39.26 70.12 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.81 -65.9 0.77 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.37 -0.831 . . . . 0.0 109.173 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.05 HG11 HD13 ' A' ' 28' ' ' LEU . 41.0 t -36.5 -57.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.652 . . . . 0.0 110.576 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -58.72 -66.09 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.539 -0.726 . . . . 0.0 110.492 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.3 tp -35.19 -54.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.544 0.687 . . . . 0.0 110.09 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.797 HG22 HD11 ' A' ' 79' ' ' ILE . 27.3 t -56.63 -56.11 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 115' ' ' VAL . 54.9 tt0 -34.91 -42.17 0.15 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.421 0.629 . . . . 0.0 109.917 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' ALA . 22.4 mtp180 -73.57 -54.86 7.19 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.068 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.99 -66.84 0.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.163 -0.961 . . . . 0.0 109.157 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 50' ' ' VAL . 4.1 mt -37.53 -41.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.672 . . . . 0.0 109.932 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 121' ' ' HIS . 6.1 m -46.15 -55.1 7.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.413 -0.805 . . . . 0.0 109.9 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -38.64 -43.84 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.885 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.78 96.43 4.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.49 40.71 3.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.87 . . . . 0.0 109.334 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.471 ' CG ' ' OXT' ' A' ' 124' ' ' GLU . 35.5 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.8 mt-30 -135.7 122.31 20.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.165 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -132.28 52.74 2.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 110.22 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.683 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -174.59 120.64 0.79 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.507 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.83 HD12 ' H ' ' A' ' 5' ' ' ILE . 1.1 mp -106.31 118.03 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.297 . . . . 0.0 108.601 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.67 112.72 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.594 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.45 92.31 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.69 -1.256 . . . . 0.0 108.746 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.88 HG22 ' HB2' ' A' ' 52' ' ' LEU . 57.6 t -83.66 150.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.444 0.64 . . . . 0.0 110.899 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 76.2 t -89.7 122.34 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.978 ' HA ' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.94 143.05 55.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.824 0.821 . . . . 0.0 110.819 -178.389 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 57' ' ' MET . 5.1 t0 -99.29 -65.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.523 ' O ' ' CG1' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -110.01 174.73 5.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.292 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 14' ' ' SER . 52.0 p -64.45 148.79 49.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 78.25 24.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.884 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.978 HG21 ' HA ' ' A' ' 10' ' ' ASP . 3.2 mm -83.63 -47.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 7.4 mtm180 -53.17 -47.95 68.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.494 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 22.9 t90 -55.51 -61.5 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 17' ' ' TRP . 15.9 t -36.98 -68.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.506 -0.746 . . . . 0.0 110.643 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 21' ' ' ARG . 6.9 mt -59.85 -74.56 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 110.878 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 19' ' ' LEU . 12.2 tt0 -34.56 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.771 -0.581 . . . . 0.0 111.057 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -69.87 -56.39 7.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.998 . . . . 0.0 108.593 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.679 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -72.06 -3.75 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.38 -0.825 . . . . 0.0 108.82 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.04 HD11 HG21 ' A' ' 112' ' ' VAL . 3.1 mm? -103.43 -10.89 18.22 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.392 -0.818 . . . . 0.0 109.522 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.88 -35.11 24.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.31 -36.78 49.46 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -69.4 -34.04 73.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -1.052 . . . . 0.0 108.637 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 90.26 73.08 1.26 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.04 HD13 HG11 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -146.67 174.61 11.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -1.207 . . . . 0.0 109.935 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.712 ' CG2' HG23 ' A' ' 5' ' ' ILE . 92.7 m -102.98 61.19 0.79 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . 35.9 t -83.85 96.79 8.89 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.532 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 5.7 m -100.02 154.62 18.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 108.662 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.486 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 p -139.98 158.77 43.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.99 -1.069 . . . . 0.0 109.36 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.895 ' HB2' HG23 ' A' ' 39' ' ' VAL . 6.2 m-85 -135.95 120.56 18.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.602 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 3.0 mt-10 -42.84 -42.86 3.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.966 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -110.05 119.74 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -51.68 -48.96 48.79 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 17.0 t30 -42.53 -71.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -1.045 . . . . 0.0 108.4 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.7 mt-10 -34.51 -42.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.79 -0.568 . . . . 0.0 109.755 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.969 HG12 HD22 ' A' ' 40' ' ' LEU . 1.2 t -58.01 -54.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.887 . . . . 0.0 108.688 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.969 HD22 HG12 ' A' ' 39' ' ' VAL . 3.1 mm? -61.36 -19.28 61.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -75.1 -45.28 42.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.163 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.45 -19.34 59.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.094 HD12 ' CD2' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -80.76 -105.04 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.28 -57.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.74 . . . . 0.0 109.497 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.5 t -100.99 -3.73 28.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.742 ' HE2' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER 83.42 110.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.78 0.8 . . . . 0.0 109.141 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.652 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 21.2 m -104.04 -74.77 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.584 -1.323 . . . . 0.0 111.84 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.715 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 45.4 Cg_endo -55.51 -161.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.441 1.232 . . . . 0.0 109.766 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.909 ' HB2' HD13 ' A' ' 119' ' ' ILE . 8.1 p30 -115.7 -8.4 12.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.182 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.924 HG21 HG13 ' A' ' 115' ' ' VAL . 2.3 t -156.91 123.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.959 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.915 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -100.3 143.97 29.86 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.954 HD22 ' CG2' ' A' ' 79' ' ' ILE . 5.2 mt -123.21 163.86 19.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.765 -1.209 . . . . 0.0 110.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 80' ' ' ILE . 20.4 t -133.01 115.48 15.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' O ' HG22 ' A' ' 55' ' ' ILE . 8.8 m-20 -60.87 -25.85 66.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.173 -0.955 . . . . 0.0 110.44 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER 49.79 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 108.984 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER 57.05 111.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.025 -1.047 . . . . 0.0 109.361 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.916 ' SD ' HD22 ' A' ' 63' ' ' LEU . 3.6 mtm -157.11 -176.15 0.59 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 109.649 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -103.43 70.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.008 1.53 . . . . 0.0 110.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.61 -155.43 7.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -81.81 127.33 32.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -1.147 . . . . 0.0 109.611 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.46 -92.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 109.537 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -119.51 -111.28 2.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.916 HD22 ' SD ' ' A' ' 57' ' ' MET . 11.4 tp -124.02 -7.06 7.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.66 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 63' ' ' LEU . . . 73.78 50.62 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.77 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.655 HD21 HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -162.17 16.98 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.106 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.4 mm? -70.61 -67.29 0.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.043 -1.036 . . . . 0.0 108.825 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -28.05 3.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.621 ' NE2' ' HA ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -57.07 -53.44 58.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.75 ' HA ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.57 -32.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.935 -0.478 . . . . 0.0 110.432 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.9 mmmt -99.15 -65.1 0.98 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.035 -1.041 . . . . 0.0 109.935 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -33.17 -33.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.799 -0.563 . . . . 0.0 110.896 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.565 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -92.5 -68.34 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.094 ' CD2' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -126.14 112.03 24.01 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 38.1 Cg_endo -134.05 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.67 1.353 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.545 ' CB ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -131.04 -14.89 3.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.912 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 50' ' ' VAL . 3.7 pp -131.23 167.16 22.96 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.092 -1.005 . . . . 0.0 108.531 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.2 Cg_endo -65.69 159.63 47.42 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.222 1.117 . . . . 0.0 111.247 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -126.48 101.26 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 109.337 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.954 ' CG2' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -65.24 157.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.195 -0.941 . . . . 0.0 109.108 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.581 HD11 ' CD1' ' A' ' 101' ' ' TYR . 6.5 pt -157.11 118.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.64 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.08 138.24 57.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.402 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 103' ' ' PRO . 16.8 m -75.39 121.65 22.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' HG23 ' A' ' 55' ' ' ILE . . . -171.4 40.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.754 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.3 m-70 67.92 110.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 84' ' ' HIS . 12.3 t 156.68 -73.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' ASP . 2.2 p30 -48.22 -28.98 3.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 110.054 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -36.06 -29.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -0.881 . . . . 0.0 111.198 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' ASP . 47.4 m-20 -107.61 -79.87 0.57 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.045 -1.034 . . . . 0.0 110.517 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 92' ' ' SER . . . -36.68 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.405 -0.809 . . . . 0.0 110.355 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 88' ' ' ASP . . . -74.39 -79.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 85.2 t -33.49 -41.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -113.61 -172.21 2.03 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 109.406 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 70.67 68.41 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.778 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.63 65.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 15.1 pt20 -73.87 -125.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.323 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.4 tp60 76.85 69.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.871 -1.143 . . . . 0.0 109.546 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 48.53 -158.38 0.88 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 67.8 20.32 9.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -1.152 . . . . 0.0 109.481 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' O ' ' CE1' ' A' ' 101' ' ' TYR . 1.1 m-85 -151.54 53.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.75 154.24 41.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.209 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 80' ' ' ILE . 1.3 m-85 -108.98 166.87 10.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.22 89.05 24.32 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.847 . . . . 0.0 109.163 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' A' ' 82' ' ' THR . 36.7 Cg_endo -58.94 168.21 4.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.076 1.566 . . . . 0.0 110.971 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -116.02 158.35 42.69 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.771 . . . . 0.0 109.058 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -83.23 169.74 56.67 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.63 -2.654 . . . . 0.0 110.312 0.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 13.7 p90 -149.39 163.1 38.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 109.09 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 5.6 t70 -87.78 -156.21 0.34 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.679 HG21 ' HB3' ' A' ' 22' ' ' ALA . 19.4 mm -120.61 -70.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.857 -1.152 . . . . 0.0 109.606 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' GLU . 9.2 t70 -54.46 -51.18 65.81 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 19.1 tp10 -42.85 -42.27 3.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -67.3 -72.98 0.15 Allowed 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.335 -0.853 . . . . 0.0 108.988 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.04 HG21 HD11 ' A' ' 23' ' ' LEU . 35.8 t -36.86 -68.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.789 -0.57 . . . . 0.0 110.2 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.35 -65.17 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' O ' ' A' ' 113' ' ' ALA . 33.7 tp -35.47 -53.93 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.676 0.751 . . . . 0.0 109.763 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.924 HG13 HG21 ' A' ' 50' ' ' VAL . 1.8 t -56.09 -57.53 8.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.497 ' C ' ' O ' ' A' ' 115' ' ' VAL . 19.3 mt-10 -33.54 -41.94 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.422 0.63 . . . . 0.0 110.187 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.6 mtt-85 -76.04 -54.85 6.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.697 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.2 -63.22 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 108.931 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.909 HD13 ' HB2' ' A' ' 49' ' ' ASP . 7.6 mt -33.84 -44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.152 0.501 . . . . 0.0 110.55 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.22 61.81 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.64 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -106.8 -40.25 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.611 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.0 p90 -120.55 31.01 6.64 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -135.66 36.08 2.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.947 -1.096 . . . . 0.0 109.728 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.578 179.713 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.451 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 2.4 pt20 -154.32 82.68 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 108.991 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 8.6 tpt180 -121.9 60.73 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.031 -1.043 . . . . 0.0 110.506 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 165.34 93.95 0.1 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 48' ' ' PRO . 5.8 mt -83.4 93.12 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.401 -1.058 . . . . 0.0 109.671 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.105 HG23 ' CG1' ' A' ' 50' ' ' VAL . 8.5 p -96.1 122.48 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.722 -0.611 . . . . 0.0 109.412 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.81 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.71 102.97 14.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.686 -1.259 . . . . 0.0 109.047 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.01 HG22 ' CB ' ' A' ' 52' ' ' LEU . 13.4 t -100.93 125.03 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.958 . . . . 0.0 110.625 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.15 112.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.572 -1.33 . . . . 0.0 108.366 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.698 ' OD1' HG22 ' A' ' 15' ' ' ILE . 20.9 t0 -68.1 164.98 19.07 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.272 0.558 . . . . 0.0 109.88 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 1.5 m-20 -96.21 -89.07 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.397 -0.815 . . . . 0.0 109.643 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 15' ' ' ILE . 1.1 m-20 -106.59 174.75 5.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.4 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 14.0 m -57.75 148.16 25.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.4 t 81.79 -11.96 1.01 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.961 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.698 HG22 ' OD1' ' A' ' 10' ' ' ASP . 12.6 mm -79.19 -35.81 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.0 -1.063 . . . . 0.0 108.745 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.601 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.3 ttp-105 -59.94 -46.03 90.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.482 ' O ' ' C ' ' A' ' 18' ' ' VAL . 55.1 t90 -58.29 -59.68 4.95 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.297 -0.877 . . . . 0.0 108.919 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.6 t -34.92 -60.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.579 0.704 . . . . 0.0 110.506 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 21' ' ' ARG . 3.1 mt -53.1 -71.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.978 -1.076 . . . . 0.0 109.152 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -35.13 -33.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.263 0.554 . . . . 0.0 110.818 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.02 -56.13 19.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 108.241 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.982 ' HB1' HG21 ' A' ' 108' ' ' ILE . . . -64.96 -9.83 24.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.119 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.785 HD11 HG21 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -85.77 -24.5 26.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.631 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.7 -43.96 85.53 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.26 -47.79 28.01 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -58.45 -17.59 21.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.157 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.815 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 63.08 54.01 36.08 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.933 HD22 HG13 ' A' ' 112' ' ' VAL . 2.7 mp -144.48 175.4 10.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.289 . . . . 0.0 109.999 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.526 ' CG2' HG23 ' A' ' 5' ' ' ILE . 30.4 m -107.78 85.34 2.1 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.858 -0.526 . . . . 0.0 110.994 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.58 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 50.8 t -88.69 83.34 6.73 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.872 -1.143 . . . . 0.0 109.853 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.523 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 15.7 m -80.04 125.15 29.41 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 8' ' ' VAL . 75.2 p -118.52 140.61 49.61 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.83 -1.169 . . . . 0.0 110.642 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.934 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 m-30 -116.24 113.38 22.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.618 -0.676 . . . . 0.0 109.215 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 47.1 mt-10 -37.24 -28.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.557 -0.714 . . . . 0.0 110.014 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -118.36 116.63 27.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.628 ' O ' HD13 ' A' ' 40' ' ' LEU . . . -49.19 -51.89 24.4 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.652 ' O ' HD22 ' A' ' 40' ' ' LEU . 17.3 t-20 -43.56 -72.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.568 -0.96 . . . . 0.0 108.934 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 37' ' ' ASN . 32.1 tp10 -31.49 -39.32 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.811 . . . . 0.0 110.133 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.934 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -63.99 -56.41 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.989 ' H ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -78.87 3.01 18.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.585 -1.322 . . . . 0.0 109.689 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.491 ' N ' HD22 ' A' ' 40' ' ' LEU . . . -99.47 -24.08 14.9 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.35 -19.85 15.44 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.041 HD13 HG23 ' A' ' 47' ' ' THR . 13.8 mt -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.505 -0.747 . . . . 0.0 109.47 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . . . -35.21 -31.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.786 -0.571 . . . . 0.0 110.732 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -65.51 -55.26 18.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 108.527 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER 164.86 115.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.056 HG22 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -44.59 167.54 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.186 -0.946 . . . . 0.0 109.103 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.056 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.8 Cg_endo -90.92 -65.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.679 1.358 . . . . 0.0 111.456 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.792 ' HB3' HG21 ' A' ' 119' ' ' ILE . 17.7 m-20 -121.49 -55.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.704 -1.248 . . . . 0.0 111.363 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.105 ' CG1' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -148.97 139.24 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.723 -1.236 . . . . 0.0 110.353 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.829 HD13 HG23 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.26 108.4 20.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.731 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.01 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.48 178.94 4.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.984 . . . . 0.0 108.971 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.754 ' HA ' HG12 ' A' ' 9' ' ' VAL . 38.2 m -162.42 126.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.087 . . . . 0.0 110.601 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 14.0 t0 -73.0 -144.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.094 -1.004 . . . . 0.0 108.401 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 54' ' ' ASP . 0.8 OUTLIER 174.57 78.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' CD ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -174.98 83.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.642 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.43 ' HB2' HD22 ' A' ' 63' ' ' LEU . 1.4 mmm -131.31 125.03 20.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -48.72 107.9 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.08 1.569 . . . . 0.0 110.518 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 125.1 140.73 5.49 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 87.3 mmm 61.64 11.83 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -1.086 . . . . 0.0 109.837 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 44.68 80.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.282 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . 66.54 90.09 0.05 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.718 ' CD1' HD21 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -56.76 -162.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -1.127 . . . . 0.0 109.416 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' N ' ' HG ' ' A' ' 63' ' ' LEU . . . -171.33 89.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.008 . . . . 0.0 109.994 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.718 HD21 ' CD1' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -88.24 -6.51 57.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 109.122 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -49.74 -22.02 1.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.33 -45.48 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.022 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.701 ' HG3' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.55 -45.96 23.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.15 . . . . 0.0 109.931 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.829 HG23 HD13 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -38.82 -32.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.902 -1.123 . . . . 0.0 110.161 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -95.6 -67.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.836 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -36.25 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.745 0.784 . . . . 0.0 110.339 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' LYS . 1.6 mmt85 -88.53 -93.32 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.262 0.553 . . . . 0.0 111.094 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.703 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 2.1 m-70 -53.03 144.38 27.83 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.3 Cg_endo -34.74 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 124.17 1.616 . . . . 0.0 111.196 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.42 94.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.802 HD21 ' OG1' ' A' ' 47' ' ' THR . 1.8 pp -125.61 151.73 70.94 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 1.075 ' HG2' HG23 ' A' ' 50' ' ' VAL . 36.9 Cg_endo -28.84 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.991 1.521 . . . . 0.0 112.219 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.89 146.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 42.8 mt -143.92 148.48 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -133.6 150.3 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.539 ' CE ' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.58 164.46 25.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.406 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 1.2 m -93.02 162.78 13.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 161.3 -62.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 109.063 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.467 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 t60 -176.44 -176.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 t 61.04 -124.0 0.9 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.609 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 36.56 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.254 -0.904 . . . . 0.0 109.818 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 10.79 -77.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.309 0.576 . . . . 0.0 111.78 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' ASP . 9.3 t70 -53.27 -64.74 0.72 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.193 . . . . 0.0 109.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -52.28 -46.16 65.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.272 -0.893 . . . . 0.0 110.56 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.5 -73.97 0.13 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 110.536 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 62.4 t -32.02 -32.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.996 -0.44 . . . . 0.0 111.205 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 19.4 t -102.95 161.45 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.758 -1.214 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 79.07 82.05 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.484 -0.76 . . . . 0.0 109.76 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ALA . 58.4 m-85 42.47 63.2 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -0.827 . . . . 0.0 109.899 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.27 134.66 49.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.065 -1.022 . . . . 0.0 109.345 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER 76.54 151.06 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 80.37 94.52 0.4 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 76.08 5.23 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -1.127 . . . . 0.0 109.111 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -126.87 112.36 15.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.276 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -124.72 167.52 14.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.168 -0.957 . . . . 0.0 109.661 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.17 105.19 9.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.042 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.8 OUTLIER -73.36 124.73 90.79 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 110.032 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -91.3 171.59 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.143 1.601 . . . . 0.0 109.716 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -117.21 145.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.725 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -82.05 166.99 70.15 Favored 'Cis proline' 0 C--N 1.317 -1.084 0 C-N-CA 120.401 -2.749 . . . . 0.0 110.114 -0.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.539 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 39.4 p90 -136.61 140.85 43.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.342 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.3 t0 -72.47 122.94 22.11 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.096 -1.003 . . . . 0.0 108.801 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.982 HG21 ' HB1' ' A' ' 22' ' ' ALA . 1.5 tp -61.44 -29.58 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 110.137 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -80.45 -49.43 11.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 108.518 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 17.2 tp10 -52.3 -31.65 33.92 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -78.72 -69.65 0.55 Allowed 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.293 -0.879 . . . . 0.0 109.194 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.933 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 t -35.37 -55.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.506 0.67 . . . . 0.0 110.148 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.595 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -64.55 -65.4 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 110.196 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.887 HD13 ' N ' ' A' ' 115' ' ' VAL . 1.3 tm? -33.46 -61.44 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.408 0.623 . . . . 0.0 110.293 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.989 ' CG1' HG21 ' A' ' 50' ' ' VAL . 84.4 t -56.64 -52.15 57.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 18.6 tp10 -35.42 -45.12 0.32 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.32 0.581 . . . . 0.0 110.233 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -52.55 -55.91 18.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.092 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.17 -58.39 5.69 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.258 -0.901 . . . . 0.0 108.765 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.828 HD11 HG12 ' A' ' 115' ' ' VAL . 2.4 mm -37.37 -38.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.73 -0.606 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.546 ' C ' ' O ' ' A' ' 119' ' ' ILE . 6.0 t -20.0 -66.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.173 0.511 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 120' ' ' SER . 21.0 t-80 160.2 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 121' ' ' HIS . 2.4 m-85 37.91 30.58 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.716 0.77 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -49.8 -24.68 2.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.759 -0.588 . . . . 0.0 109.728 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.35 179.86 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.242 0.544 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -75.74 167.64 21.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 4.1 ptm180 -154.0 83.56 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.996 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -134.54 87.46 0.25 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.087 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.847 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.36 87.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.159 -1.201 . . . . 0.0 108.468 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.75 111.46 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.743 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.855 ' CE3' HG21 ' A' ' 31' ' ' THR . 10.6 m0 -101.71 106.86 17.94 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.995 . . . . 0.0 108.524 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.001 HG23 ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -85.6 169.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.794 0.807 . . . . 0.0 111.688 -177.507 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 39' ' ' VAL . 68.8 t -121.42 94.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 64.1 m-20 -93.37 -173.08 3.12 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.501 0.667 . . . . 0.0 110.432 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 24.5 t0 -122.24 -9.71 8.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB2' HG12 ' A' ' 15' ' ' ILE . 8.2 m-20 -147.12 164.48 32.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -42.6 73.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.408 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -54.52 -24.93 22.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.308 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.491 ' CG2' ' CG ' ' A' ' 10' ' ' ASP . 15.3 mm -71.59 -43.07 71.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.352 -0.843 . . . . 0.0 109.112 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.493 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.3 -44.14 75.49 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.456 ' O ' ' C ' ' A' ' 18' ' ' VAL . 19.8 t90 -60.41 -58.03 10.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.437 -0.789 . . . . 0.0 109.169 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.456 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.3 t -36.2 -62.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.645 -0.659 . . . . 0.0 110.743 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -57.36 -68.91 0.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.056 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -34.5 -32.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.683 -0.635 . . . . 0.0 110.455 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.7 tpp180 -66.97 -55.86 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.907 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -68.25 -5.99 21.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.462 -0.773 . . . . 0.0 109.059 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 3.3 mm? -102.15 -12.57 17.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.69 -40.85 28.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.66 97.52 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.0 -32.88 65.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.417 -1.049 . . . . 0.0 109.248 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 84.73 66.41 1.46 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.683 HD21 HG13 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -134.71 -176.14 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.195 -1.179 . . . . 0.0 110.587 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 18.1 m -99.21 78.23 2.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.59 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 43.8 t -80.23 84.77 5.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.587 -0.696 . . . . 0.0 111.331 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.855 HG21 ' CE3' ' A' ' 7' ' ' TRP . 2.6 m -88.52 141.24 28.69 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.617 ' CB ' HG12 ' A' ' 8' ' ' VAL . 66.5 p -146.33 119.66 8.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.702 -1.249 . . . . 0.0 109.846 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.128 ' HB2' HG22 ' A' ' 39' ' ' VAL . 12.1 m-85 -103.55 129.74 50.83 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.365 -0.834 . . . . 0.0 109.019 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG2' ' C ' ' A' ' 11' ' ' ASP . 0.8 OUTLIER -63.45 -8.49 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.864 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 1.019 ' O ' HG23 ' A' ' 39' ' ' VAL . 10.6 t30 -136.61 133.57 36.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.622 -1.299 . . . . 0.0 110.48 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.864 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . -51.09 -59.95 7.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.567 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -46.78 -73.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.272 -1.134 . . . . 0.0 108.92 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 37' ' ' ASN . 13.9 tp10 -32.7 -34.43 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.364 -0.835 . . . . 0.0 110.616 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.128 HG22 ' HB2' ' A' ' 33' ' ' PHE . 15.3 t -61.61 -57.97 9.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.099 -1.001 . . . . 0.0 109.015 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.956 HD12 ' N ' ' A' ' 41' ' ' ALA . 1.3 pp -62.42 -12.38 21.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.236 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.956 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -81.02 -30.2 34.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.468 -0.77 . . . . 0.0 109.183 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . . . -88.47 -28.45 20.83 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.604 HD11 ' HG3' ' A' ' 48' ' ' PRO . 13.0 mt -88.08 6.14 37.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 109.853 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -36.27 -28.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.876 -0.515 . . . . 0.0 110.327 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' LEU . 11.6 t -61.98 -56.68 16.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.882 -1.136 . . . . 0.0 108.222 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 173.59 -165.81 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.441 -0.787 . . . . 0.0 110.524 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.584 ' CG2' ' CB ' ' A' ' 76' ' ' LEU . 4.4 m -70.15 154.0 94.89 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.67 . . . . 0.0 110.929 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.604 ' HG3' HD11 ' A' ' 43' ' ' LEU . 38.6 Cg_endo -115.6 -116.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 N-CA-C 107.395 -1.81 . . . . 0.0 107.395 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.706 ' C ' HD13 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -100.08 -75.32 0.58 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.207 -1.558 . . . . 0.0 108.605 178.083 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.026 HG21 HG22 ' A' ' 115' ' ' VAL . 13.1 t -145.63 137.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.164 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.7 HD23 ' CG1' ' A' ' 69' ' ' ILE . 2.8 mp -102.51 110.61 22.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.931 -1.106 . . . . 0.0 110.606 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.001 ' HB3' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -83.72 161.11 21.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.31 -0.869 . . . . 0.0 109.685 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 80' ' ' ILE . 68.4 m -152.23 136.31 16.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 2.4 p30 -100.72 -158.61 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.072 -1.017 . . . . 0.0 110.047 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.69 HG12 ' HB3' ' A' ' 83' ' ' ALA . 1.2 pp -143.09 120.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 57' ' ' MET . 3.2 ttm-85 178.72 -78.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 12.7 mmt 54.22 170.06 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.076 -1.015 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.2 Cg_endo -84.32 161.68 13.09 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.856 1.45 . . . . 0.0 110.24 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.71 101.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -176.84 -40.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.0 109.491 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 60' ' ' MET . 0.4 OUTLIER -162.8 -77.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 57' ' ' MET . . . 152.74 -45.53 0.59 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -154.69 -76.48 0.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.312 -1.111 . . . . 0.0 109.3 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 63' ' ' LEU . . . 41.34 44.26 2.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.864 HD22 ' HA3' ' A' ' 36' ' ' GLY . 6.4 mt -130.86 -25.01 2.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HA ' ' CG2' ' A' ' 69' ' ' ILE . 1.2 tp -66.24 -10.39 41.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.718 -1.239 . . . . 0.0 108.719 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -71.86 -55.06 8.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.595 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -67.02 -53.78 27.97 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.701 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 0.8 OUTLIER -43.13 -14.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.228 -0.92 . . . . 0.0 111.017 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' GLN . 19.1 tptp -100.93 -74.08 0.62 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.31 -1.494 . . . . 0.0 108.003 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 70' ' ' LYS . 32.9 mm-40 -36.96 -59.25 0.72 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.501 0.667 . . . . 0.0 111.216 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.701 ' NE ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -35.74 -48.09 0.52 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.504 -0.748 . . . . 0.0 111.716 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.804 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 14.6 m-70 -107.58 142.16 24.57 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.68 -1.262 . . . . 0.0 109.428 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 32.1 Cg_endo -26.36 -78.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 124.203 1.633 . . . . 0.0 112.777 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -175.58 100.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.42 -1.425 . . . . 0.0 110.544 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER -123.14 168.09 13.06 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 108.857 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.801 ' HG2' HG22 ' A' ' 50' ' ' VAL . 33.7 Cg_endo -71.37 137.43 30.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.676 1.356 . . . . 0.0 111.63 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.673 ' CG2' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -126.32 156.29 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.932 HD11 HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -131.1 147.44 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.81 HG22 ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -153.91 125.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 2.7 mtt -66.43 125.73 26.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.474 HG21 ' HD1' ' A' ' 101' ' ' TYR . 27.6 p -86.93 87.35 7.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.609 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.69 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -109.76 -19.27 13.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.42 -65.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.549 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 3.5 m -77.94 -172.22 2.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 83.76 -44.52 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.666 -0.647 . . . . 0.0 109.551 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.2 mm? -34.19 -32.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.786 -0.571 . . . . 0.0 110.482 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.8 t0 -70.28 -68.91 0.39 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 88' ' ' ASP . . . -41.89 -26.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -82.51 -74.59 0.34 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.091 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 87' ' ' LEU . 99.0 t -34.25 -30.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.863 -0.523 . . . . 0.0 111.162 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.0 m -97.94 -153.32 0.42 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.974 -1.079 . . . . 0.0 109.708 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.12 69.81 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.049 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 95' ' ' GLN . 1.4 t80 67.64 10.42 7.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.3 -0.875 . . . . 0.0 109.004 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 10.7 tm0? 44.78 82.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.8 mt-30 163.37 -25.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.03 -144.35 44.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -143.06 59.5 1.42 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -1.125 . . . . 0.0 109.346 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.727 ' CE1' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 82.61 -24.57 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.633 -0.667 . . . . 0.0 109.887 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.81 ' HB2' HG22 ' A' ' 80' ' ' ILE . 44.3 p-10 -42.07 127.89 3.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 162.78 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.495 -0.753 . . . . 0.0 109.412 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' MET . 12.6 tp -109.12 141.83 24.26 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 108.977 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -104.93 -167.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.758 1.399 . . . . 0.0 111.04 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -154.69 160.63 30.74 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -72.76 143.87 79.03 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.387 -2.339 . . . . 0.0 110.764 0.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.773 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 88.4 t80 -129.64 169.68 14.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' CG ' ' A' ' 106' ' ' PHE . 3.7 t70 -85.91 -157.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.625 -0.672 . . . . 0.0 109.948 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.907 HD13 ' CB ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -130.12 -48.88 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 108.443 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.2 -41.45 81.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 11.3 tp10 -50.77 -47.84 59.5 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.773 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -62.0 -65.24 0.72 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.78 HG12 ' N ' ' A' ' 113' ' ' ALA . 2.2 t -34.7 -78.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.78 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -39.03 -70.28 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.647 -0.658 . . . . 0.0 111.578 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 113' ' ' ALA . 27.8 tp -36.35 -43.21 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.972 0.891 . . . . 0.0 110.073 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.026 HG22 HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -68.43 -58.73 5.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.657 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.1 mt-10 -36.92 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.488 0.661 . . . . 0.0 109.536 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 115' ' ' VAL . 1.7 mtp180 -85.05 -48.04 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.481 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -53.79 -62.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 108.96 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.839 ' CD1' HG23 ' A' ' 50' ' ' VAL . 7.1 mt -36.22 -40.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 t -71.86 -46.02 59.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.991 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -47.86 -71.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 109.903 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 3.2 m-85 -44.85 112.13 0.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.912 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER 168.85 -27.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.405 -0.809 . . . . 0.0 109.362 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.53 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.318 0.58 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 178.2 -81.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.563 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 63.01 144.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.74 145.41 16.14 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.887 HG22 HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.39 95.81 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.471 -1.017 . . . . 0.0 110.419 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -91.22 113.04 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.009 -1.057 . . . . 0.0 108.604 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CE3' HG21 ' A' ' 31' ' ' THR . 12.8 m95 -102.84 98.85 8.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 109.934 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.689 HG22 ' CB ' ' A' ' 52' ' ' LEU . 15.2 t -85.48 167.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.483 -0.76 . . . . 0.0 109.378 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 39' ' ' VAL . 99.0 t -132.4 113.59 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 109.792 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.869 ' HB3' HG21 ' A' ' 15' ' ' ILE . 6.1 t70 177.87 -65.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.807 . . . . 0.0 109.484 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.562 ' HB3' ' CA ' ' A' ' 34' ' ' GLU . 20.9 t0 17.21 55.07 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.198 0.523 . . . . 0.0 111.478 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.893 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -112.95 52.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 11.9 t 144.22 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER 178.21 42.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.663 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.893 HD13 ' H ' ' A' ' 12' ' ' ASP . 2.4 mp -89.49 -40.53 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.987 . . . . 0.0 108.979 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.517 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 23.7 ttp180 -61.21 -41.39 96.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.455 ' O ' ' C ' ' A' ' 18' ' ' VAL . 76.5 t90 -62.66 -63.71 1.14 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 14' ' ' SER . 41.6 t -37.99 -65.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.759 0.79 . . . . 0.0 110.528 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' ARG . 16.4 mt -56.52 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 110.785 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 15.2 tm-20 -34.61 -30.13 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.907 -0.495 . . . . 0.0 111.215 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.3 tpt180 -68.12 -56.64 8.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.943 -1.098 . . . . 0.0 108.644 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.092 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -71.34 -8.69 55.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 0.0 109.015 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.804 HD22 ' SG ' ' A' ' 30' ' ' CYS . 3.0 mp -96.31 -16.69 21.18 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.82 -37.4 64.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.6 -36.3 58.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.21 -13.95 62.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -1.177 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.63 56.84 7.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.853 HD22 HG13 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -131.1 -178.04 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -1.234 . . . . 0.0 110.009 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.887 HG21 HG22 ' A' ' 5' ' ' ILE . 30.0 m -101.47 90.45 4.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.804 ' SG ' HD22 ' A' ' 23' ' ' LEU . 25.2 t -84.46 86.05 7.33 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.942 HG21 ' CE3' ' A' ' 7' ' ' TRP . 17.4 m -91.0 137.48 32.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 16.1 p -156.34 135.79 12.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.677 -1.264 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.569 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 29.8 m-85 -108.87 -170.44 1.66 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' CA ' ' HB3' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -108.92 -6.08 15.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.055 . . . . 0.0 109.536 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.86 143.84 26.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.86 ' CA ' HG11 ' A' ' 9' ' ' VAL . . . -60.02 -42.86 98.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.671 ' H ' HD22 ' A' ' 65' ' ' LEU . 4.4 t-20 -49.42 -79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.052 -1.263 . . . . 0.0 108.866 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 37' ' ' ASN . 50.2 mt-10 -34.46 -42.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.765 -0.584 . . . . 0.0 110.434 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.886 HG21 HG22 ' A' ' 9' ' ' VAL . 18.1 t -54.84 -55.48 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 40' ' ' LEU . 2.6 mm? -65.98 -18.13 65.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 108.829 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -73.8 -25.53 60.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 108.951 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.6 -17.27 17.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 73' ' ' HIS . 1.4 mm? -77.69 -9.2 58.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.99 -19.81 0.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -57.38 4.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 179.3 -164.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.935 ' CB ' HD22 ' A' ' 76' ' ' LEU . 10.2 t -100.03 135.72 20.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 36.2 Cg_endo -95.17 -95.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.04 1.547 . . . . 0.0 109.389 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.712 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -115.39 -75.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.864 -1.148 . . . . 0.0 109.086 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.834 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -149.57 142.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.33 -0.856 . . . . 0.0 109.467 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.948 ' CB ' HG12 ' A' ' 78' ' ' VAL . 6.5 tp -94.75 158.74 15.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.033 . . . . 0.0 108.797 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.689 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -141.57 127.76 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.998 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.3 p -94.04 103.79 15.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.333 -0.855 . . . . 0.0 108.889 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -88.01 122.64 31.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.955 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -98.06 81.86 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.65 ' HD3' HD11 ' A' ' 15' ' ' ILE . 1.8 ttt180 -114.27 -19.35 11.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.883 . . . . 0.0 109.754 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -45.14 140.89 3.53 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -100.11 147.36 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.956 1.503 . . . . 0.0 110.199 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.65 -174.77 17.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -24.24 64.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -1.153 . . . . 0.0 109.661 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -111.73 159.44 18.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.534 ' HA3' ' CD1' ' A' ' 55' ' ' ILE . . . -118.94 -53.82 0.28 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.889 ' HB2' HD12 ' A' ' 65' ' ' LEU . 0.7 OUTLIER 179.13 111.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.99 29.47 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.364 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.889 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -99.74 6.61 45.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 89' ' ' ALA . 10.4 tp -65.8 -60.74 2.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.649 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -48.02 -39.12 18.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.171 -0.956 . . . . 0.0 108.523 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 69' ' ' ILE . 3.8 tp60 -52.09 -56.59 13.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.692 HG12 HD23 ' A' ' 51' ' ' LEU . 8.2 mt -33.49 -76.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.266 0.555 . . . . 0.0 110.025 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.62 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -40.49 -59.37 1.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 110.085 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.85 -68.38 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.785 -0.572 . . . . 0.0 110.9 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 73' ' ' HIS . 1.7 mpp_? -73.06 -62.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -31.81 115.85 0.38 Allowed Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.778 -0.576 . . . . 0.0 110.327 -179.567 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 36.9 Cg_endo -41.26 -74.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.017 1.535 . . . . 0.0 110.441 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.2 ptp -178.39 64.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.54 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.935 HD22 ' CB ' ' A' ' 47' ' ' THR . 0.6 OUTLIER -126.31 148.63 64.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.726 ' HG2' HG22 ' A' ' 50' ' ' VAL . 37.0 Cg_endo -48.53 141.16 20.36 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.828 1.436 . . . . 0.0 111.815 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.948 HG12 ' CB ' ' A' ' 51' ' ' LEU . 2.5 m -139.63 97.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.643 HD11 HG23 ' A' ' 115' ' ' VAL . 11.2 mt -65.72 160.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 101' ' ' TYR . 1.3 pp -142.69 133.98 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -71.74 170.47 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.148 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.603 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.09 157.36 15.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.091 -1.006 . . . . 0.0 110.283 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.789 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . 169.6 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.46 ' C ' ' N ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 178.18 -77.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 110.497 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 86' ' ' ASP . 78.9 p 47.62 26.99 0.93 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 60.22 120.28 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.916 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 18.5 tp -38.12 -26.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.21 1.005 . . . . 0.0 108.523 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.7 t0 -32.7 -65.39 0.16 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.065 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.791 ' O ' HD23 ' A' ' 66' ' ' LEU . . . -82.43 -30.89 29.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.956 ' HB1' ' OH ' ' A' ' 101' ' ' TYR . . . -64.34 -65.65 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.171 -0.955 . . . . 0.0 109.144 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.49 -53.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 122.978 0.511 . . . . 0.0 111.504 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.59 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 1.6 t -56.66 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.043 -1.036 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 99' ' ' PHE . . . -128.27 -73.89 0.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.485 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 11.61 35.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 96' ' ' GLN . 5.5 mt-30 -98.24 108.54 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 108.55 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 11.3 tt0 61.39 164.13 0.08 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.988 . . . . 0.0 108.508 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.01 172.92 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.674 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . . . -125.63 103.83 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.05 -1.265 . . . . 0.0 109.791 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.836 ' CD1' HG23 ' A' ' 78' ' ' VAL . 33.2 p90 170.63 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.0 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.07 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.956 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -167.04 138.16 3.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.007 . . . . 0.0 110.024 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -128.47 113.46 19.52 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -103.94 164.95 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.668 1.351 . . . . 0.0 111.187 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 13.0 pttp -92.87 160.34 34.16 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.515 -0.741 . . . . 0.0 109.286 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -79.29 159.02 90.23 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 120.773 -2.594 . . . . 0.0 110.483 -0.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' A' ' 81' ' ' MET . 13.1 p90 -139.12 146.46 40.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.563 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 2.4 t70 -86.36 146.61 26.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 108.868 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.092 HD13 ' CB ' ' A' ' 22' ' ' ALA . 1.5 mp -76.8 -26.56 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.267 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.11 -36.58 19.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 40.8 tt0 -61.73 -42.19 98.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.96 -67.46 0.53 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.853 HG13 HD22 ' A' ' 28' ' ' LEU . 24.8 t -38.01 -52.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.497 -0.752 . . . . 0.0 110.937 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -62.58 -69.45 0.26 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.495 -0.753 . . . . 0.0 110.873 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.489 ' C ' ' O ' ' A' ' 113' ' ' ALA . 16.9 tp -34.79 -55.68 0.56 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.509 0.671 . . . . 0.0 109.943 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.712 HG22 HG21 ' A' ' 50' ' ' VAL . 1.2 t -54.79 -56.77 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.614 ' N ' HG12 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -38.02 -37.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 110.751 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.619 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -83.53 -35.69 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 110.268 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.619 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.4 -59.88 4.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.787 -1.195 . . . . 0.0 108.326 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.834 ' CD1' HG23 ' A' ' 50' ' ' VAL . 8.6 mt -34.5 -40.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.12 0.486 . . . . 0.0 110.384 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -85.61 53.32 2.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.585 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.564 ' NE2' ' CE1' ' A' ' 122' ' ' TYR . 23.7 p-80 -96.31 -9.19 30.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.564 ' CE1' ' NE2' ' A' ' 121' ' ' HIS . 8.2 m-85 -69.3 -5.86 25.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.79 53.01 1.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.395 179.9 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 3.8 pt20 -121.67 160.99 23.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.851 . . . . 0.0 109.341 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 -152.25 49.5 0.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.056 -1.028 . . . . 0.0 109.907 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.63 112.42 0.61 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.354 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.84 HG23 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -90.73 111.62 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 108.892 179.27 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.696 HG12 HG23 ' A' ' 8' ' ' VAL . 61.5 t -104.51 107.28 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.031 . . . . 0.0 109.555 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.762 ' CZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.45 93.77 6.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 108.551 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.974 HG22 ' CB ' ' A' ' 52' ' ' LEU . 54.4 t -102.89 127.43 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.557 ' CG1' ' HA2' ' A' ' 36' ' ' GLY . 1.9 m -66.6 121.37 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB2' HG21 ' A' ' 15' ' ' ILE . 53.7 p-10 -110.45 178.67 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.206 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 34.1 t0 -74.4 -86.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.32 -0.862 . . . . 0.0 109.788 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.72 173.65 11.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 11.7 p -75.93 -30.37 58.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.805 . . . . 0.0 109.358 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -73.82 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.317 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 10' ' ' ASP . 24.6 mm -66.01 -32.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 108.831 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.63 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 11.6 ptt180 -68.08 -35.31 77.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.517 ' CH2' ' HG3' ' A' ' 21' ' ' ARG . 1.8 t-105 -55.12 -66.16 0.46 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 54.0 t -40.77 -65.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.816 0.817 . . . . 0.0 110.478 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.659 ' C ' HD12 ' A' ' 23' ' ' LEU . 4.1 mm? -54.78 -75.07 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.569 -0.707 . . . . 0.0 110.986 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -34.5 -31.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.331 0.586 . . . . 0.0 110.219 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.08 -58.61 6.69 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.92 -10.07 50.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -0.823 . . . . 0.0 109.238 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.993 HD22 ' CB ' ' A' ' 30' ' ' CYS . 1.5 mt -93.15 -13.03 28.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 109.758 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.34 61.95 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.93 -38.0 37.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.02 79.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -1.142 . . . . 0.0 108.726 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 95.69 50.11 2.03 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.977 HD13 HG11 ' A' ' 112' ' ' VAL . 1.1 mt -141.03 166.66 24.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.937 -1.331 . . . . 0.0 109.941 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 5' ' ' ILE . 87.5 m -101.4 60.04 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.993 ' CB ' HD22 ' A' ' 23' ' ' LEU . 33.7 t -81.4 88.49 6.12 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 109.658 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 11.8 m -101.18 137.46 39.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 109.472 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 8' ' ' VAL . 1.2 p -109.66 165.49 11.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 108.671 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.65 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.0 m-85 -137.91 115.97 11.68 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.082 -1.012 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 14.3 tt0 -36.67 -39.1 0.19 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.96 -0.462 . . . . 0.0 110.461 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -111.92 126.1 54.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 110.521 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.557 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -51.68 -45.84 54.36 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.699 ' HA ' HD12 ' A' ' 40' ' ' LEU . 8.7 t-20 -60.28 -63.53 1.27 Allowed 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.181 -1.187 . . . . 0.0 107.866 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 20.0 tp10 -34.57 -28.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.551 -0.718 . . . . 0.0 110.809 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -81.88 -51.08 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.919 -1.113 . . . . 0.0 110.504 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.059 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.47 -11.36 60.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.791 -1.193 . . . . 0.0 109.753 -179.124 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.973 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -94.44 -49.11 5.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.24 -25.11 46.43 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.762 HD21 ' CZ3' ' A' ' 7' ' ' TRP . 7.9 mt -73.17 -77.64 0.1 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.39 -47.94 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -99.24 -26.12 14.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.732 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 64.42 62.82 0.79 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 123.49 1.614 . . . . 0.0 109.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.62 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -104.33 40.97 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 119.752 -1.842 . . . . 0.0 112.771 -179.135 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.766 ' HA ' HD12 ' A' ' 5' ' ' ILE . 38.0 Cg_endo -101.08 -167.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 116.842 -1.638 . . . . 0.0 109.633 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -92.97 -52.48 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.969 HG23 ' CD1' ' A' ' 119' ' ' ILE . 6.6 t -146.59 128.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 108.89 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.943 ' O ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -98.47 114.82 27.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 0.0 108.376 179.096 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.974 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -108.4 -174.28 2.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.371 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.569 ' OG ' HD13 ' A' ' 63' ' ' LEU . 26.6 t -155.24 123.89 6.05 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 9' ' ' VAL . 13.9 p-10 -102.63 149.75 24.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.98 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -102.88 109.78 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -161.63 28.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.469 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.404 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 3.7 mtt -93.74 125.94 51.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.491 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.6 Cg_endo -103.55 131.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.929 1.489 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.15 -74.23 0.31 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -161.1 128.28 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.422 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 68.72 149.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.98 -84.15 0.66 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.992 ' HB2' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -146.52 -54.3 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -1.107 . . . . 0.0 109.484 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . . . 47.47 60.83 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.427 -0.795 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.992 HD12 ' HB2' ' A' ' 63' ' ' LEU . 1.4 mt -124.35 8.41 8.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.742 HD11 HD12 ' A' ' 80' ' ' ILE . 4.9 mp -75.73 -19.18 59.25 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.278 -0.889 . . . . 0.0 108.699 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 2.9 pttt -66.01 -39.2 90.07 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.529 ' OE1' ' CA ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -80.38 -57.06 3.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 109.235 179.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.892 HG12 HD23 ' A' ' 51' ' ' LEU . 2.6 mt -39.71 -32.71 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.896 -1.127 . . . . 0.0 110.239 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -92.09 -73.09 0.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.087 -1.008 . . . . 0.0 110.379 -178.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -35.22 -30.78 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.554 -0.716 . . . . 0.0 110.565 -179.021 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.548 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -97.91 -58.55 1.96 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 110.368 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' CB ' ' A' ' 46' ' ' LYS . 1.2 m-70 -98.38 133.03 23.2 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.403 -0.811 . . . . 0.0 109.496 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.598 ' N ' ' HE2' ' A' ' 46' ' ' LYS . 39.6 Cg_endo -138.59 1.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 117.341 -1.306 . . . . 0.0 112.162 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.56 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 3.6 mtt -68.59 7.12 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.695 -1.253 . . . . 0.0 112.778 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -163.06 177.76 1.78 Allowed Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.186 -1.571 . . . . 0.0 109.918 179.007 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.0 Cg_endo -86.99 164.66 8.72 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.885 1.466 . . . . 0.0 111.064 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.943 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.17 144.91 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.734 HD12 ' C ' ' A' ' 78' ' ' VAL . 3.5 mp -137.78 164.0 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 109.739 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.742 HD12 HD11 ' A' ' 66' ' ' LEU . 11.9 tt -141.99 157.39 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -81.93 166.49 19.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.28 102.7 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.564 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.76 ' HB3' ' OD2' ' A' ' 86' ' ' ASP . . . -96.74 -151.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -144.23 32.36 1.22 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.62 -34.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.76 ' OD2' ' HB3' ' A' ' 83' ' ' ALA . 1.3 p30 -49.93 -24.17 2.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.017 -1.052 . . . . 0.0 109.692 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 87' ' ' LEU . 4.0 tp -34.97 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.83 -0.544 . . . . 0.0 110.913 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 86' ' ' ASP . 42.8 t0 -58.83 -59.19 5.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.995 -1.065 . . . . 0.0 109.883 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.26 -44.49 29.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 109.961 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -50.21 -41.7 50.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.689 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -33.07 -41.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.457 0.646 . . . . 0.0 109.99 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 5.9 t -64.11 86.18 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.359 0.6 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.75 -47.96 0.19 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -72.67 -18.95 61.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -69.02 -12.04 61.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.54 -0.725 . . . . 0.0 109.204 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.42 -157.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 109.33 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.81 67.88 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . -168.08 52.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -1.122 . . . . 0.0 109.324 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 36.7 m-85 -151.92 164.41 37.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.607 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.469 ' HB3' HG12 ' A' ' 79' ' ' ILE . 2.4 t0 -158.44 -157.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.37 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.14 142.83 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 109.791 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.23 139.86 35.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 108.893 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -114.72 176.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.748 1.394 . . . . 0.0 110.806 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 2.6 mtmp? -121.92 158.41 54.87 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 0.0 109.153 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -89.72 174.04 24.02 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 120.505 -2.706 . . . . 0.0 110.195 -0.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 33.2 p90 -153.59 161.17 42.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 14.6 t0 -73.92 -146.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 108' ' ' ILE . 16.2 mm -120.48 -68.05 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 108.798 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.514 ' OD1' ' HB2' ' A' ' 113' ' ' ALA . 11.7 t0 -59.79 -46.55 88.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 28.1 tt0 -43.09 -41.69 3.69 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.76 -75.88 0.11 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.977 HG11 HD13 ' A' ' 28' ' ' LEU . 52.1 t -38.39 -69.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 110.243 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . . . -39.36 -62.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' A' ' 113' ' ' ALA . 7.4 tp -34.3 -56.11 0.51 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.375 0.607 . . . . 0.0 109.944 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -58.24 -52.66 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.526 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 37.7 tp10 -39.19 -36.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.419 -0.801 . . . . 0.0 110.807 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.615 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -77.92 -36.77 49.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 110.74 -178.388 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.615 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.75 -53.61 51.77 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.733 -1.229 . . . . 0.0 108.044 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.969 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.3 mt -41.14 -50.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.517 0.675 . . . . 0.0 111.008 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.487 ' O ' ' C ' ' A' ' 121' ' ' HIS . 1.5 t -35.02 -34.9 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.447 -0.783 . . . . 0.0 111.998 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 t-80 -32.65 -66.37 0.14 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.546 -0.721 . . . . 0.0 111.273 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.63 -19.31 13.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.03 -1.044 . . . . 0.0 109.931 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.403 ' HB2' HG22 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -88.54 55.99 3.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.207 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.498 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' ' C ' ' A' ' 2' ' ' GLN . 6.7 ttt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 3' ' ' ARG . 3.0 pt20 -43.54 131.07 5.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.271 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 2' ' ' GLN . 6.3 ttp85 179.47 95.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.184 -0.947 . . . . 0.0 109.676 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.772 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -162.62 119.84 0.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.799 HD13 ' N ' ' A' ' 5' ' ' ILE . 1.1 mm -102.54 116.12 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -1.205 . . . . 0.0 109.528 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.586 ' CG1' HG23 ' A' ' 8' ' ' VAL . 1.5 t -123.65 109.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -0.796 . . . . 0.0 108.951 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.646 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 27.7 m0 -99.13 89.16 4.15 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.351 -1.339 . . . . 0.0 107.489 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.821 HG22 ' CG ' ' A' ' 52' ' ' LEU . 27.6 t -73.28 142.68 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.547 -0.721 . . . . 0.0 110.136 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.899 HG22 HG21 ' A' ' 39' ' ' VAL . 40.6 t -92.7 102.4 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.95 -1.094 . . . . 0.0 109.251 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.656 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 88.8 m-20 -53.96 -173.23 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 110.002 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -137.47 -5.97 1.77 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.337 -0.852 . . . . 0.0 110.786 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 171.29 55.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.458 -1.402 . . . . 0.0 110.871 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 54.69 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.559 0.695 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 75.4 -7.82 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.161 -0.962 . . . . 0.0 109.828 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' A' ' 10' ' ' ASP . 18.0 mm -85.48 -32.16 7.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.074 -1.017 . . . . 0.0 108.718 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.486 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.7 OUTLIER -62.38 -45.5 92.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.436 ' O ' ' C ' ' A' ' 18' ' ' VAL . 26.9 t90 -58.7 -60.49 3.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.5 t -39.21 -70.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 110.914 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 8' ' ' VAL . 7.8 mt -57.35 -72.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.391 -0.818 . . . . 0.0 110.838 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 19' ' ' LEU . 3.3 tt0 -35.8 -30.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 110.526 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 8.7 tpt85 -66.41 -56.0 13.08 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -71.11 -4.43 25.16 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.484 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.775 HD12 ' HB2' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -103.73 -11.35 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -43.88 42.68 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.62 -19.56 69.2 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.71 -19.37 32.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.581 -0.952 . . . . 0.0 108.726 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.6 50.03 33.62 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.808 HD12 HG11 ' A' ' 112' ' ' VAL . 13.8 mt -123.77 179.01 4.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 110.425 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 29' ' ' THR . 18.0 m -95.49 67.3 2.87 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 23' ' ' LEU . 38.6 t -79.64 83.64 5.59 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.953 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.646 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 5.2 m -94.84 143.29 26.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.7 p -138.67 119.43 14.15 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.519 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.99 ' HB2' HG22 ' A' ' 39' ' ' VAL . 7.5 m-85 -85.01 -157.65 0.31 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -118.36 -37.36 3.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.913 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.786 ' O ' HG23 ' A' ' 39' ' ' VAL . 49.1 m-80 -131.1 146.8 52.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.005 . . . . 0.0 109.81 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 37' ' ' ASN . . . -53.12 -39.71 58.18 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 2.2 m-20 -47.63 -84.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.904 -1.35 . . . . 0.0 108.343 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.8 mt-10 -35.14 -48.09 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.757 -0.589 . . . . 0.0 110.969 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 33' ' ' PHE . 48.6 t -50.37 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.984 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.4 tm? -54.21 -20.72 7.36 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.527 -0.733 . . . . 0.0 109.527 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -68.7 -41.49 79.08 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.6 -15.63 48.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.919 HD11 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -84.1 -0.81 53.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.0 109.862 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.91 -19.59 7.01 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.14 -0.975 . . . . 0.0 108.753 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 2.4 m -88.74 -27.81 20.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER 90.21 69.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -102.32 -90.57 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 111.185 -179.119 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 1.038 ' HG2' HD21 ' A' ' 51' ' ' LEU . 37.4 Cg_endo -40.55 130.84 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.835 1.439 . . . . 0.0 111.129 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.814 ' HB3' HG21 ' A' ' 119' ' ' ILE . 4.8 m-20 -75.88 -23.76 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.89 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -136.95 123.52 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.038 HD21 ' HG2' ' A' ' 48' ' ' PRO . 3.9 mm? -102.06 132.25 48.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.301 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 79' ' ' ILE . 2.5 mt -104.71 165.37 11.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.065 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.479 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 49.1 m -142.5 109.95 5.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.43 169.98 16.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.726 ' HB ' HD13 ' A' ' 63' ' ' LEU . 2.1 tp -130.33 97.04 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -175.53 73.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.414 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.4 ' HB2' ' CA ' ' A' ' 62' ' ' GLY . 26.7 mtm -134.1 171.69 8.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.378 -0.826 . . . . 0.0 109.452 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -97.64 143.45 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.001 1.527 . . . . 0.0 110.181 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.37 -173.92 16.87 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -59.99 109.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' CA ' ' A' ' 85' ' ' SER . 0.1 OUTLIER 72.21 -165.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.969 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 169.85 39.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.846 HD23 HD21 ' A' ' 66' ' ' LEU . 51.7 tp -105.09 64.54 0.72 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -1.184 . . . . 0.0 109.549 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . 41.8 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.348 -0.845 . . . . 0.0 109.787 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 68' ' ' GLN . 1.1 tp -127.7 70.85 1.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 109.296 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.947 HD11 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -71.45 -59.68 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 109.713 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -46.58 -31.72 2.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.818 -1.176 . . . . 0.0 108.261 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.579 ' HG3' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.74 -57.41 7.17 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.63 HG23 ' CG ' ' A' ' 73' ' ' HIS . 1.5 mt -38.67 -64.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.569 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -42.75 -64.61 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.233 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.1 tp60 -34.05 -43.35 0.14 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.847 -0.533 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.721 ' O ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.7 60.55 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.057 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.818 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.7 t-80 -156.71 131.17 5.05 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -52.39 -170.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.604 1.318 . . . . 0.0 110.49 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mmt -95.53 48.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 110.763 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 73' ' ' HIS . 3.3 pp -91.17 122.41 66.44 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.869 -1.144 . . . . 0.0 108.463 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.687 ' O ' HD12 ' A' ' 76' ' ' LEU . 34.8 Cg_endo -34.31 147.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.11 1.584 . . . . 0.0 112.52 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.8 124.3 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.939 HG21 HD13 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -89.16 133.31 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.0 109.313 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.605 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -119.35 140.66 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.385 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.9 ttm -109.56 113.64 26.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.507 ' O ' HG21 ' A' ' 55' ' ' ILE . 87.5 m 49.89 72.83 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.605 ' HB2' ' CG2' ' A' ' 80' ' ' ILE . . . -91.0 165.11 13.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.888 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -167.78 -88.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.699 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER 40.19 44.64 1.59 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 10.2 t70 67.74 132.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.901 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 15.1 mt -35.17 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 109.271 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -35.68 -67.03 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.947 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -72.46 -24.28 61.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 108.626 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -71.41 -76.17 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 109.564 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' A' ' 90' ' ' ALA . 2.9 t -11.27 -58.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 122.804 0.442 . . . . 0.0 111.744 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 90' ' ' ALA . 4.9 t -40.42 108.81 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 109.75 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 92' ' ' SER . . . 176.4 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.802 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.54 -11.21 59.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.279 -0.888 . . . . 0.0 109.96 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.35 107.49 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.834 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER 55.77 45.46 24.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.88 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 96' ' ' GLN . . . 43.14 -122.63 3.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.58 -93.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.454 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 92' ' ' SER . 5.6 m-85 -62.92 171.52 2.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.87 134.52 7.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.0 109.998 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.01 95.22 9.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 79' ' ' ILE . 2.3 tp -101.27 132.55 21.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.97 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -121.57 -161.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.834 1.439 . . . . 0.0 109.94 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 8.4 mttt -117.99 159.75 41.65 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.213 -0.929 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -83.22 173.23 44.99 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.703 -2.624 . . . . 0.0 110.476 0.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 38.6 p90 -167.9 130.32 1.54 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 7.4 t70 -70.28 149.07 47.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.154 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 19' ' ' LEU . 36.9 mm -66.11 -40.72 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -74.96 -40.85 60.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 9.9 tp10 -51.05 -33.64 26.42 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -83.06 -73.67 0.39 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.47 -0.769 . . . . 0.0 109.666 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -36.6 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.495 -0.753 . . . . 0.0 110.069 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.596 ' HA ' ' HG2' ' A' ' 116' ' ' GLU . . . -79.9 -66.83 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.747 0.784 . . . . 0.0 109.861 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.8 tm? -38.47 -36.71 0.26 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.278 1.037 . . . . 0.0 109.259 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 50' ' ' VAL . 1.1 t -74.13 -59.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.62 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.1 pt-20 -38.72 -30.88 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.939 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -77.14 -54.36 6.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.118 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 121' ' ' HIS . . . -46.07 -60.93 1.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 108.972 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.89 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.2 mt -35.78 -42.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.227 0.537 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -92.21 50.29 1.62 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 3.4 t60 -97.79 -41.36 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.219 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -84.35 10.99 9.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.325 -0.86 . . . . 0.0 109.584 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -95.74 18.75 12.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.609 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 1.4 mp0 -103.11 -80.33 0.52 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.43 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -151.71 40.1 0.65 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.142 0.973 . . . . 0.0 108.858 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.833 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 136.07 161.38 9.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.833 HD13 ' O ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER -131.61 112.37 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.245 . . . . 0.0 109.628 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 6' ' ' VAL . 1.1 t -126.84 114.22 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.687 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.63 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 15.3 m0 -99.88 89.59 4.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.793 -1.192 . . . . 0.0 108.668 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.977 HG22 ' CB ' ' A' ' 52' ' ' LEU . 70.8 t -77.18 143.64 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.661 -0.649 . . . . 0.0 110.846 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 75.5 t -82.44 110.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 0.0 109.109 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 16' ' ' ARG . 14.0 m-20 -56.32 168.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 109.923 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.85 23.44 4.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 109.321 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 170.49 176.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.156 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' SER . 81.0 p -79.05 146.57 33.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.0 OUTLIER 75.74 4.65 3.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 12' ' ' ASP . 45.5 mm -78.11 -32.47 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.796 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -58.93 -47.61 84.44 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 15.3 t90 -58.19 -64.22 0.99 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.2 t -37.0 -69.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.534 -0.729 . . . . 0.0 110.83 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.4 mt -49.54 -76.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 110.52 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 19' ' ' LEU . 10.6 tp10 -36.05 -29.38 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.701 -0.624 . . . . 0.0 110.737 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -65.4 -55.77 16.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.0 -7.27 33.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.485 -0.759 . . . . 0.0 109.135 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.012 HD11 HG21 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -104.9 -5.36 21.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.79 26.92 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.35 38.59 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.94 80.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -1.12 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 2' ' ' GLN . . . 98.23 61.42 0.89 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.83 HD13 HG11 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -136.82 179.1 6.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -1.162 . . . . 0.0 109.765 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 29' ' ' THR . 24.2 m -100.4 75.56 1.8 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.0 t -81.09 88.66 5.97 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.384 -0.823 . . . . 0.0 110.02 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.63 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 20.2 m -97.79 145.28 26.54 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -139.93 152.16 46.15 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.732 -1.23 . . . . 0.0 110.09 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.895 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.9 m-85 -134.1 122.91 23.58 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.778 0.799 . . . . 0.0 109.023 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -43.81 -49.75 8.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.997 ' O ' HG23 ' A' ' 39' ' ' VAL . 6.5 m-20 -117.25 138.28 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.437 -1.415 . . . . 0.0 112.188 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.56 -15.03 15.92 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' VAL . 9.4 t30 -67.28 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.0 tt0 -35.66 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.869 -0.519 . . . . 0.0 109.821 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 35' ' ' ASN . 35.2 t -61.93 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.064 HD11 ' CB ' ' A' ' 72' ' ' ARG . 3.4 tm? -64.88 -16.58 63.38 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.319 0.581 . . . . 0.0 109.65 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.35 -21.06 21.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.935 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.08 -21.26 18.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 46' ' ' LYS . 7.5 mt -88.85 -96.84 0.09 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.38 -54.72 0.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 12.6 m -101.06 -5.51 25.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.941 ' HA ' HD22 ' A' ' 43' ' ' LEU . 11.7 mttt 62.73 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 109.202 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -100.66 -61.88 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 111.638 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.738 ' O ' HD22 ' A' ' 76' ' ' LEU . 36.8 Cg_endo -49.88 -177.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.6 1.316 . . . . 0.0 110.56 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.705 ' HB3' HG21 ' A' ' 119' ' ' ILE . 2.5 m-20 -90.85 -25.3 19.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 110.487 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.5 t -148.79 132.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.846 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -101.23 126.65 47.98 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.977 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -108.71 174.42 5.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.803 ' OG ' HD21 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -155.72 124.07 5.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.03 169.78 10.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 ' CE1' ' A' ' 84' ' ' HIS . 1.1 tp -144.31 115.3 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 109.403 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -141.91 -28.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.358 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.487 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -97.36 105.22 23.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.973 -1.08 . . . . 0.0 109.513 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 36.6 Cg_endo -75.99 137.91 20.11 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.042 1.549 . . . . 0.0 110.399 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 60' ' ' MET . . . 144.26 -114.18 0.79 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 3.2 mpp? -145.78 32.9 1.03 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -1.129 . . . . 0.0 109.403 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.17 4.4 2.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.897 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.487 ' HA3' ' HG3' ' A' ' 57' ' ' MET . . . -105.73 -86.88 1.94 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -79.13 -0.5 31.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 109.488 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.33 64.49 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 108.944 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.0 mp -81.65 0.21 39.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.522 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.803 HD21 ' OG ' ' A' ' 53' ' ' SER . 2.6 mm? -78.23 -14.55 59.4 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.181 -0.949 . . . . 0.0 108.525 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.08 57.09 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -69.46 -50.94 40.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 108.847 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.63 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 2.2 tt -33.59 -60.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.643 -0.66 . . . . 0.0 110.302 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 1.1 tptm -69.72 -55.75 9.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.797 -1.189 . . . . 0.0 110.152 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.8 tt0 -35.49 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.84 -0.538 . . . . 0.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 1.064 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.16 -48.4 3.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.682 -1.261 . . . . 0.0 112.232 -178.18 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.63 ' HD2' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -105.08 134.54 19.59 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.286 -1.509 . . . . 0.0 111.482 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.508 ' O ' ' HG2' ' A' ' 75' ' ' MET . 38.6 Cg_endo -133.97 95.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 117.376 -1.283 . . . . 0.0 111.173 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 23.1 mtt -152.41 -102.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.125 -0.984 . . . . 0.0 109.601 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -55.82 176.89 0.16 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.872 -1.143 . . . . 0.0 109.215 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.5 Cg_endo -83.85 173.16 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.716 1.377 . . . . 0.0 110.412 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 118.53 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 2.8 mt -113.56 133.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 109.767 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 ' HB2' ' A' ' 53' ' ' SER . 4.1 pt -131.13 172.22 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -85.96 153.06 22.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -89.84 137.28 32.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.396 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 169.61 41.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -162.51 164.79 26.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.463 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 29.0 t -62.04 87.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 108.705 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.919 ' HA ' HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER 61.84 30.13 18.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.945 HD12 ' CB ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 35.55 35.71 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -177.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 10.49 -61.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.082 -1.872 . . . . 0.0 111.199 -177.295 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . -69.68 14.49 0.1 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.825 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.945 ' CB ' HD12 ' A' ' 87' ' ' LEU . . . -128.38 -77.37 0.56 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 119.812 -1.805 . . . . 0.0 107.464 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.919 HG21 ' HA ' ' A' ' 86' ' ' ASP . 53.0 t -38.01 -29.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.711 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -103.32 -165.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 109.786 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 76.29 -165.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.306 -0.871 . . . . 0.0 109.473 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -45.56 -58.22 3.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.156 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.09 55.19 9.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -33.66 0.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 98' ' ' ALA . . . -50.95 -73.81 0.34 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . 167.65 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -137.28 -176.24 4.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.551 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.6 OUTLIER -150.76 -42.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.923 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' A' ' 100' ' ' ASP . 9.8 m-85 75.91 136.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.2 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.81 118.87 16.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.67 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -94.79 179.38 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.013 1.533 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -113.9 153.87 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.19 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -88.7 167.3 38.07 Favored 'Cis proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.535 -2.694 . . . . 0.0 110.427 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -152.09 152.19 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.3 t0 -82.3 174.13 11.42 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.046 -1.034 . . . . 0.0 108.927 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 mm -90.47 -64.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.727 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 110' ' ' GLU . 48.3 t0 -57.28 -46.95 82.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 108.567 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 1.5 tm-20 -44.5 -42.67 7.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.05 -72.27 0.2 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.012 HG21 HD11 ' A' ' 23' ' ' LEU . 40.8 t -36.21 -70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.333 0.587 . . . . 0.0 110.204 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.3 -65.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.967 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 117' ' ' ARG . 2.0 tt -34.07 -52.69 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.692 0.758 . . . . 0.0 109.576 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 50' ' ' VAL . 2.3 t -55.9 -56.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 115' ' ' VAL . 59.3 mm-40 -36.9 -37.45 0.15 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 110.61 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.552 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -84.86 -36.06 21.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.109 -179.11 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.552 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.23 -61.36 2.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.779 -1.201 . . . . 0.0 108.007 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.1 mt -34.84 -42.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.298 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.12 56.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -138.76 -64.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 122' ' ' TYR . 36.6 p90 -91.28 29.78 1.38 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.327 -0.858 . . . . 0.0 109.773 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -80.44 -15.27 57.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.0 109.532 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.58 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -124.66 -29.73 3.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.58 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -78.62 -179.76 6.64 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.19 -0.943 . . . . 0.0 109.464 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.509 ' CA ' HD23 ' A' ' 28' ' ' LEU . . . -146.55 177.98 24.53 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.723 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 69.9 mt -142.11 104.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.058 . . . . 0.0 109.006 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.979 HG13 HD13 ' A' ' 52' ' ' LEU . 2.4 t -99.47 106.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.728 -0.607 . . . . 0.0 110.464 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.661 ' HB2' HD12 ' A' ' 51' ' ' LEU . 40.6 m0 -98.73 92.32 5.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.997 HG22 ' HB2' ' A' ' 52' ' ' LEU . 59.7 t -90.86 167.76 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.904 0.859 . . . . 0.0 112.076 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.654 HG22 ' HA2' ' A' ' 36' ' ' GLY . 58.0 t -98.36 129.95 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.823 ' HA ' HG21 ' A' ' 15' ' ' ILE . 6.5 m-20 -49.3 -171.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.262 1.03 . . . . 0.0 112.187 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 29.6 t0 -159.58 -67.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -108.1 174.91 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.5 t -70.44 137.13 50.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.2 p 79.61 33.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.445 -0.785 . . . . 0.0 109.738 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.823 HG21 ' HA ' ' A' ' 10' ' ' ASP . 2.1 mm -80.95 -36.51 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 108.86 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 12.9 mtt180 -59.74 -44.54 93.74 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.446 ' O ' ' C ' ' A' ' 18' ' ' VAL . 10.7 t90 -64.57 -67.55 0.43 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.3 t -38.39 -68.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 110.734 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' HD23 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -52.1 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.486 -0.759 . . . . 0.0 110.693 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 19' ' ' LEU . 5.4 tt0 -34.62 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.795 -0.566 . . . . 0.0 110.821 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' LEU . 2.2 mmm180 -67.82 -56.65 8.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.972 -1.08 . . . . 0.0 108.655 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -6.08 34.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.184 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.997 HD11 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -102.92 -8.7 20.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.893 . . . . 0.0 109.646 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.43 -42.24 23.04 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.24 97.97 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.82 71.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.35 -1.088 . . . . 0.0 108.552 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.01 49.7 1.44 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.09 HD22 ' CG1' ' A' ' 112' ' ' VAL . 2.3 mp -141.03 173.48 11.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.867 -1.373 . . . . 0.0 110.081 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 29' ' ' THR . 3.6 m -98.96 89.93 4.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.539 -0.726 . . . . 0.0 109.165 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.516 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 21.1 t -90.75 90.91 8.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 110.283 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.575 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 m -92.74 146.97 23.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.77 135.57 28.01 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.913 -1.117 . . . . 0.0 109.464 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.584 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 47.3 m-85 -108.82 126.37 52.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.065 -1.022 . . . . 0.0 109.159 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -42.13 -25.26 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.043 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' PHE . 16.7 t-20 -125.96 127.95 46.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.054 . . . . 0.0 110.487 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.717 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -55.81 -50.0 63.32 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -45.26 -65.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 2.9 tt0 -34.63 -48.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.977 -0.452 . . . . 0.0 110.484 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.796 ' CG1' HD11 ' A' ' 51' ' ' LEU . 99.7 t -47.48 -55.56 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 40' ' ' LEU . 2.9 mm? -65.41 -27.59 68.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -62.4 -29.06 70.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.0 -35.25 29.1 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 43' ' ' LEU . 1.2 tm? -48.57 -25.76 1.88 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -35.52 -49.01 0.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.596 0.712 . . . . 0.0 109.156 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -78.41 -51.86 9.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.319 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 160.91 135.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.639 HG21 HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.93 -155.92 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.723 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.2 Cg_endo -129.64 -86.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 117.205 -1.397 . . . . 0.0 111.474 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 66.7 m-20 -115.52 -73.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.453 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.881 HG22 ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -119.29 124.02 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.08 . . . . 0.0 111.41 -177.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.796 HD11 ' CG1' ' A' ' 39' ' ' VAL . 7.7 tp -99.16 109.91 22.54 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.997 ' HB2' HG22 ' A' ' 8' ' ' VAL . 4.0 mp -103.33 160.85 14.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.6 ' OG ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.07 112.81 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.47 -0.769 . . . . 0.0 109.324 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 11' ' ' ASP . 5.8 t0 -61.09 -143.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.279 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.805 ' O ' HG23 ' A' ' 55' ' ' ILE . 1.1 tp -172.34 84.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.944 -1.098 . . . . 0.0 110.185 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.781 ' H ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER 163.72 129.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.566 ' CB ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 166.95 -61.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.442 -0.786 . . . . 0.0 109.443 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.598 ' HD3' HD22 ' A' ' 63' ' ' LEU . 36.7 Cg_endo -70.09 142.5 46.64 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 124.305 1.687 . . . . 0.0 110.233 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.39 -21.52 66.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 25.3 ttp -94.0 114.79 27.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 0.7 OUTLIER 44.32 -159.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.549 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.908 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -101.42 -109.73 3.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.908 HD23 ' C ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -175.7 105.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.658 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -57.48 -79.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.27 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.785 HD11 HD12 ' A' ' 63' ' ' LEU . 23.4 mt 81.49 -22.57 0.26 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -60.17 -42.9 95.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.669 -1.27 . . . . 0.0 108.68 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -31.57 72.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 4.4 tp-100 -60.36 -62.4 1.89 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.854 HG23 ' CD2' ' A' ' 73' ' ' HIS . 1.8 mp -35.92 -77.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.755 -0.591 . . . . 0.0 109.933 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -34.07 -64.8 0.22 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.949 -0.47 . . . . 0.0 109.902 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.1 mm-40 -35.05 -51.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.738 -0.601 . . . . 0.0 110.21 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.39 53.92 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 110.911 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.854 ' CD2' HG23 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -130.55 163.79 45.92 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.948 -1.095 . . . . 0.0 109.406 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 36.7 Cg_endo -84.05 -69.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.041 1.548 . . . . 0.0 110.161 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.07 45.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 77' ' ' PRO . 3.1 pp -109.28 161.55 23.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.086 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.878 ' O ' HD12 ' A' ' 76' ' ' LEU . 31.9 Cg_endo -68.63 155.06 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.88 1.463 . . . . 0.0 112.001 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -136.93 165.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.785 ' CD1' HD22 ' A' ' 102' ' ' LEU . 4.4 tt -132.59 145.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.753 -1.217 . . . . 0.0 110.796 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 100' ' ' ASP . 8.8 mt -108.46 93.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.653 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER -65.2 96.88 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.97 . . . . 0.0 109.537 -179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 81' ' ' MET . 14.9 t 123.72 177.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.67 19.81 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 109.154 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -91.49 -95.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.63 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m -71.73 86.51 0.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.059 -1.026 . . . . 0.0 109.405 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.897 ' OD2' HD13 ' A' ' 80' ' ' ILE . 9.8 t70 -179.3 -36.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.016 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.598 HD13 ' OH ' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -35.35 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.292 0.568 . . . . 0.0 110.536 -179.685 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -91.77 -53.51 4.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.348 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -17.55 1.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 110.361 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -96.57 -74.51 0.56 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.968 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 90' ' ' ALA . 45.8 t -33.71 -33.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.762 -0.586 . . . . 0.0 110.872 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -97.58 -160.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.814 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 95' ' ' GLN . . . 45.48 -168.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -58.2 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.126 -0.983 . . . . 0.0 109.096 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp0? -94.47 15.2 18.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.762 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -38.74 24.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 167.02 -94.38 0.11 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 69.64 7.25 6.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -1.091 . . . . 0.0 110.047 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER 49.14 112.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.636 0.732 . . . . 0.0 110.401 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.026 ' HB2' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -147.09 -169.2 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.662 -1.274 . . . . 0.0 109.843 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.598 ' OH ' HD13 ' A' ' 87' ' ' LEU . 4.8 m-85 65.32 96.1 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.433 0.635 . . . . 0.0 110.672 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.785 HD22 ' CD1' ' A' ' 79' ' ' ILE . 12.8 tp -139.36 95.59 9.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.01 -172.44 0.71 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.084 1.571 . . . . 0.0 111.525 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -141.38 166.21 23.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.592 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -75.63 119.8 6.35 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.249 -2.396 . . . . 0.0 110.767 0.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.994 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 58.5 t80 -93.18 167.17 11.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.202 -0.936 . . . . 0.0 109.398 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.618 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 16.6 t0 -74.5 -145.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.475 -0.765 . . . . 0.0 109.48 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.614 HG23 ' CD2' ' A' ' 23' ' ' LEU . 6.7 mm -139.93 -73.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.101 -0.999 . . . . 0.0 109.119 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.497 ' N ' HG22 ' A' ' 108' ' ' ILE . 42.0 t0 -60.76 -31.82 71.15 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 69.0 tt0 -55.83 -38.21 69.72 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.994 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -75.47 -70.84 0.4 Allowed 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.352 -0.842 . . . . 0.0 109.504 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.09 ' CG1' HD22 ' A' ' 28' ' ' LEU . 47.6 t -36.99 -45.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.66 0.743 . . . . 0.0 110.962 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -76.81 -72.0 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.802 . . . . 0.0 110.944 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.512 ' C ' ' O ' ' A' ' 113' ' ' ALA . 54.5 tp -33.07 -56.34 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.365 0.602 . . . . 0.0 109.946 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.799 HG11 HG11 ' A' ' 50' ' ' VAL . 93.5 t -61.86 -55.44 24.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.687 ' HA ' HD12 ' A' ' 119' ' ' ILE . 17.3 tt0 -33.09 -34.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.406 0.622 . . . . 0.0 109.962 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 115' ' ' VAL . 35.5 mtm180 -60.17 -60.71 3.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -55.13 -52.89 61.83 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 50' ' ' VAL . 4.5 mt -35.63 -35.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.245 0.545 . . . . 0.0 110.365 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -77.35 31.48 0.15 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.267 -0.896 . . . . 0.0 110.791 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -64.86 -18.04 64.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.68 -1.263 . . . . 0.0 109.228 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -86.78 40.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 109.621 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.34 50.88 2.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.398 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.1 mtm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -64.97 135.67 55.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.324 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 59.8 ttm-85 -179.66 68.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.32 -0.862 . . . . 0.0 109.321 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.709 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . -151.46 92.39 0.14 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.102 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.806 HG22 ' HE1' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -92.93 88.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 108.581 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 6' ' ' VAL . 5.4 p -98.46 118.2 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.445 0.641 . . . . 0.0 110.566 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 1.054 ' CE3' HG21 ' A' ' 31' ' ' THR . 11.4 m0 -101.77 87.74 3.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.006 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 19' ' ' LEU . 24.1 t -76.02 156.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.821 0.82 . . . . 0.0 111.079 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.992 ' CG2' HG21 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -118.61 114.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.589 ' HB3' HG21 ' A' ' 15' ' ' ILE . 3.6 t0 -175.83 172.93 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.586 -0.696 . . . . 0.0 109.418 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' N ' HG13 ' A' ' 15' ' ' ILE . 64.0 t0 -144.72 -76.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.15 -0.968 . . . . 0.0 109.151 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 13' ' ' SER . 5.1 t70 35.91 53.09 0.87 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.672 -0.642 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.0 p 36.97 100.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.129 0.49 . . . . 0.0 111.106 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 83.39 45.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.463 -0.773 . . . . 0.0 110.712 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -81.5 -38.15 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.66 -1.275 . . . . 0.0 107.86 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.53 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 1.6 mtm-85 -66.81 -31.89 72.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CE3' ' HG3' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -61.54 -69.35 0.25 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.214 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.582 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 41.1 t -40.43 -64.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.708 0.765 . . . . 0.0 110.75 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 21' ' ' ARG . 51.4 mt -62.02 -72.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 111.349 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 1.6 tt0 -33.81 -34.64 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.683 -0.636 . . . . 0.0 110.832 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.62 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 63.9 mmt-85 -67.22 -55.38 14.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 108.529 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.666 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -71.3 -3.21 19.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.203 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.042 HD11 HG21 ' A' ' 112' ' ' VAL . 1.7 mm? -102.7 -17.15 15.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 109.393 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.0 11.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.7 -21.05 49.62 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.24 -31.16 19.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.405 -1.056 . . . . 0.0 108.941 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.63 63.72 1.4 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.814 HD12 HG11 ' A' ' 112' ' ' VAL . 17.7 mt -144.73 177.53 8.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 11.5 m -98.93 93.27 5.93 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 22.4 t -89.36 78.97 7.1 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.283 -0.885 . . . . 0.0 110.07 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.054 HG21 ' CE3' ' A' ' 7' ' ' TRP . 11.5 m -76.03 126.33 30.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 108.619 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.53 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 65.3 p -132.01 138.45 48.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.953 -1.092 . . . . 0.0 109.698 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.021 ' HB2' HG22 ' A' ' 39' ' ' VAL . 11.8 m-85 -127.61 137.51 52.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 1.4 mt-10 -72.11 -27.55 62.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.46 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.978 ' O ' HG23 ' A' ' 39' ' ' VAL . 5.7 m-80 -111.01 133.71 53.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 110.137 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.862 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -56.37 -64.74 4.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -39.15 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.611 -0.935 . . . . 0.0 109.627 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.0 mm-40 -31.21 -43.82 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.43 0.634 . . . . 0.0 110.103 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.021 HG22 ' HB2' ' A' ' 33' ' ' PHE . 21.5 t -54.55 -61.83 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.429 -0.794 . . . . 0.0 109.2 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.037 HD12 HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -63.07 -12.53 27.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -77.2 -35.03 56.06 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.17 62.64 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.094 HD12 HD11 ' A' ' 69' ' ' ILE . 27.8 mt -68.97 -8.61 46.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.533 -0.729 . . . . 0.0 109.078 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -3.84 -64.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.337 0.589 . . . . 0.0 112.054 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.573 ' C ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -70.68 -61.01 1.93 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.84 -173.77 3.1 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.553 0.692 . . . . 0.0 109.407 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.024 ' HA ' HD22 ' A' ' 43' ' ' LEU . 31.5 m -99.98 150.42 36.85 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 32.8 Cg_endo -75.39 -81.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 117.485 -1.21 . . . . 0.0 112.448 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.85 -76.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.356 -1.465 . . . . 0.0 110.462 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.999 HG23 ' CD1' ' A' ' 119' ' ' ILE . 9.8 t -132.92 143.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.83 . . . . 0.0 109.062 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.899 ' HB3' HG12 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -100.08 133.0 45.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.591 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -118.85 137.86 53.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -139.22 118.98 13.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.048 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 10' ' ' ASP . 1.5 p30 -104.67 160.25 15.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.087 -1.008 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.579 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -87.67 135.42 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.499 -0.751 . . . . 0.0 109.189 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.752 ' HG3' ' HE2' ' A' ' 57' ' ' MET . 7.1 ptt85 -151.15 34.36 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.297 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.752 ' HE2' ' HG3' ' A' ' 56' ' ' ARG . 11.6 mtm -148.41 112.2 3.74 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.564 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -107.94 136.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.11 1.584 . . . . 0.0 110.149 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.23 -84.42 0.23 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.09 -32.67 4.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.172 . . . . 0.0 109.951 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' MET . 0.8 OUTLIER -122.02 150.76 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.856 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 -67.89 0.11 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.48 94.09 3.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -1.177 . . . . 0.0 109.729 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 44.04 2.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.208 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' HA3' ' A' ' 36' ' ' GLY . 11.4 mt -118.37 -28.86 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -69.85 -50.92 37.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.1 . . . . 0.0 108.108 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 66' ' ' LEU . 15.6 tttm -44.54 -35.26 2.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.886 ' HG2' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.26 -56.67 18.74 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.094 HD11 HD12 ' A' ' 43' ' ' LEU . 2.2 tp -36.39 -54.13 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.656 -0.653 . . . . 0.0 110.561 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 13.1 mmtp -53.25 -66.18 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.2 tt0 -36.74 -29.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.868 -0.52 . . . . 0.0 110.321 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -105.23 -81.22 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.154 -0.966 . . . . 0.0 111.567 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.543 ' CD2' ' HB3' ' A' ' 43' ' ' LEU . 2.4 p-80 -153.44 133.76 7.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.627 -1.295 . . . . 0.0 112.048 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.558 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 37.7 Cg_endo -134.46 -93.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.988 1.52 . . . . 0.0 109.224 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.555 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 19.0 mtt 69.19 4.6 4.66 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.403 -0.81 . . . . 0.0 110.676 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.768 HD21 ' HB ' ' A' ' 47' ' ' THR . 0.3 OUTLIER -142.37 167.12 17.37 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.984 -1.073 . . . . 0.0 109.548 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.867 ' HG2' HG22 ' A' ' 50' ' ' VAL . 32.1 Cg_endo -62.96 155.03 63.0 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.556 1.293 . . . . 0.0 111.255 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.86 101.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.824 . . . . 0.0 110.083 -178.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 50' ' ' VAL . 1.7 mp -76.44 138.83 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.128 -0.982 . . . . 0.0 109.645 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 80' ' ' ILE . 3.0 tt -126.55 113.8 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.484 ' O ' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER -62.5 148.53 45.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 109.529 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER 60.84 175.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.423 -0.798 . . . . 0.0 109.487 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' N ' HG23 ' A' ' 82' ' ' THR . . . -145.96 76.21 1.45 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' C ' ' N ' ' A' ' 86' ' ' ASP . 13.5 m80 -138.9 -101.19 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.958 . . . . 0.0 110.524 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.54 ' OG ' ' HB3' ' A' ' 89' ' ' ALA . 21.7 p 46.87 30.09 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -177.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 88' ' ' ASP . 73.2 m-20 63.57 125.38 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.024 HD12 HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -36.15 -32.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -37.45 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.343 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -44.17 -35.99 2.46 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.974 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -62.3 -90.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.337 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.024 HG23 HD12 ' A' ' 87' ' ' LEU . 35.6 t -35.61 -63.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.602 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 14.5 m -79.94 -149.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.833 . . . . 0.0 110.351 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' ALA . . . 68.19 -87.12 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 109.901 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.504 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 2.0 p90 -106.66 -16.36 14.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.081 -1.012 . . . . 0.0 109.514 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 14.5 mt-30 44.45 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -83.72 136.33 34.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.848 -1.158 . . . . 0.0 109.358 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.03 -174.79 30.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -121.86 95.21 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.356 -1.085 . . . . 0.0 109.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 50.7 p90 163.54 -174.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -144.28 134.0 23.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.554 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.476 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 88.3 m-85 -43.77 122.24 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -100.38 112.12 63.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.151 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 36.8 Cg_endo -91.8 168.27 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.907 1.477 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -95.03 158.6 34.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -101.44 166.52 7.53 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.043 -2.482 . . . . 0.0 110.16 0.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 25.3 p90 -147.7 174.17 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 10.6 t0 -87.23 -154.91 0.26 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.302 -0.874 . . . . 0.0 108.907 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.666 HD13 ' CB ' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -121.69 -42.92 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 108.677 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -82.34 -35.07 28.23 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.49 -38.09 76.91 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -79.95 -72.14 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.639 -0.663 . . . . 0.0 109.343 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.042 HG21 HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -37.4 -53.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.661 -0.649 . . . . 0.0 110.066 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.57 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -60.58 -60.86 3.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.602 -0.686 . . . . 0.0 109.988 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -34.45 -46.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.749 0.785 . . . . 0.0 109.66 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 116' ' ' GLU . 0.8 OUTLIER -66.49 -54.67 23.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.151 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.604 ' N ' HG12 ' A' ' 115' ' ' VAL . 6.1 tt0 -34.08 -39.46 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.433 0.635 . . . . 0.0 109.847 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' VAL . 11.4 mtp180 -77.43 -47.71 19.06 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.242 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' VAL . . . -52.22 -64.53 0.79 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 0.0 108.835 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.999 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.3 mt -35.45 -41.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.597 . . . . 0.0 110.22 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.46 58.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -117.73 -19.89 9.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -78.06 -7.85 57.46 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.32 -0.863 . . . . 0.0 109.396 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.27 -34.92 24.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.442 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -154.77 74.92 0.95 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.8 162.62 38.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -153.43 146.41 14.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.625 HG23 ' CG2' ' A' ' 29' ' ' THR . 2.7 mp -105.59 112.74 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -1.159 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 52' ' ' LEU . 2.3 p -105.59 120.52 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.578 -0.701 . . . . 0.0 110.016 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.742 ' CZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -101.19 105.81 16.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.136 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' A' ' 52' ' ' LEU . 42.6 t -87.99 146.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.141 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 22.6 t -99.24 95.73 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 110.084 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 31.52 -160.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.78 0.8 . . . . 0.0 112.696 178.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.698 ' HB3' HD11 ' A' ' 15' ' ' ILE . 6.8 t0 152.48 -25.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.62 146.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 14' ' ' SER . 11.3 t -45.4 135.8 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.717 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 77.45 34.7 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -72.73 -47.55 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 108.975 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -53.0 -47.74 68.05 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.492 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 83.9 t90 -56.56 -63.77 1.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 109.667 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 17' ' ' TRP . 42.1 t -38.88 -74.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.07 0.938 . . . . 0.0 110.648 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -60.53 -68.18 0.32 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.531 -0.731 . . . . 0.0 110.858 -178.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -35.52 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.547 -0.721 . . . . 0.0 110.88 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -71.82 -53.63 12.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.991 -1.068 . . . . 0.0 108.252 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -71.87 -2.98 19.8 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.984 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.956 HD11 HG21 ' A' ' 112' ' ' VAL . 2.5 mm? -103.88 -14.9 15.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.353 -0.842 . . . . 0.0 109.411 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.58 -30.65 32.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 -38.96 58.22 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.52 72.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -1.113 . . . . 0.0 108.913 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.26 66.01 0.91 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.027 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -141.52 176.9 8.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.091 -1.241 . . . . 0.0 110.019 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 29' ' ' THR . 6.8 m -100.13 77.09 1.96 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.1 t -83.08 90.37 7.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.313 -0.867 . . . . 0.0 110.427 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 3.3 m -100.7 140.67 34.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.499 ' OG1' HG22 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -142.31 138.47 31.33 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.571 -1.331 . . . . 0.0 110.164 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.888 ' HB2' HG23 ' A' ' 39' ' ' VAL . 18.3 m-85 -107.46 159.82 16.12 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -92.02 11.5 25.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.898 -1.126 . . . . 0.0 109.711 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -149.94 128.56 12.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.813 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -56.24 -62.45 6.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.473 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -41.47 -65.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.354 -1.086 . . . . 0.0 109.383 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.5 tp10 -35.05 -47.01 0.35 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.611 -0.68 . . . . 0.0 110.276 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.895 HG12 HD13 ' A' ' 40' ' ' LEU . 1.4 t -60.83 -50.7 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 108.636 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.895 HD13 HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -69.81 -5.85 28.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 0.0 109.572 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.36 -22.07 18.57 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.3 -0.875 . . . . 0.0 108.802 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.77 -33.5 18.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.4 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 47' ' ' THR . 4.1 mt -98.59 -114.35 0.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.214 -0.929 . . . . 0.0 108.742 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.4 -51.28 0.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 58.7 m -75.23 -34.65 61.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.326 -0.859 . . . . 0.0 108.924 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 176.77 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.01 HG23 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -71.27 -152.85 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.884 ' CD ' HG22 ' A' ' 47' ' ' THR . 37.0 Cg_endo -125.32 -75.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 117.093 -1.471 . . . . 0.0 111.2 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -112.85 -73.92 0.65 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.733 -1.229 . . . . 0.0 111.14 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.907 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.6 t -140.27 137.0 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.013 -1.054 . . . . 0.0 110.672 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.653 HD23 ' CG1' ' A' ' 69' ' ' ILE . 12.5 tp -100.42 159.89 14.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.583 ' CD1' HG22 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -138.93 141.7 38.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 -179.797 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.541 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 6.3 t -119.27 111.21 17.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 10' ' ' ASP . 34.0 p-10 -59.77 175.13 0.39 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.909 -1.119 . . . . 0.0 109.097 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.606 HG21 ' O ' ' A' ' 81' ' ' MET . 1.2 tt -161.72 38.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -80.22 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.46 ' CE ' ' CA ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -48.59 139.0 11.53 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.653 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -113.61 165.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.818 1.43 . . . . 0.0 110.167 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 61' ' ' ASP . . . 124.03 89.31 0.85 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.1 mmt 49.05 -95.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -1.109 . . . . 0.0 109.738 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' GLY . 2.0 m-20 -50.89 164.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.09 -1.006 . . . . 0.0 109.353 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.646 ' C ' HD22 ' A' ' 63' ' ' LEU . . . 108.73 -62.38 0.29 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 86' ' ' ASP . 2.4 mm? -116.92 1.76 12.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -1.167 . . . . 0.0 109.715 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.69 67.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.176 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.713 HD22 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -167.77 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.661 ' O ' HG22 ' A' ' 69' ' ' ILE . 2.9 tp -40.18 -30.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.109 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 65' ' ' LEU . 10.8 tptt -57.66 -54.73 43.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.609 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 65' ' ' LEU . 9.4 pm0 -58.09 -39.23 78.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.204 . . . . 0.0 108.241 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 66' ' ' LEU . 1.4 tt -38.21 -36.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.577 -0.702 . . . . 0.0 110.064 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' ARG . 5.0 tptm -109.05 -69.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 110.334 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 5.7 tt0 -36.12 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.402 -0.811 . . . . 0.0 110.834 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -96.89 -34.93 11.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.277 -0.889 . . . . 0.0 110.06 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.759 ' CE1' HD12 ' A' ' 40' ' ' LEU . 4.7 m80 -96.83 137.14 21.37 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.547 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.6 Cg_endo -39.23 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.999 1.526 . . . . 0.0 110.999 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.85 95.72 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.726 HD12 ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -133.23 171.71 8.66 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.769 ' HG2' HG22 ' A' ' 50' ' ' VAL . 34.2 Cg_endo -59.28 107.87 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.441 1.232 . . . . 0.0 110.982 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.517 ' CG1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -102.12 82.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.54 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mp -62.73 155.56 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.988 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 79' ' ' ILE . 1.3 pp -160.39 150.88 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.606 ' O ' HG21 ' A' ' 55' ' ' ILE . 40.3 mtt -90.85 126.99 36.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 109.511 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 77.8 p -74.27 153.53 39.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 0.0 109.708 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 163.65 39.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.349 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER 69.06 157.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 51.0 m 63.04 152.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.838 ' HB2' HD12 ' A' ' 63' ' ' LEU . 32.1 t0 84.2 -49.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.726 -0.609 . . . . 0.0 109.868 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -33.75 -51.02 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.0 110.528 -179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.23 -55.48 10.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.649 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.5 -40.1 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 109.679 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -73.19 -81.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 42.8 t -33.38 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.776 -0.578 . . . . 0.0 110.613 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -99.79 -155.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.919 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 56.63 75.68 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.442 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' GLN . 0.7 OUTLIER 59.95 -89.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.378 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 71.42 138.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -146.01 -63.18 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.303 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.37 52.72 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.82 38.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -1.151 . . . . 0.0 109.398 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 100' ' ' ASP . 8.2 m-85 -120.42 105.52 10.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.794 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.584 ' O ' ' CD1' ' A' ' 101' ' ' TYR . 14.1 t0 -61.96 -139.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.886 . . . . 0.0 109.181 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 169.78 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 108.959 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.74 132.17 62.0 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 109.777 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 104' ' ' LYS . 36.8 Cg_endo -105.87 -92.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.89 1.469 . . . . 0.0 110.135 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER 161.28 147.77 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.253 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.436 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -82.26 170.9 56.84 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.721 -2.616 . . . . 0.0 110.392 -0.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -149.7 138.96 21.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 25.3 t0 -76.77 170.67 16.03 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.036 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 22' ' ' ALA . 19.1 mm -84.23 -58.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.049 -1.032 . . . . 0.0 109.896 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -63.33 -46.16 87.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 108.533 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 20.7 tp10 -47.22 -37.9 11.22 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -75.04 -73.76 0.23 Allowed 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.349 -0.844 . . . . 0.0 109.796 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 28' ' ' LEU . 41.4 t -39.02 -56.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -59.97 -70.15 0.18 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.729 . . . . 0.0 110.987 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.769 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.0 tm? -34.37 -57.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.435 0.636 . . . . 0.0 110.016 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.69 ' N ' HD13 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -53.92 -52.66 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.555 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.0 tt0 -34.56 -49.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.274 0.559 . . . . 0.0 110.324 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -56.02 -54.95 38.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.61 -60.56 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.09 -1.007 . . . . 0.0 108.366 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.907 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.7 mt -37.0 -35.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.739 -0.601 . . . . 0.0 110.865 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.593 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 7.6 t -33.87 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.936 -0.478 . . . . 0.0 111.52 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.593 ' CB ' ' O ' ' A' ' 120' ' ' SER . 2.2 t-160 86.52 39.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' HIS . 1.1 m-85 37.36 77.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.583 0.706 . . . . 0.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.07 39.28 1.04 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.74 . . . . 0.0 109.595 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.602 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.841 ' C ' HD12 ' A' ' 5' ' ' ILE . . . -162.78 176.94 39.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.841 HD12 ' C ' ' A' ' 4' ' ' GLY . 3.6 mp -135.95 99.27 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.055 . . . . 0.0 109.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 8' ' ' VAL . 2.7 t -101.19 111.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 109.821 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.606 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 9.5 m0 -100.18 92.78 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.106 HG22 ' HB2' ' A' ' 52' ' ' LEU . 48.3 t -95.98 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.484 -0.76 . . . . 0.0 110.735 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.686 ' HB ' HG21 ' A' ' 39' ' ' VAL . 3.7 p -119.16 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 15' ' ' ILE . 1.4 p30 -102.14 -120.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.913 -1.117 . . . . 0.0 110.181 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' HD3' ' A' ' 58' ' ' PRO . 31.8 t0 -135.43 -61.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.633 -1.292 . . . . 0.0 110.019 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 175.26 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -59.76 160.26 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.78 . . . . 0.0 109.634 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 13' ' ' SER . 2.1 m 79.93 -7.56 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.442 -0.786 . . . . 0.0 109.75 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.629 HG21 ' HB2' ' A' ' 10' ' ' ASP . 26.6 mm -96.89 -45.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -63.59 -30.96 72.0 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.468 ' O ' ' C ' ' A' ' 18' ' ' VAL . 5.7 t90 -67.28 -60.28 2.72 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 24.8 t -36.6 -57.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.165 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.585 ' C ' HD12 ' A' ' 23' ' ' LEU . 8.8 mt -55.73 -72.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 1.8 tt0 -35.14 -30.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.868 -0.52 . . . . 0.0 110.674 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -66.37 -55.16 17.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 108.437 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 -12.96 61.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD22 ' HB2' ' A' ' 30' ' ' CYS . 0.9 OUTLIER -92.9 -11.11 34.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.765 . . . . 0.0 109.754 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.69 -46.09 40.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.83 -41.97 52.32 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.49 79.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -1.003 . . . . 0.0 108.572 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.05 50.22 3.32 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.895 HD13 HG11 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -120.23 173.71 6.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 0.0 109.971 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 29' ' ' THR . 51.6 m -100.26 65.75 1.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 1.035 ' HB2' HD22 ' A' ' 23' ' ' LEU . 32.0 t -82.23 80.08 8.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.217 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.606 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 1.3 m -75.1 129.32 37.36 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -126.96 136.76 52.71 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.059 -1.026 . . . . 0.0 109.686 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.085 ' HB2' HG22 ' A' ' 39' ' ' VAL . 2.1 m-85 -110.72 -176.15 2.9 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 19.4 mt-10 -95.43 -47.57 6.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.935 . . . . 0.0 110.429 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.977 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.2 t-20 -116.15 144.7 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.064 -1.022 . . . . 0.0 109.949 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.514 ' CA ' HG21 ' A' ' 9' ' ' VAL . . . -54.14 -33.13 51.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 38' ' ' GLU . 11.4 t-20 -61.76 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.033 -1.275 . . . . 0.0 108.624 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.5 mm-40 -34.64 -35.28 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.348 0.594 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.085 HG22 ' HB2' ' A' ' 33' ' ' PHE . 75.0 t -55.33 -59.09 2.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.396 -0.815 . . . . 0.0 109.453 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.849 HD12 ' CB ' ' A' ' 72' ' ' ARG . 0.9 OUTLIER -67.66 -14.82 63.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.568 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -68.25 -30.91 70.06 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.8 -31.9 19.35 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.657 HD13 HG23 ' A' ' 47' ' ' THR . 89.9 mt -92.34 1.54 57.17 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.478 -0.764 . . . . 0.0 110.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.508 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -29.47 -38.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' LEU . 2.5 m -70.15 -55.73 8.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 108.746 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER 169.86 135.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.415 -0.803 . . . . 0.0 109.969 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.01 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -50.19 157.2 1.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 109.666 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.94 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.7 Cg_endo -88.13 -70.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.918 1.483 . . . . 0.0 110.058 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -109.32 -65.22 1.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 0.0 109.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.799 HG21 HG13 ' A' ' 115' ' ' VAL . 2.6 t -149.57 144.16 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.055 -1.028 . . . . 0.0 110.123 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 47' ' ' THR . 3.5 tp -100.54 155.16 18.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.894 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.106 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -145.43 169.45 18.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.677 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.748 ' OG ' HG23 ' A' ' 80' ' ' ILE . 27.4 p -154.56 139.7 17.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.69 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 25.4 m-20 -86.78 -172.25 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.294 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -120.67 5.54 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.12 -0.988 . . . . 0.0 109.689 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.3 OUTLIER -86.62 174.13 9.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.638 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.48 ' SD ' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 170.87 177.16 0.11 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.795 . . . . 0.0 109.176 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' SD ' ' A' ' 57' ' ' MET . 36.8 Cg_endo -98.32 120.33 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.953 1.502 . . . . 0.0 110.508 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.55 -144.89 23.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 12.2 mtt -88.56 -156.92 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' MET . 37.3 m-20 64.75 179.96 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.78 68.73 0.22 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HG ' ' HG3' ' A' ' 57' ' ' MET . 1.1 mp 61.64 92.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.611 ' C ' HD13 ' A' ' 65' ' ' LEU . . . -91.41 14.24 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.208 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.774 HD22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -100.9 14.26 32.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -0.846 . . . . 0.0 109.357 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.741 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -65.44 -65.0 0.73 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.4 ttpp -47.0 -26.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.573 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.03 -60.54 2.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -33.54 -57.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.283 0.563 . . . . 0.0 110.415 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HE2' ' CG2' ' A' ' 69' ' ' ILE . 7.0 mmtt -59.84 -61.05 2.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.258 -0.901 . . . . 0.0 109.847 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 70' ' ' LYS . 21.9 mm-40 -32.98 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.894 -0.504 . . . . 0.0 111.385 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.849 ' CB ' HD12 ' A' ' 40' ' ' LEU . 4.9 mpt_? -83.39 -91.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 110.801 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.769 ' NE2' HD22 ' A' ' 51' ' ' LEU . 3.0 p80 -68.49 151.95 96.92 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.388 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 33.8 Cg_endo -49.63 -178.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.638 1.336 . . . . 0.0 110.689 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.5 ptp -85.16 56.05 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.907 HD21 ' OG1' ' A' ' 47' ' ' THR . 0.6 OUTLIER -70.42 158.68 87.12 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.4 Cg_endo -44.61 136.98 8.88 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.501 1.263 . . . . 0.0 112.642 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.884 HG23 ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -145.24 177.99 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.547 ' O ' HD23 ' A' ' 52' ' ' LEU . 26.1 mt -158.67 119.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.216 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.748 HG23 ' OG ' ' A' ' 53' ' ' SER . 30.5 mt -108.6 128.53 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 108.818 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 54' ' ' ASP . 1.4 mtm -56.46 174.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -53.85 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 110.215 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 82' ' ' THR . . . 80.78 162.54 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -119.75 -21.55 7.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.421 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.7 m -123.57 18.22 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.74 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -96.73 -18.39 19.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.228 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.765 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.2 tt -35.15 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.897 -0.502 . . . . 0.0 110.935 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASP . 11.0 t70 -70.27 -57.79 4.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.862 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 66' ' ' LEU . . . -65.68 -16.07 63.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB1' ' OH ' ' A' ' 101' ' ' TYR . . . -83.12 -42.36 17.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 87' ' ' LEU . 46.4 t -35.85 -29.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.459 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ALA . 30.3 t -80.64 31.69 0.3 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.5 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.37 -53.6 2.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.912 -1.118 . . . . 0.0 108.624 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 10.7 m-30 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -0.894 . . . . 0.0 108.747 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 2.3 tp-100 -86.81 91.77 8.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.782 . . . . 0.0 109.424 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 45.69 64.99 1.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.29 -179.29 15.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.35 38.08 1.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.952 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.884 ' CD1' HG23 ' A' ' 78' ' ' VAL . 6.6 p90 -162.2 133.4 5.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.04 -1.038 . . . . 0.0 109.874 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 100' ' ' ASP . 58.7 p30 -97.98 -159.29 0.73 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.41 -0.806 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.594 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 5.7 m-85 -100.66 139.02 36.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.23 120.02 52.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.026 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -95.29 -165.18 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.909 1.478 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -121.86 157.69 56.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.602 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -97.28 169.92 12.43 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.712 -2.62 . . . . 0.0 110.441 0.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 106' ' ' PHE . 20.8 p90 -149.21 138.1 21.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.549 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 16.3 t70 -79.41 171.47 15.13 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.92 . . . . 0.0 109.018 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -70.82 -56.14 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.014 -1.054 . . . . 0.0 109.014 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' HG22 ' A' ' 108' ' ' ILE . 23.5 t0 -68.7 -39.72 80.37 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.549 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 4.7 tp10 -48.42 -46.79 37.89 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -72.28 -74.06 0.17 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.895 HG11 HD13 ' A' ' 28' ' ' LEU . 32.3 t -36.73 -73.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.367 0.603 . . . . 0.0 109.749 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -38.11 -64.41 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.79 -0.569 . . . . 0.0 110.292 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 113' ' ' ALA . 8.2 tp -34.83 -55.28 0.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.785 0.802 . . . . 0.0 109.741 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.799 HG13 HG21 ' A' ' 50' ' ' VAL . 1.5 t -57.01 -57.37 10.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -32.99 -40.3 0.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.324 0.583 . . . . 0.0 110.403 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' VAL . 18.1 mtm180 -75.42 -52.59 10.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.327 -0.858 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.2 -60.83 2.21 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.117 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.772 ' CD1' HG23 ' A' ' 50' ' ' VAL . 3.4 mt -36.06 -41.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.395 0.617 . . . . 0.0 109.978 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 61.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -135.42 -65.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 2.9 p90 -99.07 95.4 7.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -117.1 0.79 12.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.284 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.961 0.886 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.692 ' HA3' HD21 ' A' ' 28' ' ' LEU . . . 147.65 171.75 17.03 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 10.6 mt -147.89 97.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.954 . . . . 0.0 108.84 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.878 ' CG2' HD12 ' A' ' 52' ' ' LEU . 2.6 p -100.2 118.64 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.658 0.742 . . . . 0.0 110.651 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.635 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 37.4 m0 -103.27 104.25 14.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.938 . . . . 0.0 108.825 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.791 HG22 ' CB ' ' A' ' 52' ' ' LEU . 59.1 t -97.57 147.74 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.913 ' HB ' HG21 ' A' ' 39' ' ' VAL . 9.8 p -123.9 129.45 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.698 ' CB ' HG21 ' A' ' 15' ' ' ILE . 13.9 t0 -135.51 -77.15 0.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.817 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 34' ' ' GLU . 64.8 t0 -148.33 -70.73 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.697 -1.252 . . . . 0.0 111.624 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.71 178.05 4.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.01 -1.056 . . . . 0.0 111.141 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -66.36 -24.73 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.641 -0.662 . . . . 0.0 109.832 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -62.54 -25.24 67.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.393 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.698 HG21 ' CB ' ' A' ' 10' ' ' ASP . 1.2 mp -66.59 -31.16 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 11.4 ttp180 -61.65 -49.13 77.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 13.2 t90 -48.73 -65.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 48.2 t -39.44 -70.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.048 0.928 . . . . 0.0 110.364 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -44.88 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.2 tt0 -32.73 -40.75 0.05 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.864 -0.522 . . . . 0.0 110.773 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 4.5 mtp180 -58.06 -57.19 13.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.977 . . . . 0.0 109.043 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 108' ' ' ILE . . . -68.29 -6.34 23.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 0.0 109.579 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -98.38 -12.53 21.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.79 51.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 -33.48 87.35 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 23' ' ' LEU . . . -73.47 -24.78 60.25 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.482 -1.01 . . . . 0.0 108.761 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.768 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 69.41 62.84 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.109 HD22 HG13 ' A' ' 112' ' ' VAL . 1.2 mp -142.25 -176.5 4.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.113 -1.228 . . . . 0.0 109.974 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.562 ' CG2' HG23 ' A' ' 5' ' ' ILE . 24.2 m -92.44 100.61 13.13 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 8.9 t -95.28 88.72 5.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.393 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.631 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 2.3 m -99.45 141.63 32.0 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.54 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -134.55 167.13 21.36 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.655 -1.278 . . . . 0.0 110.14 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.827 ' HB2' HG22 ' A' ' 39' ' ' VAL . 26.8 m-85 -140.15 171.74 13.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -105.15 -13.23 15.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.175 -0.953 . . . . 0.0 108.946 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.709 ' O ' HG23 ' A' ' 39' ' ' VAL . 55.6 m-20 -138.16 137.33 37.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.554 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.543 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -55.43 -49.72 63.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 5.0 t30 -50.54 -69.41 0.11 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.187 -1.184 . . . . 0.0 108.727 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.681 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -36.06 -42.14 0.28 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.707 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.913 HG21 ' HB ' ' A' ' 9' ' ' VAL . 39.4 t -53.05 -53.43 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.205 -0.934 . . . . 0.0 108.934 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.04 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.8 mt -62.02 -28.57 69.67 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -61.19 -34.66 75.42 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . . . -68.93 -40.52 78.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -43.0 -65.35 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' N ' HD23 ' A' ' 43' ' ' LEU . . . 28.14 -73.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.916 0.865 . . . . 0.0 110.761 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.76 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -84.69 27.33 0.74 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 82.69 134.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.345 0.593 . . . . 0.0 110.193 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.595 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -64.59 -149.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.367 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HG3' ' CE2' ' A' ' 7' ' ' TRP . 38.0 Cg_endo -125.54 -83.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 117.298 -1.335 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.575 ' OD2' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -114.31 -50.78 2.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.298 -1.501 . . . . 0.0 111.814 -178.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.851 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.1 t -149.51 149.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.396 -1.44 . . . . 0.0 109.896 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.073 HD12 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.96 156.72 17.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 109.293 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.878 HD12 ' CG2' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -137.29 124.92 22.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.06 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.716 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -113.76 133.09 55.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.053 -1.029 . . . . 0.0 110.385 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.525 ' CB ' ' OD1' ' A' ' 10' ' ' ASP . 17.5 p-10 -80.0 -158.9 0.19 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.876 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.779 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -173.89 86.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.762 ' N ' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -168.38 -163.86 0.48 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.372 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.539 ' CE ' ' O ' ' A' ' 61' ' ' ASP . 2.1 mtm 72.59 131.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.626 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.38 106.6 1.55 Allowed 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.098 1.578 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.84 -130.87 8.24 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 1.3 mtt -110.14 -164.51 0.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.682 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.539 ' O ' ' CE ' ' A' ' 57' ' ' MET . 2.0 t70 80.39 -9.72 1.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.99 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.925 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -133.8 -48.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.925 HD23 ' C ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -105.88 -175.0 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.073 -1.251 . . . . 0.0 109.691 -179.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.62 21.96 9.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.035 -1.04 . . . . 0.0 108.304 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.558 ' HB3' ' NE2' ' A' ' 68' ' ' GLN . 6.1 mt -125.27 -12.47 6.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.767 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.578 HD11 HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -61.1 -65.21 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.8 tptp -44.06 -37.53 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.861 ' HG3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -57.16 -52.35 65.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.029 -1.045 . . . . 0.0 108.678 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.944 HG23 HD13 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -35.2 -56.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.647 -0.658 . . . . 0.0 110.679 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.04 -53.89 13.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 110.443 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' LYS . 13.3 mm-40 -32.42 -44.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.755 -0.591 . . . . 0.0 110.815 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 1.04 ' HB2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -91.85 -44.84 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 1.073 ' CE1' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -47.89 159.4 0.47 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.294 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD2' HD23 ' A' ' 76' ' ' LEU . 36.9 Cg_endo -80.8 -66.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.078 1.567 . . . . 0.0 110.15 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.419 ' O ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -175.45 52.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.26 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 77' ' ' PRO . 1.1 pp -114.97 157.44 43.3 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 0.0 109.05 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 50' ' ' VAL . 37.4 Cg_endo -63.81 151.7 83.97 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.931 1.49 . . . . 0.0 111.203 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.037 HG12 ' CB ' ' A' ' 51' ' ' LEU . 2.9 m -142.87 97.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.808 HD11 ' CG2' ' A' ' 115' ' ' VAL . 8.4 mt -59.99 167.03 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 109.479 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.716 HD12 ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -161.93 133.79 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.098 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.502 ' N ' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -63.78 158.0 22.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.407 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -98.0 151.65 20.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.411 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -173.46 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -178.49 65.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.683 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 p -173.67 -36.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.588 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.1 m-20 -57.17 -31.07 65.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 109.683 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -34.89 -28.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.752 -0.593 . . . . 0.0 111.437 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -93.46 -52.84 4.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.883 -1.136 . . . . 0.0 110.776 -178.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -1.69 10.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.938 -1.101 . . . . 0.0 110.484 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -107.09 -75.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 109.182 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 71.1 t -34.42 -32.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.279 0.561 . . . . 0.0 110.393 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -108.57 -149.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.66 -95.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -128.67 70.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 2.3 tm0? -60.46 -21.59 62.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -0.82 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -69.81 -165.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.56 99.33 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.506 ' C ' ' CD2' ' A' ' 99' ' ' PHE . . . -146.45 -43.51 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.276 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CD2' HG23 ' A' ' 78' ' ' VAL . 16.1 p90 172.96 137.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.446 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -104.11 -161.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -0.808 . . . . 0.0 109.294 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -104.95 149.67 25.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 106' ' ' PHE . 13.3 mt -112.41 116.21 48.8 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.944 . . . . 0.0 109.356 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 36.5 Cg_endo -93.99 148.81 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.651 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 34.3 mtmt -101.88 149.84 36.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.07 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -78.4 140.52 60.72 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.749 -2.605 . . . . 0.0 110.439 -0.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 78.0 t80 -116.14 171.51 7.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.861 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 1.1 t70 -102.25 113.4 26.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.537 -0.727 . . . . 0.0 109.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.714 HG21 ' HB1' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -55.0 -30.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.96 -1.087 . . . . 0.0 109.335 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.98 -45.19 28.36 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 108.702 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 34.8 tt0 -50.89 -34.23 27.39 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -76.51 -72.99 0.3 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.651 -0.655 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.109 HG13 HD22 ' A' ' 28' ' ' LEU . 7.0 t -35.27 -45.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.446 -0.784 . . . . 0.0 110.61 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -73.05 -72.94 0.22 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.73 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -34.69 -57.15 0.53 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.521 0.676 . . . . 0.0 109.536 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.808 ' CG2' HD11 ' A' ' 79' ' ' ILE . 1.2 t -49.78 -58.49 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.659 ' N ' HG12 ' A' ' 115' ' ' VAL . 21.1 tp10 -35.71 -41.11 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.739 -0.601 . . . . 0.0 111.092 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 114' ' ' LEU . 4.3 ptm180 -82.47 -36.78 26.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.109 -0.994 . . . . 0.0 110.207 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.38 -62.67 1.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.87 -1.144 . . . . 0.0 108.308 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 50' ' ' VAL . 10.6 mt -33.71 -39.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.98 -0.45 . . . . 0.0 110.626 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.615 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 11.7 t -5.01 -69.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.254 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 120' ' ' SER . 6.6 m170 142.3 56.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 36.01 32.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.537 0.684 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-30 -69.43 -9.36 53.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.51 -0.744 . . . . 0.0 109.804 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 8.7 mt-10 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.626 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.187 0.517 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.489 ' HA2' ' OD2' ' A' ' 49' ' ' ASP . . . -165.62 119.52 0.87 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.598 HG23 HG21 ' A' ' 29' ' ' THR . 59.0 mt -104.89 91.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.306 -1.114 . . . . 0.0 109.884 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 p -105.87 125.63 61.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.89 ' CZ2' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.73 90.01 4.09 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.808 -1.183 . . . . 0.0 109.433 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.782 HG22 HD12 ' A' ' 52' ' ' LEU . 86.1 t -79.88 113.56 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.791 HG21 ' HA2' ' A' ' 36' ' ' GLY . 7.5 p -88.82 98.29 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.213 -0.929 . . . . 0.0 109.571 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 1.046 ' HB3' HG21 ' A' ' 15' ' ' ILE . 23.0 t0 -156.61 133.21 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.627 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.56 ' HB3' ' CG1' ' A' ' 15' ' ' ILE . 2.0 t0 7.43 68.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.285 0.564 . . . . 0.0 111.804 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.4 p-10 -46.46 177.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.552 -0.718 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 3.1 t 82.86 -68.49 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -98.18 -40.0 8.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.101 -1.0 . . . . 0.0 108.951 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 1.046 HG21 ' HB3' ' A' ' 10' ' ' ASP . 20.0 mm -68.34 -36.3 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 22.9 ttp85 -60.93 -42.38 98.06 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.483 ' O ' ' C ' ' A' ' 18' ' ' VAL . 11.5 t90 -60.29 -62.03 2.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 31.1 t -37.9 -68.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 109.678 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -56.15 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.632 -0.667 . . . . 0.0 110.442 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.543 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 2.1 tt0 -36.05 -64.31 0.32 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.489 -0.757 . . . . 0.0 111.983 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -39.78 -43.53 1.44 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -178.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . -71.5 -39.69 70.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.695 -1.253 . . . . 0.0 108.548 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD11 ' CG2' ' A' ' 112' ' ' VAL . 1.3 tp -69.73 -6.13 29.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.36 -33.96 42.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.0 109.038 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.87 -27.85 73.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.83 1.52 56.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -1.108 . . . . 0.0 109.229 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.95 72.22 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.751 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -133.92 -179.84 5.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.116 -1.226 . . . . 0.0 110.008 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.598 HG21 HG23 ' A' ' 5' ' ' ILE . 29.2 m -102.1 84.49 2.51 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.2 t -93.11 90.83 7.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.482 -0.761 . . . . 0.0 110.644 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.89 HG21 ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -97.39 138.66 34.5 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 1.7 p -146.43 134.53 21.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.737 -1.227 . . . . 0.0 110.696 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.962 ' HB2' HG23 ' A' ' 39' ' ' VAL . 7.0 m-30 -108.53 -158.9 0.67 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' CB ' ' H ' ' A' ' 12' ' ' ASP . 6.7 pt-20 -121.83 -32.88 3.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.607 -1.308 . . . . 0.0 109.592 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.568 ' C ' HG21 ' A' ' 9' ' ' VAL . 28.1 m120 -116.44 123.32 47.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.863 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.8 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -41.37 -36.47 1.45 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -62.62 -61.2 2.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 0.0 108.488 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.2 tp10 -35.55 -50.95 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.496 0.665 . . . . 0.0 109.876 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.076 HG12 HD13 ' A' ' 40' ' ' LEU . 2.1 t -63.58 -44.82 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.792 . . . . 0.0 108.907 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.076 HD13 HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -78.8 4.33 14.22 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 109.476 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.55 -23.25 13.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.78 -33.03 11.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.131 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.83 HD12 ' CG2' ' A' ' 47' ' ' THR . 3.2 mm? -65.13 -12.34 49.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.152 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.46 -31.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.518 -0.738 . . . . 0.0 110.186 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -73.91 -55.98 5.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.616 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -174.33 152.89 1.85 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.135 -0.978 . . . . 0.0 109.671 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.83 ' CG2' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -95.65 171.04 6.86 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.251 -0.905 . . . . 0.0 108.92 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.9 Cg_endo -119.68 -67.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 117.211 -1.392 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.708 ' C ' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -122.68 -78.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.403 -1.436 . . . . 0.0 111.741 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.807 HG23 ' CD1' ' A' ' 119' ' ' ILE . 4.0 t -138.96 141.31 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.941 -1.1 . . . . 0.0 110.537 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.936 HD11 HG11 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -106.24 135.99 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 110.273 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.049 HD22 ' CG2' ' A' ' 79' ' ' ILE . 5.9 mt -115.99 152.77 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 0.0 109.634 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.732 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.5 t -114.77 125.95 54.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.656 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.61 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 28.1 p30 -64.52 -166.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.01 HG12 ' HB3' ' A' ' 83' ' ' ALA . 1.9 tt -178.89 33.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -130.41 6.9 4.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.678 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.926 ' HG3' HD13 ' A' ' 63' ' ' LEU . 56.8 mmm -42.97 117.39 2.19 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -55.04 145.91 61.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.89 1.469 . . . . 0.0 110.231 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.15 101.42 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 60.56 49.58 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -1.164 . . . . 0.0 109.248 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 57' ' ' MET . 11.1 p-10 -52.64 144.76 13.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.773 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 155.79 -81.81 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.926 HD13 ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER 42.95 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -1.125 . . . . 0.0 109.889 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -58.76 -74.36 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 108.52 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.822 HD21 HD23 ' A' ' 63' ' ' LEU . 11.6 mt 76.48 -10.29 1.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 53' ' ' SER . 4.0 mm? -74.92 -39.81 61.2 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.848 -1.157 . . . . 0.0 108.827 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -64.97 -27.86 69.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.86 ' CG ' HD23 ' A' ' 40' ' ' LEU . 22.2 tp60 -65.26 -62.35 1.59 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.607 ' CG1' HD11 ' A' ' 40' ' ' LEU . 17.4 mt -35.79 -76.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.557 -0.714 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -43.02 -61.23 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.972 -1.08 . . . . 0.0 109.384 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.0 mt-30 -36.56 -42.1 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.505 -0.747 . . . . 0.0 111.705 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -131.89 42.12 3.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.83 -1.169 . . . . 0.0 111.289 -177.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.63 ' NE2' ' HB2' ' A' ' 43' ' ' LEU . 54.6 m80 -147.9 154.16 43.19 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.817 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 75' ' ' MET . 35.8 Cg_endo -60.9 -5.71 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.806 1.424 . . . . 0.0 112.092 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 74' ' ' PRO . 8.2 mtp 80.02 104.86 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.026 -1.046 . . . . 0.0 110.204 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.65 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -146.24 156.13 50.26 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 31.3 Cg_endo -43.04 130.48 5.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 117.203 -1.398 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.411 HG11 HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -123.32 178.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.049 ' CG2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -149.85 171.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 79' ' ' ILE . 2.7 tt -160.67 137.81 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.59 ' O ' HD13 ' A' ' 55' ' ' ILE . 7.9 mtt -85.91 135.05 33.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.047 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -72.52 149.81 43.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.013 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . 166.32 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 109.722 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 69.46 158.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 109.975 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 58.2 m 58.64 84.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 109.759 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' HD11 ' A' ' 55' ' ' ILE . 2.3 p-10 165.89 -43.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.59 HD23 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -35.03 -29.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.869 -0.52 . . . . 0.0 111.139 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.6 t0 -67.35 -65.0 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.046 -1.034 . . . . 0.0 110.194 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.67 -10.91 9.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.078 -1.014 . . . . 0.0 110.291 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -97.28 -76.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.006 -1.059 . . . . 0.0 109.765 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG2' HD23 ' A' ' 87' ' ' LEU . 51.0 t -34.1 -30.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.834 -0.541 . . . . 0.0 110.961 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.69 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -106.34 171.49 7.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.872 -1.142 . . . . 0.0 109.992 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 77.18 56.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER 60.04 47.43 9.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 1.7 pt20 -43.31 -34.42 1.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.7 72.54 0.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.4 -69.0 0.03 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . -139.38 59.81 1.59 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.25 . . . . 0.0 110.06 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.52 167.23 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.087 -1.008 . . . . 0.0 109.255 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 4.0 t0 -134.66 -30.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 73.62 105.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.95 -1.094 . . . . 0.0 108.506 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -116.95 118.77 35.92 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.043 -1.036 . . . . 0.0 110.25 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -105.97 149.0 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.046 1.551 . . . . 0.0 109.884 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -91.41 147.95 36.51 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 0.0 109.516 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -89.92 155.9 31.1 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 120.536 -2.693 . . . . 0.0 110.396 0.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 17.2 p90 -131.14 169.22 16.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 109.357 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 1.3 t70 -85.72 168.02 14.74 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.131 -0.981 . . . . 0.0 108.7 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 23' ' ' LEU . 31.6 mm -95.15 -61.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.91 -1.119 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 110' ' ' GLU . 63.1 t0 -54.97 -50.06 69.86 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.057 -1.027 . . . . 0.0 108.934 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 21.7 tp10 -44.13 -47.57 9.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -62.46 -67.74 0.39 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.066 ' CG2' HD11 ' A' ' 23' ' ' LEU . 48.1 t -35.4 -73.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.15 0.5 . . . . 0.0 110.584 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -39.12 -66.53 0.28 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.539 -0.725 . . . . 0.0 110.492 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.78 HD13 ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -34.8 -53.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.809 0.814 . . . . 0.0 109.663 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 114' ' ' LEU . 1.6 t -56.6 -60.81 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG12 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -37.82 -43.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.652 -0.655 . . . . 0.0 111.141 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 5.7 ptp180 -77.1 -36.66 55.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 110.594 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.588 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.71 -67.17 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.862 -1.149 . . . . 0.0 108.089 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.807 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.6 mt -37.07 -41.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.237 0.541 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.23 60.74 4.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -128.92 -54.47 1.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 22.7 p90 -78.35 136.45 37.69 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.85 -30.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.397 179.889 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.629 0.728 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 5' ' ' ILE . . . 149.45 177.38 23.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -153.25 90.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -1.102 . . . . 0.0 108.821 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.882 HG12 HG23 ' A' ' 8' ' ' VAL . 4.1 t -94.85 110.5 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.587 -0.696 . . . . 0.0 110.044 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.753 ' O ' HD23 ' A' ' 51' ' ' LEU . 12.0 m0 -99.94 81.05 2.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.009 HG22 ' CB ' ' A' ' 52' ' ' LEU . 43.8 t -83.91 172.34 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.347 0.594 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.971 ' HB ' HG21 ' A' ' 39' ' ' VAL . 7.0 p -134.09 140.78 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 108.7 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.887 ' HB3' HG21 ' A' ' 15' ' ' ILE . 4.6 t0 -136.71 -153.39 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.965 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD1' ' HB3' ' A' ' 57' ' ' MET . 13.6 t70 -80.6 -95.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' SER . 2.5 p-10 169.4 176.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 109.931 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 80.7 69.48 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.652 -0.655 . . . . 0.0 109.882 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.72 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.88 46.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.887 HG21 ' HB3' ' A' ' 10' ' ' ASP . 1.2 mp -112.05 -44.34 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 14.7 ttp180 -65.72 -33.06 75.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.65 -66.29 0.57 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 17' ' ' TRP . 38.3 t -39.62 -65.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.012 0.91 . . . . 0.0 110.241 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 23' ' ' LEU . 21.2 mt -55.08 -76.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.88 -0.512 . . . . 0.0 110.845 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 3.6 tm-20 -33.62 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.573 -0.704 . . . . 0.0 110.922 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 22.1 tpt180 -64.89 -56.3 14.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.982 -1.074 . . . . 0.0 108.486 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 108' ' ' ILE . . . -72.46 -2.32 19.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD22 ' CB ' ' A' ' 30' ' ' CYS . 9.7 mt -100.23 -17.37 17.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.12 -38.73 35.4 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.47 -40.3 91.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.94 -35.88 67.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.346 -1.09 . . . . 0.0 108.472 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 28' ' ' LEU . . . 101.63 42.79 2.25 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.664 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.852 HD22 ' CG1' ' A' ' 112' ' ' VAL . 1.1 mt -141.85 165.62 26.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.878 -1.366 . . . . 0.0 110.06 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 5' ' ' ILE . 98.5 m -98.19 75.46 2.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.786 ' CB ' HD22 ' A' ' 23' ' ' LEU . 16.1 t -90.83 86.59 6.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.416 -0.803 . . . . 0.0 109.582 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -82.89 140.28 32.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.392 -0.818 . . . . 0.0 109.038 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -132.32 125.48 31.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.705 ' CD2' HG22 ' A' ' 39' ' ' VAL . 65.4 m-85 -88.32 -177.65 5.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.116 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -108.87 2.29 21.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.88 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -144.45 142.04 30.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 109.792 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.728 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -69.93 -60.72 4.73 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.447 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -45.84 -69.38 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.382 -1.069 . . . . 0.0 108.344 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.635 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.8 tp10 -35.58 -49.22 0.55 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 0.0 110.912 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.971 HG21 ' HB ' ' A' ' 9' ' ' VAL . 65.2 t -45.22 -53.1 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.188 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.926 HD21 ' CA ' ' A' ' 69' ' ' ILE . 5.1 mp -60.59 -36.96 79.82 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -49.71 -33.55 16.29 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.69 -22.75 19.24 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.01 HD21 ' HB ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -71.35 -1.23 12.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.891 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.1 65.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -100.06 26.48 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HE3' ' CG ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 63.21 136.53 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.573 -0.704 . . . . 0.0 110.139 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.01 ' HB ' HD21 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -76.8 -169.5 0.19 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.696 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HB2' HD12 ' A' ' 5' ' ' ILE . 37.0 Cg_endo -97.76 -75.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.808 1.425 . . . . 0.0 110.171 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 9.1 m-20 -101.62 -63.3 1.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.797 -1.189 . . . . 0.0 110.269 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.611 HG23 HD13 ' A' ' 119' ' ' ILE . 2.1 t -148.58 152.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.415 -1.428 . . . . 0.0 111.296 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 7' ' ' TRP . 3.2 mt -102.03 131.16 48.64 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.009 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.81 164.07 21.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 109.818 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' A' ' 9' ' ' VAL . 28.8 p -161.71 133.51 5.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.261 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.627 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.95 -177.0 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.128 -0.982 . . . . 0.0 109.911 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.939 HG22 ' HB2' ' A' ' 64' ' ' ALA . 1.1 pp -117.9 137.33 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.741 ' H ' HD21 ' A' ' 63' ' ' LEU . 4.5 mtt180 -155.82 -73.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.215 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.868 ' HG2' HD22 ' A' ' 63' ' ' LEU . 4.3 ptt? -55.72 134.92 72.07 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.089 -1.007 . . . . 0.0 109.884 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -114.83 71.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.748 1.394 . . . . 0.0 110.308 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.12 -94.86 1.38 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.06 -50.47 66.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.204 . . . . 0.0 109.074 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.02 179.62 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.199 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.753 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -87.65 45.24 3.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.868 HD22 ' HG2' ' A' ' 57' ' ' MET . 0.3 OUTLIER 33.7 -111.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.015 -0.697 . . . . 0.0 109.993 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.939 ' HB2' HG22 ' A' ' 55' ' ' ILE . . . 40.59 58.53 2.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.01 -1.056 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 37' ' ' ASN . 3.6 mp -80.04 73.48 6.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 110.28 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.764 HD22 ' CG2' ' A' ' 80' ' ' ILE . 10.0 tp -87.61 -53.47 4.77 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HD2' ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -54.44 -23.57 16.5 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.922 ' OE1' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -79.23 -56.92 4.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.926 ' CA ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.13 -42.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.498 0.666 . . . . 0.0 109.944 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -82.74 -56.98 3.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.54 -0.725 . . . . 0.0 109.286 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 70' ' ' LYS . 15.1 tt0 -33.99 -31.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.775 -0.578 . . . . 0.0 111.299 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.67 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.09 -78.58 0.58 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.863 -1.148 . . . . 0.0 110.898 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.663 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 1.6 p80 -66.75 144.57 98.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.612 -1.305 . . . . 0.0 109.392 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.663 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 36.2 Cg_endo -35.52 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 124.066 1.561 . . . . 0.0 111.525 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.485 ' CG ' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -178.33 100.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.753 -1.217 . . . . 0.0 110.459 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.874 HD22 HG22 ' A' ' 47' ' ' THR . 3.4 pp -120.67 156.48 55.98 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.705 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.5 Cg_endo -41.87 129.9 4.14 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 117.563 -1.158 . . . . 0.0 111.184 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.921 HG23 ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -137.9 161.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.39 -0.819 . . . . 0.0 109.254 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.781 HD13 ' O ' ' A' ' 78' ' ' VAL . 3.7 mm -142.84 147.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.764 ' CG2' HD22 ' A' ' 66' ' ' LEU . 7.1 tt -136.4 141.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.831 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.563 ' SD ' ' CE1' ' A' ' 106' ' ' PHE . 5.1 ttm -88.5 98.26 11.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.318 -0.863 . . . . 0.0 109.045 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -59.29 149.87 27.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 109.675 -179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.87 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . 179.28 60.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.324 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 79.26 143.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 109.496 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 45.2 p 53.65 171.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.265 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 85' ' ' SER . 5.5 m-20 84.43 -54.61 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.971 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -34.82 -30.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 110.8 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.3 p30 -64.16 -97.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.026 -1.046 . . . . 0.0 110.141 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -43.39 -40.35 3.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.969 -1.082 . . . . 0.0 109.903 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -51.07 -50.58 58.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 87' ' ' LEU . 3.3 t -32.6 -36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.222 0.534 . . . . 0.0 110.187 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.4 t -90.87 44.45 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.81 . . . . 0.0 109.465 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ALA . . . -132.31 -65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 109.19 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . 41.3 p90 -90.71 28.42 1.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.148 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.64 -42.69 99.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -86.87 -55.09 4.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.483 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.727 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 165.91 -164.3 37.33 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 81.73 22.27 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.599 -0.942 . . . . 0.0 109.688 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.921 ' CE2' HG23 ' A' ' 78' ' ' VAL . 89.4 m-85 -140.51 157.1 46.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.557 ' OD2' HD11 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -114.52 -29.91 6.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 70.93 99.6 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 0.0 109.329 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.58 HD12 ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -110.27 119.76 46.09 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.892 . . . . 0.0 109.654 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -108.45 12.74 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.45 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 64.71 159.25 0.12 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -76.14 172.6 62.33 Favored 'Cis proline' 0 C--N 1.314 -1.238 0 C-N-CA 120.664 -2.64 . . . . 0.0 110.336 -0.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.563 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 40.8 p90 -157.06 144.05 18.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 8.7 t70 -85.63 174.75 9.19 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -82.88 -48.69 17.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.778 -1.201 . . . . 0.0 109.864 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 108' ' ' ILE . 22.9 t0 -73.38 -47.37 42.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.006 -1.059 . . . . 0.0 108.15 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 tp10 -49.24 -38.02 25.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.3 -72.94 0.18 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.228 -0.92 . . . . 0.0 108.672 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.852 ' CG1' HD22 ' A' ' 28' ' ' LEU . 77.9 t -38.45 -74.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 121.513 0.673 . . . . 0.0 110.323 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.96 -62.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.714 . . . . 0.0 110.355 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -33.19 -54.65 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.432 0.634 . . . . 0.0 110.003 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.742 ' N ' HD13 ' A' ' 114' ' ' LEU . 75.2 t -60.05 -55.69 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 3.5 pt-20 -34.24 -44.85 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.905 -0.497 . . . . 0.0 111.411 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -59.77 -47.46 85.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.127 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.41 -55.29 25.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.737 -1.227 . . . . 0.0 107.953 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.611 HD13 HG23 ' A' ' 50' ' ' VAL . 3.3 mt -36.47 -34.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.943 -0.473 . . . . 0.0 109.796 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.674 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 6.8 p -22.85 -45.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.674 ' CB ' ' O ' ' A' ' 120' ' ' SER . 12.0 t-80 117.65 62.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER 32.04 39.28 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.473 0.654 . . . . 0.0 109.94 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -40.16 -30.93 0.11 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.231 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.411 ' OXT' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.546 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 -168.49 38.07 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.387 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.731 HG22 ' HE1' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -149.84 93.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.601 -0.941 . . . . 0.0 109.363 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.958 HG23 HG12 ' A' ' 50' ' ' VAL . 3.6 p -100.4 118.95 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.553 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.946 ' CE3' HG21 ' A' ' 31' ' ' THR . 11.7 m95 -103.06 102.58 12.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.96 -1.087 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.801 HG22 ' CG ' ' A' ' 52' ' ' LEU . 59.7 t -98.99 146.91 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.028 ' CG1' HG21 ' A' ' 39' ' ' VAL . 1.6 m -104.49 129.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 O-C-N 121.063 -1.023 . . . . 0.0 108.554 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.91 ' CB ' HG21 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -112.44 -99.21 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.343 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' GLU . 12.3 t0 -153.12 -49.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.679 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -144.0 -179.69 6.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.9 -1.125 . . . . 0.0 110.459 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -65.96 169.29 6.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 109.666 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.1 OUTLIER 78.08 -6.77 1.91 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.91 HG21 ' CB ' ' A' ' 10' ' ' ASP . 1.8 mp -96.91 -29.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -65.08 -36.75 85.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 54.4 t90 -61.9 -63.64 1.19 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 20.2 t -36.97 -65.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.527 0.68 . . . . 0.0 110.731 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' CD2' ' CD1' ' A' ' 108' ' ' ILE . 0.7 OUTLIER -50.77 -70.88 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.792 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -35.4 -35.4 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.0 110.77 -179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.15 -54.19 47.59 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -66.53 -19.15 65.71 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.251 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -87.21 -10.29 52.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.167 -0.958 . . . . 0.0 109.543 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.45 71.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.07 -34.46 66.25 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.16 45.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.466 -1.02 . . . . 0.0 109.143 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.37 49.58 14.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.064 HD22 ' CG1' ' A' ' 112' ' ' VAL . 0.9 OUTLIER -128.52 177.89 6.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.106 -1.232 . . . . 0.0 110.267 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.608 ' HB ' HG23 ' A' ' 5' ' ' ILE . 7.2 m -95.26 93.35 7.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.746 ' HB2' HD22 ' A' ' 23' ' ' LEU . 34.2 t -86.45 80.75 8.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.946 HG21 ' CE3' ' A' ' 7' ' ' TRP . 3.3 m -84.22 141.17 31.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -143.73 164.51 30.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.678 -1.264 . . . . 0.0 110.038 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.874 ' HB2' HG22 ' A' ' 39' ' ' VAL . 13.5 m-85 -131.13 -171.67 2.64 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.6 pt-20 -107.02 -23.97 12.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.964 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.854 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.4 m120 -140.25 147.04 39.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.927 -1.108 . . . . 0.0 109.884 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 64' ' ' ALA . . . -55.67 -31.15 57.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.57 -76.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -1.152 . . . . 0.0 108.005 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.591 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -33.83 -33.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.373 0.606 . . . . 0.0 109.753 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.028 HG21 ' CG1' ' A' ' 9' ' ' VAL . 63.1 t -60.84 -59.11 4.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 121.381 -0.824 . . . . 0.0 109.203 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.984 HD12 ' N ' ' A' ' 41' ' ' ALA . 1.6 pp -62.08 -17.46 57.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.572 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.984 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -68.01 -35.95 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.36 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.764 HD21 HD11 ' A' ' 51' ' ' LEU . 3.9 mm? -66.31 -7.82 21.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.75 60.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.5 m -100.25 26.78 6.19 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.1 mptt 71.88 139.5 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.631 0.729 . . . . 0.0 110.263 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.95 ' CG2' HD22 ' A' ' 76' ' ' LEU . 2.6 t -71.25 -177.0 0.42 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.585 -0.697 . . . . 0.0 109.496 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HB2' HD12 ' A' ' 5' ' ' ILE . 36.5 Cg_endo -114.94 -67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.799 1.42 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.665 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -121.27 -53.5 2.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.846 -1.159 . . . . 0.0 110.527 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.958 HG12 HG23 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.12 129.08 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.552 -1.342 . . . . 0.0 110.206 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.963 HD22 ' NE2' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.59 128.88 46.5 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.585 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.89 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 3.3 pp -141.39 165.84 26.4 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.753 -1.217 . . . . 0.0 110.008 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.604 ' N ' HD12 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -133.99 151.08 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' SD ' ' A' ' 81' ' ' MET . 4.4 t70 -115.91 129.4 56.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.8 144.89 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.62 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -179.3 -65.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.419 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -45.5 151.89 0.72 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.613 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -99.84 163.6 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.055 1.555 . . . . 0.0 110.207 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.86 -167.47 22.75 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.1 mmt -64.17 -32.61 74.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -1.079 . . . . 0.0 109.585 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.04 92.44 3.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.95 -45.27 7.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.97 HD11 HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -50.54 -83.12 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.136 -1.214 . . . . 0.0 109.402 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' A' ' 9' ' ' VAL . . . 168.67 35.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER 57.56 62.33 2.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 80' ' ' ILE . 15.9 tp -75.35 -13.22 60.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.997 . . . . 0.0 108.891 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -78.08 -38.95 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.592 ' HG3' HD23 ' A' ' 40' ' ' LEU . 2.1 pt20 -76.74 -52.67 9.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.065 -1.022 . . . . 0.0 108.51 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.69 HG21 HD12 ' A' ' 66' ' ' LEU . 2.9 tt -37.58 -34.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.812 0.815 . . . . 0.0 109.313 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 7.5 tptp -78.03 -54.52 6.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.98 -46.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.543 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 1.4 tpt85 -87.59 -43.44 11.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.192 -0.942 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.963 ' NE2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -40.45 162.65 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.437 -0.789 . . . . 0.0 110.341 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD2' HD23 ' A' ' 76' ' ' LEU . 37.0 Cg_endo -117.71 42.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 124.03 1.542 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.4 mtt 66.03 82.83 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 0.0 110.579 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.95 HD22 ' CG2' ' A' ' 47' ' ' THR . 1.0 OUTLIER -147.82 151.23 38.15 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 50' ' ' VAL . 36.8 Cg_endo -37.59 126.77 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.61 1.321 . . . . 0.0 111.691 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 99' ' ' PHE . 84.1 t -117.91 100.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.589 -0.694 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.89 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 1.7 mt -75.7 157.54 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 108.739 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.97 HD11 HD11 ' A' ' 63' ' ' LEU . 7.3 tt -154.15 123.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.028 -1.045 . . . . 0.0 110.569 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.516 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 15.9 mtt -97.89 99.76 11.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 58.13 161.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . . . -172.95 -175.36 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.961 -1.087 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.537 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.5 t-80 -167.49 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.934 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.537 ' C ' ' O ' ' A' ' 84' ' ' HIS . 21.7 m 40.26 31.83 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 88' ' ' ASP . 3.1 m-20 63.43 126.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 91' ' ' VAL . 3.8 tp -35.83 -31.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -38.02 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.485 0.659 . . . . 0.0 109.584 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.497 ' HB3' ' CB ' ' A' ' 85' ' ' SER . . . -47.59 -32.14 5.18 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -69.36 -87.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.329 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.869 HG23 ' HG ' ' A' ' 87' ' ' LEU . 91.2 t -33.18 -59.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.719 -0.613 . . . . 0.0 111.398 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -55.84 -99.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.356 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 48.4 -105.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.872 -1.143 . . . . 0.0 108.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -141.82 60.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 0.0 108.791 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 8.1 mm-40 -57.31 174.23 0.21 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.605 -0.685 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 27.7 mt-30 64.12 50.42 2.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.98 -120.22 0.54 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.68 89.0 2.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -1.187 . . . . 0.0 109.474 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.58 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 5.5 m-85 -133.39 136.46 45.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 0.0 109.696 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -120.06 -167.86 1.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.047 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.509 ' OH ' ' HB3' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -166.2 94.93 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.735 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.7 OUTLIER -120.64 151.67 54.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.149 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 36.8 Cg_endo -119.36 -173.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.709 1.373 . . . . 0.0 110.594 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HG2' ' CD1' ' A' ' 106' ' ' PHE . 1.2 mtmm -91.27 159.25 39.77 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.335 -0.853 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -87.33 169.76 39.54 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 120.274 -2.803 . . . . 0.0 110.308 0.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.516 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 52.6 p90 -161.97 150.05 14.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . 6.1 t0 -80.19 117.99 21.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.197 -0.94 . . . . 0.0 108.584 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.547 HG21 ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -41.77 -41.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.215 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 108' ' ' ILE . 25.8 t70 -74.48 -38.85 62.79 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.51 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 8.1 tm-20 -51.33 -38.11 51.32 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -81.94 -69.7 0.6 Allowed 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.064 ' CG1' HD22 ' A' ' 28' ' ' LEU . 24.4 t -37.31 -35.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.499 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -78.61 -66.67 0.83 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.982 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.776 HD13 ' C ' ' A' ' 114' ' ' LEU . 3.0 tm? -35.47 -51.72 0.63 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.506 0.67 . . . . 0.0 109.843 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.858 HG21 ' CG1' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -70.45 -51.47 37.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 108.948 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 9.0 tm-20 -33.35 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.523 0.677 . . . . 0.0 109.933 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' VAL . 5.1 mtm180 -76.51 -57.27 3.96 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.62 -54.37 9.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -0.973 . . . . 0.0 109.065 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.691 HG23 ' HG3' ' A' ' 77' ' ' PRO . 6.2 mt -39.77 -44.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 110.793 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -86.34 -22.6 26.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 120' ' ' SER . 63.1 t60 -37.94 -55.5 1.22 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.427 -0.796 . . . . 0.0 110.649 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.631 ' O ' ' CG ' ' A' ' 122' ' ' TYR . 3.9 p90 -91.05 48.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -73.26 -28.65 62.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.796 -1.19 . . . . 0.0 109.296 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 7.5 tpp180 . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 1.047 ' HA3' HD22 ' A' ' 28' ' ' LEU . . . -167.21 50.11 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 48' ' ' PRO . 3.6 mt -76.64 91.55 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.088 -1.242 . . . . 0.0 107.977 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.718 ' CG2' HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -100.78 123.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.433 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.708 ' CE3' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.1 87.91 4.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.018 HG22 ' HB2' ' A' ' 52' ' ' LEU . 29.9 t -84.95 146.06 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.877 . . . . 0.0 110.545 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' LEU . 8.9 t -91.64 153.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.875 ' CG ' HG21 ' A' ' 15' ' ' ILE . 9.5 t0 -179.31 -124.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.961 -1.087 . . . . 0.0 110.003 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.514 ' CA ' ' HA ' ' A' ' 34' ' ' GLU . 1.4 t70 -128.22 -8.45 5.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.602 -1.311 . . . . 0.0 110.547 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.575 ' HB2' ' N ' ' A' ' 34' ' ' GLU . 2.1 t70 48.87 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 70.01 13.44 7.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.3 p 161.62 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.875 HG21 ' CG ' ' A' ' 10' ' ' ASP . 33.0 mm -82.27 -38.34 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 108.958 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 32' ' ' THR . 12.2 ttp85 -65.67 -35.13 79.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -66.4 -62.63 1.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 14' ' ' SER . 53.4 t -40.32 -64.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.906 ' CD2' HD11 ' A' ' 108' ' ' ILE . 2.8 mt -60.24 -75.58 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.68 -0.637 . . . . 0.0 110.944 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 18.8 tt0 -34.88 -31.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.736 -0.602 . . . . 0.0 110.612 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -67.07 -56.4 10.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -13.04 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.821 HD12 ' HB2' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -82.39 -27.17 32.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.42 73.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.42 -0.8 . . . . 0.0 109.185 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.72 -27.06 39.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.73 -16.97 60.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -1.07 . . . . 0.0 109.233 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.697 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 72.98 38.11 56.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.047 HD22 ' HA3' ' A' ' 4' ' ' GLY . 78.2 mt -137.71 163.3 31.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.942 -1.328 . . . . 0.0 109.887 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 29' ' ' THR . 21.1 m -104.8 79.8 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.489 -0.757 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.672 ' HA ' HG12 ' A' ' 6' ' ' VAL . 44.3 t -80.96 80.44 7.44 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.004 -1.06 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.1 m -77.45 129.74 36.12 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.7 p -124.29 133.95 53.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.635 -1.291 . . . . 0.0 110.499 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.008 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.2 m-30 -106.56 145.54 31.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.575 ' N ' ' HB2' ' A' ' 12' ' ' ASP . 1.2 pt-20 -63.03 -8.22 6.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 110.192 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -154.81 138.44 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.787 -1.195 . . . . 0.0 110.399 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.696 ' H ' HD13 ' A' ' 65' ' ' LEU . . . -56.34 -26.16 50.33 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' GLU . 33.9 t-20 -56.28 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.261 -1.14 . . . . 0.0 108.052 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.3 mm-40 -36.14 -46.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 110.774 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.008 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -49.5 -54.19 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.013 -1.054 . . . . 0.0 108.537 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.84 HD11 ' CB ' ' A' ' 72' ' ' ARG . 8.2 tt -64.45 -26.74 68.57 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.757 . . . . 0.0 109.496 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -22.91 62.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.09 -24.05 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.765 ' CD2' HD11 ' A' ' 51' ' ' LEU . 1.3 mp -87.2 -6.87 58.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.88 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.05 -29.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.711 . . . . 0.0 109.319 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -80.88 -46.56 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER 169.91 151.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 110.117 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.708 ' HB ' HD22 ' A' ' 76' ' ' LEU . 5.9 m -87.23 164.36 36.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 108.79 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.9 Cg_endo -103.84 -71.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.611 1.322 . . . . 0.0 111.13 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' OD2' ' CA ' ' A' ' 4' ' ' GLY . 3.0 m-20 -110.75 -75.31 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 0.0 110.542 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.866 HG22 ' HG2' ' A' ' 77' ' ' PRO . 13.1 t -143.7 145.02 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.062 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.765 HD11 ' CD2' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -101.8 124.21 47.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 109.88 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.018 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -108.83 165.99 11.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.222 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -147.8 122.05 9.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 109.644 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -78.0 -171.13 2.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 55' ' ' ILE . 2.6 tp -143.21 79.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.581 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -117.74 -166.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mtt 59.62 83.75 0.21 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.09 120.4 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.944 1.497 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.76 -87.23 0.07 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 ttm -109.94 -91.71 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -1.125 . . . . 0.0 109.429 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.7 m-20 -102.53 1.26 34.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . 152.47 -90.35 0.13 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.884 HD13 HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER 176.64 25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.384 -1.068 . . . . 0.0 110.377 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 56.94 -142.18 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.848 -1.157 . . . . 0.0 109.132 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.884 HD12 HD13 ' A' ' 63' ' ' LEU . 62.9 mt 80.04 -66.76 0.15 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.682 . . . . 0.0 110.535 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 66' ' ' LEU . 2.5 tm? -57.47 -36.03 70.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.584 -1.322 . . . . 0.0 109.251 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -66.11 -30.92 71.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.643 -1.286 . . . . 0.0 107.663 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.677 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -69.08 -65.26 0.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.805 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -37.4 -24.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 111.494 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 68' ' ' GLN . 3.1 tptt -89.24 -69.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.274 -1.517 . . . . 0.0 109.277 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -34.93 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.683 -0.636 . . . . 0.0 112.01 -178.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.84 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.31 -68.7 0.86 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.545 -1.347 . . . . 0.0 111.777 -178.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.658 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 77.6 m80 -33.55 152.12 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.197 0 O-C-N 121.536 -0.728 . . . . 0.0 110.698 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -59.08 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.987 1.519 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.41 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.848 -1.158 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.708 HD22 ' HB ' ' A' ' 47' ' ' THR . 0.5 OUTLIER -146.31 -176.2 0.53 Allowed Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.866 ' HG2' HG22 ' A' ' 50' ' ' VAL . 36.0 Cg_endo -78.73 143.0 18.35 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 117.292 -1.338 . . . . 0.0 111.512 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -137.15 158.0 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.579 HG21 HD12 ' A' ' 102' ' ' LEU . 4.4 mt -142.6 145.21 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 108.995 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -127.83 138.89 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.87 142.93 49.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -93.99 178.6 5.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 109.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 166.68 -57.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.543 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.98 -52.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -109.47 107.98 18.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.646 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.5 p-10 166.74 -42.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 31.5 tp -35.02 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.247 0.546 . . . . 0.0 110.313 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 86' ' ' ASP . 5.4 t0 -63.51 -72.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -43.71 -47.32 7.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 80' ' ' ILE . . . -62.77 -76.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 72.5 t -33.69 -32.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.818 -0.551 . . . . 0.0 111.125 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' ALA . 5.1 p -92.25 -148.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.98 -1.075 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 94' ' ' TYR . . . 58.72 64.79 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.509 ' CB ' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER 76.39 -0.52 3.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.22 -179.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.6 mt-30 42.47 -97.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' TYR . 3.6 mt-30 -62.74 100.44 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.986 -1.071 . . . . 0.0 109.836 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.96 -121.63 1.01 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.12 72.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -1.21 . . . . 0.0 109.679 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 52.4 m-85 -127.05 136.13 51.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 101' ' ' TYR . 3.7 m-20 -135.78 89.59 2.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -38.34 135.56 0.74 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.652 -0.655 . . . . 0.0 109.995 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.579 HD12 HG21 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -113.33 121.79 36.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -122.3 -177.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.762 1.401 . . . . 0.0 110.578 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -100.63 156.85 34.72 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -96.88 167.61 13.67 Favored 'Cis proline' 0 C--N 1.317 -1.082 0 C-N-CA 120.8 -2.584 . . . . 0.0 110.392 0.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -164.3 146.44 8.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.6 t70 -75.95 144.02 41.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.906 HD11 ' CD2' ' A' ' 19' ' ' LEU . 4.5 tp -60.13 -48.31 88.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.942 -1.099 . . . . 0.0 110.7 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.611 ' N ' HG23 ' A' ' 108' ' ' ILE . 35.7 t0 -69.96 -54.78 11.76 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 108.744 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 9.7 tp10 -46.36 -28.73 1.42 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.96 -78.66 0.09 Allowed 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.504 -0.747 . . . . 0.0 109.328 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.819 ' CG1' HD13 ' A' ' 28' ' ' LEU . 47.5 t -41.42 -60.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 121.368 -0.832 . . . . 0.0 109.692 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -42.33 -62.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.773 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.779 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -35.0 -50.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.686 0.755 . . . . 0.0 109.317 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.767 HG21 HG11 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -59.8 -53.89 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.573 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.9 tt0 -34.48 -41.46 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.376 0.607 . . . . 0.0 110.386 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -61.99 -53.05 60.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.364 -0.835 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -52.32 -54.8 26.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.012 -1.055 . . . . 0.0 108.626 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.862 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.1 mt -36.2 -34.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.426 0.631 . . . . 0.0 110.467 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 118' ' ' ALA . 3.5 t -70.73 22.77 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.389 -0.819 . . . . 0.0 111.983 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' C ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER 53.5 35.84 21.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.353 -1.467 . . . . 0.0 109.572 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.5 OUTLIER 32.21 50.56 0.18 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.575 0.703 . . . . 0.0 110.162 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.99 -25.82 67.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.055 -1.028 . . . . 0.0 109.348 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 28' ' ' LEU . . . 178.75 141.95 4.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.563 HG13 HG21 ' A' ' 29' ' ' THR . 5.2 mp -104.94 103.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.43 -1.041 . . . . 0.0 109.729 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -104.39 128.04 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.545 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -101.57 81.56 2.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 110.608 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.808 ' HB ' HG22 ' A' ' 32' ' ' THR . 42.6 t -72.61 146.6 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 109.539 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 84.1 t -91.72 105.81 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.038 -1.039 . . . . 0.0 109.349 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.566 ' HA ' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -53.79 174.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 2.3 t70 -124.39 -50.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 110.277 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -172.42 94.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 111.271 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 12' ' ' ASP . 1.8 p 57.08 137.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.145 0.974 . . . . 0.0 111.557 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.655 ' N ' ' CE3' ' A' ' 17' ' ' TRP . 5.4 t 61.81 3.67 0.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.387 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 10' ' ' ASP . 21.4 mm -88.21 -54.81 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.184 -1.572 . . . . 0.0 109.286 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -62.69 -36.76 83.96 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.655 ' CE3' ' N ' ' A' ' 14' ' ' SER . 7.9 m-90 -71.27 -55.91 7.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 14' ' ' SER . 2.1 t -39.1 -61.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 122.057 0.932 . . . . 0.0 109.795 -177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.3 mm? -55.95 -70.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.59 -0.694 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -35.56 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.5 tmt_? -68.12 -56.52 8.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.94 -6.72 34.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.054 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.866 HD11 HG21 ' A' ' 112' ' ' VAL . 1.5 mm? -101.91 -9.11 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.67 -52.57 6.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.317 -0.865 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.48 71.43 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.42 74.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.437 -1.037 . . . . 0.0 108.809 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.37 57.73 1.34 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.857 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -140.97 179.7 6.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.073 -1.251 . . . . 0.0 110.347 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.563 HG21 HG13 ' A' ' 5' ' ' ILE . 16.4 m -103.4 83.44 2.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.503 ' HB2' ' CG ' ' A' ' 23' ' ' LEU . 19.1 t -92.64 92.54 8.05 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.17 -0.956 . . . . 0.0 110.807 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.545 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -94.18 144.87 25.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.808 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.3 p -149.96 129.25 12.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.702 -1.248 . . . . 0.0 110.258 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.66 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.6 m-85 -111.81 127.33 55.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.272 -0.892 . . . . 0.0 109.133 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HA ' ' CB ' ' A' ' 10' ' ' ASP . 1.9 pt-20 -47.63 -19.59 0.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.49 -0.756 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -131.85 132.98 44.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.503 -1.373 . . . . 0.0 111.098 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -61.78 -18.4 56.6 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.461 ' HA ' ' CD ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -68.25 -80.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.088 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -35.53 -45.86 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.848 -0.533 . . . . 0.0 110.321 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.5 OUTLIER -58.05 -52.22 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.215 -0.928 . . . . 0.0 108.995 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.9 tm? -63.52 -17.29 62.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -84.47 -25.91 28.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.13 -35.51 64.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.087 HD13 ' NE2' ' A' ' 73' ' ' HIS . 4.7 mt -72.36 -102.97 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 81.61 -40.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.122 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 70.7 m -98.99 -40.19 8.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -0.932 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.4 OUTLIER 168.06 150.09 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.096 -1.002 . . . . 0.0 108.969 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.584 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -87.37 165.81 28.94 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.255 -0.903 . . . . 0.0 109.417 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.54 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -89.27 -66.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.234 1.649 . . . . 0.0 110.319 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.755 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -109.85 -75.32 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.785 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -149.99 151.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 0.0 109.964 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.983 HD12 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -99.88 134.57 42.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.85 148.16 49.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.941 -1.099 . . . . 0.0 109.147 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.47 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t -134.66 126.4 29.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.094 -1.003 . . . . 0.0 110.428 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 m-20 -73.27 -179.93 3.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 109.173 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.578 HG21 ' O ' ' A' ' 82' ' ' THR . 0.7 OUTLIER 176.89 38.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.21 11.09 10.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.96 . . . . 0.0 109.248 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ASP . 5.9 mmt -38.08 140.51 0.57 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.3 Cg_endo -49.42 122.92 9.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.07 1.563 . . . . 0.0 110.631 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 44.39 -126.06 6.24 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 ptt? -70.44 -146.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.399 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 57' ' ' MET . 31.1 m-20 63.14 100.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 109.802 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -153.07 90.67 0.13 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.933 HD11 HD11 ' A' ' 65' ' ' LEU . 1.2 pt? -38.32 147.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.912 . . . . 0.0 110.429 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.954 ' HB1' ' HD3' ' A' ' 67' ' ' LYS . . . -90.97 122.95 34.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.933 HD11 HD11 ' A' ' 63' ' ' LEU . 5.1 mt -134.21 -43.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.535 ' HA ' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -41.25 -51.01 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.464 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.954 ' HD3' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -43.66 -50.02 7.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 6.3 pt20 -69.97 -43.09 72.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.616 -1.302 . . . . 0.0 109.429 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.587 HG21 HG11 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -37.48 -52.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 109.606 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -73.14 -57.96 3.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.851 -0.531 . . . . 0.0 110.417 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.41 -36.41 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.843 -0.536 . . . . 0.0 110.939 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.913 ' HB2' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -101.99 -30.84 10.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.694 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 1.087 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.21 -177.77 0.32 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.855 ' HD2' HD23 ' A' ' 76' ' ' LEU . 36.6 Cg_endo -113.73 39.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.162 1.612 . . . . 0.0 109.598 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 5.8 mmt 63.17 73.24 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.855 HD23 ' HD2' ' A' ' 74' ' ' PRO . 3.0 pp -130.61 176.9 2.51 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 108.886 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.638 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 36.2 Cg_endo -68.26 129.29 18.95 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.184 1.097 . . . . 0.0 112.778 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.983 HG13 ' HB3' ' A' ' 51' ' ' LEU . 45.7 t -134.42 100.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 100' ' ' ASP . 15.4 mm -80.43 160.52 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.03 -1.044 . . . . 0.0 111.055 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 80' ' ' ILE . 3.9 mp -139.71 136.19 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.519 -0.738 . . . . 0.0 109.31 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.508 ' O ' HG22 ' A' ' 55' ' ' ILE . 1.2 ttm -81.27 89.87 6.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.27 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.578 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 65.77 -177.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 109.201 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.477 ' H ' HG22 ' A' ' 82' ' ' THR . . . 179.54 142.92 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.004 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -146.33 36.82 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.1 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.86 -32.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.573 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.74 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 46.4 t0 -76.49 -17.62 59.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 109.571 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.3 mt -34.44 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.702 -0.624 . . . . 0.0 110.525 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 86' ' ' ASP . 16.5 t0 -62.85 -57.85 9.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.018 . . . . 0.0 109.746 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . . . -60.55 -57.24 13.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -52.02 -66.78 0.32 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -0.951 . . . . 0.0 109.8 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 87' ' ' LEU . 47.8 t -33.7 -31.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.98 -0.45 . . . . 0.0 111.042 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.703 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 32.6 t -95.48 170.69 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 109.897 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 78.0 74.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.82 -86.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.512 ' HG3' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 66.39 31.49 8.22 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.389 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -125.65 16.19 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 161.9 151.11 6.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . 69.43 34.03 2.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 20.3 m-85 -152.16 29.93 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.542 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -55.38 124.84 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.03 137.04 38.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.803 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -110.64 111.05 57.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -104.91 144.21 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.38 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.39 151.54 87.26 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.315 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -81.32 175.53 41.93 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.52 -2.7 . . . . 0.0 110.517 -0.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -159.5 136.31 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 17.5 t0 -76.05 -176.75 3.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 108.551 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.49 -49.48 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.639 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 26.2 t70 -69.36 -45.84 68.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 108.53 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.3 tp10 -51.1 -37.08 43.76 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.06 -70.22 0.37 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.379 -0.826 . . . . 0.0 108.81 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.866 HG21 HD11 ' A' ' 23' ' ' LEU . 39.1 t -36.45 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.744 -0.597 . . . . 0.0 110.396 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -51.32 -61.22 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 110.45 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 113' ' ' ALA . 47.6 tp -34.47 -58.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.331 0.586 . . . . 0.0 110.174 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.701 HG22 HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -59.66 -56.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.623 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.0 tm-20 -35.59 -31.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.185 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtm180 -82.63 -56.37 3.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.632 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.18 -61.33 1.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 108.734 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.785 ' CD1' HG23 ' A' ' 50' ' ' VAL . 9.6 mt -35.43 -44.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.805 -0.559 . . . . 0.0 110.55 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.74 56.62 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.91 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 34.5 t-80 -117.73 0.28 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.393 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -99.56 9.98 42.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.262 -0.899 . . . . 0.0 109.606 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 22.8 mt-30 -90.53 40.78 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 29.0 tt0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.49 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.956 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -167.61 149.5 14.74 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.839 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.827 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -101.46 110.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.616 -0.932 . . . . 0.0 109.859 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -113.86 119.09 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 1.178 ' CE3' HG21 ' A' ' 31' ' ' THR . 10.5 m95 -101.04 88.45 3.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.656 -1.278 . . . . 0.0 109.235 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.048 HG22 ' CB ' ' A' ' 52' ' ' LEU . 48.4 t -82.77 153.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.528 -0.732 . . . . 0.0 110.45 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.06 HG22 HG21 ' A' ' 39' ' ' VAL . 93.5 t -96.58 106.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -63.22 156.31 25.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 109.147 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -102.92 -29.8 11.2 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.659 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 1.7 m-20 -124.51 169.66 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.905 -1.122 . . . . 0.0 110.229 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -67.07 -3.12 6.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.895 -1.128 . . . . 0.0 110.64 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 t -121.3 8.85 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.799 -1.188 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.509 HG22 ' HB2' ' A' ' 10' ' ' ASP . 16.1 mm -78.88 -35.24 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.909 -1.119 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -49.58 77.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.541 ' CZ2' ' NH2' ' A' ' 21' ' ' ARG . 19.0 t90 -53.86 -64.4 0.84 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.2 t -37.48 -65.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.636 0.731 . . . . 0.0 110.698 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -50.39 -79.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 111.002 -178.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.8 tt0 -33.68 -33.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.826 -0.546 . . . . 0.0 110.947 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' NH2' ' CZ2' ' A' ' 17' ' ' TRP . 2.5 tpp85 -66.84 -57.16 7.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 0.0 109.037 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.617 ' CB ' HG21 ' A' ' 108' ' ' ILE . . . -71.97 -4.31 27.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.347 -0.846 . . . . 0.0 109.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.907 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -100.11 -18.62 16.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.48 -43.5 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.94 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.22 62.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -1.071 . . . . 0.0 109.013 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.7 47.88 4.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.956 HD23 ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -127.87 179.57 5.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.073 -1.251 . . . . 0.0 110.097 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.763 HG21 ' CG2' ' A' ' 5' ' ' ILE . 53.9 m -99.97 86.04 3.18 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 31.3 t -82.37 92.13 6.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.474 -0.767 . . . . 0.0 110.399 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.178 HG21 ' CE3' ' A' ' 7' ' ' TRP . 24.3 m -89.55 124.1 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 34.2 p -127.01 151.31 48.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.06 -1.025 . . . . 0.0 110.125 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.061 ' HB2' HG22 ' A' ' 39' ' ' VAL . 7.8 m-85 -143.14 119.07 10.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.48 -0.763 . . . . 0.0 109.207 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -54.16 -27.82 36.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.167 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.828 ' O ' HG23 ' A' ' 39' ' ' VAL . 18.1 m120 -109.45 125.33 52.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 110.39 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . -57.78 -46.72 91.98 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 38' ' ' GLU . 58.3 t-20 -53.62 -71.93 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.159 -1.201 . . . . 0.0 108.811 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -34.23 -38.05 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.878 -0.514 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.061 HG22 ' HB2' ' A' ' 33' ' ' PHE . 48.8 t -53.15 -59.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.764 HD23 ' NE2' ' A' ' 68' ' ' GLN . 3.9 mm? -62.57 -21.78 65.86 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -65.99 -36.68 83.97 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.67 36.29 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 43' ' ' LEU . 2.5 tm? -56.95 -19.84 20.29 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.48 -40.25 12.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 109.22 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -62.31 -39.81 94.27 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.085 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 99.33 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.351 0.596 . . . . 0.0 110.583 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.494 HG21 HD21 ' A' ' 51' ' ' LEU . 34.5 p -65.15 169.53 5.59 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HG2' ' CG1' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -129.89 -15.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 116.263 -2.025 . . . . 0.0 113.007 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -94.4 -71.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 119.867 -1.771 . . . . 0.0 110.912 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.753 HG21 HG13 ' A' ' 115' ' ' VAL . 11.3 t -163.78 144.36 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 110.168 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -101.92 125.27 48.56 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.779 178.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.048 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -113.18 160.12 18.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -153.42 131.22 11.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.397 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.581 ' O ' HD21 ' A' ' 63' ' ' LEU . 7.7 t0 -92.43 144.06 25.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.807 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -88.31 82.74 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.096 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 6.5 tpt180 178.57 128.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 108.919 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.539 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -174.18 157.61 2.59 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 57' ' ' MET . 36.2 Cg_endo -63.4 155.9 59.49 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.784 1.412 . . . . 0.0 110.298 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.23 10.82 27.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 61.14 -177.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -1.098 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.72 -146.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' O ' ' CG ' ' A' ' 57' ' ' MET . . . -107.98 -111.27 3.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.762 ' HB2' HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -130.74 -46.03 1.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -1.11 . . . . 0.0 109.413 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 63' ' ' LEU . . . 77.36 64.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.817 . . . . 0.0 109.762 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.861 HD12 HE22 ' A' ' 68' ' ' GLN . 1.0 OUTLIER -149.42 14.94 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.922 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 1.2 mm? -65.21 -40.76 94.58 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -25.82 62.89 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.861 HE22 HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.37 -58.68 7.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.3 mp -37.71 -69.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.563 -0.71 . . . . 0.0 110.452 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -48.28 -69.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.987 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 12.3 mt-30 -34.77 -31.83 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.408 0.623 . . . . 0.0 110.428 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.762 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -108.64 -81.29 0.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.73 ' NE2' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -35.78 140.33 0.36 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.313 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.522 ' HD2' ' ND1' ' A' ' 73' ' ' HIS . 36.8 Cg_endo -59.49 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.104 1.581 . . . . 0.0 110.278 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.5 ptp 178.96 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 4.2 pp -115.95 146.61 37.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 32.8 Cg_endo -33.43 137.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.893 1.47 . . . . 0.0 112.626 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -131.13 106.8 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 16.0 mm -91.64 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.519 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 53' ' ' SER . 53.4 mt -150.22 145.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.496 ' O ' ' HB ' ' A' ' 82' ' ' THR . 1.2 mpp? -78.79 136.94 37.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 91.3 m 67.18 -83.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.559 -0.713 . . . . 0.0 110.021 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 82' ' ' THR . . . 83.93 95.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.585 -0.697 . . . . 0.0 109.171 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 86' ' ' ASP . 29.8 t60 -136.0 -87.51 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.952 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 46.67 36.66 3.88 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -178.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 88' ' ' ASP . 14.5 t0 66.11 128.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.872 HD12 HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -36.47 -31.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -36.89 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.519 0.676 . . . . 0.0 109.71 176.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.952 ' HB3' ' HB2' ' A' ' 85' ' ' SER . . . -51.7 -34.36 38.32 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.463 -0.773 . . . . 0.0 109.16 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.658 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -59.06 -80.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.062 -1.024 . . . . 0.0 109.618 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.872 HG23 HD12 ' A' ' 87' ' ' LEU . 33.3 t -14.26 -54.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 122.763 0.425 . . . . 0.0 111.987 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.658 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 4.3 t -79.53 -149.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.926 -1.109 . . . . 0.0 109.766 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 72.96 36.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.902 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 61.69 57.21 2.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.09 -1.006 . . . . 0.0 109.529 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -75.54 150.96 38.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 19.2 tt0 56.42 22.17 6.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.135 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.43 -46.83 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . -157.52 54.9 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.243 . . . . 0.0 109.985 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.29 122.5 12.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 101' ' ' TYR . 38.7 t70 -113.1 6.77 17.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.053 -1.03 . . . . 0.0 110.354 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 2.4 m-85 46.88 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.066 -1.022 . . . . 0.0 109.106 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -91.89 137.62 25.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.0 110.018 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 37.4 Cg_endo -127.54 177.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.643 1.339 . . . . 0.0 110.048 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.42 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -93.29 159.53 35.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.265 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -79.59 172.79 57.37 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.655 -2.644 . . . . 0.0 110.492 0.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 10.7 p90 -156.05 133.8 11.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.363 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 18.3 t0 -81.16 -162.39 0.49 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 108.703 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.617 HG21 ' CB ' ' A' ' 22' ' ' ALA . 36.0 mm -106.67 -65.01 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 109.208 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -57.65 -51.91 67.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.9 tp10 -43.55 -38.2 2.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.74 -73.71 0.18 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.907 HG21 HD11 ' A' ' 23' ' ' LEU . 38.4 t -37.24 -69.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.513 -0.742 . . . . 0.0 110.233 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -45.29 -63.14 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 110.441 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.3 tm? -35.29 -50.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.689 0.756 . . . . 0.0 109.524 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.753 HG13 HG21 ' A' ' 50' ' ' VAL . 1.2 t -60.18 -57.01 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.624 ' N ' HG12 ' A' ' 115' ' ' VAL . 3.4 tt0 -34.02 -39.42 0.07 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.198 0.523 . . . . 0.0 110.288 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtp85 -71.72 -52.0 19.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 109.25 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -49.09 -56.46 9.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.188 -0.945 . . . . 0.0 108.6 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.534 HG12 ' CG2' ' A' ' 50' ' ' VAL . 5.4 mt -35.27 -41.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.336 0.589 . . . . 0.0 109.774 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -88.03 53.33 2.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.153 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 6.9 t-80 -94.93 -5.73 44.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.607 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -85.64 19.8 2.32 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.235 -0.916 . . . . 0.0 109.822 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.2 -16.05 25.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.579 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.561 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 116' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.639 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 166.87 153.1 7.7 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.051 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.901 HG23 ' HB ' ' A' ' 29' ' ' THR . 1.9 mt -124.17 131.52 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.159 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.777 ' CG1' HG23 ' A' ' 8' ' ' VAL . 1.9 t -126.74 113.07 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 108.796 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.84 ' O ' HD13 ' A' ' 51' ' ' LEU . 9.2 m95 -99.9 86.9 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.425 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.041 HG22 ' HB2' ' A' ' 52' ' ' LEU . 48.7 t -84.09 159.82 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 111.076 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 65' ' ' LEU . 14.3 t -95.1 121.76 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.917 ' OD2' HG22 ' A' ' 15' ' ' ILE . 8.3 m-20 -109.07 -169.98 1.58 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.19 -0.943 . . . . 0.0 110.0 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' CG ' ' HG3' ' A' ' 57' ' ' MET . 51.8 t0 -100.87 -57.13 2.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.446 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -130.73 173.74 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 109.845 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.562 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -58.71 -41.74 87.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.958 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -28.36 34.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 108.986 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.917 HG22 ' OD2' ' A' ' 10' ' ' ASP . 43.7 mm -71.38 -40.35 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.0 -49.46 71.43 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 27.0 t90 -55.22 -59.68 4.45 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.0 t -36.18 -70.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.5 tp -55.41 -72.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.423 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 10.3 tm-20 -34.89 -30.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.795 -0.566 . . . . 0.0 110.969 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -68.45 -55.94 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.243 -0.911 . . . . 0.0 108.57 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 108' ' ' ILE . . . -72.1 -4.76 30.87 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 112' ' ' VAL . 0.4 OUTLIER -100.22 -12.75 19.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.421 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.8 -43.48 68.57 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.81 97.48 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.27 67.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.03 49.37 4.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.078 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -130.14 178.12 6.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.878 -1.366 . . . . 0.0 110.165 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.901 ' HB ' HG23 ' A' ' 5' ' ' ILE . 96.6 m -97.9 77.84 2.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 40.5 t -76.09 88.31 3.0 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.931 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.716 HG21 ' CD2' ' A' ' 7' ' ' TRP . 13.0 m -100.51 127.09 46.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.201 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 16' ' ' ARG . 43.9 p -119.06 161.01 20.98 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 109.27 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.827 ' CG ' HG23 ' A' ' 39' ' ' VAL . 2.0 m-85 -134.37 105.81 6.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' N ' ' A' ' 13' ' ' SER . 1.1 mp0 -41.94 -31.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.537 -0.727 . . . . 0.0 109.777 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -106.91 126.21 52.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.865 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -65.17 -57.35 11.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 26.5 t-20 -51.37 -66.52 0.37 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.772 -1.428 . . . . 0.0 108.956 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.55 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.5 tt0 -33.52 -53.16 0.41 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.855 -0.528 . . . . 0.0 111.465 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.92 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -58.3 -52.86 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.725 -1.235 . . . . 0.0 109.498 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.92 HD12 ' CG1' ' A' ' 39' ' ' VAL . 8.5 mp -62.34 -14.7 42.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -77.2 -37.68 53.05 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.37 1.09 48.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.774 HD11 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.11 -6.16 54.07 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.323 -0.86 . . . . 0.0 109.439 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -10.38 52.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 109.59 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.7 m -97.39 1.04 48.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HG3' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 65.33 90.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.847 . . . . 0.0 109.611 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.597 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.6 m -99.25 -72.97 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.082 -1.011 . . . . 0.0 109.847 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 38.7 Cg_endo -75.65 -162.72 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.488 1.257 . . . . 0.0 110.411 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.929 ' O ' HD13 ' A' ' 76' ' ' LEU . 2.8 p30 -110.81 -14.93 13.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.874 HG21 HG13 ' A' ' 115' ' ' VAL . 4.3 t -144.89 129.11 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.521 -0.737 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -100.42 158.4 15.92 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.041 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -146.84 157.1 43.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.072 -1.018 . . . . 0.0 110.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.883 ' CB ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -134.05 123.87 25.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 109.729 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.771 ' O ' HG22 ' A' ' 55' ' ' ILE . 27.1 m-20 -62.5 -51.93 65.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 109.779 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.906 HG21 ' HB ' ' A' ' 82' ' ' THR . 2.2 tp 83.96 26.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.326 0.584 . . . . 0.0 109.454 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 57' ' ' MET . 17.3 ptm180 -113.67 -138.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.217 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.485 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.8 ttm 70.57 128.96 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.865 -1.147 . . . . 0.0 109.301 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -89.23 173.33 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.326 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.63 -66.87 0.96 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -91.17 29.62 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -1.194 . . . . 0.0 109.527 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t0 52.48 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -138.02 83.79 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.2 mp -35.91 132.62 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.907 -0.76 . . . . 0.0 110.127 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -49.88 -80.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.014 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.0 OUTLIER 79.09 -35.93 0.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 110.529 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 89' ' ' ALA . 13.5 tp -77.0 -62.11 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.405 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -50.71 -40.29 53.81 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.679 ' CG ' HD22 ' A' ' 40' ' ' LEU . 3.7 tp-100 -57.96 -56.76 17.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.014 HD12 ' O ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -35.92 -53.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.37 0.605 . . . . 0.0 109.908 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 72' ' ' ARG . 11.3 mtmm -60.04 -63.0 1.45 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.928 -1.107 . . . . 0.0 109.609 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.96 -34.37 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.775 -0.578 . . . . 0.0 110.959 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -122.51 -68.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.066 -1.021 . . . . 0.0 109.656 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -40.07 160.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.37 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 36.8 Cg_endo -92.95 -96.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.899 1.473 . . . . 0.0 110.15 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.4 mtm -147.56 2.36 0.73 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.875 -1.14 . . . . 0.0 110.881 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.929 HD13 ' O ' ' A' ' 49' ' ' ASP . 2.5 pp -61.81 134.89 94.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 120.596 -1.315 . . . . 0.0 108.104 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.848 ' HG2' HG22 ' A' ' 50' ' ' VAL . 32.1 Cg_endo -28.94 145.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 124.176 1.619 . . . . 0.0 112.487 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.619 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 21.5 t -147.45 95.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.723 -0.611 . . . . 0.0 109.388 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 19.1 mt -75.63 136.38 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.951 -1.093 . . . . 0.0 110.635 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.89 HD12 ' CB ' ' A' ' 83' ' ' ALA . 4.0 pt -126.79 115.19 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.011 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -66.97 129.52 40.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.169 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.906 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.3 m 71.98 -78.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.717 . . . . 0.0 109.922 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.89 ' CB ' HD12 ' A' ' 80' ' ' ILE . . . 66.06 129.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 109.508 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.766 ' HA ' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -178.82 -79.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.6 t 44.59 41.04 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 69.75 131.51 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -175.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.836 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 1.7 mm? -36.35 -28.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.042 0.925 . . . . 0.0 109.104 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -35.88 -63.55 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.891 ' O ' HD23 ' A' ' 66' ' ' LEU . . . -81.18 -32.49 33.56 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 108.929 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -63.68 -67.23 0.45 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 109.033 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.75 -53.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 C-N-CA 122.779 0.432 . . . . 0.0 111.611 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.733 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -61.8 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.998 -1.064 . . . . 0.0 109.088 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 79.18 -75.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.076 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' VAL . 22.5 p90 -78.79 5.76 10.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.055 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.69 -26.97 60.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 109.286 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER 163.24 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -0.827 . . . . 0.0 109.384 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.15 -146.2 8.88 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . . . -138.88 67.6 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -1.126 . . . . 0.0 109.652 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 41.3 p90 170.66 -177.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -150.7 -176.01 5.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.272 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 83' ' ' ALA . 5.0 m-30 -81.71 130.22 34.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.252 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -114.61 115.91 43.88 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 0.0 109.404 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -117.06 171.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.875 1.46 . . . . 0.0 110.415 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 16.5 mttm -63.03 157.96 58.03 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 109.402 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 37.3 Cg_endo -79.07 161.54 88.29 Favored 'Cis proline' 0 C--N 1.315 -1.225 0 C-N-CA 120.539 -2.692 . . . . 0.0 109.905 -0.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 1.8 p90 -143.26 129.5 19.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.5 t70 -91.28 -147.25 0.21 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.062 -1.024 . . . . 0.0 108.748 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.721 HG22 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -119.18 -69.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.721 ' N ' HG22 ' A' ' 108' ' ' ILE . 13.7 t70 -62.16 -42.67 99.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.6 tm-20 -46.23 -45.7 17.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.79 -77.04 0.09 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.078 HG11 HD13 ' A' ' 28' ' ' LEU . 65.2 t -38.39 -71.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 110.155 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.59 -65.4 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.961 -0.462 . . . . 0.0 110.27 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' ALA . 13.5 tp -34.76 -49.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.826 0.822 . . . . 0.0 109.507 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.874 HG13 HG21 ' A' ' 50' ' ' VAL . 1.7 t -60.49 -55.81 21.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 115' ' ' VAL . 1.4 tt0 -34.88 -45.79 0.28 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 118' ' ' ALA . 12.5 mtm105 -70.72 -51.74 25.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 109.441 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.24 -67.56 0.27 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.889 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.756 HG21 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mt -36.29 -43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.672 -0.642 . . . . 0.0 110.062 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 121' ' ' HIS . 3.7 t -48.73 -58.2 5.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 120' ' ' SER . 4.9 t60 -42.75 -41.33 3.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.338 -0.851 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.75 49.71 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.493 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.41 28.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.39 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.806 0.812 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.719 ' HA3' HD21 ' A' ' 28' ' ' LEU . . . 161.23 168.59 23.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.667 HG23 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -144.61 104.34 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -1.119 . . . . 0.0 108.315 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' CG1' HG23 ' A' ' 8' ' ' VAL . 2.7 t -120.87 115.95 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.08 . . . . 0.0 110.253 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.82 ' CZ2' HG21 ' A' ' 31' ' ' THR . 0.2 OUTLIER -99.58 80.38 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 0.0 109.34 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 52' ' ' LEU . 9.3 t -68.22 137.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.321 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.714 HG22 HG21 ' A' ' 39' ' ' VAL . 57.4 t -85.67 108.78 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.115 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.587 ' CG ' HG22 ' A' ' 15' ' ' ILE . 71.6 m-20 -87.15 -171.72 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.326 -0.859 . . . . 0.0 109.834 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.75 -87.06 0.14 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.38 -0.825 . . . . 0.0 109.637 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 15' ' ' ILE . 3.1 m-20 -112.05 170.7 7.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.635 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.8 p -49.55 164.72 0.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER 79.73 -8.67 1.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.587 HG22 ' CG ' ' A' ' 10' ' ' ASP . 46.4 mm -92.93 -36.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.973 -1.08 . . . . 0.0 108.398 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 17' ' ' TRP . 15.8 ptt-85 -66.18 -32.59 74.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.609 ' CZ3' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -52.11 -66.34 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 49.6 t -42.49 -53.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.921 0.867 . . . . 0.0 110.072 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.704 ' HG ' HG21 ' A' ' 32' ' ' THR . 2.7 mm? -49.56 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.745 . . . . 0.0 110.343 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 23' ' ' LEU . 2.0 mt-10 -35.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.369 0.604 . . . . 0.0 110.395 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.609 ' HD3' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -62.51 -56.35 18.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.809 -1.182 . . . . 0.0 108.839 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.785 ' HB3' HD13 ' A' ' 108' ' ' ILE . . . -63.5 -20.84 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.795 HD13 ' HB2' ' A' ' 30' ' ' CYS . 19.6 tp -71.67 -25.59 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.84 -0.537 . . . . 0.0 110.165 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.66 73.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.27 -38.47 87.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.41 49.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 109.226 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.76 65.51 3.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.05 HD13 HG11 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -136.43 -177.44 4.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.238 -1.154 . . . . 0.0 110.215 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.667 ' HB ' HG23 ' A' ' 5' ' ' ILE . 32.1 m -104.93 50.96 0.77 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.795 ' HB2' HD13 ' A' ' 23' ' ' LEU . 18.4 t -79.03 87.07 4.83 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.233 0.54 . . . . 0.0 109.579 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.82 HG21 ' CZ2' ' A' ' 7' ' ' TRP . 1.4 m -85.83 170.29 12.54 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 108.66 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.71 HG22 ' HB ' ' A' ' 8' ' ' VAL . 1.1 p -155.18 143.16 20.04 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.4 m-85 -118.44 -168.87 1.61 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.936 -1.103 . . . . 0.0 109.794 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.42 -1.71 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 110.2 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 4.8 m-20 -136.56 127.36 27.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.955 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -48.99 -50.68 26.78 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 39' ' ' VAL . 18.9 t-20 -58.94 -63.67 1.22 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.3 -1.118 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -34.37 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 0.0 110.592 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 33' ' ' PHE . 1.7 t -74.54 -64.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.081 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -59.68 -14.57 14.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.949 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -85.14 -39.58 17.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.175 -0.953 . . . . 0.0 108.469 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.53 74.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.979 HD13 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -65.23 -94.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.498 -0.752 . . . . 0.0 109.135 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 84.0 -63.33 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.427 0.632 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 62.3 p -102.3 -37.88 7.88 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.514 -0.741 . . . . 0.0 109.794 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 149.72 95.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.673 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m -100.32 -74.51 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.853 -1.154 . . . . 0.0 110.475 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.673 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 40.8 Cg_endo -81.2 -162.02 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 116.916 -1.59 . . . . 0.0 109.591 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 119' ' ' ILE . 53.2 p30 -113.43 -12.11 13.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.645 HG21 HG13 ' A' ' 115' ' ' VAL . 2.4 t -155.51 121.75 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.979 HD22 HD13 ' A' ' 43' ' ' LEU . 2.5 tp -99.51 136.05 40.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.041 -1.037 . . . . 0.0 108.631 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.813 ' HB3' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -117.12 174.18 6.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.917 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 91.0 p -149.01 133.97 18.07 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.502 ' OD2' ' CG1' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -95.93 3.92 53.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 110.051 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.737 HG21 ' HB ' ' A' ' 82' ' ' THR . 1.3 tt 28.82 82.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.3 0.572 . . . . 0.0 110.738 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -162.63 73.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.995 -1.066 . . . . 0.0 109.688 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtm -128.26 136.55 29.23 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.98 113.08 2.45 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.062 1.559 . . . . 0.0 110.383 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.62 -160.99 24.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.8 mtt -76.66 -49.5 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.203 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.25 177.06 5.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.217 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.34 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.991 HD13 HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER 178.88 29.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -1.122 . . . . 0.0 110.0 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 43.23 -92.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.96 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.991 HD12 HD13 ' A' ' 63' ' ' LEU . 0.5 OUTLIER 71.72 -82.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.854 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 66' ' ' LEU . 1.1 mm? -37.35 -29.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.123 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.91 -55.02 25.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.04 -41.72 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.153 . . . . 0.0 109.191 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.674 HG22 ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -37.33 -59.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.187 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.674 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.31 -51.53 56.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.903 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -34.39 -36.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.715 -0.615 . . . . 0.0 111.119 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -109.33 -59.18 1.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 0.0 110.313 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.718 ' CD2' HD22 ' A' ' 43' ' ' LEU . 57.1 m170 -39.61 145.35 0.43 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.417 -0.802 . . . . 0.0 110.066 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.555 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 35.1 Cg_endo -87.06 47.32 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.111 1.585 . . . . 0.0 109.868 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.8 mtp 72.41 55.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.61 -0.681 . . . . 0.0 110.241 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 77' ' ' PRO . 1.2 pp -114.8 136.62 22.53 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.056 . . . . 0.0 109.235 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.786 ' O ' HD12 ' A' ' 76' ' ' LEU . 35.6 Cg_endo -40.54 141.91 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.267 1.667 . . . . 0.0 112.994 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -147.5 142.76 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.797 HD11 HG22 ' A' ' 115' ' ' VAL . 8.7 mt -126.12 167.93 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.775 -1.203 . . . . 0.0 110.524 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.616 ' N ' HG22 ' A' ' 79' ' ' ILE . 4.2 tt -149.22 144.11 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 82' ' ' THR . 1.7 mpt? -88.14 65.49 8.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.737 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.1 m 158.1 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' ' 101' ' ' TYR . . . -101.89 46.11 0.94 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.514 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.549 ' H ' HG22 ' A' ' 82' ' ' THR . 0.3 OUTLIER -123.4 -97.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 45.78 27.65 0.48 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 61.23 123.37 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.815 HD12 ' HB3' ' A' ' 90' ' ' ALA . 9.6 tp -39.32 -25.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 108.263 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -36.91 -75.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.064 -1.022 . . . . 0.0 110.234 176.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' SER . . . -68.43 -34.62 76.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.815 ' HB3' HD12 ' A' ' 87' ' ' LEU . . . -56.7 -62.2 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.37 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -27.25 -39.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 122.683 0.393 . . . . 0.0 111.099 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -38.37 -59.6 0.88 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 109.579 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.566 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -44.0 -69.24 0.14 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -51.99 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 93' ' ' ALA . 2.3 mm-40 -176.38 -42.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -136.78 -67.36 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.71 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 156.65 173.9 25.72 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 81.84 -0.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.914 . . . . 0.0 109.899 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 3.8 m-85 -112.81 119.73 39.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.082 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.31 164.39 21.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.819 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.475 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 65.7 m-85 -110.75 94.57 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.143 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.551 ' HB2' ' CG2' ' A' ' 79' ' ' ILE . 1.6 tp -83.1 153.67 66.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -122.68 -174.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.707 1.372 . . . . 0.0 110.501 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -119.14 157.66 50.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -78.81 175.31 47.12 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.887 -2.547 . . . . 0.0 110.562 0.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 106' ' ' PHE . 25.1 p90 -148.68 140.89 24.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.778 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 13.5 t0 -79.49 147.63 32.16 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -72.36 -31.09 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.722 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -82.96 -44.81 14.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 38.8 tt0 -55.46 -39.26 70.12 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.81 -65.9 0.77 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.37 -0.831 . . . . 0.0 109.173 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.05 HG11 HD13 ' A' ' 28' ' ' LEU . 41.0 t -36.5 -57.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.652 . . . . 0.0 110.576 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -58.72 -66.09 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.539 -0.726 . . . . 0.0 110.492 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.3 tp -35.19 -54.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.544 0.687 . . . . 0.0 110.09 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.797 HG22 HD11 ' A' ' 79' ' ' ILE . 27.3 t -56.63 -56.11 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 115' ' ' VAL . 54.9 tt0 -34.91 -42.17 0.15 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.421 0.629 . . . . 0.0 109.917 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' ALA . 22.4 mtp180 -73.57 -54.86 7.19 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.068 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.99 -66.84 0.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.163 -0.961 . . . . 0.0 109.157 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 50' ' ' VAL . 4.1 mt -37.53 -41.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.672 . . . . 0.0 109.932 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 121' ' ' HIS . 6.1 m -46.15 -55.1 7.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.413 -0.805 . . . . 0.0 109.9 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 120' ' ' SER . 14.4 t-160 -38.64 -43.84 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.885 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.78 96.43 4.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.49 40.71 3.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.87 . . . . 0.0 109.334 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.471 ' CG ' ' OXT' ' A' ' 124' ' ' GLU . 35.5 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.226 0.536 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.683 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -174.59 120.64 0.79 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.507 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.83 HD12 ' H ' ' A' ' 5' ' ' ILE . 1.1 mp -106.31 118.03 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.297 . . . . 0.0 108.601 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.67 112.72 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.594 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.45 92.31 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.69 -1.256 . . . . 0.0 108.746 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.88 HG22 ' HB2' ' A' ' 52' ' ' LEU . 57.6 t -83.66 150.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.444 0.64 . . . . 0.0 110.899 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 76.2 t -89.7 122.34 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.978 ' HA ' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.94 143.05 55.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.824 0.821 . . . . 0.0 110.819 -178.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 57' ' ' MET . 5.1 t0 -99.29 -65.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.523 ' O ' ' CG1' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -110.01 174.73 5.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.292 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 14' ' ' SER . 52.0 p -64.45 148.79 49.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 78.25 24.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.884 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.978 HG21 ' HA ' ' A' ' 10' ' ' ASP . 3.2 mm -83.63 -47.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 7.4 mtm180 -53.17 -47.95 68.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.494 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 22.9 t90 -55.51 -61.5 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 17' ' ' TRP . 15.9 t -36.98 -68.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.506 -0.746 . . . . 0.0 110.643 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 21' ' ' ARG . 6.9 mt -59.85 -74.56 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 110.878 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 19' ' ' LEU . 12.2 tt0 -34.56 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.771 -0.581 . . . . 0.0 111.057 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -69.87 -56.39 7.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.998 . . . . 0.0 108.593 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.679 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -72.06 -3.75 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.38 -0.825 . . . . 0.0 108.82 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.04 HD11 HG21 ' A' ' 112' ' ' VAL . 3.1 mm? -103.43 -10.89 18.22 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.392 -0.818 . . . . 0.0 109.522 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.88 -35.11 24.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.31 -36.78 49.46 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -69.4 -34.04 73.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -1.052 . . . . 0.0 108.637 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.26 73.08 1.26 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.04 HD13 HG11 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -146.67 174.61 11.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -1.207 . . . . 0.0 109.935 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.712 ' CG2' HG23 ' A' ' 5' ' ' ILE . 92.7 m -102.98 61.19 0.79 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.569 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . 35.9 t -83.85 96.79 8.89 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.532 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 5.7 m -100.02 154.62 18.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 108.662 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.486 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 p -139.98 158.77 43.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.99 -1.069 . . . . 0.0 109.36 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.895 ' HB2' HG23 ' A' ' 39' ' ' VAL . 6.2 m-85 -135.95 120.56 18.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.602 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 3.0 mt-10 -42.84 -42.86 3.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.966 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -110.05 119.74 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -51.68 -48.96 48.79 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.478 ' O ' ' C ' ' A' ' 38' ' ' GLU . 17.0 t30 -42.53 -71.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -1.045 . . . . 0.0 108.4 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.7 mt-10 -34.51 -42.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.79 -0.568 . . . . 0.0 109.755 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.969 HG12 HD22 ' A' ' 40' ' ' LEU . 1.2 t -58.01 -54.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.887 . . . . 0.0 108.688 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.969 HD22 HG12 ' A' ' 39' ' ' VAL . 3.1 mm? -61.36 -19.28 61.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -75.1 -45.28 42.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.163 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.45 -19.34 59.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.094 HD12 ' CD2' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -80.76 -105.04 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.28 -57.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.74 . . . . 0.0 109.497 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.5 t -100.99 -3.73 28.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.742 ' HE2' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER 83.42 110.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.78 0.8 . . . . 0.0 109.141 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.652 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 21.2 m -104.04 -74.77 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.584 -1.323 . . . . 0.0 111.84 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.715 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 45.4 Cg_endo -55.51 -161.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.441 1.232 . . . . 0.0 109.766 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.909 ' HB2' HD13 ' A' ' 119' ' ' ILE . 8.1 p30 -115.7 -8.4 12.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.182 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.924 HG21 HG13 ' A' ' 115' ' ' VAL . 2.3 t -156.91 123.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.959 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.915 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -100.3 143.97 29.86 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.954 HD22 ' CG2' ' A' ' 79' ' ' ILE . 5.2 mt -123.21 163.86 19.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.765 -1.209 . . . . 0.0 110.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 80' ' ' ILE . 20.4 t -133.01 115.48 15.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.642 ' O ' HG22 ' A' ' 55' ' ' ILE . 8.8 m-20 -60.87 -25.85 66.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.173 -0.955 . . . . 0.0 110.44 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER 49.79 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 108.984 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER 57.05 111.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.025 -1.047 . . . . 0.0 109.361 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.916 ' SD ' HD22 ' A' ' 63' ' ' LEU . 3.6 mtm -157.11 -176.15 0.59 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 109.649 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -103.43 70.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.008 1.53 . . . . 0.0 110.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.61 -155.43 7.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -81.81 127.33 32.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -1.147 . . . . 0.0 109.611 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.46 -92.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 109.537 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -119.51 -111.28 2.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.916 HD22 ' SD ' ' A' ' 57' ' ' MET . 11.4 tp -124.02 -7.06 7.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.66 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 63' ' ' LEU . . . 73.78 50.62 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.77 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.655 HD21 HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -162.17 16.98 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.106 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.4 mm? -70.61 -67.29 0.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.043 -1.036 . . . . 0.0 108.825 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -28.05 3.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.595 ' NE2' ' HB2' ' A' ' 65' ' ' LEU . 1.7 tt0 -57.07 -53.44 58.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.75 ' HA ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.57 -32.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.935 -0.478 . . . . 0.0 110.432 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.9 mmmt -99.15 -65.1 0.98 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.035 -1.041 . . . . 0.0 109.935 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -33.17 -33.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.799 -0.563 . . . . 0.0 110.896 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.565 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -92.5 -68.34 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 1.094 ' CD2' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -126.14 112.03 24.01 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 38.1 Cg_endo -134.05 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.67 1.353 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.545 ' CB ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -131.04 -14.89 3.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.912 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 50' ' ' VAL . 3.7 pp -131.23 167.16 22.96 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.092 -1.005 . . . . 0.0 108.531 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.2 Cg_endo -65.69 159.63 47.42 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.222 1.117 . . . . 0.0 111.247 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -126.48 101.26 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 109.337 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.954 ' CG2' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -65.24 157.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.195 -0.941 . . . . 0.0 109.108 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.581 HD11 ' CD1' ' A' ' 101' ' ' TYR . 6.5 pt -157.11 118.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.64 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.08 138.24 57.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.402 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 103' ' ' PRO . 16.8 m -75.39 121.65 22.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' HG23 ' A' ' 55' ' ' ILE . . . -171.4 40.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.754 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.3 m-70 67.92 110.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 84' ' ' HIS . 12.3 t 156.68 -73.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' ASP . 2.2 p30 -48.22 -28.98 3.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 110.054 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -36.06 -29.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -0.881 . . . . 0.0 111.198 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' ASP . 47.4 m-20 -107.61 -79.87 0.57 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.045 -1.034 . . . . 0.0 110.517 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 92' ' ' SER . . . -36.68 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.405 -0.809 . . . . 0.0 110.355 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 88' ' ' ASP . . . -74.39 -79.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 85.2 t -33.49 -41.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -113.61 -172.21 2.03 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 109.406 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 70.67 68.41 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.778 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.63 65.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 3.2 pt20 -73.87 -125.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.323 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.4 tp60 76.85 69.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.871 -1.143 . . . . 0.0 109.546 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 48.53 -158.38 0.88 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 67.8 20.32 9.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -1.152 . . . . 0.0 109.481 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' O ' ' CE1' ' A' ' 101' ' ' TYR . 1.1 m-85 -151.54 53.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.75 154.24 41.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.209 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 80' ' ' ILE . 1.3 m-85 -108.98 166.87 10.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.22 89.05 24.32 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.847 . . . . 0.0 109.163 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' A' ' 82' ' ' THR . 36.7 Cg_endo -58.94 168.21 4.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.076 1.566 . . . . 0.0 110.971 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -116.02 158.35 42.69 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.771 . . . . 0.0 109.058 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -83.23 169.74 56.67 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.63 -2.654 . . . . 0.0 110.312 0.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 13.7 p90 -149.39 163.1 38.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 109.09 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 5.6 t70 -87.78 -156.21 0.34 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.679 HG21 ' HB3' ' A' ' 22' ' ' ALA . 19.4 mm -120.61 -70.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.857 -1.152 . . . . 0.0 109.606 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' GLU . 9.2 t70 -54.46 -51.18 65.81 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 19.1 tp10 -42.85 -42.27 3.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -67.3 -72.98 0.15 Allowed 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.335 -0.853 . . . . 0.0 108.988 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.04 HG21 HD11 ' A' ' 23' ' ' LEU . 35.8 t -36.86 -68.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.789 -0.57 . . . . 0.0 110.2 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.35 -65.17 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' O ' ' A' ' 113' ' ' ALA . 33.7 tp -35.47 -53.93 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.676 0.751 . . . . 0.0 109.763 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.924 HG13 HG21 ' A' ' 50' ' ' VAL . 1.8 t -56.09 -57.53 8.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.497 ' C ' ' O ' ' A' ' 115' ' ' VAL . 19.3 mt-10 -33.54 -41.94 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.422 0.63 . . . . 0.0 110.187 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.6 mtt-85 -76.04 -54.85 6.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.697 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.2 -63.22 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 108.931 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.909 HD13 ' HB2' ' A' ' 49' ' ' ASP . 7.6 mt -33.84 -44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.152 0.501 . . . . 0.0 110.55 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.22 61.81 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.64 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -106.8 -40.25 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.611 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.0 p90 -120.55 31.01 6.64 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -135.66 36.08 2.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.947 -1.096 . . . . 0.0 109.728 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.578 179.713 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 8.6 tpt180 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.372 0.606 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 165.34 93.95 0.1 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 48' ' ' PRO . 5.8 mt -83.4 93.12 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.401 -1.058 . . . . 0.0 109.671 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.105 HG23 ' CG1' ' A' ' 50' ' ' VAL . 8.5 p -96.1 122.48 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.722 -0.611 . . . . 0.0 109.412 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.81 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.71 102.97 14.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.686 -1.259 . . . . 0.0 109.047 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.01 HG22 ' CB ' ' A' ' 52' ' ' LEU . 13.4 t -100.93 125.03 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.958 . . . . 0.0 110.625 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.15 112.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.572 -1.33 . . . . 0.0 108.366 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.698 ' OD1' HG22 ' A' ' 15' ' ' ILE . 20.9 t0 -68.1 164.98 19.07 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.272 0.558 . . . . 0.0 109.88 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 1.5 m-20 -96.21 -89.07 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.397 -0.815 . . . . 0.0 109.643 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 15' ' ' ILE . 1.1 m-20 -106.59 174.75 5.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.4 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 14.0 m -57.75 148.16 25.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.4 t 81.79 -11.96 1.01 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.961 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.698 HG22 ' OD1' ' A' ' 10' ' ' ASP . 12.6 mm -79.19 -35.81 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.0 -1.063 . . . . 0.0 108.745 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.601 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.3 ttp-105 -59.94 -46.03 90.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.482 ' O ' ' C ' ' A' ' 18' ' ' VAL . 55.1 t90 -58.29 -59.68 4.95 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.297 -0.877 . . . . 0.0 108.919 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.6 t -34.92 -60.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.579 0.704 . . . . 0.0 110.506 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 21' ' ' ARG . 3.1 mt -53.1 -71.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.978 -1.076 . . . . 0.0 109.152 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -35.13 -33.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.263 0.554 . . . . 0.0 110.818 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.02 -56.13 19.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 108.241 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.982 ' HB1' HG21 ' A' ' 108' ' ' ILE . . . -64.96 -9.83 24.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.119 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.785 HD11 HG21 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -85.77 -24.5 26.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.631 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.7 -43.96 85.53 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.26 -47.79 28.01 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -58.45 -17.59 21.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.157 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.815 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 63.08 54.01 36.08 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.933 HD22 HG13 ' A' ' 112' ' ' VAL . 2.7 mp -144.48 175.4 10.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.289 . . . . 0.0 109.999 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.526 ' CG2' HG23 ' A' ' 5' ' ' ILE . 30.4 m -107.78 85.34 2.1 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.858 -0.526 . . . . 0.0 110.994 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.58 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 50.8 t -88.69 83.34 6.73 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.872 -1.143 . . . . 0.0 109.853 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.523 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 15.7 m -80.04 125.15 29.41 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 8' ' ' VAL . 75.2 p -118.52 140.61 49.61 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.83 -1.169 . . . . 0.0 110.642 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.934 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 m-30 -116.24 113.38 22.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.618 -0.676 . . . . 0.0 109.215 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 47.1 mt-10 -37.24 -28.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.557 -0.714 . . . . 0.0 110.014 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -118.36 116.63 27.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.628 ' O ' HD13 ' A' ' 40' ' ' LEU . . . -49.19 -51.89 24.4 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.652 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -43.56 -72.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.568 -0.96 . . . . 0.0 108.934 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 37' ' ' ASN . 32.1 tp10 -31.49 -39.32 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.811 . . . . 0.0 110.133 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.934 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -63.99 -56.41 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.989 ' H ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -78.87 3.01 18.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.585 -1.322 . . . . 0.0 109.689 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.491 ' N ' HD22 ' A' ' 40' ' ' LEU . . . -99.47 -24.08 14.9 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.35 -19.85 15.44 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.041 HD13 HG23 ' A' ' 47' ' ' THR . 13.8 mt -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.505 -0.747 . . . . 0.0 109.47 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . . . -35.21 -31.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.786 -0.571 . . . . 0.0 110.732 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -65.51 -55.26 18.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 108.527 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER 164.86 115.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.056 HG22 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -44.59 167.54 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.186 -0.946 . . . . 0.0 109.103 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.056 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.8 Cg_endo -90.92 -65.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.679 1.358 . . . . 0.0 111.456 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.792 ' HB3' HG21 ' A' ' 119' ' ' ILE . 17.7 m-20 -121.49 -55.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.704 -1.248 . . . . 0.0 111.363 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.105 ' CG1' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -148.97 139.24 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.723 -1.236 . . . . 0.0 110.353 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.829 HD13 HG23 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.26 108.4 20.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.731 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.01 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.48 178.94 4.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.984 . . . . 0.0 108.971 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.754 ' HA ' HG12 ' A' ' 9' ' ' VAL . 38.2 m -162.42 126.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.087 . . . . 0.0 110.601 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 14.0 t0 -73.0 -144.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.094 -1.004 . . . . 0.0 108.401 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 54' ' ' ASP . 0.8 OUTLIER 174.57 78.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' CD ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -174.98 83.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.642 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.43 ' HB2' HD22 ' A' ' 63' ' ' LEU . 1.4 mmm -131.31 125.03 20.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -48.72 107.9 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.08 1.569 . . . . 0.0 110.518 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 125.1 140.73 5.49 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 87.3 mmm 61.64 11.83 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -1.086 . . . . 0.0 109.837 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 44.68 80.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.282 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . 66.54 90.09 0.05 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.718 ' CD1' HD21 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -56.76 -162.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -1.127 . . . . 0.0 109.416 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' N ' ' HG ' ' A' ' 63' ' ' LEU . . . -171.33 89.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.008 . . . . 0.0 109.994 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.718 HD21 ' CD1' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -88.24 -6.51 57.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 109.122 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -49.74 -22.02 1.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.33 -45.48 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.022 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.701 ' HG3' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.55 -45.96 23.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.15 . . . . 0.0 109.931 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.829 HG23 HD13 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -38.82 -32.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.902 -1.123 . . . . 0.0 110.161 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -95.6 -67.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.836 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -36.25 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.745 0.784 . . . . 0.0 110.339 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' LYS . 1.6 mmt85 -88.53 -93.32 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.262 0.553 . . . . 0.0 111.094 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.703 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 2.1 m-70 -53.03 144.38 27.83 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.3 Cg_endo -34.74 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 124.17 1.616 . . . . 0.0 111.196 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.42 94.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.802 HD21 ' OG1' ' A' ' 47' ' ' THR . 1.8 pp -125.61 151.73 70.94 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 1.075 ' HG2' HG23 ' A' ' 50' ' ' VAL . 36.9 Cg_endo -28.84 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.991 1.521 . . . . 0.0 112.219 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.89 146.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 42.8 mt -143.92 148.48 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -133.6 150.3 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.539 ' CE ' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.58 164.46 25.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.406 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 1.2 m -93.02 162.78 13.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 161.3 -62.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 109.063 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.467 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 t60 -176.44 -176.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 t 61.04 -124.0 0.9 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.609 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 36.56 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.254 -0.904 . . . . 0.0 109.818 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 10.79 -77.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.309 0.576 . . . . 0.0 111.78 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' ASP . 9.3 t70 -53.27 -64.74 0.72 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.193 . . . . 0.0 109.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -52.28 -46.16 65.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.272 -0.893 . . . . 0.0 110.56 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.5 -73.97 0.13 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 110.536 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 62.4 t -32.02 -32.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.996 -0.44 . . . . 0.0 111.205 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 19.4 t -102.95 161.45 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.758 -1.214 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 79.07 82.05 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.484 -0.76 . . . . 0.0 109.76 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ALA . 58.4 m-85 42.47 63.2 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -0.827 . . . . 0.0 109.899 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.27 134.66 49.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.065 -1.022 . . . . 0.0 109.345 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER 76.54 151.06 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 80.37 94.52 0.4 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 76.08 5.23 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -1.127 . . . . 0.0 109.111 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -126.87 112.36 15.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.276 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -124.72 167.52 14.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.168 -0.957 . . . . 0.0 109.661 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.17 105.19 9.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.042 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.8 OUTLIER -73.36 124.73 90.79 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 110.032 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -91.3 171.59 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.143 1.601 . . . . 0.0 109.716 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -117.21 145.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.725 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -82.05 166.99 70.15 Favored 'Cis proline' 0 C--N 1.317 -1.084 0 C-N-CA 120.401 -2.749 . . . . 0.0 110.114 -0.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.539 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 39.4 p90 -136.61 140.85 43.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.342 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.3 t0 -72.47 122.94 22.11 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.096 -1.003 . . . . 0.0 108.801 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.982 HG21 ' HB1' ' A' ' 22' ' ' ALA . 1.5 tp -61.44 -29.58 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 110.137 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -80.45 -49.43 11.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 108.518 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 17.2 tp10 -52.3 -31.65 33.92 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -78.72 -69.65 0.55 Allowed 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.293 -0.879 . . . . 0.0 109.194 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.933 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 t -35.37 -55.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.506 0.67 . . . . 0.0 110.148 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.595 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -64.55 -65.4 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 110.196 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.887 HD13 ' N ' ' A' ' 115' ' ' VAL . 1.3 tm? -33.46 -61.44 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.408 0.623 . . . . 0.0 110.293 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.989 ' CG1' HG21 ' A' ' 50' ' ' VAL . 84.4 t -56.64 -52.15 57.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 18.6 tp10 -35.42 -45.12 0.32 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.32 0.581 . . . . 0.0 110.233 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -52.55 -55.91 18.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.092 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.17 -58.39 5.69 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.258 -0.901 . . . . 0.0 108.765 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.828 HD11 HG12 ' A' ' 115' ' ' VAL . 2.4 mm -37.37 -38.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.73 -0.606 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.546 ' C ' ' O ' ' A' ' 119' ' ' ILE . 6.0 t -20.0 -66.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.173 0.511 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 120' ' ' SER . 21.0 t-80 160.2 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 121' ' ' HIS . 2.4 m-85 37.91 30.58 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.716 0.77 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -49.8 -24.68 2.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.759 -0.588 . . . . 0.0 109.728 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.35 179.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 4.1 ptm180 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.09 0.472 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -134.54 87.46 0.25 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.087 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.847 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.36 87.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.159 -1.201 . . . . 0.0 108.468 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.75 111.46 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.743 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.855 ' CE3' HG21 ' A' ' 31' ' ' THR . 10.6 m0 -101.71 106.86 17.94 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.995 . . . . 0.0 108.524 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.001 HG23 ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -85.6 169.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.794 0.807 . . . . 0.0 111.688 -177.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 39' ' ' VAL . 68.8 t -121.42 94.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 64.1 m-20 -93.37 -173.08 3.12 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.501 0.667 . . . . 0.0 110.432 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 24.5 t0 -122.24 -9.71 8.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB2' HG12 ' A' ' 15' ' ' ILE . 8.2 m-20 -147.12 164.48 32.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -42.6 73.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.408 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -54.52 -24.93 22.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.308 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.491 ' CG2' ' CG ' ' A' ' 10' ' ' ASP . 15.3 mm -71.59 -43.07 71.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.352 -0.843 . . . . 0.0 109.112 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.493 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.3 -44.14 75.49 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.456 ' O ' ' C ' ' A' ' 18' ' ' VAL . 19.8 t90 -60.41 -58.03 10.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.437 -0.789 . . . . 0.0 109.169 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.456 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.3 t -36.2 -62.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.645 -0.659 . . . . 0.0 110.743 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -57.36 -68.91 0.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.056 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -34.5 -32.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.683 -0.635 . . . . 0.0 110.455 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.7 tpp180 -66.97 -55.86 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.907 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -68.25 -5.99 21.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.462 -0.773 . . . . 0.0 109.059 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 3.3 mm? -102.15 -12.57 17.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.69 -40.85 28.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.66 97.52 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.0 -32.88 65.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.417 -1.049 . . . . 0.0 109.248 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 84.73 66.41 1.46 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.683 HD21 HG13 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -134.71 -176.14 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.195 -1.179 . . . . 0.0 110.587 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 18.1 m -99.21 78.23 2.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.59 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 43.8 t -80.23 84.77 5.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.587 -0.696 . . . . 0.0 111.331 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.855 HG21 ' CE3' ' A' ' 7' ' ' TRP . 2.6 m -88.52 141.24 28.69 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.617 ' CB ' HG12 ' A' ' 8' ' ' VAL . 66.5 p -146.33 119.66 8.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.702 -1.249 . . . . 0.0 109.846 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.128 ' HB2' HG22 ' A' ' 39' ' ' VAL . 12.1 m-85 -103.55 129.74 50.83 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.365 -0.834 . . . . 0.0 109.019 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG2' ' C ' ' A' ' 11' ' ' ASP . 0.8 OUTLIER -63.45 -8.49 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.864 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 1.019 ' O ' HG23 ' A' ' 39' ' ' VAL . 10.6 t30 -136.61 133.57 36.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.622 -1.299 . . . . 0.0 110.48 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.864 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . -51.09 -59.95 7.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.567 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -46.78 -73.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.272 -1.134 . . . . 0.0 108.92 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 37' ' ' ASN . 13.9 tp10 -32.7 -34.43 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.364 -0.835 . . . . 0.0 110.616 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.128 HG22 ' HB2' ' A' ' 33' ' ' PHE . 15.3 t -61.61 -57.97 9.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.099 -1.001 . . . . 0.0 109.015 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.956 HD12 ' N ' ' A' ' 41' ' ' ALA . 1.3 pp -62.42 -12.38 21.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.236 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.956 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -81.02 -30.2 34.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.468 -0.77 . . . . 0.0 109.183 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . . . -88.47 -28.45 20.83 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.604 HD11 ' HG3' ' A' ' 48' ' ' PRO . 13.0 mt -88.08 6.14 37.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 109.853 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -36.27 -28.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.876 -0.515 . . . . 0.0 110.327 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' LEU . 11.6 t -61.98 -56.68 16.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.882 -1.136 . . . . 0.0 108.222 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 173.59 -165.81 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.441 -0.787 . . . . 0.0 110.524 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.584 ' CG2' ' CB ' ' A' ' 76' ' ' LEU . 4.4 m -70.15 154.0 94.89 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.67 . . . . 0.0 110.929 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.604 ' HG3' HD11 ' A' ' 43' ' ' LEU . 38.6 Cg_endo -115.6 -116.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 N-CA-C 107.395 -1.81 . . . . 0.0 107.395 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.706 ' C ' HD13 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -100.08 -75.32 0.58 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.207 -1.558 . . . . 0.0 108.605 178.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.026 HG21 HG22 ' A' ' 115' ' ' VAL . 13.1 t -145.63 137.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.164 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.7 HD23 ' CG1' ' A' ' 69' ' ' ILE . 2.8 mp -102.51 110.61 22.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.931 -1.106 . . . . 0.0 110.606 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.001 ' HB3' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -83.72 161.11 21.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.31 -0.869 . . . . 0.0 109.685 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 80' ' ' ILE . 68.4 m -152.23 136.31 16.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 2.4 p30 -100.72 -158.61 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.072 -1.017 . . . . 0.0 110.047 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.69 HG12 ' HB3' ' A' ' 83' ' ' ALA . 1.2 pp -143.09 120.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 57' ' ' MET . 3.2 ttm-85 178.72 -78.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 12.7 mmt 54.22 170.06 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.076 -1.015 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.2 Cg_endo -84.32 161.68 13.09 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.856 1.45 . . . . 0.0 110.24 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.71 101.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -176.84 -40.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.0 109.491 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 60' ' ' MET . 0.4 OUTLIER -162.8 -77.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 57' ' ' MET . . . 152.74 -45.53 0.59 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -154.69 -76.48 0.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.312 -1.111 . . . . 0.0 109.3 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 63' ' ' LEU . . . 41.34 44.26 2.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.864 HD22 ' HA3' ' A' ' 36' ' ' GLY . 6.4 mt -130.86 -25.01 2.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HA ' ' CG2' ' A' ' 69' ' ' ILE . 1.2 tp -66.24 -10.39 41.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.718 -1.239 . . . . 0.0 108.719 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -71.86 -55.06 8.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.595 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -67.02 -53.78 27.97 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.701 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 0.8 OUTLIER -43.13 -14.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.228 -0.92 . . . . 0.0 111.017 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' GLN . 19.1 tptp -100.93 -74.08 0.62 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.31 -1.494 . . . . 0.0 108.003 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 70' ' ' LYS . 32.9 mm-40 -36.96 -59.25 0.72 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.501 0.667 . . . . 0.0 111.216 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.701 ' NE ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -35.74 -48.09 0.52 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.504 -0.748 . . . . 0.0 111.716 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.804 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 14.6 m-70 -107.58 142.16 24.57 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.68 -1.262 . . . . 0.0 109.428 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 32.1 Cg_endo -26.36 -78.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 124.203 1.633 . . . . 0.0 112.777 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -175.58 100.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.42 -1.425 . . . . 0.0 110.544 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER -123.14 168.09 13.06 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 108.857 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.801 ' HG2' HG22 ' A' ' 50' ' ' VAL . 33.7 Cg_endo -71.37 137.43 30.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.676 1.356 . . . . 0.0 111.63 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.673 ' CG2' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -126.32 156.29 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.932 HD11 HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -131.1 147.44 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.81 HG22 ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -153.91 125.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 2.7 mtt -66.43 125.73 26.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.474 HG21 ' HD1' ' A' ' 101' ' ' TYR . 27.6 p -86.93 87.35 7.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.609 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.69 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -109.76 -19.27 13.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.42 -65.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.549 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 3.5 m -77.94 -172.22 2.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 83.76 -44.52 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.666 -0.647 . . . . 0.0 109.551 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.2 mm? -34.19 -32.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.786 -0.571 . . . . 0.0 110.482 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.8 t0 -70.28 -68.91 0.39 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 88' ' ' ASP . . . -41.89 -26.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -82.51 -74.59 0.34 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.091 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 87' ' ' LEU . 99.0 t -34.25 -30.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.863 -0.523 . . . . 0.0 111.162 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.0 m -97.94 -153.32 0.42 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.974 -1.079 . . . . 0.0 109.708 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.12 69.81 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.049 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 95' ' ' GLN . 1.4 t80 67.64 10.42 7.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.3 -0.875 . . . . 0.0 109.004 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 10.7 tm0? 44.78 82.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.8 mt-30 163.37 -25.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.03 -144.35 44.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -143.06 59.5 1.42 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -1.125 . . . . 0.0 109.346 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.727 ' CE1' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 82.61 -24.57 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.633 -0.667 . . . . 0.0 109.887 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.81 ' HB2' HG22 ' A' ' 80' ' ' ILE . 44.3 p-10 -42.07 127.89 3.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 162.78 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.495 -0.753 . . . . 0.0 109.412 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' MET . 12.6 tp -109.12 141.83 24.26 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 108.977 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -104.93 -167.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.758 1.399 . . . . 0.0 111.04 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -154.69 160.63 30.74 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -72.76 143.87 79.03 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.387 -2.339 . . . . 0.0 110.764 0.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.773 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 88.4 t80 -129.64 169.68 14.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' CG ' ' A' ' 106' ' ' PHE . 3.7 t70 -85.91 -157.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.625 -0.672 . . . . 0.0 109.948 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.907 HD13 ' CB ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -130.12 -48.88 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 108.443 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.2 -41.45 81.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 11.3 tp10 -50.77 -47.84 59.5 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.773 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -62.0 -65.24 0.72 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.78 HG12 ' N ' ' A' ' 113' ' ' ALA . 2.2 t -34.7 -78.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.78 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -39.03 -70.28 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.647 -0.658 . . . . 0.0 111.578 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 113' ' ' ALA . 27.8 tp -36.35 -43.21 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.972 0.891 . . . . 0.0 110.073 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.026 HG22 HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -68.43 -58.73 5.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.657 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.1 mt-10 -36.92 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.488 0.661 . . . . 0.0 109.536 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 115' ' ' VAL . 1.7 mtp180 -85.05 -48.04 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.481 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -53.79 -62.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 108.96 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.839 ' CD1' HG23 ' A' ' 50' ' ' VAL . 7.1 mt -36.22 -40.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 t -71.86 -46.02 59.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.991 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -47.86 -71.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 109.903 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 3.2 m-85 -44.85 112.13 0.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.912 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER 168.85 -27.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.405 -0.809 . . . . 0.0 109.362 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.53 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.287 0.565 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.74 145.41 16.14 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.887 HG22 HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.39 95.81 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.471 -1.017 . . . . 0.0 110.419 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -91.22 113.04 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.009 -1.057 . . . . 0.0 108.604 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CE3' HG21 ' A' ' 31' ' ' THR . 12.8 m95 -102.84 98.85 8.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 109.934 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.689 HG22 ' CB ' ' A' ' 52' ' ' LEU . 15.2 t -85.48 167.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.483 -0.76 . . . . 0.0 109.378 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 39' ' ' VAL . 99.0 t -132.4 113.59 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 109.792 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.869 ' HB3' HG21 ' A' ' 15' ' ' ILE . 6.1 t70 177.87 -65.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.807 . . . . 0.0 109.484 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.562 ' HB3' ' CA ' ' A' ' 34' ' ' GLU . 20.9 t0 17.21 55.07 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.198 0.523 . . . . 0.0 111.478 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.893 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -112.95 52.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 11.9 t 144.22 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER 178.21 42.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.663 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.893 HD13 ' H ' ' A' ' 12' ' ' ASP . 2.4 mp -89.49 -40.53 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.987 . . . . 0.0 108.979 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.517 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 23.7 ttp180 -61.21 -41.39 96.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.455 ' O ' ' C ' ' A' ' 18' ' ' VAL . 76.5 t90 -62.66 -63.71 1.14 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 14' ' ' SER . 41.6 t -37.99 -65.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.759 0.79 . . . . 0.0 110.528 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' ARG . 16.4 mt -56.52 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 110.785 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.518 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 15.2 tm-20 -34.61 -30.13 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.907 -0.495 . . . . 0.0 111.215 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.3 tpt180 -68.12 -56.64 8.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.943 -1.098 . . . . 0.0 108.644 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.092 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -71.34 -8.69 55.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 0.0 109.015 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.804 HD22 ' SG ' ' A' ' 30' ' ' CYS . 3.0 mp -96.31 -16.69 21.18 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.82 -37.4 64.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.6 -36.3 58.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.21 -13.95 62.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -1.177 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.63 56.84 7.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.853 HD22 HG13 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -131.1 -178.04 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -1.234 . . . . 0.0 110.009 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.887 HG21 HG22 ' A' ' 5' ' ' ILE . 30.0 m -101.47 90.45 4.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.804 ' SG ' HD22 ' A' ' 23' ' ' LEU . 25.2 t -84.46 86.05 7.33 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.942 HG21 ' CE3' ' A' ' 7' ' ' TRP . 17.4 m -91.0 137.48 32.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 16.1 p -156.34 135.79 12.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.677 -1.264 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.569 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 29.8 m-85 -108.87 -170.44 1.66 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' CA ' ' HB3' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -108.92 -6.08 15.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.055 . . . . 0.0 109.536 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.86 143.84 26.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.86 ' CA ' HG11 ' A' ' 9' ' ' VAL . . . -60.02 -42.86 98.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.671 ' H ' HD22 ' A' ' 65' ' ' LEU . 4.4 t-20 -49.42 -79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.052 -1.263 . . . . 0.0 108.866 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 37' ' ' ASN . 50.2 mt-10 -34.46 -42.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.765 -0.584 . . . . 0.0 110.434 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.886 HG21 HG22 ' A' ' 9' ' ' VAL . 18.1 t -54.84 -55.48 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 40' ' ' LEU . 2.6 mm? -65.98 -18.13 65.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 108.829 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -73.8 -25.53 60.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 108.951 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.6 -17.27 17.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 73' ' ' HIS . 1.4 mm? -77.69 -9.2 58.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.99 -19.81 0.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -57.38 4.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 179.3 -164.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.935 ' CB ' HD22 ' A' ' 76' ' ' LEU . 10.2 t -100.03 135.72 20.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 36.2 Cg_endo -95.17 -95.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.04 1.547 . . . . 0.0 109.389 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.712 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -115.39 -75.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.864 -1.148 . . . . 0.0 109.086 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.834 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -149.57 142.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.33 -0.856 . . . . 0.0 109.467 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.948 ' CB ' HG12 ' A' ' 78' ' ' VAL . 6.5 tp -94.75 158.74 15.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.033 . . . . 0.0 108.797 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.689 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -141.57 127.76 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.998 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.3 p -94.04 103.79 15.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.333 -0.855 . . . . 0.0 108.889 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -88.01 122.64 31.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.955 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -98.06 81.86 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.65 ' HD3' HD11 ' A' ' 15' ' ' ILE . 1.8 ttt180 -114.27 -19.35 11.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.883 . . . . 0.0 109.754 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -45.14 140.89 3.53 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -100.11 147.36 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.956 1.503 . . . . 0.0 110.199 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.65 -174.77 17.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -24.24 64.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -1.153 . . . . 0.0 109.661 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -111.73 159.44 18.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.534 ' HA3' ' CD1' ' A' ' 55' ' ' ILE . . . -118.94 -53.82 0.28 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.889 ' HB2' HD12 ' A' ' 65' ' ' LEU . 0.7 OUTLIER 179.13 111.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.99 29.47 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.364 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.889 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -99.74 6.61 45.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 89' ' ' ALA . 10.4 tp -65.8 -60.74 2.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.649 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -48.02 -39.12 18.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.171 -0.956 . . . . 0.0 108.523 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 69' ' ' ILE . 3.8 tp60 -52.09 -56.59 13.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.692 HG12 HD23 ' A' ' 51' ' ' LEU . 8.2 mt -33.49 -76.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.266 0.555 . . . . 0.0 110.025 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.62 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -40.49 -59.37 1.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 110.085 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.85 -68.38 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.785 -0.572 . . . . 0.0 110.9 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 73' ' ' HIS . 1.7 mpp_? -73.06 -62.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -31.81 115.85 0.38 Allowed Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.778 -0.576 . . . . 0.0 110.327 -179.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 36.9 Cg_endo -41.26 -74.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.017 1.535 . . . . 0.0 110.441 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.2 ptp -178.39 64.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.54 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.935 HD22 ' CB ' ' A' ' 47' ' ' THR . 0.6 OUTLIER -126.31 148.63 64.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.726 ' HG2' HG22 ' A' ' 50' ' ' VAL . 37.0 Cg_endo -48.53 141.16 20.36 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.828 1.436 . . . . 0.0 111.815 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.948 HG12 ' CB ' ' A' ' 51' ' ' LEU . 2.5 m -139.63 97.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.643 HD11 HG23 ' A' ' 115' ' ' VAL . 11.2 mt -65.72 160.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 101' ' ' TYR . 1.3 pp -142.69 133.98 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -71.74 170.47 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.148 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.603 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.09 157.36 15.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.091 -1.006 . . . . 0.0 110.283 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.789 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . 169.6 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.46 ' C ' ' N ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 178.18 -77.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 110.497 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 86' ' ' ASP . 78.9 p 47.62 26.99 0.93 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 60.22 120.28 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.916 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 18.5 tp -38.12 -26.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.21 1.005 . . . . 0.0 108.523 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.7 t0 -32.7 -65.39 0.16 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.065 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.791 ' O ' HD23 ' A' ' 66' ' ' LEU . . . -82.43 -30.89 29.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.956 ' HB1' ' OH ' ' A' ' 101' ' ' TYR . . . -64.34 -65.65 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.171 -0.955 . . . . 0.0 109.144 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.49 -53.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 122.978 0.511 . . . . 0.0 111.504 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.59 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 1.6 t -56.66 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.043 -1.036 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 99' ' ' PHE . . . -128.27 -73.89 0.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.485 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 11.61 35.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 96' ' ' GLN . 5.5 mt-30 -98.24 108.54 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 108.55 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 11.3 tt0 61.39 164.13 0.08 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.988 . . . . 0.0 108.508 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.01 172.92 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.674 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . . . -125.63 103.83 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.05 -1.265 . . . . 0.0 109.791 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.836 ' CD1' HG23 ' A' ' 78' ' ' VAL . 33.2 p90 170.63 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.0 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.07 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.956 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -167.04 138.16 3.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.007 . . . . 0.0 110.024 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -128.47 113.46 19.52 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -103.94 164.95 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.668 1.351 . . . . 0.0 111.187 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 13.0 pttp -92.87 160.34 34.16 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.515 -0.741 . . . . 0.0 109.286 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -79.29 159.02 90.23 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 120.773 -2.594 . . . . 0.0 110.483 -0.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' A' ' 81' ' ' MET . 13.1 p90 -139.12 146.46 40.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.563 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 2.4 t70 -86.36 146.61 26.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 108.868 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.092 HD13 ' CB ' ' A' ' 22' ' ' ALA . 1.5 mp -76.8 -26.56 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.267 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.11 -36.58 19.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 40.8 tt0 -61.73 -42.19 98.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.96 -67.46 0.53 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.853 HG13 HD22 ' A' ' 28' ' ' LEU . 24.8 t -38.01 -52.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.497 -0.752 . . . . 0.0 110.937 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -62.58 -69.45 0.26 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.495 -0.753 . . . . 0.0 110.873 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.489 ' C ' ' O ' ' A' ' 113' ' ' ALA . 16.9 tp -34.79 -55.68 0.56 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.509 0.671 . . . . 0.0 109.943 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.712 HG22 HG21 ' A' ' 50' ' ' VAL . 1.2 t -54.79 -56.77 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.614 ' N ' HG12 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -38.02 -37.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 110.751 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.619 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -83.53 -35.69 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 110.268 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.619 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.4 -59.88 4.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.787 -1.195 . . . . 0.0 108.326 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.834 ' CD1' HG23 ' A' ' 50' ' ' VAL . 8.6 mt -34.5 -40.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.12 0.486 . . . . 0.0 110.384 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -85.61 53.32 2.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.585 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.564 ' NE2' ' CE1' ' A' ' 122' ' ' TYR . 23.7 p-80 -96.31 -9.19 30.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.564 ' CE1' ' NE2' ' A' ' 121' ' ' HIS . 8.2 m-85 -69.3 -5.86 25.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.79 53.01 1.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.395 179.9 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.489 0.662 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.63 112.42 0.61 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.354 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.84 HG23 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -90.73 111.62 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 108.892 179.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.696 HG12 HG23 ' A' ' 8' ' ' VAL . 61.5 t -104.51 107.28 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.031 . . . . 0.0 109.555 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.762 ' CZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.45 93.77 6.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 108.551 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.974 HG22 ' CB ' ' A' ' 52' ' ' LEU . 54.4 t -102.89 127.43 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.557 ' CG1' ' HA2' ' A' ' 36' ' ' GLY . 1.9 m -66.6 121.37 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB2' HG21 ' A' ' 15' ' ' ILE . 53.7 p-10 -110.45 178.67 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.206 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 34.1 t0 -74.4 -86.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.32 -0.862 . . . . 0.0 109.788 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.72 173.65 11.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 11.7 p -75.93 -30.37 58.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.805 . . . . 0.0 109.358 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -73.82 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.317 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 10' ' ' ASP . 24.6 mm -66.01 -32.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 108.831 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.63 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 11.6 ptt180 -68.08 -35.31 77.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.517 ' CH2' ' HG3' ' A' ' 21' ' ' ARG . 1.8 t-105 -55.12 -66.16 0.46 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 54.0 t -40.77 -65.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.816 0.817 . . . . 0.0 110.478 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.659 ' C ' HD12 ' A' ' 23' ' ' LEU . 4.1 mm? -54.78 -75.07 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.569 -0.707 . . . . 0.0 110.986 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -34.5 -31.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.331 0.586 . . . . 0.0 110.219 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.08 -58.61 6.69 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.92 -10.07 50.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -0.823 . . . . 0.0 109.238 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.993 HD22 ' CB ' ' A' ' 30' ' ' CYS . 1.5 mt -93.15 -13.03 28.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 109.758 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.34 61.95 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.93 -38.0 37.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.02 79.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -1.142 . . . . 0.0 108.726 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' HG ' ' A' ' 28' ' ' LEU . . . 95.69 50.11 2.03 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.977 HD13 HG11 ' A' ' 112' ' ' VAL . 1.1 mt -141.03 166.66 24.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.937 -1.331 . . . . 0.0 109.941 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 5' ' ' ILE . 87.5 m -101.4 60.04 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.993 ' CB ' HD22 ' A' ' 23' ' ' LEU . 33.7 t -81.4 88.49 6.12 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 109.658 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 11.8 m -101.18 137.46 39.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 109.472 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 8' ' ' VAL . 1.2 p -109.66 165.49 11.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 108.671 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.65 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.0 m-85 -137.91 115.97 11.68 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.082 -1.012 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 14.3 tt0 -36.67 -39.1 0.19 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.96 -0.462 . . . . 0.0 110.461 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -111.92 126.1 54.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 110.521 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.557 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -51.68 -45.84 54.36 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.699 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -60.28 -63.53 1.27 Allowed 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.181 -1.187 . . . . 0.0 107.866 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 20.0 tp10 -34.57 -28.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.551 -0.718 . . . . 0.0 110.809 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -81.88 -51.08 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.919 -1.113 . . . . 0.0 110.504 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.059 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.47 -11.36 60.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.791 -1.193 . . . . 0.0 109.753 -179.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.973 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -94.44 -49.11 5.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.24 -25.11 46.43 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.762 HD21 ' CZ3' ' A' ' 7' ' ' TRP . 7.9 mt -73.17 -77.64 0.1 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.39 -47.94 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -99.24 -26.12 14.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.732 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 64.42 62.82 0.79 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 123.49 1.614 . . . . 0.0 109.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.62 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -104.33 40.97 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 119.752 -1.842 . . . . 0.0 112.771 -179.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.766 ' HA ' HD12 ' A' ' 5' ' ' ILE . 38.0 Cg_endo -101.08 -167.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 116.842 -1.638 . . . . 0.0 109.633 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -92.97 -52.48 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.969 HG23 ' CD1' ' A' ' 119' ' ' ILE . 6.6 t -146.59 128.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 108.89 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.943 ' O ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -98.47 114.82 27.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 0.0 108.376 179.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.974 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -108.4 -174.28 2.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.371 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.569 ' OG ' HD13 ' A' ' 63' ' ' LEU . 26.6 t -155.24 123.89 6.05 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 9' ' ' VAL . 13.9 p-10 -102.63 149.75 24.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.98 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -102.88 109.78 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -161.63 28.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.469 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.404 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 3.7 mtt -93.74 125.94 51.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.491 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.6 Cg_endo -103.55 131.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.929 1.489 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.15 -74.23 0.31 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -161.1 128.28 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.422 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 68.72 149.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.98 -84.15 0.66 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.992 ' HB2' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -146.52 -54.3 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -1.107 . . . . 0.0 109.484 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . . . 47.47 60.83 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.427 -0.795 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.992 HD12 ' HB2' ' A' ' 63' ' ' LEU . 1.4 mt -124.35 8.41 8.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.742 HD11 HD12 ' A' ' 80' ' ' ILE . 4.9 mp -75.73 -19.18 59.25 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.278 -0.889 . . . . 0.0 108.699 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 2.9 pttt -66.01 -39.2 90.07 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.529 ' OE1' ' CA ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -80.38 -57.06 3.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 109.235 179.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.892 HG12 HD23 ' A' ' 51' ' ' LEU . 2.6 mt -39.71 -32.71 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.896 -1.127 . . . . 0.0 110.239 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -92.09 -73.09 0.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.087 -1.008 . . . . 0.0 110.379 -178.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -35.22 -30.78 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.554 -0.716 . . . . 0.0 110.565 -179.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.548 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -97.91 -58.55 1.96 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 110.368 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' CB ' ' A' ' 46' ' ' LYS . 1.2 m-70 -98.38 133.03 23.2 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.403 -0.811 . . . . 0.0 109.496 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.598 ' N ' ' HE2' ' A' ' 46' ' ' LYS . 39.6 Cg_endo -138.59 1.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 117.341 -1.306 . . . . 0.0 112.162 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.56 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 3.6 mtt -68.59 7.12 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.695 -1.253 . . . . 0.0 112.778 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -163.06 177.76 1.78 Allowed Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.186 -1.571 . . . . 0.0 109.918 179.007 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.0 Cg_endo -86.99 164.66 8.72 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.885 1.466 . . . . 0.0 111.064 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.943 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.17 144.91 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.734 HD12 ' C ' ' A' ' 78' ' ' VAL . 3.5 mp -137.78 164.0 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 109.739 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.742 HD12 HD11 ' A' ' 66' ' ' LEU . 11.9 tt -141.99 157.39 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -81.93 166.49 19.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.28 102.7 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.564 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.76 ' HB3' ' OD2' ' A' ' 86' ' ' ASP . . . -96.74 -151.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -144.23 32.36 1.22 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.62 -34.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.76 ' OD2' ' HB3' ' A' ' 83' ' ' ALA . 1.3 p30 -49.93 -24.17 2.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.017 -1.052 . . . . 0.0 109.692 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 87' ' ' LEU . 4.0 tp -34.97 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.83 -0.544 . . . . 0.0 110.913 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 86' ' ' ASP . 42.8 t0 -58.83 -59.19 5.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.995 -1.065 . . . . 0.0 109.883 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.26 -44.49 29.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 109.961 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -50.21 -41.7 50.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.689 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -33.07 -41.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.457 0.646 . . . . 0.0 109.99 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 5.9 t -64.11 86.18 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.359 0.6 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.75 -47.96 0.19 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -72.67 -18.95 61.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -69.02 -12.04 61.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.54 -0.725 . . . . 0.0 109.204 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.42 -157.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 109.33 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.81 67.88 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . -168.08 52.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -1.122 . . . . 0.0 109.324 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 36.7 m-85 -151.92 164.41 37.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.607 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.469 ' HB3' HG12 ' A' ' 79' ' ' ILE . 2.4 t0 -158.44 -157.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.37 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.14 142.83 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 109.791 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.23 139.86 35.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 108.893 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -114.72 176.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.748 1.394 . . . . 0.0 110.806 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 2.6 mtmp? -121.92 158.41 54.87 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 0.0 109.153 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -89.72 174.04 24.02 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 120.505 -2.706 . . . . 0.0 110.195 -0.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 33.2 p90 -153.59 161.17 42.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 14.6 t0 -73.92 -146.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 108' ' ' ILE . 16.2 mm -120.48 -68.05 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 108.798 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.514 ' OD1' ' HB2' ' A' ' 113' ' ' ALA . 11.7 t0 -59.79 -46.55 88.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 28.1 tt0 -43.09 -41.69 3.69 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.76 -75.88 0.11 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.977 HG11 HD13 ' A' ' 28' ' ' LEU . 52.1 t -38.39 -69.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 110.243 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . . . -39.36 -62.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' A' ' 113' ' ' ALA . 7.4 tp -34.3 -56.11 0.51 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.375 0.607 . . . . 0.0 109.944 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -58.24 -52.66 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.526 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 37.7 tp10 -39.19 -36.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.419 -0.801 . . . . 0.0 110.807 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.615 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -77.92 -36.77 49.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 110.74 -178.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.615 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.75 -53.61 51.77 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.733 -1.229 . . . . 0.0 108.044 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.969 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.3 mt -41.14 -50.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.517 0.675 . . . . 0.0 111.008 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.487 ' O ' ' C ' ' A' ' 121' ' ' HIS . 1.5 t -35.02 -34.9 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.447 -0.783 . . . . 0.0 111.998 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 t-80 -32.65 -66.37 0.14 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.546 -0.721 . . . . 0.0 111.273 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.63 -19.31 13.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.03 -1.044 . . . . 0.0 109.931 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.403 ' HB2' HG22 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -88.54 55.99 3.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.207 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.498 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.182 0.515 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.772 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -162.62 119.84 0.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.799 HD13 ' N ' ' A' ' 5' ' ' ILE . 1.1 mm -102.54 116.12 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -1.205 . . . . 0.0 109.528 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.586 ' CG1' HG23 ' A' ' 8' ' ' VAL . 1.5 t -123.65 109.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -0.796 . . . . 0.0 108.951 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.646 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 27.7 m0 -99.13 89.16 4.15 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.351 -1.339 . . . . 0.0 107.489 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.821 HG22 ' CG ' ' A' ' 52' ' ' LEU . 27.6 t -73.28 142.68 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.547 -0.721 . . . . 0.0 110.136 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.899 HG22 HG21 ' A' ' 39' ' ' VAL . 40.6 t -92.7 102.4 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.95 -1.094 . . . . 0.0 109.251 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.656 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 88.8 m-20 -53.96 -173.23 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 110.002 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -137.47 -5.97 1.77 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.337 -0.852 . . . . 0.0 110.786 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 171.29 55.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.458 -1.402 . . . . 0.0 110.871 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 54.69 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.559 0.695 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 75.4 -7.82 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.161 -0.962 . . . . 0.0 109.828 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' A' ' 10' ' ' ASP . 18.0 mm -85.48 -32.16 7.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.074 -1.017 . . . . 0.0 108.718 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.486 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.7 OUTLIER -62.38 -45.5 92.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.436 ' O ' ' C ' ' A' ' 18' ' ' VAL . 26.9 t90 -58.7 -60.49 3.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.5 t -39.21 -70.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 110.914 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 8' ' ' VAL . 7.8 mt -57.35 -72.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.391 -0.818 . . . . 0.0 110.838 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 19' ' ' LEU . 3.3 tt0 -35.8 -30.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 110.526 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 8.7 tpt85 -66.41 -56.0 13.08 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -71.11 -4.43 25.16 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.484 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.775 HD12 ' HB2' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -103.73 -11.35 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -43.88 42.68 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.62 -19.56 69.2 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.71 -19.37 32.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.581 -0.952 . . . . 0.0 108.726 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.6 50.03 33.62 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.808 HD12 HG11 ' A' ' 112' ' ' VAL . 13.8 mt -123.77 179.01 4.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 110.425 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 29' ' ' THR . 18.0 m -95.49 67.3 2.87 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 23' ' ' LEU . 38.6 t -79.64 83.64 5.59 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.953 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.646 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 5.2 m -94.84 143.29 26.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.7 p -138.67 119.43 14.15 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.519 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.99 ' HB2' HG22 ' A' ' 39' ' ' VAL . 7.5 m-85 -85.01 -157.65 0.31 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -118.36 -37.36 3.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.913 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.786 ' O ' HG23 ' A' ' 39' ' ' VAL . 49.1 m-80 -131.1 146.8 52.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.005 . . . . 0.0 109.81 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 37' ' ' ASN . . . -53.12 -39.71 58.18 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 2.2 m-20 -47.63 -84.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.904 -1.35 . . . . 0.0 108.343 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.8 mt-10 -35.14 -48.09 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.757 -0.589 . . . . 0.0 110.969 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 33' ' ' PHE . 48.6 t -50.37 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.984 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.4 tm? -54.21 -20.72 7.36 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.527 -0.733 . . . . 0.0 109.527 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -68.7 -41.49 79.08 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.6 -15.63 48.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.919 HD11 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -84.1 -0.81 53.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.0 109.862 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.91 -19.59 7.01 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.14 -0.975 . . . . 0.0 108.753 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 2.4 m -88.74 -27.81 20.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER 90.21 69.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -102.32 -90.57 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 111.185 -179.119 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 1.038 ' HG2' HD21 ' A' ' 51' ' ' LEU . 37.4 Cg_endo -40.55 130.84 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.835 1.439 . . . . 0.0 111.129 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.814 ' HB3' HG21 ' A' ' 119' ' ' ILE . 4.8 m-20 -75.88 -23.76 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.89 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -136.95 123.52 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.038 HD21 ' HG2' ' A' ' 48' ' ' PRO . 3.9 mm? -102.06 132.25 48.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.301 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 79' ' ' ILE . 2.5 mt -104.71 165.37 11.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.065 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.479 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 49.1 m -142.5 109.95 5.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.43 169.98 16.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.726 ' HB ' HD13 ' A' ' 63' ' ' LEU . 2.1 tp -130.33 97.04 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -175.53 73.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.414 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.4 ' HB2' ' CA ' ' A' ' 62' ' ' GLY . 26.7 mtm -134.1 171.69 8.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.378 -0.826 . . . . 0.0 109.452 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -97.64 143.45 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.001 1.527 . . . . 0.0 110.181 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.37 -173.92 16.87 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -59.99 109.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' CA ' ' A' ' 85' ' ' SER . 0.1 OUTLIER 72.21 -165.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.969 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 169.85 39.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.846 HD23 HD21 ' A' ' 66' ' ' LEU . 51.7 tp -105.09 64.54 0.72 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -1.184 . . . . 0.0 109.549 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . 41.8 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.348 -0.845 . . . . 0.0 109.787 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 68' ' ' GLN . 1.1 tp -127.7 70.85 1.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 109.296 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.947 HD11 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -71.45 -59.68 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 109.713 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -46.58 -31.72 2.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.818 -1.176 . . . . 0.0 108.261 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.579 ' HG3' ' N ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -66.74 -57.41 7.17 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.63 HG23 ' CG ' ' A' ' 73' ' ' HIS . 1.5 mt -38.67 -64.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.569 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -42.75 -64.61 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.233 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.1 tp60 -34.05 -43.35 0.14 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.847 -0.533 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.721 ' O ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.7 60.55 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.057 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.818 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.7 t-80 -156.71 131.17 5.05 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -52.39 -170.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.604 1.318 . . . . 0.0 110.49 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mmt -95.53 48.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 110.763 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 73' ' ' HIS . 3.3 pp -91.17 122.41 66.44 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.869 -1.144 . . . . 0.0 108.463 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.687 ' O ' HD12 ' A' ' 76' ' ' LEU . 34.8 Cg_endo -34.31 147.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.11 1.584 . . . . 0.0 112.52 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.8 124.3 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.939 HG21 HD13 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -89.16 133.31 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.0 109.313 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.605 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -119.35 140.66 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.385 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.9 ttm -109.56 113.64 26.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.507 ' O ' HG21 ' A' ' 55' ' ' ILE . 87.5 m 49.89 72.83 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.605 ' HB2' ' CG2' ' A' ' 80' ' ' ILE . . . -91.0 165.11 13.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.888 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -167.78 -88.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.699 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER 40.19 44.64 1.59 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 10.2 t70 67.74 132.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.901 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 15.1 mt -35.17 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 109.271 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -35.68 -67.03 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.947 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -72.46 -24.28 61.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 108.626 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -71.41 -76.17 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 109.564 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' A' ' 90' ' ' ALA . 2.9 t -11.27 -58.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 122.804 0.442 . . . . 0.0 111.744 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 90' ' ' ALA . 4.9 t -40.42 108.81 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 109.75 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 92' ' ' SER . . . 176.4 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.802 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.54 -11.21 59.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.279 -0.888 . . . . 0.0 109.96 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.35 107.49 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.834 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER 55.77 45.46 24.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.88 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 96' ' ' GLN . . . 43.14 -122.63 3.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.58 -93.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.454 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 92' ' ' SER . 5.6 m-85 -62.92 171.52 2.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.87 134.52 7.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.0 109.998 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.01 95.22 9.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 79' ' ' ILE . 2.3 tp -101.27 132.55 21.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.97 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -121.57 -161.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.834 1.439 . . . . 0.0 109.94 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 8.4 mttt -117.99 159.75 41.65 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.213 -0.929 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -83.22 173.23 44.99 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.703 -2.624 . . . . 0.0 110.476 0.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 38.6 p90 -167.9 130.32 1.54 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 7.4 t70 -70.28 149.07 47.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.154 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 19' ' ' LEU . 36.9 mm -66.11 -40.72 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -74.96 -40.85 60.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 9.9 tp10 -51.05 -33.64 26.42 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -83.06 -73.67 0.39 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.47 -0.769 . . . . 0.0 109.666 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -36.6 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.495 -0.753 . . . . 0.0 110.069 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.596 ' HA ' ' HG2' ' A' ' 116' ' ' GLU . . . -79.9 -66.83 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.747 0.784 . . . . 0.0 109.861 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.8 tm? -38.47 -36.71 0.26 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.278 1.037 . . . . 0.0 109.259 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 50' ' ' VAL . 1.1 t -74.13 -59.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.62 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.1 pt-20 -38.72 -30.88 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.939 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -77.14 -54.36 6.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.118 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 121' ' ' HIS . . . -46.07 -60.93 1.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 108.972 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.89 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.2 mt -35.78 -42.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.227 0.537 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -92.21 50.29 1.62 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 3.4 t60 -97.79 -41.36 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.219 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -84.35 10.99 9.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.325 -0.86 . . . . 0.0 109.584 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -95.74 18.75 12.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.609 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 122.142 0.973 . . . . 0.0 108.858 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.833 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 136.07 161.38 9.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.833 HD13 ' O ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER -131.61 112.37 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.245 . . . . 0.0 109.628 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 6' ' ' VAL . 1.1 t -126.84 114.22 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.687 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.63 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 15.3 m0 -99.88 89.59 4.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.793 -1.192 . . . . 0.0 108.668 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.977 HG22 ' CB ' ' A' ' 52' ' ' LEU . 70.8 t -77.18 143.64 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.661 -0.649 . . . . 0.0 110.846 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 75.5 t -82.44 110.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 0.0 109.109 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 16' ' ' ARG . 14.0 m-20 -56.32 168.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 109.923 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.85 23.44 4.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 109.321 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 170.49 176.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.156 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' SER . 81.0 p -79.05 146.57 33.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.0 OUTLIER 75.74 4.65 3.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 12' ' ' ASP . 45.5 mm -78.11 -32.47 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.796 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -58.93 -47.61 84.44 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 15.3 t90 -58.19 -64.22 0.99 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.2 t -37.0 -69.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.534 -0.729 . . . . 0.0 110.83 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.4 mt -49.54 -76.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 110.52 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 19' ' ' LEU . 10.6 tp10 -36.05 -29.38 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.701 -0.624 . . . . 0.0 110.737 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -65.4 -55.77 16.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.0 -7.27 33.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.485 -0.759 . . . . 0.0 109.135 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.012 HD11 HG21 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -104.9 -5.36 21.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.79 26.92 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.35 38.59 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.94 80.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -1.12 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 3' ' ' ARG . . . 98.23 61.42 0.89 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.83 HD13 HG11 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -136.82 179.1 6.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -1.162 . . . . 0.0 109.765 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 29' ' ' THR . 24.2 m -100.4 75.56 1.8 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.0 t -81.09 88.66 5.97 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.384 -0.823 . . . . 0.0 110.02 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.63 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 20.2 m -97.79 145.28 26.54 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -139.93 152.16 46.15 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.732 -1.23 . . . . 0.0 110.09 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.895 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.9 m-85 -134.1 122.91 23.58 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.778 0.799 . . . . 0.0 109.023 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -43.81 -49.75 8.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.997 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.5 m120 -117.25 138.28 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.437 -1.415 . . . . 0.0 112.188 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.56 -15.03 15.92 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' VAL . 9.4 t30 -67.28 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.0 tt0 -35.66 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.869 -0.519 . . . . 0.0 109.821 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 35' ' ' ASN . 35.2 t -61.93 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.064 HD11 ' CB ' ' A' ' 72' ' ' ARG . 3.4 tm? -64.88 -16.58 63.38 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.319 0.581 . . . . 0.0 109.65 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.35 -21.06 21.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.935 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.08 -21.26 18.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 46' ' ' LYS . 7.5 mt -88.85 -96.84 0.09 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.38 -54.72 0.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 12.6 m -101.06 -5.51 25.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.941 ' HA ' HD22 ' A' ' 43' ' ' LEU . 11.7 mttt 62.73 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 109.202 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -100.66 -61.88 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 111.638 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.738 ' O ' HD22 ' A' ' 76' ' ' LEU . 36.8 Cg_endo -49.88 -177.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.6 1.316 . . . . 0.0 110.56 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.705 ' HB3' HG21 ' A' ' 119' ' ' ILE . 2.5 m-20 -90.85 -25.3 19.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 110.487 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.5 t -148.79 132.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.846 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -101.23 126.65 47.98 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.977 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -108.71 174.42 5.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.803 ' OG ' HD21 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -155.72 124.07 5.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.03 169.78 10.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 ' CE1' ' A' ' 84' ' ' HIS . 1.1 tp -144.31 115.3 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 109.403 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -141.91 -28.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.358 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.487 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -97.36 105.22 23.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.973 -1.08 . . . . 0.0 109.513 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 36.6 Cg_endo -75.99 137.91 20.11 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.042 1.549 . . . . 0.0 110.399 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 60' ' ' MET . . . 144.26 -114.18 0.79 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 3.2 mpp? -145.78 32.9 1.03 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -1.129 . . . . 0.0 109.403 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.17 4.4 2.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.897 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.487 ' HA3' ' HG3' ' A' ' 57' ' ' MET . . . -105.73 -86.88 1.94 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -79.13 -0.5 31.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 109.488 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.33 64.49 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 108.944 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.0 mp -81.65 0.21 39.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.522 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.803 HD21 ' OG ' ' A' ' 53' ' ' SER . 2.6 mm? -78.23 -14.55 59.4 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.181 -0.949 . . . . 0.0 108.525 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.08 57.09 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -69.46 -50.94 40.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 108.847 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.63 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 2.2 tt -33.59 -60.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.643 -0.66 . . . . 0.0 110.302 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 1.1 tptm -69.72 -55.75 9.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.797 -1.189 . . . . 0.0 110.152 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.8 tt0 -35.49 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.84 -0.538 . . . . 0.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 1.064 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.16 -48.4 3.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.682 -1.261 . . . . 0.0 112.232 -178.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.63 ' HD2' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -105.08 134.54 19.59 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.286 -1.509 . . . . 0.0 111.482 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.508 ' O ' ' HG2' ' A' ' 75' ' ' MET . 38.6 Cg_endo -133.97 95.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 117.376 -1.283 . . . . 0.0 111.173 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 23.1 mtt -152.41 -102.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.125 -0.984 . . . . 0.0 109.601 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -55.82 176.89 0.16 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.872 -1.143 . . . . 0.0 109.215 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.5 Cg_endo -83.85 173.16 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.716 1.377 . . . . 0.0 110.412 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 118.53 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 2.8 mt -113.56 133.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 109.767 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 ' HB2' ' A' ' 53' ' ' SER . 4.1 pt -131.13 172.22 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -85.96 153.06 22.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -89.84 137.28 32.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.396 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 169.61 41.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -162.51 164.79 26.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.463 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 29.0 t -62.04 87.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 108.705 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.919 ' HA ' HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER 61.84 30.13 18.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.945 HD12 ' CB ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 35.55 35.71 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -177.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 10.49 -61.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.082 -1.872 . . . . 0.0 111.199 -177.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . -69.68 14.49 0.1 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.825 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.945 ' CB ' HD12 ' A' ' 87' ' ' LEU . . . -128.38 -77.37 0.56 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 119.812 -1.805 . . . . 0.0 107.464 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.919 HG21 ' HA ' ' A' ' 86' ' ' ASP . 53.0 t -38.01 -29.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.711 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -103.32 -165.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 109.786 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 76.29 -165.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.306 -0.871 . . . . 0.0 109.473 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -45.56 -58.22 3.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.156 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.09 55.19 9.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -33.66 0.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 98' ' ' ALA . . . -50.95 -73.81 0.34 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . 167.65 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -137.28 -176.24 4.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.551 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.6 OUTLIER -150.76 -42.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.923 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' A' ' 100' ' ' ASP . 9.8 m-85 75.91 136.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.2 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.81 118.87 16.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.67 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -94.79 179.38 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.013 1.533 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -113.9 153.87 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.19 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -88.7 167.3 38.07 Favored 'Cis proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.535 -2.694 . . . . 0.0 110.427 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -152.09 152.19 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.3 t0 -82.3 174.13 11.42 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.046 -1.034 . . . . 0.0 108.927 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 mm -90.47 -64.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.727 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 110' ' ' GLU . 48.3 t0 -57.28 -46.95 82.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 108.567 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 1.5 tm-20 -44.5 -42.67 7.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.05 -72.27 0.2 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.012 HG21 HD11 ' A' ' 23' ' ' LEU . 40.8 t -36.21 -70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.333 0.587 . . . . 0.0 110.204 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.3 -65.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.967 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 117' ' ' ARG . 2.0 tt -34.07 -52.69 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.692 0.758 . . . . 0.0 109.576 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 50' ' ' VAL . 2.3 t -55.9 -56.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 115' ' ' VAL . 59.3 mm-40 -36.9 -37.45 0.15 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 110.61 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.552 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -84.86 -36.06 21.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.109 -179.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.552 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.23 -61.36 2.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.779 -1.201 . . . . 0.0 108.007 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.1 mt -34.84 -42.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.298 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.12 56.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -138.76 -64.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 122' ' ' TYR . 36.6 p90 -91.28 29.78 1.38 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.327 -0.858 . . . . 0.0 109.773 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -80.44 -15.27 57.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.0 109.532 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.58 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.524 0.678 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.509 ' CA ' HD23 ' A' ' 28' ' ' LEU . . . -146.55 177.98 24.53 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.723 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 69.9 mt -142.11 104.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.058 . . . . 0.0 109.006 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.979 HG13 HD13 ' A' ' 52' ' ' LEU . 2.4 t -99.47 106.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.728 -0.607 . . . . 0.0 110.464 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.661 ' HB2' HD12 ' A' ' 51' ' ' LEU . 40.6 m0 -98.73 92.32 5.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.997 HG22 ' HB2' ' A' ' 52' ' ' LEU . 59.7 t -90.86 167.76 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.904 0.859 . . . . 0.0 112.076 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.654 HG22 ' HA2' ' A' ' 36' ' ' GLY . 58.0 t -98.36 129.95 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.823 ' HA ' HG21 ' A' ' 15' ' ' ILE . 6.5 m-20 -49.3 -171.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.262 1.03 . . . . 0.0 112.187 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 29.6 t0 -159.58 -67.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -108.1 174.91 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.5 t -70.44 137.13 50.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.2 p 79.61 33.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.445 -0.785 . . . . 0.0 109.738 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.823 HG21 ' HA ' ' A' ' 10' ' ' ASP . 2.1 mm -80.95 -36.51 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 108.86 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 12.9 mtt180 -59.74 -44.54 93.74 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.446 ' O ' ' C ' ' A' ' 18' ' ' VAL . 10.7 t90 -64.57 -67.55 0.43 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.3 t -38.39 -68.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 110.734 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' HD23 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -52.1 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.486 -0.759 . . . . 0.0 110.693 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 19' ' ' LEU . 5.4 tt0 -34.62 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.795 -0.566 . . . . 0.0 110.821 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' LEU . 2.2 mmm180 -67.82 -56.65 8.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.972 -1.08 . . . . 0.0 108.655 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -6.08 34.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.184 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.997 HD11 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -102.92 -8.7 20.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.893 . . . . 0.0 109.646 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.43 -42.24 23.04 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.24 97.97 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.82 71.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.35 -1.088 . . . . 0.0 108.552 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.01 49.7 1.44 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.09 HD22 ' CG1' ' A' ' 112' ' ' VAL . 2.3 mp -141.03 173.48 11.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.867 -1.373 . . . . 0.0 110.081 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 29' ' ' THR . 3.6 m -98.96 89.93 4.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.539 -0.726 . . . . 0.0 109.165 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.516 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 21.1 t -90.75 90.91 8.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 110.283 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.575 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 m -92.74 146.97 23.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.77 135.57 28.01 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.913 -1.117 . . . . 0.0 109.464 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.584 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 47.3 m-85 -108.82 126.37 52.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.065 -1.022 . . . . 0.0 109.159 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -42.13 -25.26 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.043 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' PHE . 16.7 t-20 -125.96 127.95 46.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.054 . . . . 0.0 110.487 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.717 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -55.81 -50.0 63.32 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -45.26 -65.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 2.9 tt0 -34.63 -48.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.977 -0.452 . . . . 0.0 110.484 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.796 ' CG1' HD11 ' A' ' 51' ' ' LEU . 99.7 t -47.48 -55.56 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 40' ' ' LEU . 2.9 mm? -65.41 -27.59 68.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -62.4 -29.06 70.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.0 -35.25 29.1 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 43' ' ' LEU . 1.2 tm? -48.57 -25.76 1.88 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -35.52 -49.01 0.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.596 0.712 . . . . 0.0 109.156 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -78.41 -51.86 9.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 160.91 135.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.639 HG21 HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.93 -155.92 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.723 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.2 Cg_endo -129.64 -86.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 117.205 -1.397 . . . . 0.0 111.474 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.487 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 66.7 m-20 -115.52 -73.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.453 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.881 HG22 ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -119.29 124.02 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.08 . . . . 0.0 111.41 -177.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.796 HD11 ' CG1' ' A' ' 39' ' ' VAL . 7.7 tp -99.16 109.91 22.54 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.997 ' HB2' HG22 ' A' ' 8' ' ' VAL . 4.0 mp -103.33 160.85 14.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.6 ' OG ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.07 112.81 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.47 -0.769 . . . . 0.0 109.324 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 11' ' ' ASP . 5.8 t0 -61.09 -143.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.279 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.805 ' O ' HG23 ' A' ' 55' ' ' ILE . 1.1 tp -172.34 84.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.944 -1.098 . . . . 0.0 110.185 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.781 ' H ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER 163.72 129.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.566 ' CB ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 166.95 -61.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.442 -0.786 . . . . 0.0 109.443 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.598 ' HD3' HD22 ' A' ' 63' ' ' LEU . 36.7 Cg_endo -70.09 142.5 46.64 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 124.305 1.687 . . . . 0.0 110.233 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.39 -21.52 66.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 25.3 ttp -94.0 114.79 27.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 0.7 OUTLIER 44.32 -159.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.549 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.908 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -101.42 -109.73 3.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.908 HD23 ' C ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -175.7 105.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.658 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -57.48 -79.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.27 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.785 HD11 HD12 ' A' ' 63' ' ' LEU . 23.4 mt 81.49 -22.57 0.26 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -60.17 -42.9 95.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.669 -1.27 . . . . 0.0 108.68 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -31.57 72.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 27.1 tp60 -60.36 -62.4 1.89 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.788 HG23 ' CG ' ' A' ' 73' ' ' HIS . 1.8 mp -35.92 -77.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.755 -0.591 . . . . 0.0 109.933 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -34.07 -64.8 0.22 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.949 -0.47 . . . . 0.0 109.902 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.1 mm-40 -35.05 -51.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.738 -0.601 . . . . 0.0 110.21 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.39 53.92 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 110.911 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.788 ' CG ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -130.55 163.79 45.92 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.948 -1.095 . . . . 0.0 109.406 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 36.7 Cg_endo -84.05 -69.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.041 1.548 . . . . 0.0 110.161 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.07 45.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 77' ' ' PRO . 3.1 pp -109.28 161.55 23.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.086 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.878 ' O ' HD12 ' A' ' 76' ' ' LEU . 31.9 Cg_endo -68.63 155.06 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.88 1.463 . . . . 0.0 112.001 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -136.93 165.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.785 ' CD1' HD22 ' A' ' 102' ' ' LEU . 4.4 tt -132.59 145.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.753 -1.217 . . . . 0.0 110.796 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 100' ' ' ASP . 8.8 mt -108.46 93.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.653 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER -65.2 96.88 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.97 . . . . 0.0 109.537 -179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 81' ' ' MET . 14.9 t 123.72 177.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.67 19.81 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 109.154 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -91.49 -95.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.63 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m -71.73 86.51 0.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.059 -1.026 . . . . 0.0 109.405 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.897 ' OD2' HD13 ' A' ' 80' ' ' ILE . 9.8 t70 -179.3 -36.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.016 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.598 HD13 ' OH ' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -35.35 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.292 0.568 . . . . 0.0 110.536 -179.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -91.77 -53.51 4.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.348 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -17.55 1.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 110.361 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -96.57 -74.51 0.56 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.968 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 90' ' ' ALA . 45.8 t -33.71 -33.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.762 -0.586 . . . . 0.0 110.872 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -97.58 -160.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.814 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 95' ' ' GLN . . . 45.48 -168.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -58.2 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.126 -0.983 . . . . 0.0 109.096 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp0? -94.47 15.2 18.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.762 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -38.74 24.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 167.02 -94.38 0.11 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 69.64 7.25 6.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -1.091 . . . . 0.0 110.047 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER 49.14 112.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.636 0.732 . . . . 0.0 110.401 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.026 ' HB2' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -147.09 -169.2 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.662 -1.274 . . . . 0.0 109.843 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.598 ' OH ' HD13 ' A' ' 87' ' ' LEU . 4.8 m-85 65.32 96.1 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.433 0.635 . . . . 0.0 110.672 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.785 HD22 ' CD1' ' A' ' 79' ' ' ILE . 12.8 tp -139.36 95.59 9.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.01 -172.44 0.71 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.084 1.571 . . . . 0.0 111.525 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -141.38 166.21 23.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.592 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -75.63 119.8 6.35 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.249 -2.396 . . . . 0.0 110.767 0.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.994 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 58.5 t80 -93.18 167.17 11.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.202 -0.936 . . . . 0.0 109.398 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.618 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 16.6 t0 -74.5 -145.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.475 -0.765 . . . . 0.0 109.48 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.614 HG23 ' CD2' ' A' ' 23' ' ' LEU . 6.7 mm -139.93 -73.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.101 -0.999 . . . . 0.0 109.119 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.497 ' N ' HG22 ' A' ' 108' ' ' ILE . 42.0 t0 -60.76 -31.82 71.15 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 69.0 tt0 -55.83 -38.21 69.72 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.994 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -75.47 -70.84 0.4 Allowed 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.352 -0.842 . . . . 0.0 109.504 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.09 ' CG1' HD22 ' A' ' 28' ' ' LEU . 47.6 t -36.99 -45.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.66 0.743 . . . . 0.0 110.962 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -76.81 -72.0 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.802 . . . . 0.0 110.944 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.512 ' C ' ' O ' ' A' ' 113' ' ' ALA . 54.5 tp -33.07 -56.34 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.365 0.602 . . . . 0.0 109.946 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.799 HG11 HG11 ' A' ' 50' ' ' VAL . 93.5 t -61.86 -55.44 24.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.687 ' HA ' HD12 ' A' ' 119' ' ' ILE . 17.3 tt0 -33.09 -34.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.406 0.622 . . . . 0.0 109.962 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 115' ' ' VAL . 35.5 mtm180 -60.17 -60.71 3.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -55.13 -52.89 61.83 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 50' ' ' VAL . 4.5 mt -35.63 -35.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.245 0.545 . . . . 0.0 110.365 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -77.35 31.48 0.15 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.267 -0.896 . . . . 0.0 110.791 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -64.86 -18.04 64.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.68 -1.263 . . . . 0.0 109.228 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -86.78 40.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 109.621 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.34 50.88 2.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.398 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 59.8 ttm-85 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.709 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . -151.46 92.39 0.14 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.102 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.806 HG22 ' HE1' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -92.93 88.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 108.581 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 6' ' ' VAL . 5.4 p -98.46 118.2 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.445 0.641 . . . . 0.0 110.566 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 1.054 ' CE3' HG21 ' A' ' 31' ' ' THR . 11.4 m0 -101.77 87.74 3.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.006 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 19' ' ' LEU . 24.1 t -76.02 156.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.821 0.82 . . . . 0.0 111.079 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.992 ' CG2' HG21 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -118.61 114.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.589 ' HB3' HG21 ' A' ' 15' ' ' ILE . 3.6 t0 -175.83 172.93 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.586 -0.696 . . . . 0.0 109.418 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' N ' HG13 ' A' ' 15' ' ' ILE . 64.0 t0 -144.72 -76.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.15 -0.968 . . . . 0.0 109.151 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 13' ' ' SER . 5.1 t70 35.91 53.09 0.87 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.672 -0.642 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.0 p 36.97 100.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.129 0.49 . . . . 0.0 111.106 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 83.39 45.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.463 -0.773 . . . . 0.0 110.712 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -81.5 -38.15 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.66 -1.275 . . . . 0.0 107.86 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.53 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 1.6 mtm-85 -66.81 -31.89 72.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CE3' ' HG3' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -61.54 -69.35 0.25 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.214 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.582 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 41.1 t -40.43 -64.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.708 0.765 . . . . 0.0 110.75 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 21' ' ' ARG . 51.4 mt -62.02 -72.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 111.349 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 1.6 tt0 -33.81 -34.64 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.683 -0.636 . . . . 0.0 110.832 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.62 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 63.9 mmt-85 -67.22 -55.38 14.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 108.529 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.666 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -71.3 -3.21 19.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.203 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.042 HD11 HG21 ' A' ' 112' ' ' VAL . 1.7 mm? -102.7 -17.15 15.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 109.393 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.0 11.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.7 -21.05 49.62 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.24 -31.16 19.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.405 -1.056 . . . . 0.0 108.941 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.63 63.72 1.4 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.814 HD12 HG11 ' A' ' 112' ' ' VAL . 17.7 mt -144.73 177.53 8.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 11.5 m -98.93 93.27 5.93 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 22.4 t -89.36 78.97 7.1 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.283 -0.885 . . . . 0.0 110.07 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.054 HG21 ' CE3' ' A' ' 7' ' ' TRP . 11.5 m -76.03 126.33 30.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 108.619 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.53 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 65.3 p -132.01 138.45 48.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.953 -1.092 . . . . 0.0 109.698 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.021 ' HB2' HG22 ' A' ' 39' ' ' VAL . 11.8 m-85 -127.61 137.51 52.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 1.4 mt-10 -72.11 -27.55 62.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.46 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.978 ' O ' HG23 ' A' ' 39' ' ' VAL . 5.7 m-80 -111.01 133.71 53.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 110.137 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.862 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -56.37 -64.74 4.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -39.15 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.611 -0.935 . . . . 0.0 109.627 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.0 mm-40 -31.21 -43.82 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.43 0.634 . . . . 0.0 110.103 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.021 HG22 ' HB2' ' A' ' 33' ' ' PHE . 21.5 t -54.55 -61.83 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.429 -0.794 . . . . 0.0 109.2 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.037 HD12 HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -63.07 -12.53 27.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -77.2 -35.03 56.06 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.17 62.64 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.094 HD12 HD11 ' A' ' 69' ' ' ILE . 27.8 mt -68.97 -8.61 46.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.533 -0.729 . . . . 0.0 109.078 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -3.84 -64.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.337 0.589 . . . . 0.0 112.054 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.573 ' C ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -70.68 -61.01 1.93 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.84 -173.77 3.1 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.553 0.692 . . . . 0.0 109.407 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.024 ' HA ' HD22 ' A' ' 43' ' ' LEU . 31.5 m -99.98 150.42 36.85 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 32.8 Cg_endo -75.39 -81.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 117.485 -1.21 . . . . 0.0 112.448 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.85 -76.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.356 -1.465 . . . . 0.0 110.462 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.999 HG23 ' CD1' ' A' ' 119' ' ' ILE . 9.8 t -132.92 143.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.83 . . . . 0.0 109.062 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.899 ' HB3' HG12 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -100.08 133.0 45.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.591 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -118.85 137.86 53.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -139.22 118.98 13.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.048 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 10' ' ' ASP . 1.5 p30 -104.67 160.25 15.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.087 -1.008 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.579 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -87.67 135.42 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.499 -0.751 . . . . 0.0 109.189 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.752 ' HG3' ' HE2' ' A' ' 57' ' ' MET . 7.1 ptt85 -151.15 34.36 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.297 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.752 ' HE2' ' HG3' ' A' ' 56' ' ' ARG . 11.6 mtm -148.41 112.2 3.74 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.564 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -107.94 136.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.11 1.584 . . . . 0.0 110.149 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.23 -84.42 0.23 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.09 -32.67 4.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.172 . . . . 0.0 109.951 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' MET . 0.8 OUTLIER -122.02 150.76 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.856 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 -67.89 0.11 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.48 94.09 3.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -1.177 . . . . 0.0 109.729 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 44.04 2.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.208 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' HA3' ' A' ' 36' ' ' GLY . 11.4 mt -118.37 -28.86 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -69.85 -50.92 37.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.1 . . . . 0.0 108.108 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 66' ' ' LEU . 15.6 tttm -44.54 -35.26 2.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.886 ' HG2' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.26 -56.67 18.74 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.094 HD11 HD12 ' A' ' 43' ' ' LEU . 2.2 tp -36.39 -54.13 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.656 -0.653 . . . . 0.0 110.561 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 13.1 mmtp -53.25 -66.18 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.2 tt0 -36.74 -29.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.868 -0.52 . . . . 0.0 110.321 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -105.23 -81.22 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.154 -0.966 . . . . 0.0 111.567 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.543 ' CD2' ' HB3' ' A' ' 43' ' ' LEU . 2.4 p-80 -153.44 133.76 7.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.627 -1.295 . . . . 0.0 112.048 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.558 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 37.7 Cg_endo -134.46 -93.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.988 1.52 . . . . 0.0 109.224 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.555 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 19.0 mtt 69.19 4.6 4.66 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.403 -0.81 . . . . 0.0 110.676 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.768 HD21 ' HB ' ' A' ' 47' ' ' THR . 0.3 OUTLIER -142.37 167.12 17.37 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.984 -1.073 . . . . 0.0 109.548 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.867 ' HG2' HG22 ' A' ' 50' ' ' VAL . 32.1 Cg_endo -62.96 155.03 63.0 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.556 1.293 . . . . 0.0 111.255 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.86 101.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.824 . . . . 0.0 110.083 -178.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 50' ' ' VAL . 1.7 mp -76.44 138.83 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.128 -0.982 . . . . 0.0 109.645 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 80' ' ' ILE . 3.0 tt -126.55 113.8 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.484 ' O ' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER -62.5 148.53 45.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 109.529 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER 60.84 175.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.423 -0.798 . . . . 0.0 109.487 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' N ' HG23 ' A' ' 82' ' ' THR . . . -145.96 76.21 1.45 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' C ' ' N ' ' A' ' 86' ' ' ASP . 7.1 m-70 -138.9 -101.19 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.958 . . . . 0.0 110.524 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.54 ' OG ' ' HB3' ' A' ' 89' ' ' ALA . 21.7 p 46.87 30.09 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -177.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 88' ' ' ASP . 73.2 m-20 63.57 125.38 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.024 HD12 HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -36.15 -32.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -37.45 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.343 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -44.17 -35.99 2.46 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.974 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -62.3 -90.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.337 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.024 HG23 HD12 ' A' ' 87' ' ' LEU . 35.6 t -35.61 -63.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.602 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 14.5 m -79.94 -149.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.833 . . . . 0.0 110.351 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' ALA . . . 68.19 -87.12 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 109.901 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.504 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 2.0 p90 -106.66 -16.36 14.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.081 -1.012 . . . . 0.0 109.514 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 14.5 mt-30 44.45 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -83.72 136.33 34.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.848 -1.158 . . . . 0.0 109.358 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.03 -174.79 30.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -121.86 95.21 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.356 -1.085 . . . . 0.0 109.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 50.7 p90 163.54 -174.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -144.28 134.0 23.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.554 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.476 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 88.3 m-85 -43.77 122.24 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -100.38 112.12 63.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.151 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 36.8 Cg_endo -91.8 168.27 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.907 1.477 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -95.03 158.6 34.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -101.44 166.52 7.53 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.043 -2.482 . . . . 0.0 110.16 0.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 25.3 p90 -147.7 174.17 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 10.6 t0 -87.23 -154.91 0.26 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.302 -0.874 . . . . 0.0 108.907 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.666 HD13 ' CB ' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -121.69 -42.92 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 108.677 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -82.34 -35.07 28.23 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.49 -38.09 76.91 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -79.95 -72.14 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.639 -0.663 . . . . 0.0 109.343 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.042 HG21 HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -37.4 -53.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.661 -0.649 . . . . 0.0 110.066 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.57 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -60.58 -60.86 3.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.602 -0.686 . . . . 0.0 109.988 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -34.45 -46.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.749 0.785 . . . . 0.0 109.66 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 116' ' ' GLU . 0.8 OUTLIER -66.49 -54.67 23.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.604 ' N ' HG12 ' A' ' 115' ' ' VAL . 6.1 tt0 -34.08 -39.46 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.433 0.635 . . . . 0.0 109.847 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' VAL . 11.4 mtp180 -77.43 -47.71 19.06 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.242 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' VAL . . . -52.22 -64.53 0.79 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 0.0 108.835 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.999 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.3 mt -35.45 -41.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.597 . . . . 0.0 110.22 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.46 58.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -117.73 -19.89 9.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -78.06 -7.85 57.46 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.32 -0.863 . . . . 0.0 109.396 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.27 -34.92 24.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.442 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -153.43 146.41 14.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.625 HG23 ' CG2' ' A' ' 29' ' ' THR . 2.7 mp -105.59 112.74 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -1.159 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 52' ' ' LEU . 2.3 p -105.59 120.52 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.578 -0.701 . . . . 0.0 110.016 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.742 ' CZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -101.19 105.81 16.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.136 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' A' ' 52' ' ' LEU . 42.6 t -87.99 146.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.141 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 22.6 t -99.24 95.73 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 110.084 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 31.52 -160.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.78 0.8 . . . . 0.0 112.696 178.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.698 ' HB3' HD11 ' A' ' 15' ' ' ILE . 6.8 t0 152.48 -25.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.62 146.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 14' ' ' SER . 11.3 t -45.4 135.8 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.717 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 77.45 34.7 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -72.73 -47.55 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 108.975 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -53.0 -47.74 68.05 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.492 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 83.9 t90 -56.56 -63.77 1.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 109.667 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 17' ' ' TRP . 42.1 t -38.88 -74.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.07 0.938 . . . . 0.0 110.648 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -60.53 -68.18 0.32 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.531 -0.731 . . . . 0.0 110.858 -178.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -35.52 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.547 -0.721 . . . . 0.0 110.88 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -71.82 -53.63 12.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.991 -1.068 . . . . 0.0 108.252 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -71.87 -2.98 19.8 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.984 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.956 HD11 HG21 ' A' ' 112' ' ' VAL . 2.5 mm? -103.88 -14.9 15.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.353 -0.842 . . . . 0.0 109.411 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.58 -30.65 32.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 -38.96 58.22 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.52 72.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -1.113 . . . . 0.0 108.913 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.26 66.01 0.91 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.027 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -141.52 176.9 8.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.091 -1.241 . . . . 0.0 110.019 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 29' ' ' THR . 6.8 m -100.13 77.09 1.96 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.1 t -83.08 90.37 7.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.313 -0.867 . . . . 0.0 110.427 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 3.3 m -100.7 140.67 34.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.499 ' OG1' HG22 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -142.31 138.47 31.33 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.571 -1.331 . . . . 0.0 110.164 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.888 ' HB2' HG23 ' A' ' 39' ' ' VAL . 18.3 m-85 -107.46 159.82 16.12 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -92.02 11.5 25.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.898 -1.126 . . . . 0.0 109.711 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -149.94 128.56 12.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.813 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -56.24 -62.45 6.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.473 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -41.47 -65.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.354 -1.086 . . . . 0.0 109.383 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.5 tp10 -35.05 -47.01 0.35 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.611 -0.68 . . . . 0.0 110.276 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.895 HG12 HD13 ' A' ' 40' ' ' LEU . 1.4 t -60.83 -50.7 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 108.636 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.895 HD13 HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -69.81 -5.85 28.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 0.0 109.572 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.36 -22.07 18.57 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.3 -0.875 . . . . 0.0 108.802 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.77 -33.5 18.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.4 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 47' ' ' THR . 4.1 mt -98.59 -114.35 0.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.214 -0.929 . . . . 0.0 108.742 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.4 -51.28 0.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 58.7 m -75.23 -34.65 61.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.326 -0.859 . . . . 0.0 108.924 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 176.77 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.01 HG23 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -71.27 -152.85 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.884 ' CD ' HG22 ' A' ' 47' ' ' THR . 37.0 Cg_endo -125.32 -75.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 117.093 -1.471 . . . . 0.0 111.2 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -112.85 -73.92 0.65 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.733 -1.229 . . . . 0.0 111.14 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.907 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.6 t -140.27 137.0 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.013 -1.054 . . . . 0.0 110.672 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.653 HD23 ' CG1' ' A' ' 69' ' ' ILE . 12.5 tp -100.42 159.89 14.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.583 ' CD1' HG22 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -138.93 141.7 38.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 -179.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.541 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 6.3 t -119.27 111.21 17.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 10' ' ' ASP . 34.0 p-10 -59.77 175.13 0.39 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.909 -1.119 . . . . 0.0 109.097 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.606 HG21 ' O ' ' A' ' 81' ' ' MET . 1.2 tt -161.72 38.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -80.22 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.46 ' CE ' ' CA ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -48.59 139.0 11.53 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.653 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -113.61 165.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.818 1.43 . . . . 0.0 110.167 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 61' ' ' ASP . . . 124.03 89.31 0.85 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.1 mmt 49.05 -95.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -1.109 . . . . 0.0 109.738 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' GLY . 2.0 m-20 -50.89 164.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.09 -1.006 . . . . 0.0 109.353 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.646 ' C ' HD22 ' A' ' 63' ' ' LEU . . . 108.73 -62.38 0.29 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 86' ' ' ASP . 2.4 mm? -116.92 1.76 12.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -1.167 . . . . 0.0 109.715 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.69 67.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.176 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.713 HD22 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -167.77 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.661 ' O ' HG22 ' A' ' 69' ' ' ILE . 2.9 tp -40.18 -30.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.109 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 65' ' ' LEU . 10.8 tptt -57.66 -54.73 43.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.609 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 65' ' ' LEU . 9.4 pm0 -58.09 -39.23 78.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.204 . . . . 0.0 108.241 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 66' ' ' LEU . 1.4 tt -38.21 -36.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.577 -0.702 . . . . 0.0 110.064 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' ARG . 5.0 tptm -109.05 -69.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 110.334 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.3 tt0 -36.12 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.402 -0.811 . . . . 0.0 110.834 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -96.89 -34.93 11.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.277 -0.889 . . . . 0.0 110.06 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.759 ' CE1' HD12 ' A' ' 40' ' ' LEU . 4.7 m80 -96.83 137.14 21.37 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.547 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.6 Cg_endo -39.23 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.999 1.526 . . . . 0.0 110.999 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.85 95.72 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.726 HD12 ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -133.23 171.71 8.66 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.769 ' HG2' HG22 ' A' ' 50' ' ' VAL . 34.2 Cg_endo -59.28 107.87 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.441 1.232 . . . . 0.0 110.982 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.517 ' CG1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -102.12 82.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.54 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mp -62.73 155.56 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.988 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 79' ' ' ILE . 1.3 pp -160.39 150.88 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.606 ' O ' HG21 ' A' ' 55' ' ' ILE . 40.3 mtt -90.85 126.99 36.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 109.511 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 77.8 p -74.27 153.53 39.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 0.0 109.708 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 163.65 39.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.349 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER 69.06 157.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 51.0 m 63.04 152.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.838 ' HB2' HD12 ' A' ' 63' ' ' LEU . 32.1 t0 84.2 -49.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.726 -0.609 . . . . 0.0 109.868 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -33.75 -51.02 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.0 110.528 -179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.23 -55.48 10.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.649 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.5 -40.1 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 109.679 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -73.19 -81.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 42.8 t -33.38 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.776 -0.578 . . . . 0.0 110.613 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -99.79 -155.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.919 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 56.63 75.68 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.442 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' GLN . 0.7 OUTLIER 59.95 -89.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.378 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 71.42 138.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -146.01 -63.18 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.303 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.37 52.72 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.82 38.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -1.151 . . . . 0.0 109.398 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 100' ' ' ASP . 8.2 m-85 -120.42 105.52 10.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.794 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.584 ' O ' ' CD1' ' A' ' 101' ' ' TYR . 14.1 t0 -61.96 -139.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.886 . . . . 0.0 109.181 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 169.78 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 108.959 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.74 132.17 62.0 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 109.777 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 104' ' ' LYS . 36.8 Cg_endo -105.87 -92.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.89 1.469 . . . . 0.0 110.135 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER 161.28 147.77 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.253 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.436 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -82.26 170.9 56.84 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.721 -2.616 . . . . 0.0 110.392 -0.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -149.7 138.96 21.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 25.3 t0 -76.77 170.67 16.03 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.036 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 22' ' ' ALA . 19.1 mm -84.23 -58.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.049 -1.032 . . . . 0.0 109.896 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -63.33 -46.16 87.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 108.533 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 20.7 tp10 -47.22 -37.9 11.22 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -75.04 -73.76 0.23 Allowed 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.349 -0.844 . . . . 0.0 109.796 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 28' ' ' LEU . 41.4 t -39.02 -56.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -59.97 -70.15 0.18 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.729 . . . . 0.0 110.987 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.769 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.0 tm? -34.37 -57.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.435 0.636 . . . . 0.0 110.016 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.69 ' N ' HD13 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -53.92 -52.66 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.555 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.0 tt0 -34.56 -49.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.274 0.559 . . . . 0.0 110.324 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -56.02 -54.95 38.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.61 -60.56 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.09 -1.007 . . . . 0.0 108.366 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.907 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.7 mt -37.0 -35.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.739 -0.601 . . . . 0.0 110.865 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.593 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 7.6 t -33.87 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.936 -0.478 . . . . 0.0 111.52 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.593 ' CB ' ' O ' ' A' ' 120' ' ' SER . 2.2 t-160 86.52 39.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' HIS . 1.1 m-85 37.36 77.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.583 0.706 . . . . 0.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.07 39.28 1.04 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.74 . . . . 0.0 109.595 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.602 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.318 0.58 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 3' ' ' ARG . 3.5 mm-40 63.92 -163.83 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 109.277 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 65.41 156.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 109.198 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.841 ' C ' HD12 ' A' ' 5' ' ' ILE . . . -162.78 176.94 39.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.841 HD12 ' C ' ' A' ' 4' ' ' GLY . 3.6 mp -135.95 99.27 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.055 . . . . 0.0 109.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 8' ' ' VAL . 2.7 t -101.19 111.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 109.821 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.606 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 9.5 m0 -100.18 92.78 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.106 HG22 ' HB2' ' A' ' 52' ' ' LEU . 48.3 t -95.98 162.92 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.484 -0.76 . . . . 0.0 110.735 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.686 ' HB ' HG21 ' A' ' 39' ' ' VAL . 3.7 p -119.16 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 15' ' ' ILE . 1.4 p30 -102.14 -120.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.913 -1.117 . . . . 0.0 110.181 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' HD3' ' A' ' 58' ' ' PRO . 31.8 t0 -135.43 -61.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.633 -1.292 . . . . 0.0 110.019 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.45 175.26 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -59.76 160.26 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.451 -0.78 . . . . 0.0 109.634 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 13' ' ' SER . 2.1 m 79.93 -7.56 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.442 -0.786 . . . . 0.0 109.75 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.629 HG21 ' HB2' ' A' ' 10' ' ' ASP . 26.6 mm -96.89 -45.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -63.59 -30.96 72.0 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.468 ' O ' ' C ' ' A' ' 18' ' ' VAL . 5.7 t90 -67.28 -60.28 2.72 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 24.8 t -36.6 -57.5 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.165 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.585 ' C ' HD12 ' A' ' 23' ' ' LEU . 8.8 mt -55.73 -72.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 1.8 tt0 -35.14 -30.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.868 -0.52 . . . . 0.0 110.674 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -66.37 -55.16 17.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 108.437 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.01 -12.96 61.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD22 ' HB2' ' A' ' 30' ' ' CYS . 0.9 OUTLIER -92.9 -11.11 34.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.475 -0.765 . . . . 0.0 109.754 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.69 -46.09 40.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.83 -41.97 52.32 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.49 79.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -1.003 . . . . 0.0 108.572 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.05 50.22 3.32 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.895 HD13 HG11 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -120.23 173.71 6.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 0.0 109.971 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 29' ' ' THR . 51.6 m -100.26 65.75 1.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 1.035 ' HB2' HD22 ' A' ' 23' ' ' LEU . 32.0 t -82.23 80.08 8.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.217 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.606 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 1.3 m -75.1 129.32 37.36 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -126.96 136.76 52.71 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.059 -1.026 . . . . 0.0 109.686 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.085 ' HB2' HG22 ' A' ' 39' ' ' VAL . 2.1 m-85 -110.72 -176.15 2.9 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 109.214 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 19.4 mt-10 -95.43 -47.57 6.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.935 . . . . 0.0 110.429 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.977 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.2 t-20 -116.15 144.7 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.064 -1.022 . . . . 0.0 109.949 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.514 ' CA ' HG21 ' A' ' 9' ' ' VAL . . . -54.14 -33.13 51.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 38' ' ' GLU . 11.4 t-20 -61.76 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.033 -1.275 . . . . 0.0 108.624 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.5 mm-40 -34.64 -35.28 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.348 0.594 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.085 HG22 ' HB2' ' A' ' 33' ' ' PHE . 75.0 t -55.33 -59.09 2.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.396 -0.815 . . . . 0.0 109.453 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.849 HD12 ' CB ' ' A' ' 72' ' ' ARG . 0.9 OUTLIER -67.66 -14.82 63.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.568 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -68.25 -30.91 70.06 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.8 -31.9 19.35 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.657 HD13 HG23 ' A' ' 47' ' ' THR . 89.9 mt -92.34 1.54 57.17 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.478 -0.764 . . . . 0.0 110.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.508 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -29.47 -38.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' LEU . 2.5 m -70.15 -55.73 8.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 108.746 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER 169.86 135.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.415 -0.803 . . . . 0.0 109.969 179.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.01 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -50.19 157.2 1.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 109.666 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.94 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.7 Cg_endo -88.13 -70.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.918 1.483 . . . . 0.0 110.058 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -109.32 -65.22 1.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 0.0 109.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.799 HG21 HG13 ' A' ' 115' ' ' VAL . 2.6 t -149.57 144.16 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.055 -1.028 . . . . 0.0 110.123 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 47' ' ' THR . 3.5 tp -100.54 155.16 18.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.894 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.106 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -145.43 169.45 18.31 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.677 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.748 ' OG ' HG23 ' A' ' 80' ' ' ILE . 27.4 p -154.56 139.7 17.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.69 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 25.4 m-20 -86.78 -172.25 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.294 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -120.67 5.54 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.12 -0.988 . . . . 0.0 109.689 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.3 OUTLIER -86.62 174.13 9.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.638 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.48 ' SD ' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 170.87 177.16 0.11 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.795 . . . . 0.0 109.176 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' SD ' ' A' ' 57' ' ' MET . 36.8 Cg_endo -98.32 120.33 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.953 1.502 . . . . 0.0 110.508 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.55 -144.89 23.55 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 12.2 mtt -88.56 -156.92 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.384 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' MET . 37.3 m-20 64.75 179.96 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.78 68.73 0.22 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HG ' ' HG3' ' A' ' 57' ' ' MET . 1.1 mp 61.64 92.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.611 ' C ' HD13 ' A' ' 65' ' ' LEU . . . -91.41 14.24 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.208 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.774 HD22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -100.9 14.26 32.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -0.846 . . . . 0.0 109.357 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.741 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -65.44 -65.0 0.73 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.4 ttpp -47.0 -26.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.573 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.03 -60.54 2.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -33.54 -57.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.283 0.563 . . . . 0.0 110.415 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HE2' ' CG2' ' A' ' 69' ' ' ILE . 7.0 mmtt -59.84 -61.05 2.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.258 -0.901 . . . . 0.0 109.847 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 70' ' ' LYS . 21.9 mm-40 -32.98 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.894 -0.504 . . . . 0.0 111.385 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.849 ' CB ' HD12 ' A' ' 40' ' ' LEU . 4.9 mpt_? -83.39 -91.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 110.801 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.769 ' NE2' HD22 ' A' ' 51' ' ' LEU . 3.0 p80 -68.49 151.95 96.92 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.388 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 33.8 Cg_endo -49.63 -178.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.638 1.336 . . . . 0.0 110.689 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.5 ptp -85.16 56.05 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.907 HD21 ' OG1' ' A' ' 47' ' ' THR . 0.6 OUTLIER -70.42 158.68 87.12 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.4 Cg_endo -44.61 136.98 8.88 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.501 1.263 . . . . 0.0 112.642 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.884 HG23 ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -145.24 177.99 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.547 ' O ' HD23 ' A' ' 52' ' ' LEU . 26.1 mt -158.67 119.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.216 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.748 HG23 ' OG ' ' A' ' 53' ' ' SER . 30.5 mt -108.6 128.53 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 108.818 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 54' ' ' ASP . 1.4 mtm -56.46 174.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.73 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -53.85 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 110.215 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 82' ' ' THR . . . 80.78 162.54 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.651 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -119.75 -21.55 7.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.421 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.7 m -123.57 18.22 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.74 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -96.73 -18.39 19.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.228 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.765 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.2 tt -35.15 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.897 -0.502 . . . . 0.0 110.935 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASP . 11.0 t70 -70.27 -57.79 4.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.862 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 66' ' ' LEU . . . -65.68 -16.07 63.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB1' ' OH ' ' A' ' 101' ' ' TYR . . . -83.12 -42.36 17.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 87' ' ' LEU . 46.4 t -35.85 -29.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.459 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ALA . 30.3 t -80.64 31.69 0.3 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.5 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.37 -53.6 2.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.912 -1.118 . . . . 0.0 108.624 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 10.7 m-30 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -0.894 . . . . 0.0 108.747 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 2.3 tp-100 -86.81 91.77 8.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.782 . . . . 0.0 109.424 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 45.69 64.99 1.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.29 -179.29 15.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.35 38.08 1.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.952 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.884 ' CD1' HG23 ' A' ' 78' ' ' VAL . 6.6 p90 -162.2 133.4 5.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.04 -1.038 . . . . 0.0 109.874 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 100' ' ' ASP . 58.7 p30 -97.98 -159.29 0.73 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.41 -0.806 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.594 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 5.7 m-85 -100.66 139.02 36.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.23 120.02 52.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.026 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -95.29 -165.18 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.909 1.478 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -121.86 157.69 56.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.602 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -97.28 169.92 12.43 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.712 -2.62 . . . . 0.0 110.441 0.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 106' ' ' PHE . 20.8 p90 -149.21 138.1 21.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.549 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 16.3 t70 -79.41 171.47 15.13 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.92 . . . . 0.0 109.018 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -70.82 -56.14 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.014 -1.054 . . . . 0.0 109.014 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' HG22 ' A' ' 108' ' ' ILE . 23.5 t0 -68.7 -39.72 80.37 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.549 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 4.7 tp10 -48.42 -46.79 37.89 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -72.28 -74.06 0.17 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.895 HG11 HD13 ' A' ' 28' ' ' LEU . 32.3 t -36.73 -73.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.367 0.603 . . . . 0.0 109.749 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -38.11 -64.41 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.79 -0.569 . . . . 0.0 110.292 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 113' ' ' ALA . 8.2 tp -34.83 -55.28 0.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.785 0.802 . . . . 0.0 109.741 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.799 HG13 HG21 ' A' ' 50' ' ' VAL . 1.5 t -57.01 -57.37 10.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -32.99 -40.3 0.05 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.324 0.583 . . . . 0.0 110.403 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' VAL . 18.1 mtm180 -75.42 -52.59 10.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.327 -0.858 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.2 -60.83 2.21 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.117 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.772 ' CD1' HG23 ' A' ' 50' ' ' VAL . 3.4 mt -36.06 -41.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.395 0.617 . . . . 0.0 109.978 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 61.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.321 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -135.42 -65.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 2.9 p90 -99.07 95.4 7.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -117.1 0.79 12.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.284 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 2' ' ' GLN . 7.2 pt20 -159.91 101.53 1.45 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.031 -1.043 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.53 44.15 1.04 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.136 -0.977 . . . . 0.0 109.34 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.692 ' HA3' HD21 ' A' ' 28' ' ' LEU . . . 147.65 171.75 17.03 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 10.6 mt -147.89 97.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.954 . . . . 0.0 108.84 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.878 ' CG2' HD12 ' A' ' 52' ' ' LEU . 2.6 p -100.2 118.64 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.658 0.742 . . . . 0.0 110.651 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.635 ' CE2' ' HG3' ' A' ' 48' ' ' PRO . 37.4 m0 -103.27 104.25 14.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.938 . . . . 0.0 108.825 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.791 HG22 ' CB ' ' A' ' 52' ' ' LEU . 59.1 t -97.57 147.74 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.913 ' HB ' HG21 ' A' ' 39' ' ' VAL . 9.8 p -123.9 129.45 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.698 ' CB ' HG21 ' A' ' 15' ' ' ILE . 13.9 t0 -135.51 -77.15 0.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.817 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 34' ' ' GLU . 64.8 t0 -148.33 -70.73 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.697 -1.252 . . . . 0.0 111.624 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.71 178.05 4.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.01 -1.056 . . . . 0.0 111.141 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 p -66.36 -24.73 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.641 -0.662 . . . . 0.0 109.832 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.4 p -62.54 -25.24 67.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.393 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.698 HG21 ' CB ' ' A' ' 10' ' ' ASP . 1.2 mp -66.59 -31.16 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 11.4 ttp180 -61.65 -49.13 77.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 13.2 t90 -48.73 -65.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 48.2 t -39.44 -70.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.048 0.928 . . . . 0.0 110.364 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -44.88 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.2 tt0 -32.73 -40.75 0.05 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.864 -0.522 . . . . 0.0 110.773 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 4.5 mtp180 -58.06 -57.19 13.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.977 . . . . 0.0 109.043 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.714 ' HB1' HG21 ' A' ' 108' ' ' ILE . . . -68.29 -6.34 23.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 0.0 109.579 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -98.38 -12.53 21.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.79 51.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 -33.48 87.35 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 23' ' ' LEU . . . -73.47 -24.78 60.25 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.482 -1.01 . . . . 0.0 108.761 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.768 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 69.41 62.84 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.109 HD22 HG13 ' A' ' 112' ' ' VAL . 1.2 mp -142.25 -176.5 4.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.113 -1.228 . . . . 0.0 109.974 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.562 ' CG2' HG23 ' A' ' 5' ' ' ILE . 24.2 m -92.44 100.61 13.13 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 8.9 t -95.28 88.72 5.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 110.393 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.631 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 2.3 m -99.45 141.63 32.0 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.54 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -134.55 167.13 21.36 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.655 -1.278 . . . . 0.0 110.14 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.827 ' HB2' HG22 ' A' ' 39' ' ' VAL . 26.8 m-85 -140.15 171.74 13.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -105.15 -13.23 15.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.175 -0.953 . . . . 0.0 108.946 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.709 ' O ' HG23 ' A' ' 39' ' ' VAL . 55.6 m-20 -138.16 137.33 37.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.554 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.543 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -55.43 -49.72 63.26 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 5.0 t30 -50.54 -69.41 0.11 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.187 -1.184 . . . . 0.0 108.727 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.681 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -36.06 -42.14 0.28 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 110.707 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.913 HG21 ' HB ' ' A' ' 9' ' ' VAL . 39.4 t -53.05 -53.43 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.205 -0.934 . . . . 0.0 108.934 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.04 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.8 mt -62.02 -28.57 69.67 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -61.19 -34.66 75.42 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . . . -68.93 -40.52 78.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -43.0 -65.35 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' N ' HD23 ' A' ' 43' ' ' LEU . . . 28.14 -73.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.916 0.865 . . . . 0.0 110.761 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.76 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -84.69 27.33 0.74 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 82.69 134.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.345 0.593 . . . . 0.0 110.193 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.595 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -64.59 -149.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.367 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HG3' ' CE2' ' A' ' 7' ' ' TRP . 38.0 Cg_endo -125.54 -83.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 117.298 -1.335 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.575 ' OD2' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -114.31 -50.78 2.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.298 -1.501 . . . . 0.0 111.814 -178.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.851 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.1 t -149.51 149.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.396 -1.44 . . . . 0.0 109.896 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.073 HD12 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.96 156.72 17.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 109.293 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.878 HD12 ' CG2' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -137.29 124.92 22.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.06 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.716 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -113.76 133.09 55.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.053 -1.029 . . . . 0.0 110.385 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.525 ' CB ' ' OD1' ' A' ' 10' ' ' ASP . 17.5 p-10 -80.0 -158.9 0.19 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -0.816 . . . . 0.0 109.876 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.779 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -173.89 86.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.762 ' N ' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -168.38 -163.86 0.48 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.372 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.539 ' CE ' ' O ' ' A' ' 61' ' ' ASP . 2.1 mtm 72.59 131.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.626 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -82.38 106.6 1.55 Allowed 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.098 1.578 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.84 -130.87 8.24 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 1.3 mtt -110.14 -164.51 0.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.682 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.539 ' O ' ' CE ' ' A' ' 57' ' ' MET . 2.0 t70 80.39 -9.72 1.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.99 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.925 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -133.8 -48.7 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.925 HD23 ' C ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -105.88 -175.0 2.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.073 -1.251 . . . . 0.0 109.691 -179.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.62 21.96 9.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.035 -1.04 . . . . 0.0 108.304 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.558 ' HB3' ' NE2' ' A' ' 68' ' ' GLN . 6.1 mt -125.27 -12.47 6.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.767 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.578 HD11 HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -61.1 -65.21 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.8 tptp -44.06 -37.53 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.861 ' HG3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -57.16 -52.35 65.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.029 -1.045 . . . . 0.0 108.678 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.944 HG23 HD13 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -35.2 -56.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.647 -0.658 . . . . 0.0 110.679 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.04 -53.89 13.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 110.443 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' LYS . 13.3 mm-40 -32.42 -44.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.755 -0.591 . . . . 0.0 110.815 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 1.04 ' HB2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -91.85 -44.84 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.174 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 1.073 ' CE1' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -47.89 159.4 0.47 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.294 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD2' HD23 ' A' ' 76' ' ' LEU . 36.9 Cg_endo -80.8 -66.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.078 1.567 . . . . 0.0 110.15 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.419 ' O ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -175.45 52.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.26 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 77' ' ' PRO . 1.1 pp -114.97 157.44 43.3 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 0.0 109.05 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 50' ' ' VAL . 37.4 Cg_endo -63.81 151.7 83.97 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.931 1.49 . . . . 0.0 111.203 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.037 HG12 ' CB ' ' A' ' 51' ' ' LEU . 2.9 m -142.87 97.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.808 HD11 ' CG2' ' A' ' 115' ' ' VAL . 8.4 mt -59.99 167.03 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.058 -1.026 . . . . 0.0 109.479 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.716 HD12 ' O ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -161.93 133.79 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.098 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.502 ' N ' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -63.78 158.0 22.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.407 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -98.0 151.65 20.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.411 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -173.46 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -178.49 65.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.683 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 p -173.67 -36.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.588 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.1 m-20 -57.17 -31.07 65.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 109.683 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -34.89 -28.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.752 -0.593 . . . . 0.0 111.437 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -93.46 -52.84 4.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.883 -1.136 . . . . 0.0 110.776 -178.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -1.69 10.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.938 -1.101 . . . . 0.0 110.484 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -107.09 -75.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 109.182 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 71.1 t -34.42 -32.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.279 0.561 . . . . 0.0 110.393 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -108.57 -149.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 53.66 -95.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -128.67 70.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.0 109.084 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 2.3 tm0? -60.46 -21.59 62.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -0.82 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -69.81 -165.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.56 99.33 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.506 ' C ' ' CD2' ' A' ' 99' ' ' PHE . . . -146.45 -43.51 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.276 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CD2' HG23 ' A' ' 78' ' ' VAL . 16.1 p90 172.96 137.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.446 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -104.11 -161.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -0.808 . . . . 0.0 109.294 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -104.95 149.67 25.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 106' ' ' PHE . 13.3 mt -112.41 116.21 48.8 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.944 . . . . 0.0 109.356 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 36.5 Cg_endo -93.99 148.81 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.651 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 34.3 mtmt -101.88 149.84 36.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.07 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -78.4 140.52 60.72 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.749 -2.605 . . . . 0.0 110.439 -0.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 78.0 t80 -116.14 171.51 7.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.861 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 1.1 t70 -102.25 113.4 26.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.537 -0.727 . . . . 0.0 109.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.714 HG21 ' HB1' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -55.0 -30.29 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.96 -1.087 . . . . 0.0 109.335 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.98 -45.19 28.36 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 108.702 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 34.8 tt0 -50.89 -34.23 27.39 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -76.51 -72.99 0.3 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.651 -0.655 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.109 HG13 HD22 ' A' ' 28' ' ' LEU . 7.0 t -35.27 -45.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.446 -0.784 . . . . 0.0 110.61 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -73.05 -72.94 0.22 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.73 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -34.69 -57.15 0.53 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.521 0.676 . . . . 0.0 109.536 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.808 ' CG2' HD11 ' A' ' 79' ' ' ILE . 1.2 t -49.78 -58.49 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.659 ' N ' HG12 ' A' ' 115' ' ' VAL . 21.1 tp10 -35.71 -41.11 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.739 -0.601 . . . . 0.0 111.092 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 114' ' ' LEU . 4.3 ptm180 -82.47 -36.78 26.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.109 -0.994 . . . . 0.0 110.207 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.38 -62.67 1.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.87 -1.144 . . . . 0.0 108.308 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 50' ' ' VAL . 10.6 mt -33.71 -39.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.98 -0.45 . . . . 0.0 110.626 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.615 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 11.7 t -5.01 -69.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.254 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 120' ' ' SER . 6.6 m170 142.3 56.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 36.01 32.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.537 0.684 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-30 -69.43 -9.36 53.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.51 -0.744 . . . . 0.0 109.804 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 8.7 mt-10 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.626 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.389 0.614 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 1.3 mt-30 -73.41 -178.43 3.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.438 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.8 OUTLIER 70.66 89.81 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.917 . . . . 0.0 109.81 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.489 ' HA2' ' OD2' ' A' ' 49' ' ' ASP . . . -165.62 119.52 0.87 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.598 HG23 HG21 ' A' ' 29' ' ' THR . 59.0 mt -104.89 91.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.306 -1.114 . . . . 0.0 109.884 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 p -105.87 125.63 61.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.89 ' CZ2' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.73 90.01 4.09 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.808 -1.183 . . . . 0.0 109.433 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.782 HG22 HD12 ' A' ' 52' ' ' LEU . 86.1 t -79.88 113.56 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 108.982 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.791 HG21 ' HA2' ' A' ' 36' ' ' GLY . 7.5 p -88.82 98.29 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.213 -0.929 . . . . 0.0 109.571 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 1.046 ' HB3' HG21 ' A' ' 15' ' ' ILE . 23.0 t0 -156.61 133.21 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.627 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.56 ' HB3' ' CG1' ' A' ' 15' ' ' ILE . 2.0 t0 7.43 68.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.285 0.564 . . . . 0.0 111.804 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.4 p-10 -46.46 177.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.552 -0.718 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 3.1 t 82.86 -68.49 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -98.18 -40.0 8.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.101 -1.0 . . . . 0.0 108.951 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 1.046 HG21 ' HB3' ' A' ' 10' ' ' ASP . 20.0 mm -68.34 -36.3 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 22.9 ttp85 -60.93 -42.38 98.06 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.483 ' O ' ' C ' ' A' ' 18' ' ' VAL . 11.5 t90 -60.29 -62.03 2.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 31.1 t -37.9 -68.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 109.678 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -56.15 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.632 -0.667 . . . . 0.0 110.442 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 2.1 tt0 -36.05 -64.31 0.32 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.489 -0.757 . . . . 0.0 111.983 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -39.78 -43.53 1.44 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -178.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . -71.5 -39.69 70.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.695 -1.253 . . . . 0.0 108.548 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD11 ' CG2' ' A' ' 112' ' ' VAL . 1.3 tp -69.73 -6.13 29.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.36 -33.96 42.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.0 109.038 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.87 -27.85 73.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' A' ' 2' ' ' GLN . . . -93.83 1.52 56.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -1.108 . . . . 0.0 109.229 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.95 72.22 0.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.751 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -133.92 -179.84 5.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.116 -1.226 . . . . 0.0 110.008 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.598 HG21 HG23 ' A' ' 5' ' ' ILE . 29.2 m -102.1 84.49 2.51 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.2 t -93.11 90.83 7.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.482 -0.761 . . . . 0.0 110.644 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.89 HG21 ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -97.39 138.66 34.5 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 1.7 p -146.43 134.53 21.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.737 -1.227 . . . . 0.0 110.696 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.962 ' HB2' HG23 ' A' ' 39' ' ' VAL . 7.0 m-30 -108.53 -158.9 0.67 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' CB ' ' H ' ' A' ' 12' ' ' ASP . 6.7 pt-20 -121.83 -32.88 3.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.607 -1.308 . . . . 0.0 109.592 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.568 ' C ' HG21 ' A' ' 9' ' ' VAL . 28.1 m120 -116.44 123.32 47.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.863 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.8 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -41.37 -36.47 1.45 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -62.62 -61.2 2.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 0.0 108.488 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.2 tp10 -35.55 -50.95 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.496 0.665 . . . . 0.0 109.876 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.076 HG12 HD13 ' A' ' 40' ' ' LEU . 2.1 t -63.58 -44.82 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.792 . . . . 0.0 108.907 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.076 HD13 HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -78.8 4.33 14.22 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 109.476 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.55 -23.25 13.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.78 -33.03 11.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.131 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.83 HD12 ' CG2' ' A' ' 47' ' ' THR . 3.2 mm? -65.13 -12.34 49.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.152 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.46 -31.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.518 -0.738 . . . . 0.0 110.186 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -73.91 -55.98 5.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.616 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -174.33 152.89 1.85 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.135 -0.978 . . . . 0.0 109.671 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.83 ' CG2' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -95.65 171.04 6.86 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.251 -0.905 . . . . 0.0 108.92 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.9 Cg_endo -119.68 -67.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 117.211 -1.392 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.708 ' C ' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -122.68 -78.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.403 -1.436 . . . . 0.0 111.741 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.807 HG23 ' CD1' ' A' ' 119' ' ' ILE . 4.0 t -138.96 141.31 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.941 -1.1 . . . . 0.0 110.537 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.936 HD11 HG11 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -106.24 135.99 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 110.273 -179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.049 HD22 ' CG2' ' A' ' 79' ' ' ILE . 5.9 mt -115.99 152.77 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 0.0 109.634 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.732 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.5 t -114.77 125.95 54.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.656 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.61 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 28.1 p30 -64.52 -166.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.01 HG12 ' HB3' ' A' ' 83' ' ' ALA . 1.9 tt -178.89 33.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -130.41 6.9 4.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.678 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.926 ' HG3' HD13 ' A' ' 63' ' ' LEU . 56.8 mmm -42.97 117.39 2.19 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -55.04 145.91 61.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.89 1.469 . . . . 0.0 110.231 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.15 101.42 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 60.56 49.58 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -1.164 . . . . 0.0 109.248 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 57' ' ' MET . 11.1 p-10 -52.64 144.76 13.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.773 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 155.79 -81.81 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.926 HD13 ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER 42.95 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -1.125 . . . . 0.0 109.889 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -58.76 -74.36 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 108.52 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.822 HD21 HD23 ' A' ' 63' ' ' LEU . 11.6 mt 76.48 -10.29 1.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 53' ' ' SER . 4.0 mm? -74.92 -39.81 61.2 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.848 -1.157 . . . . 0.0 108.827 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -64.97 -27.86 69.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.86 ' CG ' HD23 ' A' ' 40' ' ' LEU . 22.2 tp60 -65.26 -62.35 1.59 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.607 ' CG1' HD11 ' A' ' 40' ' ' LEU . 17.4 mt -35.79 -76.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.557 -0.714 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -43.02 -61.23 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.972 -1.08 . . . . 0.0 109.384 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.0 mt-30 -36.56 -42.1 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.505 -0.747 . . . . 0.0 111.705 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -131.89 42.12 3.19 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.83 -1.169 . . . . 0.0 111.289 -177.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.63 ' NE2' ' HB2' ' A' ' 43' ' ' LEU . 54.6 m80 -147.9 154.16 43.19 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.817 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 75' ' ' MET . 35.8 Cg_endo -60.9 -5.71 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.806 1.424 . . . . 0.0 112.092 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 74' ' ' PRO . 8.2 mtp 80.02 104.86 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.026 -1.046 . . . . 0.0 110.204 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.65 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -146.24 156.13 50.26 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 31.3 Cg_endo -43.04 130.48 5.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 117.203 -1.398 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.411 HG11 HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -123.32 178.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.049 ' CG2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -149.85 171.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 79' ' ' ILE . 2.7 tt -160.67 137.81 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.59 ' O ' HD13 ' A' ' 55' ' ' ILE . 7.9 mtt -85.91 135.05 33.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.047 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -72.52 149.81 43.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.013 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . 166.32 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 109.722 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 69.46 158.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 109.975 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 58.2 m 58.64 84.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 109.759 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' HD11 ' A' ' 55' ' ' ILE . 2.3 p-10 165.89 -43.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.59 HD23 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -35.03 -29.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.869 -0.52 . . . . 0.0 111.139 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.6 t0 -67.35 -65.0 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.046 -1.034 . . . . 0.0 110.194 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.67 -10.91 9.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.078 -1.014 . . . . 0.0 110.291 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -97.28 -76.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.006 -1.059 . . . . 0.0 109.765 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG2' HD23 ' A' ' 87' ' ' LEU . 51.0 t -34.1 -30.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.834 -0.541 . . . . 0.0 110.961 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.69 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -106.34 171.49 7.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.872 -1.142 . . . . 0.0 109.992 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 77.18 56.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER 60.04 47.43 9.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 1.7 pt20 -43.31 -34.42 1.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.7 72.54 0.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.4 -69.0 0.03 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . -139.38 59.81 1.59 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.25 . . . . 0.0 110.06 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.52 167.23 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.087 -1.008 . . . . 0.0 109.255 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 101' ' ' TYR . 4.0 t0 -134.66 -30.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 73.62 105.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.95 -1.094 . . . . 0.0 108.506 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -116.95 118.77 35.92 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.043 -1.036 . . . . 0.0 110.25 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -105.97 149.0 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.046 1.551 . . . . 0.0 109.884 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -91.41 147.95 36.51 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 0.0 109.516 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -89.92 155.9 31.1 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 120.536 -2.693 . . . . 0.0 110.396 0.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 17.2 p90 -131.14 169.22 16.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 109.357 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 1.3 t70 -85.72 168.02 14.74 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.131 -0.981 . . . . 0.0 108.7 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 23' ' ' LEU . 31.6 mm -95.15 -61.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.91 -1.119 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 110' ' ' GLU . 63.1 t0 -54.97 -50.06 69.86 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.057 -1.027 . . . . 0.0 108.934 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 21.7 tp10 -44.13 -47.57 9.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -62.46 -67.74 0.39 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.066 ' CG2' HD11 ' A' ' 23' ' ' LEU . 48.1 t -35.4 -73.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.15 0.5 . . . . 0.0 110.584 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -39.12 -66.53 0.28 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.539 -0.725 . . . . 0.0 110.492 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.78 HD13 ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -34.8 -53.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.809 0.814 . . . . 0.0 109.663 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 114' ' ' LEU . 1.6 t -56.6 -60.81 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG12 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -37.82 -43.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.652 -0.655 . . . . 0.0 111.141 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 5.7 ptp180 -77.1 -36.66 55.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.975 -1.078 . . . . 0.0 110.594 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.588 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.71 -67.17 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.862 -1.149 . . . . 0.0 108.089 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.807 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.6 mt -37.07 -41.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.237 0.541 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.23 60.74 4.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -128.92 -54.47 1.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.461 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 22.7 p90 -78.35 136.45 37.69 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.85 -30.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.397 179.889 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 17.1 ttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 1' ' ' MET . 2.2 pt20 173.99 164.39 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.35 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -156.13 51.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 5' ' ' ILE . . . 149.45 177.38 23.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -153.25 90.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -1.102 . . . . 0.0 108.821 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.882 HG12 HG23 ' A' ' 8' ' ' VAL . 4.1 t -94.85 110.5 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.587 -0.696 . . . . 0.0 110.044 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.753 ' O ' HD23 ' A' ' 51' ' ' LEU . 12.0 m0 -99.94 81.05 2.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.009 HG22 ' CB ' ' A' ' 52' ' ' LEU . 43.8 t -83.91 172.34 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.347 0.594 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.971 ' HB ' HG21 ' A' ' 39' ' ' VAL . 7.0 p -134.09 140.78 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 108.7 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.887 ' HB3' HG21 ' A' ' 15' ' ' ILE . 4.6 t0 -136.71 -153.39 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.965 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD1' ' HB3' ' A' ' 57' ' ' MET . 13.6 t70 -80.6 -95.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' SER . 2.5 p-10 169.4 176.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 109.931 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 80.7 69.48 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.652 -0.655 . . . . 0.0 109.882 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.72 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.88 46.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.887 HG21 ' HB3' ' A' ' 10' ' ' ASP . 1.2 mp -112.05 -44.34 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 14.7 ttp180 -65.72 -33.06 75.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.65 -66.29 0.57 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 17' ' ' TRP . 38.3 t -39.62 -65.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.012 0.91 . . . . 0.0 110.241 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 23' ' ' LEU . 21.2 mt -55.08 -76.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.88 -0.512 . . . . 0.0 110.845 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 3.6 tm-20 -33.62 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.573 -0.704 . . . . 0.0 110.922 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 19' ' ' LEU . 22.1 tpt180 -64.89 -56.3 14.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.982 -1.074 . . . . 0.0 108.486 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 108' ' ' ILE . . . -72.46 -2.32 19.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD22 ' CB ' ' A' ' 30' ' ' CYS . 9.7 mt -100.23 -17.37 17.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.12 -38.73 35.4 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.47 -40.3 91.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.94 -35.88 67.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.346 -1.09 . . . . 0.0 108.472 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 28' ' ' LEU . . . 101.63 42.79 2.25 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.664 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.852 HD22 ' CG1' ' A' ' 112' ' ' VAL . 1.1 mt -141.85 165.62 26.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.878 -1.366 . . . . 0.0 110.06 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 5' ' ' ILE . 98.5 m -98.19 75.46 2.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.786 ' CB ' HD22 ' A' ' 23' ' ' LEU . 16.1 t -90.83 86.59 6.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.416 -0.803 . . . . 0.0 109.582 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -82.89 140.28 32.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.392 -0.818 . . . . 0.0 109.038 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -132.32 125.48 31.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.705 ' CD2' HG22 ' A' ' 39' ' ' VAL . 65.4 m-85 -88.32 -177.65 5.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.116 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -108.87 2.29 21.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.88 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -144.45 142.04 30.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 109.792 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.728 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -69.93 -60.72 4.73 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.447 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -45.84 -69.38 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.382 -1.069 . . . . 0.0 108.344 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.635 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.8 tp10 -35.58 -49.22 0.55 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 0.0 110.912 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.971 HG21 ' HB ' ' A' ' 9' ' ' VAL . 65.2 t -45.22 -53.1 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.188 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.926 HD21 ' CA ' ' A' ' 69' ' ' ILE . 5.1 mp -60.59 -36.96 79.82 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -49.71 -33.55 16.29 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.69 -22.75 19.24 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.01 HD21 ' HB ' ' A' ' 47' ' ' THR . 0.1 OUTLIER -71.35 -1.23 12.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.891 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.1 65.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 m -100.06 26.48 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HE3' ' CG ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 63.21 136.53 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.573 -0.704 . . . . 0.0 110.139 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.01 ' HB ' HD21 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -76.8 -169.5 0.19 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.696 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HB2' HD12 ' A' ' 5' ' ' ILE . 37.0 Cg_endo -97.76 -75.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.808 1.425 . . . . 0.0 110.171 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 9.1 m-20 -101.62 -63.3 1.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.797 -1.189 . . . . 0.0 110.269 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.611 HG23 HD13 ' A' ' 119' ' ' ILE . 2.1 t -148.58 152.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.415 -1.428 . . . . 0.0 111.296 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 7' ' ' TRP . 3.2 mt -102.03 131.16 48.64 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.009 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.81 164.07 21.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 109.818 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' A' ' 9' ' ' VAL . 28.8 p -161.71 133.51 5.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.261 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.627 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.95 -177.0 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.128 -0.982 . . . . 0.0 109.911 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.939 HG22 ' HB2' ' A' ' 64' ' ' ALA . 1.1 pp -117.9 137.33 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.741 ' H ' HD21 ' A' ' 63' ' ' LEU . 4.5 mtt180 -155.82 -73.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.215 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.868 ' HG2' HD22 ' A' ' 63' ' ' LEU . 4.3 ptt? -55.72 134.92 72.07 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.089 -1.007 . . . . 0.0 109.884 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -114.83 71.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.748 1.394 . . . . 0.0 110.308 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.12 -94.86 1.38 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.06 -50.47 66.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.204 . . . . 0.0 109.074 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.02 179.62 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.199 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.753 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -87.65 45.24 3.33 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.868 HD22 ' HG2' ' A' ' 57' ' ' MET . 0.3 OUTLIER 33.7 -111.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.015 -0.697 . . . . 0.0 109.993 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.939 ' HB2' HG22 ' A' ' 55' ' ' ILE . . . 40.59 58.53 2.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.01 -1.056 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 37' ' ' ASN . 3.6 mp -80.04 73.48 6.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 110.28 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.764 HD22 ' CG2' ' A' ' 80' ' ' ILE . 10.0 tp -87.61 -53.47 4.77 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HD2' ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -54.44 -23.57 16.5 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.922 ' OE1' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -79.23 -56.92 4.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.926 ' CA ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.13 -42.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.498 0.666 . . . . 0.0 109.944 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -82.74 -56.98 3.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.54 -0.725 . . . . 0.0 109.286 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 70' ' ' LYS . 15.1 tt0 -33.99 -31.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.775 -0.578 . . . . 0.0 111.299 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.67 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.09 -78.58 0.58 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.863 -1.148 . . . . 0.0 110.898 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.663 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 1.6 p80 -66.75 144.57 98.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.612 -1.305 . . . . 0.0 109.392 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.663 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 36.2 Cg_endo -35.52 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 124.066 1.561 . . . . 0.0 111.525 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.485 ' CG ' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -178.33 100.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.753 -1.217 . . . . 0.0 110.459 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.874 HD22 HG22 ' A' ' 47' ' ' THR . 3.4 pp -120.67 156.48 55.98 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.705 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 34.5 Cg_endo -41.87 129.9 4.14 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 117.563 -1.158 . . . . 0.0 111.184 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.921 HG23 ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -137.9 161.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.39 -0.819 . . . . 0.0 109.254 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.781 HD13 ' O ' ' A' ' 78' ' ' VAL . 3.7 mm -142.84 147.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.764 ' CG2' HD22 ' A' ' 66' ' ' LEU . 7.1 tt -136.4 141.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.831 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.563 ' SD ' ' CE1' ' A' ' 106' ' ' PHE . 5.1 ttm -88.5 98.26 11.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.318 -0.863 . . . . 0.0 109.045 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -59.29 149.87 27.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 109.675 -179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.87 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . 179.28 60.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.324 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.54 ' CB ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 79.26 143.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 109.496 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 45.2 p 53.65 171.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.265 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 85' ' ' SER . 5.5 m-20 84.43 -54.61 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.971 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -34.82 -30.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 110.8 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.3 p30 -64.16 -97.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.026 -1.046 . . . . 0.0 110.141 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -43.39 -40.35 3.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.969 -1.082 . . . . 0.0 109.903 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -51.07 -50.58 58.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 87' ' ' LEU . 3.3 t -32.6 -36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.222 0.534 . . . . 0.0 110.187 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.4 t -90.87 44.45 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.81 . . . . 0.0 109.465 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ALA . . . -132.31 -65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 109.19 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . 41.3 p90 -90.71 28.42 1.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.148 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.64 -42.69 99.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -86.87 -55.09 4.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.483 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.727 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 165.91 -164.3 37.33 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 81.73 22.27 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.599 -0.942 . . . . 0.0 109.688 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.921 ' CE2' HG23 ' A' ' 78' ' ' VAL . 89.4 m-85 -140.51 157.1 46.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.557 ' OD2' HD11 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -114.52 -29.91 6.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 70.93 99.6 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 0.0 109.329 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.58 HD12 ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -110.27 119.76 46.09 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.892 . . . . 0.0 109.654 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -108.45 12.74 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.45 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 64.71 159.25 0.12 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -76.14 172.6 62.33 Favored 'Cis proline' 0 C--N 1.314 -1.238 0 C-N-CA 120.664 -2.64 . . . . 0.0 110.336 -0.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.563 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 40.8 p90 -157.06 144.05 18.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 8.7 t70 -85.63 174.75 9.19 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -82.88 -48.69 17.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.778 -1.201 . . . . 0.0 109.864 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 108' ' ' ILE . 22.9 t0 -73.38 -47.37 42.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.006 -1.059 . . . . 0.0 108.15 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.0 tp10 -49.24 -38.02 25.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.3 -72.94 0.18 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.228 -0.92 . . . . 0.0 108.672 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.852 ' CG1' HD22 ' A' ' 28' ' ' LEU . 77.9 t -38.45 -74.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 121.513 0.673 . . . . 0.0 110.323 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.96 -62.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.714 . . . . 0.0 110.355 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 114' ' ' LEU . 1.3 tm? -33.19 -54.65 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.432 0.634 . . . . 0.0 110.003 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.742 ' N ' HD13 ' A' ' 114' ' ' LEU . 75.2 t -60.05 -55.69 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 3.5 pt-20 -34.24 -44.85 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.905 -0.497 . . . . 0.0 111.411 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -59.77 -47.46 85.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.043 . . . . 0.0 110.127 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.41 -55.29 25.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.737 -1.227 . . . . 0.0 107.953 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.611 HD13 HG23 ' A' ' 50' ' ' VAL . 3.3 mt -36.47 -34.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.943 -0.473 . . . . 0.0 109.796 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.674 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 6.8 p -22.85 -45.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.674 ' CB ' ' O ' ' A' ' 120' ' ' SER . 12.0 t-80 117.65 62.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER 32.04 39.28 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.473 0.654 . . . . 0.0 109.94 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -40.16 -30.93 0.11 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.231 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.411 ' OXT' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.082 -1.011 . . . . 0.0 109.546 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.376 0.608 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 2.2 tt0 -113.95 121.4 43.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.439 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -156.76 172.83 17.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.342 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 -168.49 38.07 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.387 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.731 HG22 ' HE1' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -149.84 93.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.601 -0.941 . . . . 0.0 109.363 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.958 HG23 HG12 ' A' ' 50' ' ' VAL . 3.6 p -100.4 118.95 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.553 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.946 ' CE3' HG21 ' A' ' 31' ' ' THR . 11.7 m95 -103.06 102.58 12.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.96 -1.087 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.801 HG22 ' CG ' ' A' ' 52' ' ' LEU . 59.7 t -98.99 146.91 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.028 ' CG1' HG21 ' A' ' 39' ' ' VAL . 1.6 m -104.49 129.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 O-C-N 121.063 -1.023 . . . . 0.0 108.554 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.91 ' CB ' HG21 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -112.44 -99.21 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.343 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' GLU . 12.3 t0 -153.12 -49.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.679 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -144.0 -179.69 6.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.9 -1.125 . . . . 0.0 110.459 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -65.96 169.29 6.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 109.666 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.1 OUTLIER 78.08 -6.77 1.91 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.91 HG21 ' CB ' ' A' ' 10' ' ' ASP . 1.8 mp -96.91 -29.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -65.08 -36.75 85.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 54.4 t90 -61.9 -63.64 1.19 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 20.2 t -36.97 -65.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.527 0.68 . . . . 0.0 110.731 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' CD2' ' CD1' ' A' ' 108' ' ' ILE . 0.7 OUTLIER -50.77 -70.88 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.792 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -35.4 -35.4 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.0 110.77 -179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.15 -54.19 47.59 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.547 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -66.53 -19.15 65.71 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.251 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -87.21 -10.29 52.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.167 -0.958 . . . . 0.0 109.543 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.45 71.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.07 -34.46 66.25 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.16 45.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.466 -1.02 . . . . 0.0 109.143 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.37 49.58 14.86 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.064 HD22 ' CG1' ' A' ' 112' ' ' VAL . 0.9 OUTLIER -128.52 177.89 6.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.106 -1.232 . . . . 0.0 110.267 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.608 ' HB ' HG23 ' A' ' 5' ' ' ILE . 7.2 m -95.26 93.35 7.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.746 ' HB2' HD22 ' A' ' 23' ' ' LEU . 34.2 t -86.45 80.75 8.55 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.946 HG21 ' CE3' ' A' ' 7' ' ' TRP . 3.3 m -84.22 141.17 31.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -143.73 164.51 30.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.678 -1.264 . . . . 0.0 110.038 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.874 ' HB2' HG22 ' A' ' 39' ' ' VAL . 13.5 m-85 -131.13 -171.67 2.64 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.6 pt-20 -107.02 -23.97 12.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 109.964 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.854 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.4 m120 -140.25 147.04 39.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.927 -1.108 . . . . 0.0 109.884 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 64' ' ' ALA . . . -55.67 -31.15 57.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.57 -76.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -1.152 . . . . 0.0 108.005 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.591 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -33.83 -33.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.373 0.606 . . . . 0.0 109.753 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.028 HG21 ' CG1' ' A' ' 9' ' ' VAL . 63.1 t -60.84 -59.11 4.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 121.381 -0.824 . . . . 0.0 109.203 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.984 HD12 ' N ' ' A' ' 41' ' ' ALA . 1.6 pp -62.08 -17.46 57.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 108.572 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.984 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -68.01 -35.95 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.36 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.764 HD21 HD11 ' A' ' 51' ' ' LEU . 3.9 mm? -66.31 -7.82 21.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.75 60.1 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.5 m -100.25 26.78 6.19 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.1 mptt 71.88 139.5 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.631 0.729 . . . . 0.0 110.263 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.95 ' CG2' HD22 ' A' ' 76' ' ' LEU . 2.6 t -71.25 -177.0 0.42 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.585 -0.697 . . . . 0.0 109.496 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HB2' HD12 ' A' ' 5' ' ' ILE . 36.5 Cg_endo -114.94 -67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.799 1.42 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.665 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -121.27 -53.5 2.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.846 -1.159 . . . . 0.0 110.527 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.958 HG12 HG23 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.12 129.08 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.552 -1.342 . . . . 0.0 110.206 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.963 HD22 ' NE2' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -100.59 128.88 46.5 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.585 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.89 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 3.3 pp -141.39 165.84 26.4 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.753 -1.217 . . . . 0.0 110.008 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.604 ' N ' HD12 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -133.99 151.08 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.143 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' SD ' ' A' ' 81' ' ' MET . 4.4 t70 -115.91 129.4 56.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.8 144.89 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.62 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -179.3 -65.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.419 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -45.5 151.89 0.72 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.613 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -99.84 163.6 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.055 1.555 . . . . 0.0 110.207 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.86 -167.47 22.75 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.1 mmt -64.17 -32.61 74.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -1.079 . . . . 0.0 109.585 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.04 92.44 3.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.95 -45.27 7.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.97 HD11 HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -50.54 -83.12 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.136 -1.214 . . . . 0.0 109.402 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' A' ' 9' ' ' VAL . . . 168.67 35.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER 57.56 62.33 2.17 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 80' ' ' ILE . 15.9 tp -75.35 -13.22 60.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.997 . . . . 0.0 108.891 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -78.08 -38.95 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.592 ' HG3' HD23 ' A' ' 40' ' ' LEU . 2.1 pt20 -76.74 -52.67 9.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.065 -1.022 . . . . 0.0 108.51 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.69 HG21 HD12 ' A' ' 66' ' ' LEU . 2.9 tt -37.58 -34.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.812 0.815 . . . . 0.0 109.313 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 7.5 tptp -78.03 -54.52 6.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.98 -46.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.543 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 1.4 tpt85 -87.59 -43.44 11.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.192 -0.942 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.963 ' NE2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -40.45 162.65 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.437 -0.789 . . . . 0.0 110.341 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD2' HD23 ' A' ' 76' ' ' LEU . 37.0 Cg_endo -117.71 42.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 124.03 1.542 . . . . 0.0 110.164 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.4 mtt 66.03 82.83 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 0.0 110.579 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.95 HD22 ' CG2' ' A' ' 47' ' ' THR . 1.0 OUTLIER -147.82 151.23 38.15 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 50' ' ' VAL . 36.8 Cg_endo -37.59 126.77 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.61 1.321 . . . . 0.0 111.691 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.58 ' HB ' ' CZ ' ' A' ' 99' ' ' PHE . 84.1 t -117.91 100.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.589 -0.694 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.89 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 1.7 mt -75.7 157.54 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 108.739 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.97 HD11 HD11 ' A' ' 63' ' ' LEU . 7.3 tt -154.15 123.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.028 -1.045 . . . . 0.0 110.569 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.516 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 15.9 mtt -97.89 99.76 11.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 58.13 161.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . . . -172.95 -175.36 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.961 -1.087 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.537 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.5 t-80 -167.49 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.934 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.537 ' C ' ' O ' ' A' ' 84' ' ' HIS . 21.7 m 40.26 31.83 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 88' ' ' ASP . 3.1 m-20 63.43 126.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 91' ' ' VAL . 3.8 tp -35.83 -31.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -38.02 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.485 0.659 . . . . 0.0 109.584 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.497 ' HB3' ' CB ' ' A' ' 85' ' ' SER . . . -47.59 -32.14 5.18 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -69.36 -87.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.329 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.869 HG23 ' HG ' ' A' ' 87' ' ' LEU . 91.2 t -33.18 -59.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.719 -0.613 . . . . 0.0 111.398 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -55.84 -99.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.356 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 48.4 -105.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.872 -1.143 . . . . 0.0 108.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -141.82 60.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 0.0 108.791 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 8.1 mm-40 -57.31 174.23 0.21 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.605 -0.685 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 27.7 mt-30 64.12 50.42 2.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.98 -120.22 0.54 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.68 89.0 2.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -1.187 . . . . 0.0 109.474 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.58 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 5.5 m-85 -133.39 136.46 45.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 0.0 109.696 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -120.06 -167.86 1.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 109.047 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.509 ' OH ' ' HB3' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -166.2 94.93 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.735 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.7 OUTLIER -120.64 151.67 54.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.149 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 36.8 Cg_endo -119.36 -173.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.709 1.373 . . . . 0.0 110.594 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HG2' ' CD1' ' A' ' 106' ' ' PHE . 1.2 mtmm -91.27 159.25 39.77 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.335 -0.853 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.4 Cg_endo -87.33 169.76 39.54 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 120.274 -2.803 . . . . 0.0 110.308 0.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.516 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 52.6 p90 -161.97 150.05 14.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . 6.1 t0 -80.19 117.99 21.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.197 -0.94 . . . . 0.0 108.584 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.547 HG21 ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -41.77 -41.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.215 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.476 ' N ' HG23 ' A' ' 108' ' ' ILE . 25.8 t70 -74.48 -38.85 62.79 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.51 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 8.1 tm-20 -51.33 -38.11 51.32 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -81.94 -69.7 0.6 Allowed 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.064 ' CG1' HD22 ' A' ' 28' ' ' LEU . 24.4 t -37.31 -35.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.499 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -78.61 -66.67 0.83 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.982 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.776 HD13 ' C ' ' A' ' 114' ' ' LEU . 3.0 tm? -35.47 -51.72 0.63 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.506 0.67 . . . . 0.0 109.843 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.858 HG21 ' CG1' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -70.45 -51.47 37.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 108.948 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 9.0 tm-20 -33.35 -34.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.523 0.677 . . . . 0.0 109.933 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' VAL . 5.1 mtm180 -76.51 -57.27 3.96 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.62 -54.37 9.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -0.973 . . . . 0.0 109.065 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.691 HG23 ' HG3' ' A' ' 77' ' ' PRO . 6.2 mt -39.77 -44.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 110.793 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -86.34 -22.6 26.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 120' ' ' SER . 63.1 t60 -37.94 -55.5 1.22 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.427 -0.796 . . . . 0.0 110.649 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.631 ' O ' ' CG ' ' A' ' 122' ' ' TYR . 3.9 p90 -91.05 48.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -73.26 -28.65 62.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.796 -1.19 . . . . 0.0 109.296 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.439 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.501 ' O ' ' CB ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 1' ' ' MET . 1.3 mm100 76.31 105.47 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 7.5 tpp180 -101.3 66.1 1.09 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.288 -0.882 . . . . 0.0 109.342 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 1.047 ' HA3' HD22 ' A' ' 28' ' ' LEU . . . -167.21 50.11 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 48' ' ' PRO . 3.6 mt -76.64 91.55 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.088 -1.242 . . . . 0.0 107.977 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.718 ' CG2' HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -100.78 123.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.433 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.708 ' CE3' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.1 87.91 4.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.018 HG22 ' HB2' ' A' ' 52' ' ' LEU . 29.9 t -84.95 146.06 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -0.877 . . . . 0.0 110.545 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' LEU . 8.9 t -91.64 153.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.875 ' CG ' HG21 ' A' ' 15' ' ' ILE . 9.5 t0 -179.31 -124.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.961 -1.087 . . . . 0.0 110.003 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' CA ' ' HA ' ' A' ' 34' ' ' GLU . 1.4 t70 -128.22 -8.45 5.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.602 -1.311 . . . . 0.0 110.547 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.575 ' HB2' ' N ' ' A' ' 34' ' ' GLU . 2.1 t70 48.87 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 70.01 13.44 7.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.3 p 161.62 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.875 HG21 ' CG ' ' A' ' 10' ' ' ASP . 33.0 mm -82.27 -38.34 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 108.958 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 32' ' ' THR . 12.2 ttp85 -65.67 -35.13 79.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -66.4 -62.63 1.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 14' ' ' SER . 53.4 t -40.32 -64.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.906 ' CD2' HD11 ' A' ' 108' ' ' ILE . 2.8 mt -60.24 -75.58 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.68 -0.637 . . . . 0.0 110.944 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 18.8 tt0 -34.88 -31.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.736 -0.602 . . . . 0.0 110.612 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -67.07 -56.4 10.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -13.04 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.821 HD12 ' HB2' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -82.39 -27.17 32.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.42 73.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.42 -0.8 . . . . 0.0 109.185 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.72 -27.06 39.74 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.73 -16.97 60.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -1.07 . . . . 0.0 109.233 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.697 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 72.98 38.11 56.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.047 HD22 ' HA3' ' A' ' 4' ' ' GLY . 78.2 mt -137.71 163.3 31.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.942 -1.328 . . . . 0.0 109.887 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 29' ' ' THR . 21.1 m -104.8 79.8 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.489 -0.757 . . . . 0.0 110.187 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.672 ' HA ' HG12 ' A' ' 6' ' ' VAL . 44.3 t -80.96 80.44 7.44 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.004 -1.06 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.1 m -77.45 129.74 36.12 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.7 p -124.29 133.95 53.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.635 -1.291 . . . . 0.0 110.499 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.008 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.2 m-30 -106.56 145.54 31.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.575 ' N ' ' HB2' ' A' ' 12' ' ' ASP . 1.2 pt-20 -63.03 -8.22 6.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.075 -1.016 . . . . 0.0 110.192 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -154.81 138.44 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.787 -1.195 . . . . 0.0 110.399 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.696 ' H ' HD13 ' A' ' 65' ' ' LEU . . . -56.34 -26.16 50.33 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' GLU . 33.9 t-20 -56.28 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.261 -1.14 . . . . 0.0 108.052 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.3 mm-40 -36.14 -46.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 110.774 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.008 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -49.5 -54.19 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.013 -1.054 . . . . 0.0 108.537 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.84 HD11 ' CB ' ' A' ' 72' ' ' ARG . 8.2 tt -64.45 -26.74 68.57 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.757 . . . . 0.0 109.496 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -22.91 62.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.09 -24.05 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.765 ' CD2' HD11 ' A' ' 51' ' ' LEU . 1.3 mp -87.2 -6.87 58.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.88 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -40.05 -29.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.711 . . . . 0.0 109.319 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -80.88 -46.56 15.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER 169.91 151.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 110.117 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.708 ' HB ' HD22 ' A' ' 76' ' ' LEU . 5.9 m -87.23 164.36 36.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 108.79 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.9 Cg_endo -103.84 -71.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.611 1.322 . . . . 0.0 111.13 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.488 ' OD2' ' CA ' ' A' ' 4' ' ' GLY . 3.0 m-20 -110.75 -75.31 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 0.0 110.542 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.866 HG22 ' HG2' ' A' ' 77' ' ' PRO . 13.1 t -143.7 145.02 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.062 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.765 HD11 ' CD2' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -101.8 124.21 47.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 109.88 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.018 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -108.83 165.99 11.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.222 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -147.8 122.05 9.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 109.644 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -78.0 -171.13 2.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 55' ' ' ILE . 2.6 tp -143.21 79.63 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.581 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -117.74 -166.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mtt 59.62 83.75 0.21 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.09 120.4 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.944 1.497 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.76 -87.23 0.07 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 ttm -109.94 -91.71 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -1.125 . . . . 0.0 109.429 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' SER . 1.7 m-20 -102.53 1.26 34.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . 152.47 -90.35 0.13 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.884 HD13 HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER 176.64 25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.384 -1.068 . . . . 0.0 110.377 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 56.94 -142.18 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.848 -1.157 . . . . 0.0 109.132 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.884 HD12 HD13 ' A' ' 63' ' ' LEU . 62.9 mt 80.04 -66.76 0.15 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.682 . . . . 0.0 110.535 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 66' ' ' LEU . 2.5 tm? -57.47 -36.03 70.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.584 -1.322 . . . . 0.0 109.251 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -66.11 -30.92 71.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.643 -1.286 . . . . 0.0 107.663 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.677 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -69.08 -65.26 0.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.805 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -37.4 -24.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 111.494 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 68' ' ' GLN . 3.1 tptt -89.24 -69.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.274 -1.517 . . . . 0.0 109.277 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -34.93 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.683 -0.636 . . . . 0.0 112.01 -178.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.84 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.31 -68.7 0.86 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.545 -1.347 . . . . 0.0 111.777 -178.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.658 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 77.6 m80 -33.55 152.12 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.197 0 O-C-N 121.536 -0.728 . . . . 0.0 110.698 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -59.08 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.987 1.519 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.41 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.848 -1.158 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.708 HD22 ' HB ' ' A' ' 47' ' ' THR . 0.5 OUTLIER -146.31 -176.2 0.53 Allowed Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.866 ' HG2' HG22 ' A' ' 50' ' ' VAL . 36.0 Cg_endo -78.73 143.0 18.35 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 117.292 -1.338 . . . . 0.0 111.512 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -137.15 158.0 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.579 HG21 HD12 ' A' ' 102' ' ' LEU . 4.4 mt -142.6 145.21 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 108.995 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -127.83 138.89 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.87 142.93 49.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -93.99 178.6 5.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 109.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 166.68 -57.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.543 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.98 -52.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -109.47 107.98 18.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.646 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 88' ' ' ASP . 4.5 p-10 166.74 -42.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 31.5 tp -35.02 -30.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.247 0.546 . . . . 0.0 110.313 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 86' ' ' ASP . 5.4 t0 -63.51 -72.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -43.71 -47.32 7.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 80' ' ' ILE . . . -62.77 -76.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 72.5 t -33.69 -32.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.818 -0.551 . . . . 0.0 111.125 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' ALA . 5.1 p -92.25 -148.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.98 -1.075 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 94' ' ' TYR . . . 58.72 64.79 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.509 ' CB ' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER 76.39 -0.52 3.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.22 -179.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.6 mt-30 42.47 -97.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' TYR . 3.6 mt-30 -62.74 100.44 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.986 -1.071 . . . . 0.0 109.836 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.96 -121.63 1.01 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.12 72.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -1.21 . . . . 0.0 109.679 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 52.4 m-85 -127.05 136.13 51.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 101' ' ' TYR . 3.7 m-20 -135.78 89.59 2.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -38.34 135.56 0.74 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.652 -0.655 . . . . 0.0 109.995 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.579 HD12 HG21 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -113.33 121.79 36.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -122.3 -177.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.762 1.401 . . . . 0.0 110.578 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -100.63 156.85 34.72 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -96.88 167.61 13.67 Favored 'Cis proline' 0 C--N 1.317 -1.082 0 C-N-CA 120.8 -2.584 . . . . 0.0 110.392 0.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -164.3 146.44 8.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.6 t70 -75.95 144.02 41.26 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.906 HD11 ' CD2' ' A' ' 19' ' ' LEU . 4.5 tp -60.13 -48.31 88.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.942 -1.099 . . . . 0.0 110.7 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.611 ' N ' HG23 ' A' ' 108' ' ' ILE . 35.7 t0 -69.96 -54.78 11.76 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 108.744 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 9.7 tp10 -46.36 -28.73 1.42 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.96 -78.66 0.09 Allowed 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.504 -0.747 . . . . 0.0 109.328 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.819 ' CG1' HD13 ' A' ' 28' ' ' LEU . 47.5 t -41.42 -60.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 121.368 -0.832 . . . . 0.0 109.692 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -42.33 -62.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.773 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.779 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -35.0 -50.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.686 0.755 . . . . 0.0 109.317 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.767 HG21 HG11 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -59.8 -53.89 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.573 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.9 tt0 -34.48 -41.46 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.376 0.607 . . . . 0.0 110.386 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -61.99 -53.05 60.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.364 -0.835 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -52.32 -54.8 26.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.012 -1.055 . . . . 0.0 108.626 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.862 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.1 mt -36.2 -34.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.426 0.631 . . . . 0.0 110.467 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 118' ' ' ALA . 3.5 t -70.73 22.77 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.389 -0.819 . . . . 0.0 111.983 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' C ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER 53.5 35.84 21.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.353 -1.467 . . . . 0.0 109.572 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.5 OUTLIER 32.21 50.56 0.18 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.575 0.703 . . . . 0.0 110.162 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.99 -25.82 67.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.055 -1.028 . . . . 0.0 109.348 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.302 0.572 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 68.13 85.79 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.614 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.02 145.71 2.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 28' ' ' LEU . . . 178.75 141.95 4.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.563 HG13 HG21 ' A' ' 29' ' ' THR . 5.2 mp -104.94 103.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.43 -1.041 . . . . 0.0 109.729 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -104.39 128.04 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.545 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -101.57 81.56 2.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 110.608 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.808 ' HB ' HG22 ' A' ' 32' ' ' THR . 42.6 t -72.61 146.6 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 109.539 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 84.1 t -91.72 105.81 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.038 -1.039 . . . . 0.0 109.349 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.566 ' HA ' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -53.79 174.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 2.3 t70 -124.39 -50.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 110.277 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -172.42 94.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 111.271 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 12' ' ' ASP . 1.8 p 57.08 137.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.145 0.974 . . . . 0.0 111.557 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.655 ' N ' ' CE3' ' A' ' 17' ' ' TRP . 5.4 t 61.81 3.67 0.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.387 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 10' ' ' ASP . 21.4 mm -88.21 -54.81 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.184 -1.572 . . . . 0.0 109.286 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -62.69 -36.76 83.96 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.655 ' CE3' ' N ' ' A' ' 14' ' ' SER . 7.9 m-90 -71.27 -55.91 7.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 14' ' ' SER . 2.1 t -39.1 -61.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 122.057 0.932 . . . . 0.0 109.795 -177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.3 mm? -55.95 -70.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.59 -0.694 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -35.56 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.181 0.515 . . . . 0.0 110.423 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.5 tmt_? -68.12 -56.52 8.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.94 -6.72 34.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.054 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.866 HD11 HG21 ' A' ' 112' ' ' VAL . 1.5 mm? -101.91 -9.11 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.67 -52.57 6.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.317 -0.865 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.27 -29.48 71.43 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.42 74.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.437 -1.037 . . . . 0.0 108.809 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.37 57.73 1.34 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.857 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -140.97 179.7 6.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.073 -1.251 . . . . 0.0 110.347 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.563 HG21 HG13 ' A' ' 5' ' ' ILE . 16.4 m -103.4 83.44 2.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.503 ' HB2' ' CG ' ' A' ' 23' ' ' LEU . 19.1 t -92.64 92.54 8.05 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.17 -0.956 . . . . 0.0 110.807 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.545 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -94.18 144.87 25.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.808 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.3 p -149.96 129.25 12.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.702 -1.248 . . . . 0.0 110.258 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.66 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.6 m-85 -111.81 127.33 55.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.272 -0.892 . . . . 0.0 109.133 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.538 ' HA ' ' CB ' ' A' ' 10' ' ' ASP . 1.9 pt-20 -47.63 -19.59 0.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.49 -0.756 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -131.85 132.98 44.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.503 -1.373 . . . . 0.0 111.098 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -61.78 -18.4 56.6 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.461 ' HA ' ' CD ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -68.25 -80.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.088 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -35.53 -45.86 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.848 -0.533 . . . . 0.0 110.321 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.5 OUTLIER -58.05 -52.22 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.215 -0.928 . . . . 0.0 108.995 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.9 tm? -63.52 -17.29 62.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -84.47 -25.91 28.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.13 -35.51 64.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.087 HD13 ' NE2' ' A' ' 73' ' ' HIS . 4.7 mt -72.36 -102.97 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 81.61 -40.13 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.122 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 70.7 m -98.99 -40.19 8.17 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -0.932 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.4 OUTLIER 168.06 150.09 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.096 -1.002 . . . . 0.0 108.969 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.584 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -87.37 165.81 28.94 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.255 -0.903 . . . . 0.0 109.417 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.54 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -89.27 -66.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.234 1.649 . . . . 0.0 110.319 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.755 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -109.85 -75.32 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.785 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -149.99 151.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 0.0 109.964 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.983 HD12 ' CE1' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -99.88 134.57 42.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.85 148.16 49.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.941 -1.099 . . . . 0.0 109.147 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.47 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t -134.66 126.4 29.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.094 -1.003 . . . . 0.0 110.428 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 m-20 -73.27 -179.93 3.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 109.173 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.578 HG21 ' O ' ' A' ' 82' ' ' THR . 0.7 OUTLIER 176.89 38.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.21 11.09 10.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.96 . . . . 0.0 109.248 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.52 ' CB ' ' O ' ' A' ' 61' ' ' ASP . 5.9 mmt -38.08 140.51 0.57 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.3 Cg_endo -49.42 122.92 9.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.07 1.563 . . . . 0.0 110.631 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 44.39 -126.06 6.24 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 ptt? -70.44 -146.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.399 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 57' ' ' MET . 31.1 m-20 63.14 100.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 109.802 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -153.07 90.67 0.13 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.933 HD11 HD11 ' A' ' 65' ' ' LEU . 1.2 pt? -38.32 147.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.912 . . . . 0.0 110.429 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.954 ' HB1' ' HD3' ' A' ' 67' ' ' LYS . . . -90.97 122.95 34.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.933 HD11 HD11 ' A' ' 63' ' ' LEU . 5.1 mt -134.21 -43.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 109.745 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.535 ' HA ' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -41.25 -51.01 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.464 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.954 ' HD3' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -43.66 -50.02 7.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 6.3 pt20 -69.97 -43.09 72.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.616 -1.302 . . . . 0.0 109.429 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.587 HG21 HG11 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -37.48 -52.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 109.606 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -73.14 -57.96 3.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.851 -0.531 . . . . 0.0 110.417 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -32.41 -36.41 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.843 -0.536 . . . . 0.0 110.939 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.913 ' HB2' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -101.99 -30.84 10.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.694 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 1.087 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.21 -177.77 0.32 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.855 ' HD2' HD23 ' A' ' 76' ' ' LEU . 36.6 Cg_endo -113.73 39.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.162 1.612 . . . . 0.0 109.598 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 5.8 mmt 63.17 73.24 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.855 HD23 ' HD2' ' A' ' 74' ' ' PRO . 3.0 pp -130.61 176.9 2.51 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 108.886 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.638 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 36.2 Cg_endo -68.26 129.29 18.95 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.184 1.097 . . . . 0.0 112.778 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.983 HG13 ' HB3' ' A' ' 51' ' ' LEU . 45.7 t -134.42 100.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 100' ' ' ASP . 15.4 mm -80.43 160.52 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.03 -1.044 . . . . 0.0 111.055 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 80' ' ' ILE . 3.9 mp -139.71 136.19 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.519 -0.738 . . . . 0.0 109.31 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.508 ' O ' HG22 ' A' ' 55' ' ' ILE . 1.2 ttm -81.27 89.87 6.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.27 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.578 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 65.77 -177.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 109.201 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' H ' HG22 ' A' ' 82' ' ' THR . . . 179.54 142.92 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.004 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -146.33 36.82 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.1 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.86 -32.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.573 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.74 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 46.4 t0 -76.49 -17.62 59.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 109.571 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.3 mt -34.44 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.702 -0.624 . . . . 0.0 110.525 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 86' ' ' ASP . 16.5 t0 -62.85 -57.85 9.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.018 . . . . 0.0 109.746 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . . . -60.55 -57.24 13.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -52.02 -66.78 0.32 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -0.951 . . . . 0.0 109.8 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 87' ' ' LEU . 47.8 t -33.7 -31.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.98 -0.45 . . . . 0.0 111.042 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.703 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 32.6 t -95.48 170.69 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 109.897 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 78.0 74.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.82 -86.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.512 ' HG3' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 66.39 31.49 8.22 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.161 -0.962 . . . . 0.0 109.389 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -125.65 16.19 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 161.9 151.11 6.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . 69.43 34.03 2.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 20.3 m-85 -152.16 29.93 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.542 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -55.38 124.84 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.03 137.04 38.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.803 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -110.64 111.05 57.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -104.91 144.21 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.946 1.498 . . . . 0.0 110.38 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.39 151.54 87.26 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.315 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -81.32 175.53 41.93 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.52 -2.7 . . . . 0.0 110.517 -0.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -159.5 136.31 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 17.5 t0 -76.05 -176.75 3.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 108.551 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.49 -49.48 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.639 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 26.2 t70 -69.36 -45.84 68.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 108.53 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.3 tp10 -51.1 -37.08 43.76 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.06 -70.22 0.37 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.379 -0.826 . . . . 0.0 108.81 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.866 HG21 HD11 ' A' ' 23' ' ' LEU . 39.1 t -36.45 -65.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.744 -0.597 . . . . 0.0 110.396 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -51.32 -61.22 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 110.45 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 113' ' ' ALA . 47.6 tp -34.47 -58.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.331 0.586 . . . . 0.0 110.174 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.701 HG22 HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -59.66 -56.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.623 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.0 tm-20 -35.59 -31.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.185 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtm180 -82.63 -56.37 3.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.632 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -46.18 -61.33 1.82 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 108.734 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.785 ' CD1' HG23 ' A' ' 50' ' ' VAL . 9.6 mt -35.43 -44.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.805 -0.559 . . . . 0.0 110.55 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.74 56.62 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.91 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 34.5 t-80 -117.73 0.28 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.393 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -99.56 9.98 42.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.262 -0.899 . . . . 0.0 109.606 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 22.8 mt-30 -90.53 40.78 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 29.0 tt0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.49 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.6 mt-30 68.52 20.24 8.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -112.9 145.99 39.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 108.715 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.956 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -167.61 149.5 14.74 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.839 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.827 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -101.46 110.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.616 -0.932 . . . . 0.0 109.859 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -113.86 119.09 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 1.178 ' CE3' HG21 ' A' ' 31' ' ' THR . 10.5 m95 -101.04 88.45 3.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.656 -1.278 . . . . 0.0 109.235 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.048 HG22 ' CB ' ' A' ' 52' ' ' LEU . 48.4 t -82.77 153.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.528 -0.732 . . . . 0.0 110.45 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.06 HG22 HG21 ' A' ' 39' ' ' VAL . 93.5 t -96.58 106.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -63.22 156.31 25.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 109.147 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -102.92 -29.8 11.2 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 110.659 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 1.7 m-20 -124.51 169.66 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.905 -1.122 . . . . 0.0 110.229 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -67.07 -3.12 6.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.895 -1.128 . . . . 0.0 110.64 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 t -121.3 8.85 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.799 -1.188 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.509 HG22 ' HB2' ' A' ' 10' ' ' ASP . 16.1 mm -78.88 -35.24 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.909 -1.119 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -49.58 77.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.541 ' CZ2' ' NH2' ' A' ' 21' ' ' ARG . 19.0 t90 -53.86 -64.4 0.84 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.2 t -37.48 -65.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.636 0.731 . . . . 0.0 110.698 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -50.39 -79.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 111.002 -178.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 19' ' ' LEU . 1.8 tt0 -33.68 -33.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.826 -0.546 . . . . 0.0 110.947 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' NH2' ' CZ2' ' A' ' 17' ' ' TRP . 2.5 tpp85 -66.84 -57.16 7.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 0.0 109.037 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.617 ' CB ' HG21 ' A' ' 108' ' ' ILE . . . -71.97 -4.31 27.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.347 -0.846 . . . . 0.0 109.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.907 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -100.11 -18.62 16.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.48 -43.5 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.94 77.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.22 62.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.379 -1.071 . . . . 0.0 109.013 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.7 47.88 4.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.956 HD23 ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -127.87 179.57 5.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.073 -1.251 . . . . 0.0 110.097 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.763 HG21 ' CG2' ' A' ' 5' ' ' ILE . 53.9 m -99.97 86.04 3.18 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 31.3 t -82.37 92.13 6.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.474 -0.767 . . . . 0.0 110.399 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.178 HG21 ' CE3' ' A' ' 7' ' ' TRP . 24.3 m -89.55 124.1 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 34.2 p -127.01 151.31 48.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.06 -1.025 . . . . 0.0 110.125 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.061 ' HB2' HG22 ' A' ' 39' ' ' VAL . 7.8 m-85 -143.14 119.07 10.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.48 -0.763 . . . . 0.0 109.207 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -54.16 -27.82 36.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.46 -0.775 . . . . 0.0 110.167 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.828 ' O ' HG23 ' A' ' 39' ' ' VAL . 18.1 m120 -109.45 125.33 52.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 110.39 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . -57.78 -46.72 91.98 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 38' ' ' GLU . 58.3 t-20 -53.62 -71.93 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.159 -1.201 . . . . 0.0 108.811 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -34.23 -38.05 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.878 -0.514 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.061 HG22 ' HB2' ' A' ' 33' ' ' PHE . 48.8 t -53.15 -59.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.764 HD23 ' NE2' ' A' ' 68' ' ' GLN . 3.9 mm? -62.57 -21.78 65.86 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -65.99 -36.68 83.97 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.67 36.29 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 43' ' ' LEU . 2.5 tm? -56.95 -19.84 20.29 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.48 -40.25 12.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 109.22 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.624 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -62.31 -39.81 94.27 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.085 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 99.33 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.351 0.596 . . . . 0.0 110.583 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.494 HG21 HD21 ' A' ' 51' ' ' LEU . 34.5 p -65.15 169.53 5.59 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HG2' ' CG1' ' A' ' 5' ' ' ILE . 37.1 Cg_endo -129.89 -15.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 116.263 -2.025 . . . . 0.0 113.007 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -94.4 -71.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 119.867 -1.771 . . . . 0.0 110.912 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.753 HG21 HG13 ' A' ' 115' ' ' VAL . 11.3 t -163.78 144.36 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.079 -1.013 . . . . 0.0 110.168 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -101.92 125.27 48.56 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.779 178.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.048 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -113.18 160.12 18.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -153.42 131.22 11.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.397 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.581 ' O ' HD21 ' A' ' 63' ' ' LEU . 7.7 t0 -92.43 144.06 25.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.807 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -88.31 82.74 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.096 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 6.5 tpt180 178.57 128.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 108.919 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.539 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -174.18 157.61 2.59 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 57' ' ' MET . 36.2 Cg_endo -63.4 155.9 59.49 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.784 1.412 . . . . 0.0 110.298 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.23 10.82 27.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 61.14 -177.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -1.098 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.72 -146.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' O ' ' CG ' ' A' ' 57' ' ' MET . . . -107.98 -111.27 3.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.762 ' HB2' HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -130.74 -46.03 1.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -1.11 . . . . 0.0 109.413 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 63' ' ' LEU . . . 77.36 64.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.817 . . . . 0.0 109.762 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.861 HD12 HE22 ' A' ' 68' ' ' GLN . 1.0 OUTLIER -149.42 14.94 0.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.922 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 1.2 mm? -65.21 -40.76 94.58 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -25.82 62.89 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.861 HE22 HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.37 -58.68 7.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.3 mp -37.71 -69.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.563 -0.71 . . . . 0.0 110.452 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -48.28 -69.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.987 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' LYS . 12.3 mt-30 -34.77 -31.83 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.408 0.623 . . . . 0.0 110.428 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.762 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -108.64 -81.29 0.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.73 ' NE2' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -35.78 140.33 0.36 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.564 -0.71 . . . . 0.0 110.313 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.522 ' HD2' ' ND1' ' A' ' 73' ' ' HIS . 36.8 Cg_endo -59.49 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.104 1.581 . . . . 0.0 110.278 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.5 ptp 178.96 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 4.2 pp -115.95 146.61 37.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 32.8 Cg_endo -33.43 137.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.893 1.47 . . . . 0.0 112.626 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -131.13 106.8 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 16.0 mm -91.64 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.519 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 53' ' ' SER . 53.4 mt -150.22 145.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.496 ' O ' ' HB ' ' A' ' 82' ' ' THR . 1.2 mpp? -78.79 136.94 37.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 91.3 m 67.18 -83.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.559 -0.713 . . . . 0.0 110.021 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 82' ' ' THR . . . 83.93 95.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.585 -0.697 . . . . 0.0 109.171 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 86' ' ' ASP . 29.8 t60 -136.0 -87.51 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.952 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 46.67 36.66 3.88 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -178.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 88' ' ' ASP . 14.5 t0 66.11 128.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.872 HD12 HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -36.47 -31.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -36.89 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.519 0.676 . . . . 0.0 109.71 176.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.952 ' HB3' ' HB2' ' A' ' 85' ' ' SER . . . -51.7 -34.36 38.32 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.463 -0.773 . . . . 0.0 109.16 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.658 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -59.06 -80.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.062 -1.024 . . . . 0.0 109.618 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.872 HG23 HD12 ' A' ' 87' ' ' LEU . 33.3 t -14.26 -54.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 122.763 0.425 . . . . 0.0 111.987 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.658 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 4.3 t -79.53 -149.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.926 -1.109 . . . . 0.0 109.766 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 72.96 36.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.902 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 61.69 57.21 2.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.09 -1.006 . . . . 0.0 109.529 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -75.54 150.96 38.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 19.2 tt0 56.42 22.17 6.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.135 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.43 -46.83 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 77' ' ' PRO . . . -157.52 54.9 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.243 . . . . 0.0 109.985 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.29 122.5 12.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 101' ' ' TYR . 38.7 t70 -113.1 6.77 17.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.053 -1.03 . . . . 0.0 110.354 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 2.4 m-85 46.88 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.066 -1.022 . . . . 0.0 109.106 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -91.89 137.62 25.23 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.0 110.018 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 37.4 Cg_endo -127.54 177.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.643 1.339 . . . . 0.0 110.048 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -93.29 159.53 35.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.265 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -79.59 172.79 57.37 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.655 -2.644 . . . . 0.0 110.492 0.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 10.7 p90 -156.05 133.8 11.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.363 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 18.3 t0 -81.16 -162.39 0.49 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 108.703 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.617 HG21 ' CB ' ' A' ' 22' ' ' ALA . 36.0 mm -106.67 -65.01 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 109.208 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -57.65 -51.91 67.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.9 tp10 -43.55 -38.2 2.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.74 -73.71 0.18 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.907 HG21 HD11 ' A' ' 23' ' ' LEU . 38.4 t -37.24 -69.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.513 -0.742 . . . . 0.0 110.233 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -45.29 -63.14 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 110.441 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.3 tm? -35.29 -50.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.689 0.756 . . . . 0.0 109.524 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.753 HG13 HG21 ' A' ' 50' ' ' VAL . 1.2 t -60.18 -57.01 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.624 ' N ' HG12 ' A' ' 115' ' ' VAL . 3.4 tt0 -34.02 -39.42 0.07 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.198 0.523 . . . . 0.0 110.288 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' VAL . 4.4 mtp85 -71.72 -52.0 19.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 109.25 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -49.09 -56.46 9.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.188 -0.945 . . . . 0.0 108.6 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.534 HG12 ' CG2' ' A' ' 50' ' ' VAL . 5.4 mt -35.27 -41.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.336 0.589 . . . . 0.0 109.774 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -88.03 53.33 2.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.153 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 6.9 t-80 -94.93 -5.73 44.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.607 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -85.64 19.8 2.32 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.235 -0.916 . . . . 0.0 109.822 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.2 -16.05 25.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.579 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.561 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.436 ' OE1' HD11 ' A' ' 28' ' ' LEU . 16.0 mt-30 -146.37 177.18 9.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 109.615 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 116' ' ' GLU . 0.3 OUTLIER -151.63 120.79 6.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 109.395 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.639 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 166.87 153.1 7.7 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.051 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.901 HG23 ' HB ' ' A' ' 29' ' ' THR . 1.9 mt -124.17 131.52 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.159 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.777 ' CG1' HG23 ' A' ' 8' ' ' VAL . 1.9 t -126.74 113.07 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 108.796 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.84 ' O ' HD13 ' A' ' 51' ' ' LEU . 9.2 m95 -99.9 86.9 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.425 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.041 HG22 ' HB2' ' A' ' 52' ' ' LEU . 48.7 t -84.09 159.82 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.544 -0.722 . . . . 0.0 111.076 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 65' ' ' LEU . 14.3 t -95.1 121.76 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.917 ' OD2' HG22 ' A' ' 15' ' ' ILE . 8.3 m-20 -109.07 -169.98 1.58 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.19 -0.943 . . . . 0.0 110.0 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' CG ' ' HG3' ' A' ' 57' ' ' MET . 51.8 t0 -100.87 -57.13 2.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.446 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -130.73 173.74 10.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 109.845 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.562 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -58.71 -41.74 87.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.958 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -28.36 34.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 108.986 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.917 HG22 ' OD2' ' A' ' 10' ' ' ASP . 43.7 mm -71.38 -40.35 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.0 -49.46 71.43 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.438 ' O ' ' C ' ' A' ' 18' ' ' VAL . 27.0 t90 -55.22 -59.68 4.45 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.0 t -36.18 -70.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.666 0.746 . . . . 0.0 110.921 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.5 tp -55.41 -72.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.423 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 10.3 tm-20 -34.89 -30.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.795 -0.566 . . . . 0.0 110.969 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -68.45 -55.94 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.243 -0.911 . . . . 0.0 108.57 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 108' ' ' ILE . . . -72.1 -4.76 30.87 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 112' ' ' VAL . 0.4 OUTLIER -100.22 -12.75 19.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.421 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.8 -43.48 68.57 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.55 -44.81 97.48 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -31.27 67.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.03 49.37 4.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.078 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -130.14 178.12 6.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.878 -1.366 . . . . 0.0 110.165 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.901 ' HB ' HG23 ' A' ' 5' ' ' ILE . 96.6 m -97.9 77.84 2.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 40.5 t -76.09 88.31 3.0 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.931 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.716 HG21 ' CD2' ' A' ' 7' ' ' TRP . 13.0 m -100.51 127.09 46.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.201 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 16' ' ' ARG . 43.9 p -119.06 161.01 20.98 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 109.27 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.827 ' CG ' HG23 ' A' ' 39' ' ' VAL . 2.0 m-85 -134.37 105.81 6.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' N ' ' A' ' 13' ' ' SER . 1.1 mp0 -41.94 -31.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.537 -0.727 . . . . 0.0 109.777 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -106.91 126.21 52.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.641 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.865 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -65.17 -57.35 11.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 26.5 t-20 -51.37 -66.52 0.37 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.772 -1.428 . . . . 0.0 108.956 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.55 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.5 tt0 -33.52 -53.16 0.41 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.855 -0.528 . . . . 0.0 111.465 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.92 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -58.3 -52.86 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.725 -1.235 . . . . 0.0 109.498 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.92 HD12 ' CG1' ' A' ' 39' ' ' VAL . 8.5 mp -62.34 -14.7 42.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -77.2 -37.68 53.05 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.37 1.09 48.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.774 HD11 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.11 -6.16 54.07 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.323 -0.86 . . . . 0.0 109.439 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -10.38 52.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 109.59 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.7 m -97.39 1.04 48.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HG3' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 65.33 90.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.847 . . . . 0.0 109.611 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.597 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.6 m -99.25 -72.97 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.082 -1.011 . . . . 0.0 109.847 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 38.7 Cg_endo -75.65 -162.72 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.488 1.257 . . . . 0.0 110.411 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.929 ' O ' HD13 ' A' ' 76' ' ' LEU . 2.8 p30 -110.81 -14.93 13.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.874 HG21 HG13 ' A' ' 115' ' ' VAL . 4.3 t -144.89 129.11 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.521 -0.737 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -100.42 158.4 15.92 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.041 ' HB2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -146.84 157.1 43.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.072 -1.018 . . . . 0.0 110.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.883 ' CB ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -134.05 123.87 25.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 109.729 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.771 ' O ' HG22 ' A' ' 55' ' ' ILE . 27.1 m-20 -62.5 -51.93 65.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 109.779 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.906 HG21 ' HB ' ' A' ' 82' ' ' THR . 2.2 tp 83.96 26.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.326 0.584 . . . . 0.0 109.454 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 57' ' ' MET . 17.3 ptm180 -113.67 -138.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.217 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.485 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.8 ttm 70.57 128.96 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.865 -1.147 . . . . 0.0 109.301 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -89.23 173.33 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.326 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.63 -66.87 0.96 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -91.17 29.62 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -1.194 . . . . 0.0 109.527 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t0 52.48 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -138.02 83.79 0.25 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.2 mp -35.91 132.62 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.907 -0.76 . . . . 0.0 110.127 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -49.88 -80.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.014 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.0 OUTLIER 79.09 -35.93 0.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 110.529 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 89' ' ' ALA . 13.5 tp -77.0 -62.11 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.405 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -50.71 -40.29 53.81 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.679 ' CG ' HD22 ' A' ' 40' ' ' LEU . 3.7 tp-100 -57.96 -56.76 17.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.014 HD12 ' O ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -35.92 -53.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.37 0.605 . . . . 0.0 109.908 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 72' ' ' ARG . 11.3 mtmm -60.04 -63.0 1.45 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.928 -1.107 . . . . 0.0 109.609 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.96 -34.37 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.775 -0.578 . . . . 0.0 110.959 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -122.51 -68.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.066 -1.021 . . . . 0.0 109.656 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -40.07 160.56 0.11 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.595 -0.691 . . . . 0.0 109.37 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 36.8 Cg_endo -92.95 -96.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.899 1.473 . . . . 0.0 110.15 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.4 mtm -147.56 2.36 0.73 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.875 -1.14 . . . . 0.0 110.881 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.929 HD13 ' O ' ' A' ' 49' ' ' ASP . 2.5 pp -61.81 134.89 94.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 120.596 -1.315 . . . . 0.0 108.104 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.848 ' HG2' HG22 ' A' ' 50' ' ' VAL . 32.1 Cg_endo -28.94 145.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 124.176 1.619 . . . . 0.0 112.487 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.619 ' O ' ' CG ' ' A' ' 99' ' ' PHE . 21.5 t -147.45 95.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.723 -0.611 . . . . 0.0 109.388 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 19.1 mt -75.63 136.38 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.951 -1.093 . . . . 0.0 110.635 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.89 HD12 ' CB ' ' A' ' 83' ' ' ALA . 4.0 pt -126.79 115.19 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.011 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -66.97 129.52 40.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.169 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.906 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.3 m 71.98 -78.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.717 . . . . 0.0 109.922 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.89 ' CB ' HD12 ' A' ' 80' ' ' ILE . . . 66.06 129.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 109.508 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.766 ' HA ' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -178.82 -79.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.472 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.6 t 44.59 41.04 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 69.75 131.51 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -175.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.836 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 1.7 mm? -36.35 -28.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.042 0.925 . . . . 0.0 109.104 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -35.88 -63.55 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.891 ' O ' HD23 ' A' ' 66' ' ' LEU . . . -81.18 -32.49 33.56 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 108.929 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -63.68 -67.23 0.45 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 109.033 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.75 -53.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 C-N-CA 122.779 0.432 . . . . 0.0 111.611 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.733 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -61.8 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.998 -1.064 . . . . 0.0 109.088 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 79.18 -75.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.076 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' VAL . 22.5 p90 -78.79 5.76 10.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.055 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.69 -26.97 60.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 109.286 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER 163.24 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -0.827 . . . . 0.0 109.384 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.15 -146.2 8.88 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . . . -138.88 67.6 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -1.126 . . . . 0.0 109.652 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 41.3 p90 170.66 -177.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -150.7 -176.01 5.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.272 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 83' ' ' ALA . 5.0 m-30 -81.71 130.22 34.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.252 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -114.61 115.91 43.88 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 0.0 109.404 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -117.06 171.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.875 1.46 . . . . 0.0 110.415 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 16.5 mttm -63.03 157.96 58.03 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 109.402 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 37.3 Cg_endo -79.07 161.54 88.29 Favored 'Cis proline' 0 C--N 1.315 -1.225 0 C-N-CA 120.539 -2.692 . . . . 0.0 109.905 -0.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 1.8 p90 -143.26 129.5 19.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.5 t70 -91.28 -147.25 0.21 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.062 -1.024 . . . . 0.0 108.748 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.721 HG22 ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -119.18 -69.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.721 ' N ' HG22 ' A' ' 108' ' ' ILE . 13.7 t70 -62.16 -42.67 99.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 11.6 tm-20 -46.23 -45.7 17.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.79 -77.04 0.09 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.078 HG11 HD13 ' A' ' 28' ' ' LEU . 65.2 t -38.39 -71.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 110.155 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.59 -65.4 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.961 -0.462 . . . . 0.0 110.27 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' ALA . 13.5 tp -34.76 -49.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.826 0.822 . . . . 0.0 109.507 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.874 HG13 HG21 ' A' ' 50' ' ' VAL . 1.7 t -60.49 -55.81 21.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 115' ' ' VAL . 1.4 tt0 -34.88 -45.79 0.28 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 118' ' ' ALA . 12.5 mtm105 -70.72 -51.74 25.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 109.441 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -47.24 -67.56 0.27 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.889 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.756 HG21 ' HB2' ' A' ' 49' ' ' ASP . 5.5 mt -36.29 -43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.672 -0.642 . . . . 0.0 110.062 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 121' ' ' HIS . 3.7 t -48.73 -58.2 5.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 120' ' ' SER . 4.9 t60 -42.75 -41.33 3.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.338 -0.851 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.75 49.71 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.493 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.41 28.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.39 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 67.11 129.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 109.653 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 2' ' ' GLN . 7.7 mtt180 -165.88 46.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.779 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.719 ' HA3' HD21 ' A' ' 28' ' ' LEU . . . 161.23 168.59 23.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.667 HG23 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -144.61 104.34 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -1.119 . . . . 0.0 108.315 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' CG1' HG23 ' A' ' 8' ' ' VAL . 2.7 t -120.87 115.95 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.08 . . . . 0.0 110.253 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.82 ' CZ2' HG21 ' A' ' 31' ' ' THR . 0.2 OUTLIER -99.58 80.38 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 0.0 109.34 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 52' ' ' LEU . 9.3 t -68.22 137.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.321 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.714 HG22 HG21 ' A' ' 39' ' ' VAL . 57.4 t -85.67 108.78 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.115 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.587 ' CG ' HG22 ' A' ' 15' ' ' ILE . 71.6 m-20 -87.15 -171.72 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.326 -0.859 . . . . 0.0 109.834 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.75 -87.06 0.14 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.38 -0.825 . . . . 0.0 109.637 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 15' ' ' ILE . 3.1 m-20 -112.05 170.7 7.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.635 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.8 p -49.55 164.72 0.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.9 OUTLIER 79.73 -8.67 1.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 109.747 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.587 HG22 ' CG ' ' A' ' 10' ' ' ASP . 46.4 mm -92.93 -36.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.973 -1.08 . . . . 0.0 108.398 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 17' ' ' TRP . 15.8 ptt-85 -66.18 -32.59 74.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.609 ' CZ3' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -52.11 -66.34 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 49.6 t -42.49 -53.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.921 0.867 . . . . 0.0 110.072 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.704 ' HG ' HG21 ' A' ' 32' ' ' THR . 2.7 mm? -49.56 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.745 . . . . 0.0 110.343 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 23' ' ' LEU . 2.0 mt-10 -35.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.369 0.604 . . . . 0.0 110.395 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.609 ' HD3' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -62.51 -56.35 18.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.809 -1.182 . . . . 0.0 108.839 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.785 ' HB3' HD13 ' A' ' 108' ' ' ILE . . . -63.5 -20.84 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.795 HD13 ' HB2' ' A' ' 30' ' ' CYS . 19.6 tp -71.67 -25.59 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.84 -0.537 . . . . 0.0 110.165 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.66 73.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.27 -38.47 87.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.41 49.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 109.226 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 57.76 65.51 3.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.05 HD13 HG11 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -136.43 -177.44 4.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.238 -1.154 . . . . 0.0 110.215 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.667 ' HB ' HG23 ' A' ' 5' ' ' ILE . 32.1 m -104.93 50.96 0.77 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.795 ' HB2' HD13 ' A' ' 23' ' ' LEU . 18.4 t -79.03 87.07 4.83 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.233 0.54 . . . . 0.0 109.579 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.82 HG21 ' CZ2' ' A' ' 7' ' ' TRP . 1.4 m -85.83 170.29 12.54 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 108.66 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.71 HG22 ' HB ' ' A' ' 8' ' ' VAL . 1.1 p -155.18 143.16 20.04 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.4 m-85 -118.44 -168.87 1.61 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.936 -1.103 . . . . 0.0 109.794 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.42 -1.71 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 110.2 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 4.8 m-20 -136.56 127.36 27.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.955 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -48.99 -50.68 26.78 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 39' ' ' VAL . 18.9 t-20 -58.94 -63.67 1.22 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.3 -1.118 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -34.37 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 0.0 110.592 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 33' ' ' PHE . 1.7 t -74.54 -64.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.081 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -59.68 -14.57 14.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.949 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -85.14 -39.58 17.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.175 -0.953 . . . . 0.0 108.469 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.53 74.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.979 HD13 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -65.23 -94.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.498 -0.752 . . . . 0.0 109.135 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 84.0 -63.33 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.427 0.632 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 62.3 p -102.3 -37.88 7.88 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.514 -0.741 . . . . 0.0 109.794 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 149.72 95.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.673 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m -100.32 -74.51 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.853 -1.154 . . . . 0.0 110.475 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.673 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 40.8 Cg_endo -81.2 -162.02 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 116.916 -1.59 . . . . 0.0 109.591 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 119' ' ' ILE . 53.2 p30 -113.43 -12.11 13.02 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.645 HG21 HG13 ' A' ' 115' ' ' VAL . 2.4 t -155.51 121.75 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.979 HD22 HD13 ' A' ' 43' ' ' LEU . 2.5 tp -99.51 136.05 40.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.041 -1.037 . . . . 0.0 108.631 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.813 ' HB3' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -117.12 174.18 6.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.917 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 91.0 p -149.01 133.97 18.07 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.502 ' OD2' ' CG1' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -95.93 3.92 53.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 110.051 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.737 HG21 ' HB ' ' A' ' 82' ' ' THR . 1.3 tt 28.82 82.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.3 0.572 . . . . 0.0 110.738 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -162.63 73.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.995 -1.066 . . . . 0.0 109.688 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtm -128.26 136.55 29.23 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.98 113.08 2.45 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.062 1.559 . . . . 0.0 110.383 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.62 -160.99 24.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.8 mtt -76.66 -49.5 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.203 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.25 177.06 5.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.217 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.34 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.991 HD13 HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER 178.88 29.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -1.122 . . . . 0.0 110.0 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . 43.23 -92.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.96 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.991 HD12 HD13 ' A' ' 63' ' ' LEU . 0.5 OUTLIER 71.72 -82.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.854 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 66' ' ' LEU . 1.1 mm? -37.35 -29.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.123 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.91 -55.02 25.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.04 -41.72 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.153 . . . . 0.0 109.191 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.674 HG22 ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -37.33 -59.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.187 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.674 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -66.31 -51.53 56.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.903 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -34.39 -36.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.715 -0.615 . . . . 0.0 111.119 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -109.33 -59.18 1.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 0.0 110.313 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.718 ' CD2' HD22 ' A' ' 43' ' ' LEU . 57.1 m170 -39.61 145.35 0.43 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.417 -0.802 . . . . 0.0 110.066 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.555 ' HG3' ' HG3' ' A' ' 46' ' ' LYS . 35.1 Cg_endo -87.06 47.32 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.111 1.585 . . . . 0.0 109.868 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 6.8 mtp 72.41 55.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.61 -0.681 . . . . 0.0 110.241 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 77' ' ' PRO . 1.2 pp -114.8 136.62 22.53 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.056 . . . . 0.0 109.235 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.786 ' O ' HD12 ' A' ' 76' ' ' LEU . 35.6 Cg_endo -40.54 141.91 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.267 1.667 . . . . 0.0 112.994 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -147.5 142.76 19.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.797 HD11 HG22 ' A' ' 115' ' ' VAL . 8.7 mt -126.12 167.93 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.775 -1.203 . . . . 0.0 110.524 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.616 ' N ' HG22 ' A' ' 79' ' ' ILE . 4.2 tt -149.22 144.11 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 82' ' ' THR . 1.7 mpt? -88.14 65.49 8.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.319 -0.863 . . . . 0.0 109.109 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.737 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.1 m 158.1 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' ' 101' ' ' TYR . . . -101.89 46.11 0.94 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.514 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.549 ' H ' HG22 ' A' ' 82' ' ' THR . 0.3 OUTLIER -123.4 -97.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 45.78 27.65 0.48 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 61.23 123.37 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.815 HD12 ' HB3' ' A' ' 90' ' ' ALA . 9.6 tp -39.32 -25.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 108.263 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -36.91 -75.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.064 -1.022 . . . . 0.0 110.234 176.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' SER . . . -68.43 -34.62 76.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.815 ' HB3' HD12 ' A' ' 87' ' ' LEU . . . -56.7 -62.2 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.37 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -27.25 -39.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 122.683 0.393 . . . . 0.0 111.099 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -38.37 -59.6 0.88 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 109.579 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.566 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -44.0 -69.24 0.14 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -51.99 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 93' ' ' ALA . 2.3 mm-40 -176.38 -42.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -136.78 -67.36 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.71 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 156.65 173.9 25.72 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 81.84 -0.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.914 . . . . 0.0 109.899 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 3.8 m-85 -112.81 119.73 39.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.082 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.31 164.39 21.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.819 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.475 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 65.7 m-85 -110.75 94.57 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.143 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.551 ' HB2' ' CG2' ' A' ' 79' ' ' ILE . 1.6 tp -83.1 153.67 66.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -122.68 -174.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.707 1.372 . . . . 0.0 110.501 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -119.14 157.66 50.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.6 Cg_endo -78.81 175.31 47.12 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.887 -2.547 . . . . 0.0 110.562 0.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 106' ' ' PHE . 25.1 p90 -148.68 140.89 24.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.778 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 13.5 t0 -79.49 147.63 32.16 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -72.36 -31.09 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.722 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -82.96 -44.81 14.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 38.8 tt0 -55.46 -39.26 70.12 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -73.81 -65.9 0.77 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.37 -0.831 . . . . 0.0 109.173 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.05 HG11 HD13 ' A' ' 28' ' ' LEU . 41.0 t -36.5 -57.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.652 . . . . 0.0 110.576 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -58.72 -66.09 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.539 -0.726 . . . . 0.0 110.492 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.3 tp -35.19 -54.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.544 0.687 . . . . 0.0 110.09 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.797 HG22 HD11 ' A' ' 79' ' ' ILE . 27.3 t -56.63 -56.11 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 115' ' ' VAL . 54.9 tt0 -34.91 -42.17 0.15 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.421 0.629 . . . . 0.0 109.917 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' ALA . 22.4 mtp180 -73.57 -54.86 7.19 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.068 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.99 -66.84 0.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.163 -0.961 . . . . 0.0 109.157 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 50' ' ' VAL . 4.1 mt -37.53 -41.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.672 . . . . 0.0 109.932 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 121' ' ' HIS . 6.1 m -46.15 -55.1 7.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.413 -0.805 . . . . 0.0 109.9 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 120' ' ' SER . 14.4 t-160 -38.64 -43.84 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.885 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.78 96.43 4.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.49 40.71 3.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.87 . . . . 0.0 109.334 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.471 ' CG ' ' OXT' ' A' ' 124' ' ' GLU . 35.5 tt0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 12.4 mt-30 -135.7 122.31 20.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.165 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -132.28 52.74 2.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 110.22 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.683 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -174.59 120.64 0.79 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.507 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.83 HD12 ' H ' ' A' ' 5' ' ' ILE . 1.1 mp -106.31 118.03 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.297 . . . . 0.0 108.601 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.67 112.72 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.338 -0.851 . . . . 0.0 109.695 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.594 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.45 92.31 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.69 -1.256 . . . . 0.0 108.746 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.88 HG22 ' HB2' ' A' ' 52' ' ' LEU . 57.6 t -83.66 150.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.444 0.64 . . . . 0.0 110.899 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 76.2 t -89.7 122.34 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.978 ' HA ' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.94 143.05 55.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.824 0.821 . . . . 0.0 110.819 -178.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 57' ' ' MET . 5.1 t0 -99.29 -65.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.523 ' O ' ' CG1' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -110.01 174.73 5.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.292 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 14' ' ' SER . 52.0 p -64.45 148.79 49.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 78.25 24.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.884 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.978 HG21 ' HA ' ' A' ' 10' ' ' ASP . 3.2 mm -83.63 -47.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 7.4 mtm180 -53.17 -47.95 68.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.494 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 22.9 t90 -55.51 -61.5 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 17' ' ' TRP . 15.9 t -36.98 -68.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.506 -0.746 . . . . 0.0 110.643 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 21' ' ' ARG . 6.9 mt -59.85 -74.56 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.42 -0.8 . . . . 0.0 110.878 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 19' ' ' LEU . 12.2 tt0 -34.56 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.771 -0.581 . . . . 0.0 111.057 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -69.87 -56.39 7.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.998 . . . . 0.0 108.593 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.679 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -72.06 -3.75 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.38 -0.825 . . . . 0.0 108.82 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.04 HD11 HG21 ' A' ' 112' ' ' VAL . 3.1 mm? -103.43 -10.89 18.22 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.392 -0.818 . . . . 0.0 109.522 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.88 -35.11 24.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.31 -36.78 49.46 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -69.4 -34.04 73.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -1.052 . . . . 0.0 108.637 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 90.26 73.08 1.26 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.04 HD13 HG11 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -146.67 174.61 11.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -1.207 . . . . 0.0 109.935 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.712 ' CG2' HG23 ' A' ' 5' ' ' ILE . 92.7 m -102.98 61.19 0.79 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . 35.9 t -83.85 96.79 8.89 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.532 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 5.7 m -100.02 154.62 18.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 108.662 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.486 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 p -139.98 158.77 43.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.99 -1.069 . . . . 0.0 109.36 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.895 ' HB2' HG23 ' A' ' 39' ' ' VAL . 6.2 m-85 -135.95 120.56 18.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.602 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 3.0 mt-10 -42.84 -42.86 3.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.966 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -110.05 119.74 40.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -51.68 -48.96 48.79 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.478 ' O ' ' C ' ' A' ' 38' ' ' GLU . 17.0 t30 -42.53 -71.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -1.045 . . . . 0.0 108.4 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.7 mt-10 -34.51 -42.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.79 -0.568 . . . . 0.0 109.755 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.969 HG12 HD22 ' A' ' 40' ' ' LEU . 1.2 t -58.01 -54.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.887 . . . . 0.0 108.688 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.969 HD22 HG12 ' A' ' 39' ' ' VAL . 3.1 mm? -61.36 -19.28 61.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -75.1 -45.28 42.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.163 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.45 -19.34 59.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.094 HD12 ' CD2' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -80.76 -105.04 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.28 -57.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.74 . . . . 0.0 109.497 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.5 t -100.99 -3.73 28.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.742 ' HE2' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER 83.42 110.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.78 0.8 . . . . 0.0 109.141 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.652 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 21.2 m -104.04 -74.77 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.584 -1.323 . . . . 0.0 111.84 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.715 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 45.4 Cg_endo -55.51 -161.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.441 1.232 . . . . 0.0 109.766 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.909 ' HB2' HD13 ' A' ' 119' ' ' ILE . 8.1 p30 -115.7 -8.4 12.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.182 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.924 HG21 HG13 ' A' ' 115' ' ' VAL . 2.3 t -156.91 123.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.144 -0.972 . . . . 0.0 109.959 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.915 ' C ' HD23 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -100.3 143.97 29.86 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.954 HD22 ' CG2' ' A' ' 79' ' ' ILE . 5.2 mt -123.21 163.86 19.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.765 -1.209 . . . . 0.0 110.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 80' ' ' ILE . 20.4 t -133.01 115.48 15.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' O ' HG22 ' A' ' 55' ' ' ILE . 8.8 m-20 -60.87 -25.85 66.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.173 -0.955 . . . . 0.0 110.44 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER 49.79 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 108.984 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER 57.05 111.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.025 -1.047 . . . . 0.0 109.361 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.916 ' SD ' HD22 ' A' ' 63' ' ' LEU . 3.6 mtm -157.11 -176.15 0.59 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 109.649 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -103.43 70.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.008 1.53 . . . . 0.0 110.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.61 -155.43 7.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -81.81 127.33 32.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -1.147 . . . . 0.0 109.611 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.46 -92.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 109.537 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -119.51 -111.28 2.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.916 HD22 ' SD ' ' A' ' 57' ' ' MET . 11.4 tp -124.02 -7.06 7.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.66 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 63' ' ' LEU . . . 73.78 50.62 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.77 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.655 HD21 HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -162.17 16.98 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.192 -0.943 . . . . 0.0 110.106 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.4 mm? -70.61 -67.29 0.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.043 -1.036 . . . . 0.0 108.825 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -28.05 3.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.595 ' NE2' ' HB2' ' A' ' 65' ' ' LEU . 1.7 tt0 -57.07 -53.44 58.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.75 ' HA ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -33.57 -32.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.935 -0.478 . . . . 0.0 110.432 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' GLN . 1.9 mmmt -99.15 -65.1 0.98 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.035 -1.041 . . . . 0.0 109.935 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 70' ' ' LYS . 4.4 tt0 -33.17 -33.48 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.799 -0.563 . . . . 0.0 110.896 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.565 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -92.5 -68.34 0.8 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 1.094 ' CD2' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -126.14 112.03 24.01 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 38.1 Cg_endo -134.05 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.67 1.353 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.545 ' CB ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -131.04 -14.89 3.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.912 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 50' ' ' VAL . 3.7 pp -131.23 167.16 22.96 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.092 -1.005 . . . . 0.0 108.531 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.2 Cg_endo -65.69 159.63 47.42 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.222 1.117 . . . . 0.0 111.247 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.668 HG11 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -126.48 101.26 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 109.337 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.954 ' CG2' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -65.24 157.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.195 -0.941 . . . . 0.0 109.108 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.581 HD11 ' CD1' ' A' ' 101' ' ' TYR . 6.5 pt -157.11 118.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.64 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.08 138.24 57.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.402 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 103' ' ' PRO . 16.8 m -75.39 121.65 22.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' HG23 ' A' ' 55' ' ' ILE . . . -171.4 40.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.754 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.3 m-70 67.92 110.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 84' ' ' HIS . 12.3 t 156.68 -73.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' ASP . 2.2 p30 -48.22 -28.98 3.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 110.054 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -36.06 -29.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -0.881 . . . . 0.0 111.198 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' ASP . 47.4 m-20 -107.61 -79.87 0.57 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.045 -1.034 . . . . 0.0 110.517 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 92' ' ' SER . . . -36.68 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.405 -0.809 . . . . 0.0 110.355 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 88' ' ' ASP . . . -74.39 -79.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 85.2 t -33.49 -41.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -113.61 -172.21 2.03 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 109.406 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 70.67 68.41 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.778 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.63 65.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 3.2 pt20 -73.87 -125.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.323 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.4 tp60 76.85 69.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.871 -1.143 . . . . 0.0 109.546 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 48.53 -158.38 0.88 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 67.8 20.32 9.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -1.152 . . . . 0.0 109.481 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' O ' ' CE1' ' A' ' 101' ' ' TYR . 1.1 m-85 -151.54 53.59 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.75 154.24 41.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.209 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 80' ' ' ILE . 1.3 m-85 -108.98 166.87 10.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.22 89.05 24.32 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.847 . . . . 0.0 109.163 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' A' ' 82' ' ' THR . 36.7 Cg_endo -58.94 168.21 4.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.076 1.566 . . . . 0.0 110.971 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -116.02 158.35 42.69 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.771 . . . . 0.0 109.058 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -83.23 169.74 56.67 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.63 -2.654 . . . . 0.0 110.312 0.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 13.7 p90 -149.39 163.1 38.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 109.09 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 5.6 t70 -87.78 -156.21 0.34 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.199 -0.938 . . . . 0.0 108.801 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.679 HG21 ' HB3' ' A' ' 22' ' ' ALA . 19.4 mm -120.61 -70.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.857 -1.152 . . . . 0.0 109.606 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' GLU . 9.2 t70 -54.46 -51.18 65.81 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 19.1 tp10 -42.85 -42.27 3.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -67.3 -72.98 0.15 Allowed 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.335 -0.853 . . . . 0.0 108.988 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.04 HG21 HD11 ' A' ' 23' ' ' LEU . 35.8 t -36.86 -68.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.789 -0.57 . . . . 0.0 110.2 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -37.35 -65.17 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.0 110.294 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.473 ' C ' ' O ' ' A' ' 113' ' ' ALA . 33.7 tp -35.47 -53.93 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.676 0.751 . . . . 0.0 109.763 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.924 HG13 HG21 ' A' ' 50' ' ' VAL . 1.8 t -56.09 -57.53 8.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.497 ' C ' ' O ' ' A' ' 115' ' ' VAL . 19.3 mt-10 -33.54 -41.94 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.422 0.63 . . . . 0.0 110.187 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.6 mtt-85 -76.04 -54.85 6.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.697 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -44.2 -63.22 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 108.931 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.909 HD13 ' HB2' ' A' ' 49' ' ' ASP . 7.6 mt -33.84 -44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.152 0.501 . . . . 0.0 110.55 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.22 61.81 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.64 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -106.8 -40.25 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.611 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.0 p90 -120.55 31.01 6.64 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -135.66 36.08 2.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.947 -1.096 . . . . 0.0 109.728 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.578 179.713 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.451 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 2.4 pt20 -154.32 82.68 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 108.991 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 8.6 tpt180 -121.9 60.73 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.031 -1.043 . . . . 0.0 110.506 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' HD23 ' A' ' 28' ' ' LEU . . . 165.34 93.95 0.1 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 48' ' ' PRO . 5.8 mt -83.4 93.12 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.401 -1.058 . . . . 0.0 109.671 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.105 HG23 ' CG1' ' A' ' 50' ' ' VAL . 8.5 p -96.1 122.48 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.722 -0.611 . . . . 0.0 109.412 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.81 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.71 102.97 14.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.686 -1.259 . . . . 0.0 109.047 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.01 HG22 ' CB ' ' A' ' 52' ' ' LEU . 13.4 t -100.93 125.03 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.958 . . . . 0.0 110.625 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.15 112.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.572 -1.33 . . . . 0.0 108.366 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.698 ' OD1' HG22 ' A' ' 15' ' ' ILE . 20.9 t0 -68.1 164.98 19.07 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.272 0.558 . . . . 0.0 109.88 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 1.5 m-20 -96.21 -89.07 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.397 -0.815 . . . . 0.0 109.643 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 15' ' ' ILE . 1.1 m-20 -106.59 174.75 5.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.4 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 14' ' ' SER . 14.0 m -57.75 148.16 25.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.4 t 81.79 -11.96 1.01 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.961 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.698 HG22 ' OD1' ' A' ' 10' ' ' ASP . 12.6 mm -79.19 -35.81 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.0 -1.063 . . . . 0.0 108.745 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.601 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.3 ttp-105 -59.94 -46.03 90.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.482 ' O ' ' C ' ' A' ' 18' ' ' VAL . 55.1 t90 -58.29 -59.68 4.95 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.297 -0.877 . . . . 0.0 108.919 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.6 t -34.92 -60.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.579 0.704 . . . . 0.0 110.506 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 21' ' ' ARG . 3.1 mt -53.1 -71.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.978 -1.076 . . . . 0.0 109.152 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -35.13 -33.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.263 0.554 . . . . 0.0 110.818 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.02 -56.13 19.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 108.241 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.982 ' HB1' HG21 ' A' ' 108' ' ' ILE . . . -64.96 -9.83 24.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.119 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.785 HD11 HG21 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -85.77 -24.5 26.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.631 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.7 -43.96 85.53 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.26 -47.79 28.01 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -58.45 -17.59 21.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.157 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.815 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 63.08 54.01 36.08 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.933 HD22 HG13 ' A' ' 112' ' ' VAL . 2.7 mp -144.48 175.4 10.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.289 . . . . 0.0 109.999 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.526 ' CG2' HG23 ' A' ' 5' ' ' ILE . 30.4 m -107.78 85.34 2.1 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.858 -0.526 . . . . 0.0 110.994 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.58 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 50.8 t -88.69 83.34 6.73 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.872 -1.143 . . . . 0.0 109.853 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.523 ' CG2' ' NE1' ' A' ' 7' ' ' TRP . 15.7 m -80.04 125.15 29.41 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 8' ' ' VAL . 75.2 p -118.52 140.61 49.61 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.83 -1.169 . . . . 0.0 110.642 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.934 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 m-30 -116.24 113.38 22.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.618 -0.676 . . . . 0.0 109.215 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 10' ' ' ASP . 47.1 mt-10 -37.24 -28.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.557 -0.714 . . . . 0.0 110.014 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -118.36 116.63 27.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.628 ' O ' HD13 ' A' ' 40' ' ' LEU . . . -49.19 -51.89 24.4 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.652 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -43.56 -72.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.568 -0.96 . . . . 0.0 108.934 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 37' ' ' ASN . 32.1 tp10 -31.49 -39.32 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.811 . . . . 0.0 110.133 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.934 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -63.99 -56.41 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.989 ' H ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -78.87 3.01 18.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.585 -1.322 . . . . 0.0 109.689 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.491 ' N ' HD22 ' A' ' 40' ' ' LEU . . . -99.47 -24.08 14.9 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.35 -19.85 15.44 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.041 HD13 HG23 ' A' ' 47' ' ' THR . 13.8 mt -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.505 -0.747 . . . . 0.0 109.47 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . . . -35.21 -31.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.786 -0.571 . . . . 0.0 110.732 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -65.51 -55.26 18.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 108.527 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER 164.86 115.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.056 HG22 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -44.59 167.54 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.186 -0.946 . . . . 0.0 109.103 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.056 ' HD2' HG22 ' A' ' 47' ' ' THR . 36.8 Cg_endo -90.92 -65.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.679 1.358 . . . . 0.0 111.456 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.792 ' HB3' HG21 ' A' ' 119' ' ' ILE . 17.7 m-20 -121.49 -55.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.704 -1.248 . . . . 0.0 111.363 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.105 ' CG1' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -148.97 139.24 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.723 -1.236 . . . . 0.0 110.353 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.829 HD13 HG23 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.26 108.4 20.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.227 -0.921 . . . . 0.0 109.731 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.01 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.48 178.94 4.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.984 . . . . 0.0 108.971 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.754 ' HA ' HG12 ' A' ' 9' ' ' VAL . 38.2 m -162.42 126.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.087 . . . . 0.0 110.601 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 14.0 t0 -73.0 -144.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.094 -1.004 . . . . 0.0 108.401 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 54' ' ' ASP . 0.8 OUTLIER 174.57 78.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' CD ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -174.98 83.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.642 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.43 ' HB2' HD22 ' A' ' 63' ' ' LEU . 1.4 mmm -131.31 125.03 20.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -48.72 107.9 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.08 1.569 . . . . 0.0 110.518 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 125.1 140.73 5.49 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 87.3 mmm 61.64 11.83 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -1.086 . . . . 0.0 109.837 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 44.68 80.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.282 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . 66.54 90.09 0.05 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.718 ' CD1' HD21 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -56.76 -162.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -1.127 . . . . 0.0 109.416 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' N ' ' HG ' ' A' ' 63' ' ' LEU . . . -171.33 89.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.088 -1.008 . . . . 0.0 109.994 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.718 HD21 ' CD1' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -88.24 -6.51 57.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 109.122 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -49.74 -22.02 1.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.33 -45.48 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.022 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.701 ' HG3' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.55 -45.96 23.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.86 -1.15 . . . . 0.0 109.931 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.829 HG23 HD13 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -38.82 -32.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.902 -1.123 . . . . 0.0 110.161 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -95.6 -67.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.836 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -36.25 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.745 0.784 . . . . 0.0 110.339 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' LYS . 1.6 mmt85 -88.53 -93.32 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.262 0.553 . . . . 0.0 111.094 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.703 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 2.1 m-70 -53.03 144.38 27.83 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.3 Cg_endo -34.74 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 124.17 1.616 . . . . 0.0 111.196 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.42 94.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.802 HD21 ' OG1' ' A' ' 47' ' ' THR . 1.8 pp -125.61 151.73 70.94 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 1.075 ' HG2' HG23 ' A' ' 50' ' ' VAL . 36.9 Cg_endo -28.84 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.991 1.521 . . . . 0.0 112.219 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.89 146.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 42.8 mt -143.92 148.48 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 53' ' ' SER . 0.3 OUTLIER -133.6 150.3 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.539 ' CE ' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.58 164.46 25.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.406 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 1.2 m -93.02 162.78 13.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 161.3 -62.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 109.063 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.467 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 t60 -176.44 -176.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 t 61.04 -124.0 0.9 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.609 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 36.56 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.254 -0.904 . . . . 0.0 109.818 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 10.79 -77.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.309 0.576 . . . . 0.0 111.78 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' ASP . 9.3 t70 -53.27 -64.74 0.72 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.193 . . . . 0.0 109.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -52.28 -46.16 65.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.272 -0.893 . . . . 0.0 110.56 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.5 -73.97 0.13 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 110.536 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 62.4 t -32.02 -32.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.996 -0.44 . . . . 0.0 111.205 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 19.4 t -102.95 161.45 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.758 -1.214 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 79.07 82.05 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.484 -0.76 . . . . 0.0 109.76 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ALA . 58.4 m-85 42.47 63.2 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -0.827 . . . . 0.0 109.899 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.27 134.66 49.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.065 -1.022 . . . . 0.0 109.345 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER 76.54 151.06 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 80.37 94.52 0.4 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 76.08 5.23 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -1.127 . . . . 0.0 109.111 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -126.87 112.36 15.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.276 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -124.72 167.52 14.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.168 -0.957 . . . . 0.0 109.661 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.17 105.19 9.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.042 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.8 OUTLIER -73.36 124.73 90.79 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 110.032 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -91.3 171.59 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.143 1.601 . . . . 0.0 109.716 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -117.21 145.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.725 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -82.05 166.99 70.15 Favored 'Cis proline' 0 C--N 1.317 -1.084 0 C-N-CA 120.401 -2.749 . . . . 0.0 110.114 -0.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.539 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 39.4 p90 -136.61 140.85 43.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.342 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.3 t0 -72.47 122.94 22.11 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.096 -1.003 . . . . 0.0 108.801 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.982 HG21 ' HB1' ' A' ' 22' ' ' ALA . 1.5 tp -61.44 -29.58 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 110.137 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -80.45 -49.43 11.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 108.518 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 17.2 tp10 -52.3 -31.65 33.92 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -78.72 -69.65 0.55 Allowed 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.293 -0.879 . . . . 0.0 109.194 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.933 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 t -35.37 -55.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.506 0.67 . . . . 0.0 110.148 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.595 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -64.55 -65.4 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 110.196 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.887 HD13 ' N ' ' A' ' 115' ' ' VAL . 1.3 tm? -33.46 -61.44 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.408 0.623 . . . . 0.0 110.293 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.989 ' CG1' HG21 ' A' ' 50' ' ' VAL . 84.4 t -56.64 -52.15 57.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 18.6 tp10 -35.42 -45.12 0.32 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.32 0.581 . . . . 0.0 110.233 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -52.55 -55.91 18.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.092 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.17 -58.39 5.69 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.258 -0.901 . . . . 0.0 108.765 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.828 HD11 HG12 ' A' ' 115' ' ' VAL . 2.4 mm -37.37 -38.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.73 -0.606 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.546 ' C ' ' O ' ' A' ' 119' ' ' ILE . 6.0 t -20.0 -66.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.173 0.511 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 120' ' ' SER . 21.0 t-80 160.2 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 121' ' ' HIS . 2.4 m-85 37.91 30.58 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.716 0.77 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -49.8 -24.68 2.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.759 -0.588 . . . . 0.0 109.728 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.35 179.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.242 0.544 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -75.74 167.64 21.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 4.1 ptm180 -154.0 83.56 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.996 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -134.54 87.46 0.25 Allowed Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.087 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.847 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -88.36 87.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.159 -1.201 . . . . 0.0 108.468 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.75 111.46 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.743 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.855 ' CE3' HG21 ' A' ' 31' ' ' THR . 10.6 m0 -101.71 106.86 17.94 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.995 . . . . 0.0 108.524 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.001 HG23 ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -85.6 169.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.794 0.807 . . . . 0.0 111.688 -177.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 39' ' ' VAL . 68.8 t -121.42 94.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 64.1 m-20 -93.37 -173.08 3.12 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.501 0.667 . . . . 0.0 110.432 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' C ' ' HG2' ' A' ' 34' ' ' GLU . 24.5 t0 -122.24 -9.71 8.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB2' HG12 ' A' ' 15' ' ' ILE . 8.2 m-20 -147.12 164.48 32.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -42.6 73.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.408 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -54.52 -24.93 22.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.308 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.491 ' CG2' ' CG ' ' A' ' 10' ' ' ASP . 15.3 mm -71.59 -43.07 71.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.352 -0.843 . . . . 0.0 109.112 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.493 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.4 OUTLIER -55.3 -44.14 75.49 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.456 ' O ' ' C ' ' A' ' 18' ' ' VAL . 19.8 t90 -60.41 -58.03 10.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.437 -0.789 . . . . 0.0 109.169 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.456 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.3 t -36.2 -62.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.645 -0.659 . . . . 0.0 110.743 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -57.36 -68.91 0.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.056 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -34.5 -32.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.683 -0.635 . . . . 0.0 110.455 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.7 tpp180 -66.97 -55.86 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.907 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -68.25 -5.99 21.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.462 -0.773 . . . . 0.0 109.059 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 30' ' ' CYS . 3.3 mm? -102.15 -12.57 17.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.69 -40.85 28.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.66 97.52 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.0 -32.88 65.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.417 -1.049 . . . . 0.0 109.248 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 28' ' ' LEU . . . 84.73 66.41 1.46 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.683 HD21 HG13 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -134.71 -176.14 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.195 -1.179 . . . . 0.0 110.587 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 18.1 m -99.21 78.23 2.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.59 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 43.8 t -80.23 84.77 5.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.587 -0.696 . . . . 0.0 111.331 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.855 HG21 ' CE3' ' A' ' 7' ' ' TRP . 2.6 m -88.52 141.24 28.69 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.617 ' CB ' HG12 ' A' ' 8' ' ' VAL . 66.5 p -146.33 119.66 8.98 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.702 -1.249 . . . . 0.0 109.846 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.128 ' HB2' HG22 ' A' ' 39' ' ' VAL . 12.1 m-85 -103.55 129.74 50.83 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.365 -0.834 . . . . 0.0 109.019 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG2' ' C ' ' A' ' 11' ' ' ASP . 0.8 OUTLIER -63.45 -8.49 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.864 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 1.019 ' O ' HG23 ' A' ' 39' ' ' VAL . 10.6 t30 -136.61 133.57 36.46 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.622 -1.299 . . . . 0.0 110.48 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.864 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . -51.09 -59.95 7.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.567 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -46.78 -73.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.272 -1.134 . . . . 0.0 108.92 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 37' ' ' ASN . 13.9 tp10 -32.7 -34.43 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.364 -0.835 . . . . 0.0 110.616 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.128 HG22 ' HB2' ' A' ' 33' ' ' PHE . 15.3 t -61.61 -57.97 9.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.099 -1.001 . . . . 0.0 109.015 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.956 HD12 ' N ' ' A' ' 41' ' ' ALA . 1.3 pp -62.42 -12.38 21.35 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.236 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.956 ' N ' HD12 ' A' ' 40' ' ' LEU . . . -81.02 -30.2 34.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.468 -0.77 . . . . 0.0 109.183 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . . . -88.47 -28.45 20.83 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.604 HD11 ' HG3' ' A' ' 48' ' ' PRO . 13.0 mt -88.08 6.14 37.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 109.853 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -36.27 -28.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.876 -0.515 . . . . 0.0 110.327 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' LEU . 11.6 t -61.98 -56.68 16.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.882 -1.136 . . . . 0.0 108.222 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 173.59 -165.81 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.441 -0.787 . . . . 0.0 110.524 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.584 ' CG2' ' CB ' ' A' ' 76' ' ' LEU . 4.4 m -70.15 154.0 94.89 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.67 . . . . 0.0 110.929 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.604 ' HG3' HD11 ' A' ' 43' ' ' LEU . 38.6 Cg_endo -115.6 -116.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 N-CA-C 107.395 -1.81 . . . . 0.0 107.395 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.706 ' C ' HD13 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -100.08 -75.32 0.58 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.207 -1.558 . . . . 0.0 108.605 178.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.026 HG21 HG22 ' A' ' 115' ' ' VAL . 13.1 t -145.63 137.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.393 -0.817 . . . . 0.0 109.164 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.7 HD23 ' CG1' ' A' ' 69' ' ' ILE . 2.8 mp -102.51 110.61 22.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.931 -1.106 . . . . 0.0 110.606 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.001 ' HB3' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -83.72 161.11 21.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.31 -0.869 . . . . 0.0 109.685 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 80' ' ' ILE . 68.4 m -152.23 136.31 16.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 2.4 p30 -100.72 -158.61 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.072 -1.017 . . . . 0.0 110.047 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.69 HG12 ' HB3' ' A' ' 83' ' ' ALA . 1.2 pp -143.09 120.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.658 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 57' ' ' MET . 3.2 ttm-85 178.72 -78.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 12.7 mmt 54.22 170.06 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.076 -1.015 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 57' ' ' MET . 36.2 Cg_endo -84.32 161.68 13.09 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.856 1.45 . . . . 0.0 110.24 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.71 101.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -176.84 -40.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.0 109.491 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 60' ' ' MET . 0.4 OUTLIER -162.8 -77.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 57' ' ' MET . . . 152.74 -45.53 0.59 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -154.69 -76.48 0.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.312 -1.111 . . . . 0.0 109.3 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 63' ' ' LEU . . . 41.34 44.26 2.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.864 HD22 ' HA3' ' A' ' 36' ' ' GLY . 6.4 mt -130.86 -25.01 2.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 110.355 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HA ' ' CG2' ' A' ' 69' ' ' ILE . 1.2 tp -66.24 -10.39 41.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.718 -1.239 . . . . 0.0 108.719 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -71.86 -55.06 8.23 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.595 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -67.02 -53.78 27.97 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.701 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 0.8 OUTLIER -43.13 -14.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.228 -0.92 . . . . 0.0 111.017 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' GLN . 19.1 tptp -100.93 -74.08 0.62 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.31 -1.494 . . . . 0.0 108.003 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 70' ' ' LYS . 32.9 mm-40 -36.96 -59.25 0.72 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.501 0.667 . . . . 0.0 111.216 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.701 ' NE ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -35.74 -48.09 0.52 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.504 -0.748 . . . . 0.0 111.716 -178.049 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.804 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 14.6 m-70 -107.58 142.16 24.57 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.68 -1.262 . . . . 0.0 109.428 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 32.1 Cg_endo -26.36 -78.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 124.203 1.633 . . . . 0.0 112.777 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -175.58 100.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.42 -1.425 . . . . 0.0 110.544 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER -123.14 168.09 13.06 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 108.857 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.801 ' HG2' HG22 ' A' ' 50' ' ' VAL . 33.7 Cg_endo -71.37 137.43 30.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.676 1.356 . . . . 0.0 111.63 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.673 ' CG2' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -126.32 156.29 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.932 HD11 HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -131.1 147.44 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.81 HG22 ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -153.91 125.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 2.7 mtt -66.43 125.73 26.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.474 HG21 ' HD1' ' A' ' 101' ' ' TYR . 27.6 p -86.93 87.35 7.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.609 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.69 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -109.76 -19.27 13.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.42 -65.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.549 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 3.5 m -77.94 -172.22 2.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 83.76 -44.52 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.666 -0.647 . . . . 0.0 109.551 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.2 mm? -34.19 -32.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.786 -0.571 . . . . 0.0 110.482 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.8 t0 -70.28 -68.91 0.39 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 88' ' ' ASP . . . -41.89 -26.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -82.51 -74.59 0.34 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.091 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 87' ' ' LEU . 99.0 t -34.25 -30.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.863 -0.523 . . . . 0.0 111.162 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.0 m -97.94 -153.32 0.42 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.974 -1.079 . . . . 0.0 109.708 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.12 69.81 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.049 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 95' ' ' GLN . 1.4 t80 67.64 10.42 7.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.3 -0.875 . . . . 0.0 109.004 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 10.7 tm0? 44.78 82.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.8 mt-30 163.37 -25.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.03 -144.35 44.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -143.06 59.5 1.42 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -1.125 . . . . 0.0 109.346 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.727 ' CE1' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 82.61 -24.57 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.633 -0.667 . . . . 0.0 109.887 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.81 ' HB2' HG22 ' A' ' 80' ' ' ILE . 44.3 p-10 -42.07 127.89 3.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CB ' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 162.78 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.495 -0.753 . . . . 0.0 109.412 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' MET . 12.6 tp -109.12 141.83 24.26 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 108.977 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -104.93 -167.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.758 1.399 . . . . 0.0 111.04 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -154.69 160.63 30.74 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -72.76 143.87 79.03 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.387 -2.339 . . . . 0.0 110.764 0.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.773 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 88.4 t80 -129.64 169.68 14.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' CG ' ' A' ' 106' ' ' PHE . 3.7 t70 -85.91 -157.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.625 -0.672 . . . . 0.0 109.948 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.907 HD13 ' CB ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -130.12 -48.88 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 108.443 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.2 -41.45 81.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 11.3 tp10 -50.77 -47.84 59.5 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.773 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -62.0 -65.24 0.72 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.78 HG12 ' N ' ' A' ' 113' ' ' ALA . 2.2 t -34.7 -78.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.78 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -39.03 -70.28 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.647 -0.658 . . . . 0.0 111.578 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 113' ' ' ALA . 27.8 tp -36.35 -43.21 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.972 0.891 . . . . 0.0 110.073 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.026 HG22 HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -68.43 -58.73 5.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.657 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.1 mt-10 -36.92 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.488 0.661 . . . . 0.0 109.536 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 115' ' ' VAL . 1.7 mtp180 -85.05 -48.04 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.481 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -53.79 -62.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 108.96 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.839 ' CD1' HG23 ' A' ' 50' ' ' VAL . 7.1 mt -36.22 -40.6 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 t -71.86 -46.02 59.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.991 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -47.86 -71.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 109.903 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 3.2 m-85 -44.85 112.13 0.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.912 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER 168.85 -27.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.405 -0.809 . . . . 0.0 109.362 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.53 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.318 0.58 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 178.2 -81.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.563 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 63.01 144.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.74 145.41 16.14 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.887 HG22 HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.39 95.81 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.471 -1.017 . . . . 0.0 110.419 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -91.22 113.04 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.009 -1.057 . . . . 0.0 108.604 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CE3' HG21 ' A' ' 31' ' ' THR . 12.8 m95 -102.84 98.85 8.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 109.934 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.689 HG22 ' CB ' ' A' ' 52' ' ' LEU . 15.2 t -85.48 167.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.483 -0.76 . . . . 0.0 109.378 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 39' ' ' VAL . 99.0 t -132.4 113.59 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 109.792 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.869 ' HB3' HG21 ' A' ' 15' ' ' ILE . 6.1 t70 177.87 -65.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.408 -0.807 . . . . 0.0 109.484 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.562 ' HB3' ' CA ' ' A' ' 34' ' ' GLU . 20.9 t0 17.21 55.07 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.198 0.523 . . . . 0.0 111.478 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.893 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -112.95 52.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' ASP . 11.9 t 144.22 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER 178.21 42.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.663 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.893 HD13 ' H ' ' A' ' 12' ' ' ASP . 2.4 mp -89.49 -40.53 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.987 . . . . 0.0 108.979 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.517 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 23.7 ttp180 -61.21 -41.39 96.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.455 ' O ' ' C ' ' A' ' 18' ' ' VAL . 76.5 t90 -62.66 -63.71 1.14 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 14' ' ' SER . 41.6 t -37.99 -65.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.759 0.79 . . . . 0.0 110.528 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' ARG . 16.4 mt -56.52 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 110.785 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 15.2 tm-20 -34.61 -30.13 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.907 -0.495 . . . . 0.0 111.215 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 19' ' ' LEU . 1.3 tpt180 -68.12 -56.64 8.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.943 -1.098 . . . . 0.0 108.644 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.092 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -71.34 -8.69 55.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.41 -0.806 . . . . 0.0 109.015 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.804 HD22 ' SG ' ' A' ' 30' ' ' CYS . 3.0 mp -96.31 -16.69 21.18 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.82 -37.4 64.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.6 -36.3 58.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.21 -13.95 62.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -1.177 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.63 56.84 7.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.853 HD22 HG13 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -131.1 -178.04 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -1.234 . . . . 0.0 110.009 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.887 HG21 HG22 ' A' ' 5' ' ' ILE . 30.0 m -101.47 90.45 4.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.804 ' SG ' HD22 ' A' ' 23' ' ' LEU . 25.2 t -84.46 86.05 7.33 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.942 HG21 ' CE3' ' A' ' 7' ' ' TRP . 17.4 m -91.0 137.48 32.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 16.1 p -156.34 135.79 12.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.677 -1.264 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.569 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 29.8 m-85 -108.87 -170.44 1.66 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' CA ' ' HB3' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -108.92 -6.08 15.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.055 . . . . 0.0 109.536 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.86 143.84 26.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.86 ' CA ' HG11 ' A' ' 9' ' ' VAL . . . -60.02 -42.86 98.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.671 ' H ' HD22 ' A' ' 65' ' ' LEU . 4.4 t-20 -49.42 -79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.052 -1.263 . . . . 0.0 108.866 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 37' ' ' ASN . 50.2 mt-10 -34.46 -42.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.765 -0.584 . . . . 0.0 110.434 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.886 HG21 HG22 ' A' ' 9' ' ' VAL . 18.1 t -54.84 -55.48 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 40' ' ' LEU . 2.6 mm? -65.98 -18.13 65.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 108.829 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -73.8 -25.53 60.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 108.951 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.6 -17.27 17.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 73' ' ' HIS . 1.4 mm? -77.69 -9.2 58.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.99 -19.81 0.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -57.38 4.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 179.3 -164.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.935 ' CB ' HD22 ' A' ' 76' ' ' LEU . 10.2 t -100.03 135.72 20.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 36.2 Cg_endo -95.17 -95.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.04 1.547 . . . . 0.0 109.389 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.712 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -115.39 -75.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.864 -1.148 . . . . 0.0 109.086 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.834 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -149.57 142.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.33 -0.856 . . . . 0.0 109.467 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.948 ' CB ' HG12 ' A' ' 78' ' ' VAL . 6.5 tp -94.75 158.74 15.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.033 . . . . 0.0 108.797 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.689 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -141.57 127.76 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.998 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.3 p -94.04 103.79 15.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.333 -0.855 . . . . 0.0 108.889 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -88.01 122.64 31.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.955 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -98.06 81.86 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 109.35 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.65 ' HD3' HD11 ' A' ' 15' ' ' ILE . 1.8 ttt180 -114.27 -19.35 11.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.883 . . . . 0.0 109.754 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -45.14 140.89 3.53 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -100.11 147.36 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.956 1.503 . . . . 0.0 110.199 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.65 -174.77 17.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -24.24 64.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -1.153 . . . . 0.0 109.661 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -111.73 159.44 18.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.534 ' HA3' ' CD1' ' A' ' 55' ' ' ILE . . . -118.94 -53.82 0.28 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.889 ' HB2' HD12 ' A' ' 65' ' ' LEU . 0.7 OUTLIER 179.13 111.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -1.155 . . . . 0.0 109.522 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.99 29.47 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.364 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.889 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -99.74 6.61 45.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 89' ' ' ALA . 10.4 tp -65.8 -60.74 2.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.945 -1.097 . . . . 0.0 108.649 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -48.02 -39.12 18.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.171 -0.956 . . . . 0.0 108.523 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 69' ' ' ILE . 3.8 tp60 -52.09 -56.59 13.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.692 HG12 HD23 ' A' ' 51' ' ' LEU . 8.2 mt -33.49 -76.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.266 0.555 . . . . 0.0 110.025 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.62 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -40.49 -59.37 1.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 110.085 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -33.85 -68.38 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.785 -0.572 . . . . 0.0 110.9 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 73' ' ' HIS . 1.7 mpp_? -73.06 -62.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -31.81 115.85 0.38 Allowed Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.778 -0.576 . . . . 0.0 110.327 -179.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 36.9 Cg_endo -41.26 -74.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.017 1.535 . . . . 0.0 110.441 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.2 ptp -178.39 64.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.54 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.935 HD22 ' CB ' ' A' ' 47' ' ' THR . 0.6 OUTLIER -126.31 148.63 64.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.726 ' HG2' HG22 ' A' ' 50' ' ' VAL . 37.0 Cg_endo -48.53 141.16 20.36 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.828 1.436 . . . . 0.0 111.815 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.948 HG12 ' CB ' ' A' ' 51' ' ' LEU . 2.5 m -139.63 97.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.643 HD11 HG23 ' A' ' 115' ' ' VAL . 11.2 mt -65.72 160.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 101' ' ' TYR . 1.3 pp -142.69 133.98 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -71.74 170.47 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.148 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.603 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.09 157.36 15.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.091 -1.006 . . . . 0.0 110.283 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.789 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . 169.6 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.46 ' C ' ' N ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 178.18 -77.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 110.497 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 86' ' ' ASP . 78.9 p 47.62 26.99 0.93 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 60.22 120.28 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.916 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 18.5 tp -38.12 -26.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.21 1.005 . . . . 0.0 108.523 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 86' ' ' ASP . 1.7 t0 -32.7 -65.39 0.16 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.065 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.791 ' O ' HD23 ' A' ' 66' ' ' LEU . . . -82.43 -30.89 29.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.956 ' HB1' ' OH ' ' A' ' 101' ' ' TYR . . . -64.34 -65.65 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.171 -0.955 . . . . 0.0 109.144 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -14.49 -53.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 122.978 0.511 . . . . 0.0 111.504 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.59 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 1.6 t -56.66 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.043 -1.036 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 99' ' ' PHE . . . -128.27 -73.89 0.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.485 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 11.61 35.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 96' ' ' GLN . 5.5 mt-30 -98.24 108.54 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 108.55 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 11.3 tt0 61.39 164.13 0.08 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.988 . . . . 0.0 108.508 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.01 172.92 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.674 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . . . -125.63 103.83 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.05 -1.265 . . . . 0.0 109.791 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.836 ' CD1' HG23 ' A' ' 78' ' ' VAL . 33.2 p90 170.63 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.0 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.07 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.956 ' OH ' ' HB1' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -167.04 138.16 3.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.007 . . . . 0.0 110.024 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -128.47 113.46 19.52 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -103.94 164.95 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.668 1.351 . . . . 0.0 111.187 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 13.0 pttp -92.87 160.34 34.16 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.515 -0.741 . . . . 0.0 109.286 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.2 Cg_endo -79.29 159.02 90.23 Favored 'Cis proline' 0 C--N 1.313 -1.306 0 C-N-CA 120.773 -2.594 . . . . 0.0 110.483 -0.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' A' ' 81' ' ' MET . 13.1 p90 -139.12 146.46 40.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -0.812 . . . . 0.0 109.198 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.563 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 2.4 t70 -86.36 146.61 26.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.123 -0.986 . . . . 0.0 108.868 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.092 HD13 ' CB ' ' A' ' 22' ' ' ALA . 1.5 mp -76.8 -26.56 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.267 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.11 -36.58 19.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 40.8 tt0 -61.73 -42.19 98.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -71.96 -67.46 0.53 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.853 HG13 HD22 ' A' ' 28' ' ' LEU . 24.8 t -38.01 -52.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.497 -0.752 . . . . 0.0 110.937 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -62.58 -69.45 0.26 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.495 -0.753 . . . . 0.0 110.873 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.489 ' C ' ' O ' ' A' ' 113' ' ' ALA . 16.9 tp -34.79 -55.68 0.56 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.509 0.671 . . . . 0.0 109.943 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.712 HG22 HG21 ' A' ' 50' ' ' VAL . 1.2 t -54.79 -56.77 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.614 ' N ' HG12 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -38.02 -37.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.501 -0.749 . . . . 0.0 110.751 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.619 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -83.53 -35.69 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 110.268 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.619 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.4 -59.88 4.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.787 -1.195 . . . . 0.0 108.326 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.834 ' CD1' HG23 ' A' ' 50' ' ' VAL . 8.6 mt -34.5 -40.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.12 0.486 . . . . 0.0 110.384 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -85.61 53.32 2.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.585 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.564 ' NE2' ' CE1' ' A' ' 122' ' ' TYR . 23.7 p-80 -96.31 -9.19 30.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.564 ' CE1' ' NE2' ' A' ' 121' ' ' HIS . 8.2 m-85 -69.3 -5.86 25.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.79 53.01 1.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.395 179.9 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 3.8 pt20 -121.67 160.99 23.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.851 . . . . 0.0 109.341 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 -152.25 49.5 0.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.056 -1.028 . . . . 0.0 109.907 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.63 112.42 0.61 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.354 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.84 HG23 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -90.73 111.62 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 108.892 179.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.696 HG12 HG23 ' A' ' 8' ' ' VAL . 61.5 t -104.51 107.28 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.031 . . . . 0.0 109.555 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.762 ' CZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -98.45 93.77 6.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 108.551 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.974 HG22 ' CB ' ' A' ' 52' ' ' LEU . 54.4 t -102.89 127.43 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.557 ' CG1' ' HA2' ' A' ' 36' ' ' GLY . 1.9 m -66.6 121.37 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB2' HG21 ' A' ' 15' ' ' ILE . 53.7 p-10 -110.45 178.67 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.206 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 34.1 t0 -74.4 -86.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.32 -0.862 . . . . 0.0 109.788 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.72 173.65 11.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 11.7 p -75.93 -30.37 58.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.411 -0.805 . . . . 0.0 109.358 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -73.82 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.317 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 10' ' ' ASP . 24.6 mm -66.01 -32.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.184 -0.948 . . . . 0.0 108.831 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.63 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 11.6 ptt180 -68.08 -35.31 77.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.517 ' CH2' ' HG3' ' A' ' 21' ' ' ARG . 1.8 t-105 -55.12 -66.16 0.46 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 54.0 t -40.77 -65.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.816 0.817 . . . . 0.0 110.478 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.659 ' C ' HD12 ' A' ' 23' ' ' LEU . 4.1 mm? -54.78 -75.07 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.569 -0.707 . . . . 0.0 110.986 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -34.5 -31.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.331 0.586 . . . . 0.0 110.219 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.08 -58.61 6.69 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.92 -10.07 50.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -0.823 . . . . 0.0 109.238 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.993 HD22 ' CB ' ' A' ' 30' ' ' CYS . 1.5 mt -93.15 -13.03 28.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 109.758 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.34 61.95 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.93 -38.0 37.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.02 79.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -1.142 . . . . 0.0 108.726 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 2' ' ' GLN . . . 95.69 50.11 2.03 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.977 HD13 HG11 ' A' ' 112' ' ' VAL . 1.1 mt -141.03 166.66 24.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.937 -1.331 . . . . 0.0 109.941 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 5' ' ' ILE . 87.5 m -101.4 60.04 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.993 ' CB ' HD22 ' A' ' 23' ' ' LEU . 33.7 t -81.4 88.49 6.12 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 109.658 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 11.8 m -101.18 137.46 39.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 109.472 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 8' ' ' VAL . 1.2 p -109.66 165.49 11.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 108.671 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.65 ' HB2' HG23 ' A' ' 39' ' ' VAL . 2.0 m-85 -137.91 115.97 11.68 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.082 -1.012 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 14.3 tt0 -36.67 -39.1 0.19 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.96 -0.462 . . . . 0.0 110.461 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -111.92 126.1 54.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 110.521 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.557 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -51.68 -45.84 54.36 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.699 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -60.28 -63.53 1.27 Allowed 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.181 -1.187 . . . . 0.0 107.866 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 20.0 tp10 -34.57 -28.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.551 -0.718 . . . . 0.0 110.809 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -81.88 -51.08 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.919 -1.113 . . . . 0.0 110.504 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.059 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.47 -11.36 60.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.791 -1.193 . . . . 0.0 109.753 -179.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.973 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -94.44 -49.11 5.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.24 -25.11 46.43 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.762 HD21 ' CZ3' ' A' ' 7' ' ' TRP . 7.9 mt -73.17 -77.64 0.1 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.39 -47.94 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -99.24 -26.12 14.28 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.732 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 64.42 62.82 0.79 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 123.49 1.614 . . . . 0.0 109.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.62 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -104.33 40.97 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 119.752 -1.842 . . . . 0.0 112.771 -179.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.766 ' HA ' HD12 ' A' ' 5' ' ' ILE . 38.0 Cg_endo -101.08 -167.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 116.842 -1.638 . . . . 0.0 109.633 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -92.97 -52.48 4.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.969 HG23 ' CD1' ' A' ' 119' ' ' ILE . 6.6 t -146.59 128.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 108.89 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.943 ' O ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -98.47 114.82 27.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 0.0 108.376 179.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.974 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -108.4 -174.28 2.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 110.371 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.569 ' OG ' HD13 ' A' ' 63' ' ' LEU . 26.6 t -155.24 123.89 6.05 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 9' ' ' VAL . 13.9 p-10 -102.63 149.75 24.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.98 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -102.88 109.78 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -161.63 28.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.469 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.404 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 3.7 mtt -93.74 125.94 51.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.621 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.491 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.6 Cg_endo -103.55 131.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.929 1.489 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.15 -74.23 0.31 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -161.1 128.28 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.422 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 68.72 149.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.98 -84.15 0.66 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.992 ' HB2' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -146.52 -54.3 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -1.107 . . . . 0.0 109.484 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . . . 47.47 60.83 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.427 -0.795 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.992 HD12 ' HB2' ' A' ' 63' ' ' LEU . 1.4 mt -124.35 8.41 8.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.742 HD11 HD12 ' A' ' 80' ' ' ILE . 4.9 mp -75.73 -19.18 59.25 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.278 -0.889 . . . . 0.0 108.699 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 2.9 pttt -66.01 -39.2 90.07 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.529 ' OE1' ' CA ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -80.38 -57.06 3.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 109.235 179.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.892 HG12 HD23 ' A' ' 51' ' ' LEU . 2.6 mt -39.71 -32.71 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.896 -1.127 . . . . 0.0 110.239 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -92.09 -73.09 0.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.087 -1.008 . . . . 0.0 110.379 -178.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -35.22 -30.78 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.554 -0.716 . . . . 0.0 110.565 -179.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.548 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -97.91 -58.55 1.96 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 110.368 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' CB ' ' A' ' 46' ' ' LYS . 1.2 m-70 -98.38 133.03 23.2 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.403 -0.811 . . . . 0.0 109.496 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.598 ' N ' ' HE2' ' A' ' 46' ' ' LYS . 39.6 Cg_endo -138.59 1.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 117.341 -1.306 . . . . 0.0 112.162 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.56 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 3.6 mtt -68.59 7.12 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.695 -1.253 . . . . 0.0 112.778 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -163.06 177.76 1.78 Allowed Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.186 -1.571 . . . . 0.0 109.918 179.007 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 37.0 Cg_endo -86.99 164.66 8.72 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.885 1.466 . . . . 0.0 111.064 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.943 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.17 144.91 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.734 HD12 ' C ' ' A' ' 78' ' ' VAL . 3.5 mp -137.78 164.0 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 109.739 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.742 HD12 HD11 ' A' ' 66' ' ' LEU . 11.9 tt -141.99 157.39 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -81.93 166.49 19.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.28 102.7 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.564 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.76 ' HB3' ' OD2' ' A' ' 86' ' ' ASP . . . -96.74 -151.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -144.23 32.36 1.22 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.275 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.62 -34.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.76 ' OD2' ' HB3' ' A' ' 83' ' ' ALA . 1.3 p30 -49.93 -24.17 2.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.017 -1.052 . . . . 0.0 109.692 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 87' ' ' LEU . 4.0 tp -34.97 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.83 -0.544 . . . . 0.0 110.913 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 86' ' ' ASP . 42.8 t0 -58.83 -59.19 5.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.995 -1.065 . . . . 0.0 109.883 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.26 -44.49 29.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 109.961 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' VAL . . . -50.21 -41.7 50.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.689 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER -33.07 -41.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.457 0.646 . . . . 0.0 109.99 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 5.9 t -64.11 86.18 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.359 0.6 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.75 -47.96 0.19 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -72.67 -18.95 61.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -69.02 -12.04 61.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.54 -0.725 . . . . 0.0 109.204 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.42 -157.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 109.33 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.81 67.88 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 99' ' ' PHE . . . -168.08 52.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -1.122 . . . . 0.0 109.324 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 98' ' ' ALA . 36.7 m-85 -151.92 164.41 37.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.607 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.469 ' HB3' HG12 ' A' ' 79' ' ' ILE . 2.4 t0 -158.44 -157.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.37 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.14 142.83 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 109.791 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.23 139.86 35.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 108.893 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -114.72 176.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.748 1.394 . . . . 0.0 110.806 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 2.6 mtmp? -121.92 158.41 54.87 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 0.0 109.153 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -89.72 174.04 24.02 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 120.505 -2.706 . . . . 0.0 110.195 -0.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 33.2 p90 -153.59 161.17 42.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.255 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 14.6 t0 -73.92 -146.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 108' ' ' ILE . 16.2 mm -120.48 -68.05 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 108.798 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.514 ' OD1' ' HB2' ' A' ' 113' ' ' ALA . 11.7 t0 -59.79 -46.55 88.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 28.1 tt0 -43.09 -41.69 3.69 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.76 -75.88 0.11 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.977 HG11 HD13 ' A' ' 28' ' ' LEU . 52.1 t -38.39 -69.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 110.243 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . . . -39.36 -62.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.619 -0.676 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' A' ' 113' ' ' ALA . 7.4 tp -34.3 -56.11 0.51 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.375 0.607 . . . . 0.0 109.944 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -58.24 -52.66 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.526 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 37.7 tp10 -39.19 -36.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.419 -0.801 . . . . 0.0 110.807 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.615 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -77.92 -36.77 49.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 110.74 -178.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.615 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -62.75 -53.61 51.77 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.733 -1.229 . . . . 0.0 108.044 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.969 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.3 mt -41.14 -50.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.517 0.675 . . . . 0.0 111.008 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.487 ' O ' ' C ' ' A' ' 121' ' ' HIS . 1.5 t -35.02 -34.9 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.447 -0.783 . . . . 0.0 111.998 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.487 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 t-80 -32.65 -66.37 0.14 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.546 -0.721 . . . . 0.0 111.273 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.63 -19.31 13.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.03 -1.044 . . . . 0.0 109.931 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.403 ' HB2' HG22 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -88.54 55.99 3.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.207 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.498 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' ' C ' ' A' ' 2' ' ' GLN . 6.7 ttt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 3' ' ' ARG . 3.0 pt20 -43.54 131.07 5.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.271 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 2' ' ' GLN . 6.3 ttp85 179.47 95.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.184 -0.947 . . . . 0.0 109.676 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.772 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -162.62 119.84 0.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.799 HD13 ' N ' ' A' ' 5' ' ' ILE . 1.1 mm -102.54 116.12 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -1.205 . . . . 0.0 109.528 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.586 ' CG1' HG23 ' A' ' 8' ' ' VAL . 1.5 t -123.65 109.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -0.796 . . . . 0.0 108.951 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.646 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 27.7 m0 -99.13 89.16 4.15 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.351 -1.339 . . . . 0.0 107.489 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.821 HG22 ' CG ' ' A' ' 52' ' ' LEU . 27.6 t -73.28 142.68 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.547 -0.721 . . . . 0.0 110.136 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.899 HG22 HG21 ' A' ' 39' ' ' VAL . 40.6 t -92.7 102.4 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.95 -1.094 . . . . 0.0 109.251 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.656 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 88.8 m-20 -53.96 -173.23 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 110.002 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -137.47 -5.97 1.77 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.337 -0.852 . . . . 0.0 110.786 -179.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 171.29 55.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.458 -1.402 . . . . 0.0 110.871 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER 54.69 156.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.559 0.695 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER 75.4 -7.82 1.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.161 -0.962 . . . . 0.0 109.828 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' A' ' 10' ' ' ASP . 18.0 mm -85.48 -32.16 7.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.074 -1.017 . . . . 0.0 108.718 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.486 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 0.7 OUTLIER -62.38 -45.5 92.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.436 ' O ' ' C ' ' A' ' 18' ' ' VAL . 26.9 t90 -58.7 -60.49 3.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 17' ' ' TRP . 44.5 t -39.21 -70.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 110.914 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 8' ' ' VAL . 7.8 mt -57.35 -72.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.391 -0.818 . . . . 0.0 110.838 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 19' ' ' LEU . 3.3 tt0 -35.8 -30.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 110.526 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 8.7 tpt85 -66.41 -56.0 13.08 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -71.11 -4.43 25.16 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.484 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.775 HD12 ' HB2' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -103.73 -11.35 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.636 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -43.88 42.68 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.62 -19.56 69.2 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.71 -19.37 32.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.581 -0.952 . . . . 0.0 108.726 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.6 50.03 33.62 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.808 HD12 HG11 ' A' ' 112' ' ' VAL . 13.8 mt -123.77 179.01 4.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 110.425 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 29' ' ' THR . 18.0 m -95.49 67.3 2.87 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 23' ' ' LEU . 38.6 t -79.64 83.64 5.59 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.953 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.646 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 5.2 m -94.84 143.29 26.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.7 p -138.67 119.43 14.15 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.519 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.99 ' HB2' HG22 ' A' ' 39' ' ' VAL . 7.5 m-85 -85.01 -157.65 0.31 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -118.36 -37.36 3.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.913 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.786 ' O ' HG23 ' A' ' 39' ' ' VAL . 49.1 m-80 -131.1 146.8 52.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.093 -1.005 . . . . 0.0 109.81 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 37' ' ' ASN . . . -53.12 -39.71 58.18 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLU . 2.2 m-20 -47.63 -84.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.904 -1.35 . . . . 0.0 108.343 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 2.8 mt-10 -35.14 -48.09 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.757 -0.589 . . . . 0.0 110.969 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 33' ' ' PHE . 48.6 t -50.37 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.984 HD13 ' O ' ' A' ' 40' ' ' LEU . 3.4 tm? -54.21 -20.72 7.36 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.527 -0.733 . . . . 0.0 109.527 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -68.7 -41.49 79.08 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.6 -15.63 48.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.919 HD11 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -84.1 -0.81 53.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.0 109.862 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.91 -19.59 7.01 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.14 -0.975 . . . . 0.0 108.753 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 2.4 m -88.74 -27.81 20.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER 90.21 69.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -102.32 -90.57 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 111.185 -179.119 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 1.038 ' HG2' HD21 ' A' ' 51' ' ' LEU . 37.4 Cg_endo -40.55 130.84 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.835 1.439 . . . . 0.0 111.129 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.814 ' HB3' HG21 ' A' ' 119' ' ' ILE . 4.8 m-20 -75.88 -23.76 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.89 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.8 t -136.95 123.52 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.038 HD21 ' HG2' ' A' ' 48' ' ' PRO . 3.9 mm? -102.06 132.25 48.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.301 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 79' ' ' ILE . 2.5 mt -104.71 165.37 11.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.065 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.479 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 49.1 m -142.5 109.95 5.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.43 169.98 16.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.726 ' HB ' HD13 ' A' ' 63' ' ' LEU . 2.1 tp -130.33 97.04 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -175.53 73.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.414 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.4 ' HB2' ' CA ' ' A' ' 62' ' ' GLY . 26.7 mtm -134.1 171.69 8.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.378 -0.826 . . . . 0.0 109.452 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -97.64 143.45 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.001 1.527 . . . . 0.0 110.181 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.37 -173.92 16.87 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -59.99 109.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' CA ' ' A' ' 85' ' ' SER . 0.1 OUTLIER 72.21 -165.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.969 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 169.85 39.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.846 HD23 HD21 ' A' ' 66' ' ' LEU . 51.7 tp -105.09 64.54 0.72 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -1.184 . . . . 0.0 109.549 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . 41.8 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.348 -0.845 . . . . 0.0 109.787 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 68' ' ' GLN . 1.1 tp -127.7 70.85 1.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 109.296 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.947 HD11 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -71.45 -59.68 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 109.713 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -46.58 -31.72 2.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.818 -1.176 . . . . 0.0 108.261 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.579 ' HG3' ' N ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -66.74 -57.41 7.17 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.63 HG23 ' CG ' ' A' ' 73' ' ' HIS . 1.5 mt -38.67 -64.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.569 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -42.75 -64.61 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.233 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.1 tp60 -34.05 -43.35 0.14 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.847 -0.533 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.721 ' O ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.7 60.55 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.057 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.818 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.7 t-80 -156.71 131.17 5.05 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 35.9 Cg_endo -52.39 -170.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.604 1.318 . . . . 0.0 110.49 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.4 mmt -95.53 48.36 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 110.763 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 73' ' ' HIS . 3.3 pp -91.17 122.41 66.44 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.869 -1.144 . . . . 0.0 108.463 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.687 ' O ' HD12 ' A' ' 76' ' ' LEU . 34.8 Cg_endo -34.31 147.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.11 1.584 . . . . 0.0 112.52 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.8 124.3 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.939 HG21 HD13 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -89.16 133.31 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.0 109.313 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.605 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -119.35 140.66 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.385 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.9 ttm -109.56 113.64 26.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.507 ' O ' HG21 ' A' ' 55' ' ' ILE . 87.5 m 49.89 72.83 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.605 ' HB2' ' CG2' ' A' ' 80' ' ' ILE . . . -91.0 165.11 13.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.888 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -167.78 -88.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.699 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER 40.19 44.64 1.59 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 88' ' ' ASP . 10.2 t70 67.74 132.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.901 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 15.1 mt -35.17 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 109.271 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -35.68 -67.03 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.947 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -72.46 -24.28 61.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 108.626 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -71.41 -76.17 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 109.564 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' A' ' 90' ' ' ALA . 2.9 t -11.27 -58.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 122.804 0.442 . . . . 0.0 111.744 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 90' ' ' ALA . 4.9 t -40.42 108.81 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.271 -0.893 . . . . 0.0 109.75 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 92' ' ' SER . . . 176.4 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.802 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.54 -11.21 59.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.279 -0.888 . . . . 0.0 109.96 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.35 107.49 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.834 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER 55.77 45.46 24.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.88 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 96' ' ' GLN . . . 43.14 -122.63 3.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 57.58 -93.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.454 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 92' ' ' SER . 5.6 m-85 -62.92 171.52 2.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.87 134.52 7.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.0 109.998 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.01 95.22 9.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 79' ' ' ILE . 2.3 tp -101.27 132.55 21.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 109.97 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -121.57 -161.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.834 1.439 . . . . 0.0 109.94 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 8.4 mttt -117.99 159.75 41.65 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.213 -0.929 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -83.22 173.23 44.99 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 120.703 -2.624 . . . . 0.0 110.476 0.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 38.6 p90 -167.9 130.32 1.54 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.613 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . 7.4 t70 -70.28 149.07 47.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.154 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 19' ' ' LEU . 36.9 mm -66.11 -40.72 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -74.96 -40.85 60.53 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 107' ' ' ASP . 9.9 tp10 -51.05 -33.64 26.42 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -83.06 -73.67 0.39 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.47 -0.769 . . . . 0.0 109.666 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -36.6 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.495 -0.753 . . . . 0.0 110.069 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.596 ' HA ' ' HG2' ' A' ' 116' ' ' GLU . . . -79.9 -66.83 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.747 0.784 . . . . 0.0 109.861 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.8 tm? -38.47 -36.71 0.26 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.278 1.037 . . . . 0.0 109.259 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 50' ' ' VAL . 1.1 t -74.13 -59.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.62 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.1 pt-20 -38.72 -30.88 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.939 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -77.14 -54.36 6.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.118 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 121' ' ' HIS . . . -46.07 -60.93 1.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 108.972 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.89 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.2 mt -35.78 -42.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.227 0.537 . . . . 0.0 110.114 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -92.21 50.29 1.62 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 3.4 t60 -97.79 -41.36 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.219 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -84.35 10.99 9.19 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.325 -0.86 . . . . 0.0 109.584 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -95.74 18.75 12.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.609 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 1.4 mp0 -103.11 -80.33 0.52 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.43 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -151.71 40.1 0.65 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.142 0.973 . . . . 0.0 108.858 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.833 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 136.07 161.38 9.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.833 HD13 ' O ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER -131.61 112.37 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.245 . . . . 0.0 109.628 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 6' ' ' VAL . 1.1 t -126.84 114.22 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.687 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.63 ' CD1' ' HB ' ' A' ' 31' ' ' THR . 15.3 m0 -99.88 89.59 4.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.793 -1.192 . . . . 0.0 108.668 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.977 HG22 ' CB ' ' A' ' 52' ' ' LEU . 70.8 t -77.18 143.64 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.661 -0.649 . . . . 0.0 110.846 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 75.5 t -82.44 110.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 0.0 109.109 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 16' ' ' ARG . 14.0 m-20 -56.32 168.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 109.923 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.85 23.44 4.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 109.321 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 170.49 176.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.156 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' SER . 81.0 p -79.05 146.57 33.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.0 OUTLIER 75.74 4.65 3.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 12' ' ' ASP . 45.5 mm -78.11 -32.47 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.796 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CG ' ' OG1' ' A' ' 32' ' ' THR . 0.5 OUTLIER -58.93 -47.61 84.44 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' VAL . 15.3 t90 -58.19 -64.22 0.99 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 17' ' ' TRP . 43.2 t -37.0 -69.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.534 -0.729 . . . . 0.0 110.83 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.4 mt -49.54 -76.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 110.52 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 19' ' ' LEU . 10.6 tp10 -36.05 -29.38 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.701 -0.624 . . . . 0.0 110.737 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -65.4 -55.77 16.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.0 -7.27 33.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.485 -0.759 . . . . 0.0 109.135 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.012 HD11 HG21 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -104.9 -5.36 21.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.79 26.92 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.35 38.59 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.94 80.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -1.12 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 2' ' ' GLN . . . 98.23 61.42 0.89 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.83 HD13 HG11 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -136.82 179.1 6.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -1.162 . . . . 0.0 109.765 179.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 29' ' ' THR . 24.2 m -100.4 75.56 1.8 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.0 t -81.09 88.66 5.97 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.384 -0.823 . . . . 0.0 110.02 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.63 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 20.2 m -97.79 145.28 26.54 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -139.93 152.16 46.15 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.732 -1.23 . . . . 0.0 110.09 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.895 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.9 m-85 -134.1 122.91 23.58 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.778 0.799 . . . . 0.0 109.023 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -43.81 -49.75 8.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.997 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.5 m120 -117.25 138.28 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.437 -1.415 . . . . 0.0 112.188 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.56 -15.03 15.92 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' VAL . 9.4 t30 -67.28 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' ASN . 3.0 tt0 -35.66 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.869 -0.519 . . . . 0.0 109.821 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 35' ' ' ASN . 35.2 t -61.93 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.064 HD11 ' CB ' ' A' ' 72' ' ' ARG . 3.4 tm? -64.88 -16.58 63.38 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.319 0.581 . . . . 0.0 109.65 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.35 -21.06 21.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.935 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.08 -21.26 18.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 46' ' ' LYS . 7.5 mt -88.85 -96.84 0.09 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.38 -54.72 0.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 12.6 m -101.06 -5.51 25.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.941 ' HA ' HD22 ' A' ' 43' ' ' LEU . 11.7 mttt 62.73 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 109.202 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -100.66 -61.88 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 111.638 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.738 ' O ' HD22 ' A' ' 76' ' ' LEU . 36.8 Cg_endo -49.88 -177.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.6 1.316 . . . . 0.0 110.56 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.705 ' HB3' HG21 ' A' ' 119' ' ' ILE . 2.5 m-20 -90.85 -25.3 19.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 110.487 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.5 t -148.79 132.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.846 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -101.23 126.65 47.98 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.977 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -108.71 174.42 5.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.803 ' OG ' HD21 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -155.72 124.07 5.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.03 169.78 10.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 ' CE1' ' A' ' 84' ' ' HIS . 1.1 tp -144.31 115.3 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 109.403 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -141.91 -28.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.358 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.487 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -97.36 105.22 23.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.973 -1.08 . . . . 0.0 109.513 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 36.6 Cg_endo -75.99 137.91 20.11 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.042 1.549 . . . . 0.0 110.399 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 60' ' ' MET . . . 144.26 -114.18 0.79 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 3.2 mpp? -145.78 32.9 1.03 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -1.129 . . . . 0.0 109.403 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.17 4.4 2.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.897 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.487 ' HA3' ' HG3' ' A' ' 57' ' ' MET . . . -105.73 -86.88 1.94 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -79.13 -0.5 31.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 109.488 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.33 64.49 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 108.944 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.0 mp -81.65 0.21 39.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.522 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.803 HD21 ' OG ' ' A' ' 53' ' ' SER . 2.6 mm? -78.23 -14.55 59.4 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.181 -0.949 . . . . 0.0 108.525 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.08 57.09 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -69.46 -50.94 40.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 108.847 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.63 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 2.2 tt -33.59 -60.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.643 -0.66 . . . . 0.0 110.302 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 1.1 tptm -69.72 -55.75 9.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.797 -1.189 . . . . 0.0 110.152 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.8 tt0 -35.49 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.84 -0.538 . . . . 0.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 1.064 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.16 -48.4 3.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.682 -1.261 . . . . 0.0 112.232 -178.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.63 ' HD2' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -105.08 134.54 19.59 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.286 -1.509 . . . . 0.0 111.482 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.508 ' O ' ' HG2' ' A' ' 75' ' ' MET . 38.6 Cg_endo -133.97 95.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 117.376 -1.283 . . . . 0.0 111.173 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 23.1 mtt -152.41 -102.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.125 -0.984 . . . . 0.0 109.601 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -55.82 176.89 0.16 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.872 -1.143 . . . . 0.0 109.215 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 76' ' ' LEU . 36.5 Cg_endo -83.85 173.16 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.716 1.377 . . . . 0.0 110.412 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 118.53 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 2.8 mt -113.56 133.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 109.767 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 ' HB2' ' A' ' 53' ' ' SER . 4.1 pt -131.13 172.22 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -85.96 153.06 22.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -89.84 137.28 32.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.396 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 169.61 41.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -162.51 164.79 26.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.463 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 29.0 t -62.04 87.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 108.705 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.919 ' HA ' HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER 61.84 30.13 18.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.945 HD12 ' CB ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 35.55 35.71 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -177.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 10.49 -61.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.082 -1.872 . . . . 0.0 111.199 -177.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . -69.68 14.49 0.1 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.825 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.945 ' CB ' HD12 ' A' ' 87' ' ' LEU . . . -128.38 -77.37 0.56 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 119.812 -1.805 . . . . 0.0 107.464 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.919 HG21 ' HA ' ' A' ' 86' ' ' ASP . 53.0 t -38.01 -29.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.711 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -103.32 -165.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 109.786 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 92' ' ' SER . . . 76.29 -165.06 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.306 -0.871 . . . . 0.0 109.473 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -45.56 -58.22 3.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.156 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.09 55.19 9.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -33.66 0.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 98' ' ' ALA . . . -50.95 -73.81 0.34 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . 167.65 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -137.28 -176.24 4.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.551 ' O ' ' CD2' ' A' ' 101' ' ' TYR . 0.6 OUTLIER -150.76 -42.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.923 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' A' ' 100' ' ' ASP . 9.8 m-85 75.91 136.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.2 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.81 118.87 16.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.67 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -94.79 179.38 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.013 1.533 . . . . 0.0 110.108 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -113.9 153.87 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.19 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -88.7 167.3 38.07 Favored 'Cis proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.535 -2.694 . . . . 0.0 110.427 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -152.09 152.19 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 5.3 t0 -82.3 174.13 11.42 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.046 -1.034 . . . . 0.0 108.927 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 mm -90.47 -64.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.727 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 110' ' ' GLU . 48.3 t0 -57.28 -46.95 82.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 108.567 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 1.5 tm-20 -44.5 -42.67 7.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -70.05 -72.27 0.2 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.012 HG21 HD11 ' A' ' 23' ' ' LEU . 40.8 t -36.21 -70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.333 0.587 . . . . 0.0 110.204 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -41.3 -65.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.967 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 117' ' ' ARG . 2.0 tt -34.07 -52.69 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.692 0.758 . . . . 0.0 109.576 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 50' ' ' VAL . 2.3 t -55.9 -56.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 115' ' ' VAL . 59.3 mm-40 -36.9 -37.45 0.15 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 110.61 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.552 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -84.86 -36.06 21.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.109 -179.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.552 ' N ' ' HG3' ' A' ' 117' ' ' ARG . . . -61.23 -61.36 2.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.779 -1.201 . . . . 0.0 108.007 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.1 mt -34.84 -42.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.298 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.12 56.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -138.76 -64.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.41 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 122' ' ' TYR . 36.6 p90 -91.28 29.78 1.38 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.327 -0.858 . . . . 0.0 109.773 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -80.44 -15.27 57.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.0 109.532 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.58 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -124.66 -29.73 3.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.58 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -78.62 -179.76 6.64 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.19 -0.943 . . . . 0.0 109.464 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.509 ' CA ' HD23 ' A' ' 28' ' ' LEU . . . -146.55 177.98 24.53 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.723 ' HB ' ' HB2' ' A' ' 48' ' ' PRO . 69.9 mt -142.11 104.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.058 . . . . 0.0 109.006 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.979 HG13 HD13 ' A' ' 52' ' ' LEU . 2.4 t -99.47 106.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.728 -0.607 . . . . 0.0 110.464 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.661 ' HB2' HD12 ' A' ' 51' ' ' LEU . 40.6 m0 -98.73 92.32 5.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.997 HG22 ' HB2' ' A' ' 52' ' ' LEU . 59.7 t -90.86 167.76 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.904 0.859 . . . . 0.0 112.076 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.654 HG22 ' HA2' ' A' ' 36' ' ' GLY . 58.0 t -98.36 129.95 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.823 ' HA ' HG21 ' A' ' 15' ' ' ILE . 6.5 m-20 -49.3 -171.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.262 1.03 . . . . 0.0 112.187 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 29.6 t0 -159.58 -67.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -108.1 174.91 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.5 t -70.44 137.13 50.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.2 p 79.61 33.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.445 -0.785 . . . . 0.0 109.738 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.823 HG21 ' HA ' ' A' ' 10' ' ' ASP . 2.1 mm -80.95 -36.51 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 108.86 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 12.9 mtt180 -59.74 -44.54 93.74 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.446 ' O ' ' C ' ' A' ' 18' ' ' VAL . 10.7 t90 -64.57 -67.55 0.43 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 17' ' ' TRP . 41.3 t -38.39 -68.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 110.734 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' HD23 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -52.1 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.486 -0.759 . . . . 0.0 110.693 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 19' ' ' LEU . 5.4 tt0 -34.62 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.795 -0.566 . . . . 0.0 110.821 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' LEU . 2.2 mmm180 -67.82 -56.65 8.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.972 -1.08 . . . . 0.0 108.655 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.73 -6.08 34.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.184 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.997 HD11 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -102.92 -8.7 20.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.893 . . . . 0.0 109.646 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.43 -42.24 23.04 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.24 97.97 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.82 71.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.35 -1.088 . . . . 0.0 108.552 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.01 49.7 1.44 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.09 HD22 ' CG1' ' A' ' 112' ' ' VAL . 2.3 mp -141.03 173.48 11.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.867 -1.373 . . . . 0.0 110.081 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 29' ' ' THR . 3.6 m -98.96 89.93 4.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.539 -0.726 . . . . 0.0 109.165 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.516 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 21.1 t -90.75 90.91 8.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 110.283 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.575 ' HB ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 m -92.74 146.97 23.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.77 135.57 28.01 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.913 -1.117 . . . . 0.0 109.464 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.584 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 47.3 m-85 -108.82 126.37 52.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.065 -1.022 . . . . 0.0 109.159 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -42.13 -25.26 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.043 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' PHE . 16.7 t-20 -125.96 127.95 46.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.054 . . . . 0.0 110.487 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.717 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -55.81 -50.0 63.32 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -45.26 -65.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 37' ' ' ASN . 2.9 tt0 -34.63 -48.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.977 -0.452 . . . . 0.0 110.484 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.796 ' CG1' HD11 ' A' ' 51' ' ' LEU . 99.7 t -47.48 -55.56 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 40' ' ' LEU . 2.9 mm? -65.41 -27.59 68.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.357 -0.839 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -62.4 -29.06 70.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.0 -35.25 29.1 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 43' ' ' LEU . 1.2 tm? -48.57 -25.76 1.88 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -35.52 -49.01 0.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.596 0.712 . . . . 0.0 109.156 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -78.41 -51.86 9.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 160.91 135.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.639 HG21 HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.93 -155.92 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.723 ' HB2' ' HB ' ' A' ' 5' ' ' ILE . 38.2 Cg_endo -129.64 -86.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 117.205 -1.397 . . . . 0.0 111.474 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 66.7 m-20 -115.52 -73.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.453 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.881 HG22 ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -119.29 124.02 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.08 . . . . 0.0 111.41 -177.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.796 HD11 ' CG1' ' A' ' 39' ' ' VAL . 7.7 tp -99.16 109.91 22.54 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.997 ' HB2' HG22 ' A' ' 8' ' ' VAL . 4.0 mp -103.33 160.85 14.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.6 ' OG ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.07 112.81 10.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.47 -0.769 . . . . 0.0 109.324 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 11' ' ' ASP . 5.8 t0 -61.09 -143.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.279 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.805 ' O ' HG23 ' A' ' 55' ' ' ILE . 1.1 tp -172.34 84.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.944 -1.098 . . . . 0.0 110.185 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.781 ' H ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER 163.72 129.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 179.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.566 ' CB ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 166.95 -61.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.442 -0.786 . . . . 0.0 109.443 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.598 ' HD3' HD22 ' A' ' 63' ' ' LEU . 36.7 Cg_endo -70.09 142.5 46.64 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 124.305 1.687 . . . . 0.0 110.233 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.39 -21.52 66.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 25.3 ttp -94.0 114.79 27.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 0.7 OUTLIER 44.32 -159.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.549 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.908 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -101.42 -109.73 3.26 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.908 HD23 ' C ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -175.7 105.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -1.187 . . . . 0.0 109.658 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 65' ' ' LEU . . . -57.48 -79.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.27 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.785 HD11 HD12 ' A' ' 63' ' ' LEU . 23.4 mt 81.49 -22.57 0.26 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.671 -0.643 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -60.17 -42.9 95.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.669 -1.27 . . . . 0.0 108.68 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -31.57 72.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 27.1 tp60 -60.36 -62.4 1.89 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.788 HG23 ' CG ' ' A' ' 73' ' ' HIS . 1.8 mp -35.92 -77.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.755 -0.591 . . . . 0.0 109.933 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -34.07 -64.8 0.22 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.949 -0.47 . . . . 0.0 109.902 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 70' ' ' LYS . 2.1 mm-40 -35.05 -51.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.738 -0.601 . . . . 0.0 110.21 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.39 53.92 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 110.911 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.788 ' CG ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -130.55 163.79 45.92 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.948 -1.095 . . . . 0.0 109.406 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 36.7 Cg_endo -84.05 -69.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.041 1.548 . . . . 0.0 110.161 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.07 45.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 77' ' ' PRO . 3.1 pp -109.28 161.55 23.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.086 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.878 ' O ' HD12 ' A' ' 76' ' ' LEU . 31.9 Cg_endo -68.63 155.06 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.88 1.463 . . . . 0.0 112.001 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -136.93 165.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.785 ' CD1' HD22 ' A' ' 102' ' ' LEU . 4.4 tt -132.59 145.5 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.753 -1.217 . . . . 0.0 110.796 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 100' ' ' ASP . 8.8 mt -108.46 93.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.653 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER -65.2 96.88 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.97 . . . . 0.0 109.537 -179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 81' ' ' MET . 14.9 t 123.72 177.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.67 19.81 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 109.154 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -91.49 -95.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.63 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m -71.73 86.51 0.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.059 -1.026 . . . . 0.0 109.405 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.897 ' OD2' HD13 ' A' ' 80' ' ' ILE . 9.8 t70 -179.3 -36.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.016 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.598 HD13 ' OH ' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -35.35 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.292 0.568 . . . . 0.0 110.536 -179.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -91.77 -53.51 4.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.348 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -17.55 1.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 110.361 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -96.57 -74.51 0.56 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.947 -1.096 . . . . 0.0 109.968 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 90' ' ' ALA . 45.8 t -33.71 -33.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.762 -0.586 . . . . 0.0 110.872 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -97.58 -160.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.814 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 95' ' ' GLN . . . 45.48 -168.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -58.2 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.126 -0.983 . . . . 0.0 109.096 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp0? -94.47 15.2 18.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.762 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -38.74 24.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . 167.02 -94.38 0.11 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . 69.64 7.25 6.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -1.091 . . . . 0.0 110.047 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER 49.14 112.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.636 0.732 . . . . 0.0 110.401 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.026 ' HB2' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -147.09 -169.2 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.662 -1.274 . . . . 0.0 109.843 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.598 ' OH ' HD13 ' A' ' 87' ' ' LEU . 4.8 m-85 65.32 96.1 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.433 0.635 . . . . 0.0 110.672 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.785 HD22 ' CD1' ' A' ' 79' ' ' ILE . 12.8 tp -139.36 95.59 9.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.01 -172.44 0.71 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.084 1.571 . . . . 0.0 111.525 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -141.38 166.21 23.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.592 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.5 Cg_endo -75.63 119.8 6.35 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.249 -2.396 . . . . 0.0 110.767 0.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.994 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 58.5 t80 -93.18 167.17 11.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.202 -0.936 . . . . 0.0 109.398 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.618 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 16.6 t0 -74.5 -145.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.475 -0.765 . . . . 0.0 109.48 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.614 HG23 ' CD2' ' A' ' 23' ' ' LEU . 6.7 mm -139.93 -73.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.101 -0.999 . . . . 0.0 109.119 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.497 ' N ' HG22 ' A' ' 108' ' ' ILE . 42.0 t0 -60.76 -31.82 71.15 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 69.0 tt0 -55.83 -38.21 69.72 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.994 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . . . -75.47 -70.84 0.4 Allowed 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.352 -0.842 . . . . 0.0 109.504 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.09 ' CG1' HD22 ' A' ' 28' ' ' LEU . 47.6 t -36.99 -45.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.66 0.743 . . . . 0.0 110.962 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.512 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -76.81 -72.0 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.802 . . . . 0.0 110.944 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.512 ' C ' ' O ' ' A' ' 113' ' ' ALA . 54.5 tp -33.07 -56.34 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.365 0.602 . . . . 0.0 109.946 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.799 HG11 HG11 ' A' ' 50' ' ' VAL . 93.5 t -61.86 -55.44 24.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.687 ' HA ' HD12 ' A' ' 119' ' ' ILE . 17.3 tt0 -33.09 -34.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.406 0.622 . . . . 0.0 109.962 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 115' ' ' VAL . 35.5 mtm180 -60.17 -60.71 3.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -55.13 -52.89 61.83 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.881 ' CD1' HG22 ' A' ' 50' ' ' VAL . 4.5 mt -35.63 -35.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.245 0.545 . . . . 0.0 110.365 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -77.35 31.48 0.15 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.267 -0.896 . . . . 0.0 110.791 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -64.86 -18.04 64.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.68 -1.263 . . . . 0.0 109.228 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -86.78 40.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 109.621 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.34 50.88 2.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.398 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.1 mtm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -64.97 135.67 55.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.324 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 59.8 ttm-85 -179.66 68.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.32 -0.862 . . . . 0.0 109.321 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.709 ' CA ' HD22 ' A' ' 28' ' ' LEU . . . -151.46 92.39 0.14 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.102 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.806 HG22 ' HE1' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -92.93 88.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 108.581 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 6' ' ' VAL . 5.4 p -98.46 118.2 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.445 0.641 . . . . 0.0 110.566 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 1.054 ' CE3' HG21 ' A' ' 31' ' ' THR . 11.4 m0 -101.77 87.74 3.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.006 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 19' ' ' LEU . 24.1 t -76.02 156.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.821 0.82 . . . . 0.0 111.079 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.992 ' CG2' HG21 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -118.61 114.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.589 ' HB3' HG21 ' A' ' 15' ' ' ILE . 3.6 t0 -175.83 172.93 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.586 -0.696 . . . . 0.0 109.418 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' N ' HG13 ' A' ' 15' ' ' ILE . 64.0 t0 -144.72 -76.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.15 -0.968 . . . . 0.0 109.151 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 13' ' ' SER . 5.1 t70 35.91 53.09 0.87 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.672 -0.642 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 14' ' ' SER . 10.0 p 36.97 100.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.129 0.49 . . . . 0.0 111.106 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 83.39 45.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.463 -0.773 . . . . 0.0 110.712 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -81.5 -38.15 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.66 -1.275 . . . . 0.0 107.86 178.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.53 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 1.6 mtm-85 -66.81 -31.89 72.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CE3' ' HG3' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -61.54 -69.35 0.25 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.214 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.582 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 41.1 t -40.43 -64.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.708 0.765 . . . . 0.0 110.75 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 21' ' ' ARG . 51.4 mt -62.02 -72.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.499 -0.751 . . . . 0.0 111.349 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 1.6 tt0 -33.81 -34.64 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.683 -0.636 . . . . 0.0 110.832 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.62 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 63.9 mmt-85 -67.22 -55.38 14.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.093 -1.004 . . . . 0.0 108.529 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.666 ' CB ' HD13 ' A' ' 108' ' ' ILE . . . -71.3 -3.21 19.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.203 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.042 HD11 HG21 ' A' ' 112' ' ' VAL . 1.7 mm? -102.7 -17.15 15.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 109.393 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.0 11.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.7 -21.05 49.62 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.24 -31.16 19.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.405 -1.056 . . . . 0.0 108.941 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.63 63.72 1.4 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.814 HD12 HG11 ' A' ' 112' ' ' VAL . 17.7 mt -144.73 177.53 8.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 11.5 m -98.93 93.27 5.93 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 22.4 t -89.36 78.97 7.1 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.283 -0.885 . . . . 0.0 110.07 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.054 HG21 ' CE3' ' A' ' 7' ' ' TRP . 11.5 m -76.03 126.33 30.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 108.619 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.53 ' OG1' ' CB ' ' A' ' 16' ' ' ARG . 65.3 p -132.01 138.45 48.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.953 -1.092 . . . . 0.0 109.698 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.021 ' HB2' HG22 ' A' ' 39' ' ' VAL . 11.8 m-85 -127.61 137.51 52.58 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.331 -0.856 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 1.4 mt-10 -72.11 -27.55 62.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.46 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.978 ' O ' HG23 ' A' ' 39' ' ' VAL . 5.7 m-80 -111.01 133.71 53.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 110.137 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.862 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -56.37 -64.74 4.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -39.15 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.611 -0.935 . . . . 0.0 109.627 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 37' ' ' ASN . 7.0 mm-40 -31.21 -43.82 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.43 0.634 . . . . 0.0 110.103 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.021 HG22 ' HB2' ' A' ' 33' ' ' PHE . 21.5 t -54.55 -61.83 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.429 -0.794 . . . . 0.0 109.2 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.037 HD12 HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -63.07 -12.53 27.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -77.2 -35.03 56.06 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.17 62.64 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.094 HD12 HD11 ' A' ' 69' ' ' ILE . 27.8 mt -68.97 -8.61 46.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.533 -0.729 . . . . 0.0 109.078 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 43' ' ' LEU . . . -3.84 -64.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.337 0.589 . . . . 0.0 112.054 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.573 ' C ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -70.68 -61.01 1.93 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.84 -173.77 3.1 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.553 0.692 . . . . 0.0 109.407 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.024 ' HA ' HD22 ' A' ' 43' ' ' LEU . 31.5 m -99.98 150.42 36.85 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HD2' ' CG2' ' A' ' 47' ' ' THR . 32.8 Cg_endo -75.39 -81.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 117.485 -1.21 . . . . 0.0 112.448 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.85 -76.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.356 -1.465 . . . . 0.0 110.462 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.999 HG23 ' CD1' ' A' ' 119' ' ' ILE . 9.8 t -132.92 143.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.83 . . . . 0.0 109.062 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.899 ' HB3' HG12 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -100.08 133.0 45.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.591 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -118.85 137.86 53.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -139.22 118.98 13.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.048 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 10' ' ' ASP . 1.5 p30 -104.67 160.25 15.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.087 -1.008 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.579 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -87.67 135.42 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.499 -0.751 . . . . 0.0 109.189 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.752 ' HG3' ' HE2' ' A' ' 57' ' ' MET . 7.1 ptt85 -151.15 34.36 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.297 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.752 ' HE2' ' HG3' ' A' ' 56' ' ' ARG . 11.6 mtm -148.41 112.2 3.74 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.564 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -107.94 136.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.11 1.584 . . . . 0.0 110.149 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.23 -84.42 0.23 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.09 -32.67 4.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.172 . . . . 0.0 109.951 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 57' ' ' MET . 0.8 OUTLIER -122.02 150.76 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.856 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 -67.89 0.11 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -133.48 94.09 3.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -1.177 . . . . 0.0 109.729 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 44.04 2.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.208 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' HA3' ' A' ' 36' ' ' GLY . 11.4 mt -118.37 -28.86 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -69.85 -50.92 37.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.1 . . . . 0.0 108.108 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 66' ' ' LEU . 15.6 tttm -44.54 -35.26 2.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.886 ' HG2' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -60.26 -56.67 18.74 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.094 HD11 HD12 ' A' ' 43' ' ' LEU . 2.2 tp -36.39 -54.13 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.656 -0.653 . . . . 0.0 110.561 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 13.1 mmtp -53.25 -66.18 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.2 tt0 -36.74 -29.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.868 -0.52 . . . . 0.0 110.321 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -105.23 -81.22 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.154 -0.966 . . . . 0.0 111.567 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.543 ' CD2' ' HB3' ' A' ' 43' ' ' LEU . 2.4 p-80 -153.44 133.76 7.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.627 -1.295 . . . . 0.0 112.048 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.558 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 37.7 Cg_endo -134.46 -93.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.988 1.52 . . . . 0.0 109.224 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.555 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 19.0 mtt 69.19 4.6 4.66 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.403 -0.81 . . . . 0.0 110.676 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.768 HD21 ' HB ' ' A' ' 47' ' ' THR . 0.3 OUTLIER -142.37 167.12 17.37 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.984 -1.073 . . . . 0.0 109.548 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.867 ' HG2' HG22 ' A' ' 50' ' ' VAL . 32.1 Cg_endo -62.96 155.03 63.0 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.556 1.293 . . . . 0.0 111.255 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -142.86 101.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.824 . . . . 0.0 110.083 -178.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 50' ' ' VAL . 1.7 mp -76.44 138.83 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.128 -0.982 . . . . 0.0 109.645 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 80' ' ' ILE . 3.0 tt -126.55 113.8 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.484 ' O ' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER -62.5 148.53 45.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 109.529 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER 60.84 175.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.423 -0.798 . . . . 0.0 109.487 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' N ' HG23 ' A' ' 82' ' ' THR . . . -145.96 76.21 1.45 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' C ' ' N ' ' A' ' 86' ' ' ASP . 7.1 m-70 -138.9 -101.19 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.958 . . . . 0.0 110.524 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.54 ' OG ' ' HB3' ' A' ' 89' ' ' ALA . 21.7 p 46.87 30.09 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -177.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 88' ' ' ASP . 73.2 m-20 63.57 125.38 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.024 HD12 HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -36.15 -32.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -37.45 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.343 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -44.17 -35.99 2.46 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.974 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -62.3 -90.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.337 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.024 HG23 HD12 ' A' ' 87' ' ' LEU . 35.6 t -35.61 -63.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.602 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 14.5 m -79.94 -149.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.833 . . . . 0.0 110.351 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' ALA . . . 68.19 -87.12 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 109.901 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.504 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 2.0 p90 -106.66 -16.36 14.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.081 -1.012 . . . . 0.0 109.514 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' VAL . 14.5 mt-30 44.45 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.777 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -83.72 136.33 34.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.848 -1.158 . . . . 0.0 109.358 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.03 -174.79 30.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -121.86 95.21 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.356 -1.085 . . . . 0.0 109.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 78' ' ' VAL . 50.7 p90 163.54 -174.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -144.28 134.0 23.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.554 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.476 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 88.3 m-85 -43.77 122.24 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -100.38 112.12 63.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.151 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 101' ' ' TYR . 36.8 Cg_endo -91.8 168.27 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.907 1.477 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -95.03 158.6 34.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 36.7 Cg_endo -101.44 166.52 7.53 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.043 -2.482 . . . . 0.0 110.16 0.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 107' ' ' ASP . 25.3 p90 -147.7 174.17 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 10.6 t0 -87.23 -154.91 0.26 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.302 -0.874 . . . . 0.0 108.907 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.666 HD13 ' CB ' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -121.69 -42.92 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 108.677 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -82.34 -35.07 28.23 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.49 -38.09 76.91 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -79.95 -72.14 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.639 -0.663 . . . . 0.0 109.343 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.042 HG21 HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -37.4 -53.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.661 -0.649 . . . . 0.0 110.066 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.57 ' N ' HG12 ' A' ' 112' ' ' VAL . . . -60.58 -60.86 3.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.602 -0.686 . . . . 0.0 109.988 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.5 tm? -34.45 -46.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.749 0.785 . . . . 0.0 109.66 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 116' ' ' GLU . 0.8 OUTLIER -66.49 -54.67 23.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.604 ' N ' HG12 ' A' ' 115' ' ' VAL . 6.1 tt0 -34.08 -39.46 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.433 0.635 . . . . 0.0 109.847 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' VAL . 11.4 mtp180 -77.43 -47.71 19.06 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.242 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' VAL . . . -52.22 -64.53 0.79 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 0.0 108.835 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.999 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.3 mt -35.45 -41.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.744 -0.597 . . . . 0.0 110.22 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.46 58.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -117.73 -19.89 9.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -78.06 -7.85 57.46 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.32 -0.863 . . . . 0.0 109.396 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.27 -34.92 24.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.442 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -154.77 74.92 0.95 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.8 162.62 38.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -153.43 146.41 14.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.625 HG23 ' CG2' ' A' ' 29' ' ' THR . 2.7 mp -105.59 112.74 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -1.159 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 52' ' ' LEU . 2.3 p -105.59 120.52 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.578 -0.701 . . . . 0.0 110.016 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.742 ' CZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -101.19 105.81 16.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.136 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' A' ' 52' ' ' LEU . 42.6 t -87.99 146.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.141 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 53' ' ' SER . 22.6 t -99.24 95.73 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 110.084 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 31.52 -160.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.78 0.8 . . . . 0.0 112.696 178.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.698 ' HB3' HD11 ' A' ' 15' ' ' ILE . 6.8 t0 152.48 -25.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.62 146.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 14' ' ' SER . 11.3 t -45.4 135.8 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.717 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.2 OUTLIER 77.45 34.7 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -72.73 -47.55 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 108.975 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -53.0 -47.74 68.05 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.492 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 83.9 t90 -56.56 -63.77 1.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 109.667 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 17' ' ' TRP . 42.1 t -38.88 -74.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.07 0.938 . . . . 0.0 110.648 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -60.53 -68.18 0.32 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.531 -0.731 . . . . 0.0 110.858 -178.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -35.52 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.547 -0.721 . . . . 0.0 110.88 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -71.82 -53.63 12.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.991 -1.068 . . . . 0.0 108.252 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HB3' HG21 ' A' ' 108' ' ' ILE . . . -71.87 -2.98 19.8 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.984 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.956 HD11 HG21 ' A' ' 112' ' ' VAL . 2.5 mm? -103.88 -14.9 15.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.353 -0.842 . . . . 0.0 109.411 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.58 -30.65 32.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 -38.96 58.22 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.52 72.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -1.113 . . . . 0.0 108.913 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.26 66.01 0.91 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.027 HD13 HG11 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -141.52 176.9 8.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.091 -1.241 . . . . 0.0 110.019 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 29' ' ' THR . 6.8 m -100.13 77.09 1.96 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB2' ' CB ' ' A' ' 23' ' ' LEU . 36.1 t -83.08 90.37 7.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.313 -0.867 . . . . 0.0 110.427 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 3.3 m -100.7 140.67 34.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.499 ' OG1' HG22 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -142.31 138.47 31.33 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.571 -1.331 . . . . 0.0 110.164 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.888 ' HB2' HG23 ' A' ' 39' ' ' VAL . 18.3 m-85 -107.46 159.82 16.12 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -92.02 11.5 25.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.898 -1.126 . . . . 0.0 109.711 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -149.94 128.56 12.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.813 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -56.24 -62.45 6.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.473 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -41.47 -65.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.354 -1.086 . . . . 0.0 109.383 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 37' ' ' ASN . 1.5 tp10 -35.05 -47.01 0.35 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.611 -0.68 . . . . 0.0 110.276 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.895 HG12 HD13 ' A' ' 40' ' ' LEU . 1.4 t -60.83 -50.7 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 108.636 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.895 HD13 HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -69.81 -5.85 28.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.863 . . . . 0.0 109.572 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.36 -22.07 18.57 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.3 -0.875 . . . . 0.0 108.802 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.77 -33.5 18.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.4 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 47' ' ' THR . 4.1 mt -98.59 -114.35 0.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.214 -0.929 . . . . 0.0 108.742 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 43' ' ' LEU . . . 82.4 -51.28 0.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 58.7 m -75.23 -34.65 61.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.326 -0.859 . . . . 0.0 108.924 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HE2' ' HG3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 176.77 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.01 HG23 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -71.27 -152.85 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.884 ' CD ' HG22 ' A' ' 47' ' ' THR . 37.0 Cg_endo -125.32 -75.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 117.093 -1.471 . . . . 0.0 111.2 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -112.85 -73.92 0.65 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.733 -1.229 . . . . 0.0 111.14 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.907 HG23 ' CD1' ' A' ' 119' ' ' ILE . 2.6 t -140.27 137.0 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.013 -1.054 . . . . 0.0 110.672 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.653 HD23 ' CG1' ' A' ' 69' ' ' ILE . 12.5 tp -100.42 159.89 14.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.583 ' CD1' HG22 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -138.93 141.7 38.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 -179.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.541 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 6.3 t -119.27 111.21 17.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 10' ' ' ASP . 34.0 p-10 -59.77 175.13 0.39 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.909 -1.119 . . . . 0.0 109.097 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.606 HG21 ' O ' ' A' ' 81' ' ' MET . 1.2 tt -161.72 38.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -80.22 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.46 ' CE ' ' CA ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -48.59 139.0 11.53 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.653 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -113.61 165.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.818 1.43 . . . . 0.0 110.167 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 61' ' ' ASP . . . 124.03 89.31 0.85 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.1 mmt 49.05 -95.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -1.109 . . . . 0.0 109.738 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 59' ' ' GLY . 2.0 m-20 -50.89 164.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.09 -1.006 . . . . 0.0 109.353 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.646 ' C ' HD22 ' A' ' 63' ' ' LEU . . . 108.73 -62.38 0.29 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 86' ' ' ASP . 2.4 mm? -116.92 1.76 12.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -1.167 . . . . 0.0 109.715 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.69 67.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.176 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.713 HD22 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -167.77 -31.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.661 ' O ' HG22 ' A' ' 69' ' ' ILE . 2.9 tp -40.18 -30.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.109 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 65' ' ' LEU . 10.8 tptt -57.66 -54.73 43.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.609 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 65' ' ' LEU . 9.4 pm0 -58.09 -39.23 78.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.204 . . . . 0.0 108.241 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 66' ' ' LEU . 1.4 tt -38.21 -36.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.577 -0.702 . . . . 0.0 110.064 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' ARG . 5.0 tptm -109.05 -69.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 110.334 -178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 70' ' ' LYS . 1.3 tt0 -36.12 -30.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.402 -0.811 . . . . 0.0 110.834 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -96.89 -34.93 11.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.277 -0.889 . . . . 0.0 110.06 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.759 ' CE1' HD12 ' A' ' 40' ' ' LEU . 4.7 m80 -96.83 137.14 21.37 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.547 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 36.6 Cg_endo -39.23 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.999 1.526 . . . . 0.0 110.999 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.85 95.72 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.726 HD12 ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -133.23 171.71 8.66 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.769 ' HG2' HG22 ' A' ' 50' ' ' VAL . 34.2 Cg_endo -59.28 107.87 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.441 1.232 . . . . 0.0 110.982 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.517 ' CG1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -102.12 82.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.54 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mp -62.73 155.56 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.988 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 79' ' ' ILE . 1.3 pp -160.39 150.88 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.606 ' O ' HG21 ' A' ' 55' ' ' ILE . 40.3 mtt -90.85 126.99 36.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 109.511 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 77.8 p -74.27 153.53 39.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 0.0 109.708 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . 163.65 39.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.349 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER 69.06 157.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' ASP . 51.0 m 63.04 152.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.329 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.838 ' HB2' HD12 ' A' ' 63' ' ' LEU . 32.1 t0 84.2 -49.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.726 -0.609 . . . . 0.0 109.868 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -33.75 -51.02 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.0 110.528 -179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.23 -55.48 10.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.649 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.5 -40.1 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 109.679 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -73.19 -81.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 90' ' ' ALA . 42.8 t -33.38 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.776 -0.578 . . . . 0.0 110.613 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -99.79 -155.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.919 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 56.63 75.68 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.442 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' GLN . 0.7 OUTLIER 59.95 -89.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.378 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 71.42 138.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -146.01 -63.18 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.303 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.37 52.72 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.82 38.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -1.151 . . . . 0.0 109.398 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 100' ' ' ASP . 8.2 m-85 -120.42 105.52 10.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.794 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.584 ' O ' ' CD1' ' A' ' 101' ' ' TYR . 14.1 t0 -61.96 -139.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.886 . . . . 0.0 109.181 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER 169.78 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 108.959 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.74 132.17 62.0 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 109.777 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 104' ' ' LYS . 36.8 Cg_endo -105.87 -92.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.89 1.469 . . . . 0.0 110.135 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER 161.28 147.77 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.253 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.436 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -82.26 170.9 56.84 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 120.721 -2.616 . . . . 0.0 110.392 -0.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -149.7 138.96 21.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 25.3 t0 -76.77 170.67 16.03 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.036 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 22' ' ' ALA . 19.1 mm -84.23 -58.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.049 -1.032 . . . . 0.0 109.896 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 110' ' ' GLU . 34.2 t70 -63.33 -46.16 87.93 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 108.533 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 20.7 tp10 -47.22 -37.9 11.22 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' VAL . . . -75.04 -73.76 0.23 Allowed 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.349 -0.844 . . . . 0.0 109.796 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 28' ' ' LEU . 41.4 t -39.02 -56.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 114' ' ' LEU . . . -59.97 -70.15 0.18 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.729 . . . . 0.0 110.987 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.769 HD13 ' C ' ' A' ' 114' ' ' LEU . 2.0 tm? -34.37 -57.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.435 0.636 . . . . 0.0 110.016 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.69 ' N ' HD13 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -53.92 -52.66 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.555 ' N ' HG12 ' A' ' 115' ' ' VAL . 4.0 tt0 -34.56 -49.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.274 0.559 . . . . 0.0 110.324 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -56.02 -54.95 38.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' ILE . . . -50.61 -60.56 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.09 -1.007 . . . . 0.0 108.366 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.907 ' CD1' HG23 ' A' ' 50' ' ' VAL . 5.7 mt -37.0 -35.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.739 -0.601 . . . . 0.0 110.865 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.593 ' O ' ' CB ' ' A' ' 121' ' ' HIS . 7.6 t -33.87 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.936 -0.478 . . . . 0.0 111.52 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.593 ' CB ' ' O ' ' A' ' 120' ' ' SER . 2.2 t-160 86.52 39.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.452 ' C ' ' O ' ' A' ' 121' ' ' HIS . 1.1 m-85 37.36 77.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.583 0.706 . . . . 0.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.07 39.28 1.04 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.74 . . . . 0.0 109.595 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.602 -179.872 . . . . . . . . 1 1 . 1 stop_ save_